PL00 Drugs, medicaments or biological substances associated with injury or harm in therapeutic use International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 exclusions coding note Code first the injury or harm associated with the substance. Code also the mode or mechanism that explains the main way the cause leads to injury or harm.
postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Medication - multiple selections are allowed [select] XM1LT9 Acetoxolone XM7DT2 Carbon dioxide producing drugs XM9SW3 Zolimidine XM4U05 Lubiprostone XM1Y11 Troxipide XM3086 Linaclotide XM84X1 Bismuthyl subnitrate XM2396 Prucalopride XM1364 Fixed Combinations for Helicobacter pylori eradication XM2SC1 Tegaserod XM78V7 Plecanatide XM4S40 Serotonin receptor antagonists XM6DL1 Oil – XM7423 Ondansetron – XM8123 Granisetron XM3XX3 Metoclopramide – XM3X37 Cilansetron XM3346 Cisapride XM2493 Diisopromine XM3GF5 Domperidone XM30Q8 Chlorbenzoxamine XM2Q19 Bromopride XM2GC8 Pinaverium XM6AH6 Alizapride XM3CZ9 Fenoverine XM4GL7 Clebopride XM5RS2 Alverine XM2KJ6 Itopride XM27M9 Isometheptene XM1W04 Cinitapride XM6UH6 Migalstat XM6ZM7 Mosapride XM49K4 Fenpiprane XM7F16 Idanpramine XM8136 Eluxadoline XM8N97 Proxazole XM2SK3 Trepibutone XM3R36 Caroverine XM66E5 Phloroglucinol XM7ZC5 Trimethyldiphenylpropylamine XM9K48 Valethamate bromide XM6Q06 Aluminium, aluminium tannate XM62S7 Amylopectin XM8A95 Antidiarrhoeal drug absorbent XM6V74 Attapulgite XM4SG9 Bacillus subtilis XM98L3 Bismuth salts subcarbonate XM5U61 Bismuth salts XM3962 Carbo medicinalis XM0S42 Charcoal XM46T5 Charcoal activated XM2269 Charcoal medicinal (activated) XM8D61 Charcoal medicinal antidiarrhoeal XM8ET0 Difenoxin XM15K3 Fetoxilate XM3ZU0 Intestinal motility control drug XM7CN8 Kaolin XM2GB1 Kaolin light XM1N12 Lactobacillus acidophilus compound XM0EB5 Lactobacillus acidophilus XM0QG1 Lactobacillus bifidus, lyophilized XM1TF2 Lactobacillus bulgaricus XM4KH7 Lactobacillus sporogenes XM48X2 Lignin hemicellulose XM8683 Lomotil XM2UP7 Miyari bacteria XM2HR7 Pectin XM4X08 Saccharomyces boulardii XM2663 Anise oil XM8A26 Antiflatulent XM0090 Betaine XM0TD5 Bile salts XM5TC9 Carminative XM5QD3 Cholagogues XM6RN6 Choleretic XM5CH0 Cytochrome C XM00U8 Dehydrocholic acid XM0365 Dill XM4RK4 Elastase XM5H83 Enzyme intestinal XM2Q01 Florantyrone XM5BH7 Gastric enzymes XM63F8 Gentian XM1TN8 Ginger XM0994 Glutamic acid XM15D5 Hydrochloric acid medicinal (digestant) XM2702 Ox bile extract XM6HM1 Pancreatin XM9Z07 Pancrelipase XM6DW4 Papain XM72V4 Papain digestant XM1XP0 Peppermint (oil) XM17U7 Pepsin digestant XM7L34 Phenylpropanol XM4U70 Tilactase XM4H25 Cerium oxalate XM3ME7 Copper emetic XM9FG8 Copper sulfate medicinal emetic XM2WE8 Mustard black XM5SW7 Chlorobutanol XM8SN3 Trimethobenzamide XM46N1 Metopimazine XM1DC1 Aprepitant XM2633 Casopitant XM41Y6 Rolapitant XM2170 Pipamazine XM9FU8 Pyrathiazine XM3KJ5 Ammonium sulfonate resin XM4KK2 Bacillus lactobacillus XM4663 Carrageenan XM8NM7 Charcoal medicinal poison control XM4GA5 Charcoal medicinal specified use other than for diarrhoea XM7ER1 Dimethyl polysiloxane XM30A7 Gastrointestinal drug biological XM0KJ8 Gastrointestinal drug specified XM7L13 Glucurolactone XM9Q94 Hepatic secretion stimulant XM7EV4 Intestinal motility control drug biological XM9S11 Ion exchange resin anion XM1AX0 Ion exchange resin intestinal XM0UP4 Liquorice extract XM8UW6 Mesalazine XM0TN5 Olsalazine XM73P5 Pancreatic digestive secretion stimulant XM0EK0 Polysilane XM2K96 Sodium alginate XM7M46 Sodium amylosulfate XM7AL9 Sulfated amylopectin XM6347 Alexitol sodium XM8YP0 Aluminium, aluminium carbonate (gel, basic) XM3Q55 Aluminium, aluminium chlorhydroxide-complex XM9DS4 Aluminium, aluminium hydroxide-magnesium carb. gel XM8FL6 Aluminium, aluminium silicate XM0BM4 Aluminium, aluminium sodium silicate XM37S3 Antacid XM5XT4 Anti-gastric-secretion drug XM9KD3 Benexate XM1F19 Bismuth salts aluminate XM5R07 Burimamide XM7Y04 Cetraxate XM1WQ5 Chalk, precipitated XM1622 Dihydroxyaluminum aminoacetate XM9BS9 Dimethicone XM6YR9 Magnesia magma XM7V20 Magnesium carbonate XM8L43 Magnesium trisilicate XM1EN3 Methylpolysiloxane XM9414 Metiamide XM7SH2 Milk of magnesia XM01K0 Ornoprostil XM7K87 Pepstatin XM7W08 Potassium glucaldrate XM7Z18 Rolaids XM87Z0 Rosaprostol XM64X9 Simaldrate XM38C5 Simethicone XM0QL9 Soda bicarb XM43U8 Sodium glucaldrate XM7M59 Sodium polyhydroxyaluminium monocarbonate XM38H3 Triple carbonate XM5QM5 Vitamin ulceroprotectant XM8K92 Agar XM5FL6 Arachis oil cathartic XM5993 Atonia drug, intestinal XM9281 Bran (wheat) XM21B3 Bulk filler cathartic XM0ML8 Calcium dioctyl sulfosuccinate XM0HS3 Carboxymethyl-cellulose XM3EV1 Carmellose XM99E9 Cathartic bulk XM4DA2 Cathartic emollient XM2Y48 Cathartic mucilage XM3000 Cellulose cathartic XM22V5 Cellulose hydroxyethyl XM6ZN5 Dioctyl sulfosuccinate (calcium) (sodium) XM2UB3 Ethylhydroxycellulose XM6CL0 Fecal softener XM1RJ7 Fiber, dietary XM4A22 Ispagula husk XM1J98 Karaya (gum) XM5CR2 Konsyl XM2J55 Metamucil XM0X73 Methylcellulose laxative XM5VW0 Mucilage, plant XM1VV2 Olive oil (medicinal) XM3CM0 Peach kernel oil (emulsion) XM85Z3 Peanut oil (emulsion) XM4PD5 Phosphate laxative XM95P7 Poloxamer XM9PF1 Polycarbophil XM4YU2 Psyllium hydrophilic mucilloid XM0ZU4 Soap enema XM6J59 Sodium dioctyl sulfosuccinate XM3DH4 Tartrate, laxative XM69K0 Cathartic saline XM40M7 Epsom salt XM4WX6 Laxative osmotic XM5NK8 Laxative saline XM06D3 Potassium bisulfate – XM9P20 Aloes – XM6UQ2 Aloin – XM9N98 Bryonia – XM9YN3 Carter's Little Pills – XM2632 Cathartic anthacene derivative – XM3W96 Cathartic contact XM1349 Antacids – XM53Q7 Cathartic irritant XM7GM7 Magnesium compounds – XM6LH5 Cathartic vegetable – XM39M3 Magnesium hydroxide – XM0JN3 Colocynth – XM35X7 Aluminium, aluminium magnesium silicate – XM4217 Croton (oil) XM3JP8 Aluminium compounds – XM4C29 Dianthone – XM9N47 Algeldrate – XM8PF5 Dihydroxyanthraquinone – XM2VU8 Aluminium, aluminium phosphate – XM77A6 Dulcolax – XM4NY5 Aloglutamol – XM9KZ8 Elaterium – XM7DC3 Aluminium, aluminium glycinate – XM6CR4 Ex-Lax (phenolphthalein) – XM9PG0 Dihydroxyaluminum sodium carbonate – XM7XD6 Frangula – XM38T8 Aluminum hydroxide (gel) – XM6L10 Frangula extract XM0SA0 Calcium compounds – XM1L58 Gamboge – XM9003 Calcium carbonate – XM1RP5 Hinkle's pills – XM8EF6 Calcium silicate – XM6XG3 Jalap XM0D52 Combinations and complexes of aluminium, calcium and magnesium compounds – XM9DZ3 Mineral oil emulsion – XM5R16 Magaldrate – XM4CS7 Phenisatin – XM8J56 Almagate – XM5042 Potassium sulfate – XM3EB6 Hydrotalcite – XM14Q1 Rhubarb dry extract – XM9Y49 Almasilate – XM40D1 Rhubarb tincture, compound – XM38T6 Scammony – XM91P4 Sennoside A+B – XM9YL4 Cimetidine – XM9ML9 Sodium phosphate dibasic – XM6441 Famotidine – XM38A9 Sodium phosphate monobasic – XM9ZP3 Nizatidine – XM7XV5 Squirting cucumber (cathartic) – XM6WY8 Ranitidine – XM8WQ0 Sulisatin – XM0SH0 Roxatidine – XM69R3 Yellow phenolphthalein – XM08A8 Niperotidine – XM1NY1 Softeners or emollients – XM1ZT1 Ranitidine bismuth citrate –– XM8UE2 Liquid paraffin – XM0Q37 Lafutidine –– XM59Z2 Docusate sodium XM2WX5 Proton pump inhibitors – XM5CM0 Contact laxatives – XM8X45 Omeprazole –– XM5E72 Oxyphenisatine – XM86M3 Pantoprazole –– XM14G1 Bisacodyl – XM39X4 Lansoprazole –– XM86Q2 Dantron – XM3M01 Rabeprazole –– XM30Q0 Phenolphthalein – XM8YE1 Esomeprazole –– XM7G77 Castor oil – XM5RA0 Dexlansoprazole –– XM9LC4 Senna glycosides – XM1J18 Dexrabeprazole –– XM8YN7 Sodium picosulfate – XM3MK2 Tegoprazan –– XM00W5 Bisoxatin XM4ML1 Prostaglandins –– XM8N88 Cascara – XM28N9 Misoprostol – XM42M0 Bulk-forming laxatives – XM4GD1 Enprostil –– XM9JR8 Sterculia – XM1CF2 Alprostadil –– XM3VP9 Linseed – XM3Q43 Dinoprost –– XM5DN2 Methylcellulose – XM5VF9 Dinoprostone –– XM3JB5 Ispaghula – XM2L11 Gemeprost –– XM0LV6 Ethulose – XM8XM0 Carboprost –– XM4SJ2 Triticum (wheat fibre) – XM9BJ7 Sulprostone –– XM5BR4 Polycarbophil calcium – XM2806 Osmotically acting laxatives XM2H82 Carbenoxolone –– XM7G33 Magnesium oxide XM0044 Sucralfate –– XM6EC7 Magnesium sulfate XM6690 Pirenzepine –– XM3CD3 Magnesium peroxide XM6WX3 Proglumide –– XM7W31 Lactulose XM0HB8 Gefarnate –– XM6AX9 Sodium sulfate XM2689 Sulglicotide –– XM6FQ8 Macrogol XM4H50 Alginic acid –– XM9YJ1 Sorbitol – XM2891 Rebamipide –– XM4RE1 Lactitol XM1F15 Methiosulfonium chloride –– XM7RN6 Pentaerithrityl XM1BG6 Bismuth subcitrate XM5348 Glycerol – XM2CG3 Razoxane – XM79U8 Phenindione XM2P48 Pancreatic dornase – XM9TR7 Rufocromomycin – XM86W0 Warfarin XM9J86 Penicillinase – XM4ZA6 Sarcolysin – XM4E47 Phenprocoumon XM52N4 Pronase – XM1TG4 Sarkomycin – XM6QR1 Acenocoumarol XM94J1 Serrapeptase – XM5FB8 Tauromustine – XM5XY7 Ethyl biscoumacetate XM93U7 Streptodornase – XM0L32 TEPA – XM2567 Diphenadione XM8183 Sutilains – XM3SV7 Trichlormethine – XM6550 Tioclomarol XM40V6 Trypsin – XM5FH3 Trichlorotriethylamine – XM4GN9 Fluindione XM6RN7 Reteplase – XM7TR9 Triethanomelamine – XM3508 Clorindione XM04S7 Saruplase – XM9T22 Triethylenemelamine XM2YP8 Heparin and heparin derivatives XM8K47 Drotrecogin alfa (activated) – XM6NM1 Triethylenephosphoramide – XM1MN3 Heparin XM5ZA2 Tenecteplase – XM5GV6 Triethylenethiophosphoramide – XM12N6 Antithrombin III XM35D2 Protein C – XM4J62 Trimustine – XM3DU0 Dalteparin XM32Y3 Fibrinolysin and desoxyribonuclease – XM6A19 Uracil mustard – XM8ZP5 Enoxaparin XM4XM2 Fibrinolysin – XM9AV3 Urethane – XM5727 Nadroparin XM9PZ9 Tissue plasminogen activator – XM1DU5 Zinostatin – XM9V60 Parnaparin – XM4KU8 Masoprocol – XM9JC4 Reviparin XM9AX4 C1-inhibitor, plasma derived – XM7ST9 Topotecan – XM2YJ7 Danaparoid XM7TQ2 Icatibant – XM3ZR1 Tiazofurine – XM3SS4 Tinzaparin XM9192 Ecallantide – XM0992 Irinotecan – XM3E38 Sulodexide XM7M63 Conestat alfa – XM8200 Alitretinoin – XM7QG7 Bemiparin XM2UN9 Berotralstat XM09D9 Alkylating agents – XM6AL6 Pegaspargase – XM06G0 Nitrogen mustard analogues – XM3NJ7 Bexarotene – XM9J84 Dipyridamole XM3RF2 Absorbable gelatin sponge –– XM7SY9 Cyclophosphamide – XM6027 Denileukin diftitox – XM51R2 Epoprostenol XM6EK6 Oxidized cellulose –– XM5TX7 Chlorambucil – XM5Z86 Bortezomib – XM5G01 Indobufen XM1MS7 Tetragalacturonic acid hydroxymethylester –– XM2VC7 Melphalan – XM2PZ5 Anagrelide – XM5A15 Ticlopidine XM6BS8 Adrenalone –– XM9W18 Chlormethine – XM1NQ8 Oblimersen – XM00R9 Iloprost XM1JS6 Calcium alginate –– XM7FY4 Ifosfamide – XM3VC2 Sitimagene ceradenovec – XM5PR9 Triflusal –– XM4EP0 Trofosfamide – XM7R04 Vorinostat – XM5K56 Ditazole XM8F45 Voxelotor –– XM4NR8 Prednimustine – XM91S2 Romidepsin – XM8NM5 Cloricromen –– XM45K9 Bendamustine – XM3RX2 Omacetaxine mepesuccinate – XM09W2 Picotamide –– XM0DA1 Melphalan flufenamide – XM3BC3 Eribulin – XM7CM7 Clopidogrel – XM3WS2 Alkyl sulfonates – XM96L9 Panobinostat – XM39C9 Abciximab –– XM7WX6 Busulfan – XM0N96 Vismodegib – XM2924 Eptifibatide –– XM9CR4 Treosulfan – XM4XD1 Aflibercept – XM0DS1 Tirofiban –– XM4TU0 Mannosulfan – XM0A07 Carfilzomib – XM8Y64 Beraprost – XM66A3 Ethylene imines – XM7202 Olaparib – XM5057 Treprostinil –– XM8QS9 Thiotepa – XM8F40 Idelalisib – XM8LN2 Prasugrel –– XM2RU1 Triaziquone – XM9E27 Sonidegib – XM92L1 Cilostazol –– XM8A50 Carboquone – XM0Y26 Belinostat – XM1HH4 Ticagrelor – XM9708 Nitrosoureas – XM3753 Ixazomib – XM3126 Cangrelor –– XM82H4 Carmustine – XM1BM0 Talimogene laherparepvec – XM3835 Vorapaxar –– XM2G49 Lomustine XM1CT6 Protein kinase inhibitors – XM5MZ5 Selexipag –– XM0VS7 Semustine – XM5W30 Imatinib XM17B1 Anticoagulant and antithrombotic enzymes –– XM5GB0 Streptozocin – XM3A37 Gefitinib – XM1AV3 Streptokinase –– XM1KF0 Nimustine – XM3420 Erlotinib – XM9A41 Alteplase –– XM9KU3 Uramustine – XM1982 Sunitinib – XM1P81 Anistreplase –– XM5RH5 Fotemustine – XM4A57 Sorafenib – XM1QH1 Urokinase –– XM64P5 Ranimustine – XM50U1 Dasatinib – XM77L2 Brinase – XM4KL3 Etoglucid – XM1FM4 Lapatinib – XM3YU3 Ancrod – XM31W0 Mitobronitol – XM6BP0 Nilotinib XM5PV9 Direct thrombin inhibitors – XM0MB5 Pipobroman – XM93U4 Temsirolimus – XM84G2 Desirudin – XM3VF4 Temozolomide – XM69S5 Everolimus – XM2HU1 Lepirudin – XM32Y8 Dacarbazine – XM4FT3 Pazopanib – XM7Y21 Argatroban – XM7Y28 Bis(chloromethyl) ether – XM3W52 Vandetanib – XM1D58 Melagatran – XM7917 Afatinib – XM2QF7 Ximelagatran – XM4DQ8 Folic acid analogues – XM60L5 Bosutinib – XM1WF7 Bivalirudin –– XM7KT0 Methotrexate – XM55B8 Vemurafenib – XM16E4 Dabigatran etexilate –– XM1SK9 Mercaptopurine – XM2U80 Crizotinib XM4SD9 Direct factor Xa inhibitors –– XM3FP5 Tioguanine – XM6JL9 Axitinib – XM48G2 Rivaroxaban –– XM5NF9 Raltitrexed – XM0853 Ruxolitinib – XM3Y33 Apixaban –– XM16W8 Pemetrexed – XM0SL6 Ridaforolimus – XM2SN5 Edoxaban –– XM06R0 Pralatrexate – XM0601 Regorafenib XM1AM0 Other antithrombotic agents – XM71S1 Purine analogues – XM0JZ7 Masitinib – XM2JQ1 Defibrotide –– XM3ZN1 Cytarabine – XM1HB8 Dabrafenib – XM2XP4 Dermatan sulfate –– XM55V5 Fluorouracil – XM70G2 Ponatinib – XM31P2 Fondaparinux –– XM10L4 Tegafur – XM7VJ9 Trametinib –– XM6CQ5 Carmofur – XM4TL0 Cabozantinib – XM02P8 Anisindione –– XM92X1 Azacitidine – XM0C70 Ibrutinib – XM54A7 Bromindione –– XM1055 Cladribine – XM14D3 Ceritinib – XM9E78 Coumarin –– XM9RH9 Fludarabine – XM7ZH9 Lenvatinib – XM0SY0 Coumetarol –– XM2YA3 Clofarabine – XM4EA3 Nintedanib – XM0PM7 Drotrecogin alfa –– XM6079 Nelarabine – XM2QS0 Cediranib – XM9313 Enoxaparin sodium – XM9584 Pyrimidine analogues – XM4K70 Palbociclib – XM7AL6 Ethylidene dicoumarol –– XM0YN9 Trifluridine, combinations – XM8B31 Tivozanib – XM4S57 Heparin sodium –– XM8GX9 Gemcitabine – XM8YD2 Osimertinib – XM5YT5 Heparin-fraction –– XM40Y4 Capecitabine – XM4JL2 Alectinib – XM5LC3 Heparinoid (systemic) –– XM1458 Decitabine – XM21J7 Rociletinib – XM38V8 Indandione (derivatives) – XM7GE5 Aminopterin sodium – XM6K99 Cobimetinib – XM4Z97 Indendione (derivatives) – XM3264 Antibiotic anticancer – XM5Y46 Midostaurin – XM5796 Panwarfin – XM8T13 Antimetabolite – XM0J75 Olmutinib – XM04M3 Prothrombin synthesis inhibitor – XM9D05 Antineoplastic antibiotics – XM3YP5 Binimetinib – XM8J87 Xigris – XM4TR6 Azaribine – XM2RL4 Ribociclib – XM7EQ6 Zovant – XM3HR8 Broxuridine – XM2DD8 Brigatinib – XM3A97 Chloropurine – XM59V9 Lorlatinib XM4Z15 Amino acids – XM1BL2 Doxifluridine – XM5MT6 Neratinib – XM0ES3 Arginine hydrochloride – XM5ZK1 Enocitabine – XM5RQ2 Encorafenib – XM2NR2 Alanyl glutamine – XM2SL0 Folic acid antagonist – XM15D6 Dacomitinib – XM44Y2 Lysine – XM0KZ3 Mopidamol – XM9L11 Icotinib – XM8KJ7 Tyrosine – XM2FK2 Pyrimidine antagonist – XM8E34 Abemaciclib – XM4PP7 Phenylalanine – XM09W7 Acalabrutinib – XM4H38 Leucine – XM6137 Vinca alkaloids and analogues – XM1L31 Quizartinib – XM2K61 Cysteine –– XM0BG8 Vinblastine – XM2LF4 Larotrectinib – XM6VX4 Alanine –– XM82R6 Vincristine – XM4BT2 Gilteritinib XM4BG8 Aminocaproic acid –– XM59U2 Vindesine – XM16Z9 Entrectinib XM8GE2 Tranexamic acid –– XM1Y07 Vinorelbine – XM28Z0 Fedratinib XM41G3 Aminomethylbenzoic acid –– XM9QY3 Vinflunine – XM7168 Asciminib XM3QV9 Fibrinolysis inhibitor –– XM9DS3 Vintafolide – XM7380 Pacritinib XM6Y53 Aprotinin – XM3SH7 Podophyllotoxin derivatives – XM9U75 Infigratinib XM0UH4 Antifibrinolytic drug –– XM9VL7 Etoposide – XM9XE8 Futibatinib XM7XD3 Epsilon amino-caproic acid –– XM4565 Teniposide – XM74A3 Selpercatinib XM8X82 Hemostatic drug, systemic – XM05L1 Taxanes – XM1UG8 Pralsetinib XM9PF3 Alfa1 antitrypsin –– XM5TC8 Paclitaxel XM1JG6 Monoclonal antibodies and antibody drug conjugates XM9QH4 Camostat –– XM5U86 Docetaxel – XM6TQ6 Clusters of differentiation 20 inhibitors –– XM9NR6 Paclitaxel poliglumex – XM0NB9 Clusters of differentiation 22 inhibitors XM6DJ4 Vitamin K –– XM50E3 Cabazitaxel – XM4F67 Clusters of differentiation 38 inhibitors XM1KN2 Menadione – XM6F82 Actinomycin C – XM6DT1 Human epidermal growth factor receptor 2 inhibitors XM1VC9 Etamsylate – XM7K70 Demecolcine – XM3ZP2 Epidermal growth factor receptor inhibitors XM0M37 Acetomenaphthone – XM3F90 Trabectedin –– XM9KZ5 Trastuzumab duocarmazine XM5LG4 Anticoagulant Antagonist XM4DQ7 Cytotoxic antibiotics and related substances – XM9ND9 Programmed cell death protein 1/death ligand 1 inhibitors XM0D26 Antihemophilic globulin concentrate – XM5GC9 Anthracyclines and related substances –– XM3Q80 Tislelizumab XM2KH0 Antihemophilic plasma, dried –– XM7JU8 Doxorubicin –– XM2KA7 Retifanlimab XM0RA5 Antiheparin drug –– XM0031 Daunorubicin –– XM0AN7 Oportuzumab monatox XM4Z99 Coagulant –– XM6LT8 Epirubicin –– XM5Q93 Sacituzumab govitecan XM3RB9 Cotarnine –– XM1VB7 Aclarubicin –– XM0550 Amivantamab XM8MM4 Cytozyme –– XM9R95 Zorubicin – XM1GS6 Vascular endothelial growth factor inhibitors XM5WF6 Gelfoam –– XM3PF9 Idarubicin – XM4ZA4 Other monoclonal antibodies and antibody drug conjugates XM35E4 Heparin action reverser –– XM26H0 Mitoxantrone –– XM0PX7 Pamiparib XM9CA7 Hexadimethrine (bromide) –– XM4AY9 Pirarubicin –– XM4WB3 Tazemetostat XM3AJ3 Menadiol –– XM9CA4 Valrubicin –– XM78S9 Sotorasib XM2JG9 Menadiol sodium sulfate –– XM3J03 Amrubicin –– XM7SW9 Belzutifan XM7MA9 Menadione sodium bisulfite –– XM8ZP9 Pixantrone XM8912 Menaquinone – XM0VU1 Bleomycin XM9VN3 Colony stimulating factors XM55W0 Menatetrenone – XM3JL4 Plicamycin – XM93Q2 Filgrastim XM4U16 Protamine sulfate – XM21Z8 Mitomycin – XM2M96 Molgramostim XM0SY7 Prothrombin activator – XM65P2 Ixabepilone – XM38N5 Sargramostim XM8RT8 Russel's viper venin – XM4RQ4 Fibroblast growth factor receptor tyrosine kinase inhibitors – XM7UB4 Lenograstim XM6QQ2 Snake venom or bite hemocoagulase – XM17W1 Ancestim XM0HF1 Thromboplastin – XM52L2 Edrecolomab – XM4TX7 Pegfilgrastim XM3W89 Vitamin K1 – XM3AY3 Rituximab – XM1G49 Lipegfilgrastim XM1YD0 Vitamin K2 – XM2FU8 Trastuzumab – XM7670 Balugrastim XM5UU0 Carbazochrome – XM1WL2 Gemtuzumab ozogamicin – XM9RV6 Empegfilgrastim – XM6RT1 Carbazochrome sodium sulfonate – XM3VL3 Cetuximab – XM8VY9 Pegteograstim XM7KW2 Batroxobin – XM5ST9 Bevacizumab – XM1KX1 Interferon alfa-2a XM96S9 Romiplostim – XM1GA2 Panitumumab XM58E0 Interferons XM95R8 Eltrombopag – XM9P40 Catumaxomab – XM1GZ3 Interferon alfa – XM2KB4 Ofatumumab – XM3CU5 Interferon beta XM9766 Coagulation factor VIII – XM5JH7 Ipilimumab – XM3KQ4 Interferon gamma XM3GR1 Thrombin – XM5VT7 Brentuximab vedotin – XM6QT3 Interferon alfa-2b XM04N3 Blood plasma – XM6618 Pertuzumab – XM6D22 Interferon beta-1a XM5WD4 Albumin bovine – XM6H29 Trastuzumab emtansine – XM0CS1 Interferon beta-1b XM1YW8 Albumin human serum salt-poor – XM6ES5 Obinutuzumab – XM0C05 Interferon alfacon-1 XM7150 Albumin human serum – XM74W8 Dinutuximab – XM5L32 Peginterferon alfacon-2 XM2NV9 Blood (derivatives) (natural) (plasma) (whole) – XM6M26 Nivolumab – XM70P0 Peginterferon alfa-2b XM1GJ9 Blood dried – XM8UG5 Pembrolizumab – XM1RW9 Peginterferon alfa-2a XM5GG5 Blood fraction – XM9BU9 Blinatumomab – XM1HG5 Albinterferon alfa-2b XM9TT2 EPO – XM6Y05 Ramucirumab – XM3XV8 Peginterferon beta-1a XM6BM2 Epoetin alpha – XM5WX4 Necitumumab – XM41L0 Cepeginterferon alfa-2b XM79U3 Erythropoietin human – XM10Z6 Elotuzumab – XM24N9 Ropeginterferon alfa-2b XM3TM8 Factor I (fibrinogen) – XM4ES5 Daratumumab XM2Q27 Interleukins XM3ZZ2 Factor III (thromboplastin) – XM3JP4 Mogamulizumab – XM4MJ0 Interferon alfa-n1 XM44Z6 Coagulation factor IX – XM8648 Inotuzumab ozogamicin – XM0RF4 Aldesleukin XM9JK6 Fibrin – XM3DU2 Olaratumab – XM4PY0 Oprelvekin XM6HF0 Human albumin – XM7NY5 Durvalumab – XM3SM5 Netakimab XM0XT3 Natural blood (product) – XM6PT2 Ermekumab – XM8615 Bimekizumab XM3YQ9 Normal serum albumin, salt-poor (human) – XM2065 Avelumab – XM4YW3 Spesolimab XM8TU6 Whole blood (human) – XM8SU2 Atezolizumab XM7N26 Thymopentin XM1596 Blood substitutes and plasma protein fractions – XM9Z80 Cemiplimab XM6GW5 Lentinan – XM84Y1 Other plasma protein fractions – XM5WX2 Alemtuzumab XM48E5 Roquinimex – XM0CQ3 Gelatin agents – XM8LF5 Erenumab XM9D28 Pegademase –– XM4NU0 Gelatin (intravenous) – XM4XM4 Galcanezumab XM30D0 Pidotimod –– XM99H6 Polygeline – XM47L7 Fremanezumab XM1R32 Poly I:C – XM8BW6 Hemoglobin crosfumaril – XM46X2 Ubrogepant XM4J95 Poly ICLC – XM4MK5 Hemoglobin raffimer – XM1D23 Eptinezumab XM9D43 Immunocyanin – XM6W72 Hemoglobin glutamer – XM8C95 Rimegepant XM94J4 Tasonermin – XM3CZ0 Dextran – XM4W34 Atogepant XM99P5 Melanoma vaccine – XM1H99 Plasma protein fraction, human XM3T47 Sensitizers used in photodynamic or radiation therapy XM4PM9 Glatiramer acetate – XM6KC5 Albumin – XM8EW4 Porfimer sodium XM5KS2 Histamine dihydrochloride – XM8H48 Hydroxyethylstarch – XM5GF8 Methyl aminolevulinate XM97M6 Mifamurtide – XM6YJ2 Oxypolygelatin – XM40J3 Aminolevulinic acid XM19S3 Plerixafor – XM8UH8 Polyvinylpyrrolidone – XM04X3 Temoporfin XM2ZJ6 Sipuleucel-T XM8K98 Hematin – XM2BE2 Efaproxiral XM4ZS8 Cridanimod XM3P96 Factor VIII inhibitor bypassing activity – XM1ER6 Padeliporfin XM9BT1 Dasiprotimut-T XM58W5 Coagulation factor VII XM3R87 Elapegademase XM1UV6 Coagulation factor XIII – XM40B7 Platinum compounds XM0A85 Coagulation factor VIIa –– XM05M0 Cisplatin XM5140 Selective immunosuppressants XM25U1 Von Willebrand factor –– XM6Z30 Carboplatin – XM9RY3 Muromonab-CD3 XM4S88 Catridecacog –– XM2LX1 Oxaliplatin – XM3TG8 Antilymphocyte immunoglobulin (horse) XM2RZ4 Coagulation factor X –– XM86Z5 Satraplatin – XM2Q51 Antithymocyte immunoglobulin (rabbit) XM6B13 Susoctocog alfa –– XM0FB2 Polyplatillen – XM57B1 Mycophenolic acid XM7KC2 Thrombocytes – XM1MP7 Procarbazine – XM76R4 Sirolimus XM6GB5 Stem cells from umbilical cord blood – XM8307 Amsacrine – XM5M04 Leflunomide XM7JU3 Serum complement (inhibitor) – XM4LJ7 Asparaginase – XM1PY3 Alefacept XM08V1 Serum hemolytic complement – XM9YD3 Altretamine – XM75G0 Gusperimus XM8VX7 Epoetin beta – XM7SD2 Hydroxycarbamide – XM8CX4 Efalizumab XM26D5 Red blood cells, packed – XM3R45 Lonidamine – XM4RN7 Abetimus – XM9JX7 Estramustine – XM9YN4 Natalizumab XM8ZX9 Calcium ferrous citrate – XM9DB5 Tretinoin – XM45M8 Abatacept XM6S51 Dextriferron – XM9T72 Pentostatin – XM3KK5 Eculizumab XM5DJ4 Ferric chloride – XM2Q11 Mitoguazone – XM9M75 Belimumab XM60G9 Ferric hydroxide colloidal – XM7PT2 Venetoclax – XM9K56 Fingolimod XM9W49 Ferric hydroxide polymaltose – XM1NF7 Vosaroxin – XM4FP8 Belatacept XM2C90 Ferric pyrophosphate – XM1DL2 Niraparib – XM7U27 Tofacitinib XM55G4 Ferritin – XM2G84 Rucaparib – XM1835 Teriflunomide XM8GJ1 Ferrocholinate – XM0569 Etirinotecan pegol – XM9UD1 Apremilast XM3SU9 Ferrodextrane – XM8UF4 Plitidepsin – XM5MC2 Vedolizumab XM1018 Ferropolimaler – XM8QL8 Epacadostat – XM7BS8 Begelomab XM7EW8 Ferrous fumerate, gluconate, lactate, salt, sulfate (medicinal) – XM8NP2 Enasidenib – XM2B74 Ocrelizumab XM2LA7 Ferrous phosphate – XM5QR0 Talazoparib – XM1SM6 Baricitinib XM8L47 Ferrous salt – XM44N1 Copanlisib – XM0700 Ozanimod XM8Z42 Iron (compounds) (medicinal) – XM10P3 Mitotane – XM3F23 Emapalumab XM6FS8 Iron ammonium – XM56L5 Ivosidenib – XM09N4 Imlifidase XM7PP8 Iron dextran injection – XM6038 Glasdegib – XM6N55 Siponimod XM54R9 Iron salts – XM7FX3 Entinostat – XM31G3 Ravulizumab XM3EH2 Iron sorbitol citric acid complex – XM3BC1 Alpelisib – XM0V48 Upadacitinib XM8KK0 Isomaltose, ferric complex – XM1840 Selinexor – XM6QJ6 Belumosudil XM77C5 Jectofer – XM4MB0 Tagraxofusp – XM3RJ6 Peficitinib XM1Y67 Polyferose – XM7RN1 Belotecan – XM69Y4 Ponesimod XM5SE8 Sodium iron edetate – XM5A01 Holmium-166 – XM1PC0 Anifrolumab XM85E8 Saccharated iron oxide – XM2HS5 Arsenic trioxide – XM8AR9 Teprotumumab XM5HE0 Sodium feredetate – XM3ST0 Alkylating drug antimyeloproliferative – XM8913 Pegcetacoplan XM7E86 Ferrous glycine sulfate – XM9DP5 Alkylating drug lymphatic – XM6PD2 Sutimlimab XM04C6 Ferrous fumarate – XM6AB6 Alkylating drug – XM93Q8 Deucravacitinib XM3N76 Ferrous gluconate –– XM0JA8 Hexalen XM9PG4 Tumour necrosis factor alpha inhibitors XM2865 Ferrous carbonate – XM07W3 Antramycin – XM0FU1 Etanercept XM6UB4 Ferrous chloride – XM9F82 Anticancer agents – XM3MX3 Infliximab XM8SK2 Ferrous succinate – XM3MH4 Antimitotic agent – XM31F7 Afelimomab XM3SQ1 Ferrous sulfate – XM6Q44 Antineoplastic without further specification – XM9DS9 Adalimumab XM0FD3 Ferrous tartrate – XM0V25 Antineoplastic alkaloidal – XM9QW1 Certolizumab pegol XM8638 Ferrous aspartate – XM4DV2 Antineoplastic combination – XM97H7 Golimumab XM0S20 Ferrous ascorbate – XM1Q78 Azaserine – XM0PE5 Opinercept XM1BG1 Ferrous iodine – XM0TE5 Azatepa XM5ZL1 Interleukin inhibitors XM7FV2 Ferric sodium citrate – XM7WD3 Benzcarbimine – XM3CD8 Daclizumab XM4HF0 Ferric hydroxide – XM3WB5 Cactinomycin – XM6FT1 Basiliximab XM5AW9 Ferric oxide polymaltose complexes – XM7RS5 Cancer chemotherapy drug regimen – XM3CP6 Anakinra XM6CK7 Chondroitin sulfate-iron complex – XM6Z55 Chlorhexamide – XM4YD0 Rilonacept XM5L86 Ferric acetyl transferrin – XM3ZJ5 Chromic phosphate 32P – XM1BA7 Ustekinumab XM8NX7 Ferric proteinsuccinylate – XM5VY1 Chromomycin A3 – XM2FV1 Tocilizumab XM4J31 Ferric maltol – XM6ZM0 Corynebacterium parvum – XM67R0 Canakinumab XM0216 Ferrous amino acid complex – XM8C02 Cycloleucin – XM5JM2 Briakinumab XM6435 Sodium dipantoyl ferrate – XM7L47 Dactinomycin – XM0NF8 Secukinumab – XM0HK3 Elliptinium acetate – XM9D29 Siltuximab XM7CP9 Hydroxocobalamin – XM32L4 FAC (fluorouracil + doxorubicin + cyclophosphamide) – XM6601 Brodalumab XM7R82 Folic acid – XM8NR1 Floxuridine – XM7AB4 Ixekizumab XM2AT9 Mecobalamin – XM9FT7 Hormone cancer therapy – XM45G5 Sarilumab XM2RU3 Cobalamine – XM5UH8 Imidazole-4-carboxamide – XM7N41 Sirukumab XM9KD4 Cyanocobalamin – XM2D46 Inproquone – XM2L20 Guselkumab XM20E6 Hematinic preparation – XM5DL7 Iproplatin – XM9VJ6 Tildrakizumab XM16W1 Leucovorin (factor) – XM8C52 M-vac – XM70N9 Risankizumab XM9130 Erythropoietin – XM8XQ7 Mannomustine XM3CM4 Calcineurin inhibitors XM09N3 Cyanocobalamin tannin complex – XM33V8 Matulane – XM28J8 Ciclosporin XM2NR4 Cobamamide – XM1NW0 Metoprine – XM1661 Tacrolimus XM7M42 Darbepoetin alfa – XM6VK8 Mitolactol – XM0Z09 Voclosporin XM66M0 Methoxy polyethylene glycol-epoetin beta – XM3A89 Mitopodozide XM1079 Immunosuppressive drug XM9D96 Peginesatide – XM3L39 MOPP (mechloreth-amine + vincristine + prednisone + procarbazine) XM99R8 Azathioprine XM27M4 Daprodustat – XM4582 Mustard (emetic) XM6B78 Thalidomide XM59J5 Vadadustat – XM6MP1 Myelobromal XM5Q10 Lenalidomide – XM5C25 Myleran XM7952 Pirfenidone XM6Y81 Alidase – XM5MX5 Olivomycin XM6S50 Pomalidomide XM0KX8 Alpha amylase – XM9TL3 Oncovin XM2EM8 Dimethyl fumarate XM7NZ6 Chymotrypsin – XM7TK6 Paroxypropione XM0LG0 Darvadstrocel XM8P48 Cocarboxylase – XM7040 Peplomycin XM8X05 Mepolizumab XM1819 Deoxyribonuclease – XM7NL0 Phenyl hydrazine antineoplastic XM9UK4 Diroximel fumarate XM3HF5 Diffusin – XM03S1 Phenylalanine mustard XM3TF2 Enzyme fibrolytic – XM7S82 Porfiromycin XM7S34 Vitamin K antagonists XM5GS9 Enzyme thrombolytic – XM6QJ7 Pteroyltriglutamate – XM8RN0 Dicoumarol XM0543 Hyaluronidase XM8R05 Atosiban XM5EY9 Flibanserin XM19G4 Agni casti fructus XM6DH4 Cimicifugae rhizoma XM92Y5 Plastic intrauterine contraceptive device XM0B44 Plastic intrauterine contraceptive device with copper XM7P32 Plastic intrauterine contraceptive device with progestogen XM2AH3 Vaginal ring with progestogen and estrogen XM9N33 Progestogens and estrogens, fixed combinations – XM65V3 Levonorgestrel with ethinylestradiol – XM4BC7 Gestodene and ethinylestradiol – XM5PH2 Norgestimate and ethinylestradiol – XM01B4 Norelgestromin and ethinylestradiol – XM0QV1 Nomegestrol and estradiol – XM3727 Chlormadinone and ethinylestradiol – XM4AD5 Quingestanol and ethinylestradiol – XM9ZQ5 Lynestrenol and ethinylestradiol – XM3344 Megestrol and ethinylestradiol – XM7D82 Norethisterone with ethinylestradiol – XM6EU8 Medroxyprogesterone and ethinyloestradiol – XM6Y16 Desogestrel and ethinylestradiol – XM3L86 Drospirenone and ethinylestradiol – XM5KE9 Dienogest and ethinylestradiol – XM3WW4 Ethinylestradiol, ethinyloestradiol with levonorgestrel – XM7M76 Ethinylestradiol, ethinyloestradiol with norethisterone – XM8HJ8 Ethynodiol with mestranol diacetate XM0ZZ0 Progestogens and estrogens, sequential preparations XM70N0 Estrogens – XM51S9 Diethylstilbestrol – XM7YR1 Epimestrol – XM4EH0 Estriol – XM1058 Chlorotrianisene – XM8YK8 Estrone – XM56M0 Estrogen conjugated – XM6UC0 Dienoestrol – XM4T41 Methallenestril – XM3YX8 Polyestradiol phosphate – XM03K8 Fosfestrol – XM7FC3 Promestriene – XM7ST1 Moxestrol – XM70N6 Tibolone – XM1SV5 Ethinyloestradiol – XM7CP4 Estrogen XM9HA7 Progestogens – XM2HB5 Medroxyprogesterone acetate (depot) – XM1KX5 Gestonorone caproate – XM6U53 Levonorgestrel – XM1DX1 Quingestanol – XM8Y77 Lynestrenol – XM7KS3 Megestrol – XM7LY6 Norethisterone – XM7ZG5 Desogestrel – XM7XY6 Drospirenone – XM0R79 Hydroxyprogesterone – XM3799 Progesterone – XM71X5 Dydrogesterone – XM4HQ9 Medrogestone – XM2LR3 Nomegestrol – XM6SD5 Demegestone – XM5FK8 Chlormadinone – XM71B5 Promegestone – XM0U58 Dienogest – XM77R9 Allylestrenol – XM0TH1 Ethisterone – XM6TX3 Ethynodiol – XM37T7 Methylestrenolone – XM94C4 Etonogestrel – XM31C0 Norgestrienone XM6CL2 Anhydrohydroxy-progesterone XM0W29 Antineoplastic combination estrogen XM76F9 Conjugated estrogenic substances XM4DR7 Delalutin XM49U4 Dimestrol XM5RK3 Dimethisterone XM1P34 Epiestriol XM39W0 Estradiol benzoate XM2GR3 Estrogen with progesterone XM6133 Estropipate XM7JV9 Gonadal tissue extract female XM8WE5 Hexestrol XM4NZ9 Hydroxyestrone XM5A00 Hydroxyprogesterone caproate XM3AK8 Mestranol XM1SH1 Noretynodrel XM1B43 Normethandrone XM3MJ7 Ovarian hormone XM26R0 Ovarian stimulant XM8AV0 Oxendolone XM1K26 Pregnandiol XM8FT3 Progestogen XM9HS1 Quinestradol XM3HH8 Quinestrol XM0SU9 Steroid antineoplastic, hormone estrogen XM74M2 Clomiphene XM1ZT8 Ormeloxifene XM7P20 Cyclofenil XM2CF9 Raloxifene XM8818 Bazedoxifene XM4JW0 Lasofoxifene XM8HF1 Ospemifene XM4RW1 Mifepristone XM04R5 Ulipristal XM8VE0 Stanozolol XM24D1 Methandrostenolone XM0E55 Mestanolone XM1E21 Oxymesterone XM7WQ1 Oxymetholone XM8788 Quinbolone XM5Q72 Prasterone XM6327 Oxandrolone XM5115 Norethandrolone XM29P0 Fluoxymesterone XM4TC8 Methyltestosterone XM3HM6 Testosterone XM3QK3 Mesterolone XM3478 Androstalone XM3BT9 Anabolic steroid XM65R6 Androgen XM5CT6 Androgen-estrogen mixture XM89R1 Androsterone XM7LM1 Antineoplastic steroid XM0T50 Calusterone XM1SV6 Congener, anabolic XM1RM3 Dromostanolone XM81H5 Durabolin XM76Q0 Epitiostanol XM3UJ6 Estradiol with testosterone XM7X01 Gonadal tissue extract male XM6R95 Macrolide anabolic drug XM21D8 Mepitiostane XM2GQ1 Metenolone XM6966 Methandriol XM8HC6 Methyl androstanolone XM8NZ0 Nandrolone XM3KV3 Steroid androgenic XM1KA5 Steroid antineoplastic, hormone XM5T49 Testolactone XM50S2 Zeranol XM54A1 Ethylestrenol XM6RN8 Oxabolone cipionate XM11B1 Drugs for urinary frequency and incontinence XM1TG5 Phenyl salicylate XM5549 Acetohydroxamic acid XM2VJ5 Phenazopyridine XM1JS5 Dimethyl sulfoxide XM8GM2 Pentosan polysulfate sodium XM2D76 Tiopronin XM6VX1 Succinimide XM8BX6 Dapoxetine XM3WK8 Prunus africanae cortex XM5B91 Sabalis serrulatae fructus XM2Y08 Fexapotide – XM4VT6 Nafarelin – XM1NP2 Canagliflozin – XM78X7 Histrelin – XM9RW3 Empagliflozin – XM3S25 Leuprorelin – XM66V1 Ertugliflozin XM9XC3 Somatostatin and analogues – XM8Y84 Ipragliflozin – XM5L29 Somatostatin – XM7947 Sotagliflozin – XM01Z4 Octreotide XM29C4 Insulin (beef) – XM7GZ3 Lanreotide XM8YE2 Insulin (pork) – XM28Z2 Vapreotide XM6NY5 Insulin lispro – XM3AN9 Pasireotide XM0HQ0 Insulin aspart XM7WH3 Insulin glulisine XM4S44 Cabergoline XM96W1 Insulin detemir XM7828 Metergoline XM6R62 Insulin degludec XM96P1 Quinagolide XM65E7 Tolrestat XM3MG0 Terguride XM93G5 Imeglimin XM5374 Cholecystokinin XM51K6 Adrenal (extract, cortex or medulla) (glucocorticoids) (hormones) (mineralocorticoids) XM6SU0 Betamethasone XM0XB5 Clocortolone XM4AF4 Cloprednol XM3R56 Compound E (cortisone) XM4HH6 Compound F (hydrocortisone) XM6FJ6 Cortate XM6TY3 Corticosteroid XM5AE3 Cortisone XM17S1 Cortivazol XM25L1 Cortone XM5CF7 Deflazacort XM72R5 Dexamethasone XM48E4 Fluorinated corticosteroids XM2GK4 Fluprednisolone XM4Z52 Glucocorticoids XM0XY8 Hormone adrenal cortical steroids XM2UL5 Kenacort XM5V41 Meprednisone XM4RH1 Paramethasone XM5AM2 Percorten XM6JJ4 Prednisolone XM39W4 Prednisone XM3YJ1 Prednylidene XM8JY6 Steroid XM5FR6 Fluocortolone XM4J30 Triamcinolone XM21H0 Hydrocortisone XM3UP9 Budesonide XM9VX0 Flunisolide XM8PN0 Mometasone XM5PW9 Fluticasone XM3FX7 Methylprednisolone XM3SM4 Rimexolone XM3293 Beclometasone XM4TY1 Ciclesonide XM1XF3 Fluticasone furoate XM7DQ5 Trilostane XM8676 Osilodrostat XM6W81 Gonadotrophin-releasing hormone antagonists – XM5JS1 Ganirelix – XM8Z22 Cetrorelix – XM5064 Elagolix – XM5ZS9 Abarelix – XM8292 Degarelix – XM3NR0 Linzagolix XM10A6 Antiestrogen – XM2UX2 Tamoxifen – XM1312 Toremifene – XM2ZV3 Fulvestrant XM7JF4 Antiandrogen – XM3G31 Flutamide – XM9AL0 Nilutamide – XM5FE9 Bicalutamide – XM7BF6 Enzalutamide – XM6Q81 Apalutamide – XM3FZ0 Darolutamide XM9X91 Aromatase inhibitors – XM7D25 Aminoglutethimide – XM14P8 Formestane – XM4Z64 Anastrozole – XM2J37 Letrozole – XM6976 Vorozole – XM2VT0 Exemestane XM8MB2 Antigonadotrophin XM3C58 Cyproterone XM0FW7 Danazol XM9QT3 Nafoxidine XM0P47 Taleranol XM40Q3 Mepartricin XM3028 Testosterone-5-alpha reductase inhibitors – XM8P68 Finasteride – XM01Y3 Dutasteride XM7E94 Gestrinone XM1517 Abiraterone XM5XB7 Relugolix XM68B8 Detrothyronine XM2YU4 Dextrothyroxine XM27J7 Dextrothyroxine sodium XM5M40 Euthroid XM93X7 Hormone thyroid XM10Z7 Levoid XM5G81 Levothyroxine XM2WC1 Levothyroxine sodium XM2XB6 Liothyronine XM0P56 Liotrix XM9RU3 Proloid XM65J7 Sodium L-triiodothyronine XM66B8 Thyroglobulin XM5685 Thyroxine XM4H64 Tiratricol XM5590 Titroid XM47Z3 Liothyronine sodium XM8CX3 Thyroid gland preparations XM1H03 Benzylthiouracil XM35K1 Carbimazole XM6Y24 Diiodotyrosine XM8492 Iodine 131 therapeutic XM6VL9 Iodine for thyroid conditions (antithyroid) XM7TM9 Iothiouracil XM38T7 Methimazole XM54P6 Methylthiouracil XM6V39 Potassium perchlorate antithyroid XM9LL4 Potassium perchlorate medicinal XM5DE7 Propylthiouracil XM8X98 Thiouracil (benzyl) (methyl) (propyl) XM3G29 Thiourea XM2MJ8 Dibromotyrosine XM8AS5 Sodium iodide XM9N95 Glucagon XM7GD6 Parathyroid gland extract XM59Z3 Teriparatide XM4RN4 Parathyroid hormone XM0S16 Calcitonin preparations – XM74V3 Calcitonin, salmon synthetic – XM28Z6 Calcitonin, pork natural – XM32U7 Calcitonin, human synthetic – XM6US3 Elcatonin XM40P9 Cinacalcet XM9LS5 Paricalcitol XM48A9 Doxercalciferol XM0NY4 Etelcalcetide XM21C9 Insulin human XM8S35 Antidiabetic XM9AX5 Antidiabetic biguanide and sulfonyl combined XM5DC4 Biguanides – XM4K79 Phenformin – XM0JN5 Metformin – XM6EJ2 Buformin – XM0S91 Proguanil – XM0EG5 Cycloguanil embonate XM5SK7 Antidiabetic combined XM11C9 Sulfonylureas – XM8S18 Chlorpropamide – XM1RV6 Tolbutamide – XM8E97 Glibornuride – XM8YD0 Tolazamide – XM8ZU0 Carbutamide – XM3TQ4 Glipizide – XM8597 Gliquidone – XM2G21 Gliclazide – XM65J8 Glisoxepide – XM60R0 Acetohexamide – XM5N48 Metahexamide – XM5N74 Glimepiride XM6932 Biguanide derivatives, oral XM06A4 Glimidine XM2584 Glisolamide XM4SE3 Globin zinc insulin XM6JN8 Glyburide XM0K09 Glyclopyramide XM6861 Glycyclamide XM88E8 Glymidine sodium XM4M26 Hormone antidiabetic agents XM5MV9 Iletin XM4C63 Insular tissue extract XM2JC7 Insulin (amorphous) (globin) (isophane) (Lente) (NPH) (Semilente) (Ultralente) XM3RW5 Insulin defalan XM16M5 Biphasic insulin injection XM1DZ9 Insulin injection, soluble XM9728 Insulin intermediate acting XM54Q2 Insulin protamine zinc XM0KT2 Insulin slow acting XM7VD3 Protamine zinc insulin injection XM0US2 Insulin zinc suspension (amorphous) (crystalline) XM73L8 Isophane insulin XM9AZ3 Lente iletin (insulin) XM8502 Neutral insulin injection XM8VX4 NPH iletin (insulin) XM5Y80 Adrenocorticotrophic hormone XM3J06 Protamine sulfate zinc insulin – XM7XJ1 Corticotropin XM8QQ1 PZI – XM4B77 Tetracosactide XM73P6 Sulfonylurea derivatives, oral XM7309 Anterior pituitary hormone XM99F8 Insulins and analogues XM1EM4 Cosyntropin XM2WY1 Alpha glucosidase inhibitors XM4MB2 Follicle-stimulating hormone, human – XM9JV9 Acarbose XM1027 FSH – XM9EX0 Miglitol XM1NX7 Human growth hormone (HGH) – XM4QD6 Voglibose XM86N5 Luteinizing hormone XM92R5 Menotropins – XM19U1 Acedapsone XM4QA7 Pergonal – XM91Z9 Acesulfamethoxypyridazine XM0Y82 Pituitary extracts anterior – XM1RU4 Acetylsulfamethoxypyridazine XM77Q1 Prolactin – XM7WC8 Diaphenylsulfone XM9NW5 Seractide – XM96M6 Disulfanilamide XM3LZ6 Somatotropin – XM3GA0 Neoprontosil XM52T6 Tetracosactrin – XM1RY1 Phthalylsulfathiazole XM4WS0 Thyrotrophin – XM55D8 Prontosil XM7J71 Thyrotropic hormone – XM85A7 Succinylsulfathiazole XM8HC4 Urofollitropin – XM69G3 Sulfachlorpyridazine XM03E8 Somatropin and somatropin agonists – XM5C46 Sulfacitine – XM96L8 Somatrem – XM57L7 Sulfadoxine – XM30J6 Sermorelin – XM03X3 Sulfaethidole – XM3038 Mecasermin – XM0F36 Sulfaguanidine –– XM5CS4 Pegvisomant – XM6N26 Sulfaloxate – XM9BW0 Mecasermin rinfabate – XM57M8 Sulfaloxic acid – XM9109 Tesamorelin – XM8UP5 Sulfameter – XM9WW0 Somatrogon – XM5X85 Sulfamethylthiazole XM49L1 Chorionic gonadotrophin – XM6D90 Sulfamonomethoxine XM2J59 Human menopausal gonadotrophin – XM2187 Sulfaphenylthiazole XM5ZL8 Serum gonadotrophin – XM8QW8 Sulfaproxyline XM4K30 Follitropin alfa – XM2XQ2 Sulfasalazine XM6EZ5 Follitropin beta – XM9MJ3 Sulfasuxidine XM8TP5 Lutropin alfa – XM2Y59 Sulfasymazine XM6HX4 Choriogonadotropin alfa – XM6BM7 Sulfisomidine XM5M71 Corifollitropin alfa – XM7Z85 Trisulfapyrimidines XM0RZ5 Follitropin delta – XM5EH1 Glymidine XM26R5 Thyrotropin alfa XM4UA3 Thiazolidinediones – XM0NQ7 Troglitazone XM9EQ9 Enterogastrone – XM27D8 Rosiglitazone XM3MT8 Felypressin – XM0TX6 Pioglitazone XM6X07 Gonadal tissue extract XM9SM6 Dipeptidyl peptidase 4 inhibitors XM10K7 Gonadotropin – XM4M71 Sitagliptin XM3GP5 Leuprolide – XM9867 Vildagliptin XM7399 Melanocyte-stimulating hormone – XM5QH2 Saxagliptin XM00P3 Pituitary extracts (posterior) – XM1044 Alogliptin XM0J12 Placental hormone – XM9X94 Linagliptin XM5714 Posterior pituitary hormone – XM5T11 Gemigliptin XM7LM2 Thymus extract – XM5SF9 Evogliptin XM1Y33 Vasopressor drugs XM4MK4 Glucagon-like peptide-1 analogues XM25M7 Vasopressin and analogues – XM06C6 Exenatide – XM6A76 Vasopressin – XM0EQ7 Liraglutide – XM77T2 Desmopressin – XM3U71 Lixisenatide – XM3GU1 Lypressin – XM2516 Albiglutide – XM4E12 Terlipressin – XM1FT0 Dulaglutide – XM3LP5 Ornipressin – XM9KJ3 Semaglutide XM1DB3 Oxytocin and analogues XM0FD1 Meglitinide – XM9SN0 Oxytocin – XM9V31 Repaglinide – XM41G8 Demoxytocin – XM5Z74 Nateglinide – XM4ZX0 Carbetocin – XM7967 Mitiglinide XM9EK1 Other blood glucose lowering drugs – XM62R6 Pramlintide – XM32E8 Buserelin – XM7VJ0 Teduglutide – XM8CG4 Goserelin XM0615 Sodium-glucose co-transporter 2 inhibitors – XM2TU9 Gonadorelin – XM97T4 Dapagliflozin XM7171 Clodronic acid XM6UW3 Etidronic acid XM55G3 Pamidronic acid XM94M8 Alendronic acid XM2M01 Tiludronic acid XM93D5 Ibandronic acid XM5CM8 Risedronic acid XM5908 Zoledronic acid XM5GF1 Dibotermin alfa XM8NB9 Eptotermin alfa XM94X8 Collagen XM2UE2 Chymopapain XM6F64 Bromelains XM0NQ8 Collagenase clostridium histolyticum XM4GT8 Ipriflavone XM5AP2 Aluminium chlorohydrate XM6U91 Strontium ranelate XM2P79 Denosumab XM4MQ4 Burosumab XM7AJ2 Romosozumab XM6EQ0 Hyaluronic acid XM2SL6 Chondrocytes, autologous XM99J5 Vosoritide –– XM3WN8 Quinethazone –– XM7A66 Clopamide –– XM51L8 Chlortalidone –– XM1DG9 Mefruside –– XM0EZ6 Clofenamide –– XM7G39 Metolazone –– XM3GK5 Meticrane –– XM4U11 Xipamide –– XM49L3 Indapamide –– XM8GT1 Clorexolone –– XM6CD1 Fenquizone XM3L93 Aldosterone antagonists and other potassium-sparing agents –– XM94A6 Aldosterone –– XM6QK1 Canrenoic acid –– XM1ML2 Canrenone –– XM0TH6 Eplerenone –– XM0ET8 Potassium canrenoate –– XM1JS8 Spironolactone –– XM8ZW7 Finerenone – XM1SM2 Amiloride – XM5SJ5 Triamterene – XM8CG7 Diuretic loop (high-ceiling) – XM79L6 Ethacrynate sodium – XM2LW1 Etacrynic acid – XM1H00 Etozolin – XM06E2 Lasix – XM2C78 Lyovac Sodium Edecrin – XM9KF7 Tienilic acid – XM6M47 Muzolimine – XM2W24 Loop [high-ceiling] diuretic sulfonamides –– XM8UE3 Furosemide –– XM6MV2 Bumetanide –– XM9ML2 Piretanide –– XM4DR4 Torasemide XM7VU2 Vasopressin antagonists – XM9LF5 Tolvaptan – XM25L2 Conivaptan XM44R0 Antagonist Aldosterone XM8CC8 Corticosteroid mineral XM4HZ4 Salt-retaining mineralocorticoid XM9SX2 Deoxycortone XM2ZB4 Preparations inhibiting uric acid production XM6PJ9 Desoxycorticosteroid – XM9589 Allopurinol XM9HZ6 Desoxycortone – XM47Z2 Tisopurine XM6JQ6 Fludrocortisone – XM0K04 Febuxostat XM9X54 Mineralocorticosteroid XM7F05 Preparations increasing uric acid excretion – XM0WT0 Probenecid XM5G71 Vitamin D – XM7K05 Sulfinpyrazone – XM75Z5 Ergocalciferol – XM9DK8 Benzbromarone – XM37C2 Dihydrotachysterol – XM3WF1 Isobromindione – XM3NT7 Alfacalcidol – XM95H8 Lesinurad – XM85V3 Calcitriol XM2D08 Atophan – XM11C6 Cholecalciferol XM3WA0 Cinchophen – XM8SM6 Calcifediol XM0M93 Ethebenecid XM4H09 B complex vitamins and derivates XM5VG7 Neocinchophen – XM5HF5 Benfotiamine XM6FA5 Oxipurinol – XM4PS9 Nicotinamide XM3JP7 Phenoquin – XM8V93 Riboflavin XM9DH5 Spindle inactivator – XM9RX3 Biotin XM56G7 Urate oxidase – XM4GD2 Pyridoxal phosphate XM95S3 Uric acid metabolism drug – XM41P5 Dexpanthenol XM6953 Uricosuric agent – XM7398 Calcium pantothenate XM9TL4 Pegloticase – XM50T4 Thiamine – XM42G9 sulbutiamine XM8KC2 Calcium – XM2SV4 Vitamin B-complex, plain – XM1AY1 Calcium phosphate – XM0Y25 Potassium aminobenzoate – XM7ND2 Calcium glubionate – XM3UQ2 Acetiamine – XM3EU2 Calcium gluconate – XM3HE8 Bisbentiamine – XM46G3 Calcium lactate – XM5LG0 Bisbutiamine – XM0VY0 Calcium acetate – XM8SY7 Cetotiamine – XM4N33 Calcium lactate gluconate – XM20C9 Fursultiamine – XM9WA2 Calcium glycerylphosphate – XM9609 Octotiamine – XM4X88 Calcium citrate lysine complex – XM72U8 Panthenol – XM08S9 Calcium glucoheptonate – XM7D01 Prosultiamine – XM7G46 Calcium pangamate – XM5MM0 Pyridoxine – XM5TW4 Calcium acetate anhydrous XM7XY8 Ascorbic acid – XM4S97 Calcium citrate XM1PU6 Tocopherol – XM6AK3 Calcium laevulate – XM5TU4 Vitamin E – XM8AM9 Calcium bromolactobionate XM9CG5 Thioctic acid – XM9566 Calcium salts XM1SD9 Octyl gallate XM8278 Potassium XM88X6 Sodium metabisulfite – XM7D96 Potassium citrate XM4BD4 Chlorophyll – XM46S4 Potassium bitartrate XM31S0 Thioctamide – XM56J9 Potassium bicarbonate XM2EM5 Pangamic acid – XM2P49 Potassium gluconate XM7E89 Betacarotene – XM0H50 Potassium salts XM4BT6 Retinol XM1ZS4 Sodium – XM0VG1 Sodium acid phosphate XM7KX6 Chenodeoxycholic acid – XM6R29 Sodium biphosphate XM8MG9 Ursodeoxycholic acid – XM8ZD6 Sodium cyclamate XM37T5 Cholic acid – XM9KZ3 Sodium hydrogen carbonate XM1F53 Diastase – XM7L15 Sodium magnesium citrate XM5888 Multienzymes – XM3H90 Sodium salt – XM2VN0 Protease XM1U95 Zinc XM3UE5 Pepsin – XM3E63 Zinc chloride nonmedicinal XM6F61 Hydrochloric acid – XM52P2 Zinc chromate – XM6QZ3 Hydrochloric acid vapor – XM93K2 Zinc oxide nonmedicinal XM3RH9 Citric acid – XM6D77 Zinc phosphide XM96V4 Alglucerase – XM82L3 Zinc sulfate nonmedicinal XM51F9 Obeticholic acid – XM27E8 Zinc pesticide, not elsewhere classified XM3UT3 Glutamic acid hydrochloride – XM68Z2 Zinc sulfate XM7Y97 Betaine hydrochloride – XM5WL8 Zinc gluconate XM7EN2 Imiglucerase – XM0418 Zinc protein complex XM3EW0 Agalsidase alfa – XM3R55 Zinc acetate XM1CJ9 Agalsidase beta XM5TD2 Magnesium XM4PC4 Laronidase – XM7KF0 Magnesium citrate XM69V4 Sacrosidase – XM1AU1 Magnesium gluconate XM3EE9 Alglucosidase alfa – XM2U66 Magnesium aspartate XM11U1 Galsulfase – XM3U21 Magnesium lactate XM3Z98 Idursulfase – XM8W21 Magnesium levulinate XM8J61 Velaglucerase alfa – XM9GU6 Magnesium pidolate XM8HN5 Taliglucerase alfa – XM8P82 Magnesium orotate XM7QH6 Elosulfase alfa – XM5VT1 Magnesium silicofluoride XM5U98 Asfotase alfa XM1VS5 Fluoride XM6UN5 Sebelipase alfa – XM1F39 Sodium fluoride XM5U91 Velmanase alfa – XM82S0 Sodium monofluorophosphate XM98F5 Idursulfase beta XM47M7 Selenium XM9L40 Cerliponase alfa – XM4HH9 Selenium fumes XM3FP4 Vestronidase alfa – XM5RR4 Sodium selenate XM8F43 Pegvaliase – XM7809 Sodium selenite XM30U5 Pegunigalsidase alfa XM6777 Acetic acid irrigating solution XM56M4 Atidarsagene autotemcel XM7KG7 Aminoacetic acid (derivatives) XM9F01 Avalglucosidase alfa XM6DF0 Carbacrylamine (resin) XM1619 Dialysis solution (intraperitoneal) XM4HD8 Arginine glutamate XM6YF0 Electrolytic agent XM5RS5 Silymarin XM6598 Glucose with sodium chloride XM6T01 Epomediol XM02Y3 Glycerol intravenous XM1GT0 Ornithine XM7NQ3 Glycine XM1R31 Nicotinyl methylamide XM8UU5 Lactated potassic saline XM03F0 Piprozolin XM5FN3 Mineral salt XM0HT0 Hymecromone XM6P40 Polyaminostyrene resins XM2EM9 Cyclobutyrol XM3UT8 Potassic saline injection (lactated) XM0413 Citiolone XM11X8 Ringer solution (lactate) XM0F81 Tidiacic arginine XM6XG7 Sodium free salt XM7600 Anethole trithione XM7JQ2 Travert XM8B34 Sodium dehydrocholate XM1DP8 Water balance drug XM56J1 Monooctanoin XM5N49 Water distilled XM44G8 Orazamide XM9V59 Water purified XM3E24 Tidiacic XM8323 Cobalt medicinal (trace) (chloride) XM3VV1 Maralixibat chloride XM5DN1 Copper medicinal (trace) XM30B2 Odevixibat XM3046 Dietary supplements rich in vitamins and antioxidants – XM7113 Liver extract XM9UB7 Benfluorex – XM9GC7 Liver fraction 1 XM2AF4 Centrally acting antiobesity products – XM25P4 Liver hydrolysate – XM5VK3 Phentermine – XM09R3 Cod-liver oil – XM5TZ8 Fenfluramine – XM9FC4 Yeast – XM84W9 Amfepramone – XM2W18 Yeast dried – XM5WS4 Dexfenfluramine XM40J4 Ready-to-use therapeutic food – XM25W6 Mazindol – XM8K95 Cathine XM0N15 Solutions producing osmotic diuresis – XM2NX7 Clobenzorex – XM5BJ8 Mannitol – XM3DL8 Mefenorex – XM4HL5 Carbamide – XM7830 Etilamfetamine XM62S0 Antikaluretic – XM13P5 Sibutramine XM51Y8 Caloric agent – XM4NN9 Lorcaserin XM7BR0 Dextrose – XM54E8 Aminorex XM7UQ5 Electrolyte balance drug – XM4DD3 Benzphetamine XM9SL7 Electrolyte solutions – XM16Q1 Chlorphentermine – XM0U09 Potassium chloride – XM3AJ4 Cloforex – XM4XZ4 Sodium bicarbonate – XM8H60 Clortermine – XM0X22 Sodium chloride – XM5FP0 Diethylpropion – XM9VN8 Calcium chloride – XM1145 Fenproporex – XM1W37 Ammonium chloride – XM4PR1 Phenbutrazate – XM76C9 Sodium phosphate – XM6AJ3 Phendimetrazine – XM7F36 Sodium acetate – XM73T8 Phenmetrazine – XM6NV5 Magnesium phosphate – XM5DN4 Setmelanotide – XM03Q8 Magnesium chloride XM0NL0 Orlistat – XM40H8 Zinc chloride XM7GX4 Rimonabant – XM83Z9 Sodium glycerophosphate XM2520 Amfetamine and amfetamine derivatives – XM3T43 Potassium lactate – XM48Z9 Amfetamine – XM99L3 Cardioplegia solutions – XM2154 Fencamfamin – XM45S7 Potassium acetate – XM8N26 Fenetylline – XM3US9 Compound solution of sodium lactate – XM4SD7 Lisdexamfetamine – XM7E16 Gluconic acid – XM0462 Solriamfetol – XM2S34 Glycerophosphate – XM61E9 Sodium citrate XM5SC6 Sodium phenylbutyrate XM5Y58 Hartmann's solution XM1843 Nitisinone XM0KH7 Invert sugar XM19C6 Miglustat XM9XU2 Levulose XM6ZV0 Sapropterin XM39B5 Oral rehydration salts XM4F44 Glycerol phenylbutyrate XM39C1 Peritoneal dialysis solution XM0K95 Eliglustat XM03B7 Potassium-removing resin XM2QP5 Sodium benzoate XM5KE7 Potassium-retaining drug XM6QN8 Migalastat XM3UA2 Replacement solution XM53N4 Choline chloride XM4EK0 Sodium removing resins XM3KK0 Choline dihydrogen citrate XM9Y86 Sucrose XM7291 Inositol XM6JX1 Carnitine XM9J35 Adenine XM5S14 Electrolytes XM3CJ7 Flavine adenine dinucleotide XM9QW3 Trometamol XM7ZH6 Fosdenopterin XM7345 Ademethionine XM4L78 Lonafarnib XM1P36 Glutamine XM85F8 Mercaptamine XM0977 Carglumic acid XM9GM1 Fat emulsions XM4YU3 Carbohydrates XM55C2 Protein hydrolysates XM5W29 Aminometradine XM2E81 Amisometradine XM8U06 Anhydron XM8TM1 Benzothiadiazides XM0JW3 Benzylhydrochlorothiazide XM3ER5 Carbonic acid gas anhydrase inhibitor XM80T6 Chlorazanil XM6946 Chlormerodrin XM4JM8 Diupres XM4D06 Diuretic XM68T7 Diuretic benzothiadiazine XM8B36 Diuretic carbonic acid anhydrase inhibitors XM1N83 Diuretic furfuryl XM6VW0 Diuretic mercurial XM43Q2 Diuretic saluretic XM3558 Diuretic sulfonamide XM58W3 Diuretic thiazide XM04R3 Diurgin XM5L31 Flumethiazide XM8T28 Hydromox XM8HM6 Meralluride XM5R34 Merbaphen XM1SB8 Mercaptomerin XM3PF7 Mercumatilin XM3L13 Mercurophylline XM4B84 Osmotic diuretics XM6BR0 Purine diuretics XM7660 Regroton XM01E9 Salicylate theobromine calcium XM9409 Saluretic XM7J43 Sodium mersalate XM9VJ2 Thiomercaptomerin XM1177 Thiomerin XM0YS2 Tiamizide XM3YV1 Tripamide XM93H5 Xanthine diuretics XM3K70 Low-ceiling diuretics –– XM5FV5 Altizide –– XM64R7 Bendroflumethiazide –– XM7Q17 Benzthiazide –– XM83Q3 Butizide –– XM3PJ4 Chlorothiazide –– XM4SP9 Cyclopenthiazide –– XM1PM4 Cyclothiazide –– XM71N6 Disulfamide –– XM8532 Epitizide –– XM6910 Hydrochlorothiazide –– XM2671 Hydroflumethiazide –– XM3EW9 Mebutizide –– XM9T97 Methyclothiazide –– XM1DC4 Penflutizide –– XM7NZ7 Polythiazide –– XM26G2 Teclothiazide –– XM1L59 Trichlormethiazide – XM4AF6 Mersalyl – XM0G11 Cicletanine – XM6U69 Low-ceiling diuretic sulfonamides XM3N68 Antiarteriosclerotic drug –– XM8LD0 Betanidine XM2EA3 Anticholesterolemic drug –– XM3QD6 Guanethidine XM3108 Antihyperlipidemic drug –– XM3952 Guanoxan XM4FN5 Antilipemic drug –– XM4L51 Debrisoquine XM2GM2 b-benzalbutyramide –– XM4189 Guanoclor XM4KW6 b-sitosterol (s) –– XM4L63 Guanoxabenz XM6BA8 Benzalbutyramide –– XM6N54 Guanazodine XM4WS4 Benzyl nicotinate –– XM9M92 Ripasudil XM43X4 Binifibrate XM1AF9 Agents affecting arteriolar smooth muscle XM35X4 Cholesterol-lowering agents – XM7XR3 Thiazide derivatives XM8FB5 Cholestyramine (resin) –– XM8YG1 Diazoxide XM2LR7 Clinofibrate – XM9021 Hydrazinophthalazine derivatives XM6DX0 Clofibric acid –– XM2FP9 Dihydralazine XM2R17 Cyamopsis tetragono-loba –– XM8D89 Hydralazine XM8K49 Detaxtran –– XM1KN9 Endralazine XM8FC2 Ethylparachlorophen-oxyisobutyrate –– XM33U1 Cadralazine XM0TN1 Etiroxate – XM8V56 Antihypertensives for pulmonary arterial hypertension XM6B07 Etofylline clofibrate –– XM4KA3 Bosentan XM6DW9 Guar gum (medicinal) –– XM8HR5 Ambrisentan XM4E46 Halofenate –– XM7WR2 Sitaxentan XM2WA3 Ion exchange resin cholestyramine –– XM21T1 Macitentan XM0H99 Linoleic acid –– XM8BU0 Riociguat XM5VN6 Linolenic acid XM4NN7 Alkavervir XM0KD7 Mesoglycan XM28Y3 Alseroxylon XM45F6 Oleic acid XM6T97 Amiquinsin XM68L2 Pirozadil XM3WP0 Antagonist serotonin XM1Q10 Polidexide sulfate XM2PT6 Antihypertensive drug XM4UK3 Probucol XM0CY8 Apresoline XM2YX6 Safflower oil XM4FW8 Benazepril hydrochloride XM5F26 Sitosterols XM5E71 Budralazine XM2LX5 Soysterol XM9W04 Cryptenamine (tannates) XM3C43 Sunflower seed oil XM1TT7 DHE 45 XM95B1 Triparanol XM24X9 Dihydrazine XM3PL9 Unsaturated fatty acid XM7NV2 Guanabenz XM2KC4 Omega-3-triglycerides XM5ET8 Guanacline XM2AL6 Tiadenol XM5JL6 Guanadrel XM44B6 Meglutol XM7TE8 Guanoctine XM10P8 Magnesium pyridoxal 5-phosphate glutamate XM1LN2 Harmonyl XM9HP8 Policosanol XM4EP4 Hypotensive drug XM5BK7 Ezetimibe XM7W35 Methyldopate XM52K4 Alipogene tiparvovec XM1F18 Metirosine XM7049 Mipomersen XM7HA8 Moderil XM3RL5 Lomitapide XM1U35 Pargyline XM9F64 Evolocumab XM1GS9 Protoveratrine (s) (A) (B) XM1LB0 Alirocumab XM01D4 Raudixin XM2KT4 Evinacumab XM74W2 Rautina XM4RG7 Volanesorsen XM5FH0 Rautotal XM5PW7 Rauwoldin XM8BT9 Selective calcium-channel blockers XM00F2 Saralasin – XM3D74 Dihydropyridine derivatives XM6E07 Serpasil –– XM1BZ0 Felodipine XM2W66 Sodium nitroprusside –– XM1SC0 Isradipine XM8AK5 Syrosingopine –– XM3L32 Nicardipine XM3HS0 Teprotide –– XM3N90 Nifedipine XM5T36 Todralazine –– XM5TX8 Nimodipine XM48R9 Veratrine –– XM5W45 Nisoldipine XM8BQ9 Veratrum –– XM17Z8 Nitrendipine XM0YY0 Ketanserin –– XM2QH8 Lacidipine –– XM68M5 Amlodipine XM2856 Organic nitrates –– XM6PC3 Nilvadipine – XM8LK8 Glyceryl trinitrate –– XM3GA2 Manidipine – XM7KD0 Pentaerythrityl tetranitrate –– XM84M5 Barnidipine – XM0DY4 Propatylnitrate –– XM3MV9 Lercanidipine – XM3077 Isosorbide dinitrate –– XM3TF3 Cilnidipine – XM55H8 Trolnitrate –– XM8EW6 Benidipine – XM8SP5 Eritrityl tetranitrate –– XM5GS7 Clevidipine – XM5KH9 Tenitramine –– XM91L4 Levamlodipine – XM9UE1 Methylpropylpropanediol dinitrate – XM2XU6 Phenylalkylamine derivatives - selective – XM01Q8 Isosorbide –– XM5GX3 Verapamil XM6801 Amikhelline –– XM2WH6 Gallopamil XM5QW3 Bendazol – XM6GX5 Mibefradil XM3K91 Benziodarone – XM5K59 Diltiazem XM38C7 Carbocromen – XM1EL1 Tiapamil XM38U6 Coronary vasodilator – XM3BC0 Oxodipine XM0SG8 Cromonar XM2JS2 Non-selective calcium-channel blockers XM0MW9 Diisopropylamine – XM6T88 Phenylalkylamine derivatives - non-selective XM1E15 Dilazep –– XM1LR8 Bepridil XM8Q26 Dimoxyline –– XM5BR3 Fendiline XM5M47 Efloxate – XM3NU8 Lidoflazine XM3ZB0 Etafenone XM0T83 Moxonidine hydrochloride XM3E93 Fenalcomine XM6QE9 Fluorosol XM5JS3 Cardiac glycosides XM8Y13 Heptaminol – XM2EL5 Digitalis glycosides XM4A49 Hexadiline –– XM0QK0 Acetyldigitoxin XM5MP5 Hexobendine –– XM1640 Acetyldigoxin XM5B68 Isoamyl nitrite –– XM2GT4 Digitalis leaves XM5BS6 Itramin tosilate –– XM8VJ6 Digoxin XM9PV4 Khellin –– XM13W9 Digitoxin XM39T6 Khelloside –– XM8036 Lanatoside C XM30P9 Mannitol hexanitrate –– XM8XH2 Deslanoside XM5720 Molsidomine –– XM37V6 Metildigoxin XM7HW6 Nicorandil –– XM2505 Gitoformate XM5YX5 Nitrite, amyl (medicinal) (vapor) – XM71V6 Scilla glycosides XM4J35 Nitrous ether spirit –– XM1EG1 Proscillaridin XM1VC4 Octyl nitrite – XM6GX1 Strophanthus glycosides XM0A82 Organonitrate –– XM30Z9 Cymarin XM5YA6 Oxyfedrine –– XM9YU9 g-Strophanthin XM2N57 Pentaerythritol – XM3WU3 Peruvoside XM3VX9 Pentrinat XM2PQ4 Phosphodiesterase inhibitors XM7F31 Perhexiline – XM0QD0 Amrinone XM7FE6 Piridoxilate – XM6JT4 Milrinone XM4K89 Prenylamine – XM2H68 Enoximone XM2BJ0 Sweet niter spirit – XM4BC1 Bucladesine XM24R2 Trapidil XM1K71 Predominantly alpha-adrenoreceptor and dopamine receptor agonists XM5770 Triethanolamine trinitrate (biphosphate) – XM9NM4 Dopamine XM8YZ8 Trinitrine – XM2A75 Norfenefrine XM23M8 Flosequinan – XM5HS9 Oxedrine XM6V17 Imolamine – XM6L38 Metaraminol XM0UA6 Cinepazet – XM2CG2 Methoxamine XM30L8 Cloridarol – XM4B54 Gepefrine XM5AY1 Linsidomine – XM1641 Ibopamine XM2460 Nesiritide – XM6LP2 Dimetofrine XM1M18 Serelaxin – XM4ZY2 Dopexamine XM2VG8 Regadenoson – XM79K5 Midodrine XM1HP8 Meldonium – XM91X4 Fenoldopam – XM2BX9 Cafedrine XM6G82 Tadalafil – XM1CS6 Theodrenaline XM9AZ1 Vardenafil – XM9QY5 Dexmedetomidine XM65A3 Sildenafil – XM38P3 Amidefrine mesilate XM7DC4 Aluminium nicotinate – XM7AV8 Fenoxazoline XM1269 Azapetine – XM0H59 Indanazoline XM3GB4 Bencyclane – XM5J98 Metizoline XM3FH5 Brovincamine – XM3Q12 Naphazoline XM3B71 Buflomedil – XM4KH5 Oxymetazoline XM6XW8 Butalamine – XM4435 Propylhexedrine XM1UQ0 Cetiedil – XM1RJ9 Tramazoline XM7LH3 Cinepazide – XM8706 Tuaminoheptane XM16K3 Cyclandelate – XM0240 Tymazoline XM9Q04 Dihydroergocornine – XM8US0 Xylometazoline XM7K86 Dihydroergokryptine XM3WW1 Dihydroergotoxine – XM96M5 Agonist predominantly beta-adrenoreceptor XM9CH9 Etofylline – XM10L5 Angiotensin XM8317 Hepronicate – XM3D85 Beclomethasone XM2LT4 Hydromethylpyridine – XM4E14 Dobutamine XM86J1 Ifenprodil – XM18Q9 Prenalterol XM8MZ0 Kallidinogenase – XM5HL3 Racepinephrine XM5TC7 Kallikrein – XM1CS3 Ritodrine XM6F75 Lipo-alprostadil – XM1X48 Selective beta-2-adrenoceptor agonists XM46T4 Minoxidil –– XM8MA0 Salbutamol XM8YE5 Moxisylyte –– XM6NE3 Terbutaline XM3J93 Naftidrofuryl –– XM2HS2 Fenoterol XM3PK2 Niacin –– XM3NS3 Clenbuterol XM2GA2 Nicametate –– XM7MM4 Reproterol XM5TA2 Nicofuranose –– XM2YD0 Procaterol XM0274 Nicotinyl alcohol –– XM15R7 Bitolterol XM6B85 Nylidrin –– XM2U16 Bambuterol XM12T2 Phenoxybenzamine –– XM51C1 Indacaterol XM67M9 Prostaglandin E1 –– XM1QR3 Olodaterol XM1B47 Raubasine –– XM05Y4 Broxaterol XM9761 Suloctidil –– XM4ZB3 Carbuterol XM07V4 Tetranicotinoyl fructose –– XM22C3 Rimiterol XM4074 Thurfyl nicotinate –– XM1GA5 Hexoprenaline XM79S2 Thymoxamine –– XM8ZC3 Isoetarine XM1UM9 Vasodilan –– XM1QR7 Pirbuterol XM3LG1 Vinburnine –– XM3GQ2 Tretoquinol XM51E4 Viquidil –– XM2YE0 Tulobuterol XM0122 Xanthinol nicotinate –– XM6B34 Salmeterol XM0BT5 2-amino-1-phenylethanol derivatives –– XM27W7 Clorprenaline – XM5RH0 Isoxsuprine –– XM4YX5 Etafedrine – XM0HU4 Bamethan –– XM55D7 Ibuterol XM0B82 Imidazoline derivatives –– XM6EU7 Levalbuterol – XM5NP2 Phentolamine –– XM0QJ7 Formoterol – XM3BY1 Tolazoline – XM6KG3 Isoprenaline XM5NF4 Purine derivatives – XM6AG0 Orciprenaline – XM5RL7 Pentifylline – XM78W6 Methoxyphenamine – XM91G7 Xantinol nicotinate – XM9TS0 Octopamine – XM8BD1 Pentoxifylline – XM17S3 Arbutamine – XM0JV4 Etofylline nicotinate – XM0FE9 Protokylol XM9PA9 Pinacidil XM7YK1 Alpha acetyldigoxin XM3VH9 Vincamine XM0SY1 b-acetyldigoxin XM68C7 Visnadine XM91S1 Cardiotonic (glycoside) XM0XY6 Ergot alkaloids XM1W74 Cerberin – XM0U65 Ergoloid mesylates XM5NG4 Ch'an su – XM5TD8 Nicergoline XM11U7 Convallaria glycosides – XM0TP6 Dihydroergocristine (mesilate) XM4Q19 Crataegus extract – XM93Q7 Methylergometrine XM7RY5 Digitalin (e) – XM3LX6 Ergometrine XM2SP4 Digitalis lanata – XM5P25 Ergotamine XM3Y64 Digitalis purpurea – XM4G36 Methysergide XM0V98 Digitoxose – XM4E49 Lisuride XM0DG3 Gitalin XM4CT2 fasudil XM8K74 Gitaloxin XM5021 Yohimbine XM7KP5 Lanatosides XM1WB2 Avanafil XM2X57 Meproscillarin XM4914 Udenafil XM6AA6 Oleandrin XM0N63 Ouabain (e) XM20Z9 Adrenochrome semicarbazone (mono) XM02F5 Pengitoxin XM7NH6 Adrenochrome derivative XM77L9 Squill XM8ZY5 Aurantiin XM2AW9 Strophanthin XM6YS0 Benzopyrone XM0EP6 Angiotensinamide XM3LU4 Calcium dobesilate XM45U9 Xamoterol XM53V8 Chlorisondamine chloride XM88B5 Levosimendan XM1H36 Escin XM11H1 Angiotensin II XM8AB2 Ethoxazorutoside XM6BM1 Flavodic acid XM4MG6 Imidapril XM2FU1 Antiarrhythmics, class Ia XM0WZ5 Hesperidin XM72L5 Angiotensin-converting-enzyme inhibitors – XM8AL5 Quinidine XM63M1 Leucocianidol – XM3FH7 Renin-inhibitors – XM4MK3 Procainamide XM4U20 Metescufylline – XM9N15 Zofenopril – XM8B35 Disopyramide XM6102 Phenopyrazone – XM8091 Spirapril – XM9ZC0 Sparteine XM6EY7 Pholedrine – XM2A48 Ramipril – XM5CS7 Ajmaline XM62Q1 Adenosine – XM3DU1 Quinapril – XM18V8 Lorajmine XM3PB7 Trimetazidine – XM58G7 Perindopril – XM0D87 Hydroquinidine XM5FW1 Camphora – XM7TF8 Lisinopril – XM6FW1 Prajmaline XM7F77 Crataegus glycosides – XM4Z53 Fosinopril XM7844 Antiarrhythmics, class Ib XM6619 Creatinolfosfate – XM5609 Enalaprilat – XM2BR1 Lidocaine XM8R77 Fosfocreatine – XM6X56 Enalapril –– XM93V0 Lidocaine regional XM2PV3 Fructose 1,6-diphosphate – XM1AZ4 Cilazapril –– XM4RU4 Lidocaine spinal XM4MP2 Ubidecarenone – XM6P97 Captopril – XM3XK1 Mexiletine XM2UJ1 Acadesine – XM0HG1 Benazepril – XM1V81 Tocainide XM09Q3 Ivabradine – XM7169 Angiotensin II antagonists – XM37J0 Aprindine XM9DF5 Ranolazine –– XM7DY0 Losartan XM0NC9 Antiarrhythmics, class Ic XM2DH5 Tiazotic acid –– XM2F90 Eprosartan – XM9R82 Propafenone –– XM29M2 Valsartan – XM1E38 Flecainide XM50P4 Capillary stabilising agents –– XM1935 Irbesartan – XM04P2 Lorcainide – XM41G5 Bioflavonoids –– XM0T42 Tasosartan – XM6TZ8 Encainide –– XM5734 Rutoside –– XM4168 Candesartan – XM23Q8 Ethacizine –– XM6UE1 Diosmin –– XM2P63 Telmisartan XM1AP6 Antiarrhythmics, class III –– XM71U2 Troxerutin –– XM1B39 Olmesartan medoxomil – XM3ZJ7 Amiodarone –– XM7EF1 monoxerutin –– XM5GC5 Azilsartan – XM3ZG2 Bretylium tosilate –– XM2SA0 hidrosmin –– XM2T51 Fimasartan – XM56N7 Bunaftine – XM6N03 Tribenoside – XM3YY8 Alacepril – XM1143 Dofetilide – XM1PT0 Naftazone – XM3F15 Trandolapril – XM8AA1 Ibutilide – XM0MJ2 Hippocastani semen – XM3DT0 Delapril – XM8QN8 Tedisamil – XM93T6 Esculin – XM6DX1 Moexipril – XM8K75 Dronedarone – XM25N5 Temocapril XM5JW0 Other antiarrhythmics, class I and III – XM0NL5 Antivaricose drug – XM1SV2 Cibenzoline – XM57B0 Dextrose concentrated solution, intravenous XM5SK2 HMG CoA reductase inhibitors – XM6KX7 Moracizine – XM1ME2 Ethanolamine oleate – XM7AU9 Simvastatin – XM6602 Vernakalant – XM6C05 Phenol in oil injection – XM7SM7 Pravastatin XM0KK7 Antidysrhythmic – XM9854 Sclerosing agent – XM72M6 Lovastatin XM9ZL3 Cardiac depressants – XM3846 Sodium morrhuate – XM5UF1 Fluvastatin XM2W76 Cardiac rhythm regulator specified – XM52L8 Sodium psylliate – XM2WF6 Atorvastatin XM88L7 Cardiac rhythm regulator – XM2N32 Sodium tetradecyl sulfate – XM0M94 Cerivastatin XM0Y13 Pilsicainide – XM1LV9 Varicose reduction drug – XM6NK5 Rosuvastatin XM64X0 Prajmalium bitartrate – XM3FL1 Venous sclerosing drug – XM8420 Pitavastatin XM1NG6 Quinaglute – XM4J29 Zinc antivaricose XM1KP1 Fibrates XM7MH8 Tiracizine – XM3WS8 Monoethanolamine – XM19J9 Clofibrate – XM4DD8 Polidocanol – XM3F75 Bezafibrate XM4X84 Centrally acting antiadrenergic agents – XM81W1 Sotradecol – XM7929 Aluminium clofibrate – XM67X4 Rauwolfia alkaloids – XM01S9 Gemfibrozil –– XM9SB3 Rescinnamine – XM73E0 Fenofibrate –– XM7424 Deserpidine – XM6MW5 Simfibrate –– XM0ND0 Methoserpidine – XM39Z8 Ronifibrate –– XM2764 Reserpine – XM9HU7 Ciprofibrate –– XM39Z4 Rauwolfia alkaloids, whole root – XM4390 Etofibrate –– XM64M5 Bietaserpine – XM93U8 Clofibride – XM9G49 Methyldopa – XM9554 Choline fenofibrate –– XM54Y3 Methyldopa, levorotatory XM1W44 Bile acid sequestrants –– XM9ZV9 Methyldopa, racemic – XM0HQ4 Colestyramine – XM2298 Imidazoline receptor agonists – XM0KK8 Colestipol –– XM6GV8 Clonidine – XM5RQ3 Colextran –– XM5KP4 Guanfacine – XM6MC3 Colesevelam –– XM9SU8 Tolonidine XM0563 Nicotinic acid and derivatives –– XM4NH5 Moxonidine – XM5QD1 Inositol nicotinate –– XM6AB8 Rilmenidine – XM48Y3 Ciclonicate XM7NT3 Ganglion-blocking antiadrenergic agents – XM6QT0 Acipimox XM8SX7 Peripherally acting antiadrenergic agents – XM2KX4 Oxiniacic acid – XM3EN5 Guanidine derivatives – XM2305 Homochlorcyclizine – XM1389 Diflos – XM59T1 Embramine – XM86K6 Difluorophate – XM8ZH9 Dimenhydrinate – XM0UQ3 Diisopropylfluorophosphonate – XM29D4 Difenidol – XM5YK5 Distigmine bromide – XM62B0 Dibenzheptropine – XM6565 Edrophonium chloride – XM8Y26 Cyclopentamine – XM99M6 Galantamine – XM0Y33 Clemizole – XM1NE7 Isoflurophate – XM4PH8 Chlorothen – XM40R6 Neomycin with neostigmine – XM66X7 Chlor-Trimeton – XM3671 Neostigmine bromide – XM0AN5 Cetoxime – XM3YR0 Prostigmin – XM88Z7 Bisulepin (hydrochloride) – XM41N9 Pyridostigmine bromide – XM35M7 Benzquinamide – XM4LN1 Tacrine – XM25T0 Apraclonidine (hydrochloride) – XM62U1 Donepezil – XM0W81 Antistine – XM0NP3 Rivastigmine – XM6XN3 Phenylpropanolamine – XM3B88 Ipidacrine – XM6ZQ3 Phenylephrine – XM8C30 Neostigmine – XM0CL2 Pseudoephedrine – XM4NE1 Pyridostigmine XM7494 Arecoline XM0000 Benzpyrinium bromide – XM45W7 Prazosin XM0MZ4 Bethanechol chloride – XM3L37 Indoramin XM4LE7 Cholinergic (drug) – XM58X5 Doxazosin XM4ZZ7 Cholinergic muscle tone enhancer – XM30L7 Urapidil XM6VJ2 Cholinergic trimethyl ammonium propanediol – XM2L44 Alpha adrenergic blocking drug XM8JX6 Parasympathomimetic drug – XM6MJ9 Bunazosin XM0RX5 Pilocarpine – XM4UW6 Dibenamine XM5EY0 Pilocarpus extract (jaborandi) – XM70W7 Dibenzyline XM9223 Choline esters – XM3Y81 Hydergine – XM4AT9 Carbachol – XM81R1 Priscol, Priscoline – XM9XA2 Bethanechol – XM3F82 Tamsulosin XM63Q0 Choline alfoscerate – XM9LH2 Terazosin XM31K4 Cevimeline – XM1C94 Alfuzosin XM6PN9 Varenicline – XM7D19 Trimazosin XM7HS1 Cytisinicline – XM1FQ5 Silodosin XM4C58 Amifampridine – XM7R98 Beta-adrenoreceptor antagonists, non selective XM90S5 Hexamethonium bromide –– XM2YK6 Alprenolol XM13Z0 Mecamylamine –– XM0M15 Oxprenolol XM8JB8 Pempidine –– XM2SH3 Pindolol XM68K9 Pentamethonium bromide –– XM3HA9 Propranolol XM2A33 Pentolonium tartrate –– XM1KQ9 Timolol XM3YS6 Quaternary ammonium ganglion blocking –– XM5BT4 Sotalol XM6JW6 Tetraethylammonium chloride –– XM69F3 Nadolol XM9MS2 Tetrylammonium chloride –– XM89L8 Mepindolol XM3YZ9 Trimetaphan camsilate –– XM1AJ9 Carteolol XM4BZ9 Trimethaphan –– XM6489 Tertatolol XM9BT3 Trimethidinium –– XM79L8 Bopindolol –– XM9RX1 Bupranolol –– XM17Y6 Penbutolol –– XM2M62 Cloranolol – XM9MF0 Beta-adrenoreceptor antagonists, selective –– XM9VG1 Practolol –– XM8L21 Metoprolol –– XM0M62 Atenolol –– XM0V36 Acebutolol –– XM7U87 Betaxolol –– XM0HY3 Bevantolol –– XM8QC9 Bisoprolol –– XM54E1 Celiprolol –– XM4AB1 Esmolol –– XM1T80 Epanolol –– XM7115 S-atenolol –– XM0995 Nebivolol –– XM3156 Talinolol –– XM44F9 Landiolol – XM5S93 Beta adrenergic blocking agent, heart – XM8026 Bunitrolol – XM3N87 Carazolol – XM7V19 Indenolol – XM91L7 Pronetalol – XM77W2 Tolamolol XM77E7 Alpha and beta blocking agents, antagonists – XM8ER3 Labetalol – XM80G6 Carvedilol – XM0TY3 Medroxalol XM9FY5 Agents predominantly used for gastrointestinal disorders – XM8921 Synthetic anticholinergics, esters with tertiary amino group –– XM5D56 Oxyphencyclimine –– XM5RM7 Camylofin –– XM90R8 Mebeverine –– XM0EL4 Trimebutine –– XM7GS6 Rociverine –– XM0CE0 Dicycloverine –– XM24K8 Piperidolate –– XM1LM4 Oxyphenonium –– XM05C6 Propantheline –– XM8YF7 Otilonium bromide –– XM5WL4 Methantheline –– XM6XN4 Isopropamide –– XM1WN2 Hexocyclium –– XM7EV5 Poldine –– XM7W33 Mepenzolate –– XM6FV2 Pipenzolate –– XM63B0 Bevonium –– XM4SN3 Dihexyverine –– XM2043 Difemerine – XM26J4 Synthetic anticholinergics, quaternary ammonium compounds –– XM2WF7 (2-benzhydryloxyethyl)diethyl-methylammonium iodide –– XM2LU4 Tiemonium iodide –– XM6X69 Prifinium bromide –– XM51J2 Timepidium bromide –– XM7XV6 Benzilone –– XM4LY7 Tridihexethyl –– XM0D83 Fenpiverinium – XM7W64 Synthetic antispasmodics, amides with tertiary amines –– XM4VE1 Dimethylaminopropionylphenothiazine –– XM5LN3 Nicofetamide –– XM36J3 Tiropramide – XM7FH3 Papaverine and derivatives –– XM8X70 Papaverine –– XM13K8 Drotaverine –– XM1V30 Moxaverine – XM6089 Belladonna alkaloids and derivatives –– XM7Y01 Atropine –– XM11J9 Hyoscyamine –– XM4P67 Methylatropine –– XM0PN2 Cimetropium bromide –– XM1642 Homatropine methylbromide –– XM1MW1 Scopolamine –– XM0QS6 Butylscopolamine –– XM3068 Methylscopolamine –– XM08K5 Fentonium XM1JA8 Agents predominantly used for urinary frequency and incontinence XM6WD2 Anticholinergics predominantly used for Parkinson disease – XM8U00 Tertiary amines –– XM4RV4 Metixene –– XM9W98 Trihexyphenidyl –– XM65C9 Biperiden –– XM9AG2 Procyclidine –– XM8VR6 Profenamine –– XM1H88 Dexetimide –– XM64K1 Phenglutarimide –– XM8T72 Bornaprine –– XM4YL9 Tropatepine –– XM3FW6 Mazaticol –– XM0HT8 Diethazine – XM3B14 Ethers chemically close to antihistamines –– XM7U62 Orphenadrine –– XM8UB6 Etanautine – XM72C6 Ethers of tropine or tropine derivatives –– XM8ZR2 Benzatropine –– XM2789 Etybenzatropine XM0CR7 Emepronium bromide XM1Q67 Adiphenine XM0DF0 Ambutonium bromide XM0TL7 Aminopentamide XM1Q22 Amprotropine XM3HR2 Aniscoropine XM0B31 Anticholinergic XM5BE4 Antimuscarinic XM66R0 Artane XM7LZ6 Atropine derivative XM5098 Belladonna alkaloids XM6RQ9 Belladonna extract XM2YW9 Belladonna herb XM29D7 Benactyzine XM3NJ0 Benaprizine XM54W7 Benzilonium bromide XM8NZ1 Benztropine anticholinergic XM5ML2 Butropium bromide XM1T59 Butyl scopolamine bromide XM9633 Caramiphen XM8JS6 Carpronium chloride XM2619 Clidinium bromide XM8KY2 Clorotepine XM2HD0 Cogentin XM0VC2 Cyclodrine XM7VB2 Cyclopentolate XM93T2 Cycrimine XM4CZ8 Dibutoline sulfate XM89R5 Diphemanil XM1M52 Duboisine XM3A08 Dyphylline XM17M9 Ethaverine XM62B7 Etomidoline XM1VS4 Euphthalmine XM6L51 Extrapyramidal antagonist XM3L41 Flopropione XM8WX2 Hexasonium iodide XM7832 Homatropine XM1EF8 Hyoscyamus XM4FB2 Hyoscyamus dry extract XM4QH8 Isopropamide iodide XM5ED5 Levsin XM0WK8 Mepenzolate bromide XM1FH6 Mepiperphenidol XM39X0 Methanthelinium bromide XM0E13 Methscopolamine bromide XM3KR9 Methylatropine nitrate XM14X3 Methylbenactyzium bromide XM5F96 Milverine XM3YV6 Muscle affecting agents relaxants smooth XM4U03 Octatropine methyl-bromide XM5YT3 Oxapium iodide XM3A77 Parasympatholytic XM8U27 Penthienate XM6MG0 Pipethanate XM7711 Pramiverine XM3CK8 Profenil XM7VK4 Propantheline bromide XM1JN1 Quaternary ammonium parasympatholytic XM3UE6 Scopolia extract XM31L2 Smooth muscle relaxant XM7PY1 Spacoline XM14Z1 Spasmolytic anticholinergics XM6RA6 Spasmolytic autonomic XM9NH9 Spasmolytic quaternary ammonium XM0GS2 Thiphenamil XM9WW9 Tiemonium XM8346 Tigloidine XM2595 Tiquizium bromide XM8YD7 Toquizine XM64P0 Triampyzine XM2TJ3 Tricyclamol chloride XM17K9 Tridihexethyl iodide XM5S52 Trimeprazine (tartrate) XM2M46 Triperiden XM4YB7 Tritiozine XM2973 Tropacine XM4466 Tropicamide XM8F25 Trospium chloride XM1CE8 Anticholinergics predominantly used for obstructive airway diseases – XM54K2 Ipratropium bromide – XM55K5 Oxitropium bromide – XM42V2 Glycopyrronium bromide – XM6LS6 Stramonium – XM9HA8 Tiotropium bromide – XM2PE9 Aclidinium bromide – XM3MF8 Umeclidinium bromide – XM8BL4 Revefenacin – XM4DL3 Flutropium bromide XM9FU4 Propiverine XM82U8 Tolterodine XM2Z66 Solifenacin XM7V08 Trospium XM1N89 Darifenacin XM4265 Fesoterodine XM5L72 Mirabegron XM36U7 Alpha- and beta-adrenoreceptor agonists XM5QR7 Desfesoterodine – XM9187 Etilefrine XM6190 Emepronium – XM6RQ3 Mephentermine XM0CH2 Flavoxate – XM3273 Epinephrine XM0M49 Meladrazine – XM10F0 Amezinium metilsulfate XM0LB8 Oxybutynin – XM5H72 Ephedrine XM4DW3 Terodiline – XM7B75 Droxidopa – XM9K94 Ethylnorepinephrine XM4AJ3 Aceclidine – XM1H52 Cinnamedrine XM1EC3 Acetylcholine chloride XM3LR7 Predominantly alpha-adrenoreceptor agonists XM3GM3 Acetylcholine derivative – XM39Y4 Thenyldiamine – XM2V55 Phenyltoloxamine – XM4PZ3 Ambenonium – XM7D21 Paredrine – XM8KF3 Anticholinesterase – XM81D8 Norepinephrine – XM87V2 Anticholinesterase organophosphorus – XM7RF2 Moxastine – XM9D92 Anticholinesterase reversible – XM8TK4 Methaphenilene – XM4VC4 Cholinergic organophosphorus – XM4TB9 Levocabastine (hydrochloride) – XM1L81 DFP XM51D2 Disulfiram XM2FC3 Calcium carbimide XM6BN2 Nicotine XM9T01 Acamprosate XM14C0 Betahistine XM7CE7 Cinnarizine XM52G4 Flunarizine XM2U21 Acetylleucine XM9KN8 Zipeprol XM6SJ0 Dibunate XM1G75 Meprotixol XM2W89 Morclofone XM7UA5 Nepinalone XM06F9 Butetamate XM4SL3 Gefapixant XM4J58 Antihistamines XM2JE5 First-generation antihistamine – XM8MV2 Aminoalkyl ethers –– XM1TL5 Bromazine –– XM6KY0 Diphenhydramine –– XM3DL4 Clemastine –– XM4QD7 Chlorphenoxamine –– XM7GV4 Diphenylpyraline –– XM9KZ9 Carbinoxamine –– XM77K6 Doxylamine –– XM7180 Piprinhydrinate –– XM3FN3 Rotoxamine – XM5YE8 Substituted alkylamines –– XM5PK9 Brompheniramine –– XM6CF9 Dexchlorpheniramine –– XM74S1 Dimetindene –– XM9VG3 Chlorpheniramine –– XM4UU4 Pheniramine –– XM1107 Dexbrompheniramine –– XM4AA0 Talastine – XM9MB0 Substituted ethylene diamines –– XM54R1 Pyrilamine –– XM9CM1 Chloropyramine –– XM0N55 Tripelennamine –– XM7TD1 Methapyrilene –– XM6NM2 Thonzylamine –– XM4NS9 Histapyrrodine – XM52P9 Phenothiazine derivatives –– XM1N75 Alimemazine –– XM0605 Promethazine –– XM9QY1 Thiethylperazine –– XM5E89 Methdilazine –– XM5EB9 Mequitazine –– XM5DB5 Oxomemazine –– XM4Z91 Isothipendyl –– XM5QG6 Hydroxyethylpromethazine –– XM29Q8 Thiazinam – XM9NA0 Piperazine derivatives of first-generation antihistaminic agents –– XM8GH2 Buclizine –– XM0S26 Cyclizine –– XM9SK3 Chlorcyclizine –– XM1A78 Meclozine –– XM6AV1 Oxatomide –– XM0QD9 Cetirizine –– XM07V7 Piperazine –– XM1VF1 Diethylcarbamazine –– XM5AC9 Levocetirizine – XM4GX4 Bamipine – XM11C5 Cyproheptadine – XM9BD4 Phenindamine – XM5Q41 Antazolin XM0Q45 Ergot derivative – XM8RT2 Triprolidine XM77J5 Ergot prepared – XM6Z93 Azatadine XM5NB5 Ergotocine – XM4280 Mebhydrolin XM4534 Hormone oxytocic – XM7ZS2 Thenalidine XM8BU6 Muscle affecting agents oxytocic – XM0404 Pipoxizine XM5606 Prostaglandin F2 alpha – XM5463 Setastine XM7F20 Tocosamine XM3B95 Second-generation antihistamine XM6MR2 Vetrabutine – XM6G21 Piperazine derivatives of second-generation antihistaminic agents – XM7S59 Astemizole XM8SY4 Muscle relaxants, peripherally acting – XM2S36 Terfenadine – XM23H5 Alcuronium – XM4PE5 Loratadine – XM7139 Tubocurarine – XM4F63 Ketotifen – XM2RT6 Dimethyltubocurarine – XM4GA2 Acrivastine – XM0L61 Hexafluronium – XM9VB8 Azelastine – XM87E3 Fazadinium bromide – XM9EU0 Ebastine – XM2SB5 Mivacurium chloride – XM7J45 Mizolastine – XM0FZ0 Atracurium – XM1586 Fexofenadine – XM0Q59 Pipecuronium bromide – XM2656 Desloratadine – XM2811 Doxacurium chloride – XM3E25 Rupatadine – XM4R62 Rocuronium bromide – XM1WZ8 Bilastine – XM0SQ7 Cisatracurium – XM3YG8 Quifenadine – XM9M51 Botulinum toxin XM57C9 Pyrrobutamine XM9YY8 Muscle relaxants, centrally acting XM8ZS4 Deptropine – XM5AB5 Carbamic acid esters XM0J21 Tritoqualine –– XM8DV7 Phenprobamate XM70F3 Pimethixene –– XM2DC7 Carisoprodol XM5BJ5 Epinastine –– XM7AC3 Methocarbamol XM40P7 Sequifenadine –– XM3KM3 Styramate XM9L77 Doxantrazole –– XM2339 Febarbamate – XM09D8 Oxazol, thiazine, and triazine derivatives XM0AP5 Almitrine –– XM8MD5 Chlormezanone XM9QA2 Amiphenazole –– XM7Q44 Chlorzoxazone XM0WB3 Bemegride –– XM7ZQ9 Zoxazolamine XM5T65 Bicuculline –– XM5PZ1 Metaxalone XM7BN2 Central nervous system stimulants analeptics – XM09Y8 Suxamethonium XM6938 Central nervous system stimulants opiate antagonists – XM5CB4 Pancuronium XM3465 Crotethamide with cropropamide – XM9416 Gallamine XM0A24 Dimefline – XM7S28 Vecuronium XM2ZT4 Dimorpholamine – XM6X03 Orphenadrine citrate XM3FP9 Doxapram – XM5US2 Baclofen XM6D72 Etamivan – XM1BK1 Tizanidine XM6YR1 Leptazol – XM26R3 Pridinol XM4CU0 Lobeline – XM4MA5 Tolperisone XM0001 Nikethamide – XM1HD7 Mephenesin XM0Q86 Pentetrazol – XM2RH8 Tetrazepam XM5VY2 Pimeclone – XM7LP5 Cyclobenzaprine XM4901 Prethcamide – XM52Y2 Thiocolchicoside XM1D17 Mepixanox – XM9UU4 Eperisone XM04S2 Other respiratory system products – XM7995 Fenyramidol XM4HQ2 Nitric oxide – XM0W80 Afloqualone XM3CW0 Ivacaftor XM3V06 Aclatonium napadisilate XM15G5 Ivacaftor and lumacaftor XM9RW1 Anesthesia muscle relaxation XM2QZ5 Ivacaftor and tezacaftor XM5GC4 Atracurium besilate XM8PU1 Carbolonium (bromide) XM7DG2 Decamethonium bromide XM6XS1 Dimethyltubocurarinium chloride XM8A87 Flaxedil XM9QC2 Hexafluorenium bromide XM9WH2 Hexanuorenium XM82Z5 Hexcarbacholine bromide XM3676 Laudexium XM3RJ7 Methocarbamol skeletal muscle relaxant XM4W78 Muscle affecting agents relaxants skeletal XM3SC6 Myoneural blocking agents XM2UG5 Neuromuscular blocking drug XM8QC2 Skeletal muscle relaxants XM91M0 Spasmolytic skeletal muscle XM7142 Suxethonium chloride XM9502 Woorali XM5ZN8 Dantrolene XM82K6 Botox XM0WW2 Bruceine XM7E87 Hydrastine XM7C89 Lututrin XM20G5 Strychnine medicinal XM8NV1 Duchenne muscular dystrophy therapy – XM1CL7 Ataluren – XM7H79 Drisapersen – XM0BM1 Eteplirsen XM6TG6 Hydroquinine XM0TQ8 Aceneuramic acid XM90G7 Nusinersen XM0U21 Viltolarsen XM4VE2 Casimersen XM9P78 Drugs for obstructive airway diseases XM3R34 Cromoglicic acid XM4TP3 Nedocromil XM0B09 Antileukotrienes – XM9BZ0 Zafirlukast – XM1C43 Pranlukast – XM10P5 Montelukast – XM12R0 Ibudilast XM4U85 Monoclonal antibodies used in airway diseases – XM4LH9 Omalizumab – XM6VB5 Reslizumab – XM0KT0 Benralizumab XM82N7 Amlexanox – XM5SD1 Acefylline piperazine – XM1719 Acepifylline – XM6493 Ambuphylline – XM5XJ1 Aminophylline – XM5Y44 Bamifylline – XM1QL3 Bufylline – XM31P6 Enprofylline – XM1W21 Etamiphylline – XM3ZP6 Levoproxyphylline – XM81W0 Oxtriphylline – XM5YJ3 Proxyphylline – XM4L37 Theobromine – XM1FP4 Theophylline – XM07L0 Theophylline aminobenzoic acid – XM07F4 Theophylline piperazine p-amino-benzoate – XM9608 Doxofylline – XM7X44 Mepyramine theophyllinacetate XM42T9 Fenspiride XM40T5 Eprozinol XM8DS8 Seratrodast XM53U2 Roflumilast XM5Y33 Tranilast XM2351 Bufrolin XM9Y50 Tezepelumab XM6JV7 Ambroxol XM4A47 Ammonium chloride expectorant XM8CT0 Bromhexine XM9FP2 Calcium iodide XM3XU8 Carbocisteine XM2NU9 Cough mixture (syrup) XM1MJ1 Cough mixture expectorants XM81Q9 Creosote XM4C87 Creosote syrup XM68U4 Deglycyrrhizinized extract of liquorice XM1KM0 Domiodol XM28N4 Dornase XM71N5 Eprazinone XM7QX2 Glyceryl guaiacolate XM86G0 Glycyrrhiza extract XM3CL2 Glycyrrhizic acid XM8EW0 Glycyrrhizinate potassium XM0G60 Guaiacol derivatives XM48K1 Guaimesal XM8GY5 Guaiphenesin XM31Y1 Hydriodic acid XM3E62 Iodide potassium (expectorant) XM60L0 Iodinated glycerol XM8BL3 Ipecacuanha XM2K57 Letosteine XM9Q09 Liquorice XM6MB5 Mecysteine XM4DQ1 Mucolytic drug XM4KG8 Organidin XM8A78 Quillaja extract XM44A1 Respiratory drug expectorant XM4Y94 S-Carboxymethyl-cysteine XM1Y62 Senega XM92P8 Sobrerol XM06E7 Sodium dibunate XM2BM5 Sputum viscosity-lowering drug XM7BF1 Stepronin XM1PU5 Sulfogaiacol XM6JE5 Superinone XM1CP3 Tenoglicin XM0ES0 Terpin hydrate (cis) XM1F74 Tyloxapol XM1KG9 Antimony pentasulfide XM61F4 Dornase alfa XM48C4 Althaeae radix XM8983 Guaiacolsulfonate XM5QU8 Levoverbenone XM48W4 Hederae helicis folium XM7Q79 Cineole XM66E3 Neltenexine XM7Y66 Erdosteine XM6NJ7 Benproperine XM8G23 Benzonatate XM1U36 Bibenzonium bromide XM8WM3 Butamirate XM4D27 Clobutinol XM9DL9 Chlophedianol XM80M9 Cloperastine XM9KL2 Dimethoxanate XM6995 Dropropizine XM61F3 Ethyl dibunate XM0SA9 Fedrilate XM5BB1 Fominoben XM8300 Isoaminile XM97D0 Levodropropizine XM3WX2 Methorate XM2ET3 Oxeladin XM9FU3 Oxolamine XM4331 Pentoxyverine XM7G25 Picoperine XM84C4 Pipazetate XM0HR9 Piperidione XM8JR1 Prenoxdiazine – XM2LW5 Ceftaroline fosamil XM2SD6 Imidazole derivatives – XM9EM7 Pneumococcal vaccines XM4393 Antiprotozoal drug – XM7RT0 Ceftolozane and beta-lactamase inhibitor – XM9UH0 Miconazole –– XM9G97 Pneumococcal conjugate (13-valent) vaccines XM2HL1 Antitrichomonal drug XM8SY8 Sulfonamides and trimethoprim derivatives – XM9795 Ketoconazole –– XM2249 Pneumococcal polysaccharide 23-valent vaccines XM83L5 Bialamicol – XM3MG7 Trimethoprim derivatives XM4GT1 Triazole and tetrazole derivatives –– XM91D7 Pneumococcus, purified polysaccharides antigen vaccines XM8E05 Carbarsone –– XM7NY9 Trimethoprim – XM97S6 Fluconazole –– XM96S7 Pneumococcus, purified polysaccharides antigen conjugated vaccines XM8DJ7 DHE – XM8162 Short-acting sulfonamides – XM5XD2 Itraconazole –– XM4R39 Pneumococcus purified polysaccharides antigen and Haemophilus influenzae, conjugated vaccines XM1RE2 Glaucarubin –– XM0XY9 Sulfamethizole – XM70R4 Voriconazole – XM5L44 Tetanus vaccines XM1LB9 Hydroxystilbamidine –– XM72R1 Sulfapyridine – XM1VE3 Posaconazole –– XM29H5 Tetanus toxoid vaccines XM5NQ7 Melarsonyl potassium –– XM3G53 Sulfathiazole – XM69J7 Oteseconazole –– XM1G86 Tetanus toxoid, combinations with diphtheria toxoid vaccines XM4UC9 Melarsoprol –– XM72K1 Sulfanilamide XM8YE6 Griseofulvin –– XM9AK2 Tetanus toxoid, combinations with tetanus immunoglobulin vaccines XM1HA1 Misonidazole –– XM9TQ5 Sulfisoxazole XM32L5 Nystatin –– XM31Q8 Tetanus, diphtheria, acellular pertussis vaccines XM3WL0 Ornidazole – XM06K1 Intermediate-acting sulfonamides XM2H01 Pimaricin ––– XM1PB8 Triple vaccines DPT XM3E43 Oxophenarsine –– XM1AM5 Sulphamethoxazole XM3BU7 Flucytosine ––– XM9ZL9 Pertussis vaccines (with diphtheria toxoid) (with tetanus toxoid) XM45H6 Stibogluconate –– XM12D1 Sulfadiazine XM7HQ1 Terbinafine ––– XM9YH9 Diphtheria toxoid with tetanus toxoid with pertussis component vaccines XM0CL7 Stilbamidine isetionate –– XM43U3 Sulfamoxole XM0K47 Caspofungin –– XM32Q5 Tetanus and diphtheria vaccines XM05U5 Teclozan – XM4J39 Long-acting sulfonamides XM1F82 Micafungin ––– XM4039 Vaccines diphtheria with tetanus XM6XS3 Trichomonacides –– XM3ER6 Sulfadimethoxine XM0HG4 Anidulafungin ––– XM8XH5 Tetanus toxoid or vaccines toxoid with diphtheria toxoid XM5R30 Tryparsamide –– XM8LL9 Sulfalene XM7S10 Antifungal antibiotics – XM8BU8 Typhoid vaccines XM7BM9 Nitroimidazole derivatives –– XM7XJ2 Sulfamethoxypyridazine – XM5TR4 Amphotericin B –– XM33K4 Typhoid, oral, live attenuated vaccines – XM4HZ1 Azanidazole –– XM92E0 Sulfaperin – XM9CM4 Hachimycin –– XM89G3 Typhoid, inactivated, whole cell vaccines – XM5LH9 Nimorazole –– XM7R74 Sulfamerazine –– XM3SF6 Typhoid, purified polysaccharide antigen vaccines – XM98K0 Secnidazole –– XM1G41 Sulfaphenazole XM56B8 Nucleosides and nucleotides –– XM9UB1 Typhoid-paratyphoid vaccines – XM0JG6 Benznidazole –– XM0ZN8 Sulfamazone – XM3MC4 Aciclovir ––– XM3VD2 Vaccines TAB – XM61Z9 Propenidazole –– XM95D0 Sulfametomidine – XM30N1 Vidarabine ––– XM95H3 Paratyphoid vaccines – XM5VX1 Fexinidazole – XM3EU7 Sulfonamides and trimethoprim derivatives, fixed combinations – XM1M61 Ganciclovir – XM8ZX8 Plague vaccines XM4RW6 Dichloroacetamide derivatives –– XM22Y8 Trimethoprim with sulfamethoxazole – XM2GP5 Idoxuridine –– XM3796 Plague, inactivated, whole cell vaccines – XM7AM3 Diloxanide –– XM18A9 Sulfadiazine and trimethoprim – XM3RL1 Famciclovir – XM9SW5 Vaccines bacterial with other bacterial component – XM9H76 Clefamide –– XM87N2 Sulfametrole and trimethoprim – XM4GK4 Valaciclovir – XM91J8 Vaccines rickettsial – XM3PL8 Etofamide –– XM4008 Sulfamoxole and trimethoprim – XM6HE0 Cidofovir –– XM3JJ2 Typhus (exanthematicus) vaccines XM4787 Arsenic compounds –– XM4WW1 Sulfadimidine and trimethoprim – XM3AF7 Penciclovir ––– XM2NU8 Typhus exanthematicus, inactivated, whole cell vaccines – XM09B5 Arsthinol –– XM1UR3 Sulfadiazine and tetroxoprim – XM2RU2 Valganciclovir –– XM4F19 Vaccines rickettsial with bacterial component – XM0A09 Difetarsone –– XM3Y04 Sulfamerazine and trimethoprim – XM5L76 Brivudine –– XM0E84 Rocky Mountain spotted fever vaccines – XM6V40 Glycobiarsol – XM4YB5 Brodimoprim – XM1ES0 Remdesivir – XM5926 Vaccines bacterial mixed, not elsewhere classified XM64G7 Antimony compounds – XM98X3 Iclaprim – XM4CD1 Brincidofovir – XM8NU9 Anthrax vaccines – XM2TP0 Meglumine antimonate – XM4L44 Sulfathiourea XM7QR0 Cyclic amines –– XM2C05 Anthrax antigen vaccines – XM2284 Sodium stibogluconate – XM2TS5 Rimantadine – XM7PB3 Brucellosis vaccines – XM1329 Azithromycin – XM7GR8 Tromantadine –– XM7RX8 Brucella antigen vaccines – XM3E78 Akritoin – XM36F7 Erythromycin XM90G3 Phosphonic acid derivatives – XM8AW3 Diphtheria vaccines – XM8LB8 Anti-infective arsenical – XM2YT6 Josamycin – XM5XQ9 Foscarnet –– XM86V7 Diphtheria toxoid vaccines – XM44A9 Anti-infective heavy metals – XM06K0 Kitasamycin – XM8Z26 Fosfonet –– XM46V1 Diphtheria vaccines combination including pertussis – XM8CX5 Antimony anti-infectives – XM80A1 Midecamycin XM8GK2 Protease inhibitors –– XM39K8 Diphtheria vaccines combination without pertussis – XM69W3 Antimony potassium tartrate (sodium) – XM3CC3 Miocamycin – XM7YP4 Saquinavir –– XM8YP9 Diphtheria vaccines combination – XM2AH2 Antimony tartrated – XM8HR9 Oleandomycin – XM1VT6 Indinavir – XM4639 Tuberculosis vaccines – XM1Z32 Antiparasitic drug specified – XM8UC1 Rokitamycin – XM56L1 Ritonavir –– XM8142 Tuberculosis, live attenuated vaccines – XM0L93 Arsphenamine (silver) – XM98M0 Roxithromycin – XM6175 Nelfinavir XM61M7 Viral vaccines – XM12U8 Bismuth salts anti-infectives – XM1K16 Spiramycin – XM6WJ3 Amprenavir – XM68M6 COVID-19 vaccines – XM7A39 Bismuth salts subsalicylate – XM2WF8 Troleandomycin – XM2AR2 Fosamprenavir –– XM1NL1 COVID-19 vaccines, inactivated virus – XM8SJ3 Bithionol – XM1VG4 Clarithromycin – XM2U50 Atazanavir ––– XM7HT3 CoronaVac® – XM7PV2 Chiniofon – XM0EH3 Dirithromycin – XM8QH1 Tipranavir ––– XM8866 Covilo – XM6DH1 Cinoxacin – XM2J45 Flurithromycin – XM63Q8 Darunavir ––– XM9TQ1 KCONVAC – XM0402 Croconazole – XM5TV4 Telithromycin XM3EZ0 Nucleoside and nucleotide reverse transcriptase inhibitors ––– XM1G90 Covaxin – XM1YN6 Dichlorhydroxyquinoline – XM2LU0 Solithromycin – XM9C07 Zidovudine ––– XM85P5 Covi-Vac – XM59A1 Disinfectant intestinal – XM4094 Ansamycin – XM7XQ2 Zalcitabine ––– XM9FQ7 Hayat-Vax – XM4923 Flumequine XM7E36 Lincosamides – XM8Z78 Didanosine ––– XM97N6 QazVac – XM7BY8 Flunidazole – XM8158 Clindamycin – XM7RM1 Stavudine ––– XM2YG8 COVIran Barekat – XM4XE9 Fluorocytosine – XM53Q9 Lincomycin – XM5471 Lamivudine ––– XM0K39 Covidful – XM6UT2 Hexetidine XM69N7 Streptogramins – XM35P4 Abacavir ––– XM0J98 FAKHRAVAC (MIVAC) – XM74Y8 Iodobismitol – XM48W5 Pristinamycin – XM67N3 Tenofovir disoproxil ––– XM1FB4 Inactivated SARS-CoV-2 vaccine – XM80M5 Iodoquinol – XM4NJ6 Quinupristin – XM96H1 Adefovir ––– XM86F7 Turkovac – XM7T64 Lead anti-infectives – XM2YS9 Dalfopristin – XM2L06 Emtricitabine ––– XM42N8 VLA2001 – XM0FS9 Mapharsen – XM0Z52 Entecavir –– XM5DF6 COVID-19 vaccines, live attenuated virus – XM0RW4 Mercury, mercurial, mercuric, mercurous anti-infective systemic – XM3X89 Amikacin – XM2P85 Telbivudine –– XM9QW8 COVID-19 vaccines, non-replicating viral vector – XM08P3 Neoarsphenamine – XM4LV0 Antibiotic aminoglycoside – XM9K66 Clevudine ––– XM4YL8 COVID-19 Vaccine AstraZeneca - Vaxzevria – XM0M05 Neosilversalvarsan – XM7WC2 Antitubercular antibiotics – XM06Z6 Tenofovir alafenamide ––– XM97T2 Covishield® – XM39N3 Nifuratel – XM4BG6 Astromicin XM5PT4 Non-nucleoside reverse transcriptase inhibitors ––– XM6QV1 COVID-19 Vaccine Janssen – XM70Q8 Oxolinic acid – XM4PT0 Bekanamycin – XM10T5 Nevirapine ––– XM1AG7 Convidecia – XM10R8 Potassium antimony tartrate – XM45U4 Dibekacin – XM0LC3 Delavirdine ––– XM5QM6 Sputnik-Light – XM8WV6 Quiniobine – XM8KT1 Dihydrostreptomycin – XM1DX2 Efavirenz ––– XM4T09 Convidecia Air – XM8U22 Quinoline (derivatives) – XM0PH0 Framycetin – XM7N44 Etravirine ––– XM2LP0 Convidecia Air XBB1.5. – XM3VB9 Salvarsan 606 (neosilver) (silver) – XM3YS5 Gentamicin – XM1KD4 Rilpivirine ––– XM6Z24 Gam-COVID-Vac (intranasal) – XM6260 Silver salvarsan – XM6YS3 Isepamicin XM6DT0 Neuraminidase inhibitors ––– XM4PM4 Gam-COVID-Vac-M – XM3DB2 Sodium cacodylate anti-infective – XM0C03 Kanamycin – XM0JN4 Zanamivir ––– XM5309 iNCOVACC – XM9L57 Stovarsal – XM9VS3 Micronomicin – XM6823 Oseltamivir ––– XM4N49 Jcovden – XM80F6 Sulfarsphenamine – XM2YC8 Neomycin (derivatives) – XM0AQ6 Peramivir ––– XM37C0 Sputnik-V – XM96Q1 Tartar emetic – XM1W69 Netilmicin – XM6M67 Laninamivir –– XM0CX4 COVID-19 vaccines, replicating viral vector – XM6A32 Tartrated antimony (anti-infective) – XM1QQ2 Novobiocin XM9DH8 Antivirals for treatment of hepatitis C infections ––– XM5BL0 DelNS1-2019-nCoV-RBD-OPT1 – XM9KU4 Thiobismol – XM1696 Paromomycin – XM8YT1 Ribavirin –– XM5JC5 COVID-19 vaccines, virus protein subunit – XM9UP9 Thiocarbarsone – XM58T2 Ribostamycin – XM2WF9 Telaprevir ––– XM3CT4 Zifivax – XM5VM3 Tin anti-infectives – XM4GS3 Sisomicin – XM07W4 Boceprevir ––– XM8T18 Abdala – XM2SB0 Urinary anti-infective – XM6T34 Streptomycin – XM1QK4 Faldaprevir ––– XM3PG0 Soberana-02 – XM2HD6 Emetine –– XM32G0 Streptomycin derivative – XM9FF9 Simeprevir ––– XM4EC8 MVC COVID-19 – XM5GF4 Phanquinone –– XM7N64 Streptoduocin – XM6LF8 Asunaprevir ––– XM6SZ8 EpiVacCorona – XM9VB9 Mepacrine – XM4YK6 Streptonivicin – XM41F6 Daclatasvir ––– XM0RV9 Soberana Plus – XM5RX3 Tenonitrozole – XM40X6 Streptovarycin – XM0ZZ5 Sofosbuvir ––– XM3SK8 Aurora-CoV – XM28N6 Dehydroemetine – XM6G20 Tobramycin – XM34X5 Dasabuvir ––– XM9P21 SpikoGen – XM5WJ8 Fumagillin – XM79T7 Arbekacin – XM5HK2 Elbasvir ––– XM9T65 NUVAXOVID – XM84S6 Nitazoxanide – XM1KN3 Plazomicin – XM9WK5 Grazoprevir ––– XM9N08 Razi COV PARS XM9JL2 Eflornithine XM7YK9 Quinolones and derivatives – XM6ZX2 Coblopasvir ––– XM6790 Bimervax – XM3HL2 Fluoroquinolones XM3SJ3 Antivirals for treatment of hepatitis C infections, combinations ––– XM8R60 Bivalent Omicron XM2NT3 Alantolactone –– XM8072 Ofloxacin – XM5CA7 Sofosbuvir and Ledipasvir ––– XM63N7 Corbevax XM1PP4 Amphotalide –– XM77G2 Ciprofloxacin – XM4R75 Dasabuvir, Ombitasvir, Paritaprevir and Ritonavir ––– XM2NP9 Coviccine XM8LU8 Anthiolimine –– XM1Z91 Pefloxacin – XM70P2 Ombitasvir, Paritaprevir and Ritonavir ––– XM0E93 Coviccine Trivalent (XBB.1.5+BA.5+Delta) XM95R7 Anti-infective anthelmintic –– XM7SH9 Enoxacin – XM7VS7 Elbasvir and Grazoprevir ––– XM85Q5 Covovax XM43K9 Antifilarial drug –– XM85E7 Norfloxacin – XM3K33 Sofosbuvir and Velpatasvir ––– XM85Q8 EuCorVac-19 XM4EC0 Antihelmintics –– XM2GR2 Fleroxacin – XM14S9 Sofosbuvir, Velpatasvir and Voxilaprevir ––– XM7E37 Indovac XM9637 Antihookworm drug –– XM98Z1 Temafloxacin – XM1NF4 Glecaprevir and Pibrentasvir ––– XM7P85 Noora XM16G5 Antinematode drug –– XM3JX8 Lomefloxacin – XM10G0 Daclatasvir, Asunaprevir and Beclabuvir ––– XM2FM2 NUVAXOVID XBB1.5. XM2078 Antiplatyhelmintic drug –– XM6MR3 Sparfloxacin XM3U67 Antivirals for treatment of human immunodeficiency virus infections, combinations ––– XM97Q5 PastoCovac XM60W7 Antischistosomal drug –– XM7BN7 Rufloxacin – XM5UM7 Zidovudine and Lamivudine ––– XM8BU1 PastoCovac Plus XM6500 Antitapeworm drug –– XM6RS6 Grepafloxacin – XM41D4 Lamivudine and Abacavir ––– XM9P29 Recombinant SARS-CoV-2 Vaccine (CHO Cell) XM5273 Antiwhipworm drug –– XM7KX7 Levofloxacin – XM75H2 Tenofovir disoproxil and Emtricitabine ––– XM5YS2 SARS-COV-2 Bivalent XM7QL4 Ascaridole –– XM6YH9 Trovafloxacin – XM2F89 Zidovudine, Lamivudine and Abacavir ––– XM8ME2 SCB-2019 XM9GK4 Aspidium (oleoresin) –– XM8147 Moxifloxacin – XM0SL5 Zidovudine, Lamivudine and Nevirapine ––– XM71X6 SCTV01C XM3JR4 Benzimidazole derivatives –– XM5HN4 Gemifloxacin – XM7RZ6 Emtricitabine, Tenofovir disoproxil and Efavirenz ––– XM62V8 SKYCovione – XM3GX0 Mebendazole –– XM17A4 Gatifloxacin – XM99U8 Stavudine, Lamivudine and Nevirapine ––– XM8267 Tetravalent SCTV01E – XM0CU8 Tiabendazole –– XM3NU2 Prulifloxacin – XM1KH0 Emtricitabine, Tenofovir disoproxil and Rilpivirine ––– XM6WB0 V-01 – XM79J1 Albendazole –– XM3Z59 Pazufloxacin – XM99Q5 Emtricitabine, Tenofovir disoproxil, Elvitegravir and Cobicistat ––– XM9ZB6 Vidprevtyn Beta – XM8RG6 Flubendazole –– XM1QZ5 Garenoxacin – XM3EH7 Lopinavir –– XM1J92 COVID-19 vaccines, virus like particle – XM5XC2 Fenbendazole –– XM5MK4 Sitafloxacin – XM9NL2 Lamivudine, Tenofovir disoproxil and Efavirenz ––– XM0BS6 Covifenz – XM7982 Ciclobendazole –– XM3S71 Tosufloxacin – XM50Z0 Lamivudine and Tenofovir disoproxil –– XM6AT1 COVID-19 vaccines, DNA based XM3667 Bephenium –– XM9CC7 Delafloxacin – XM2UU9 Lamivudine, Abacavir and Dolutegravir ––– XM52P3 ZyCov-D XM6FY4 Bithionol anthelminthic – XM8SV4 Rosoxacin – XM1FA4 Darunavir and Cobicistat –– XM0GQ8 COVID-19 vaccines, RNA based XM5L27 Bitoscanate XM0MG9 Amphenicols – XM82P4 Nalidixic acid – XM4KM0 Atazanavir and Cobicistat ––– XM8NQ0 Comirnaty® XM4WY5 Chenopodium – XM2TE7 Chloramphenicol – XM1298 Piromidic acid – XM0229 Lamivudine and Raltegravir ––– XM3DT5 COVID-19 Vaccine Moderna - Spikevax XM0ZD3 Dichlorophen – XM40F4 Thiamphenicol – XM61M8 Pipemidic acid – XM8RF0 Emtricitabine and Tenofovir alafenamide ––– XM5E97 AWcorna XM8C12 Dithiazanine iodide XM3GX9 Combinations of antibacterials – XM4JT2 Emtricitabine, Tenofovir alafenamide, Elvitegravir and Cobicistat ––– XM1CQ8 Comirnaty Bivalent Original/Omicron BA.1 XM2RX7 Filix mas – XM1JY8 Adicillin – XM5CX9 Sulfonamides, combinations with other antibacterials – XM08B7 Emtricitabine, Tenofovir alafenamide and Rilpivirine ––– XM5U85 Comirnaty Bivalent Original/Omicron BA.4/BA.5 XM05F2 Ivermectin – XM1LV7 Ancillin – XM39C8 Penicillins, combinations with other antibacterials – XM0UN9 Emtricitabine, Tenofovir alafenamide and Bictegravir ––– XM7U45 Comirnaty XBB.1.5. XM5W42 Levamisole – XM0JT4 Apalcillin – XM9162 Cefuroxime and metronidazole – XM4C60 Dolutegravir and Rilpivirine ––– XM6HM3 Daichirona XM9Z70 Lucanthone – XM46K9 Bacampicillin – XM3E19 Spiramycin and metronidazole – XM7T33 Emtricitabine, Tenofovir alafenamide, Darunavir and Cobicistat ––– XM15E9 Duentai XM4SZ4 Male fern extract – XM94E1 Benethamine penicillin – XM8TH8 Levofloxacin and ornidazole – XM4TF3 Atazanavir and Ritonavir ––– XM2708 Duentai Bivalent (XBB.1.5+BQ.1) XM2034 Niclosamide – XM2SP1 Carfecillin – XM3DB6 Cefepime and amikacin – XM5FB9 Lamivudine, Tenofovir disoproxil and Doravirine ––– XM3X29 Gemcovac-19 XM2WY0 Niridazole – XM9MK4 Cephalosporins N (adicillin) – XM5QC3 Azithromycin, fluconazole and secnidazole – XM9CE4 Lamivudine and Dolutegravir ––– XM8FH6 Gemcovac-OM XM7NR1 Nitrothiazol – XM4YY1 Clemizole penicillin – XM1CM9 Tetracycline and oleandomycin – XM8ZN1 Darunavir and Ritonavir ––– XM6FF0 KOSTAIVE XM5JZ6 Oxamniquine – XM2361 Ciclacillin – XM2CJ8 Ofloxacin and ornidazole – XM8QY9 Lamivudine, Tenofovir disoproxil and Dolutegravir ––– XM0QH5 COVID-19 Vaccine Moderna - Spikevax Bivalent Original/Omicron BA.1 XM9FH0 Pelletierine tannate – XM9VG2 Hydrabamine penicillin – XM9T47 Ciprofloxacin and metronidazole XM63K0 Anti-infective antiviral ––– XM3984 COVID-19 Vaccine Moderna - Spikevax Bivalent Original/Omicron BA.4/BA.5 XM5ZH0 Perchloroethylene medicinal – XM7LA4 Imipenem – XM36B5 Ciprofloxacin and tinidazole XM7SG2 Dideoxyinosine ––– XM21B8 COVID-19 Vaccine Moderna - Spikevax XBB1.5. XM3T27 Pinkroot – XM0V84 Isoxazolyl penicillin – XM51W6 Ciprofloxacin and ornidazole XM9VL0 Foscarnet sodium – XM38G7 Dengue vaccines XM8205 Praziquantel – XM00H2 Methoxybenzyl penicillin – XM31E8 Norfloxacin and tinidazole XM6CJ2 Fosfonet sodium – XM7P50 Ebola vaccines XM7SZ5 Pumpkin seed extract – XM9XB6 Penethamate XM8S33 Glycopeptides XM1R42 Ibacitabine – XM0RC1 Encephalitis vaccines XM5PX0 Pyrvinium – XM7Q57 Penicillin (any) – XM9YD1 Vancomycin XM6SP8 Metisazone –– XM8MP6 Encephalitis, tick borne, inactivated, whole virus XM9KL1 Santonin – XM71L1 Phenbenicillin – XM2004 Teicoplanin XM5GV1 Moroxydine –– XM0LB5 Encephalitis, Japanese, inactivated, whole virus XM3FE9 Spigelia (root) – XM3UP8 Xantocillin – XM8WT1 Telavancin XM6WB2 Trifluridine –– XM47S0 Encephalitis, Japanese, live attenuated XM5VV1 Stibophen – XM3173 Penicillins with extended spectrum – XM4F99 Dalbavancin XM60K5 Lysozyme – XM1LR5 Influenza vaccines XM4GA8 Teroxalene –– XM5MY7 Ampicillin – XM9LJ3 Oritavancin XM8AQ1 Inosine pranobex –– XM8857 Influenza vaccines, inactivated, whole virus XM7PN4 Tetrachloroethylene medicinal –– XM7CR7 Pivampicillin XM2CE2 Nitrofuran derivatives XM23V6 Pleconaril –– XM5V64 Influenza vaccines, live attenuated XM93X2 Tetramisole –– XM3D58 Carbenicillin – XM09K7 Nitrofurantoin XM1EQ6 Enfuvirtide –– XM8MP2 Influenza vaccines, inactivated, split virus or surface antigen XM2621 Urea stibamine –– XM7CM1 Amoxicillin – XM1QV5 Nifurtoinol XM82D3 Raltegravir –– XM9E16 Influenza vaccines, virus like particle XM5C18 Veroxil –– XM7J83 Carindacillin – XM9F49 Nifurtimox XM3FG0 Maraviroc –– XM33X8 Influenza, purified antigen XM3AT4 Viprynium –– XM31J4 Epicillin – XM8FX2 Furazidin XM7HJ6 Maribavir – XM6LL6 Hepatitis vaccines XM4555 Wormseed, American –– XM9LR3 Pivmecillinam – XM08Z2 Furazolidone XM7WY9 Elvitegravir –– XM9V38 Hepatitis B, purified antigen XM6U56 Tetrahydropyrimidine derivatives –– XM8820 Azlocillin XM3DZ3 Polymyxins XM6K45 Dolutegravir –– XM2A12 Hepatitis A, inactivated, whole virus – XM90N4 Pyrantel –– XM1Z93 Mezlocillin – XM6510 Colistin XM3S98 Umifenovir –– XM03Y7 Combinations hepatitis vaccines – XM05V2 Oxantel –– XM5562 Mecillinam – XM0NQ2 Polymyxin B XM8CN1 Enisamium iodide – XM28X5 Measles vaccines XM9H59 Metrifonate –– XM3MP9 Piperacillin – XM8MH4 Polymyxin XM01X3 Letermovir –– XM8L15 Measles, live attenuated XM7VW8 Triclabendazole –– XM4D90 Ticarcillin XM1UC2 Tilorone –– XM9439 Measles, combinations with mumps, live attenuated XM7F99 Moxidectin –– XM1HX8 Metampicillin – XM5183 Aerosporin XM90X2 Pentanedioic acid imidazolyl ethanamide –– XM8TF3 Measles, combinations with mumps and rubella, live attenuated XM0399 Desaspidin –– XM3Z13 Talampicillin – XM5PV6 Albamycin XM2KW1 Ibalizumab –– XM21H2 Measles, combinations with rubella, live attenuated –– XM3S35 Sulbenicillin – XM4E54 Amphomycin XM7FP8 Tecovirimat –– XM4AJ8 Measles, combinations with mumps, rubella and varicella, live attenuated –– XM1QC3 Temocillin – XM2H40 Anti-infective antibiotics specified XM9A16 Baloxavir marboxil – XM1131 Mumps vaccines –– XM9HP3 Hetacillin – XM41T2 Antibiotic intestinal XM1QY5 Amenamevir –– XM2340 Mumps, live attenuated –– XM70P4 Aspoxicillin – XM0MJ1 Antibiotic polypeptide XM2L29 Favipiravir – XM0N50 Poliomyelitis vaccines – XM9FQ5 Beta-lactamase sensitive penicillins – XM7SQ4 Antibiotic specified XM1KL9 Cobicistat –– XM4KG4 Orimune –– XM83S8 Benzylpenicillin – XM2EH2 Betamicin XM85A9 Lenacapavir –– XM1Y59 Vaccine sabin oral –– XM9B11 Phenoxymethylpenicillin – XM0D75 Carbomycin –– XM2KH7 Diplovax –– XM5MN2 Propicillin – XM74K5 Enviomycin XM6MB2 AHLG –– XM0VX8 Poliomyelitis oral, monovalent live attenuated –– XM4EZ4 Azidocillin – XM0HU8 Fosfomycin XM9CH0 Anti-human lymphocytic globulin –– XM0KZ1 Poliomyelitis oral, trivalent, live attenuated –– XM9NF6 Pheneticillin – XM5UL0 Fusafungine XM9L34 Antidiphtheria serum –– XM79H3 Poliomyelitis oral, bivalent, live attenuated –– XM16L6 Penamecillin – XM6AH3 Fusidic acid XM9D37 Antiscorpion sera –– XM5V19 Poliomyelitis, trivalent, inactivated, whole virus –– XM5N44 Clometocillin – XM14K4 Neosporin XM5CP2 Antitoxin – XM1CE0 Rotavirus diarrhoea vaccines –– XM4E82 Benzathine benzylpenicillin – XM19A7 Ristocetin XM81Z0 Antitoxin gas gangrene –– XM4GV0 Rota virus, live attenuated –– XM4HD6 Procaine benzylpenicillin – XM0BX1 Sodium fusidate XM5TW5 Antivenin, antivenom (sera) –– XM4VG1 Rota virus, pentavalent, live, reassorted –– XM6MK0 Benzathine phenoxymethylpenicillin – XM4F54 Sulfomyxin XM2T48 Antivenin, antivenom crotaline – XM7PP1 Rubella vaccines – XM9QY0 Beta-lactamase resistant penicillins – XM6HE3 Viomycin XM6D91 Antivenin, antivenom spider bite –– XM9PS9 Rubella, live attenuated –– XM5SF7 Dicloxacillin – XM2A60 Virginiamycin XM4XP6 Black widow spider antivenin –– XM3B09 Rubella, combinations with mumps, live attenuated –– XM6L30 Cloxacillin – XM71G5 Xibornol XM7VG2 Gamimune – XM8DG3 Varicella zoster vaccines –– XM0PP7 Methicillin – XM2TG1 Spectinomycin XM6Z81 Gamma globulin –– XM0NS8 Varicella, live attenuated –– XM2UY3 Oxacillin – XM02L5 Methenamine (mandelate) XM7MC6 Gamulin –– XM1SS1 Zoster, live attenuated –– XM6AV2 Flucloxacillin – XM3HJ6 Mandelic acid XM1AG2 Glandular extract (medicinal) – XM9QP0 Papillomavirus vaccines –– XM8HL9 Nafcillin – XM33S9 Nitroxoline XM8MQ7 Globulin antilymphocytic –– XM1821 Papillomavirus (human types 6,11,16,18) – XM6QQ6 Combinations of penicillins – XM11V4 Clofoctol XM6UW5 Globulin antirhesus –– XM9BT4 Papillomavirus (human types 16,18) –– XM0RU1 Sultamicillin – XM9WV9 Linezolid XM3LT2 Globulin antivenin –– XM5CE9 Papillomavirus (human types 6,11,16,18,31,33,45,52,58) –– XM3DN8 Ampicillin and beta-lactamase inhibitor – XM2NL4 Daptomycin XM9XP6 Globulin antiviral – XM95R0 Smallpox vaccine –– XM7UP4 Amoxicillin and beta-lactamase inhibitor – XM20R8 Bacitracin XM5443 Homo-tet – XM6T09 Rabies vaccines –– XM1FZ0 Ticarcillin and beta-lactamase inhibitor – XM9GT9 Tedizolid XM3KZ0 Horse anti-human lymphocytic serum –– XM7BE8 Rabies, inactivated, whole virus –– XM0LH3 Piperacillin and beta-lactamase inhibitor – XM9QK9 Lefamulin XM7BR5 Human immune serum – XM02Y0 Respiratory syncytial virus vaccines XM9XT2 Beta-lactamase inhibitors XM42S1 Hypertussis –– XM69P6 Synagis – XM3Y87 Sulbactam – XM8124 Antibiotic tetracycline (group) XM5DZ4 Pegademase, bovine – XM0N24 Yellow fever vaccines – XM2D37 Tazobactam – XM7FD5 Chlormethylenecycline XM67L1 RhoGAM –– XM3418 Yellow fever, live attenuated – XM1JT2 Chlortetracycline XM77D4 Serum anti-Rh XM7C66 Bacterial and viral vaccines, combined – XM3WK4 Antibiotic b-lactam – XM0WY0 Clomocycline XM3HE6 Serum antibotulinus – XM8AW1 Diphtheria, poliomyelitis, tetanus vaccines – XM7TD6 Antibiotic cephalosporin (group) – XM9219 Demeclocycline XM9V23 Serum anticytotoxic – XM09Q7 Diphtheria, pertussis, poliomyelitis, tetanus vaccines – XM5J74 Cefaloglycin – XM17F8 Demethylchlortetracycline XM7HP0 Serum antimeningococcus – XM9744 Diphtheria, rubella, tetanus vaccines – XM8J52 Cefamycin antibiotic – XM7KG3 Demethyltetracycline XM5F14 Serum antitetanic – XM41N3 Diphtheria, hepatitis B, pertussis, tetanus vaccines – XM01V2 Cefpimizole – XM7J58 Doxycycline XM8MX1 Serum antitoxic – XM1LX9 Diphtheria, hemophilus influenzae B, pertussis, poliomyelitis, tetanus vaccines – XM45T3 Cefteram – XM4492 Guamecycline XM9QJ7 Serum convalescent – XM3G68 Diphtheria, hepatitis B, tetanus vaccines – XM0C25 Cefuzonam – XM47D7 Lymecycline XM0SJ2 Serum protective – XM32L7 Hemophilus influenzae B and hepatitis B vaccines – XM4HC8 Cephalosporins – XM9KD5 Meclocycline XM5CC6 Spider antivenin – XM3JA6 Typhoid, hepatitis A vaccines – XM67G9 Cephalothin – XM4CA1 Metacycline XM2042 Tetanus toxoid or vaccine antitoxin – XM7JP3 Diphtheria, hemophilus influenzae B, pertussis, tetanus, hepatitis B vaccines – XM2K88 Clavulanic acid – XM5TY0 Minocycline XM2GK5 Tetanus toxoid or vaccine immune globulin (human) – XM0LT9 Diphtheria, pertussis, poliomyelitis, tetanus, hepatitis B vaccines – XM9BE0 First-generation cephalosporins – XM8DQ8 Oxytetracycline XM8Y67 Vaccine antineoplastic – XM5XP9 Diphtheria, hemophilus influenzae B, pertussis, tetanus-hepatitis B, meningococcus A + C vaccines –– XM9Z22 Cefalexin – XM3D34 Penimepicycline XM6VF9 Immune sera – XM21E6 Diphtheria tetanus, acellular pertussis, inactivated polio virus, haemophilus Influenzae type B vaccines –– XM7GR3 Cefaloridine – XM45X2 Rolitetracycline – XM2MN8 Diphtheria antitoxin – XM84S1 Diphtheria, hepatitis B, tetanus, acellular pertussis, inactivated polio virus, haemophilus Influenzae type B vaccines –– XM0BY6 Cefazolin – XM0BP1 Tetracycline – XM18X1 Tetanus antitoxin – XM9JP8 Diphtheria, tetanus, acellular pertussis, inactivated polio virus vaccines –– XM11S1 Cefadroxil – XM74B7 Tigecycline – XM5083 Antirabies hyperimmune serum – XM01H1 Hemophilus influenzae B and poliomyelitis vaccines –– XM1EQ8 Cefazedone – XM18Y9 Snake venom antiserum –– XM8UF3 Cefatrizine XM8781 Aminosalicylic acid and derivatives – XM0AD6 Botulinum antitoxin XM5YM6 Metronidazole –– XM6DE1 Cefapirin – XM1X82 Aminosalicylic acid – XM1FR6 Gas-gangrene sera XM7Z72 Tinidazole –– XM8X72 Cefradine – XM6TY4 Sodium aminosalicylate XM1RS8 Immunoglobulins XM6BF7 Trimetrexate –– XM7DR9 Cefacetrile – XM7FE7 Calcium aminosalicylate – XM0AQ7 Immunoglobulins, normal human XM3Y85 Acetarsol –– XM75P2 Cefroxadine XM3BE3 Thiocarbamide derivatives –– XM26U5 Immunoglobulins, normal human, intravenous XM0067 Pentamidine –– XM2L78 Ceftezole – XM1GT1 Protionamide –– XM3H32 Immunoglobulins, normal human, extravascular XM11F5 Suramin sodium – XM4DG8 Second-generation cephalosporins – XM86N7 Ethionamide – XM5YM7 Specific immunoglobulins XM9CB1 Atovaquone –– XM26N9 Cefoxitin XM8Q31 Drugs for treatment of lepra –– XM4361 Anti-D (rh) immunoglobulin XM71Y7 Miltefosine –– XM7VY3 Cefuroxime – XM3122 Clofazimine –– XM8824 Tetanus immunoglobulin –– XM8839 Cefamandole – XM73W4 Dapsone –– XM6JK2 Hepatitis B immunoglobulin XM21E9 Hydroxyquinoline derivatives –– XM1ZJ9 Cefaclor – XM34C6 Clascoterone –– XM5R25 Rabies immunoglobulin – XM5MW6 Broxyquinoline –– XM5QJ0 Cefotetan XM6QT5 Aminosalylum –– XM8Q08 Vaccinia immunoglobulin – XM1V59 Clioquinol –– XM3M14 Cefonicid XM4TV0 Anti-infective antimycobacterial –– XM3FU2 Pertussis immunoglobulin – XM56H5 Chlorquinaldol –– XM3V37 Cefotiam XM5K63 Antimycobacterial drug combination –– XM8Z30 Mumps immunoglobulin – XM1KS8 Tilbroquinol –– XM8S59 Cefmetazole XM6DX3 Antituberculars –– XM7X82 Varicella zoster immunoglobulin – XM0V89 Tiliquinol –– XM3QK7 Ceforanide XM18Y4 Benzoylpas calcium –– XM3ZS8 Rubella immunoglobulin –– XM27Z3 Cefminox XM3307 Bromosalicylhydroxamic acid –– XM1V63 Staphylococcus immunoglobulin – XM6M61 8-Aminoquinoline drugs –– XM14Q0 Cefbuperazone XM2754 Calcium benzamidosalicylate –– XM7NM9 Cytomegalovirus immunoglobulin – XM0NC8 Amopyroquin –– XM83K2 Flomoxef XM7TM4 Chaulmosulfone –– XM4YT6 Diphtheria immunoglobulin – XM37R2 Anti-infective antimalarial –– XM6KH0 Loracarbef XM95S8 Cyanacetyl hydrazide –– XM7LD1 Hepatitis A immunoglobulin – XM0VE8 Anti-infective antiprotozoal blood –– XM4CP3 Cefprozil XM4N96 Ethambutol –– XM5NX5 Encephalitis, tick borne immunoglobulin – XM1914 Antimalarial – XM3FN8 Third-generation cephalosporins XM64N2 Ethyl chaulmoograte –– XM1GU6 Measles immunoglobulin – XM5WN6 Antimalarial prophylactic –– XM7CZ4 Cefotaxime XM23G7 Fenamisal –– XM45N8 Palivizumab – XM5Q32 Antimalarial pyrimidine derivative –– XM94G4 Ceftazidime XM4RF4 Glucosulfone sodium –– XM0QB1 Motavizumab – XM7LP3 Antiprotozoal drug blood –– XM9732 Cefsulodin XM7945 Glyconiazide –– XM0U74 Raxibacumab – XM0KE4 Chlorproguanil –– XM3P83 Ceftriaxone XM5FH2 Isoniazid –– XM8Y60 Anthrax immunoglobulin – XM38E0 Cinchona –– XM6FL0 Cefmenoxime XM2ZK2 Isonicotinic acid hydrazide –– XM6GD5 Bezlotoxumab – XM9V39 Cinchonine alkaloids –– XM0B94 Latamoxef XM3XE5 Methaniazide –– XM54X9 Obiltoxaximab – XM9511 Daraprim –– XM1064 Ceftizoxime XM8UX1 Morinamide – XM1BS2 Immunoglobulin not elsewhere classified – XM23A5 Guanatol –– XM4Q77 Cefixime XM6LM1 Morphazinamide – XM3NK9 Antiviral monoclonal antibodies – XM3T26 Halofantrine –– XM8YC6 Cefetamet XM2QH1 Pasiniazid –– XM78P5 Tixagevimab – XM17W0 Isopentaquine –– XM9YD6 Cefpiramide XM4Q32 Pentylsalicylamide –– XM1CT9 Cilgavimab – XM50J2 Mefloquine –– XM5425 Cefoperazone XM3UQ6 Potassium aminosalicylate – XM08Q1 Pamaquine (naphthoate) –– XM12J5 Cefodizime XM8DJ8 Promacetin XM3KV2 Bacterial vaccines – XM0346 Pentaquine –– XM85Q0 Cefpodoxime XM8CP2 Promin – XM29K4 Cholera vaccines – XM0XQ2 Pyrimethamine –– XM2D98 Ceftibuten XM4611 Pyrazinamide –– XM3Z26 Cholera, inactivated, whole cell vaccines – XM90Z4 Pyrimethamine with sulfadoxine –– XM2141 Cefdinir XM4GU0 Rimifon –– XM72A0 Cholera, live attenuated vaccines – XM10R3 Quinacrine –– XM2SP6 Cefditoren XM7SC9 Salinazid –– XM1FT6 Cholera, combinations with typhoid vaccine, inactivated, whole cell vaccines – XM8RC3 Quinine –– XM0H82 Cefcapene XM3070 Acetosulfone sodium – XM11V3 Haemophilus influenzae B vaccines – XM0RU7 Quinocide –– XM9RH3 Cefotaxime and beta-lactamase inhibitor XM06Z9 Solasulfone –– XM6RG9 Hib, purified antigen conjugated vaccines – XM9Z81 Schizontocide (blood) (tissue) –– XM8EN5 Ceftazidime and beta-lactamase inhibitor XM3SD9 Sulfonazide –– XM7F70 Hib, combinations with toxoids vaccines – XM50C8 Aminoquinolines –– XM4UZ8 Cefoperazone and beta-lactamase inhibitor XM3SN8 Sulfones –– XM81F7 Hib, combinations with pertussis and toxoids vaccines –– XM6ZE6 Chloroquine –– XM19K3 Ceftriaxone and beta-lactamase inhibitor XM72Q4 Aldesulfone sodium –– XM0X86 Hib, combinations with meningococcus C, conjugated vaccines –– XM9YB2 Hydroxychloroquine – XM60V7 Fourth-generation cephalosporins XM9TD0 Terizidone – XM2WV4 Meningococcal vaccines –– XM9F55 Primaquine –– XM1HW5 Cefepime XM99P0 Thiambutosine –– XM92B2 Meningococcal monovalent purified polysaccharides antigen vaccines –– XM3GB3 Amodiaquine –– XM0MR4 Cefpirome XM0AR8 Thioacetazone –– XM5LC2 Meningococcal polyvalent purified polysaccharides antigen vaccines –– XM5EL4 Tafenoquine –– XM1BL5 Cefozopran XM5MQ5 Thioacetazone with isoniazid ––– XM3T39 Meningococcus A, C, bivalent purified polysaccharides antigen vaccines – XM5SP0 Artemisinin and derivatives, plain – XM3XC6 Monobactams XM62H2 Tiocarlide ––– XM2AR0 Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen vaccines –– XM1ED1 Artemisinin –– XM3DB8 Aztreonam XM60U0 Bedaquiline ––– XM2EH7 Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen conjugated vaccines –– XM7D52 Artemether –– XM9FE9 Carumonam XM1FD5 Delamanid –– XM18Y8 Meningococcus C, purified polysaccharides antigen conjugated vaccines –– XM7Q22 Artesunate – XM1JU9 Carbapenems XM7AQ6 Antimycobacterial antibiotic –– XM2280 Meningococcus A, purified polysaccharides antigen conjugated vaccines –– XM37K1 Artemotil –– XM82S6 Meropenem – XM63V4 Cycloserine –– XM9GJ1 Meningococcus B, outer membrane vesicle vaccines –– XM9ND1 Artenimol –– XM50J4 Ertapenem – XM0R30 Rifampicin –– XM1X81 Meningococcus B, multicomponent vaccines – XM3B54 Arterolane and Piperaquine –– XM27D0 Doripenem – XM7HL1 Rifamycin –– XM37L5 Meningococcus A, purified polysaccharides antigen vaccines – XM8H63 Naphthoquine –– XM1Q21 Biapenem – XM5QH8 Rifabutin – XM43M9 Pertussis vaccines – XM6TH1 Artemether and Lumefantrine –– XM12K6 Imipenem and cilastatin – XM8MQ4 Rifapentine –– XM45L8 Pertussis, inactivated, whole cell vaccines XM8MB3 Acterol –– XM02N8 Panipenem – XM0892 Capreomycin –– XM62J1 Pertussis, purified antigen vaccines XM0FS7 Aminitrozole –– XM1N97 Faropenem – XM2LE1 Rifaximin –– XM2TK2 Pertussis, inactivated, whole cell, combinations with toxoids vaccines XM4GE4 Anti-infective antiprotozoal –– XM5261 Betamipron XM38J6 Rifamide –– XM4082 Pertussis, purified antigen, combinations with toxoids vaccines XM4W96 Antimony dimercaptosuccinate – XM3QS2 Ceftobiprole medocaril –– XM2CV8 Vaccines pertussis with diphtheria XM9GG8 Antimony sodium dimercaptosuccinate XM9DZ4 Tetrabenazine XM3BR4 Memantine XM1CG4 Ginkgo folium XM9VG8 Tirilazad XM9Z74 Riluzole XM4ER7 Xaliproden XM5PS1 Fampridine XM2AL2 Tafamidis XM1LU9 Laquinimod XM3QR7 Pitolisant XM3FT2 Patisiran XM1KZ8 Edaravone XM7DT3 Inotersen XM8MX8 Valbenazine XM87M0 Aducanumab XM5UK9 Deutetrabenazine XM4F26 Arimoclomol XM8526 Aurothioglycanide XM4XH9 Farnesil XM4DJ6 Sodium aurothiosulfate XM3LE3 Gold preparations – XM9ZC2 Sodium aurothiomalate – XM5HT1 Auranofin – XM1MX1 Aurothioglucose – XM28Y9 Aurotioprol – XM8CF5 Sodium aurotiosulfate XM0VQ7 Bucillamine XM5L52 Oxycinchophen XM1QA0 Penicillamine XM4G06 Acetylsalicylic acid XM0XT0 Carbaspirin XM0GX7 Choline salicylate XM72N6 Fiorinal XM6PW4 Sodium salicylate XM4WV7 Salicylamide XM68K3 Salsalate XM5UX6 Diflunisal XM2JA1 Aloxiprin XM3ZP5 Ethenzamide XM49Y6 Morpholine salicylate XM9TC0 Dipyrocetyl XM1UA7 Benorilate XM2CV1 Potassium salicylate XM1DD2 Guacetisal XM4TV1 Carbasalate calcium XM5UF9 Imidazole salicylate XM8F16 Calcium salicylate XM5X48 Carbethyl salicylate XM6M40 Magnesium salicylate XM8FA6 Sodium thiosalicylate XM7045 Aminophenazone XM7840 Analgesic pyrazole XM22E9 Antipyrine XM60M2 Coal tar medicinal analgesics XM4T98 Dipyrone XM2FJ5 Isopropylaminophenazone XM8762 Myochrysin (e) XM4YB4 Nifenazone XM53Q3 Noramidopyrine XM6GV7 Propyphenazone XM5H28 Pyrazole (derivatives) XM5L33 Pyrazolone analgesic XM0K68 Ramifenazone XM1SG0 Sulfamidopyrine XM9CV5 Suxibuzone XM5DJ7 Acetaminophen XM75Y5 Para-aminophenol derivatives XM43A6 Phenacetin XM7HP8 Bucetin XM8QF6 Propacetamol XM24R8 Acetaminosalol XM45S5 Acetanilide XM4T97 Bromo-seltzer XM2XD8 Acetylphenylhydrazine XM3J63 Clonixin XM1LX8 Cropropamide XM0LT4 Crotethamide XM0M53 Cyclopyrabital XM3YJ4 Darvon XM7K04 Diclonixin XM2PY3 Doloxene XM7SA1 Emorfazone XM9455 Etomide XM5YR6 Fluradoline XM7983 Jamaica dogwood (bark) XM6233 Lefetamine XM03M0 Methopholine XM4WT5 Nefopam XM8QV3 Perisoxal XM0D38 Phenicarbazide XM2DH4 Phenyramidol XM0X95 Piroxicam beta-cyclodextrin complex XM63V3 Piscidia (bark) (erythrina) XM49C9 Pyrabital XM3WM4 Pyridium XM4PW4 Rimazolium metilsulfate XM3375 Tiaramide XM9YA8 Tinoridine XM0794 Zactane XM3P63 Methoxyflurane XM6Z00 Rimazolium XM5WQ7 Flupirtine XM5XN0 Ziconotide XM70Q6 Tanezumab XM6HK1 Antimigraine drugs XM6FB9 Triptans – XM9AV2 Sumatriptan – XM8BC6 Naratriptan – XM06P8 Zolmitriptan – XM6W13 Rizatriptan – XM92S7 Almotriptan – XM7YU2 Eletriptan – XM4WN0 Frovatriptan – XM7P17 Lasmiditan XM81Q8 Dimetotiazine XM7N03 Oxetorone XM4WH4 Pizotifen XM2G27 Iprazochrome XM4KS4 Nonsteroidal anti-inflammatory and antirheumatic agents XM7W23 Butylpyrazolidines – XM8HN0 Phenylbutazone – XM8P27 Mofebutazone – XM12M5 Oxyphenbutazone – XM8X86 Clofezone – XM4H41 Kebuzone XM74U4 Acetic acid derivatives and related substances – XM7497 Indometacin – XM24W2 Sulindac – XM97N5 Tolmetin – XM92G8 Zomepirac – XM2AU1 Diclofenac – XM2186 Etodolac – XM8M52 Ketorolac – XM6KJ8 Bumadizone – XM12Q6 Lonazolac – XM2AX1 Fentiazac – XM3458 Acemetacin – XM7K80 Difenpiramide – XM7CA3 Oxametacin – XM2P51 Proglumetacin – XM5W40 Aceclofenac – XM7AB1 Bufexamac – XM9S89 Alclofenac – XM8G95 Ibufenac XM0UL8 Oxicams – XM9MD6 Piroxicam – XM7WP9 Droxicam – XM3X14 Lornoxicam – XM1XY0 Meloxicam – XM83U4 Isoxicam – XM1867 Tenoxicam XM2S54 Propionic acid derivatives – XM2RR6 Ibuprofen – XM1KL8 Naproxen – XM63J5 Ketoprofen – XM7BS7 Fenoprofen – XM2N63 Suprofen – XM8VP8 Flurbiprofen – XM0WQ1 Tiaprofenic acid – XM9694 Oxaprozin – XM1918 Ibuproxam – XM4W51 Fenbufen – XM7F06 Benoxaprofen – XM4KX7 Pirprofen – XM3G14 Indoprofen – XM32V2 Dexibuprofen – XM4FK3 Flunoxaprofen – XM1W06 Alminoprofen – XM1ZF2 Dexketoprofen – XM9ES5 Naproxcinod – XM8GM3 Carprofen XM9DC7 Fenamates – XM6Q83 Mefenamic acid – XM31G8 Flufenamic acid – XM3W40 Meclofenamic acid – XM9WQ9 Tolfenamic acid XM16D6 Coxibs – XM63D2 Celecoxib – XM70K9 Rofecoxib – XM4SK9 Valdecoxib – XM96Q4 Parecoxib – XM2W58 Etoricoxib – XM0BC7 Lumiracoxib – XM1N20 Polmacoxib XM7AM9 Glafenine XM3WB0 Floctafenine XM8WS4 Nabumetone XM6SW5 Azapropazone XM6SR1 Glucosamine XM73Q0 Benzydamine XM8GX7 Proquazone XM5C49 Nimesulide XM37T1 Feprazone XM4KV5 Niflumic acid XM5Z51 Glucosaminoglycan polysulfate XM9Z19 Orgotein XM51H0 Diacerein XM1019 Morniflumate XM7Z95 Tenidap XM4L54 Oxaceprol XM9352 Chondroitin sulfate XM0H27 Avocado and soyabean oil, unsaponifiables XM9C36 Ethoxazene XM85Z4 Fenflumizol XM46B3 Analgesic antirheumatic XM8DE1 Antiphlogistic XM95N2 Antirheumatic XM63D6 Antiepileptics – XM52B4 Albutoin – XM9QF8 Amino(diphenylhydantoin) valeric acid – XM55H4 Anticonvulsant hydantoin – XM08H9 Dilantin – XM45R0 Epanutin – XM8MV0 Ethotoin – XM4A36 Mephenytoin – XM02E9 Metetoin – XM0RY4 Phenytoin XM4DR6 Oxazolidine derivatives – XM7N89 Paramethadione – XM31H5 Trimethadione – XM9993 Ethadione – XM1535 Aloxidone XM4521 Fatty acid derivatives – XM29Q3 Valproic acid – XM71X1 Valpromide – XM5G31 Vigabatrin – XM2HC7 Progabide – XM5ZT1 Aminobutyric acid – XM8HQ0 Tiagabine XM3C23 Succinimide derivatives – XM1K85 Ethosuximide – XM9E68 Phensuximide – XM2KZ3 Mesuximide – XM6421 Morsuximide XM9GA9 Other antiepileptics – XM1RS9 Sultiame – XM7BQ9 Phenacemide – XM4RJ7 Pheneturide – XM6KR2 Beclamide – XM6FN4 Lamotrigine – XM15W2 Felbamate – XM2103 Topiramate – XM0J96 Gabapentin – XM9326 Levetiracetam – XM0SP9 Zonisamide – XM0AK1 Pregabalin – XM34S0 Stiripentol – XM30R8 Lacosamide – XM7PP9 Carisbamate – XM1P90 Retigabine – XM46J5 Perampanel – XM78C3 Brivaracetam – XM7QW2 Ganaxolone XM70W8 Carboxamide derivatives – XM3D95 Carbamazepine – XM69D6 Oxcarbazepine – XM6BU4 Rufinamide – XM5HL7 Eslicarbazepine XM2909 Clonazepam XM9G63 Antiparkinson drugs XM5Y20 Dopaminergic agents – XM1Z60 Carbidopa – XM7SN1 Dopa and dopa derivatives –– XM2WU7 Levodopa ––– XM7RF5 Difluoromethyldopa ––– XM3MW1 Levodopa with carbidopa –– XM7ZB9 Levodopa and decarboxylase inhibitor –– XM3PK3 Levodopa, Decarboxylase inhibitor and COMT inhibitor –– XM1JZ7 Melevodopa –– XM0D22 Melevodopa and Decarboxylase inhibitor –– XM6R13 Etilevodopa and Decarboxylase inhibitor –– XM5QR9 Bromocriptine –– XM1GL7 Pergolide –– XM5PE4 Apomorphine –– XM2QX7 Piribedil –– XM5DT8 Dihydroergocryptine mesylate –– XM9D35 Ropinirole –– XM5YJ4 Pramipexole –– XM7B98 Rotigotine –– XM50V4 Mesulergine – XM9GG4 Monoamine oxidase B inhibitors –– XM8FH5 Selegiline –– XM6XW7 Rasagiline –– XM8H59 Safinamide – XM2H09 Amantadine – XM0BA4 Tolcapone – XM07G6 Entacapone – XM0K96 Budipine – XM6TZ5 Opicapone XM1QY7 Indole derivatives XM84W2 Oxypertine XM61G1 Molindone XM69Z2 Sertindole XM8YM0 Ziprasidone XM9EW5 Lurasidone XM8X87 Thioxanthene derivatives XM4EY8 Flupentixol XM87S1 Clopenthixol XM2H35 Chlorprothixene XM6B79 Tiotixene XM3MW6 Zuclopenthixol XM2NF9 Diphenylbutylpiperidine derivatives XM0Q81 Fluspirilene XM1FB1 Pimozide XM5SZ6 Penfluridol XM12F2 Diazepines, oxazepines, thiazepines and oxepines XM8FG8 Loxapine XM8UG6 Clozapine XM6GK7 Olanzapine XM4G70 Quetiapine XM90C7 Asenapine XM9DC4 Clotiapine XM9Q20 Veralipride XM0624 Levosulpiride XM1W79 Benzamides XM7Z05 Sulpiride XM9G21 Sultopride XM8KD4 Tiapride XM3WA3 Remoxipride XM1DG3 Amisulpride XM0W09 Lithium gluconate XM5C35 Lithium salts (carbonate) XM4GQ2 Amperozide XM3JM5 Amphenidone XM7AA5 Antipsychotic drug specified XM23M7 Azacyclonol XM56Y5 Benzperidine XM9VY2 Benzperidol XM3KB9 Enpiprazole XM9097 Hydroxyphenamate XM7EB1 Mebutamate XM88L2 Mosapramine XM7B44 Nemonapride XM5F36 Oxanamide XM9799 Phenaglycodol XM3BH3 Prothipendyl XM7L04 Raclopride XM7KX5 Setoperone XM6YS4 Spirilene XM0ES8 Tranquilizer carbamate XM7Z64 Tranquilizer hydroxyzine XM3ES1 Tranquilizer specified XM0GN3 Tranquilizer thioxanthene XM06W2 Tybamate XM4EU4 Zotepine XM1Z15 Risperidone XM67P4 Aripiprazole XM7H28 Paliperidone XM0FR9 Iloperidone XM1SS2 Cariprazine XM8504 Brexpiprazole XM0715 Pimavanserin XM7KE0 Carphenazine XM83L8 Compazine XM7WF8 Dioxopromethazine XM5EP8 Ethyl aminophenothiazine XM9C32 Isopromethazine XM2WD3 Mellaril XM2VU6 Mepazine XM8ZW1 Methoxypromazine XM4TX5 Metofenazate XM52V9 Phenothiazine (psychotropic) XM0F82 Piperacetazine XM6GY2 Propylaminopheno-thiazine XM2XX6 Sparine XM5JH1 Stelazine XM9Q32 Stemetil XM5Z28 Sulforidazine XM6YW4 Thiazinamium metilsulfate XM87F3 Tindal XM0EE9 Tranquilizer dimethylamine XM9B27 Tranquilizer ethylamine XM1QV8 Tranquilizer phenothiazine XM7057 Tranquilizer piperazine XM5KD3 Tranquilizer piperidine XM3Z20 Tranquilizer propylamine XM4SG0 Phenothiazines with aliphatic side-chain – XM4U75 Chlorpromazine – XM61Z1 Levomepromazine – XM3CL7 Promazine – XM8LW2 Acepromazine – XM1TZ3 Triflupromazine – XM3AU5 Cyamemazine – XM6WY7 Chlorproethazine XM1YC7 Phenothiazines with piperazine structure – XM75P4 Dixyrazine – XM6Z10 Fluphenazine – XM5Z27 Perphenazine – XM84U4 Prochlorperazine – XM0PU2 Thiopropazate – XM18F5 Trifluoperazine – XM3EY1 Acetophenazine – XM1V98 Thioproperazine – XM5JD6 Butaperazine – XM0TU3 Perazine XM9HH5 Phenothiazines with piperidine structure – XM5664 Periciazine – XM4DG6 Thioridazine – XM6447 Mesoridazine – XM0168 Pipotiazine XM12B1 Benperidol XM4QG3 Bromperidol XM2HT3 Butyrophenone(-based tranquilizers) XM6FV0 Droperidol XM0FM0 Fluanisone XM9580 Haloperidol XM6E81 Lenperone XM26W9 Melperone XM7DW6 Moperone XM5AB4 Pipamperone XM1UG0 Spiperone XM7RP6 Timiperone XM5NL7 Tranquilizer butyrophenone XM4U52 Trifluperidol XM9NX2 Lumateperone XM3533 Amiflamine XM8CW9 Antidepressant monoamine oxidase inhibitor XM9VZ7 Clorgiline XM2WY9 Iproclozide XM6DW5 Iproniazid XM4T23 Isocarboxazid XM2K50 Mebanazine XM2GX9 Monoamine oxidase inhibitor hydrazine XM6944 Monoamine oxidase inhibitor XM0158 Nialamide XM3KZ3 Parnate XM4S21 Phenelzine XM4A50 Pheniprazine XM96M0 Safrazine XM1023 Tranylcypromine XM2NP3 Antidepressant selective serotonin reuptake inhibitor XM6WT9 Citalopram XM24M0 Femoxetine XM7LE6 Fluoxetine XM64L1 Fluvoxamine XM5R26 Indalpine XM3PJ6 Paroxetine XM6WB9 Zimeldine XM5TZ9 Sertraline XM7ZN2 Alaproclate XM4MF4 Etoperidone XM7PX8 Escitalopram XM0HR7 Cianopramine XM0PE4 Antidepressant selective serotonin norepinephrine reuptake inhibitor XM8D31 Antidepressant triazolopyridine XM10Q5 Duloxetine XM3KS5 Desvenlafaxine XM6J21 Milnacipran XM17Z4 Levomilnacipran XM36V6 Venlafaxine XM03J9 Bifemelane XM03E6 Bupropion XM7U12 Diclofensine XM78C1 Other specified antidepressant XM0T46 Mianserin XM5QV7 Minaprine XM6X89 Nomifensine XM6AP8 Oxitriptan XM4WM9 Prazitone XM0ST5 Thiazesim XM5DV5 Tianeptine XM5L45 Viloxazine XM62E7 Trazodone XM0B23 Mirtazapine XM54Q7 Tryptophan XM85H1 Nefazodone XM4ML8 Oxaflozane XM80H8 Medifoxamine XM4ZF1 Pivagabine XM70H2 Reboxetine XM5KP8 Gepirone XM5F11 Agomelatine XM7T91 Vilazodone XM4230 Hyperici herba XM0EP0 Vortioxetine XM8FB6 Serotonin XM0227 Metapramine XM9KG1 Non-selective monoamine reuptake inhibitors XM6FC9 Desipramine XM6PZ9 Imipramine XM76Z6 Clomipramine XM37K4 Opipramol XM9WZ5 Trimipramine XM7T42 Lofepramine XM6H22 Dibenzepin XM7BL0 Amitriptyline XM79G5 Nortriptyline XM2WA4 Protriptyline XM1LC7 Doxepin XM24M7 Iprindole XM1575 Melitracen XM8QA6 Butriptyline XM2T20 Dosulepin XM8TQ9 Amoxapine XM1190 Amineptine XM41L8 Maprotiline XM34S5 Quinupramine XM4SZ9 Imipramine oxide XM3MV6 Dimetacrine XM5RG3 Oxaprotiline XM7GY1 Noxiptiline XM1UL5 Monoamine oxidase A inhibitors XM14X9 Moclobemide XM1TG1 Toloxatone XM2PL7 Cannabinoids XM3UF9 Nabilone XM4HM2 Tetrahydrocannabinol XM5B55 Cannabidiol XM1W83 Dronabinol XM4SV9 Hallucinogens XM5JH5 Psilocin XM7642 Psilocybin XM0T53 Mescaline XM78V1 Aeruginascin XM9WX3 Bufotenine XM9T61 N,N-Dimethyltryptamine XM9CL3 Lysergic acid amide XM5M84 Phencyclidine XM50E4 Muscimol XM1PJ8 Ibotenic acid XM5SB5 Salvinorin A – XM3C53 Amfetaminil – XM3E65 Benzedrine (amphetamine) – XM1NA8 Central nervous system stimulants amphetamines – XM1WW4 Dexedrine – XM6LD5 Dextroamphetamine – XM07Y4 Ecstasy – XM5B49 Methamphetamine – XM3WD9 Methedrine – XM3Q37 Methylamphetamine –– XM9932 Psychostimulant caffeine – XM6RB6 Psychostimulant amphetamine – XM6V10 Tenamfetamine XM12M9 Psychostimulants, ADHD and nootropic agents XM7LR7 Centrally acting sympathomimetics – XM1NX2 Methylphenidate – XM52S5 Pemoline – XM75Z6 Modafinil – XM5921 Fenozolone – XM9DQ5 Atomoxetine – XM5288 Dexmethylphenidate – XM3ZW9 Armodafinil – XM9FY1 Etryptamine – XM3K58 Levopropylhexedrine XM2XU4 Xanthine derivatives – XM0NG8 Caffeine – XM3Y68 Propentofylline XM1SE2 Meclofenoxate XM8QG2 Nizofenone XM84X9 Prolintane XM8EX0 Pipradrol XM8029 Vinpocetine XM37E2 Tipepidine XM1LB1 Pyritinol XM5207 Piracetam XM3HZ4 Deanol XM2AB6 Fipexide XM5TT1 Citicoline XM5N75 Oxiracetam XM6EM2 Pirisudanol XM1MZ1 Linopirdine XM0Z60 Aniracetam XM77H2 Acetylcarnitine XM5CY6 Idebenone XM59Z4 Pramiracetam XM3WZ9 Adrafinil XM94C0 Mebicar XM3J14 Phenibut XM45U3 Deanol aceglumate XM9DQ3 Diethyltryptamine (DET) XM6LV4 Dimethyl tryptamine XM9438 Hawaiian Woodrose seeds XM52J2 Heavenly Blue (morning glory) XM79N5 Magic mushroom XM0169 Mescal buttons XM32H5 Morning glory seeds XM4B51 Pearly Gates (morning glory seeds) XM0QA2 Peyote XM0075 Yohimbic acid XM8E16 Cannabinol XM0XQ5 Central nervous system depressants hallucinogenics XM31A7 Psychodysleptic drug XM3Z58 Psychotomimetic agents XM8X97 Hallucinogen XM7DW4 Megahallucinogen – XM3473 Hydromorphinol – XM8SD7 Hydromorphone – XM78E0 Metopon – XM7VL7 Morpholinylethylmorphine – XM7W06 Nicomorphine – XM9BE3 Normorphine – XM64M0 Oxymorphone – XM1KZ5 Morphine – XM0P98 Benzylmorphine – XM7ZJ1 Myrophine XM4ES0 Opium – XM2T93 Opium alkaloids (total) – XM69X3 Opium alkaloids standardized powdered – XM91H1 Opium alkaloids tincture (camphorated) – XM1EE2 Laudanum – XM1YK2 Papaveretum – XM1LB8 Paregoric XM4SL9 Oxycodone – XM79K2 Acetyldihydrocodeinone – XM7HX3 Eucodal XM9UH3 Nalfurafine XM4587 Codeine, codeine derivatives and other opioids used in cough suppression – XM3DS6 Acetyldihydrocodeine – XM05R0 Antitussive codeine mixture – XM3YP8 Cliradon – XM4046 Desocodeine – XM06K5 Dihydrocodeine – XM77C9 Dihydroisocodeine – XM9UN6 Hycodan – XM0YG5 Hydroxydihydrocodeinone – XM07U7 Percodan – XM5NP7 Piminodine – XM3WN9 Ethylmorphine – XM8E09 Hydrocodone – XM6RX7 Noscapine – XM4QV7 Pholcodine – XM9UV0 Dextromethorphan – XM2358 Thebacon – XM7V96 Dimemorfan – XM5PZ4 Normethadone XM1ZY9 Methadone, methadone derivatives and other drugs used to treat opioid addictive disorders – XM7XP1 Methadone –– XM9RG7 Levo-iso-methadone XM4MV8 Opioid anaesthetics – XM4G88 Alfentanil – XM1EF3 Sufentanil – XM7YQ6 Anileridine – XM0YQ0 Remifentanil – XM7TT0 Antagonist narcotic analgesic – XM0850 Cyclazocine – XM65J2 Levallorphan – XM4HP3 Morphine antagonist – XM14T9 Naloxone – XM2M16 Naltrexone – XM9BM4 Narcotic antagonist – XM5DJ2 Opiate antagonists – XM3TK0 Methylnaltrexone bromide – XM4GP3 Alvimopan – XM93Z3 Naloxegol – XM6KY8 Opioid antagonist XM4S22 Other opioid analgesics, natural, synthetic and semi-synthetic – XM30T6 Prodine – XM9907 Antitussive opiate – XM6C31 Cough mixture containing opiates – XM8ZF5 Dextrorphan – XM1K75 Difencloxazine – XM1HE9 Dilaudid – XM9SW6 Dipipanone – XM81P5 Dromoran – XM4EW3 Eptazocine – XM6CK0 Ethoheptazine – XM35C1 Heptalgin – XM5F21 Levo-dromoran – XM4P40 Levopropoxyphene – XM1R71 Levorphanol – XM0GS3 Meperidine – XM8PP7 Narcotic synthetic – XM8MP5 Nisentil – XM7S23 Opioid – XM04Z5 Phenadoxone – XM2542 Phenazocine – XM9B34 Phenomorphan – XM72D5 Pipadone – XM39L3 Profadol – XM9AZ5 Promedol – XM3E08 Propoxyphene – XM6625 Racemoramide – XM8804 Thebaine – XM09H6 Tilidine – XM7KC0 Tramadol – XM5UK3 Viminol – XM9Y28 Diphenoxylate – XM86N4 Loperamide – XM9NL3 Phenylpiperidine derivatives –– XM9HP7 Ketobemidone –– XM76M8 Fentanyl – XM8286 Diphenylpropylamine derivatives –– XM3246 Dextromoramide –– XM55Z5 Piritramide –– XM8GB8 Dextropropoxyphene –– XM5GN5 Bezitramide – XM1QE0 Benzomorphan derivatives –– XM9K14 Pentazocine – XM09R6 Morphinan derivatives –– XM1682 Butorphanol –– XM4P05 Nalbuphine – XM9Z94 Buprenorphine – XM02X7 Etorphine – XM3PK7 Acetorphine – XM0K66 Phenoperidine – XM40T9 Meptazinol – XM0GU8 Drotebanol – XM7VK6 Loperamide oxide – XM13Q9 Dezocine – XM25Z3 Tapentadol – XM1G85 Oliceridine XM4PD9 Nalmefene XM4M74 Difelikefalin XM05B3 Diamorphine XM69R4 Morphine, morphine derivatives and metabolites – XM39E2 14-hydroxydihydro-morphinone – XM5CY8 Acemorphan – XM0E25 Benzomorphan – XM8YM7 Benzyl morphine – XM0BB1 Blue velvet – XM45R8 Desomorphine – XM4T95 Dihydromorphine XM0VG7 Catha (edulis) (tea) XM0238 Khat XM3GQ0 Central nervous system stimulants, not elsewhere classified XM0854 Cerebral stimulants psychotherapeutic XM93X4 Cerebral stimulants XM7125 Stimulant central nervous system psychotherapeutic – XM6R58 Novocain topical XM0217 Methitural – XM6NN7 Nupercaine, spinal XM2XY6 4-Aminobutyric acid – XM8739 Nupercaine topical – XM0QU2 Orthocaine – XM5HP0 Oxetacaine – XM6V01 Oxethazine – XM6RN9 Oxybuprocaine – XM7H65 Percaine, spinal – XM7EK6 Percaine topical – XM6Z26 Phenacaine – XM2ZH3 Piperocaine –– XM7UW6 Piperocaine infiltration –– XM8J09 Piperocaine nerve block –– XM40M8 Piperocaine topical – XM8AE6 Pitkin's solution – XM2X66 Prilocaine –– XM9NH0 Prilocaine infiltration –– XM85Q7 Prilocaine nerve block – XM4EE1 Prilocaine regional – XM5L66 Procaine –– XM05Z5 Procaine nerve block –– XM1CG3 Procaine regional –– XM8KS3 Procaine spinal – XM97J9 Proparacaine – XM72A2 Propoxycaine –– XM9BY7 Propoxycaine infiltration –– XM2DT4 Propoxycaine nerve block –– XM0BG4 Propoxycaine topical – XM87E0 Quotane – XM2MX6 Stovaine –– XM79W4 Stovaine infiltration –– XM08B5 Stovaine nerve block –– XM9657 Stovaine spinal –– XM3MW8 Stovaine topical – XM6392 Surfacaine – XM1HW1 Tetracaine –– XM32E4 Tetracaine nerve block –– XM9H96 Tetracaine regional –– XM9CQ9 Tetracaine spinal – XM3QD1 Trimecaine – XM2FR2 Tronothane – XM7771 Xylocaine infiltration – XM18M2 Xylocaine nerve block – XM5K48 Xylocaine spinal – XM5G11 Xylocaine topical – XM1030 Alprazolam – XM4R58 Bentazepam – XM2GL0 Benzodiapin – XM9JC7 Bromazepam – XM2S43 Brotizolam – XM5133 Camazepam – XM9S41 Carpipramine – XM1J81 Central nervous system depressants benzodiazepines – XM5JC4 Chlordiazepoxide – XM43U0 Clobazam – XM3C29 Dipotassium clorazepate – XM0A75 Clotiazepam – XM5M11 Cloxazolam – XM0GD3 Delorazepam – XM8P99 Diazepam – XM9YX9 Estazolam – XM54N1 Ethyl loflazepate – XM9DN9 Etizolam – XM8NC2 Fludiazepam – XM9W71 Flunitrazepam – XM73H1 Flurazepam – XM68Z6 Flutazolam – XM81V7 Flutoprazepam – XM3FR2 Halazepam – XM86G3 Haloxazolam – XM5WE7 Ketazolam – XM6KW2 Loprazolam – XM85H7 Lorazepam – XM1EE3 Lormetazepam – XM9KN4 Medazepam – XM7QC1 Mexazolam – XM9PG6 Midazolam – XM8TH1 Nimetazepam – XM4TR7 Nitrazepam – XM4FQ9 Nordazepam – XM1A29 Oxazepam – XM62U2 Oxazolam – XM3LR9 Perlapine – XM0GW7 Pinazepam – XM4M86 Prazepam – XM42F4 Quazepam – XM3215 Temazepam – XM79N8 Tofisopam – XM9X46 Tranquilizer benzodiazepine – XM0G58 Tranxene – XM1VC3 Triazolam – XM1YU1 Valium – XM36R8 Potassium clorazepate – XM94Z2 Adinazolam – XM66N4 Doxefazepam – XM4BU2 Cinolazepam XM8CM3 Diphenylmethane derivatives – XM8CV8 Hydroxyzine – XM70L1 Captodiame XM96H3 Carbamates – XM3MX1 Meprobamate – XM8G67 Emylcamate XM3XU7 Aldehydes and derivatives – XM8AH5 Chloral hydrate – XM8D85 Chloralodol –– XM0ZC2 Paracetaldehyde – XM46J8 Acetylglycinamide chloral hydrate – XM9V32 Dichloralphenazone – XM0V58 Cinnamaldehyde – XM37U9 Hexyl cinnamal – XM5TZ2 Amyl cinnamal – XM9J50 Butylchloral hydrate XM6R00 Piperidinedione derivatives – XM5S80 Glutethimide – XM2MN1 Methyprylon – XM2MC9 Pyrithyldione XM4YG0 Barbiturates and derivatives – XM3Z73 Narcobarbital – XM01Z3 Pentobarbital – XM01F5 Amobarbital – XM8TB8 Butobarbital – XM2B90 Barbital – XM6QG0 Secobarbital – XM28V1 Talbutal – XM6NX3 Vinylbital – XM9VX7 Vinbarbital – XM89L9 Cyclobarbital – XM7ZK9 Heptabarbital – XM8FN0 Allobarbital – XM8T75 Inhaled anaesthetics – XM8C15 Proxibarbal –– XM4VX3 Ethers – XM60H4 Methylphenobarbital ––– XM3J00 Diethyl ether – XM2605 Phenobarbital ––– XM7UB3 Vinyl ether – XM5J41 Primidone –– XM0TE1 Halogenated hydrocarbons – XM45T7 Barbexaclone ––– XM2FH0 Halothane – XM64T5 Metharbital ––– XM7MX5 Chloroform – XM1ZM1 Reposal –––– XM1GP5 Chloroform vapor – XM1WN6 Etallobarbital ––– XM35M6 Enflurane – XM8YV1 Aprobarbital ––– XM1E91 Trichloroethylene anaesthetic gas – XM50Q3 Brallobarbital ––– XM9HY9 Isoflurane – XM3UQ5 Butalbital –– XM0ZA2 Anaesthesia endotracheal – XM6XH1 Butallylonal –– XM05Z8 Anaesthetic gaseous – XM4C65 Difebarbamate –– XM8V73 Anaesthetic halogenated hydrocarbon derivatives – XM8DQ9 Methobarbital, methobarbitone –– XM5UK1 Central nervous system depressants anaesthetic gases – XM3YG4 Nealbarbital –– XM42D4 Chloroform anaesthetic – XM6F85 Probarbital –– XM2DK4 Chloroform water, concentrated – XM37N4 Propallylonal –– XM9TE3 Divinyl ether – XM81J9 Secbutabarbital –– XM3EA4 Ethyl bromide anaesthetic XM4843 Z-drugs –– XM2D90 Ethyl chloride anaesthetic – XM8LM1 Zopiclone –– XM6WF0 Ethylene anaesthetic – XM8188 Zolpidem –– XM9K99 Fluroxene – XM0UU3 zaleplon –– XM73B5 Nitrous oxide – XM4DP1 Eszopiclone –– XM9NP2 Trifluoroethyl vinyl ether XM0GA0 Melatonin receptor agonists –– XM7Q24 Vinesthene – XM7R38 Melatonin –– XM1C44 Desflurane – XM4Y11 Ramelteon –– XM07G7 Sevoflurane – XM0DX1 Tasimelteon –– XM8X62 Xenon – XM7D47 Intravenous anaesthetics – XM93J2 Bromide salts –– XM14F2 Alphadolone – XM5V35 Acecarbromal –– XM4PF7 Alfaxalone – XM3260 Bromisoval –– XM59B1 Barbiturate anaesthetic, intravenous – XM7XH5 Bromoform –– XM9CB4 Brevital sodium – XM68H5 Carbromal –– XM6LE6 Buthalitone sodium –– XM5K69 Butyl thiobarbital sodium – XM4JD8 Acetylpheneturide –– XM9SR9 Central nervous system depressants anaesthetic, intravenous – XM0Y74 Allylisopropylacetylurea –– XM5MB2 Etomidate – XM2MT0 Allyltribromide –– XM93E9 Evipal sodium – XM0FX2 Ammonium bromide –– XM5ZF4 Sernyl – XM2P06 Anticonvulsant hypnotic –– XM4XN0 Thialbarbital – XM4LR0 Anticonvulsant pyrimidinedione –– XM66H8 Thiamylal – XM80V1 Anticonvulsant specified –– XM8UK0 Thiamylal sodium – XM2851 Apronal –– XM4NL3 Thiobarbital sodium – XM8WF0 Avomine –– XM1QW9 Thiobarbiturate anaesthetic – XM34M8 Beta-Chlor –– XM72F2 Thiobutabarbital sodium – XM2S35 Bromal (hydrate) –– XM7JR4 Methohexital – XM16D8 Bromine compounds (medicinal) –– XM08U4 Hexobarbital – XM0JD2 Bromine sedative –– XM0EL8 Thiopental sodium – XM14P7 Bromisovalum –– XM7C11 Ketamine – XM0L99 Bromural –– XM4BS0 Propanidid – XM7Q19 Calcium bromide –– XM1903 Propofol – XM44G1 Bromides –– XM2W08 Esketamine – XM6Z70 Central nervous system depressants chloral hydrate – XM7T11 Cyclopropane – XM4A26 Central nervous system depressants hypnotics specified – XM9MS5 Gammahydroxybutyrate – XM0MP0 Central nervous system depressants paraldehyde – XM5C03 Hexobarbital rectal – XM2PX1 Chloral derivative – XM20X3 Minaxolone – XM5HQ1 Chloralamide – XM2MR8 Tiletamine – XM1XU2 Chloretone – XM8DR0 Tribromoethanol, rectal – XM7N56 Chlorhexadol XM7Y85 Local anaesthetics – XM7GE6 Clomethiazole – XM1FJ6 Amylocaine, regional – XM58S5 Croton chloral –– XM1H49 Amylocaine, regional infiltration – XM1L51 Diethylsulfone-diethylmethane –– XM7CH6 Amylocaine, regional nerve block – XM5P16 Divalproex –– XM37J6 Amylocaine, regional spinal – XM2ML0 Doriden –– XM5JY6 Amylocaine, regional topical – XM0YS0 Dormison – XM5R82 Anaesthesia, caudal – XM76A5 Ectylurea – XM8MY3 Anaesthesia, epidural – XM4SW2 Ethchlorvynol – XM25C7 Anaesthesia, mucosal – XM8HM5 Ethinamate – XM0D14 Anesthesia rectal local – XM0959 Etifoxine – XM0FJ3 Anesthesia regional – XM5084 Hexapropymate – XM0LM0 Anaesthetic infiltration – XM3GR8 Hypnotic drug specified – XM7EC3 Anaesthetic spinal – XM1H40 Lactuca (virosa) (extract) – XM8E23 Anesthetic topical – XM7EA2 Lactucarium – XM3S41 Anaesthetic with local muscle relaxant – XM2447 Lettuce opium – XM5ZK7 Aptocaine – XM1SJ9 Levanil – XM52S4 Articaine – XM9S20 Levoprome – XM4YN0 Benzamine – XM3C52 Methaqualone – XM8KD9 Benzocaine – XM8UW8 Methyl sulfonal – XM1604 Betoxycaine – XM79Y3 Methylpentynol – XM5YL1 Bupivacaine – XM9L86 Niaprazine –– XM7WQ7 Bupivacaine infiltration – XM67F2 Noludar –– XM4216 Bupivacaine nerve block – XM41Z4 Periclor –– XM46M2 Bupivacaine spinal – XM7865 Petrichloral – XM3781 Butacaine – XM8U36 Phenergan – XM7MD5 Butamben – XM3YQ0 Potassium bromide – XM9VA7 Butanilicaine – XM23J2 Propionaldehyde (medicinal) – XM0HA0 Butyl aminobenzoate – XM5KU5 Quaalude – XM5NW5 Butyn – XM5YQ4 Sedative mixed – XM2YU2 Carbocaine infiltration – XM53R6 Sedormid – XM8C65 Carbocaine nerve block – XM5BF2 Serenesil – XM2DT1 Carbocaine topical – XM8SU3 Sodium bromide – XM6HZ0 Chloroprocaine – XM9F88 Sodium valproate –– XM8XD3 Chloroprocaine infiltration – XM4ZG6 Somnos –– XM0GC2 Chloroprocaine nerve block – XM1BT3 Sopor –– XM94U2 Chloroprocaine spinal – XM2N03 Soporific drug specified type – XM0L28 Cinchocaine – XM81Z5 Sulfonal –– XM5Y10 Cinchocaine topical – XM9QV2 Sulfonethylmethane – XM7FD6 Cyclaine – XM4YF8 Sulfonmethane – XM41W7 Cyclomethycaine – XM8296 Tetronal – XM3BB4 Dimethocaine – XM6WP4 Tranquilizer with hypnotic or sedative – XM8UZ3 Diperodon – XM9XF5 Tribromacetaldehyde – XM23R3 Dorsacaine – XM1DU6 Trichloroethanol – XM5601 Dyclone – XM4236 Trichloroethyl phosphate – XM3QB4 Dyclonine – XM68E8 Triclofos – XM20M0 Endocaine – XM2334 Trional – XM0P92 EPAB – XM16S3 Triple bromides – XM2H77 Ethocaine infiltration – XM3PP3 Valerian root – XM6585 Ethocaine nerve block – XM0MV0 Valerian tincture – XM7217 Ethocaine spinal – XM1WZ4 Valmid – XM1WJ3 Ethyl aminobenzoate – XM2TP4 Valnoctamide – XM87H9 Ethyl chloride local anaesthetic – XM2AQ9 Welldorm – XM8X57 Etidocaine – XM1ZF1 Buspirone –– XM8013 Etidocaine infiltration – XM01J5 Mephenoxalone –– XM8RU6 Etidocaine nerve block – XM9TL2 Propiomazine – XM2F20 Eucaine – XM15N4 Sodium oxybate – XM76M6 Hexylcaine – XM3EH5 Benzoctamine – XM5863 Leucinocaine – XM9727 Gedocarnil – XM1MK4 Mepivacaine – XM5928 Fabomotizole –– XM0EH7 Mepivacaine epidural – XM4DF5 Lavandulae aetheroleum – XM9DE9 Meprylcaine – XM8488 Valerianae radix – XM7CG8 Metabutethamine – XM2HN6 Suvorexant – XM68T6 Nesacaine – XM2AY7 Dipiperonylaminoethanol –– XM6AA0 Nesacaine infiltration – XM9235 Lemborexant –– XM4148 Nesacaine nerve block XM1VL2 Hexethal (sodium) – XM38C9 Novocain infiltration XM7MG1 Mephebarbital – XM6Z69 Xenon (127Xe) gas – XM6EQ3 Xenon (133xe) – XM39A6 Sodium iodide (124I) – XM9F18 Maternal antibodies XM3XY4 Alcohol deterrent – XM3HU5 ferric (59Fe) citrate XM2XV6 Antabuse – XM1899 Sodium iodide (123I) XM1S43 Antidote – XM9063 Sodium iodohippurate (123I) XM65Y8 Chelating agent – XM60X3 Iobenguane (131I) XM68U2 Cholinesterase reactivator – XM1QL4 Iobenguane (123I) XM81B1 Cysteamine – XM6UT0 Fluoroethyl-L-tyrosine (18F) XM9M46 Detoxifying agent – XM80F7 Fluoroestradiol (18F) XM0ZM0 Disodium edetate – XM5G08 Fluciclovine (18F) XM1V56 EDTA – XM3LK2 Fluorodopa (18F) XM0FL5 Phytic acid, nonasodium – XM1N90 Fluoromethylcholine (18F) XM7SW5 Glutathione – XM5XR7 Fluoroethylcholine (18F) XM1YY3 Methylthioninium chloride – XM5EC5 Gallium (68Ga) edotreotide XM7Z31 Nitrefazole – XM7VT3 Cobalt (57Co) cyanocobalamine XM7HV6 Obidoxime chloride – XM8YZ3 Cobalt (58Co) cyanocobalamine XM2ZD4 Pralidoxime – XM5FA9 Tauroselcholic acid XM6TE9 Potassium ferric hexacyanoferrate (medicinal) – XM42A5 Selenium (75Se) norcholesterol XM7K47 Pralidoxime iodide – XM2MJ2 Iodinated (131i) human serum albumin XM6BZ5 Pralidoxime chloride – XM2YP2 Iodine 125 XM8P25 Prussian blue therapeutic – XM8YZ7 Iodine 131 XM6DU2 Pyridine aldoxime methiodide – XM0RB0 Sodium iodohippurate (131I) XM6043 Pyridine aldoxime methyl chloride – XM15W7 Sodium iothalamate (125I) XM3810 Sodium nitrite – XM5674 Ammonia (13N) XM7LV6 Sodium phytate – XM05N6 Gallium (68Ga) gozetotide XM6NW5 Thiosulfate XM45C8 Therapeutic radiopharmaceuticals XM2KC9 Sodium versenate – XM6RC9 Sodium iodide I-131 therapeutic XM99S5 Tetraethylthiuram disulfide – XM01S1 Isoaminile (citrate) XM6GP9 Trientine – XM9XW5 Antimonic sulfide XM2U68 Trisodium hydrogen edetate – XM8Z31 Yttrium (90Y) ferrihydroxide colloid XM7KV3 Versenate – XM0JJ4 Samarium (153Sm) hydroxyapatite colloid XM4UW9 Nalorphine – XM56F9 Dysprosium (165Dy) colloid XM89R9 Dimercaprol – XM10B1 Yttrium (90Y) citrate colloid XM1260 Potassium iodide – XM3MD6 Erbium (169Er) citrate colloid XM7372 Acetylcysteine – XM5ZE8 Amylene dichloride XM5MC0 Methionine – XM1WG6 Ethiodized oil (131 i) XM28B1 Uridine triacetate – XM7MV3 Iodine (131I) omburtamab XM0588 Edetates XM5VJ5 Prednisolone and Promethazine XM8ET8 Obidoxime XM2GR4 Protamine XM4JM7 Copper sulfate XM9AD6 Digitalis antitoxin XM2UQ5 Flumazenil XM2H17 4-dimethylaminophenol XM8ZA0 Cholinesterase XM62Q3 Prussian blue XM7LQ9 Fomepizole XM9NQ8 Sugammadex XM0666 Idarucizumab XM01C9 Andexanet alfa XM5A41 Deferoxamine XM03A5 Deferiprone XM12X8 Deferasirox XM3B07 Polystyrene sulfonate XM8NS1 Ferric citrate XM1AY3 Sodium phosphate cellulose XM6Q80 Sevelamer XM22K8 Lanthanum carbonate XM4MP9 Calcium acetate and Magnesium carbonate XM9188 Sucroferric oxyhydroxide XM4C26 Colestilan XM1JB5 Mesna XM7BJ9 Calcium folinate XM45R5 Dexrazoxane XM2852 Calcium levofolinate XM5GF2 Amifostine XM61A6 Sodium folinate XM4NB1 Rasburicase XM8J47 Palifermin XM8L87 Glucarpidase XM1EU2 Sodium levofolinate XM0MC0 Arginine and Lysine XM7PK0 Trilaciclib XM0LA6 Afamelanotide XM8337 Canthaxanthin XM3GF4 Retinoids – XM0Z07 Etretinate – XM2M63 Acitretin XM4RP3 Trioxysalen XM47G3 Methoxsalen XM1G69 Bergapten XM7WA3 Fumaric acid XM98J9 Isotretinoin XM9FP6 Ichtasol XM4CF3 Coccidioidin XM1V31 Congo red XM34X2 Evans blue XM5618 Fluorescein XM3Y60 Histoplasmin XM2818 Indocyanine green XM3WZ1 Lymphogranuloma venereum antigen XM1VN8 Mumps skin test antigen XM3Q40 Penicilloyl polylysine XM36R6 Sodium metrizoate XM1QL6 Sulfonphthalein, sulfonphthol XM8478 Sulkowitch's reagent XM4DA3 Toxin, diphtheria (Schick Test) XM0EK6 Tuberculin, purified protein derivative (PPD) XM6XX8 Glucose – XM53M3 Sincalide – XM0D92 Ceruletide – XM5GR6 Metyrapone – XM7E13 Somatorelin – XM1UJ0 Corticorelin – XM5AM6 Macimorelin XM60V4 Tests for liver functional capacity – XM9ZW8 Galactose – XM1XE0 Sulfobromophthalein – XM0N95 Methacetin (13C) – XM90L9 Iprofenin – XM3114 Lidofenin – XM2PX0 Rose bengal sodium (131i) XM9H30 Tests for gastric secretion – XM44K8 Cation exchange resin – XM1MP2 Betazole – XM1286 Histamine phosphate – XM9AU1 Pentagastrin – XM1Q27 Caffeine and Sodium benzoate – XM1F97 Azuresin XM4E68 Tests for renal function and ureteral injuries – XM9RK1 Indigo carmine – XM3G67 Alsactide – XM27H8 Aminohippuric acid –– XM87Y9 Sodium para-aminohippurate – XM2JZ2 Inulin and other polyfructosans – XM7M20 Phenolsulfonphthalein XM0N07 Tests for thyroid function – XM7R30 Protirelin XM76Z9 Tests for pancreatic function – XM3L99 Secretin – XM7A79 Bentiromide – XM6014 Pancreozymin-cholecystokinin – XM24K5 Selenomethionine (75Se) XM8B05 Edrophonium XM3YJ9 Methacholine XM5K20 Fructose XM9258 Vitamin A concentrates XM7PF6 Tuberculin XM9QZ5 13C-urea XM0UW4 Hexaminolevulinate XM02S2 Patent blue XM9Y95 Bromophenol blue reagent XM5PT0 Diacetyl monoxime XM8M78 Guaiac reagent XM3385 Oxalic acid ammonium salt XM74W0 Phenaphthazine reagent XM4SZ3 Oxygen XM6NZ1 Carbon dioxide medicinal XM3K31 Nitrogen XM7EZ9 Medical air XM2S71 X-ray contrast media, iodinated – XM7YS2 Watersoluble, nephrotropic, high osmolar X-ray contrast media –– XM7PH4 Metrizoic acid –– XM6583 Iodamide –– XM8XV8 Iotalamic acid –– XM34M9 Ioxitalamic acid –– XM50Y6 Acetrizoic acid –– XM7ZV2 Iocarmic acid –– XM2DC4 Diodone –– XM8KK9 Diatrizoic acid –– XM50U3 Ioglicic acid –– XM9C52 Methiodal – XM4AG5 Watersoluble, nephrotropic, low osmolar X-ray contrast media –– XM3WB6 Metrizamide –– XM3R65 Iohexol –– XM5EP5 Ioxaglic acid –– XM8C50 Iopamidol –– XM4UK7 Iopromide –– XM8VT7 Iotrolan –– XM5LW4 Iotroxic acid –– XM6227 Iopentol –– XM8NA7 Iodixanol –– XM75B4 Iomeprol –– XM79B6 Iobitridol –– XM6VV1 Ioxilan – XM0KA6 Watersoluble, hepatotropic X-ray contrast media –– XM2VE6 Iodoxamic acid –– XM8411 Ioglycamic acid –– XM7QU5 Adipiodone –– XM1QH8 Iobenzamic acid –– XM2NU7 Iopanoic acid –– XM8PW2 Iocetamic acid –– XM4ZU7 Sodium iopodate –– XM8WD0 Tyropanoic acid –– XM6TF5 Calcium iopodate – XM0LK3 Non-watersoluble X-ray contrast media –– XM1AX3 Iopydol –– XM1YV8 Propyliodone –– XM1R87 Iofendylate –– XM6SE3 Ethyl esters of iodised fatty acids – XM6XU2 Diatrizoate – XM8QZ2 Iodophthalein sodium – XM0L44 Amidotrizoate – XM80W7 Bunamiodyl – XM5NA9 Iodipamide – XM4E01 Iodohippuric acid – XM9402 Iophenoic acid – XM7S30 Iopodic acid – XM4R74 Iotroxate – XM44B9 Ioxaglate – XM5N73 Methiodal sodium – XM96Q8 Phenobutiodil – XM3E15 Thorium dioxide suspension – XM90A9 Tyropanoate – XM2MR0 Barium sulfate with suspending agents – XM1FW7 Barium sulfate without suspending agents XM05Z9 Magnetic resonance imaging contrast media – XM2LS2 Paramagnetic contrast media –– XM7CY5 Gadopentetic acid –– XM4UX1 Gadoteric acid –– XM1564 Gadodiamide –– XM0FN2 Gadoteridol –– XM73Z5 Mangafodipir –– XM3BF7 Gadoversetamide –– XM29E1 Ferric ammonium citrate –– XM0XE4 Gadobenic acid –– XM3VG2 Gadobutrol –– XM7W85 Gadoxetic acid –– XM6GF6 Gadofosveset – XM8966 Superparamagnetic contrast media –– XM33C2 ferumoxsil –– XM84N5 ferristene –– XM2945 iron oxide, nanoparticles – XM2666 Perflubron XM5TN4 Ultrasound contrast media – XM40N1 Microspheres of human albumin – XM3PF3 Microparticles of galactose – XM7S16 Perflenapent – XM4VR4 Microspheres of phospholipids – XM8169 Sulfur hexafluoride – XM8G80 Perflubutane polymer microspheres XM9320 Diagnostic radiopharmaceuticals – XM8ZM1 Technetium (99mTc) compounds –– XM5VK7 Sodium pertechnetate Tc99m – XM9YB1 Iodine (123I) compounds – XM2R88 sodium iodide (131i) – XM6941 Rubidium chloride Rb82 – XM3GL6 Gallium citrate –– XM8SB4 Gallium (67Ga) citrate – XM3WK3 Fludeoxyglucose (18F) – XM4ML0 Iodocholesterol (131I) XM8469 Netarsudil XM0GR6 Tyrothricin XM0GK6 Pegaptanib XM0FD5 Fidaxomicin XM95Y7 Ranibizumab XM1071 Nifuroxazide XM42E0 Iodoheparinate XM5BH0 Nifurzide XM67C4 Lifitegrast XM7MF9 Balsalazide XM57P1 Cenegermin XM0JJ7 Dimeticone topical XM2RM5 Ocriplasmin XM6XD8 Streptomycin topical XM0YQ8 Autologous limbal stem cells XM4KV4 Acetic acid medicinal XM2GK8 Artificial tears and other indifferent preparations XM7014 Terbinafine topical XM3PF8 Anecortave XM0K16 Idoxuridine topical XM7CE4 Guaiazulen XM43M3 Benzoyl peroxide XM0ST2 Olopatadine XM9X60 Penciclovir topical XM49V8 Azidamfenicol XM3SK7 Famciclovir topical XM3G39 Sulfadicramide XM7A63 Ganciclovir topical XM13T1 Sulfafenazol XM1P27 Lomefloxacin topical XM4F24 Interferon ophthalmic preparation XM3CL3 Levofloxacin topical XM0C71 Fomivirsen XM92Q3 Gatifloxacin topical XM1A96 Besifloxacin XM6VX8 Moxifloxacin topical XM7415 Mercury compounds XM1HU5 Loxoprofen XM9KL6 Loteprednol XM8TB9 Abametapir XM6GF5 Formocortal XM7QG0 Benzyl benzoate XM9166 Pranoprofen XM0GX2 Benzyl Benzoic acid XM4GZ0 Nepafenac XM9208 BHC (medicinal) XM0QS2 Bromfenac XM7S48 Bismuth salts glycolylarsenate XM14H0 Brimonidine ophthalmic preparation XM5RT8 Boric acid XM9KS5 Acetylcholine ophthalmic preparation XM84D8 Bromosalicylchloranitide XM32J7 Levocabastine XM0YT9 Buclosamide XM9L65 Lodoxamide XM6862 Butoconazole (nitrate) XM1CM1 Emedastine XM7VA5 Calomel XM4JE3 Alcaftadine XM2AV1 Candicidin XM7SY2 Sodium chloride, hypertonic (ophthalmic) XM2V43 Carbamide peroxide XM2LQ4 Sodium edetate ophthalmic preparation XM2ZX1 Carbol fuchsin XM3ZG3 Ciclosporin ophthalmic preparation XM6C04 Carfusin XM7UH0 Nandrolone ophthalmic preparation XM9H69 Castellani's paint XM3XE4 Apraclonidine XM5ZY9 Ceepryn XM2Y24 Verteporfin XM9432 Cetalkonium chloride XM63C9 Spaglumic acid XM1BP8 Cethexonium chloride XM62D0 Cetrimide XM3YZ7 Dentifrice XM6ZW9 Cetrimonium bromide XM1JW3 Dressing, live pulp XM94W4 Cetylpyridinium chloride XM0PR1 Eucalyptus oil XM7CX5 Chamomile XM32B6 b-eucaine XM3XP7 Oil cloves XM8HU1 Chloramine T XM79Q0 Benzamine lactate XM8PE1 Pulp devitalizing paste XM72P5 Chloramphenicol topical XM8MM9 Coal tar XM9023 Acetylsalicylic acid topical XM7DZ3 Chlorhexidine XM96H7 Ether-soluble tar distillate XM7K59 Olaflur XM2ZT2 Chlorhydroxyquinolin XM6PP6 Juniper tar XM5GY2 Sodium monofluorophosphate topical XM5D99 Chlorinated lime and boric acid solution XM8YS8 Phenol medicinal XM0HL8 Chlorinated soda solution XM96T6 Phenolic preparation XM53X2 Tetracycline topical XM8FE7 Chlorocresol XM8485 Pramoxine XM2FL0 Acriflavinium chloride XM3XC5 Chloroxylenol XM6A20 Quinisocaine XM8K50 Acrinol XM93C6 Chlorphenesin topical (antifungal) XM8W74 Tar distillate XM5PD0 Acrisorcin XM2CN0 Chlorquinol XM8WM2 Tar ointment XM7696 Adrenal topical XM0852 Ciclopirox (olamine) XM4543 Tolpropamine XM9B70 Aerosporin topical XM6MJ1 Clobetasone XM2833 Mepyramine topical XM2ET5 Alclometasone XM2WP5 Clodantoin XM29P8 Diphenhydramine methylbromide XM3NX2 Alkonium (bromide) XM8TG2 Clofenotane XM9UN5 Thonzylamine topical XM7TF6 Allethrin XM8W85 Clotrimazole XM7JY5 Thenalidine topical XM0CC9 Aluminium acetate solution XM6BT6 Cloxiquine XM6WM2 Promethazine topical XM6JG7 Aluminium sulfate XM4M83 Copper gluconate XM18N0 Glutaraldehyde medicinal XM42L5 Creosol (compound) XM7XA4 Glyceryl triacetate topical XM35M5 Creosote (coal tar) (beechwood) XM4B01 Acetic acid with sodium acetate (ointment) XM7Y78 Gramicidin XM7ZK1 Cresol (s) XM7MV6 Acrylic resin XM5UQ0 Halcinolone XM0WM0 Cresol and soap solution XM8U60 Allylthiourea XM9Q64 Halethazole XM4YB3 Cresyl acetate XM06X6 Aluminium, aluminum ointment (surgical) (topical) XM0C80 Haloprogin XM0348 Cresylic acid XM1S82 Aminobenzoic acid (-p) XM3KW0 Halquinols XM3726 Crotamiton XM3VB3 Arachis oil XM6XH7 HCH medicinal XM7YY8 Dakin's solution XM8SU9 Barrier cream XM8UW4 Hedaquinium XM8CF0 Dequalinium chloride XM5L08 Bentonite XM95K6 Hexachlorophene XM6LZ1 Desonide XM7D95 Benzophenones XM6RK6 Aminoacridine XM0PQ7 Dettol – XM6F99 Benzophenone-3 XM7RK5 Hexamidine XM1RR7 Dibromopropamidine isethionate – XM4DT5 Benzophenone-4 XM19W1 Hydrargaphen XM0UE0 Dibrompropamidine XM08U7 Betula oil XM0JC1 Hydrargyri amino-chloridum XM06U7 Dicophane XM7K00 Calamine (lotion) XM4AG2 Hydrogen peroxide XM2355 Diethyltoluamide XM2EP3 Cellulose nitrates (topical) XM6E35 Hydroxytoluene medicinal XM4A13 Dimazole XM9ZA9 Chlordiethyl benzamide XM02H1 Hypochlorite XM42D3 Dixanthogen XM88R8 Cold cream XM3PT9 Ichthammol XM3JL3 Dodicin XM7033 Corn starch XM6BF8 Isoconazole XM7YF5 Dofamium chloride XM38M3 Cornhusker's lotion XM07S0 Kwell anti-infective (topical) XM3TY6 Domiphen bromide XM8P34 Cottonseed oil XM3U48 Laurolinium XM5XH3 Econazole XM5PK1 Demulcent (external) XM7CU1 Amphotericin B topical XM8E88 Erythromycin topical XM0XB3 Diethyl toluamide medicinal XM8C45 Lidex XM5QE6 Ethacridine XM9U76 Dimethyl phthalate XM8E58 Lindane medicinal XM09B1 Ethylene oxide medicinal XM8KY4 Flaxseed (medicinal) XM7CM3 Locorten XM91H3 Eurax XM6694 Homosalate XM5MZ8 Mafenide XM2258 Exalamide XM8M74 Hydrophilic lotion XM6QD7 Malathion (medicinal) XM9K22 Fenticlor XM8WH4 Lanolin XM6L15 Medrysone XM2E99 Fluocinonide – XM4HE0 Lanolin alcohol XM53R5 Melaleuca alternifolia oil XM67C1 Flurobate XM7TK2 Mecrilate XM35K3 Merbromin XM6AZ9 Furazolium chloride XM7VP7 Melanizing agents XM7FY5 Mercaptobenzothiazole salts XM5JA4 Gamma-benzene hexachloride (medicinal) XM8EY7 Mexenone XM1B13 Mercurochrome XM0XR4 Gentamicin topical XM9TZ7 Mineral oil topical XM8GN4 Anti-infective bismuth, local XM3214 Octafonium chloride XM2J64 Mercury ammoniated XM3P38 Aluminium acetate XM66S8 Oil wintergreen (bitter) XM9Z76 Mercury anti-infective topical XM7FE1 Aluminium chloride XM9CQ4 Methoxsalen topical XM10V3 Mercury chloride (ammoniated) XM2D21 Aluminium diacetate XM0VT0 Padimate XM6Q50 Mercury oxide, yellow XM2399 Aluminium subacetate XM9AG3 Para-aminobenzoic acid XM9613 Merthiolate XM38V9 Antihemorrhoidal preparation XM1U48 Peanut oil topical XM2JH4 Mesulfen XM1KT1 Detergent external medication XM8PB6 Petrolatum XM2M00 Metactesylacetate XM16X4 Dial (soap) XM8J96 Plaster dressing XM0XV0 Methyl paraben XM2KD7 Duponol (C) (EP) XM9V04 Plastic dressing XM1910 Methyl prednisolone topical XM3Y82 Green soap XM2BL7 Polyethylene adhesive XM5HR1 Methylbenzethonium chloride XM2273 Lauryl sulfoacetate XM6J14 Protectant, skin XM1JC6 Antifungal disinfectant, local XM8P35 Lead acetate XM9VE3 Pyroxylin XM7C91 Methylrosaniline XM3E94 Polyethanolamine alkyl sulfate XM8293 Rose water ointment XM2793 Methylrosanilinium chloride XM2P20 Soap medicinal, soft XM06Y2 Silicone medicinal XM0ZY9 Micatin XM6EW6 Soap superfatted XM9410 Topical sunscreen XM9A06 Monistat XM1X23 Sodium lauryl (sulfate) XM4YA6 Sulisobenzone XM23B6 Mupirocin XM1484 Tannic acid medicinal (astringent) XM7YQ8 Sweet oil (birch) XM43U9 Mycifradin topical XM7KD1 Thiram medicinal XM3599 Talcum XM14D6 Myralact XM19Y0 Vegetable extract, astringent XM3MF9 Thiosinamine XM1HX1 Naftifine XM4S15 Witch hazel XM7Q94 Titanium dioxide XM2BK7 Natamycin XM4KJ0 Antiperspirant XM6WX7 Titanium oxide XM7D13 Neomycin topical XM20Y8 Hamamelis XM5E39 Ultraviolet light protectants XM44R8 Argyrol XM1DT0 Iproheptine – XM4D35 2-(4-Diethylamino-2-hydroxybenzoyl)-benzoic acid hexylester XM51P6 Neomycin with bacitracin XM9RY1 Lowila – XM8A13 Methylene-bis-benzotriazolyltetramethylbutylphenol XM6YS1 Neosporin topical XM1AY0 Septisol – XM6UT3 Phenylbenzimidazol-5-sulfonic acid XM5BH2 Nilstat topical XM3DK8 Sulfatostearate – XM65Q8 2,4,6-Trianilino-p-(carbo-2-ethylhexyl-1-oxi)-1,3,5-triazine XM71W2 Nitrofurazone XM5PP3 Unna's boot XM4T72 Nitromersol XM9R98 Benoquin XM8H46 Zinc gelatin XM2HP9 Nitrozone XM4597 Cantharides XM7RG9 Zinc oxide XM1102 Noxytiolin XM8JB2 Cell stimulants and proliferants XM4NT3 Zinc stearate XM70Z6 Orthoboric acid XM4JD6 Charcoal medicinal topical XM8YJ6 Colophonium XM63S9 Oxiconazole XM6GG8 Chloresium XM1LY7 Sorbitan sesquioleate XM8610 Oxychlorosene XM9YX8 Dextromoramide topical XM2M34 Octinoxate XM7VP9 Asiaticoside XM1KB4 Elase XM2F87 Hyaluronic acid topical XM7N08 Oxylone XM0M69 Enzyme depolymerizing XM90Q0 Cetomacrogol XM9LG4 Parachlorophenol (camphorated) XM5VL6 Gelfilm XM8N69 Etofenamate XM12F4 Paramethasone acetate XM1FF8 Heet XM0MS1 Peruvian balsam XM6P44 Lactic acid XM85Z1 Fluoride medicinal dental use XM70C4 Phenoctide XM2D09 Lytta (vitatta) XM9RB7 Stannous fluoride XM6L76 Phenol XM54L7 Nonoxinol XM4H85 Phenothrin XM4M68 Nonylphenoxy (polyethoxy-ethanol) XM60N7 Bismuth salts formic iodide XM9D74 Phenoxyethanol XM2TV0 Octoxinol-9 XM0DJ3 Cadexomer XM3R68 Phenylmercuric acetate XM7DL5 Panthenol topical XM12P7 Diiodohydroxypropane XM89P9 Phenylmercuric borate XM8865 Podophyllotoxin XM8UZ7 Diiodohydroxyquin topical XM0295 Chlortetracycline topical XM3403 Preparation H XM0809 Iodide XM0K18 Phenylmercuric nitrate XM0VK2 Santyl XM8C24 Iodide mercury (ointment) XM3DV8 Piketoprofen XM4AZ3 Scarlet red XM3Q63 Iodide methylate XM7B69 Polymyxin B topical XM6Z04 Sodium borate therapeutic XM6TG8 Iodochlorhydroxyquin topical XM0J95 Polynoxylin XM8EC8 Spermicide XM3X72 Iodoform XM2G74 Polyoxymethyleneurea XM0M54 Tosylchloramide sodium XM58X1 Potassium iodate XM0XP0 Potassium Permanganate medicinal XM8WU4 Urea topical XM24J7 Povidone iodine XM6YA5 Proflavine XM0M02 Becaplermin XM35Q1 Propamidine XM4QZ6 Gamolenic acid XM9ZS1 Allantoin XM4TA7 Propiolactone XM14C4 Capsaicin XM7H25 Alum (medicinal) XM3DH9 Propion gel XM5DL8 Zucapsaicin XM2GV6 Ammonium ichthyosulfonate XM6SG3 Azelaic acid XM7ZQ6 Organo-heparinoid XM8RR9 Ammonium persulfate XM77H8 Propionate (calcium) (sodium) XM1485 Sodium apolate XM8HL4 Anthralin XM03K3 Pyrethrum extract XM3711 Tacalcitol XM8SX1 Antiseborrheics XM2A13 Pyrogallic acid XM6BQ3 Tazarotene XM8GU1 Butantrone XM8BE0 Pyrogallol XM3GL1 Dextranomer XM4FV2 Cade oil XM97F8 Quaternary ammonium anti-infective XM7618 Crilanomer XM2ST0 Cadmium sulfide (medicinal) XM2SR9 Retinoic acid XM1JG0 Enoxolone XM9TT3 Capsicum XM9773 Salicylhydroxamic acid XM0W31 Trolamine XM4AW0 Carbon dioxide snow XM5GX7 Sodium hypochlorite medicinal (anti-infective) (external) XM1W34 Betulae cortex XM01Q7 Chlorothymol XM5372 Sodium hyposulfite XM1NP5 Ingenol mebutate XM92H5 Chloroxine XM7Z80 Sodium perborate medicinal XM60N1 Selenium compounds XM7HY4 Chrysarobin XM4PL5 Bacimycin XM4HG0 Metandienone topical XM3P37 Coal tar medicinal (ointment) XM7EV2 Sodium propionate XM5DF2 Pimecrolimus XM3LD7 Collagenase topical XM1VV3 Sporostacin XM1015 Dupilumab XM7PM1 Corn cures XM38S1 Staphisagria or stavesacre (pediculicide) XM1A95 Brimonidine XM5W78 Depilatory XM8HC5 Steroid topical XM8HP9 Deoxycholic acid XM95C8 Diachylon plaster XM2237 Sulbentine XM2TT0 Calcipotriol XM64V2 Dimethyl sulfoxide medicinal XM2CH0 Sulfacetamide XM41S0 Aluminium oxide XM26P0 Dimethylamine sulfate XM06Y3 Sulfiram XM8ZR0 Cadmium compounds (medicinal) XM8RS8 Dithranol XM4XY4 Sulfur ointment XM9MC0 Lithium succinate XM17Y7 Enzyme proteolytic XM9ST9 Synalar XM0RJ6 Mequinol XM3JC8 Ethyl chloride local XM33Y9 Terconazole XM7XL9 Albumin tannate XM4P92 Ethyl fumarate XM00V5 Bacitracin zinc XM87L7 Diosmectite XM7WC9 Euresol XM2GG6 Tetramethylthiuram medicinal XM0XA0 Ceratonia XM7VL9 Hair dye XM9ZY9 Thimerosal XM3AJ8 Crospovidone XM8GV4 Hemostyptic XM7W47 Thymol XM86M9 Racecadotril XM7KM8 Isopropyl alcohol medicinal XM3C36 Ticlatone XM33M4 Trafermin XM6ES1 Keratolytic drug anthracene XM9HG1 Tioconazole XM0A16 Abrocitinib XM23V5 Keratolytic drug XM9SF6 Tolciclate XM4KL1 Keratoplastic XM23C3 Tolnaftate XM7BG3 Alkaline antiseptic solution (aromatic) XM76E0 Lassar's paste XM6848 Triacetin XM7CJ4 Ambazone XM1VX5 Methyl nicotinate XM4873 Triamcinolone hexacetonide XM9SX0 Amylmetacresol XM8N27 Monobenzone XM5KU0 Triclobisonium chloride XM59F4 Biclotymol XM6YQ8 Pyrithione zinc XM6Y48 Bacitracin zinc with neomycin XM51P8 Bisdequalinium (salts) (diacetate) XM4549 Resorcin, resorcinol medicinal XM74T6 Triclocarban XM0LW6 Chloromycetin otic solution XM5DQ2 Rubefacient XM5WW5 Triclosan XM2954 Copper sulfate cupric medicinal ear XM68B5 Salicylic acid XM93J3 Tridesilon XM6270 Corbadrine XM02N6 Savin (oil) XM84C7 Undecenoic acid XM96Z5 Dichlorobenzyl alcohol XM4CB3 Selenium disulfide XM5GQ1 Undecoylium XM37H6 Glycerol borax XM43T8 Selenium sulfide XM1TP6 Undecylenic acid (derivatives) XM4UQ0 Levonordefrin XM1UK4 Selsun XM81Z1 Urea peroxide XM9EQ5 Neosporin ENT agent XM3E07 Silver nitrate toughened (keratolytic) XM2VU7 Valisone XM4RA5 Nose preparations XM1FW6 Sulfur compounds not elsewhere classified (medicinal) XM0GR5 Vioform topical XM8YH0 Thenoic acid XM6ZA6 Sulfur keratolytic ointment XM2B18 Zinc anti-infectives XM9VY0 Zinc chloride (mouthwash) XM1W96 Thioglycolate XM7E88 Basic fuchsin XM83Z7 Acetic acid ENT agent XM7GY2 Tioxolone XM6KL1 Zinc peroxide XM0G17 Ritiometan XM4ZP4 Triacetoxyanthracene XM8SM1 Zinc sulfate topical XM3RP3 Myristyl-benzalkonium XM6U21 Trichloroacetic acid medicinal XM5L28 Zinc undecylenate XM8XE9 Antazoline topical XM2V83 Vleminckx's solution XM71H0 Cloponone XM9FX7 Calcium hexamine thiocyanate XM6T99 White lotion (keratolytic) XM0BF3 Acriflavine XM3NR8 Octenidine XM25J6 Xenysalate XM1KZ4 Nifuraldezone XM0M82 Phenazone topical XM7AM5 Glyceryl monothioglycolate XM4DT4 Tibezonium iodide XM5HX7 Podophyllin XM5L79 p-Toluenediamine XM5U34 Eosin XM4L14 Podophyllum (resin) XM24W5 Propanol XM75W8 Adrenal ophthalmic preparation XM5DR7 Isopropanol XM35S7 Amcinonide XM6H73 Ammonium acid tartrate XM2ZR2 Benisone XM8WS1 Triamcinolone topical XM6G79 Anti-infective ophthalmic preparation XM2Q40 Pecilocin XM46G7 Betamethasone topical XM5568 Anticholinesterase reversible ophthalmological XM6UW2 Pyrrolnitrin XM4FN3 Clobetasol XM5T83 Befunolol XM8S89 Polihexanide XM57Z7 Corticosteroid topical XM6NB7 Bibrocathol XM0SV3 Policresulen XM5PM3 Desoximetasone XM32H1 Chymotrypsin ophthalmic preparation XM80T0 Biphenylol XM6TE1 Dexamethasone topical XM6E41 Colistin sulfate (eye preparation) XM68P2 Didecyldimethylammonium chloride XM8V58 Diflorasone XM1WZ1 Contact lens solution XM5LX3 Mercury, metallic XM4XD6 Diflucortolone XM3X79 Copper sulfate cupric medicinal eye XM53J8 Decamethoxine XM4TV8 Fluclorolone acetonide XM3918 Cycloplegic drug XM2UH3 Euflavine XM0WP2 Fludrocortisone topical XM8S71 Demecarium bromide XM7KH0 Sodium chlorite XM84F4 Fludroxycortide XM1X30 Dendrid XM2VS1 Benzalkonium chloride XM6LQ2 Flumethasone XM0L12 Dipivefrine XM7022 Nadifloxacin XM3EM1 Fluocortin (butyl) XM17P1 Echothiophate XM8BY6 Clindamycin topical XM7MM0 Fluorometholone XM7K14 Ecothiopate iodide XM6AC5 Chlormidazole XM52K8 Fluprednidene XM09W6 Edoxudine XM2NB3 Sulconazole XM5086 Flurandrenolide XM8PJ6 Eucatropine XM8B91 Bifonazole XM0ZX1 Halcinonide XM45L3 Fluorphenylalanine XM4J78 Fenticonazole XM8TL4 Halometasone XM1783 Herplex XM0072 Omoconazole XM8KB5 Hydrocortisone aceponate XM9EN3 Hydroxyamphetamine XM9U15 Sertaconazole XM6JE7 Hydrocortisone topical XM9E72 Hypromellose XM49Z6 Flutrimazole XM0ME0 Prednicarbate XM0PE3 Lachesine XM5XM5 Eberconazole XM1B59 Prednisolone steaglate XM8098 Levobunolol XM1QH3 Benzethonium chloride XM09Z4 Prednisolone topical XM4QZ9 Methylparaben (ophthalmic) XM6H72 Luliconazole XM4Y24 Hydrocortisone butyrate XM0YH4 Metipranolol XM7CT0 Bromochlorosalicylanilide XM55S3 Flumetasone XM2JE0 Miotic drug XM89W5 Tribromometacresol XM41T8 Fluperolone XM4DY8 Mycitracin ophthalmic preparation XM8JJ2 2-(4-chlorphenoxy)-ethanol XM5ZS6 Buteprate XM5PU9 Mydriatic drug XM67B0 Ethyl hydroxybenzoate XM64R0 Ulobetasol XM28C3 Neosporin ophthalmic preparation XM6474 Amorolfine XM6DT9 Difluprednate XM4PY4 Phospholine XM2L70 Butenafine XM5EY3 Methylprednisolone aceponate XM4605 Physostigmine XM3PR6 Tavaborole XM4HA4 Fluocinolone acetonide XM9N59 Polymyxin E sulfate (eye preparation) XM20T9 Efinaconazole XM1068 Fluclorolone XM2WK3 Propylparaben (ophthalmic) XM0CH6 Imiquimod XM9DE4 Ciclesonide topical XM56H1 Silver protein XM7SQ2 Benzoic acid with salicylic acid XM8963 Tixocortol pivalate XM7AV0 Sodium borate cleanser eye XM8BH0 Inosine XM5PA8 Ufenamate XM6Q18 Stoxil XM4BA3 Docosanol XM3VA9 Chlorphenesin XM8A14 Sulfisoxazole ophthalmic preparation XM2CA6 Sinecatechins XM2NU3 Idrocilamide XM9PG5 Sulfonamide eye XM0N01 Mercuric iodide XM6H69 Methyl salicylate XM61C9 Tear solution XM4796 Benzododecinium XM5RC2 Tetrahydrozoline XM2PS8 Aluminium acetotartrate XM10R5 Adapalene XM31C8 Visine XM0P54 Bendazac XM6KD7 Motretinide XM9X81 Acetazolamide XM3J77 Bioallethrin XM7C94 Tretinoin topical XM4LU1 Dichlorphenamide XM7MQ0 Copper oleinate XM6PV8 Retinol topical XM4DH5 Ethoxzolamide XM73B3 Decamethrin XM2PQ2 Isotretinoin topical XM8P33 Methazolamide XM9JZ6 Benzoic acid XM01G3 Silver XM3ZJ4 Pemirolast XM4KG9 Dibutylsuccinate XM0CN1 Silver anti-infectives XM2JR8 Picloxydine XM84S5 Dibutylphthalate XM3QX7 Silver colloidal XM6JB1 Fluostigmine XM1BB3 Dimethylcarbate XM2U36 Silver nitrate ophthalmic preparation XM3BT0 Dorzolamide XM74X3 Dimethylphthalate XM9R64 Silver sulfadiazine XM9GB8 Brinzolamide XM4UE1 Ethacridine lactate XM6RF0 Silver nitrate XM5130 Latanoprost XM2Y03 Etohexadiol XM5ZG4 Unoprostone XM8XZ0 Felbinac XM6E95 Bimatoprost XM6XJ9 Oxyquinoline XM9BS0 Travoprost XM4PX0 Potassium polysulfide XM3UC8 Tafluprost XM9R96 Quassia XM6PD6 Dapiprazole XM63Y9 Benzoxonium chloride Associated with - multiple selections are allowed [select] 1A00 Cholera 1A01 Intestinal infection due to other Vibrio 1A02 Intestinal infections due to Shigella 1A03 Intestinal infections due to Escherichia coli – 1A03.0 Enteropathogenic Escherichia coli infection – 1A03.1 Enterotoxigenic Escherichia coli infection – 1A03.2 Enteroinvasive Escherichia coli infection – 1A03.3 Enterohaemorrhagic Escherichia coli infection – 1A03.Y Intestinal infections due to other specified Escherichia coli – 1A03.Z Intestinal infections due to Escherichia coli, unspecified 1A04 Intestinal infections due to Clostridioides difficile 1A05 Intestinal infections due to Yersinia enterocolitica 1A06 Gastroenteritis due to Campylobacter 1A07 Typhoid fever – 1A07.0 Typhoid peritonitis – 1A07.Y Other specified typhoid fever – 1A07.Z Typhoid fever, unspecified 1A08 Paratyphoid fever 1A09 Infections due to other Salmonella – 1A09.0 Salmonella enteritis – 1A09.Y Infections due to other Salmonella in other organs – 1A09.Z Salmonella infection, unspecified 1A0Y Other specified bacterial intestinal infections 1A0Z Bacterial intestinal infections, unspecified 1A10 Foodborne staphylococcal intoxication 1A11 Botulism – 1A11.0 Foodborne intoxication by botulinum toxin – 1A11.1 Other forms of botulism – 1A11.Z Botulism, unspecified 1A12 Foodborne Clostridium perfringens intoxication 1A13 Foodborne Bacillus cereus intoxication 1A1Y Other specified bacterial foodborne intoxications 1A1Z Bacterial foodborne intoxications, unspecified 1A20 Enteritis due to Adenovirus 1A21 Gastroenteritis due to Astrovirus 1A22 Gastroenteritis due to Rotavirus 1A23 Enteritis due to Norovirus 1A24 Intestinal infections due to Cytomegalovirus 1A2Y Other specified viral intestinal infections 1A2Z Viral intestinal infections, unspecified 1A30 Infections due to Balantidium coli 1A31 Giardiasis 1A32 Cryptosporidiosis 1A33 Cystoisosporiasis – 1A33.0 Cystoisosporiasis of small intestine – 1A33.1 Cystoisosporiasis of colon – 1A33.Y Other specified cystoisosporiasis – 1A33.Z Cystoisosporiasis, unspecified 1A34 Sarcocystosis 1A35 Blastocystosis 1A36 Amoebiasis – 1A36.0 Intestinal infections due to Entamoeba – 1A36.1 Extraintestinal infections due to Entamoeba – 1A36.Z Amoebiasis, unspecified –– 1A36.00 Acute amoebiasis –– 1A36.01 Amoeboma of intestine –– 1A36.0Z Intestinal infections due to Entamoeba, unspecified –– 1A36.10 Amoebic liver abscess –– 1A36.11 Amoebic lung abscess –– 1A36.12 Cutaneous amoebiasis –– 1A36.1Y Amoebiasis of other specified sites 1A3Y Other specified protozoal intestinal infections 1A3Z Protozoal intestinal infections, unspecified 1A40 Gastroenteritis or colitis without specification of infectious agent 1A40.0 Gastroenteritis or colitis without specification of origin 1A40.Z Infectious gastroenteritis or colitis without specification of infectious agent 1A60 Congenital syphilis – 1A60.0 Early congenital syphilis, symptomatic – 1A60.1 Early congenital syphilis, latent – 1A60.2 Late congenital syphilitic oculopathy – 1A60.3 Late congenital neurosyphilis – 1A60.4 Other late congenital syphilis, symptomatic – 1A60.5 Late congenital syphilis, latent – 1A60.Z Congenital syphilis, unspecified 1A61 Early syphilis – 1A61.0 Primary genital syphilis – 1A61.1 Primary anal syphilis – 1A61.2 Primary syphilis of other sites – 1A61.3 Secondary syphilis of skin or mucous membranes – 1A61.4 Secondary syphilis of other sites – 1A61.5 Latent early syphilis – 1A61.Y Other specified early syphilis – 1A61.Z Early syphilis, unspecified 1A62 Late syphilis – 1A62.0 Neurosyphilis – 1A62.1 Cardiovascular late syphilis – 1A62.2 Symptomatic late syphilis of other sites – 1A62.Y Other specified late syphilis – 1A62.Z Late syphilis, unspecified –– 1A62.00 Asymptomatic neurosyphilis –– 1A62.01 Symptomatic late neurosyphilis –– 1A62.0Z Neurosyphilis, unspecified –– 1A62.20 Ocular late syphilis –– 1A62.21 Late syphilis involving the musculoskeletal system –– 1A62.22 Late syphilis of skin or mucous membranes –– 1A62.2Y Symptomatic late syphilis of other specified sites –– 1A62.2Z Symptomatic late syphilis of unspecified site 1A63 Latent syphilis, unspecified as early or late 1A6Z Syphilis, unspecified 1A70 Gonococcal genitourinary infection – 1A70.0 Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess – 1A70.1 Gonococcal infection of lower genitourinary tract with periurethral or accessory gland abscess – 1A70.Y Gonococcal infection of other specified genitourinary organ – 1A70.Z Gonococcal genitourinary infection, unspecified –– 1A70.00 Gonorrhoea of penis –– 1A70.0Y Other specified gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess –– 1A70.0Z Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess, unspecified 1A71 Gonococcal pelviperitonitis 1A72 Gonococcal infection of other sites – 1A72.0 Gonococcal infection of musculoskeletal system – 1A72.1 Gonococcal infection of rectum – 1A72.2 Gonococcal infection of anus – 1A72.3 Gonococcal pharyngitis – 1A72.4 Gonococcal infection of eye – 1A72.Y Gonococcal infection of other specified sites 1A73 Disseminated gonococcal infection 1A7Z Gonococcal infection, unspecified 1A80 Chlamydial lymphogranuloma 1A81 Non-ulcerative sexually transmitted chlamydial infection – 1A81.0 Chlamydial infection of lower genitourinary tract – 1A81.1 Chlamydial infection of internal reproductive organs – 1A81.Y Non-ulcerative sexually transmitted chlamydial infection of other specified site – 1A81.Z Non-ulcerative sexually transmitted chlamydial infection of unspecified site 1A8Y Other specified sexually transmissible infections due to chlamydia 1A8Z Sexually transmissible infections due to chlamydia, unspecified 1A90 Chancroid 1A91 Granuloma inguinale 1A92 Trichomoniasis 1A93 Sexually transmissible infestations 1A94 Anogenital herpes simplex infection 1A94.0 Herpes simplex infection of genitalia or urogenital tract 1A94.1 Herpes simplex infection of perianal skin or rectum 1A94.Z Anogenital herpes simplex infection without further specification 1A95 Anogenital warts 1A95.0 Anal warts 1A95.1 Genital warts 1A95.2 Extragenital condylomata acuminata 1A95.Z Anogenital warts, unspecified 1A9Y Other specified predominantly sexually transmitted infections 1A9Z Predominantly sexually transmitted infections, unspecified 1B10 Tuberculosis of the respiratory system – 1B10.0 Respiratory tuberculosis, confirmed – 1B10.1 Respiratory tuberculosis, not confirmed – 1B10.Z Respiratory tuberculosis, without mention of bacteriological or histological confirmation 1B11 Tuberculosis of the nervous system – 1B11.0 Tuberculous meningitis – 1B11.1 Tuberculous meningoencephalitis – 1B11.2 Meningeal tuberculoma – 1B11.3 Tuberculous granuloma of brain – 1B11.Y Tuberculosis of other specified part of nervous system – 1B11.Z Tuberculosis of the nervous system, unspecified 1B12 Tuberculosis of other systems and organs – 1B12.0 Tuberculosis of heart – 1B12.1 Tuberculosis of eye – 1B12.2 Tuberculosis of ear – 1B12.3 Tuberculosis of endocrine glands – 1B12.4 Tuberculosis of the musculoskeletal system – 1B12.5 Tuberculosis of the genitourinary system – 1B12.6 Tuberculous peripheral lymphadenopathy – 1B12.7 Tuberculosis of the digestive system – 1B12.8 Cutaneous tuberculosis – 1B12.Y Tuberculosis of other specified organ or site –– 1B12.40 Tuberculosis of bones or joints –– 1B12.41 Tuberculous myositis –– 1B12.4Y Tuberculosis of other specified part of the musculoskeletal system –– 1B12.4Z Tuberculosis of the musculoskeletal system, unspecified 1B13 Miliary tuberculosis – 1B13.0 Acute miliary tuberculosis of a single specified site – 1B13.1 Acute miliary tuberculosis of multiple sites – 1B13.2 Acute miliary tuberculosis, unspecified site – 1B13.Y Other specified miliary tuberculosis – 1B13.Z Miliary tuberculosis, unspecified 1B14 Latent tuberculosis 1B1Y Other specified tuberculosis 1B1Z Tuberculosis, unspecified 1B20 Leprosy 1B20.0 Paucibacillary leprosy 1B20.1 Multibacillary leprosy 1B20.2 Leprosy reactions 1B20.3 Complications of leprosy 1B20.Z Leprosy, unspecified – 1B20.20 Type I leprosy reaction – 1B20.21 Type II leprosy reaction 1B21 Infections due to non-tuberculous mycobacteria 1B21.0 Pulmonary infection due to non-tuberculous mycobacterium 1B21.1 Non-tuberculous mycobacterial lymphadenitis 1B21.2 Cutaneous non-tuberculous mycobacterial infection 1B21.3 Disseminated non-tuberculous mycobacterial infection 1B21.4 Gastrointestinal non-tuberculous mycobacterial infection 1B21.Y Non-tuberculous mycobacterial infection of other specified site 1B21.Z Non-tuberculous mycobacterial infection of unspecified site – 1B21.20 Mycobacterium ulcerans infection – 1B21.2Y Cutaneous infection due to other specified non-tuberculous mycobacteria – 1B21.2Z Cutaneous infection due to unspecified non-tuberculous mycobacteria 1B2Y Other specified mycobacterial diseases 1B2Z Mycobacterial diseases, unspecified 1B40 Acute rheumatic fever without mention of heart involvement – 1B40.0 Rheumatic arthritis, acute or subacute – 1B40.Y Other specified acute rheumatic fever without mention of heart involvement – 1B40.Z Acute rheumatic fever without mention of heart involvement, unspecified 1B41 Acute rheumatic fever with heart involvement – 1B41.0 Acute rheumatic pericarditis – 1B41.1 Acute rheumatic endocarditis – 1B41.2 Acute rheumatic myocarditis – 1B41.Y Other acute rheumatic heart disease – 1B41.Z Acute rheumatic heart disease, unspecified –– 1B41.10 Rheumatic aortitis –– 1B41.1Y Other specified acute rheumatic endocarditis –– 1B41.1Z Acute rheumatic endocarditis, unspecified 1B42 Rheumatic chorea 1B50 Scarlet fever 1B51 Streptococcal pharyngitis 1B53 Meningitis due to Streptococcus 1B54 Meningitis due to Staphylococcus 1B5Y Other specified staphylococcal or streptococcal diseases 1B5Z Staphylococcal or streptococcal diseases, unspecified 1B70 Bacterial cellulitis, erysipelas or lymphangitis 1B70.0 Erysipelas 1B70.1 Streptococcal cellulitis of skin 1B70.2 Staphylococcal cellulitis of skin 1B70.3 Ascending bacterial lymphangitis 1B70.Y Bacterial cellulitis or lymphangitis due to other specified bacterium 1B70.Z Bacterial cellulitis or lymphangitis due to unspecified bacterium – 1B70.00 Erysipelas of face – 1B70.01 Erysipelas of external ear – 1B70.02 Erysipelas of lower limb – 1B70.0Y Erysipelas of other specified site – 1B70.0Z Erysipelas, unspecified 1B71 Necrotising fasciitis 1B71.0 Streptococcal necrotising fasciitis 1B71.1 Polymicrobial necrotising fasciitis 1B71.2 Neonatal necrotising fasciitis 1B71.Y Necrotising fasciitis due to other specified bacterial infection 1B71.Z Necrotising fasciitis, unspecified 1B72 Impetigo 1B72.0 Bullous impetigo 1B72.1 Non-bullous impetigo 1B72.2 Secondary impetiginisation of the skin 1B72.Y Other specified impetigo 1B72.Z Impetigo, unspecified 1B73 Ecthyma 1B73.0 Streptococcal ecthyma 1B73.1 Staphylococcal ecthyma 1B73.2 Ecthyma gangrenosum 1B73.Y Other specified ecthyma 1B73.Z Ecthyma, unspecified 1B74 Superficial bacterial folliculitis 1B74.0 Staphylococcus aureus superficial folliculitis 1B74.Y Superficial bacterial folliculitis due to other specified organism 1B74.Z Superficial bacterial folliculitis due to unspecified organism 1B75 Deep bacterial folliculitis or pyogenic abscess of the skin 1B75.0 Furuncle 1B75.1 Carbuncle 1B75.2 Furunculosis 1B75.3 Pyogenic abscess of the skin 1B75.4 Chronic deep bacterial folliculitis 1B75.Z Deep bacterial folliculitis or pyogenic abscess of the skin, unspecified 1B7Y Other specified pyogenic bacterial infection of skin or subcutaneous tissue 1B7Z Pyogenic bacterial infection of skin or subcutaneous tissue, unspecified 1B90 Rat-bite fevers 1B90.0 Spirillosis 1B90.1 Streptobacillosis 1B91 Leptospirosis 1B92 Glanders 1B93 Plague 1B93.0 Bubonic plague 1B93.1 Cellulocutaneous plague 1B93.2 Pneumonic plague 1B93.3 Plague meningitis 1B93.Y Other specified plague 1B93.Z Plague, unspecified 1B94 Tularaemia 1B94.0 Ulceroglandular tularaemia 1B94.Y Other specified tularaemia 1B94.Z Tularaemia, unspecified 1B95 Brucellosis 1B96 Erysipeloid 1B97 Anthrax 1B98 Cat-scratch disease 1B99 Pasteurellosis 1B9A Extraintestinal yersiniosis 1B9Z Unspecified zoonotic bacterial disease 1C10 Actinomycosis 1C10.0 Pulmonary actinomycosis 1C10.1 Abdominal actinomycosis 1C10.2 Cervicofacial actinomycosis 1C10.3 Primary cutaneous actinomycosis 1C10.Y Other specified forms of actinomycosis 1C10.Z Actinomycosis, unspecified 1C11 Bartonellosis 1C11.0 Carrion disease 1C11.1 Trench fever 1C11.Y Other forms of bartonellosis 1C11.Z Bartonellosis, unspecified – 1C11.00 Oroya fever – 1C11.01 Verruga peruana 1C12 Whooping cough 1C12.0 Whooping cough due to Bordetella pertussis 1C12.1 Whooping cough due to Bordetella parapertussis 1C12.Y Other specified whooping cough 1C12.Z Whooping cough, unspecified 1C13 Tetanus 1C14 Obstetrical tetanus 1C15 Tetanus neonatorum 1C16 Gas gangrene 1C17 Diphtheria 1C17.0 Pharyngeal or tonsillar diphtheria 1C17.1 Nasal diphtheria 1C17.2 Laryngeal diphtheria 1C17.3 Cutaneous diphtheria 1C17.Y Other specified diphtheria 1C17.Z Diphtheria, unspecified – 1C17.00 Postdiphtheritic paralysis of uvula – 1C17.0Y Other specified pharyngeal or tonsillar diphtheria – 1C17.0Z Pharyngeal or tonsillar diphtheria, unspecified 1C18 Brazilian purpuric fever 1C19 Legionellosis 1C19.0 Nonpneumonic Legionnaires' disease 1C19.1 Legionnaires disease 1C19.Z Legionellosis, unspecified 1C1A Listeriosis 1C1A.0 Cutaneous listeriosis 1C1A.1 Listerial meningitis or meningoencephalitis 1C1A.Y Other specified listeriosis 1C1A.Z Listeriosis, unspecified 1C1B Nocardiosis 1C1B.0 Pulmonary nocardiosis 1C1B.1 Cutaneous nocardiosis 1C1B.Y Other specified forms of nocardiosis 1C1B.Z Nocardiosis, unspecified 1C1C Meningococcal disease 1C1C.0 Meningococcal meningitis 1C1C.1 Waterhouse-Friderichsen syndrome 1C1C.2 Meningococcaemia 1C1C.Y Other specified meningococcal disease 1C1C.Z Meningococcal disease, unspecified – 1C1C.20 Acute meningococcaemia – 1C1C.2Y Other specified meningococcaemia – 1C1C.2Z Meningococcaemia, unspecified 1C1D Yaws 1C1D.0 Primary yaws 1C1D.1 Secondary yaws 1C1D.2 Tertiary yaws 1C1D.3 Latent yaws 1C1D.Z Yaws, unspecified 1C1E Pinta 1C1E.0 Primary lesions of pinta 1C1E.1 Intermediate lesions of pinta 1C1E.2 Late lesions of pinta 1C1E.3 Mixed lesions of pinta 1C1E.Z Pinta, unspecified 1C1F Endemic non-venereal syphilis 1C1G Lyme borreliosis 1C1G.0 Early cutaneous Lyme borreliosis 1C1G.1 Disseminated Lyme borreliosis 1C1G.Y Other specified Lyme borreliosis 1C1G.Z Lyme borreliosis, unspecified – 1C1G.10 Lyme neuroborreliosis – 1C1G.11 Lyme carditis – 1C1G.12 Ophthalmic Lyme borreliosis – 1C1G.13 Lyme arthritis – 1C1G.14 Late cutaneous Lyme borreliosis – 1C1G.1Y Other specified disseminated Lyme borreliosis – 1C1G.1Z Disseminated Lyme borreliosis, unspecified 1C1H Necrotising ulcerative gingivitis 1C1H.0 Other Vincent infections 1C1H.Y Other specified necrotising ulcerative gingivitis 1C1H.Z Necrotising ulcerative gingivitis, unspecified 1C1J Relapsing fever 1C1J.0 Tick-borne relapsing fever 1C1J.1 Louse-borne relapsing fever 1C1J.Z Relapsing fever, unspecified 1C20 Chlamydial conjunctivitis 1C21 Chlamydial peritonitis 1C22 Infections due to Chlamydia psittaci 1C23 Trachoma – 1C23.0 Initial stage of trachoma – 1C23.1 Active stage of trachoma – 1C23.Y Other specified trachoma – 1C23.Z Trachoma, unspecified 1C2Y Other specified diseases due to chlamydiae 1C2Z Diseases due to chlamydiae, unspecified 1C30 Typhus fever – 1C30.0 Epidemic louse-borne typhus fever due to Rickettsia prowazekii – 1C30.1 Recrudescent typhus – 1C30.2 Typhus fever due to Rickettsia typhi – 1C30.3 Typhus fever due to Orientia tsutsugamushi – 1C30.Y Other specified typhus fever – 1C30.Z Typhus fever, unspecified 1C31 Spotted fever – 1C31.0 Spotted fever due to Rickettsia rickettsii – 1C31.1 Spotted fever due to Rickettsia conorii – 1C31.2 Spotted fever due to Rickettsia sibirica – 1C31.3 Spotted fever due to Rickettsia australis – 1C31.Y Other specified spotted fever – 1C31.Z Spotted fever, unspecified 1C32 Rickettsialpox 1C33 Q fever 1C3Y Other specified rickettsioses 1C3Z Rickettsioses, unspecified 1C40 Campylobacteriosis 1C41 Bacterial infection of unspecified site 1C42 Melioidosis 1C43 Actinomycetoma 1C44 Non-pyogenic bacterial infections of the skin 1C45 Toxic shock syndrome 1C45.0 Streptococcal toxic shock syndrome 1C45.1 Staphylococcal toxic shock syndrome 1C45.Y Toxic shock syndrome due to other specified infectious agent 1C45.Z Toxic shock syndrome without specified infectious agent 1C4Y Other specified bacterial diseases 1C4Z Unspecified bacterial disease 1C60 Human immunodeficiency virus disease associated with tuberculosis 1C60.0 HIV disease clinical stage 1 associated with tuberculosis 1C60.1 HIV disease clinical stage 2 associated with tuberculosis 1C60.2 HIV disease clinical stage 3 associated with tuberculosis 1C60.3 HIV disease clinical stage 4 associated with tuberculosis 1C60.Z Human immunodeficiency virus disease associated with tuberculosis, clinical stage unspecified – 1C60.30 Kaposi sarcoma associated with human immunodeficiency virus disease associated with tuberculosis – 1C60.3Y Other specified HIV disease clinical stage 4 associated with tuberculosis – 1C60.3Z HIV disease clinical stage 4 associated with tuberculosis, unspecified 1C61 Human immunodeficiency virus disease associated with malaria 1C61.0 HIV disease clinical stage 1 associated with malaria 1C61.1 HIV disease clinical stage 2 associated with malaria 1C61.2 HIV disease clinical stage 3 associated with malaria 1C61.3 HIV disease clinical stage 4 associated with malaria 1C61.Z Human immunodeficiency virus disease associated with malaria, clinical stage unspecified – 1C61.30 Kaposi sarcoma associated with human immunodeficiency virus disease associated with malaria – 1C61.3Y Other specified HIV disease clinical stage 4 associated with malaria – 1C61.3Z HIV disease clinical stage 4 associated with malaria, unspecified 1C62 Human immunodeficiency virus disease without mention of tuberculosis or malaria 1C62.0 HIV disease clinical stage 1 without mention of tuberculosis or malaria 1C62.1 HIV disease clinical stage 2 without mention of tuberculosis or malaria 1C62.2 HIV disease clinical stage 3 without mention of tuberculosis or malaria 1C62.3 HIV disease clinical stage 4 without mention of tuberculosis or malaria 1C62.Z Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified – 1C62.30 Kaposi sarcoma associated with human immunodeficiency virus disease without mention of tuberculosis or malaria – 1C62.3Y Other specified HIV disease clinical stage 4 without mention of tuberculosis or malaria – 1C62.3Z HIV disease clinical stage 4 without mention of tuberculosis or malaria, unspecified 1C80 Viral encephalitis, not elsewhere classified 1C81 Acute poliomyelitis 1C82 Rabies 1C83 Western equine encephalitis 1C84 Eastern equine encephalitis 1C85 Japanese encephalitis 1C86 St Louis encephalitis 1C87 Rocio viral encephalitis 1C88 Murray Valley encephalitis 1C8B California encephalitis 1C8C Venezuelan equine encephalitis 1C8D La Crosse encephalitis 1C8E Viral meningitis, not elsewhere classified 1C8E.1 Enteroviral meningitis 1C8E.2 Meningitis due to adenovirus 1C8E.Y Other specified viral meningitis, not elsewhere classified 1C8E.Z Viral meningitis, unspecified 1C8F Lymphocytic choriomeningitis 1C8G Tick-borne encephalitis 1C8G.0 Far Eastern tick-borne encephalitis 1C8G.1 Central European tick-borne encephalitis 1C8G.2 Siberian tick-borne encephalitis 1C8G.Z Tick-borne encephalitis, unspecified 1C8Y Other specified viral infections of the central nervous system 1C8Z Viral infections of the central nervous system, unspecified 1D00 Infectious encephalitis, not elsewhere classified 1D00.0 Bacterial encephalitis 1D00.1 Fungal encephalitis 1D00.2 Parasitic or protozoal encephalitis 1D00.Y Other specified infectious encephalitis, not elsewhere classified 1D00.Z Infectious encephalitis, unspecified 1D01 Infectious meningitis, not elsewhere classified 1D01.0 Bacterial meningitis 1D01.1 Fungal meningitis 1D01.2 Parasitic or protozoal meningitis 1D01.3 Benign recurrent meningitis 1D01.Y Other specified infectious meningitis, not elsewhere classified 1D01.Z Infectious meningitis, unspecified – 1D01.00 Meningitis due to Haemophilus influenzae – 1D01.0Y Other specified bacterial meningitis – 1D01.0Z Bacterial meningitis, unspecified 1D02 Infectious myelitis, not elsewhere classified 1D02.0 Bacterial myelitis 1D02.1 Viral myelitis 1D02.2 Fungal myelitis 1D02.3 Parasitic myelitis 1D02.Y Other specified infectious myelitis, not elsewhere classified 1D02.Z Infectious myelitis, unspecified 1D03 Infectious abscess of the central nervous system 1D03.0 Intraspinal intramedullary abscess 1D03.1 Intraspinal subdural abscess 1D03.2 Intraspinal extradural abscess 1D03.3 Intracranial abscess 1D03.4 Intraspinal epidural abscess 1D03.5 Spinal cord abscess 1D03.Y Other specified site of infectious abscess of the central nervous system 1D03.Z Infectious abscess of the central nervous system, site unspecified – 1D03.30 Deep cerebral hemispheric abscess – 1D03.31 Abscess of the corpus callosum – 1D03.32 Pituitary abscess – 1D03.33 Multiple or widespread intracranial abscess – 1D03.3Y Other specified intracranial abscess – 1D03.3Z Intracranial abscess, unspecified 1D04 Infectious granulomas of the central nervous system 1D04.0 Parasitic intracerebral granuloma 1D04.1 Intracranial granuloma 1D04.2 Intraspinal intramedullary granuloma 1D04.3 Intraspinal subdural granuloma 1D04.4 Intraspinal extradural granuloma 1D04.5 Intraspinal epidural granuloma 1D04.Y Other specified site of infectious granulomas of the central nervous system 1D04.Z Infectious granulomas of the central nervous system, site unspecified – 1D04.10 Fungal intracranial granuloma – 1D04.1Y Other specified intracranial granuloma – 1D04.1Z Intracranial granuloma, unspecified 1D05 Infectious cysts of the central nervous system 1D05.0 Epidural infectious cyst 1D05.1 Subdural infectious cyst 1D05.Y Other specified infectious cysts of the central nervous system 1D05.Z Infectious cysts of the central nervous system, unspecified 1D0Y Other specified non-viral and unspecified infections of the central nervous system 1D0Z Non-viral and unspecified infections of the central nervous system, unspecified 1D20 Dengue without warning signs 1D21 Dengue with warning signs 1D22 Severe dengue 1D2Z Dengue fever, unspecified 1D40 Chikungunya virus disease 1D41 Colorado tick fever 1D42 O'nyong-nyong fever 1D43 Oropouche virus disease 1D44 Rift Valley fever 1D45 Sandfly fever 1D46 West Nile virus infection 1D47 Yellow fever 1D48 Zika virus disease 1D49 Crimean-Congo haemorrhagic fever 1D4A Omsk haemorrhagic fever 1D4B Kyasanur Forest disease 1D4C Alkhurma haemorrhagic fever 1D4D Ross River disease 1D4E Severe fever with thrombocytopenia syndrome 1D4Y Other specified arthropod-borne viral fevers 1D4Z Arthropod-borne viral fever, virus unspecified 1D60 Filovirus disease 1D60.0 Ebola disease 1D60.1 Marburg disease 1D60.Y Other specified filovirus disease 1D60.Z Filovirus disease, virus unspecified – 1D60.00 Bundibugyo virus disease – 1D60.01 Ebola virus disease – 1D60.02 Sudan virus disease – 1D60.03 Atypical Ebola disease – 1D60.0Y Other specified Ebola disease – 1D60.0Z Ebola disease, virus unspecified – 1D60.10 Marburg virus disease – 1D60.11 Atypical Marburg disease – 1D60.1Y Other specified Marburg disease – 1D60.1Z Marburg disease, virus unspecified 1D61 Arenavirus disease 1D61.0 Argentinian haemorrhagic fever 1D61.1 Bolivian haemorrhagic fever 1D61.2 Lassa fever 1D61.3 Venezuelan haemorrhagic fever 1D61.Y Other specified arenavirus disease 1D61.Z Arenavirus disease, unspecified 1D62 Hantavirus disease 1D62.0 Haemorrhagic fever with renal syndrome 1D62.1 Hantavirus pulmonary syndrome 1D62.2 Atypical hantavirus disease 1D62.Y Other specified hantavirus disease 1D62.Z Hantavirus disease, unspecified 1D63 Henipavirus encephalitis 1D64 Middle East respiratory syndrome 1D65 Severe acute respiratory syndrome 1D6Y Other specified zoonotic viral diseases 1D6Z Zoonotic viral disease, virus unspecified 1D80 Mumps 1D80.0 Mumps without complication 1D80.1 Orchitis due to mumps virus 1D80.2 Meningitis due to mumps virus 1D80.3 Encephalitis due to mumps virus 1D80.4 Pancreatitis due to mumps virus 1D80.Y Other specified mumps 1D81 Infectious mononucleosis 1D81.0 Mononucleosis due to Epstein-Barr virus 1D81.1 Mononucleosis due to cytomegalovirus 1D81.Y Other specified infectious mononucleosis 1D81.Z Infectious mononucleosis, unspecified 1D82 Cytomegaloviral disease 1D82.0 Cytomegaloviral hepatitis 1D82.1 Cytomegaloviral pancreatitis 1D82.Y Other specified cytomegaloviral disease 1D82.Z Cytomegaloviral disease, unspecified 1D83 Epidemic myalgia 1D84 Viral conjunctivitis 1D84.0 Conjunctivitis due to adenovirus 1D84.1 Acute epidemic haemorrhagic conjunctivitis 1D84.Y Other specified viral conjunctivitis 1D84.Z Viral conjunctivitis, unspecified 1D85 Viral carditis 1D85.0 Dilated cardiomyopathy secondary to viral myocarditis 1D85.1 Acute viral carditis 1D85.2 Chronic viral carditis 1D85.3 Aseptic myocarditis of newborn 1D85.4 Coxsackie carditis 1D85.Y Other specified viral carditis 1D85.Z Viral carditis, unspecified 1D86 Viral haemorrhagic fever, not elsewhere classified 1D90 Adenovirus infection of unspecified site 1D91 Enterovirus infection of unspecified site 1D92 Coronavirus infection, unspecified site 1D93 Parvovirus infection of unspecified site 1D9Y Other viral infections of unspecified site 1D9Z Unspecified viral infection of unspecified site 1E1Y Other specified viral diseases 1E1Z Unspecified viral disease 1E30 Influenza due to identified seasonal influenza virus 1E31 Influenza due to identified zoonotic or pandemic influenza virus 1E32 Influenza, virus not identified 1E50 Acute viral hepatitis 1E50.0 Acute hepatitis A 1E50.1 Acute hepatitis B 1E50.2 Acute hepatitis C 1E50.3 Acute hepatitis D 1E50.4 Acute hepatitis E 1E50.Y Other specified acute viral hepatitis 1E50.Z Acute viral hepatitis, unspecified 1E51 Chronic viral hepatitis 1E51.0 Chronic hepatitis B 1E51.1 Chronic hepatitis C 1E51.2 Chronic hepatitis D 1E51.3 Chronic hepatitis E 1E51.Y Other specified chronic viral hepatitis 1E51.Z Chronic viral hepatitis, unspecified – 1E51.00 Chronic hepatitis B with human immunodeficiency virus co-infection – 1E51.0Y Other specified chronic hepatitis B – 1E51.0Z Chronic hepatitis B, unspecified 1E5Z Viral hepatitis, unspecified 1E70 Smallpox 1E71 Mpox 1E72 Cowpox 1E73 Vaccinia 1E74 Buffalopox 1E75 Orf 1E76 Molluscum contagiosum 1E7Y Other specified infections due to poxvirus 1E7Z Infections due to poxvirus, unspecified 1E80 Common warts – 1E80.0 Digital or periungual warts – 1E80.1 Plantar warts – 1E80.Y Other specified common warts – 1E80.Z Common warts, unspecified 1E81 Plane warts 1E82 Warts of lips or oral cavity – 1E82.0 Focal epithelial hyperplasia of oral mucous membranes 1E83 Wart virus proliferation in immune-deficient states 1E8Z Viral warts, not elsewhere classified 1E90 Varicella – 1E90.0 Varicella without complication – 1E90.1 Varicella meningitis – 1E90.2 Varicella encephalitis – 1E90.Y Varicella with other specified complication – 1E90.Z Varicella, unspecified 1E91 Zoster – 1E91.0 Zoster without complications – 1E91.1 Ophthalmic zoster – 1E91.2 Disseminated zoster – 1E91.3 Zoster with central nervous system involvement – 1E91.4 Acute neuropathy of cranial nerve due to zoster – 1E91.5 Postherpetic polyneuropathy – 1E91.Y Zoster with other specified complications – 1E91.Z Zoster, unspecified –– 1E91.40 Acute trigeminal zoster neuropathy –– 1E91.41 Acute herpetic geniculate ganglionitis –– 1E91.4Y Other specified acute neuropathy of cranial nerve due to zoster –– 1E91.4Z Acute neuropathy of cranial nerve due to zoster, unspecified 1F00 Herpes simplex infections 1F00.0 Herpes simplex infection of skin or mucous membrane 1F00.1 Herpes simplex infection of the eye 1F00.2 Herpes simplex infection of central nervous system 1F00.3 Disseminated herpes simplex infection 1F00.Y Other specified herpes simplex infections 1F00.Z Herpes simplex infections, unspecified – 1F00.00 Herpes simplex infection of skin – 1F00.01 Herpes simplex labialis – 1F00.02 Herpes simplex gingivostomatitis – 1F00.03 Disseminated cutaneous herpes simplex infection complicating other skin diseases – 1F00.0Y Other specified herpes simplex infection of skin or mucous membrane – 1F00.10 Herpes simplex keratitis – 1F00.11 Herpes simplex infection of eyelid – 1F00.1Y Other specified herpes simplex infection of the eye – 1F00.1Z Herpes simplex infection of the eye, unspecified – 1F00.20 Herpes simplex meningitis – 1F00.21 Encephalitis due to herpes simplex virus – 1F00.2Y Other specified herpes simplex infection of central nervous system 1F01 Roseola infantum 1F02 Rubella 1F02.0 Rubella with neurological complications 1F02.1 Rubella arthritis 1F02.2 Rubella without complication 1F02.Y Rubella with other specified complication 1F03 Measles 1F03.0 Measles without complication 1F03.1 Measles complicated by encephalitis 1F03.2 Measles complicated by meningitis 1F03.Y Measles with other complications 1F04 Erythema infectiosum 1F05 Picornavirus infections presenting in the skin or mucous membranes 1F05.0 Enteroviral vesicular stomatitis 1F05.1 Enteroviral vesicular pharyngitis 1F05.2 Enteroviral exanthematous fever 1F05.3 Foot and mouth disease 1F05.Y Other specified picornavirus infections presenting in the skin or mucous membranes 1F0Y Other specified viral infections characterised by skin or mucous membrane lesions 1F0Z Viral infections characterised by skin or mucous membrane lesions, unspecified 1F20 Aspergillosis 1F20.0 Invasive aspergillosis 1F20.1 Non-invasive aspergillosis 1F20.Z Aspergillosis, unspecified – 1F20.00 Invasive aspergillosis of the digestive tract – 1F20.01 Invasive cerebral aspergillosis – 1F20.02 Disseminated aspergillosis – 1F20.0Y Invasive aspergillosis of other specified site – 1F20.0Z Invasive aspergillosis, unspecified – 1F20.10 Aspergillus otomycosis – 1F20.11 Chronic aspergillosis of the paranasal sinuses – 1F20.12 Chronic pulmonary aspergillosis – 1F20.13 Tonsillar aspergillosis – 1F20.14 Aspergillus bronchitis – 1F20.15 Obstructing aspergillus tracheobronchitis – 1F20.1Y Other specified non-invasive aspergillosis – 1F20.1Z Non-invasive aspergillosis, unspecified 1F21 Basidiobolomycosis 1F22 Blastomycosis 1F23 Candidosis 1F23.0 Candidosis of lips or oral mucous membranes 1F23.1 Candidosis of skin or mucous membranes 1F23.2 Candidosis of gastrointestinal tract 1F23.3 Systemic or invasive candidosis 1F23.Y Other specified candidosis 1F23.Z Candidosis, unspecified – 1F23.10 Vulvovaginal candidosis – 1F23.11 Candida balanoposthitis – 1F23.12 Flexural or intertriginous candidosis – 1F23.13 Candidosis of nail or paronychium – 1F23.14 Chronic mucocutaneous candidosis – 1F23.15 Disseminated cutaneous candidosis – 1F23.16 Candida otomycosis – 1F23.1Y Candidosis of skin or mucous membrane of other specified site – 1F23.1Z Candidosis of skin or mucous membranes, unspecified – 1F23.30 Candida meningitis – 1F23.31 Pulmonary candidosis – 1F23.3Y Other specified systemic or invasive candidosis – 1F23.3Z Systemic or invasive candidosis, unspecified 1F24 Chromoblastomycosis 1F25 Coccidioidomycosis 1F25.0 Pulmonary coccidioidomycosis 1F25.1 Extrathoracic coccidioidomycosis 1F25.Z Coccidioidomycosis, unspecified – 1F25.00 Acute pulmonary coccidioidomycosis – 1F25.01 Chronic pulmonary coccidioidomycosis – 1F25.10 Disseminated coccidioidomycosis – 1F25.11 Primary cutaneous coccidioidomycosis – 1F25.12 Coccidioides meningitis – 1F25.1Y Other specified extrathoracic coccidioidomycosis – 1F25.1Z Extrathoracic coccidioidomycosis, unspecified 1F26 Conidiobolomycosis 1F27 Cryptococcosis 1F27.0 Pulmonary cryptococcosis 1F27.1 Cerebral cryptococcosis 1F27.2 Disseminated cryptococcosis 1F27.Y Other specified cryptococcosis 1F27.Z Cryptococcosis, unspecified – 1F27.10 Meningitis due to Cryptococcus neoformans 1F28 Dermatophytosis 1F28.0 Dermatophytosis of scalp 1F28.1 Dermatophytosis of nail 1F28.2 Dermatophytosis of foot 1F28.3 Genitocrural dermatophytosis 1F28.4 Kerion 1F28.5 Disseminated dermatophytosis 1F28.Y Other specified dermatophytosis 1F28.Z Dermatophytosis, unspecified 1F29 Eumycetoma 1F2A Histoplasmosis 1F2A.0 Pulmonary histoplasmosis capsulati 1F2A.1 Histoplasmosis due to Histoplasma duboisii 1F2A.Y Other specified histoplasmosis 1F2A.Z Histoplasmosis, unspecified 1F2B Lobomycosis 1F2C Mucormycosis 1F2D Non-dermatophyte superficial dermatomycoses 1F2D.0 Pityriasis versicolor 1F2D.1 Malassezia folliculitis 1F2D.2 White piedra 1F2D.3 Black piedra 1F2D.4 Tinea nigra 1F2D.5 Onychomycosis due to non-dermatophyte mould 1F2D.Y Other specified non-dermatophyte superficial dermatomycoses 1F2D.Z Non-dermatophyte superficial dermatomycoses, unspecified 1F2E Paracoccidioidomycosis 1F2E.0 Pulmonary paracoccidioidomycosis 1F2E.1 Disseminated paracoccidioidomycosis 1F2E.Y Other specified paracoccidioidomycosis 1F2E.Z Paracoccidioidomycosis, unspecified 1F2F Phaeohyphomycosis 1F2G Pneumocystosis 1F2G.0 Pulmonary pneumocystosis 1F2G.Z Pneumocystosis, unspecified 1F2H Scedosporiosis 1F2J Sporotrichosis 1F2J.0 Lymphocutaneous sporotrichosis 1F2J.1 Fixed cutaneous sporotrichosis 1F2J.2 Pulmonary sporotrichosis 1F2J.3 Disseminated sporotrichosis 1F2J.Y Other specified sporotrichosis 1F2J.Z Sporotrichosis, unspecified 1F2K Talaromycosis 1F2L Emmonsiosis 1F2L.0 Disseminated adiaspiromycosis 1F2L.1 Pulmonary adiaspiromycosis 1F2L.Y Other specified emmonsiosis 1F2L.Z Emmonsiosis, unspecified 1F2Y Other specified mycoses 1F2Z Mycoses, unspecified 1F40 Malaria due to Plasmodium falciparum – 1F40.0 Plasmodium falciparum malaria with cerebral complications – 1F40.Y Other severe and complicated Plasmodium falciparum malaria – 1F40.Z Malaria due to Plasmodium falciparum, unspecified 1F41 Malaria due to Plasmodium vivax – 1F41.0 Plasmodium vivax malaria with rupture of spleen – 1F41.Y Malaria due to Plasmodium vivax with other complications – 1F41.Z Plasmodium vivax malaria without complication 1F42 Malaria due to Plasmodium malariae – 1F42.0 Plasmodium malariae malaria with nephropathy – 1F42.Y Malaria due to Plasmodium malariae with other complications – 1F42.Z Plasmodium malariae malaria without complication 1F43 Malaria due to Plasmodium ovale 1F44 Other parasitologically confirmed malaria 1F45 Malaria without parasitological confirmation 1F4Z Malaria, unspecified 1F50 Acanthamoebiasis 1F51 African trypanosomiasis – 1F51.0 Gambiense trypanosomiasis – 1F51.1 Rhodesiense trypanosomiasis – 1F51.Y Other specified african trypanosomiasis – 1F51.Z African trypanosomiasis, unspecified –– 1F51.00 Meningitis in Gambiense trypanosomiasis –– 1F51.0Y Other specified gambiense trypanosomiasis –– 1F51.0Z Gambiense trypanosomiasis, unspecified –– 1F51.10 Meningitis in Rhodesiense trypanosomiasis –– 1F51.1Y Other specified rhodesiense trypanosomiasis –– 1F51.1Z Rhodesiense trypanosomiasis, unspecified 1F52 Babesiosis 1F53 Chagas disease – 1F53.1 Acute Chagas disease without heart involvement – 1F53.2 Chronic Chagas disease with heart involvement – 1F53.3 Chagas disease with digestive system involvement – 1F53.4 Meningitis in Chagas disease – 1F53.Y Other specified Chagas disease – 1F53.Z Chagas disease, unspecified 1F54 Leishmaniasis – 1F54.0 Visceral leishmaniasis – 1F54.1 Cutaneous leishmaniasis – 1F54.2 Mucocutaneous leishmaniasis – 1F54.Z Leishmaniasis, unspecified 1F55 Naegleriasis 1F56 Rhinosporidiosis 1F57 Toxoplasmosis – 1F57.0 Hepatitis due to Toxoplasma gondii – 1F57.1 Meningoencephalitis due to Toxoplasma gondii – 1F57.2 Pulmonary toxoplasmosis due to Toxoplasma gondii – 1F57.3 Eye disease due to Toxoplasma gondii – 1F57.Y Other specified toxoplasmosis – 1F57.Z Toxoplasmosis, unspecified 1F58 Microsporidiosis 1F5Z Unspecified protozoal disease – 1F60 Angiostrongyliasis –– 1F60.0 Eosinophilic meningitis due to Angiostrongylus cantonensis –– 1F60.1 Intestinal angiostrongyliasis –– 1F60.Y Other specified angiostrongyliasis –– 1F60.Z Angiostrongyliasis, unspecified – 1F61 Anisakiasis – 1F62 Ascariasis – 1F63 Capillariasis –– 1F63.0 Capillariasis of the intestine –– 1F63.Y Other specified capillariasis –– 1F63.Z Capillariasis, unspecified – 1F64 Dracunculiasis – 1F65 Enterobiasis – 1F66 Filariasis –– 1F66.0 Loiasis –– 1F66.1 Mansonelliasis –– 1F66.2 Filariasis due to Brugia species –– 1F66.3 Lymphatic filariasis –– 1F66.4 Subcutaneous dirofilariasis –– 1F66.Y Other specified filariasis –– 1F66.Z Filariasis, unspecified ––– 1F66.30 Filariasis due to Wuchereria bancrofti ––– 1F66.31 Filariasis due to Brugia malayi ––– 1F66.32 Filariasis due to Brugia timori ––– 1F66.3Z Lymphatic filariasis, unspecified – 1F67 Gnathostomiasis – 1F68 Hookworm diseases –– 1F68.0 Ancylostomiasis –– 1F68.1 Necatoriasis –– 1F68.2 Cutaneous larva migrans – 1F69 Oesophagostomiasis – 1F6A Onchocerciasis –– 1F6A.0 Onchocerciasis of the eye –– 1F6A.1 Onchocerciasis of the skin –– 1F6A.Y Other specified onchocerciasis –– 1F6A.Z Onchocerciasis, unspecified – 1F6B Strongyloidiasis – 1F6C Syngamosis – 1F6D Toxocariasis – 1F6E Trichinosis – 1F6F Trichostrongyliasis – 1F6G Trichuriasis – 1F6H Uncinariosis – 1F6Y Other specified diseases due to nematodes – 1F6Z Diseases due to nematodes, unspecified – 1F70 Cysticercosis –– 1F70.0 Cysticercosis of central nervous system –– 1F70.1 Cysticercosis of eye –– 1F70.Y Other specified cysticercosis –– 1F70.Z Cysticercosis, unspecified ––– 1F70.00 Meningitis due to Cysticercosis ––– 1F70.0Y Other specified cysticercosis of central nervous system – 1F71 Diphyllobothriasis – 1F72 Dipylidiasis – 1F73 Echinococcosis –– 1F73.0 Echinococcus infection of liver –– 1F73.1 Echinococcus infection of lung –– 1F73.2 Echinococcus infection of bone –– 1F73.3 Echinococcus infection of central nervous system –– 1F73.Y Other specified echinococcosis –– 1F73.Z Echinococcosis, unspecified – 1F74 Hymenolepiasis – 1F75 Sparganosis – 1F76 Taeniasis –– 1F76.0 Taeniasis due to Taenia solium –– 1F76.1 Taeniasis due to Taenia saginata –– 1F76.Y Other specified taeniasis –– 1F76.Z Taeniasis, unspecified – 1F7Y Other specified diseases due to cestodes – 1F7Z Diseases due to cestodes, unspecified – 1F80 Clonorchiasis – 1F81 Dicrocoeliasis – 1F82 Fascioliasis – 1F83 Fasciolopsiasis – 1F84 Opisthorchiasis – 1F85 Paragonimiasis – 1F86 Schistosomiasis –– 1F86.0 Schistosomiasis due to Schistosoma haematobium –– 1F86.1 Schistosomiasis due to Schistosoma mansoni –– 1F86.2 Schistosomiasis due to Schistosoma japonicum –– 1F86.3 Other schistosomiases –– 1F86.4 Cercarial dermatitis –– 1F86.5 Schistosomal pneumonitis –– 1F86.Z Schistosomiasis due to unspecified or unknown Schistosoma species – 1F8Y Other specified diseases due to trematodes – 1F8Z Diseases due to trematodes, unspecified 1F90 Other and unspecified infestation by parasitic worms – 1F90.0 Mixed intestinal helminthiases – 1F90.1 Intestinal parasitic infestation not otherwise specified – 1F90.2 Intestinal helminthiasis, unspecified – 1F90.Y Other specified other and unspecified infestation by parasitic worms – 1F90.Z Other and unspecified infestation by parasitic worms, unspecified 1F91 Diphyllobothriasis and sparganosis 1F9Z Helminthiases, unspecified 1G00 Pediculosis – 1G00.0 Pediculosis capitis – 1G00.1 Pediculosis corporis – 1G00.Z Pediculosis of unspecified site or type 1G01 Myiasis – 1G01.0 Ocular myiasis – 1G01.1 Nasopharyngeal myiasis – 1G01.2 Laryngeal myiasis – 1G01.3 Cutaneous myiasis – 1G01.Y Other specified myiasis – 1G01.Z Myiasis, unspecified 1G02 External hirudiniasis 1G03 Pthiriasis 1G04 Scabies – 1G04.0 Classical scabies – 1G04.1 Crusted scabies – 1G04.Y Other and unspecified scabies 1G05 Tungiasis 1G06 Cimicosis 1G07 Infestation by mites – 1G07.0 Infestation by Demodex – 1G07.Y Infestation of the skin by other specified parasitic mites 1G0Y Infestation by other specified ectoparasite 1G0Z Infestation by unknown or unspecified ectoparasite 1G2Y Other specified parasitic diseases 1G2Z Unspecified parasitic diseases 1G40 Sepsis without septic shock 1G41 Sepsis with septic shock 1G60 Certain other disorders of infectious origin 1G60.0 Mycetoma of unknown or unspecified type 1G60.1 Pythiosis 1G60.2 Protothecosis 1G60.Y Other specified disorders of infectious origin not elsewhere classified 1G80 Sequelae of tuberculosis 1G81 Sequelae of trachoma 1G82 Sequelae of leprosy 1G83 Sequelae of poliomyelitis 1G84 Sequelae of viral encephalitis 1G85 Sequelae of diphtheria 1G8Y Sequelae of other specified infectious diseases 1H0Z Infection, unspecified 3A00 Iron deficiency anaemia – 3A00.0 Acquired iron deficiency anaemia due to blood loss – 3A00.1 Acquired iron deficiency anaemia due to low intake – 3A00.2 Acquired iron deficiency anaemia due to decreased absorption – 3A00.3 Acquired iron deficiency anaemia due to increased requirement – 3A00.Y Other specified iron deficiency anaemia – 3A00.Z Iron deficiency anaemia, unspecified –– 3A00.01 Chronic posthaemorrhagic anaemia –– 3A00.0Z Acquired iron deficiency anaemia due to blood loss, unspecified 3A01 Megaloblastic anaemia due to vitamin B12 deficiency – 3A01.0 Hereditary vitamin B12 deficiency anaemia – 3A01.1 Neonatal vitamin B12 deficiency anaemia – 3A01.2 Vitamin B12 deficiency anaemia due to low intake – 3A01.3 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency – 3A01.4 Vitamin B12 deficiency anaemia due to intestinal disease – 3A01.5 Drug-induced vitamin B12 deficiency anaemia – 3A01.Y Other specified megaloblastic anaemia due to vitamin B12 deficiency – 3A01.Z Megaloblastic anaemia due to vitamin B12 deficiency, unspecified –– 3A01.30 Pernicious anaemia –– 3A01.3Y Other specified vitamin B12 deficiency anaemia due to intrinsic factor deficiency 3A02 Folate deficiency anaemia – 3A02.0 Hereditary folate deficiency anaemia – 3A02.1 Folate deficiency anaemia due to low intake – 3A02.2 Folate deficiency anaemia due to increased requirements – 3A02.3 Folate deficiency anaemia due to decreased intestinal absorption – 3A02.4 Drug-induced folate deficiency anaemia – 3A02.Y Other specified folate deficiency anaemia – 3A02.Z Folate deficiency anaemia, unspecified 3A03 Other nutritional or metabolic anaemias – 3A03.0 Hereditary orotic aciduria – 3A03.1 Protein deficiency anaemia – 3A03.2 Scorbutic anaemia – 3A03.3 Copper deficiency anaemia – 3A03.4 Acquired other vitamin B deficiency anaemia – 3A03.5 Acquired vitamin A deficiency anaemia – 3A03.6 Acquired vitamin E deficiency anaemia – 3A03.Y Other and unspecified nutritional or metabolic anaemia –– 3A03.40 Acquired pyridoxine deficiency anaemia –– 3A03.41 Acquired riboflavin deficiency anaemia –– 3A03.42 Acquired thiamine deficiency anaemia –– 3A03.4Y Other specified acquired other vitamin B deficiency anaemia – 3A10 Hereditary haemolytic anaemia –– 3A10.0 Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies –– 3A10.1 Haemolytic anaemia due to adenosine deaminase excess –– 3A10.2 Hereditary elliptocytosis –– 3A10.3 Familial pseudohyperkalaemia –– 3A10.Y Other specified hereditary haemolytic anaemia –– 3A10.Z Hereditary haemolytic anaemia, unspecified ––– 3A10.00 Haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency ––– 3A10.0Y Other specified haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies ––– 3A10.0Z Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies, unspecified – 3A1Y Other specified congenital haemolytic anaemia – 3A20 Acquired haemolytic anaemia, immune –– 3A20.0 Autoimmune haemolytic anaemia, warm type –– 3A20.1 Autoimmune haemolytic anaemia, cold type –– 3A20.2 Autoimmune haemolytic anaemia, mixed type, cold and warm –– 3A20.3 Paroxysmal cold haemoglobinuria –– 3A20.4 Alloimmune haemolytic anaemia –– 3A20.5 Evans syndrome –– 3A20.Y Other specified acquired haemolytic anaemia, immune – 3A21 Acquired haemolytic anaemia, non-immune –– 3A21.0 Paroxysmal nocturnal haemoglobinuria –– 3A21.1 Microangiopathic haemolytic anaemia –– 3A21.2 Haemolytic uraemic syndrome –– 3A21.Y Other specified acquired haemolytic anaemia, non-immune – 3A2Z Acquired haemolytic anaemia, unspecified 3A4Z Haemolytic anaemias, unspecified 3A50 Thalassaemias 3A50.0 Alpha thalassaemia 3A50.1 Alpha thalassaemia related syndromes 3A50.2 Beta thalassaemia 3A50.3 Delta, delta-beta or gamma-delta-beta thalassaemia 3A50.4 Hereditary persistence of fetal haemoglobin 3A50.Y Other specified thalassaemias 3A50.Z Thalassaemias, unspecified – 3A50.00 Mild alpha thalassaemia diseases – 3A50.01 Thalassaemic alpha-chain variants – 3A50.02 Haemoglobin H disease (– α/– – included) – 3A50.03 Homozygous or compound heterozygous alpha0 thalassaemia – 3A50.0Y Other specified alpha thalassaemia – 3A50.0Z Alpha thalassaemia, unspecified 3A51 Sickle cell disorders or other haemoglobinopathies 3A51.0 Sickle cell trait 3A51.1 Sickle cell disease without crisis 3A51.2 Sickle cell disease with crisis 3A51.3 Compound heterozygous sickling disorders without crisis 3A51.4 Compound heterozygous sickling disorders with crisis 3A51.5 Haemoglobin C disease 3A51.6 Haemoglobin D disease 3A51.7 High affinity haemoglobin 3A51.8 Low affinity haemoglobin 3A51.9 Haemoglobin O disease 3A51.A Haemoglobin E disease 3A51.B Haemoglobin C/beta thalassaemia compound heterozygosity 3A51.Y Other specified sickle cell disorders or other haemoglobinopathies 3A51.Z Sickle cell disorders or other haemoglobinopathies, unspecified 3A60 Congenital pure red cell aplasia – 3A60.0 Congenital non-inherited pure red cell aplasia – 3A60.1 Hereditary pure red cell aplasia – 3A60.Z Congenital pure red cell aplasia, unspecified 3A61 Acquired pure red cell aplasia – 3A61.0 Acute acquired pure red cell aplasia – 3A61.1 Chronic acquired pure red cell aplasia – 3A61.Y Other specified acquired pure red cell aplasia – 3A61.Z Acquired pure red cell aplasia, unspecified 3A6Z Pure red cell aplasia, unspecified 3A70 Aplastic anaemia 3A70.0 Congenital aplastic anaemia 3A70.1 Acquired aplastic anaemias 3A70.Z Aplastic anaemia, unspecified – 3A70.10 Drug-induced aplastic anaemia – 3A70.11 Aplastic anaemia due to other external agents – 3A70.12 Idiopathic aplastic anaemia – 3A70.1Y Other specified acquired aplastic anaemias – 3A70.1Z Acquired aplastic anaemias, unspecified 3A71 Anaemia due to chronic disease 3A71.0 Anaemia in neoplastic disease 3A71.1 Anaemia in chronic infectious diseases 3A71.2 Anaemia in chronic kidney disease 3A71.Y Anaemia due to other specified chronic disease 3A71.Z Anaemia due to chronic disease, unspecified 3A72 Sideroblastic anaemia 3A72.0 Congenital sideroblastic anaemias 3A72.1 Acquired sideroblastic anaemias 3A72.Z Sideroblastic anaemia, unspecified – 3A72.00 Hereditary sideroblastic anaemias – 3A72.01 Hereditary syndromic sideroblastic anaemia – 3A72.0Y Other specified congenital sideroblastic anaemias – 3A72.0Z Congenital sideroblastic anaemias, unspecified 3A73 Congenital dyserythropoietic anaemia 3A80 Congenital polycythaemia – 3A80.0 Primary inherited erythrocytosis – 3A80.Y Other specified congenital polycythaemia – 3A80.Z Congenital polycythaemia, unspecified 3A81 Acquired polycythaemia – 3A81.0 Polycythaemia due to hypoxia, including high altitude – 3A81.1 Polycythaemia due to over-transfusion or blood doping – 3A81.2 Relative polycythaemia – 3A81.Y Other specified acquired polycythaemia – 3A81.Z Acquired polycythaemia, unspecified 3A8Z Polycythaemia, unspecified 3A90 Anaemia due to acute disease 3A91 Congenital methaemoglobinaemia 3A92 Hereditary methaemoglobinaemia 3A93 Acquired methaemoglobinaemia 3A94 Acute posthaemorrhagic anaemia 3A9Y Other specified anaemias or erythrocyte disorders 3A9Z Anaemias or other erythrocyte disorders, unspecified – 3B10 Hereditary factor VIII deficiency –– 3B10.0 Haemophilia A –– 3B10.1 Hereditary factor VIII deficiency with anti-factor VIII inhibitor –– 3B10.Y Other specified hereditary factor VIII deficiency –– 3B10.Z Hereditary factor VIII deficiency, unspecified – 3B11 Hereditary factor IX deficiency –– 3B11.0 Haemophilia B –– 3B11.Y Other specified hereditary factor IX deficiency –– 3B11.Z Hereditary factor IX deficiency, unspecified – 3B12 Von Willebrand disease – 3B13 Haemophilia C – 3B14 Other inherited coagulation factor deficiency with bleeding tendency –– 3B14.0 Hereditary deficiency of factor I –– 3B14.1 Hereditary factor X deficiency –– 3B14.2 Combined deficiency of vitamin K-dependent clotting factors –– 3B14.Z Other inherited coagulation factor deficiency with bleeding tendency, unspecified – 3B15 Inherited coagulation factor deficiency without bleeding tendency – 3B1Z Congenital or constitutional haemorrhagic condition, unspecified – 3B20 Disseminated intravascular coagulation – 3B21 Haemorrhagic disorder due to circulating anticoagulants and coagulation factors –– 3B21.0 Haemorrhage due to thrombin inhibitor other than heparin –– 3B21.1 Haemorrhage due to factor Xa inhibitor –– 3B21.Y Haemorrhagic disorder due to other specified circulating anticoagulants –– 3B21.Z Haemorrhagic disorder due to unspecified circulating anticoagulants – 3B22 Acquired haemophilia – 3B2Y Other specified haemorrhagic diseases due to acquired coagulation factor defects 3B4Z Coagulation defects, unspecified 3B50 Inherited fibrinolytic defects – 3B50.0 Congenital alpha-2 antiplasmin deficiency – 3B50.1 Congenital plasminogen activator inhibitor type 1 deficiency – 3B50.Y Other specified inherited fibrinolytic defects – 3B50.Z Inherited fibrinolytic defects, unspecified 3B51 Acquired fibrinolytic defects 3B60 Non-thrombocytopenic purpura 3B60.0 Hereditary vascular purpura 3B60.1 Acquired vascular purpura 3B61 Thrombophilia 3B61.0 Hereditary thrombophilia 3B61.1 Acquired thrombophilia 3B61.Y Other specified thrombophilia 3B61.Z Thrombophilia, unspecified – 3B61.00 Hyperhomocysteinaemia – 3B61.0Y Other specified hereditary thrombophilia – 3B61.0Z Hereditary thrombophilia, unspecified 3B62 Qualitative platelet defects 3B62.0 Inherited qualitative platelet defects 3B62.1 Bleeding diathesis due to thromboxane synthesis deficiency 3B62.2 Isolated thrombocytopenia 3B62.3 Dense granule disease 3B62.4 Alpha-delta dense granule deficiency 3B62.5 Haemophagocytic syndrome associated with infection 3B62.Y Other specified qualitative platelet defects 3B62.Z Qualitative platelet defects, unspecified – 3B62.00 Alpha-granule diseases – 3B62.01 Inherited giant platelet disorder – 3B62.0Y Other specified inherited qualitative platelet defects – 3B62.0Z Inherited qualitative platelet defects, unspecified 3B63 Thrombocytosis 3B63.0 Congenital thrombocytosis 3B63.1 Acquired thrombocytosis 3B63.Y Other specified thrombocytosis 3B63.Z Thrombocytosis, unspecified – 3B63.10 Secondary thrombocytosis – 3B63.1Y Other specified acquired thrombocytosis – 3B63.1Z Acquired thrombocytosis, unspecified 3B64 Thrombocytopenia 3B64.0 Congenital thrombocytopenia 3B64.1 Acquired thrombocytopenia 3B64.Z Thrombocytopenia, unspecified – 3B64.00 Congenital non-inherited thrombocytopenia – 3B64.01 Hereditary thrombocytopenia – 3B64.0Z Congenital thrombocytopenia, unspecified – 3B64.10 Immune thrombocytopenic purpura – 3B64.11 Secondary thrombocytopenic purpura – 3B64.12 Drug-induced thrombocytopenic purpura – 3B64.13 Alloimmune thrombocytopenia – 3B64.14 Thrombotic thrombocytopenic purpura – 3B64.1Y Other specified acquired thrombocytopenia 3B65 Thrombotic microangiopathy, not elsewhere classified 3B6Y Other specified coagulation defects, purpura or other haemorrhagic or related conditions 3B6Z Coagulation defects, purpura or other haemorrhagic or related conditions, unspecified 3B80 Congenital disorders of spleen 3B80.0 Splenomegaly in storage diseases 3B81 Acquired disorders of spleen 3B81.0 Tumour-like conditions of spleen 3B81.1 Postsurgical asplenia 3B81.2 Atrophy of spleen 3B81.3 Nontraumatic laceration or rupture of spleen 3B81.4 Splenosis 3B81.5 Splenic cyst or pseudocyst 3B81.6 Infarction of spleen 3B81.7 Infection of spleen 3B81.8 Torsion of spleen 3B81.9 Fibrosis of spleen 3B81.A Perisplenitis 3B81.B Hypersplenism 3B81.C Chronic congestive splenomegaly 3B81.Y Other specified acquired disorders of spleen 3B81.Z Acquired disorders of spleen, unspecified – 3B81.50 Pseudocyst of spleen – 3B81.51 Epithelial cyst of spleen – 3B81.5Y Other specified splenic cyst – 3B81.5Z Splenic cyst, unspecified – 3B81.70 Acute septic splenitis – 3B81.71 Abscess of spleen – 3B81.7Y Other specified infection of spleen – 3B81.7Z Infection of spleen, unspecified 3B8Z Diseases of spleen, unspecified 3C0Y Other specified diseases of the blood or blood-forming organs 3C0Z Diseases of the blood or blood-forming organs, unspecified 4A00 Primary immunodeficiencies due to disorders of innate immunity 4A00.0 Functional neutrophil defects 4A00.1 Defects in the complement system 4A00.2 Genetic susceptibility to particular pathogens 4A00.3 Immunodeficiency with natural-killer cell deficiency 4A00.Y Other specified primary immunodeficiencies due to disorders of innate immunity 4A00.Z Primary immunodeficiencies due to disorders of innate immunity, unspecified – 4A00.00 Neutrophil immunodeficiency syndrome – 4A00.0Y Other specified functional neutrophil defects – 4A00.0Z Functional neutrophil defects, unspecified – 4A00.10 Immunodeficiency with an early component of complement deficiency – 4A00.11 Immunodeficiency with a late component of complement deficiency – 4A00.12 Immunodeficiency with factor B deficiency – 4A00.13 Immunodeficiency with factor D anomaly – 4A00.14 Hereditary angioedema – 4A00.15 Acquired angioedema – 4A00.1Y Other specified defects in the complement system – 4A00.1Z Defects in the complement system, unspecified 4A01 Primary immunodeficiencies due to disorders of adaptive immunity 4A01.0 Immunodeficiencies with predominantly antibody defects 4A01.1 Combined immunodeficiencies 4A01.2 Diseases of immune dysregulation 4A01.3 Other well-defined immunodeficiency syndromes due to defects in adaptive immunity 4A01.Z Primary immunodeficiencies due to disorders of adaptive immunity, unspecified – 4A01.00 Hereditary agammaglobulinaemia with profoundly reduced or absent B cells – 4A01.01 Immunodeficiencies with severe reduction in at least two serum immunoglobulin isotypes with normal or low numbers of B cells – 4A01.02 Specific antibody deficiency with normal immunoglobulin concentrations or normal number of B cells – 4A01.03 Transient hypogammaglobulinaemia of infancy – 4A01.04 Immunodeficiencies with isotype or light chain deficiencies with normal number of B cells – 4A01.05 Immunodeficiencies with severe reduction in serum IgG or IgA with normal or elevated IgM and normal numbers of B-cells – 4A01.0Y Other specified immunodeficiencies with predominantly antibody defects – 4A01.0Z Immunodeficiencies with predominantly antibody defects, unspecified – 4A01.10 Severe combined immunodeficiencies – 4A01.11 Major histocompatibility complex class I deficiency – 4A01.12 Major histocompatibility complex class II deficiency – 4A01.1Y Other specified combined immunodeficiencies – 4A01.1Z Combined immunodeficiencies, unspecified – 4A01.20 Immune dysregulation syndromes with hypopigmentation – 4A01.21 Immune dysregulation syndromes presenting primarily with autoimmunity – 4A01.22 Immune dysregulation syndromes presenting primarily with lymphoproliferation – 4A01.23 Primary haemophagocytic lymphohistiocytosis – 4A01.2Y Other specified diseases of immune dysregulation – 4A01.2Z Diseases of immune dysregulation, unspecified – 4A01.30 Immunodeficiency due to defects of the thymus – 4A01.31 DNA repair defects other than combined T-cell or B-cell immunodeficiencies – 4A01.32 Immuno-osseous dysplasia – 4A01.33 Hepatic veno-occlusive disease - immunodeficiency syndrome – 4A01.34 Hyperimmunoglobulin E syndromes 4A0Y Other specified primary immunodeficiencies 4A0Z Primary immunodeficiencies, unspecified 4A20 Acquired immunodeficiencies 4A20.0 Adult-onset immunodeficiency 4A20.1 Acquired immunodeficiency due to loss of immunoglobulin 4A20.Y Other specified acquired immunodeficiencies 4A20.Z Acquired immunodeficiencies, unspecified 4A40 Lupus erythematosus 4A40.0 Systemic lupus erythematosus 4A40.1 Drug-induced lupus erythematosus 4A40.Y Other specified lupus erythematosus 4A40.Z Lupus erythematosus, unspecified – 4A40.00 Systemic lupus erythematosus with skin involvement – 4A40.0Y Other specified systemic lupus erythematosus – 4A40.0Z Systemic lupus erythematosus, unspecified 4A41 Idiopathic inflammatory myopathy 4A41.0 Dermatomyositis 4A41.1 Polymyositis 4A41.2 Inclusion body myopathy 4A41.Y Other specified idiopathic inflammatory myopathy 4A41.Z Idiopathic inflammatory myopathy, unspecified – 4A41.00 Adult dermatomyositis – 4A41.01 Juvenile dermatomyositis – 4A41.0Z Dermatomyositis, unspecified – 4A41.10 Juvenile polymyositis – 4A41.11 Paraneoplastic polymyositis – 4A41.1Y Other specified polymyositis – 4A41.1Z Polymyositis, unspecified – 4A41.20 Inflammatory inclusion body myositis – 4A41.21 Noninflammatory inclusion body myopathy – 4A41.2Z Inclusion body myopathy, unspecified 4A42 Systemic sclerosis 4A42.0 Paediatric onset systemic sclerosis 4A42.1 Diffuse systemic sclerosis 4A42.2 Limited systemic sclerosis 4A42.Z Systemic sclerosis, unspecified 4A43 Overlap or undifferentiated nonorgan specific systemic autoimmune disease 4A43.0 IgG4 related disease 4A43.1 Mikulicz disease 4A43.2 Sjögren syndrome 4A43.3 Mixed connective tissue disease 4A43.4 Diffuse eosinophilic fasciitis 4A43.Y Other specified overlap non-organ specific systemic autoimmune disease 4A43.Z Undifferentiated non-organ specific systemic autoimmune disease – 4A43.20 Primary Sjögren syndrome – 4A43.21 Secondary Sjögren syndrome – 4A43.22 Paediatric onset Sjögren syndrome – 4A43.2Y Other specified sjögren syndrome – 4A43.2Z Sjögren syndrome, unspecified 4A44 Vasculitis 4A44.0 Rhizomelic pseudopolyarthritis 4A44.1 Aortic arch syndrome 4A44.2 Giant cell arteritis 4A44.3 Single organ vasculitis 4A44.4 Polyarteritis nodosa 4A44.5 Mucocutaneous lymph node syndrome 4A44.6 Sneddon syndrome 4A44.7 Primary angiitis of the central nervous system 4A44.8 Thromboangiitis obliterans 4A44.9 Immune complex small vessel vasculitis 4A44.A Antineutrophil cytoplasmic antibody-associated vasculitis 4A44.B Leukocytoclastic vasculitis 4A44.Y Other specified vasculitis 4A44.Z Vasculitis, unspecified – 4A44.90 Cryoglobulinaemic vasculitis – 4A44.91 Hypocomplementaemic urticarial vasculitis – 4A44.92 IgA vasculitis – 4A44.9Y Other specified immune complex small vessel vasculitis – 4A44.9Z Immune complex small vessel vasculitis, unspecified – 4A44.A0 Microscopic polyangiitis – 4A44.A1 Granulomatosis with polyangiitis – 4A44.A2 Eosinophilic granulomatosis with polyangiitis – 4A44.AY Other specified antineutrophil cytoplasmic antibody-associated vasculitis – 4A44.AZ Antineutrophil cytoplasmic antibody-associated vasculitis, unspecified – 4A44.B0 Cutaneous leukocytoclastic vasculitis – 4A44.BY Other specified leukocytoclastic vasculitis – 4A44.BZ Leukocytoclastic vasculitis, unspecified 4A45 Antiphospholipid syndrome 4A45.0 Primary antiphospholipid syndrome 4A45.1 Secondary antiphospholipid syndrome 4A45.2 Antiphospholipid syndrome in pregnancy 4A45.3 Lupus anticoagulant-hypoprothrombinaemia syndrome 4A45.Z Antiphospholipid syndrome, unspecified 4A4Y Other specified nonorgan specific systemic autoimmune disorders 4A4Z Nonorgan specific systemic autoimmune disorders, unspecified 4A60 Monogenic autoinflammatory syndromes 4A60.0 Familial Mediterranean fever 4A60.1 Cryopyrin-associated periodic syndromes 4A60.2 Tumour necrosis factor receptor 1 associated periodic syndrome 4A60.Y Other specified monogenic autoinflammatory syndromes 4A60.Z Autoimflammatory syndrome, unspecified 4A61 SAPHO syndrome 4A62 Behçet disease 4A6Y Other specified autoinflammatory disorders 4A6Z Autoinflammatory disorders, unspecified 4A80 Allergic or hypersensitivity disorders involving the respiratory tract 4A80.0 Drug-induced bronchospasm 4A80.1 Bronchospasm provoked by allergy to food substance 4A80.Y Other specified allergic or hypersensitivity disorders involving the respiratory tract 4A80.Z Allergic or hypersensitivity disorders involving the respiratory tract, unspecified 4A81 Allergic or hypersensitivity disorders involving the eye 4A82 Allergic or hypersensitivity disorders involving skin or mucous membranes 4A83 Allergic or hypersensitivity disorders involving the gastrointestinal tract 4A83.0 Food-induced eosinophilic gastroenteritis 4A83.1 Food-induced eosinophilic oesophagitis 4A83.Y Other specified allergic or hypersensitivity disorders involving the gastrointestinal tract 4A83.Z Allergic or hypersensitivity disorders involving the gastrointestinal tract, unspecified 4A84 Anaphylaxis 4A84.0 Anaphylaxis due to allergic reaction to food 4A84.1 Drug-induced anaphylaxis 4A84.2 Anaphylaxis due to insect venom 4A84.3 Anaphylaxis provoked by physical factors 4A84.4 Anaphylaxis due to inhaled allergens 4A84.5 Anaphylaxis due to contact with allergens 4A84.6 Anaphylaxis secondary to mast cell disorder 4A84.Y Other specified anaphylaxis 4A84.Z Anaphylaxis, unspecified – 4A84.30 Exercise-induced anaphylaxis – 4A84.31 Cold-induced anaphylaxis – 4A84.3Y Anaphylaxis provoked by other specified physical factors – 4A84.3Z Anaphylaxis provoked by unspecified physical factors 4A85 Complex allergic or hypersensitivity conditions 4A85.0 Drug or pharmacological agents hypersensitivity 4A85.1 Hypersensitivity to herbal and alternative medical therapies 4A85.2 Food hypersensitivity 4A85.3 Allergic or hypersensitivity reactions to arthropods 4A85.Y Other specified complex allergic or hypersensitivity conditions 4A85.Z Complex allergic or hypersensitivity conditions, unspecified – 4A85.00 Drug-induced liver hypersensitivity disease – 4A85.01 Drug-induced kidney hypersensitivity – 4A85.02 Drug-induced cytopenia – 4A85.03 Drug-induced vasculitis – 4A85.04 Multiple drug hypersensitivity syndrome – 4A85.0Y Drug hypersensitivity of other specified type – 4A85.0Z Drug hypersensitivity of unspecified type – 4A85.20 Food-induced gastrointestinal hypersensitivity – 4A85.21 Food-induced urticaria or angioedema – 4A85.22 Allergic contact dermatitis due to food allergen – 4A85.2Y Other specified food hypersensitivity – 4A85.2Z Food hypersensitivity, unspecified – 4A85.30 Systemic allergic reaction due to Hymenoptera venom – 4A85.31 Cutaneous allergic or hypersensitivity reactions to Hymenoptera venom – 4A85.32 Cutaneous allergic or hypersensitivity reactions to arthropods 4A8Y Allergic or hypersensitivity conditions of other specified type 4A8Z Allergic or hypersensitivity conditions of unspecified type 4B00 Disorders of neutrophil number 4B00.0 Neutropaenia 4B00.1 Neutrophilia 4B00.Y Other specified disorders of neutrophil number – 4B00.00 Constitutional neutropaenia – 4B00.01 Acquired neutropaenia – 4B00.0Z Neutropaenia, unspecified – 4B00.10 Constitutional neutrophilia – 4B00.11 Acquired neutrophilia – 4B00.1Z Neutrophilia, unspecified 4B01 Disorders of neutrophil function 4B01.0 Constitutional disorders of neutrophil function 4B01.1 Acquired disorders of neutrophil function 4B01.Z Disorders of neutrophil function, unspecified – 4B01.00 Disorders of neutrophil adhesion – 4B01.01 Disorders of neutrophil chemotaxis – 4B01.02 Disorders of neutrophil granule formation or release – 4B01.03 Disorders of neutrophil oxidative metabolism – 4B01.0Y Other specified constitutional disorders of neutrophil function – 4B01.0Z Constitutional disorders of neutrophil function, unspecified 4B02 Eosinopenia 4B02.0 Constitutional decrease in eosinophil number 4B02.1 Acquired decrease in eosinophil number 4B02.Z Eosinopenia, unspecified 4B03 Eosinophilia 4B03.0 Constitutional eosinophilia 4B03.1 Acquired eosinophilia 4B03.Z Eosinophilia, unspecified 4B04 Disorders with decreased monocyte counts 4B05 Disorders with increased monocyte counts 4B06 Acquired lymphopenia 4B07 Acquired lymphocytosis 4B0Y Other specified immune system disorders involving white cell lineages 4B0Z Immune system disorders involving white cell lineages, unspecified 4B20 Sarcoidosis 4B20.0 Sarcoidosis of lung 4B20.1 Sarcoidosis of lymph nodes 4B20.2 Sarcoidosis of the digestive system 4B20.3 Neurosarcoidosis 4B20.4 Ocular sarcoidosis 4B20.5 Cutaneous sarcoidosis 4B20.Y Other specified sarcoidosis 4B20.Z Sarcoidosis, unspecified 4B21 Polyclonal hypergammaglobulinaemia 4B22 Cryoglobulinaemia 4B23 Immune reconstitution inflammatory syndrome 4B24 Graft-versus-host disease 4B24.0 Acute graft-versus-host disease 4B24.1 Chronic graft-versus-host disease 4B24.Y Other specified graft-versus-host disease 4B24.Z Graft-versus-host disease, unspecified 4B2Y Other specified disorders involving the immune system 4B40 Diseases of thymus 4B40.0 Persistent hyperplasia of thymus 4B40.1 Abscess of thymus 4B40.2 Good syndrome 4B40.Y Other specified diseases of thymus 4B40.Z Diseases of thymus, unspecified 4B4Y Other specified diseases of the immune system 4B4Z Diseases of the immune system, unspecified 5A00 Hypothyroidism – 5A00.0 Congenital hypothyroidism – 5A00.1 Iodine-deficiency-related thyroid disorders or allied conditions – 5A00.2 Acquired hypothyroidism – 5A00.Z Hypothyroidism, unspecified –– 5A00.00 Permanent congenital hypothyroidism with diffuse goitre –– 5A00.01 Permanent congenital hypothyroidism without goitre –– 5A00.02 Pendred syndrome –– 5A00.03 Transient congenital hypothyroidism –– 5A00.04 Congenital hypothyroidism due to iodine deficiency –– 5A00.0Y Other specified congenital hypothyroidism –– 5A00.0Z Congenital hypothyroidism, unspecified –– 5A00.10 Iodine-deficiency-related diffuse goitre –– 5A00.11 Iodine-deficiency-related multinodular goitre –– 5A00.1Z Iodine-deficiency-related thyroid disorders or allied conditions, unspecified –– 5A00.20 Hypothyroidism due to medicaments or other exogenous substances –– 5A00.21 Myxoedema coma –– 5A00.22 Subclinical iodine-deficiency hypothyroidism –– 5A00.2Y Other specified acquired hypothyroidism –– 5A00.2Z Acquired hypothyroidism, unspecified 5A01 Nontoxic goitre – 5A01.0 Nontoxic diffuse goitre – 5A01.1 Nontoxic single thyroid nodule – 5A01.2 Nontoxic multinodular goitre – 5A01.Z Nontoxic goitre, unspecified 5A02 Thyrotoxicosis – 5A02.0 Thyrotoxicosis with diffuse goitre – 5A02.1 Thyrotoxicosis with toxic single thyroid nodule – 5A02.2 Thyrotoxicosis with toxic multinodular goitre – 5A02.3 Thyrotoxicosis from ectopic thyroid tissue – 5A02.4 Thyrotoxicosis factitia – 5A02.5 Thyroid crisis – 5A02.6 Secondary hyperthyroidism – 5A02.Y Other specified thyrotoxicosis – 5A02.Z Thyrotoxicosis, unspecified 5A03 Thyroiditis – 5A03.0 Acute thyroiditis – 5A03.1 Subacute thyroiditis – 5A03.2 Autoimmune thyroiditis – 5A03.Y Other specified thyroiditis – 5A03.Z Thyroiditis, unspecified –– 5A03.20 Hashimoto thyroiditis –– 5A03.21 Painless thyroiditis –– 5A03.2Y Other specified autoimmune thyroiditis –– 5A03.2Z Autoimmune thyroiditis, unspecified 5A04 Hypersecretion of calcitonin 5A05 Generalised resistance to thyroid hormone 5A06 Sick-euthyroid syndrome 5A0Y Other specified disorders of the thyroid gland or thyroid hormones system 5A0Z Disorders of the thyroid gland or thyroid hormones system, unspecified 5A10 Type 1 diabetes mellitus 5A11 Type 2 diabetes mellitus 5A12 Malnutrition-related diabetes mellitus 5A13 Diabetes mellitus, other specified type – 5A13.0 Diabetes mellitus due to genetic defects of beta cell function – 5A13.1 Diabetes mellitus due to genetic defects in insulin action – 5A13.2 Diabetes mellitus due to diseases of the exocrine pancreas – 5A13.3 Diabetes mellitus due to endocrinopathies – 5A13.4 Diabetes mellitus due to drug or chemical – 5A13.5 Diabetes mellitus due to uncommon forms of immune-mediated diabetes – 5A13.6 Diabetes mellitus due to other genetic syndromes – 5A13.7 Diabetes mellitus due to clinically defined subtypes or syndromes – 5A13.Y Diabetes mellitus due to other specified cause 5A14 Diabetes mellitus, type unspecified – 5A20 Diabetic hyperosmolar hyperglycaemic state –– 5A20.0 Hyperosmolar hyperglycaemic state without coma –– 5A20.1 Hyperosmolar hyperglycaemic state with coma –– 5A20.Z Diabetic hyperosmolar hyperglycaemic state, unspecified – 5A21 Hypoglycaemia in the context of diabetes mellitus –– 5A21.0 Hypoglycaemia in the context of diabetes mellitus without coma –– 5A21.1 Hypoglycaemia in the context of diabetes mellitus with coma –– 5A21.Z Hypoglycaemia in the context of diabetes, unspecified – 5A22 Diabetic acidosis –– 5A22.0 Diabetic ketoacidosis without coma –– 5A22.1 Diabetic lactic acidosis –– 5A22.2 Diabetic metabolic acidosis –– 5A22.3 Diabetic ketoacidosis with coma –– 5A22.Y Other specified diabetic acidosis –– 5A22.Z Diabetic acidosis, unspecified – 5A23 Diabetic coma – 5A24 Uncontrolled or unstable diabetes mellitus – 5A2Y Other specified acute complications of diabetes mellitus 5A40 Intermediate hyperglycaemia – 5A40.0 Impaired fasting glucose – 5A40.1 Impaired glucose tolerance – 5A40.Y Other specified intermediate hyperglycaemia – 5A40.Z Intermediate hyperglycaemia, unspecified 5A41 Hypoglycaemia without associated diabetes 5A42 Increased secretion of glucagon 5A43 Abnormal secretion of gastrin – 5A43.0 Drug-induced hypergastrinaemia – 5A43.1 Zollinger-Ellison syndrome – 5A43.Y Other specified abnormal secretion of gastrin – 5A43.Z Abnormal secretion of gastrin, unspecified 5A44 Insulin-resistance syndromes 5A45 Persistent hyperinsulinaemic hypoglycaemia of infancy 5A4Y Other specified disorders of glucose regulation or pancreatic internal secretion 5A4Z Disorders of glucose regulation or pancreatic internal secretion, unspecified 5A50 Hypoparathyroidism – 5A50.0 Hypoparathyroidism due to impaired parathyroid hormone secretion – 5A50.1 Pseudohypoparathyroidism – 5A50.Y Other specified hypoparathyroidism – 5A50.Z Hypoparathyroidism, unspecified –– 5A50.00 Idiopathic hypoparathyroidism –– 5A50.01 Secondary hypoparathyroidism –– 5A50.02 Hypoparathyroidism due to destruction of the parathyroid glands –– 5A50.03 Autoimmune hypoparathyroidism –– 5A50.0Y Other specified hypoparathyroidism due to impaired parathyroid hormone secretion –– 5A50.0Z Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified 5A51 Hyperparathyroidism – 5A51.0 Primary hyperparathyroidism – 5A51.1 Secondary hyperparathyroidism – 5A51.2 Familial hypocalciuric hypercalcaemia – 5A51.Y Other specified hyperparathyroidism – 5A51.Z Hyperparathyroidism, unspecified 5A5Y Other specified disorders of the parathyroids or parathyroid hormone system 5A5Z Disorders of the parathyroids or parathyroid hormone system, unspecified 5A60 Hyperfunction of pituitary gland – 5A60.0 Acromegaly or pituitary gigantism – 5A60.1 Hyperprolactinaemia – 5A60.2 Syndrome of inappropriate secretion of antidiuretic hormone – 5A60.3 Central precocious puberty – 5A60.Y Other specified hyperfunction of pituitary gland – 5A60.Z Hyperfunction of pituitary gland, unspecified –– 5A60.20 Nephrogenic syndrome of inappropriate antidiuresis –– 5A60.2Y Other specified syndrome of inappropriate secretion of antidiuretic hormone –– 5A60.2Z Syndrome of inappropriate secretion of antidiuretic hormone, unspecified 5A61 Hypofunction or certain other specified disorders of pituitary gland – 5A61.0 Hypopituitarism – 5A61.1 Adrenocorticotropic hormone deficiency – 5A61.2 Gonadotropin deficiency – 5A61.3 Growth hormone deficiency – 5A61.4 Thyroid stimulating hormone deficiency – 5A61.5 Central diabetes insipidus – 5A61.6 Oxytocin deficiency – 5A61.Y Other specified hypofunction or disorders of pituitary gland –– 5A61.40 Acquired central hypothyroidism –– 5A61.41 Congenital central hypothyroidism –– 5A61.4Y Other specified thyroid stimulating hormone deficiency –– 5A61.4Z Thyroid stimulating hormone deficiency, unspecified 5A6Z Disorders of the pituitary hormone system, unspecified 5A70 Cushing syndrome – 5A70.0 Pituitary-dependent Cushing disease – 5A70.1 Ectopic ACTH syndrome – 5A70.2 Pseudo-Cushing syndrome – 5A70.3 Nelson syndrome – 5A70.Y Other specified Cushing syndrome – 5A70.Z Cushing syndrome, unspecified 5A71 Adrenogenital disorders – 5A71.0 46,XX disorders of sex development induced by androgens of fetal origin – 5A71.1 46,XX disorders of sex development induced by androgens of maternal origin – 5A71.Y Other specified adrenogenital disorders – 5A71.Z Adrenogenital disorders, unspecified –– 5A71.00 Glucocorticoid resistance –– 5A71.01 Congenital adrenal hyperplasia –– 5A71.0Y Other specified 46,XX disorders of sex development induced by androgens of fetal origin –– 5A71.0Z 46,XX disorders of sex development induced by androgens of fetal origin, unspecified 5A72 Hyperaldosteronism – 5A72.0 Primary hyperaldosteronism – 5A72.1 Secondary hyperaldosteronism – 5A72.Z Hyperaldosteronism, unspecified 5A73 Hypoaldosteronism 5A74 Adrenocortical insufficiency – 5A74.0 Acquired adrenocortical insufficiency – 5A74.1 Adrenal crisis – 5A74.Y Other specified adrenocortical insufficiency – 5A74.Z Adrenocortical insufficiency, unspecified 5A75 Adrenomedullary hyperfunction 5A76 Certain specified disorders of adrenal gland – 5A76.0 Premature adrenarche – 5A76.Y Other specified disorders of adrenal gland 5A7Z Disorders of the adrenal glands or adrenal hormone system, unspecified 5A80 Ovarian dysfunction – 5A80.0 Clinical hyperandrogenism – 5A80.1 Polycystic ovary syndrome – 5A80.2 Polycystic ovary – 5A80.3 Anovulation – 5A80.4 Oligo-ovulation – 5A80.5 Diminished ovarian reserve – 5A80.Y Other specified ovarian dysfunction – 5A80.Z Ovarian dysfunction, unspecified 5A81 Testicular dysfunction or testosterone-related disorders – 5A81.0 Testicular hyperfunction – 5A81.1 Testicular hypofunction – 5A81.Y Other specified testicular dysfunction or testosterone-related disorders – 5A81.Z Testicular dysfunction or testosterone-related disorders, unspecified 5A8Z Disorders of the gonadal hormone system, unspecified 5A90 Disorder of puberty due to oestrogen resistance 5A91 Delayed puberty 5A92 Peripheral precocious puberty 5A9Y Other disorders of puberty 5A9Z Disorders of puberty, unspecified 5B00 Autoimmune polyendocrinopathy 5B01 Polyglandular hyperfunction 5B0Y Other specified polyglandular dysfunction 5B0Z Polyglandular dysfunction, unspecified 5B10 Carcinoid syndrome 5B11 Short stature, not elsewhere classified 5B12 Constitutional tall stature 5B1Y Other specified endocrine disorders, not elsewhere classified 5B3Y Other specified endocrine diseases 5B3Z Endocrine diseases, unspecified 5B50 Underweight in infants, children or adolescents 5B51 Wasting in infants, children or adolescents 5B52 Acute malnutrition in infants, children or adolescents 5B53 Stunting in infants, children or adolescents 5B54 Underweight in adults 5B55 Vitamin A deficiency – 5B55.0 Vitamin A deficiency with night blindness – 5B55.1 Vitamin A deficiency with conjunctival xerosis – 5B55.2 Vitamin A deficiency with conjunctival xerosis and Bitot's spots – 5B55.3 Vitamin A deficiency with corneal xerosis – 5B55.4 Vitamin A deficiency with corneal ulceration or keratomalacia – 5B55.5 Vitamin A deficiency with xerophthalmic scars of cornea or blindness – 5B55.Y Vitamin A deficiency with other specified manifestations – 5B55.Z Vitamin A deficiency, unspecified 5B56 Vitamin C deficiency – 5B56.0 Scurvy – 5B56.Y Other specified vitamin C deficiency – 5B56.Z Vitamin C deficiency, unspecified 5B57 Vitamin D deficiency – 5B57.0 Vitamin D deficiency rickets – 5B57.1 Vitamin D deficiency osteomalacia – 5B57.Y Other specified vitamin D deficiency – 5B57.Z Vitamin D deficiency, unspecified 5B58 Vitamin E deficiency 5B59 Vitamin K deficiency 5B5A Vitamin B1 deficiency – 5B5A.0 Beriberi – 5B5A.1 Wernicke-Korsakoff Syndrome – 5B5A.Y Other specified vitamin B1 deficiency – 5B5A.Z Vitamin B1 deficiency, unspecified –– 5B5A.00 Dry beriberi –– 5B5A.01 Wet beriberi –– 5B5A.0Z Beriberi, unspecified –– 5B5A.10 Wernicke encephalopathy –– 5B5A.11 Korsakoff syndrome –– 5B5A.1Y Other specified Wernicke-Korsakoff Syndrome –– 5B5A.1Z Wernicke-Korsakoff Syndrome, unspecified 5B5B Vitamin B2 deficiency 5B5C Vitamin B3 deficiency – 5B5C.0 Pellagra – 5B5C.Y Other specified vitamin B3 deficiency – 5B5C.Z Vitamin B3 deficiency, unspecified 5B5D Vitamin B6 deficiency 5B5E Folate deficiency 5B5F Vitamin B12 deficiency 5B5G Biotin deficiency 5B5H Pantothenic acid deficiency 5B5J Choline deficiency 5B5K Mineral deficiencies – 5B5K.0 Iron deficiency – 5B5K.1 Calcium deficiency – 5B5K.2 Zinc deficiency – 5B5K.3 Iodine deficiency – 5B5K.4 Fluorine deficiency – 5B5K.5 Sodium chloride deficiency – 5B5K.6 Copper deficiency – 5B5K.7 Selenium deficiency – 5B5K.8 Chromium deficiency – 5B5K.9 Manganese deficiency – 5B5K.A Molybdenum deficiency – 5B5K.B Vanadium deficiency – 5B5K.Y Other specified mineral deficiency – 5B5K.Z Mineral deficiency, unspecified –– 5B5K.10 Tetany due to acute calcium deficiency –– 5B5K.1Y Other specified calcium deficiency –– 5B5K.1Z Calcium deficiency, unspecified – 5B60 Sequelae of protein-energy malnutrition – 5B61 Sequelae of vitamin A deficiency – 5B62 Sequelae of vitamin C deficiency – 5B63 Sequelae of rickets – 5B6Y Other specified sequelae of malnutrition or certain specified nutritional deficiencies – 5B6Z Sequelae of malnutrition or certain specified nutritional deficiencies, unspecified 5B70 Essential fatty acid deficiency 5B71 Protein deficiency 5B7Y Other specified undernutrition 5B7Z Unspecified undernutrition – 5B80 Overweight or localised adiposity –– 5B80.0 Overweight –– 5B80.1 Localised adiposity ––– 5B80.00 Overweight in infants, children or adolescents ––– 5B80.01 Overweight in adults ––– 5B80.0Z Overweight, unspecified – 5B81 Obesity –– 5B81.0 Obesity due to energy imbalance –– 5B81.1 Drug-induced obesity –– 5B81.Y Other specified obesity –– 5B81.Z Obesity, unspecified ––– 5B81.00 Obesity in children or adolescents ––– 5B81.01 Obesity in adults – 5B90 Vitamin excesses –– 5B90.0 Hypervitaminosis A –– 5B90.1 Hypercarotenaemia –– 5B90.2 Hypervitaminosis D –– 5B90.3 Megavitamin-B6 syndrome –– 5B90.Y Other specified vitamin excess –– 5B90.Z Unspecified vitamin excesses – 5B91 Mineral excesses –– 5B91.0 Hypercalcaemia –– 5B91.1 Zinc excess –– 5B91.2 Sodium chloride excess –– 5B91.3 Fluorine excess –– 5B91.4 Aluminium excess –– 5B91.5 Manganese excess –– 5B91.Y Other specified mineral excess –– 5B91.Z Unspecified mineral excess – 5B9Y Other specified nutrient excesses – 5B9Z Certain specified nutrient excesses, unspecified 5C1Y Other specified overweight, obesity or specific nutrient excesses 5C1Z Overweight, obesity or specific nutrient excesses, unspecified 5C3Y Other specified nutritional disorders 5C3Z Nutritional disorders, unspecified 5C50 Inborn errors of amino acid or other organic acid metabolism – 5C50.0 Phenylketonuria – 5C50.1 Disorders of tyrosine metabolism – 5C50.2 Disorders of histidine metabolism – 5C50.3 Disorders of tryptophan metabolism – 5C50.4 Disorders of lysine or hydroxylysine metabolism – 5C50.5 Disorders of the gamma-glutamyl cycle – 5C50.6 Disorders of serine metabolism – 5C50.7 Disorders of glycine metabolism – 5C50.8 Disorders of proline or hydroxyproline metabolism – 5C50.9 Disorders of ornithine metabolism – 5C50.A Disorders of urea cycle metabolism – 5C50.B Disorders of methionine cycle or sulphur amino acid metabolism – 5C50.C Disorders of beta or omega amino acid metabolism – 5C50.D Disorders of branched-chain amino acid metabolism – 5C50.E Organic aciduria – 5C50.F Disorders of peptide metabolism – 5C50.G Trimethylaminuria – 5C50.Y Other specified inborn errors of amino acid or other organic acid metabolism – 5C50.Z Inborn errors of amino acid or other organic acid metabolism, unspecified –– 5C50.00 Classical phenylketonuria –– 5C50.01 Nonclassical phenylketonuria –– 5C50.02 Embryofetopathy due to maternal phenylketonuria –– 5C50.0Y Other specified phenylketonuria –– 5C50.0Z Phenylketonuria, unspecified –– 5C50.10 Alkaptonuria –– 5C50.11 Tyrosinaemia type 1 –– 5C50.12 Tyrosinaemia type 2 –– 5C50.1Y Other specified disorders of tyrosine metabolism –– 5C50.1Z Disorders of tyrosine metabolism, unspecified –– 5C50.20 Histidinaemia –– 5C50.21 Urocanic aciduria –– 5C50.2Y Other specified disorders of histidine metabolism –– 5C50.2Z Disorders of histidine metabolism, unspecified –– 5C50.70 Glycine encephalopathy –– 5C50.71 Sarcosinaemia –– 5C50.7Y Other specified disorders of glycine metabolism –– 5C50.7Z Disorders of glycine metabolism, unspecified –– 5C50.A0 Argininosuccinic aciduria –– 5C50.A1 Carbamoylphosphate synthetase deficiency –– 5C50.A2 Argininaemia –– 5C50.A3 Citrullinaemia –– 5C50.AY Other specified disorders of urea cycle metabolism –– 5C50.AZ Disorders of urea cycle metabolism, unspecified –– 5C50.D0 Maple-syrup-urine disease –– 5C50.DY Other specified disorders of branched-chain amino acid metabolism –– 5C50.DZ Disorders of branched-chain amino acid metabolism, unspecified –– 5C50.E0 Classical organic aciduria –– 5C50.E1 Cerebral organic aciduria –– 5C50.EY Other specified organic aciduria –– 5C50.EZ Organic aciduria, unspecified –– 5C50.F0 Prolidase deficiency –– 5C50.F1 Carnosinaemia –– 5C50.F2 Homocarnosinosis –– 5C50.FY Other specified disorders of peptide metabolism –– 5C50.FZ Disorders of peptide metabolism, unspecified 5C51 Inborn errors of carbohydrate metabolism – 5C51.0 Disorders of the pentose phosphate pathway – 5C51.1 Disorders of glycerol metabolism – 5C51.2 Disorders of glyoxylate metabolism – 5C51.3 Glycogen storage disease – 5C51.4 Disorders of galactose metabolism – 5C51.5 Disorders of fructose metabolism – 5C51.Y Other specified inborn errors of carbohydrate metabolism – 5C51.Z Inborn errors of carbohydrate metabolism, unspecified –– 5C51.20 Primary hyperoxaluria type 1 –– 5C51.2Y Other specified disorders of glyoxylate metabolism –– 5C51.2Z Disorders of glyoxylate metabolism, unspecified –– 5C51.40 Galactose-1-phosphate uridyltransferase deficiency –– 5C51.41 Galactokinase deficiency –– 5C51.42 Glucose or galactose intolerance of newborn –– 5C51.4Y Other specified disorders of galactose metabolism –– 5C51.4Z Disorders of galactose metabolism, unspecified –– 5C51.50 Hereditary fructose intolerance –– 5C51.5Y Other specified disorders of fructose metabolism –– 5C51.5Z Disorders of fructose metabolism, unspecified 5C52 Inborn errors of lipid metabolism – 5C52.0 Inborn errors of fatty acid oxidation or ketone body metabolism – 5C52.1 Inborn errors of sterol metabolism – 5C52.2 Neutral lipid storage disease – 5C52.Y Other specified inborn errors of lipid metabolism – 5C52.Z Inborn errors of lipid metabolism, unspecified –– 5C52.00 Disorders of carnitine transport or the carnitine cycle –– 5C52.01 Disorders of mitochondrial fatty acid oxidation –– 5C52.02 Disorders of ketone body metabolism –– 5C52.03 Sjögren-Larsson syndrome –– 5C52.0Y Other specified inborn errors of fatty acid oxidation or ketone body metabolism –– 5C52.0Z Inborn errors of fatty acid oxidation or ketone body metabolism, unspecified –– 5C52.10 Disorders of cholesterol synthesis –– 5C52.11 Bile acid synthesis defect with cholestasis –– 5C52.1Y Other specified inborn errors of sterol metabolism –– 5C52.1Z Inborn errors of sterol metabolism, unspecified 5C53 Inborn errors of energy metabolism – 5C53.0 Disorders of pyruvate metabolism – 5C53.1 Disorders of the citric acid cycle – 5C53.2 Disorders of mitochondrial oxidative phosphorylation – 5C53.3 Disorders of mitochondrial membrane transport – 5C53.4 Disorders of creatine metabolism – 5C53.Y Other specified inborn errors of energy metabolism – 5C53.Z Inborn errors of energy metabolism, unspecified –– 5C53.00 Pyruvate kinase deficiency –– 5C53.01 Lactate dehydrogenase deficiency –– 5C53.02 Pyruvate dehydrogenase complex deficiency –– 5C53.03 Pyruvate carboxylase deficiency –– 5C53.0Y Other specified disorders of pyruvate metabolism –– 5C53.0Z Disorders of pyruvate metabolism, unspecified –– 5C53.20 Mitochondrial DNA depletion syndromes –– 5C53.21 Multiple mitochondrial DNA deletion syndromes –– 5C53.22 Coenzyme Q10 deficiency –– 5C53.23 Mitochondrial protein translation defects –– 5C53.24 Leigh syndrome –– 5C53.25 Isolated ATP synthase deficiency –– 5C53.2Y Other specified disorders of mitochondrial oxidative phosphorylation –– 5C53.2Z Disorders of mitochondrial oxidative phosphorylation, unspecified –– 5C53.30 Mitochondrial substrate carrier disorders –– 5C53.31 Mitochondrial protein import disorders –– 5C53.3Y Other specified disorders of mitochondrial membrane transport –– 5C53.3Z Disorders of mitochondrial membrane transport, unspecified 5C54 Inborn errors of glycosylation or other specified protein modification – 5C54.0 Disorders of protein N-glycosylation – 5C54.1 Disorders of protein O-glycosylation – 5C54.2 Disorders of multiple glycosylation or other pathways – 5C54.Y Other specified congenital disorders of glycosylation and protein modification – 5C54.Z Congenital disorders of glycosylation and protein modification, unspecified 5C55 Inborn errors of purine, pyrimidine or nucleotide metabolism – 5C55.0 Disorders of purine metabolism – 5C55.1 Disorders of pyrimidine metabolism – 5C55.2 Disorders of nucleotide metabolism – 5C55.Y Other specified inborn errors of purine, pyrimidine or nucleotide metabolism – 5C55.Z Inborn errors of purine, pyrimidine or nucleotide metabolism, unspecified –– 5C55.00 Xanthinuria –– 5C55.01 Lesch-Nyhan syndrome –– 5C55.0Y Other specified disorders of purine metabolism –– 5C55.0Z Disorders of purine metabolism, unspecified 5C56 Lysosomal diseases – 5C56.0 Sphingolipidosis – 5C56.1 Neuronal ceroid lipofuscinosis – 5C56.2 Glycoproteinosis – 5C56.3 Mucopolysaccharidosis – 5C56.4 Disorders of sialic acid metabolism – 5C56.Y Other specified lysosomal diseases – 5C56.Z Lysosomal diseases, unspecified –– 5C56.00 Gangliosidosis –– 5C56.01 Fabry disease –– 5C56.02 Metachromatic leukodystrophy –– 5C56.0Y Other specified sphingolipidosis –– 5C56.0Z Sphingolipidosis, unspecified –– 5C56.20 Mucolipidosis –– 5C56.21 Oligosaccharidosis –– 5C56.2Y Other specified glycoproteinosis –– 5C56.2Z Glycoproteinosis, unspecified –– 5C56.30 Mucopolysaccharidosis type 1 –– 5C56.31 Mucopolysaccharidosis type 2 –– 5C56.32 Mucopolysaccharidosis type 4 –– 5C56.33 Mucopolysaccharidosis type 6 –– 5C56.3Y Other specified mucopolysaccharidosis –– 5C56.3Z Mucopolysaccharidosis, unspecified 5C57 Peroxisomal diseases – 5C57.0 Disorders of peroxisome biogenesis – 5C57.1 Disorders of peroxisomal alpha-, beta- or omega-oxidation – 5C57.Y Other specified peroxisomal diseases – 5C57.Z Peroxisomal diseases, unspecified 5C58 Inborn errors of porphyrin or heme metabolism – 5C58.0 Disorders of bilirubin metabolism or excretion – 5C58.1 Porphyrias – 5C58.Y Other specified inborn errors of porphyrin or heme metabolism – 5C58.Z Inborn errors of porphyrin or heme metabolism, unspecified –– 5C58.00 Crigler-Najjar syndrome –– 5C58.01 Gilbert syndrome –– 5C58.02 Dubin-Johnson syndrome –– 5C58.03 Progressive familial intrahepatic cholestasis –– 5C58.04 Benign recurrent intrahepatic cholestasis –– 5C58.0Y Other specified disorders of bilirubin metabolism or excretion –– 5C58.0Z Disorders of bilirubin metabolism or excretion, unspecified –– 5C58.10 Porphyria cutanea tarda –– 5C58.12 Erythropoietic porphyrias –– 5C58.13 Variegate porphyria –– 5C58.1Y Other specified porphyrias –– 5C58.1Z Porphyrias, unspecified 5C59 Inborn errors of neurotransmitter metabolism – 5C59.0 Disorders of biogenic amine metabolism – 5C59.1 Disorders of gamma aminobutyric acid metabolism – 5C59.2 Disorders of pyridoxine metabolism – 5C59.Y Other specified inborn errors of neurotransmitter metabolism – 5C59.Z Inborn errors of neurotransmitter metabolism, unspecified –– 5C59.00 Disorders of catecholamine synthesis –– 5C59.01 Disorders of pterin metabolism –– 5C59.0Y Other specified disorders of biogenic amine metabolism –– 5C59.0Z Disorders of biogenic amine metabolism, unspecified 5C5A Alpha-1-antitrypsin deficiency 5C5Y Other specified inborn errors of metabolism 5C5Z Inborn errors of metabolism, unspecified 5C60 Disorders of amino acid absorption or transport – 5C60.0 Oculocerebrorenal syndrome – 5C60.1 Cystinosis – 5C60.2 Cystinuria – 5C60.Y Other specified disorders of amino acid absorption or transport – 5C60.Z Disorders of amino acid absorption or transport, unspecified 5C61 Disorders of carbohydrate absorption or transport – 5C61.0 Glucose-galactose malabsorption – 5C61.1 Maltase-glucoamylase deficiency – 5C61.2 Congenital sucrase-isomaltase deficiency – 5C61.3 Alpha, alpha trehalase deficiency – 5C61.4 Acquired monosaccharide malabsorption – 5C61.5 Disorders of facilitated glucose transport – 5C61.6 Lactose intolerance – 5C61.Y Other specified disorders of carbohydrate absorption or transport – 5C61.Z Disorders of carbohydrate absorption or transport, unspecified –– 5C61.40 Fructose malabsorption –– 5C61.4Y Other specified acquired monosaccharide malabsorption –– 5C61.4Z Acquired monosaccharide malabsorption, unspecified –– 5C61.60 Primary lactase deficiency –– 5C61.61 Congenital lactase deficiency –– 5C61.62 Secondary lactase deficiency –– 5C61.6Z Lactose intolerance, unspecified 5C62 Disorders of lipid absorption or transport 5C63 Disorders of vitamin or non-protein cofactor absorption or transport – 5C63.0 Disorders of cobalamin metabolism or transport – 5C63.1 Disorders of folate metabolism or transport – 5C63.2 Disorders of vitamin D metabolism or transport – 5C63.Y Other specified disorders of vitamin or non-protein cofactor absorption or transport – 5C63.Z Disorders of vitamin or non-protein cofactor absorption or transport, unspecified –– 5C63.20 Hypocalcaemic vitamin D dependent rickets –– 5C63.21 Hypocalcaemic vitamin D resistant rickets –– 5C63.22 Hypophosphataemic rickets –– 5C63.2Y Other specified disorders of vitamin D metabolism or transport –– 5C63.2Z Disorders of vitamin D metabolism or transport, unspecified 5C64 Disorders of mineral absorption or transport – 5C64.0 Disorders of copper metabolism – 5C64.1 Disorders of iron metabolism – 5C64.2 Disorders of zinc metabolism – 5C64.3 Disorders of phosphorus metabolism or phosphatases – 5C64.4 Disorders of magnesium metabolism – 5C64.5 Disorders of calcium metabolism – 5C64.6 Disorders of sodium metabolism – 5C64.7 Disorders of chloride metabolism – 5C64.Y Disorders of other specified mineral absorption and transport – 5C64.Z Disorders of mineral absorption or transport, unspecified –– 5C64.00 Wilson disease –– 5C64.0Y Other specified disorders of copper metabolism –– 5C64.0Z Disorders of copper metabolism, unspecified –– 5C64.10 Iron overload diseases –– 5C64.1Y Other specified disorders of iron metabolism –– 5C64.1Z Disorders of iron metabolism, unspecified –– 5C64.20 Acrodermatitis enteropathica –– 5C64.21 Zinc deficiency syndromes –– 5C64.2Y Other specified disorders of zinc metabolism –– 5C64.2Z Disorders of zinc metabolism, unspecified –– 5C64.40 Hypermagnesaemia –– 5C64.41 Hypomagnesaemia –– 5C64.4Z Disorders of magnesium metabolism, unspecified 5C6Y Other specified disorders of metabolite absorption or transport 5C6Z Disorders of metabolite absorption or transport, unspecified 5C70 Volume depletion – 5C70.0 Dehydration – 5C70.1 Hypovolaemia – 5C70.Y Other specified volume depletion – 5C70.Z Volume depletion, unspecified 5C71 Hyperosmolality or hypernatraemia 5C72 Hypo-osmolality or hyponatraemia 5C73 Acidosis – 5C73.0 Acute respiratory acidosis – 5C73.1 Chronic respiratory acidosis – 5C73.2 Anion gap metabolic acidosis – 5C73.Y Other specified acidosis – 5C73.Z Acidosis, unspecified 5C74 Alkalosis 5C75 Mixed disorder of acid-base balance 5C76 Hyperkalaemia 5C77 Hypokalaemia 5C78 Fluid overload 5C7Y Other specified disorders of fluid, electrolyte or acid-base balance 5C7Z Disorders of fluid, electrolyte or acid-base balance, unspecified 5C80 Hyperlipoproteinaemia – 5C80.0 Hypercholesterolaemia – 5C80.1 Hypertriglyceridaemia – 5C80.2 Mixed hyperlipidaemia – 5C80.3 Hyperalphalipoproteinaemia – 5C80.Y Other specified hyperlipoproteinaemia – 5C80.Z Hyperlipoproteinaemia, unspecified –– 5C80.00 Primary hypercholesterolaemia –– 5C80.01 Secondary hypercholesterolaemia –– 5C80.0Z Hypercholesterolaemia, unspecified 5C81 Hypolipoproteinaemia – 5C81.0 Hypoalphalipoproteinaemia – 5C81.1 Hypobetalipoproteinaemia – 5C81.Y Other specified hypolipoproteinaemia – 5C81.Z Hypolipoproteinaemia, unspecified 5C8Y Other specified disorders of lipoprotein metabolism or lipidaemias 5C8Z Unspecified disorders of lipoprotein metabolism or lipidaemias 5C90 Metabolic or transporter liver disease 5C90.0 Liver diseases due to urea cycle defects 5C90.1 Liver diseases due to disorders of porphyrin or bilirubin metabolism or transport 5C90.2 Liver diseases due to disorders of amino acid metabolism 5C90.3 Liver disease due to disorders of lysosomal storage 5C90.4 Liver diseases due to mitochondrial disorders 5C90.5 Liver diseases due to disorders of mineral metabolism 5C90.Y Other specified metabolic or transporter liver disease 5C90.Z Metabolic or transporter liver disease, unspecified 5D00 Amyloidosis – 5D00.0 AL amyloidosis – 5D00.1 AA amyloidosis – 5D00.2 Hereditary amyloidosis – 5D00.3 Dialysis-associated amyloidosis – 5D00.Y Other specified amyloidosis – 5D00.Z Amyloidosis, unspecified –– 5D00.20 Hereditary ATTR amyloidosis –– 5D00.21 Non-neuropathic heredofamilial amyloidosis –– 5D00.2Y Other specified hereditary amyloidosis –– 5D00.2Z Hereditary amyloidosis, unspecified 5D01 Tumour lysis syndrome 5D0Y Other specified metabolic disorders 5D2Z Metabolic disorders, unspecified 5D40 Postprocedural hypothyroidism 5D40.0 Postirridation hypothyroidism 5D40.Y Other specified postprocedural hypothyroidism 5D40.Z Postprocedural hypothyroidism, unspecified – 5D40.00 Hypothyroidism postradioactive iodine ablation – 5D40.0Y Other specified postirridation hypothyroidism – 5D40.0Z Postirridation hypothyroidism, unspecified 5D41 Postprocedural hypoinsulinaemia 5D42 Postprocedural hypoparathyroidism 5D43 Postprocedural hypopituitarism 5D44 Postprocedural ovarian failure 5D45 Postprocedural testicular hypofunction 5D46 Postprocedural adrenocortical hypofunction 6A00 Disorders of intellectual development 6A00.0 Disorder of intellectual development, mild 6A00.1 Disorder of intellectual development, moderate 6A00.2 Disorder of intellectual development, severe 6A00.3 Disorder of intellectual development, profound 6A00.4 Disorder of intellectual development, provisional 6A00.Z Disorders of intellectual development, unspecified 6A01 Developmental speech or language disorders 6A01.0 Developmental speech sound disorder 6A01.1 Developmental speech fluency disorder 6A01.2 Developmental language disorder 6A01.Y Other specified developmental speech or language disorders 6A01.Z Developmental speech or language disorders, unspecified – 6A01.20 Developmental language disorder with impairment of receptive and expressive language – 6A01.21 Developmental language disorder with impairment of mainly expressive language – 6A01.22 Developmental language disorder with impairment of mainly pragmatic language – 6A01.23 Developmental language disorder, with other specified language impairment 6A02 Autism spectrum disorder 6A02.0 Autism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional language 6A02.1 Autism spectrum disorder with disorder of intellectual development and with mild or no impairment of functional language 6A02.2 Autism spectrum disorder without disorder of intellectual development and with impaired functional language 6A02.3 Autism spectrum disorder with disorder of intellectual development and with impaired functional language 6A02.5 Autism spectrum disorder with disorder of intellectual development and with absence of functional language 6A02.Y Other specified autism spectrum disorder 6A02.Z Autism spectrum disorder, unspecified 6A03 Developmental learning disorder 6A03.0 Developmental learning disorder with impairment in reading 6A03.1 Developmental learning disorder with impairment in written expression 6A03.2 Developmental learning disorder with impairment in mathematics 6A03.3 Developmental learning disorder with other specified impairment of learning 6A03.Z Developmental learning disorder, unspecified 6A04 Developmental motor coordination disorder 6A05 Attention deficit hyperactivity disorder 6A05.0 Attention deficit hyperactivity disorder, predominantly inattentive presentation 6A05.1 Attention deficit hyperactivity disorder, predominantly hyperactive-impulsive presentation 6A05.2 Attention deficit hyperactivity disorder, combined presentation 6A05.Y Attention deficit hyperactivity disorder, other specified presentation 6A05.Z Attention deficit hyperactivity disorder, presentation unspecified 6A06 Stereotyped movement disorder 6A06.0 Stereotyped movement disorder without self-injury 6A06.1 Stereotyped movement disorder with self-injury 6A06.Z Stereotyped movement disorder, unspecified 6A0Y Other specified neurodevelopmental disorders 6A0Z Neurodevelopmental disorders, unspecified 6A20 Schizophrenia 6A20.0 Schizophrenia, first episode 6A20.1 Schizophrenia, multiple episodes 6A20.2 Schizophrenia, continuous 6A20.Y Other specified episode of schizophrenia 6A20.Z Schizophrenia, episode unspecified – 6A20.00 Schizophrenia, first episode, currently symptomatic – 6A20.01 Schizophrenia, first episode, in partial remission – 6A20.02 Schizophrenia, first episode, in full remission – 6A20.0Z Schizophrenia, first episode, unspecified – 6A20.10 Schizophrenia, multiple episodes, currently symptomatic – 6A20.11 Schizophrenia, multiple episodes, in partial remission – 6A20.12 Schizophrenia, multiple episodes, in full remission – 6A20.1Z Schizophrenia, multiple episodes, unspecified – 6A20.20 Schizophrenia, continuous, currently symptomatic – 6A20.21 Schizophrenia, continuous, in partial remission – 6A20.22 Schizophrenia, continuous, in full remission – 6A20.2Z Schizophrenia, continuous, unspecified 6A21 Schizoaffective disorder 6A21.0 Schizoaffective disorder, first episode 6A21.1 Schizoaffective disorder, multiple episodes 6A21.2 Schizoaffective disorder, continuous 6A21.Y Other specified schizoaffective disorder 6A21.Z Schizoaffective disorder, unspecified – 6A21.00 Schizoaffective disorder, first episode, currently symptomatic – 6A21.01 Schizoaffective disorder, first episode, in partial remission – 6A21.02 Schizoaffective disorder, first episode, in full remission – 6A21.0Z Schizoaffective disorder, first episode, unspecified – 6A21.10 Schizoaffective disorder, multiple episodes, currently symptomatic – 6A21.11 Schizoaffective disorder, multiple episodes, in partial remission – 6A21.12 Schizoaffective disorder, multiple episodes, in full remission – 6A21.1Z Schizoaffective disorder, multiple episodes, unspecified – 6A21.20 Schizoaffective disorder, continuous, currently symptomatic – 6A21.21 Schizoaffective disorder, continuous, in partial remission – 6A21.22 Schizoaffective disorder, continuous, in full remission – 6A21.2Z Schizoaffective disorder, continuous, unspecified 6A22 Schizotypal disorder 6A23 Acute and transient psychotic disorder 6A23.0 Acute and transient psychotic disorder, first episode 6A23.1 Acute and transient psychotic disorder, multiple episodes 6A23.Y Other specified acute and transient psychotic disorder 6A23.Z Acute and transient psychotic disorder, unspecified – 6A23.00 Acute and transient psychotic disorder, first episode, currently symptomatic – 6A23.01 Acute and transient psychotic disorder, first episode, in partial remission – 6A23.02 Acute and transient psychotic disorder, first episode, in full remission – 6A23.0Z Acute and transient psychotic disorder, first episode, unspecified – 6A23.10 Acute and transient psychotic disorder, multiple episodes, currently symptomatic – 6A23.11 Acute and transient psychotic disorder, multiple episodes, in partial remission – 6A23.12 Acute and transient psychotic disorder, multiple episodes, in full remission – 6A23.1Z Acute and transient psychotic disorder, multiple episodes, unspecified 6A24 Delusional disorder 6A24.0 Delusional disorder, currently symptomatic 6A24.1 Delusional disorder, in partial remission 6A24.2 Delusional disorder, in full remission 6A24.Z Delusional disorder, unspecified 6A25 Symptomatic manifestations of primary psychotic disorders 6A25.0 Positive symptoms in primary psychotic disorders 6A25.1 Negative symptoms in primary psychotic disorders 6A25.2 Depressive mood symptoms in primary psychotic disorders 6A25.3 Manic mood symptoms in primary psychotic disorders 6A25.4 Psychomotor symptoms in primary psychotic disorders 6A25.5 Cognitive symptoms in primary psychotic disorders 6A2Y Other specified primary psychotic disorder 6A2Z Schizophrenia or other primary psychotic disorders, unspecified 6A40 Catatonia associated with another mental disorder 6A41 Catatonia induced by substances or medications 6A4Z Catatonia, unspecified 6A60 Bipolar type I disorder – 6A60.0 Bipolar type I disorder, current episode manic, without psychotic symptoms – 6A60.1 Bipolar type I disorder, current episode manic, with psychotic symptoms – 6A60.2 Bipolar type I disorder, current episode hypomanic – 6A60.3 Bipolar type I disorder, current episode depressive, mild – 6A60.4 Bipolar type I disorder, current episode depressive, moderate without psychotic symptoms – 6A60.5 Bipolar type I disorder, current episode depressive, moderate with psychotic symptoms – 6A60.6 Bipolar type I disorder, current episode depressive, severe without psychotic symptoms – 6A60.7 Bipolar type I disorder, current episode depressive, severe with psychotic symptoms – 6A60.8 Bipolar type I disorder, current episode depressive, unspecified severity – 6A60.9 Bipolar type I disorder, current episode mixed, without psychotic symptoms – 6A60.A Bipolar type I disorder, current episode mixed, with psychotic symptoms – 6A60.B Bipolar type I disorder, currently in partial remission, most recent episode manic or hypomanic – 6A60.C Bipolar type I disorder, currently in partial remission, most recent episode depressive – 6A60.D Bipolar type I disorder, currently in partial remission, most recent episode mixed – 6A60.E Bipolar type I disorder, currently in partial remission, most recent episode unspecified – 6A60.F Bipolar type I disorder, currently in full remission – 6A60.Y Other specified bipolar type I disorder – 6A60.Z Bipolar type I disorder, unspecified 6A61 Bipolar type II disorder – 6A61.0 Bipolar type II disorder, current episode hypomanic – 6A61.1 Bipolar type II disorder, current episode depressive, mild – 6A61.2 Bipolar type II disorder, current episode depressive, moderate without psychotic symptoms – 6A61.3 Bipolar type II disorder, current episode depressive, moderate with psychotic symptoms – 6A61.4 Bipolar type II disorder, current episode depressive, severe without psychotic symptoms – 6A61.5 Bipolar type II disorder, current episode depressive, severe with psychotic symptoms – 6A61.6 Bipolar type II disorder, current episode depressive, unspecified severity – 6A61.7 Bipolar type II disorder, currently in partial remission, most recent episode hypomanic – 6A61.8 Bipolar type II disorder, currently in partial remission, most recent episode depressive – 6A61.9 Bipolar type II disorder, currently in partial remission, most recent episode unspecified – 6A61.A Bipolar type II disorder, currently in full remission – 6A61.Y Other specified bipolar type II disorder – 6A61.Z Bipolar type II disorder, unspecified 6A62 Cyclothymic disorder 6A6Y Other specified bipolar or related disorders 6A6Z Bipolar or related disorders, unspecified 6A70 Single episode depressive disorder – 6A70.0 Single episode depressive disorder, mild – 6A70.1 Single episode depressive disorder, moderate, without psychotic symptoms – 6A70.2 Single episode depressive disorder, moderate, with psychotic symptoms – 6A70.3 Single episode depressive disorder, severe, without psychotic symptoms – 6A70.4 Single episode depressive disorder, severe, with psychotic symptoms – 6A70.5 Single episode depressive disorder, unspecified severity – 6A70.6 Single episode depressive disorder, currently in partial remission – 6A70.7 Single episode depressive disorder, currently in full remission – 6A70.Y Other specified single episode depressive disorder – 6A70.Z Single episode depressive disorder, unspecified 6A71 Recurrent depressive disorder – 6A71.0 Recurrent depressive disorder, current episode mild – 6A71.1 Recurrent depressive disorder, current episode moderate, without psychotic symptoms – 6A71.2 Recurrent depressive disorder, current episode moderate, with psychotic symptoms – 6A71.3 Recurrent depressive disorder, current episode severe, without psychotic symptoms – 6A71.4 Recurrent depressive disorder, current episode severe, with psychotic symptoms – 6A71.5 Recurrent depressive disorder, current episode, unspecified severity – 6A71.6 Recurrent depressive disorder, currently in partial remission – 6A71.7 Recurrent depressive disorder, currently in full remission – 6A71.Y Other specified recurrent depressive disorder – 6A71.Z Recurrent depressive disorder, unspecified 6A72 Dysthymic disorder 6A73 Mixed depressive and anxiety disorder 6A7Y Other specified depressive disorders 6A7Z Depressive disorders, unspecified 6A80 Symptomatic and course presentations for mood episodes in mood disorders 6A80.0 Prominent anxiety symptoms in mood episodes 6A80.1 Panic attacks in mood episodes 6A80.2 Current depressive episode persistent 6A80.3 Current depressive episode with melancholia 6A80.4 Seasonal pattern of mood episode onset 6A80.5 Rapid cycling 6A8Y Other specified mood disorders 6A8Z Mood disorders, unspecified 6B00 Generalised anxiety disorder 6B01 Panic disorder 6B02 Agoraphobia 6B03 Specific phobia 6B04 Social anxiety disorder 6B05 Separation anxiety disorder 6B06 Selective mutism 6B0Y Other specified anxiety or fear-related disorders 6B0Z Anxiety or fear-related disorders, unspecified 6B20 Obsessive-compulsive disorder 6B20.0 Obsessive-compulsive disorder with fair to good insight 6B20.1 Obsessive-compulsive disorder with poor to absent insight 6B20.Z Obsessive-compulsive disorder, unspecified 6B21 Body dysmorphic disorder 6B21.0 Body dysmorphic disorder with fair to good insight 6B21.1 Body dysmorphic disorder with poor to absent insight 6B21.Z Body dysmorphic disorder, unspecified 6B22 Olfactory reference disorder 6B22.0 Olfactory reference disorder with fair to good insight 6B22.1 Olfactory reference disorder with poor to absent insight 6B22.Z Olfactory reference disorder, unspecified 6B23 Hypochondriasis 6B23.0 Hypochondriasis with fair to good insight 6B23.1 Hypochondriasis with poor to absent insight 6B23.Z Hypochondriasis, unspecified 6B24 Hoarding disorder 6B24.0 Hoarding disorder with fair to good insight 6B24.1 Hoarding disorder with poor to absent insight 6B24.Z Hoarding disorder, unspecified 6B25 Body-focused repetitive behaviour disorders 6B25.0 Trichotillomania 6B25.1 Excoriation disorder 6B25.Y Other specified body-focused repetitive behaviour disorders 6B25.Z Body-focused repetitive behaviour disorders, unspecified 6B2Y Other specified obsessive-compulsive or related disorders 6B2Z Obsessive-compulsive or related disorders, unspecified 6B40 Post traumatic stress disorder 6B41 Complex post traumatic stress disorder 6B42 Prolonged grief disorder 6B43 Adjustment disorder 6B44 Reactive attachment disorder 6B45 Disinhibited social engagement disorder 6B4Y Other specified disorders specifically associated with stress 6B4Z Disorders specifically associated with stress, unspecified 6B60 Dissociative neurological symptom disorder 6B60.0 Dissociative neurological symptom disorder, with visual disturbance 6B60.1 Dissociative neurological symptom disorder, with auditory disturbance 6B60.2 Dissociative neurological symptom disorder, with vertigo or dizziness 6B60.3 Dissociative neurological symptom disorder, with other sensory disturbance 6B60.4 Dissociative neurological symptom disorder, with non-epileptic seizures 6B60.5 Dissociative neurological symptom disorder, with speech disturbance 6B60.6 Dissociative neurological symptom disorder, with paresis or weakness 6B60.7 Dissociative neurological symptom disorder, with gait disturbance 6B60.8 Dissociative neurological symptom disorder, with movement disturbance 6B60.9 Dissociative neurological symptom disorder, with cognitive symptoms 6B60.Y Dissociative neurological symptom disorder, with other specified symptoms 6B60.Z Dissociative neurological symptom disorder, with unspecified symptoms – 6B60.80 Dissociative neurological symptom disorder, with chorea – 6B60.81 Dissociative neurological symptom disorder, with myoclonus – 6B60.82 Dissociative neurological symptom disorder, with tremor – 6B60.83 Dissociative neurological symptom disorder, with dystonia – 6B60.84 Dissociative neurological symptom disorder, with facial spasm – 6B60.85 Dissociative neurological symptom disorder, with Parkinsonism – 6B60.8Y Dissociative neurological symptom disorder, with other specified movement disturbance – 6B60.8Z Dissociative neurological symptom disorder, with unspecified movement disturbance 6B61 Dissociative amnesia 6B61.0 Dissociative amnesia with dissociative fugue 6B61.1 Dissociative amnesia without dissociative fugue 6B61.Z Dissociative amnesia, unspecified 6B62 Trance disorder 6B63 Possession trance disorder 6B64 Dissociative identity disorder 6B65 Partial dissociative identity disorder 6B66 Depersonalization-derealization disorder 6B6Y Other specified dissociative disorders 6B6Z Dissociative disorders, unspecified 6B80 Anorexia Nervosa 6B80.0 Anorexia Nervosa with significantly low body weight 6B80.1 Anorexia Nervosa with dangerously low body weight 6B80.2 Anorexia Nervosa in recovery with normal body weight 6B80.Y Other specified anorexia Nervosa 6B80.Z Anorexia Nervosa, unspecified – 6B80.00 Anorexia Nervosa with significantly low body weight, restricting pattern – 6B80.01 Anorexia Nervosa with significantly low body weight, binge-purge pattern – 6B80.0Z Anorexia Nervosa with significantly low body weight, unspecified – 6B80.10 Anorexia Nervosa with dangerously low body weight, restricting pattern – 6B80.11 Anorexia Nervosa with dangerously low body weight, binge-purge pattern – 6B80.1Z Anorexia Nervosa with dangerously low body weight, unspecified 6B81 Bulimia Nervosa 6B82 Binge eating disorder 6B83 Avoidant-restrictive food intake disorder 6B84 Pica 6B85 Rumination-regurgitation disorder 6B8Y Other specified feeding or eating disorders 6B8Z Feeding or eating disorders, unspecified 6C00 Enuresis 6C00.0 Nocturnal enuresis 6C00.1 Diurnal enuresis 6C00.2 Nocturnal and diurnal enuresis 6C00.Z Enuresis, unspecified 6C01 Encopresis 6C01.0 Encopresis with constipation or overflow incontinence 6C01.1 Encopresis without constipation or overflow incontinence 6C01.Z Encopresis, unspecified 6C0Z Elimination disorders, unspecified 6C20 Bodily distress disorder 6C20.0 Mild bodily distress disorder 6C20.1 Moderate bodily distress disorder 6C20.2 Severe bodily distress disorder 6C20.Z Bodily distress disorder, unspecified 6C21 Body integrity dysphoria 6C2Y Other specified disorders of bodily distress or bodily experience 6C2Z Disorders of bodily distress or bodily experience, unspecified 6C40 Disorders due to use of alcohol – 6C40.0 Episode of harmful use of alcohol – 6C40.1 Harmful pattern of use of alcohol – 6C40.2 Alcohol dependence – 6C40.3 Alcohol intoxication – 6C40.4 Alcohol withdrawal – 6C40.5 Alcohol-induced delirium – 6C40.6 Alcohol-induced psychotic disorder – 6C40.7 Certain specified alcohol-induced mental or behavioural disorders – 6C40.Y Other specified disorders due to use of alcohol – 6C40.Z Disorders due to use of alcohol, unspecified –– 6C40.10 Harmful pattern of use of alcohol, episodic –– 6C40.11 Harmful pattern of use of alcohol, continuous –– 6C40.1Z Harmful pattern of use of alcohol, unspecified –– 6C40.20 Alcohol dependence, current use, continuous –– 6C40.21 Alcohol dependence, current use, episodic –– 6C40.22 Alcohol dependence, early full remission –– 6C40.23 Alcohol dependence, sustained partial remission –– 6C40.24 Alcohol dependence, sustained full remission –– 6C40.2Z Alcohol dependence, unspecified –– 6C40.40 Alcohol withdrawal, uncomplicated –– 6C40.41 Alcohol withdrawal with perceptual disturbances –– 6C40.42 Alcohol withdrawal with seizures –– 6C40.43 Alcohol withdrawal with perceptual disturbances and seizures –– 6C40.4Z Alcohol withdrawal, unspecified –– 6C40.60 Alcohol-induced psychotic disorder with hallucinations –– 6C40.61 Alcohol-induced psychotic disorder with delusions –– 6C40.62 Alcohol-induced psychotic disorder with mixed psychotic symptoms –– 6C40.6Z Alcohol-induced psychotic disorder, unspecified –– 6C40.70 Alcohol-induced mood disorder –– 6C40.71 Alcohol-induced anxiety disorder 6C41 Disorders due to use of cannabis – 6C41.0 Episode of harmful use of cannabis – 6C41.1 Harmful pattern of use of cannabis – 6C41.2 Cannabis dependence – 6C41.3 Cannabis intoxication – 6C41.4 Cannabis withdrawal – 6C41.5 Cannabis-induced delirium – 6C41.6 Cannabis-induced psychotic disorder – 6C41.7 Certain specified cannabis-induced mental or behavioural disorders – 6C41.Y Other specified disorders due to use of cannabis – 6C41.Z Disorders due to use of cannabis, unspecified –– 6C41.10 Harmful pattern of use of cannabis, episodic –– 6C41.11 Harmful pattern of use of cannabis, continuous –– 6C41.1Z Harmful pattern of use of cannabis, unspecified –– 6C41.20 Cannabis dependence, current use –– 6C41.21 Cannabis dependence, early full remission –– 6C41.22 Cannabis dependence, sustained partial remission –– 6C41.23 Cannabis dependence, sustained full remission –– 6C41.2Z Cannabis dependence, unspecified –– 6C41.70 Cannabis-induced mood disorder –– 6C41.71 Cannabis-induced anxiety disorder 6C42 Disorders due to use of synthetic cannabinoids – 6C42.0 Episode of harmful use of synthetic cannabinoids – 6C42.1 Harmful pattern of use of synthetic cannabinoids – 6C42.2 Synthetic cannabinoid dependence – 6C42.3 Synthetic cannabinoid intoxication – 6C42.4 Synthetic cannabinoid withdrawal – 6C42.5 Synthetic cannabinoid-induced delirium – 6C42.6 Synthetic cannabinoid-induced psychotic disorder – 6C42.7 Certain specified synthetic cannabinoids-induced mental or behavioural disorders – 6C42.Y Other specified disorders due to use of synthetic cannabinoids – 6C42.Z Disorders due to use of synthetic cannabinoids, unspecified –– 6C42.10 Harmful pattern of use of synthetic cannabinoids, episodic –– 6C42.11 Harmful pattern of use of synthetic cannabinoids, continuous –– 6C42.1Y Other specified harmful pattern of use of synthetic cannabinoids –– 6C42.1Z Harmful pattern of use of synthetic cannabinoids, unspecified –– 6C42.20 Synthetic cannabinoid dependence, current use –– 6C42.21 Synthetic cannabinoid dependence, early full remission –– 6C42.22 Synthetic cannabinoid dependence, sustained partial remission –– 6C42.23 Synthetic cannabinoid dependence, sustained full remission –– 6C42.2Y Other specified synthetic cannabinoid dependence –– 6C42.2Z Synthetic cannabinoid dependence, unspecified –– 6C42.70 Synthetic cannabinoid-induced mood disorder –– 6C42.71 Synthetic cannabinoid-induced anxiety disorder 6C43 Disorders due to use of opioids – 6C43.0 Episode of harmful use of opioids – 6C43.1 Harmful pattern of use of opioids – 6C43.2 Opioid dependence – 6C43.3 Opioid intoxication – 6C43.4 Opioid withdrawal – 6C43.5 Opioid-induced delirium – 6C43.6 Opioid-induced psychotic disorder – 6C43.7 Certain specified opioid-induced mental or behavioural disorders – 6C43.Y Other specified disorders due to use of opioids – 6C43.Z Disorders due to use of opioids, unspecified –– 6C43.10 Harmful pattern of use of opioids, episodic –– 6C43.11 Harmful pattern of use of opioids, continuous –– 6C43.1Z Harmful pattern of use of opioids, unspecified –– 6C43.20 Opioid dependence, current use –– 6C43.21 Opioid dependence, early full remission –– 6C43.22 Opioid dependence, sustained partial remission –– 6C43.23 Opioid dependence, sustained full remission –– 6C43.2Z Opioid dependence, unspecified –– 6C43.70 Opioid-induced mood disorder –– 6C43.71 Opioid-induced anxiety disorder 6C44 Disorders due to use of sedatives, hypnotics or anxiolytics – 6C44.0 Episode of harmful use of sedatives, hypnotics or anxiolytics – 6C44.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics – 6C44.2 Sedative, hypnotic or anxiolytic dependence – 6C44.3 Sedative, hypnotic or anxiolytic intoxication – 6C44.4 Sedative, hypnotic or anxiolytic withdrawal – 6C44.5 Sedative, hypnotic or anxiolytic-induced delirium – 6C44.6 Sedative, hypnotic or anxiolytic-induced psychotic disorder – 6C44.7 Certain specified sedatives, hypnotics or anxiolytic-induced mental or behavioural disorders – 6C44.Y Other specified disorders due to use of sedatives, hypnotics or anxiolytics – 6C44.Z Disorders due to use of sedatives, hypnotics or anxiolytics, unspecified –– 6C44.10 Harmful pattern of use of sedatives, hypnotics or anxiolytics, episodic –– 6C44.11 Harmful pattern of use of sedatives, hypnotics or anxiolytics, continuous –– 6C44.1Z Harmful pattern of use of sedatives, hypnotics or anxiolytics, unspecified –– 6C44.20 Sedative, hypnotic or anxiolytic dependence, current use –– 6C44.21 Sedative, hypnotic or anxiolytic dependence, early full remission –– 6C44.22 Sedative, hypnotic or anxiolytic dependence, sustained partial remission –– 6C44.23 Sedative, hypnotic or anxiolytic dependence, sustained full remission –– 6C44.2Z Sedative, hypnotic or anxiolytic dependence, unspecified –– 6C44.40 Sedative, hypnotic or anxiolytic withdrawal, uncomplicated –– 6C44.41 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances –– 6C44.42 Sedative, hypnotic or anxiolytic withdrawal, with seizures –– 6C44.43 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances and seizures –– 6C44.4Z Sedative, hypnotic or anxiolytic withdrawal, unspecified –– 6C44.70 Sedative, hypnotic or anxiolytic-induced mood disorder –– 6C44.71 Sedative, hypnotic or anxiolytic-induced anxiety disorder 6C45 Disorders due to use of cocaine – 6C45.0 Episode of harmful use of cocaine – 6C45.1 Harmful pattern of use of cocaine – 6C45.2 Cocaine dependence – 6C45.3 Cocaine intoxication – 6C45.4 Cocaine withdrawal – 6C45.5 Cocaine-induced delirium – 6C45.6 Cocaine-induced psychotic disorder – 6C45.7 Certain specified cocaine-induced mental or behavioural disorders – 6C45.Y Other specified disorders due to use of cocaine – 6C45.Z Disorders due to use of cocaine, unspecified –– 6C45.10 Harmful pattern of use of cocaine, episodic –– 6C45.11 Harmful pattern of use of cocaine, continuous –– 6C45.1Z Harmful pattern of use of cocaine, unspecified –– 6C45.20 Cocaine dependence, current use –– 6C45.21 Cocaine dependence, early full remission –– 6C45.22 Cocaine dependence, sustained partial remission –– 6C45.23 Cocaine dependence, sustained full remission –– 6C45.2Z Cocaine dependence, unspecified –– 6C45.60 Cocaine-induced psychotic disorder with hallucinations –– 6C45.61 Cocaine-induced psychotic disorder with delusions –– 6C45.62 Cocaine-induced psychotic disorder with mixed psychotic symptoms –– 6C45.6Z Cocaine-induced psychotic disorder, unspecified –– 6C45.70 Cocaine-induced mood disorder –– 6C45.71 Cocaine-induced anxiety disorder –– 6C45.72 Cocaine-induced obsessive-compulsive or related disorder –– 6C45.73 Cocaine-induced impulse control disorder 6C46 Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone – 6C46.0 Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone – 6C46.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone – 6C46.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone – 6C46.3 Stimulant intoxication including amphetamines, methamphetamine or methcathinone – 6C46.4 Stimulant withdrawal including amphetamines, methamphetamine or methcathinone – 6C46.5 Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone – 6C46.6 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone – 6C46.7 Certain specified stimulant-induced mental or behavioural disorders including amphetamines, methamphetamine or methcathinone – 6C46.Y Other specified disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone – 6C46.Z Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone, unspecified –– 6C46.10 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, episodic –– 6C46.11 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, continuous –– 6C46.1Z Harmful pattern of use of stimulants including amphetamines, methamphetamine and methcathinone, unspecified –– 6C46.20 Stimulant dependence including amphetamines, methamphetamine or methcathinone, current use –– 6C46.21 Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission –– 6C46.22 Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission –– 6C46.23 Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission –– 6C46.2Z Stimulant dependence including amphetamines, methamphetamine or methcathinone, unspecified –– 6C46.60 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with hallucinations –– 6C46.61 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with delusions –– 6C46.62 Stimulant-induced psychotic disorder including amphetamines but excluding caffeine or cocaine with mixed psychotic symptoms –– 6C46.6Z Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone, unspecified –– 6C46.70 Stimulant-induced mood disorder including amphetamines, methamphetamine or methcathinone –– 6C46.71 Stimulant-induced anxiety disorder including amphetamines, methamphetamine or methcathinone –– 6C46.72 Stimulant-induced obsessive-compulsive or related disorder including amphetamines, methamphetamine or methcathinone –– 6C46.73 Stimulant-induced impulse control disorder including amphetamines, methamphetamine or methcathinone 6C47 Disorders due to use of synthetic cathinones – 6C47.0 Episode of harmful use of synthetic cathinones – 6C47.1 Harmful pattern of use of synthetic cathinones – 6C47.2 Synthetic cathinone dependence – 6C47.3 Synthetic cathinone intoxication – 6C47.4 Synthetic cathinone withdrawal – 6C47.5 Synthetic cathinone-induced delirium – 6C47.6 Synthetic cathinone-induced psychotic disorder – 6C47.7 Certain specified synthetic cathinone-induced mental or behavioural disorders – 6C47.Y Other specified disorders due to use of synthetic cathinones – 6C47.Z Disorders due to use of synthetic cathinones, unspecified –– 6C47.10 Harmful pattern of use of synthetic cathinones, episodic –– 6C47.11 Harmful use of synthetic cathinones, continuous –– 6C47.1Y Other specified harmful pattern of use of synthetic cathinones –– 6C47.1Z Harmful pattern of use of synthetic cathinones, unspecified –– 6C47.20 Synthetic cathinone dependence, current use –– 6C47.21 Synthetic cathinone dependence, early full remission –– 6C47.22 Synthetic cathinone dependence, sustained partial remission –– 6C47.23 Synthetic cathinone dependence, sustained full remission –– 6C47.2Y Other specified synthetic cathinone dependence –– 6C47.2Z Synthetic cathinone dependence, unspecified –– 6C47.60 Synthetic cathinone-induced psychotic disorder with hallucinations –– 6C47.61 Synthetic cathinone-induced psychotic disorder with delusions –– 6C47.62 Synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms –– 6C47.6Z Synthetic cathinone-induced psychotic disorder, unspecified –– 6C47.70 Synthetic cathinone-induced mood disorder –– 6C47.71 Synthetic cathinone-induced anxiety disorder –– 6C47.72 Synthetic cathinone-induced obsessive-compulsive or related syndrome –– 6C47.73 Synthetic cathinone-induced impulse control disorder 6C48 Disorders due to use of caffeine – 6C48.0 Episode of harmful use of caffeine – 6C48.1 Harmful pattern of use of caffeine – 6C48.2 Caffeine intoxication – 6C48.3 Caffeine withdrawal – 6C48.4 Certain specified caffeine-induced mental or behavioural disorders – 6C48.Y Other specified disorders due to use of caffeine – 6C48.Z Disorders due to use of caffeine, unspecified –– 6C48.10 Harmful pattern of use of caffeine, episodic –– 6C48.11 Harmful pattern of use of caffeine, continuous –– 6C48.1Z Harmful pattern of use of caffeine, unspecified –– 6C48.40 Caffeine-induced anxiety disorder 6C49 Disorders due to use of hallucinogens – 6C49.0 Episode of harmful use of hallucinogens – 6C49.1 Harmful pattern of use of hallucinogens – 6C49.2 Hallucinogen dependence – 6C49.3 Hallucinogen intoxication – 6C49.4 Hallucinogen-induced delirium – 6C49.5 Hallucinogen-induced psychotic disorder – 6C49.6 Certain specified hallucinogen-induced mental or behavioural disorders – 6C49.Y Other specified disorders due to use of hallucinogens – 6C49.Z Disorders due to use of hallucinogens, unspecified –– 6C49.10 Harmful pattern of use of hallucinogens, episodic –– 6C49.11 Harmful pattern of use of hallucinogens, continuous –– 6C49.1Z Harmful pattern of use of hallucinogens, unspecified –– 6C49.20 Hallucinogen dependence, current use –– 6C49.21 Hallucinogen dependence, early full remission –– 6C49.22 Hallucinogen dependence, sustained partial remission –– 6C49.23 Hallucinogen dependence, sustained full remission –– 6C49.2Z Hallucinogen dependence, unspecified –– 6C49.60 Hallucinogen-induced mood disorder –– 6C49.61 Hallucinogen-induced anxiety disorder 6C4A Disorders due to use of nicotine – 6C4A.0 Episode of harmful use of nicotine – 6C4A.1 Harmful pattern of use of nicotine – 6C4A.2 Nicotine dependence – 6C4A.3 Nicotine intoxication – 6C4A.4 Nicotine withdrawal – 6C4A.Y Other specified disorders due to use of nicotine – 6C4A.Z Disorders due to use of nicotine, unspecified –– 6C4A.10 Harmful pattern of use of nicotine, episodic –– 6C4A.11 Harmful pattern of use of nicotine, continuous –– 6C4A.1Z Harmful pattern of use of nicotine, unspecified –– 6C4A.20 Nicotine dependence, current use –– 6C4A.21 Nicotine dependence, early full remission –– 6C4A.22 Nicotine dependence, sustained partial remission –– 6C4A.23 Nicotine dependence, sustained full remission –– 6C4A.2Z Nicotine dependence, unspecified 6C4B Disorders due to use of volatile inhalants – 6C4B.0 Episode of harmful use of volatile inhalants – 6C4B.1 Harmful pattern of use of volatile inhalants – 6C4B.2 Volatile inhalant dependence – 6C4B.3 Volatile inhalant intoxication – 6C4B.4 Volatile inhalant withdrawal – 6C4B.5 Volatile inhalant-induced delirium – 6C4B.6 Volatile inhalant-induced psychotic disorder – 6C4B.7 Certain specified volatile inhalants-induced mental or behavioural disorders – 6C4B.Y Other specified disorders due to use of volatile inhalants – 6C4B.Z Disorders due to use of volatile inhalants, unspecified –– 6C4B.10 Harmful pattern of use of volatile inhalants, episodic –– 6C4B.11 Harmful pattern of use of volatile inhalants, continuous –– 6C4B.1Z Harmful pattern of use of volatile inhalants, unspecified –– 6C4B.20 Volatile inhalant dependence, current use –– 6C4B.21 Volatile inhalant dependence, early full remission –– 6C4B.22 Volatile inhalant dependence, sustained partial remission –– 6C4B.23 Volatile inhalant dependence, sustained full remission –– 6C4B.2Z Volatile inhalant dependence, unspecified –– 6C4B.70 Volatile inhalant-induced mood disorder –– 6C4B.71 Volatile inhalant-induced anxiety disorder 6C4C Disorders due to use of MDMA or related drugs, including MDA – 6C4C.0 Episode of harmful use of MDMA or related drugs, including MDA – 6C4C.1 Harmful pattern of use of MDMA or related drugs, including MDA – 6C4C.2 MDMA or related drug dependence, including MDA – 6C4C.3 MDMA or related drug intoxication, including MDA – 6C4C.4 MDMA or related drug withdrawal, including MDA – 6C4C.5 MDMA or related drug-induced delirium, including MDA – 6C4C.6 MDMA or related drug-induced psychotic disorder, including MDA – 6C4C.7 Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA – 6C4C.Y Other specified disorders due to use of MDMA or related drugs, including MDA – 6C4C.Z Disorders due to use of MDMA or related drugs, including MDA, unspecified –– 6C4C.10 Harmful use of MDMA or related drugs, including MDA, episodic –– 6C4C.11 Harmful use of MDMA or related drugs, including MDA, continuous –– 6C4C.1Z Harmful pattern of use of MDMA or related drugs, including MDA, unspecified –– 6C4C.20 MDMA or related drug dependence, including MDA, current use –– 6C4C.21 MDMA or related drug dependence, including MDA, early full remission –– 6C4C.22 MDMA or related drug dependence, including MDA, sustained partial remission –– 6C4C.23 MDMA or related drug dependence, including MDA, sustained full remission –– 6C4C.2Z MDMA or related drug dependence, including MDA, unspecified –– 6C4C.70 MDMA or related drug-induced mood disorder, including MDA –– 6C4C.71 MDMA or related drug-induced anxiety disorder 6C4D Disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP] – 6C4D.0 Episode of harmful use of dissociative drugs including ketamine or PCP – 6C4D.1 Harmful pattern of use of dissociative drugs, including ketamine or PCP – 6C4D.2 Dissociative drug dependence including ketamine or PCP – 6C4D.3 Dissociative drug intoxication including Ketamine or PCP – 6C4D.4 Dissociative drug-induced delirium including ketamine or PCP – 6C4D.5 Dissociative drug-induced psychotic disorder including Ketamine or PCP – 6C4D.6 Certain specified dissociative drug-induced mental or behavioural disorders, including ketamine and phencyclidine [PCP] – 6C4D.Y Other specified disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP] – 6C4D.Z Disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP], unspecified –– 6C4D.10 Harmful pattern of use of dissociative drugs including ketamine or PCP, episodic –– 6C4D.11 Harmful pattern of use of dissociative drugs including ketamine or PCP, continuous –– 6C4D.1Z Harmful pattern of use of dissociative drugs, including ketamine or PCP, unspecified –– 6C4D.20 Dissociative drug dependence including Ketamine or PCP, current use –– 6C4D.21 Dissociative drug dependence including ketamine or PCP, early full remission –– 6C4D.22 Dissociative drug dependence including Ketamine or PCP, sustained partial remission –– 6C4D.23 Dissociative drug dependence including Ketamine or PCP, sustained full remission –– 6C4D.2Z Dissociative drug dependence including ketamine or PCP, unspecified –– 6C4D.60 Dissociative drug-induced mood disorder including Ketamine or PCP –– 6C4D.61 Dissociative drug-induced anxiety disorder including Ketamine or PCP 6C4E Disorders due to use of other specified psychoactive substances, including medications – 6C4E.0 Episode of harmful use of other specified psychoactive substance – 6C4E.1 Harmful pattern of use of other specified psychoactive substance – 6C4E.2 Other specified psychoactive substance dependence – 6C4E.3 Other specified psychoactive substance intoxication – 6C4E.4 Other specified psychoactive substance withdrawal – 6C4E.5 Delirium induced by other specified psychoactive substance including medications – 6C4E.6 Psychotic disorder induced by other specified psychoactive substance – 6C4E.7 Certain other specified psychoactive substance-induced mental or behavioural disorders – 6C4E.Y Other specified disorders due to use of other specified psychoactive substances, including medications – 6C4E.Z Disorders due to use of other specified psychoactive substances, including medications, unspecified –– 6C4E.10 Harmful pattern of use of other specified psychoactive substance, episodic –– 6C4E.11 Harmful pattern of use of other specified psychoactive substance, continuous –– 6C4E.1Z Harmful pattern of use of other specified psychoactive substance, unspecified –– 6C4E.20 Other specified psychoactive substance dependence, current use –– 6C4E.21 Other specified psychoactive substance dependence, early full remission –– 6C4E.22 Other specified psychoactive substance dependence, sustained partial remission –– 6C4E.23 Other specified psychoactive substance dependence, sustained full remission –– 6C4E.2Z Other specified psychoactive substance dependence, unspecified –– 6C4E.40 Other specified psychoactive substance withdrawal, uncomplicated –– 6C4E.41 Other specified psychoactive substance withdrawal, with perceptual disturbances –– 6C4E.42 Other specified psychoactive substance withdrawal, with seizures –– 6C4E.43 Other specified psychoactive substance withdrawal, with perceptual disturbances and seizures –– 6C4E.4Z Other specified psychoactive substance withdrawal, unspecified –– 6C4E.70 Mood disorder induced by other specified psychoactive substance –– 6C4E.71 Anxiety disorder induced by other specified psychoactive substance –– 6C4E.72 Obsessive-compulsive or related disorder induced by other specified psychoactive substance –– 6C4E.73 Impulse control disorder induced by other specified psychoactive substance 6C4F Disorders due to use of multiple specified psychoactive substances, including medications – 6C4F.0 Episode of harmful use of multiple specified psychoactive substances – 6C4F.1 Harmful pattern of use of multiple specified psychoactive substances – 6C4F.2 Multiple specified psychoactive substances dependence – 6C4F.3 Intoxication due to multiple specified psychoactive substances – 6C4F.4 Multiple specified psychoactive substances withdrawal – 6C4F.5 Delirium induced by multiple specified psychoactive substances including medications – 6C4F.6 Psychotic disorder induced by multiple specified psychoactive substances – 6C4F.7 Certain multiple specified psychoactive substances-induced mental or behavioural disorders – 6C4F.Y Other specified disorders due to use of multiple specified psychoactive substances, including medications – 6C4F.Z Disorders due to use of multiple specified psychoactive substances, including medications, unspecified –– 6C4F.10 Harmful pattern of use of multiple specified psychoactive substances, episodic –– 6C4F.11 Harmful pattern of use of multiple specified psychoactive substances, continuous –– 6C4F.1Z Harmful pattern of use of multiple specified psychoactive substances, unspecified –– 6C4F.20 Multiple specified psychoactive substances dependence, current use –– 6C4F.21 Multiple specified psychoactive substances dependence, early full remission –– 6C4F.22 Multiple specified psychoactive substances dependence, sustained partial remission –– 6C4F.23 Multiple specified psychoactive substances dependence, sustained full remission –– 6C4F.2Z Multiple specified psychoactive substances dependence, unspecified –– 6C4F.40 Multiple specified psychoactive substances withdrawal, uncomplicated –– 6C4F.41 Multiple specified psychoactive substances withdrawal, with perceptual disturbances –– 6C4F.42 Multiple specified psychoactive substances withdrawal, with seizures –– 6C4F.43 Multiple specified psychoactive substances withdrawal, with perceptual disturbances and seizures –– 6C4F.4Y Other specified multiple specified psychoactive substances withdrawal –– 6C4F.4Z Multiple specified psychoactive substances withdrawal, unspecified –– 6C4F.70 Mood disorder induced by multiple specified psychoactive substances –– 6C4F.71 Anxiety disorder induced by multiple specified psychoactive substances –– 6C4F.72 Obsessive-compulsive or related disorder induced by multiple specified psychoactive substances –– 6C4F.73 Impulse control syndrome induced by multiple specified psychoactive substances 6C4G Disorders due to use of unknown or unspecified psychoactive substances – 6C4G.0 Episode of harmful use of unknown or unspecified psychoactive substances – 6C4G.1 Harmful pattern of use of unknown or unspecified psychoactive substance – 6C4G.2 Unknown or unspecified psychoactive substance dependence – 6C4G.3 Intoxication due to unknown or unspecified psychoactive substance – 6C4G.4 Withdrawal due to unknown or unspecified psychoactive substance – 6C4G.5 Delirium induced by unknown or unspecified psychoactive substance – 6C4G.6 Psychotic disorder induced by unknown or unspecified psychoactive substance – 6C4G.7 Certain unknown or unspecified psychoactive substance-induced mental or behavioural disorders – 6C4G.Y Other specified disorders due to use of unknown or unspecified psychoactive substances – 6C4G.Z Disorders due to use of unknown or unspecified psychoactive substances, unspecified –– 6C4G.10 Harmful pattern of use of unknown or unspecified psychoactive substance, episodic –– 6C4G.11 Harmful pattern of use of unknown or unspecified psychoactive substance, continuous –– 6C4G.1Z Harmful pattern of use of unknown or unspecified psychoactive substance, unspecified –– 6C4G.20 Unknown or unspecified psychoactive substance dependence, current use –– 6C4G.21 Unknown or unspecified psychoactive substance dependence, early full remission –– 6C4G.22 Unknown or unspecified psychoactive substance dependence, sustained partial remission –– 6C4G.23 Unknown or unspecified psychoactive substance dependence, sustained full remission –– 6C4G.2Z Unknown or unspecified psychoactive substance dependence, substance and state of remission unspecified –– 6C4G.40 Withdrawal due to unknown or unspecified psychoactive substance, uncomplicated –– 6C4G.41 Withdrawal due to unknown or unspecified psychoactive substance, with perceptual disturbances –– 6C4G.42 Withdrawal due to unknown or unspecified psychoactive substance, with seizures –– 6C4G.43 Withdrawal due to unknown or unspecified psychoactive, with perceptual disturbances and seizures –– 6C4G.4Z Withdrawal due to unknown or unspecified psychoactive substance, unspecified –– 6C4G.70 Mood disorder induced by unknown or unspecified psychoactive substance –– 6C4G.71 Anxiety disorder induced by unknown or unspecified psychoactive substance –– 6C4G.72 Obsessive-compulsive or related disorder induced by unknown or unspecified psychoactive substance –– 6C4G.73 Impulse control disorder induced by unknown or unspecified psychoactive substance 6C4H Disorders due to use of non-psychoactive substances – 6C4H.0 Episode of harmful use of non-psychoactive substances – 6C4H.1 Harmful pattern of use of non-psychoactive substances – 6C4H.Y Other specified disorders due to use of non-psychoactive substances – 6C4H.Z Disorders due to use of non-psychoactive substances, unspecified –– 6C4H.10 Harmful pattern of use of non-psychoactive substances, episodic –– 6C4H.11 Harmful pattern of use of non-psychoactive substances, continuous –– 6C4H.1Z Harmful pattern of use of non-psychoactive substances, unspecified 6C4Y Other specified disorders due to substance use 6C4Z Disorders due to substance use, unspecified 6C50 Gambling disorder – 6C50.0 Gambling disorder, predominantly offline – 6C50.1 Gambling disorder, predominantly online – 6C50.Z Gambling disorder, unspecified 6C51 Gaming disorder – 6C51.0 Gaming disorder, predominantly online – 6C51.1 Gaming disorder, predominantly offline – 6C51.Z Gaming disorder, unspecified 6C5Y Other specified disorders due to addictive behaviours 6C5Z Disorders due to addictive behaviours, unspecified 6C70 Pyromania 6C71 Kleptomania 6C72 Compulsive sexual behaviour disorder 6C73 Intermittent explosive disorder 6C7Y Other specified impulse control disorders 6C7Z Impulse control disorders, unspecified 6C90 Oppositional defiant disorder 6C90.0 Oppositional defiant disorder with chronic irritability-anger 6C90.1 Oppositional defiant disorder without chronic irritability-anger 6C90.Z Oppositional defiant disorder, unspecified – 6C90.00 Oppositional defiant disorder with chronic irritability-anger with limited prosocial emotions – 6C90.01 Oppositional defiant disorder with chronic irritability-anger with typical prosocial emotions – 6C90.0Z Oppositional defiant disorder with chronic irritability-anger, unspecified – 6C90.10 Oppositional defiant disorder without chronic irritability-anger with limited prosocial emotions – 6C90.11 Oppositional defiant disorder without chronic irritability-anger with typical prosocial emotions – 6C90.1Z Oppositional defiant disorder without chronic irritability-anger, unspecified 6C91 Conduct-dissocial disorder 6C91.0 Conduct-dissocial disorder, childhood onset 6C91.1 Conduct-dissocial disorder, adolescent onset 6C91.Z Conduct-dissocial disorder, unspecified – 6C91.00 Conduct-dissocial disorder, childhood onset with limited prosocial emotions – 6C91.01 Conduct-dissocial disorder, childhood onset with typical prosocial emotions – 6C91.0Z Conduct-dissocial disorder, childhood onset, unspecified – 6C91.10 Conduct-dissocial disorder, adolescent onset with limited prosocial emotions – 6C91.11 Conduct-dissocial disorder, adolescent onset with typical prosocial emotions – 6C91.1Y Other specified conduct-dissocial disorder, adolescent onset 6C9Y Other specified disruptive behaviour or dissocial disorders 6C9Z Disruptive behaviour or dissocial disorders, unspecified 6D10 Personality disorder 6D10.0 Mild personality disorder 6D10.1 Moderate personality disorder 6D10.2 Severe personality disorder 6D10.Z Personality disorder, severity unspecified 6D11 Prominent personality traits or patterns 6D11.0 Negative affectivity in personality disorder or personality difficulty 6D11.1 Detachment in personality disorder or personality difficulty 6D11.2 Dissociality in personality disorder or personality difficulty 6D11.3 Disinhibition in personality disorder or personality difficulty 6D11.4 Anankastia in personality disorder or personality difficulty 6D11.5 Borderline pattern 6D30 Exhibitionistic disorder 6D31 Voyeuristic disorder 6D32 Pedophilic disorder 6D33 Coercive sexual sadism disorder 6D34 Frotteuristic disorder 6D35 Other paraphilic disorder involving non-consenting individuals 6D36 Paraphilic disorder involving solitary behaviour or consenting individuals 6D3Z Paraphilic disorders, unspecified 6D50 Factitious disorder imposed on self 6D51 Factitious disorder imposed on another 6D5Z Factitious disorders, unspecified 6D70 Delirium 6D70.0 Delirium due to disease classified elsewhere 6D70.1 Delirium due to psychoactive substances including medications 6D70.2 Delirium due to multiple etiological factors 6D70.Y Delirium, other specified cause 6D70.Z Delirium, unspecified or unknown cause 6D71 Mild neurocognitive disorder 6D72 Amnestic disorder 6D72.0 Amnestic disorder due to diseases classified elsewhere 6D72.1 Amnestic disorder due to psychoactive substances including medications 6D72.Y Amnestic disorder, other specified cause 6D72.Z Amnestic disorder, unknown or unspecified cause – 6D72.10 Amnestic disorder due to use of alcohol – 6D72.11 Amnestic disorder due to use of sedatives, hypnotics or anxiolytics – 6D72.12 Amnestic disorder due to other specified psychoactive substance including medications – 6D72.13 Amnestic disorder due to use of volatile inhalants 6D80 Dementia due to Alzheimer disease – 6D80.0 Dementia due to Alzheimer disease with early onset – 6D80.1 Dementia due to Alzheimer disease with late onset – 6D80.2 Alzheimer disease dementia, mixed type, with cerebrovascular disease – 6D80.3 Alzheimer disease dementia, mixed type, with other nonvascular aetiologies – 6D80.Z Dementia due to Alzheimer disease, onset unknown or unspecified 6D81 Dementia due to cerebrovascular disease 6D82 Dementia due to Lewy body disease 6D83 Frontotemporal dementia 6D84 Dementia due to psychoactive substances including medications – 6D84.0 Dementia due to use of alcohol – 6D84.1 Dementia due to use of sedatives, hypnotics or anxiolytics – 6D84.2 Dementia due to use of volatile inhalants – 6D84.Y Dementia due to other specified psychoactive substance 6D85 Dementia due to diseases classified elsewhere – 6D85.0 Dementia due to Parkinson disease – 6D85.1 Dementia due to Huntington disease – 6D85.2 Dementia due to exposure to heavy metals and other toxins – 6D85.3 Dementia due to human immunodeficiency virus – 6D85.4 Dementia due to multiple sclerosis – 6D85.5 Dementia due to prion disease – 6D85.6 Dementia due to normal pressure hydrocephalus – 6D85.7 Dementia due to injury to the head – 6D85.8 Dementia due to pellagra – 6D85.9 Dementia due to Down syndrome – 6D85.Y Dementia due to other specified diseases classified elsewhere 6D86 Behavioural or psychological disturbances in dementia – 6D86.0 Psychotic symptoms in dementia – 6D86.1 Mood symptoms in dementia – 6D86.2 Anxiety symptoms in dementia – 6D86.3 Apathy in dementia – 6D86.4 Agitation or aggression in dementia – 6D86.5 Disinhibition in dementia – 6D86.6 Wandering in dementia – 6D86.Y Other specified behavioural or psychological disturbances in dementia – 6D86.Z Behavioural or psychological disturbances in dementia, unspecified 6D8Y Dementia, other specified cause 6D8Z Dementia, unknown or unspecified cause 6E0Y Other specified neurocognitive disorders 6E0Z Neurocognitive disorders, unspecified 6E20 Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, without psychotic symptoms 6E21 Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, with psychotic symptoms 6E2Z Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, unspecified 6E40 Psychological or behavioural factors affecting disorders or diseases classified elsewhere 6E40.0 Mental disorder affecting disorders or diseases classified elsewhere 6E40.1 Psychological symptoms affecting disorders or diseases classified elsewhere 6E40.2 Personality traits or coping style affecting disorders or diseases classified elsewhere 6E40.3 Maladaptive health behaviours affecting disorders or diseases classified elsewhere 6E40.4 Stress-related physiological response affecting disorders or diseases classified elsewhere 6E40.Y Other specified psychological or behavioural factors affecting disorders or diseases classified elsewhere 6E40.Z Psychological or behavioural factors affecting disorders or diseases classified elsewhere, unspecified 6E60 Secondary neurodevelopmental syndrome 6E60.0 Secondary speech or language syndrome 6E60.Y Other specified secondary neurodevelopmental syndrome 6E60.Z Secondary neurodevelopmental syndrome, unspecified 6E61 Secondary psychotic syndrome 6E61.0 Secondary psychotic syndrome, with hallucinations 6E61.1 Secondary psychotic syndrome, with delusions 6E61.2 Secondary psychotic syndrome, with hallucinations and delusions 6E61.3 Secondary psychotic syndrome, with unspecified symptoms 6E62 Secondary mood syndrome 6E62.0 Secondary mood syndrome, with depressive symptoms 6E62.1 Secondary mood syndrome, with manic symptoms 6E62.2 Secondary mood syndrome, with mixed symptoms 6E62.3 Secondary mood syndrome, with unspecified symptoms 6E63 Secondary anxiety syndrome 6E64 Secondary obsessive-compulsive or related syndrome 6E65 Secondary dissociative syndrome 6E66 Secondary impulse control syndrome 6E67 Secondary neurocognitive syndrome 6E68 Secondary personality change 6E69 Secondary catatonia syndrome 6E6Y Other specified secondary mental or behavioural syndrome 6E6Z Secondary mental or behavioural syndrome, unspecified 6E8Y Other specified mental, behavioural or neurodevelopmental disorders 6E8Z Mental, behavioural or neurodevelopmental disorders, unspecified 7A00 Chronic insomnia 7A01 Short-term insomnia 7A0Z Insomnia disorders, unspecified 7A20 Narcolepsy 7A20.0 Narcolepsy, Type 1 7A20.1 Narcolepsy, Type 2 7A20.Z Narcolepsy, unspecified 7A21 Idiopathic hypersomnia 7A22 Kleine-Levin syndrome 7A23 Hypersomnia due to a medical condition 7A24 Hypersomnia due to a medication or substance 7A25 Hypersomnia associated with a mental disorder 7A26 Insufficient sleep syndrome 7A2Y Other specified hypersomnolence disorders 7A2Z Hypersomnolence disorders, unspecified 7A40 Central sleep apnoeas 7A40.0 Primary central sleep apnoea 7A40.1 Primary central sleep apnoea of infancy 7A40.2 Primary central sleep apnoea of prematurity 7A40.3 Central sleep apnea with Cheyne-Stokes breathing 7A40.4 Central sleep apnoea due to a medical condition without Cheyne-Stokes breathing 7A40.5 Central sleep apnoea due to high-altitude periodic breathing 7A40.6 Central sleep apnoea due to a medication or substance 7A40.7 Treatment-emergent central sleep apnoea 7A40.Y Other specified central sleep apnoeas 7A40.Z Central sleep apnoeas, unspecified 7A41 Obstructive sleep apnoea 7A42 Sleep-related hypoventilation or hypoxemia disorders 7A42.0 Obesity hypoventilation syndrome 7A42.1 Congenital central alveolar sleep-related hypoventilation 7A42.2 Non-congenital central hypoventilation with hypothalamic abnormalities 7A42.3 Idiopathic central alveolar hypoventilation 7A42.4 Sleep-related hypoventilation due to a medication or substance 7A42.5 Sleep-related hypoventilation due to medical condition 7A42.6 Sleep-related hypoxemia due to a medical condition 7A42.Y Other specified sleep-related hypoventilation or hypoxemia disorders 7A42.Z Sleep-related hypoventilation or hypoxemia disorders, unspecified 7A4Y Other specified sleep-related breathing disorders 7A4Z Sleep-related breathing disorders, unspecified 7A60 Delayed sleep-wake phase disorder 7A61 Advanced sleep-wake phase disorder 7A62 Irregular sleep-wake rhythm disorder 7A63 Non-24 hour sleep-wake rhythm disorder 7A64 Circadian rhythm sleep-wake disorder, shift work type 7A65 Circadian rhythm sleep-wake disorder, jet lag type 7A6Z Circadian rhythm sleep-wake disorders, unspecified 7A80 Restless legs syndrome 7A81 Periodic limb movement disorder 7A82 Sleep-related leg cramps 7A83 Sleep-related bruxism 7A84 Sleep-related rhythmic movement disorder 7A85 Benign sleep myoclonus of infancy 7A86 Propriospinal myoclonus at sleep onset 7A87 Sleep-related movement disorder due to a medical condition 7A88 Sleep-related movement disorder due to a medication or substance 7A8Y Other specified sleep-related movement disorders 7A8Z Sleep-related movement disorders, unspecified 7B00 Disorders of arousal from non-REM sleep 7B00.0 Confusional arousals 7B00.1 Sleepwalking disorder 7B00.2 Sleep terrors 7B00.3 Sleep-related eating disorder 7B00.Y Other specified disorders of arousal from non-REM sleep 7B00.Z Disorders of arousal from non-REM sleep, unspecified 7B01 Parasomnias related to REM sleep 7B01.0 REM sleep behaviour disorder 7B01.1 Recurrent isolated sleep paralysis 7B01.2 Nightmare disorder 7B01.Y Other specified parasomnias related to REM sleep 7B01.Z Parasomnias related to REM sleep, unspecified 7B02 Other parasomnias 7B02.0 Hypnagogic exploding head syndrome 7B02.1 Sleep-related hallucinations 7B02.2 Parasomnia disorder due to a medical condition 7B02.3 Parasomnia disorder due to a medication or substance 7B0Y Other specified parasomnia disorders 7B0Z Parasomnia disorders, unspecified 7B2Y Other specified sleep-wake disorders 7B2Z Sleep-wake disorders, unspecified 8A00 Parkinsonism 8A00.0 Parkinson disease 8A00.1 Atypical parkinsonism 8A00.2 Secondary parkinsonism 8A00.3 Functional parkinsonism 8A00.Y Other specified parkinsonism 8A00.Z Parkinsonism, unspecified – 8A00.00 Sporadic Parkinson disease – 8A00.01 Familial Parkinson disease – 8A00.0Y Other specified Parkinson disease – 8A00.0Z Parkinson disease, unspecified – 8A00.10 Progressive supranuclear palsy – 8A00.1Y Other specified atypical parkinsonism – 8A00.1Z Atypical parkinsonism, unspecified – 8A00.20 Parkinsonism due to heredodegenerative disorders – 8A00.21 Hemiparkinsonism hemiatrophy syndrome – 8A00.22 Infectious or postinfectious parkinsonism – 8A00.23 Vascular parkinsonism – 8A00.24 Drug-induced parkinsonism – 8A00.25 Post traumatic Parkinsonism – 8A00.26 Parkinsonism due to structural lesions – 8A00.2Y Other specified secondary parkinsonism – 8A00.2Z Secondary parkinsonism, unspecified 8A01 Choreiform disorders 8A01.0 Benign hereditary chorea 8A01.1 Secondary Chorea 8A01.2 Hemichorea or hemiballismus 8A01.Y Other specified choreiform disorders 8A01.Z Choreiform disorders, unspecified – 8A01.10 Huntington disease – 8A01.11 Chorea due to Huntington disease-like conditions – 8A01.12 Chorea due to Dentatorubral pallidoluysian atrophy – 8A01.13 Chorea due to Wilson disease – 8A01.14 Chorea due to infectious or para-infectious causes – 8A01.15 Chorea due to systemic lupus erythematosus – 8A01.16 Drug-induced chorea – 8A01.1Y Other specified secondary chorea – 8A01.1Z Secondary chorea, unspecified – 8A01.20 Hemichorea – 8A01.21 Ballism – 8A01.22 Hemiballism – 8A01.2Y Other specified hemichorea or hemiballismus – 8A01.2Z Hemichorea or hemiballismus, unspecified 8A02 Dystonic disorders 8A02.0 Primary dystonia 8A02.1 Secondary dystonia 8A02.2 Paroxysmal dystonia 8A02.3 Functional dystonia or spasms 8A02.Y Other specified dystonic disorders 8A02.Z Dystonic disorders, unspecified – 8A02.00 Benign essential blepharospasm – 8A02.0Y Other specified primary dystonia – 8A02.0Z Primary dystonia, unspecified – 8A02.10 Drug-induced dystonia – 8A02.11 Dystonia-plus – 8A02.12 Dystonia associated with heredodegenerative disorders – 8A02.1Y Other specified secondary dystonia – 8A02.1Z Secondary dystonia, unspecified 8A03 Ataxic disorders 8A03.0 Congenital ataxia 8A03.1 Hereditary ataxia 8A03.2 Non-hereditary degenerative ataxia 8A03.3 Acquired ataxia 8A03.Y Other specified ataxic disorders 8A03.Z Ataxic disorders, unspecified – 8A03.10 Friedreich ataxia – 8A03.11 Ataxia due to Cerebrotendinous xanthomatosis – 8A03.12 Ataxia due to Refsum disease – 8A03.13 Ataxia due to abetalipoproteinemia – 8A03.14 Hereditary episodic ataxia – 8A03.15 Ataxia due to mitochondrial mutations – 8A03.16 Spinocerebellar ataxia – 8A03.1Y Other specified hereditary ataxia – 8A03.1Z Hereditary ataxia, unspecified – 8A03.20 Late onset cerebellar cortical atrophy – 8A03.2Y Other specified non-hereditary degenerative ataxia – 8A03.2Z Non-hereditary degenerative ataxia, unspecified – 8A03.30 Ataxia due to alcoholic cerebellar degeneration – 8A03.3Y Other specified acquired ataxia – 8A03.3Z Acquired ataxia, unspecified 8A04 Disorders associated with tremor 8A04.0 Enhanced physiological tremor 8A04.1 Essential tremor or related tremors 8A04.2 Rest tremor 8A04.3 Secondary tremor 8A04.4 Functional tremor 8A04.Y Other specified disorders associated with tremor 8A04.Z Disorders associated with tremor, unspecified – 8A04.30 Tremor due to metabolic disorders – 8A04.31 Tremor due to chronic or acute substance use – 8A04.32 Tremor due to drug withdrawal – 8A04.33 Tremor due to certain specified central nervous system diseases – 8A04.3Y Other specified secondary tremor – 8A04.3Z Secondary tremor, unspecified 8A05 Tic disorders 8A05.0 Primary tics or tic disorders 8A05.1 Secondary tics 8A05.Y Other specified tic disorders 8A05.Z Tic disorders, unspecified – 8A05.00 Tourette syndrome – 8A05.01 Chronic motor tic disorder – 8A05.02 Chronic phonic tic disorder – 8A05.03 Transient motor tics – 8A05.0Y Other specified primary tics or tic disorders – 8A05.0Z Primary tics or tic disorders, unspecified – 8A05.10 Infectious or postinfectious tics – 8A05.11 Tics associated with developmental disorders – 8A05.1Y Other specified secondary tics – 8A05.1Z Secondary tics, unspecified 8A06 Myoclonic disorders 8A06.0 Essential myoclonus 8A06.1 Segmental myoclonus 8A06.2 Focal myoclonus 8A06.Y Other specified myoclonic disorders 8A06.Z Myoclonic disorders, unspecified – 8A06.20 Palatal myoclonus – 8A06.21 Chronic hiccups – 8A06.2Y Other specified focal myoclonus – 8A06.2Z Focal myoclonus, unspecified 8A07 Certain specified movement disorder 8A07.0 Stereotypies 8A07.1 Akathisia 8A07.2 Excessive startle reflex – 8A07.00 Primary stereotypy – 8A07.01 Secondary stereotypy – 8A07.0Y Other specified stereotypies – 8A07.0Z Stereotypies, unspecified 8A0Y Other specified movement disorders 8A0Z Movement disorders, unspecified 8A20 Alzheimer disease 8A21 Progressive focal atrophies 8A21.0 Posterior cortical atrophy 8A21.Y Other specified progressive focal atrophies 8A21.Z Progressive focal atrophies, unspecified 8A22 Lewy body disease 8A23 Frontotemporal lobar degeneration 8A2Y Other specified disorders with neurocognitive impairment as a major feature 8A2Z Disorders with neurocognitive impairment as a major feature, unspecified 8A40 Multiple sclerosis 8A40.0 Relapsing-remitting multiple sclerosis 8A40.1 Primary progressive multiple sclerosis 8A40.2 Secondary progressive multiple sclerosis 8A40.Y Other specified multiple sclerosis 8A40.Z Multiple sclerosis, unspecified 8A41 Isolated demyelinating syndromes of the central nervous system 8A41.0 Transverse myelitis 8A41.1 Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive 8A41.Y Other specified isolated demyelinating syndromes of the central nervous system 8A41.Z Isolated demyelinating syndromes of the central nervous system, unspecified 8A42 Acute disseminated encephalomyelitis 8A42.0 Acute haemorrhagic leukoencephalitis 8A42.Y Other specified acute disseminated encephalomyelitis 8A42.Z Acute disseminated encephalomyelitis, unspecified 8A43 Neuromyelitis optica 8A43.0 Neuromyelitis optica aquaporin-4 antibody positive 8A43.1 Neuromyelitis optica aquaporin-4 antibody negative 8A43.2 Single transverse myelitis aquaporin-4 antibody positive 8A43.3 Recurrent transverse myelitis aquaporin-4 antibody positive 8A43.4 Single optic neuritis aquaporin-4 antibody positive 8A43.5 Recurrent optic neuritis aquaporin-4 antibody positive 8A43.Y Other specified neuromyelitis optica 8A43.Z Neuromyelitis optica, unspecified 8A44 Leukodystrophies 8A44.0 Pelizaeus-Merzbacher disease 8A44.1 Adrenoleukodystrophy 8A44.2 Alexander disease 8A44.3 Certain specified leukodystrophies 8A44.4 Krabbe disease 8A44.Z Leukodystrophies, unspecified 8A45 Secondary white matter disorders 8A45.0 White matter disorders due to infections 8A45.1 White matter disorders due to toxicity 8A45.2 White matter disorders due to vascular abnormality or ischemia 8A45.3 White matter disorders due to nutritional deficiency 8A45.4 White matter disorders due to certain specified systemic disease 8A45.Y Other specified secondary white matter disorders 8A45.Z Secondary white matter disorders, unspecified – 8A45.00 Human T-cell lymphotropic virus-associated myelopathy – 8A45.01 Subacute sclerosing panencephalitis – 8A45.02 Progressive multifocal leukoencephalopathy – 8A45.0Y Other specified white matter disorders due to infections – 8A45.0Z White matter disorders due to infections, unspecified – 8A45.20 White matter disorder due to CADASIL – 8A45.21 Subacute necrotising myelitis – 8A45.2Y Other specified white matter disorders due to vascular abnormality or ischemia – 8A45.2Z White matter disorders due to vascular abnormality or ischemia, unspecified – 8A45.30 White matter disorder due to vitamin B12 deficiency – 8A45.31 Central pontine myelinolysis – 8A45.3Y Other specified white matter disorders due to nutritional deficiency – 8A45.3Z White matter disorders due to nutritional deficiency, unspecified – 8A45.40 Demyelination due to sarcoidosis – 8A45.41 Demyelination due to systemic lupus erythematosus – 8A45.42 Demyelination due to Sjögren disease – 8A45.43 Demyelination due to Behcet disease – 8A45.44 Demyelination due to systemic vasculitis – 8A45.45 Demyelination due to mitochondrial disease – 8A45.4Z White matter disorders due to certain specified systemic disease, unspecified 8A46 Central demyelination of corpus callosum 8A4Y Other specified multiple sclerosis or other white matter disorders 8A4Z Multiple sclerosis or other white matter disorders, unspecified 8A60 Epilepsy due to structural or metabolic conditions or diseases 8A60.0 Epilepsy due to prenatal or perinatal brain insults 8A60.1 Epilepsy due to cerebrovascular disorders 8A60.2 Epilepsy due to degenerative brain disorders 8A60.3 Epilepsy due to dementias 8A60.4 Epilepsy due to central nervous system infections or infestations 8A60.5 Epilepsy due to injuries to the head 8A60.6 Epilepsy due to tumours of the nervous system 8A60.7 Epilepsy with mesial temporal sclerosis 8A60.8 Epilepsy due to immune disorders 8A60.9 Epilepsy due to abnormalities of brain development 8A60.A Epilepsy due to genetic syndromes with widespread or progressive effects 8A60.B Epilepsy due to multiple sclerosis or other demyelinating disorders 8A60.Y Epilepsy due to other structural or metabolic condition or disease 8A60.Z Epilepsy due to unspecified structural or metabolic condition or disease – 8A60.00 Epilepsy due to prenatal or perinatal vascular insults – 8A60.01 Epilepsy due to neonatal hypoxic ischemic encephalopathy – 8A60.0Y Epilepsy due to other prenatal or perinatal brain insults – 8A60.0Z Epilepsy due to unspecified prenatal or perinatal brain insults 8A61 Genetic or presumed genetic syndromes primarily expressed as epilepsy 8A61.0 Genetic epileptic syndromes with neonatal onset 8A61.1 Genetic epileptic syndromes with onset in infancy 8A61.2 Genetic epileptic syndromes with childhood onset 8A61.3 Genetic epileptic syndrome with adolescent or adult onset 8A61.4 Genetic epileptic syndromes with variable age of onset 8A61.Y Other specified genetic or presumed genetic syndromes primarily expressed as epilepsy 8A61.Z Genetic or presumed genetic syndromes primarily expressed as epilepsy, unspecified – 8A61.00 Pyridoxal dependent epilepsy – 8A61.0Y Other specified genetic epileptic syndromes with neonatal onset – 8A61.0Z Genetic epileptic syndromes with neonatal onset, unspecified – 8A61.10 Benign familial infantile epilepsy – 8A61.11 Dravet syndrome – 8A61.12 Epilepsy of infancy with migrating focal seizures – 8A61.1Y Other specified genetic epileptic syndromes with onset in infancy – 8A61.1Z Genetic epileptic syndromes with onset in infancy, unspecified – 8A61.20 Benign childhood epilepsy with centro-temporal spikes – 8A61.21 Childhood absence epilepsy – 8A61.22 Epilepsy with myoclonic-astatic seizures – 8A61.23 Myoclonic absences or absences with myoclonias – 8A61.2Y Other specified genetic epileptic syndromes with childhood onset – 8A61.2Z Genetic epileptic syndromes with childhood onset, unspecified – 8A61.30 Juvenile myoclonic epilepsy – 8A61.31 Juvenile absence epilepsy – 8A61.32 Benign adult familial myoclonus epilepsy – 8A61.3Y Other specified genetic epileptic syndrome with adolescent or adult onset – 8A61.3Z Genetic epileptic syndrome with adolescent or adult onset, unspecified – 8A61.40 Reflex epilepsies – 8A61.41 Progressive myoclonic epilepsy – 8A61.4Y Other specified genetic epileptic syndromes with variable age of onset – 8A61.4Z Genetic epileptic syndromes with variable age of onset, unspecified 8A62 Epileptic encephalopathies 8A62.0 Infantile spasms 8A62.1 Lennox-Gastaut syndrome 8A62.2 Acquired epileptic aphasia 8A62.Y Other specified epileptic encephalopathies 8A62.Z Epileptic encephalopathies, unspecified 8A63 Seizure due to acute causes 8A63.0 Febrile seizures 8A63.Y Seizure due to other acute cause 8A63.Z Seizure due to unspecified acute cause – 8A63.00 Simple febrile seizures – 8A63.01 Complex febrile seizures – 8A63.0Y Other specified febrile seizures – 8A63.0Z Febrile seizures, unspecified 8A64 Single seizure due to remote causes 8A65 Single unprovoked seizure 8A66 Status epilepticus 8A66.0 Convulsive status epilepticus 8A66.1 Non-convulsive status epilepticus 8A66.Y Other specified status epilepticus 8A66.Z Status epilepticus, unspecified – 8A66.10 Absence status epilepticus – 8A66.1Y Other specified non-convulsive status epilepticus – 8A66.1Z Non-convulsive status epilepticus, unspecified 8A67 Acute repetitive seizures 8A68 Types of seizures 8A68.0 Focal unaware seizure 8A68.1 Absence seizures, atypical 8A68.2 Absence seizures, typical 8A68.3 Focal aware seizure 8A68.4 Generalised tonic-clonic seizure 8A68.5 Generalised myoclonic seizure 8A68.6 Generalised tonic seizure 8A68.7 Generalised atonic seizure 8A68.Y Other specified type of seizure 8A68.Z Type of seizure, unspecified 8A6Y Other specified epilepsy or seizures 8A6Z Epilepsy or seizures, unspecified 8A80 Migraine 8A80.0 Migraine without aura 8A80.1 Migraine with aura 8A80.2 Chronic migraine 8A80.3 Complications related to migraine 8A80.4 Cyclic vomiting syndrome 8A80.Y Other specified migraine 8A80.Z Migraine, unspecified – 8A80.10 Hemiplegic migraine – 8A80.1Y Other specified migraine with aura – 8A80.1Z Migraine with aura, unspecified – 8A80.30 Status migrainosus – 8A80.3Y Other specified complications related to migraine 8A81 Tension-type headache 8A81.0 Infrequent episodic tension-type headache 8A81.1 Frequent episodic tension-type headache 8A81.2 Chronic tension-type headache 8A81.Y Other specified tension-type headache 8A81.Z Tension-type headache, unspecified 8A82 Trigeminal autonomic cephalalgias 8A83 Other primary headache disorder 8A84 Secondary headache 8A84.0 Acute headache associated with traumatic injury to the head 8A84.1 Persistent headache associated with traumatic injury to the head 8A84.Y Other specified secondary headache 8A84.Z Secondary headache, unspecified 8A85 Painful cranial neuropathies or other facial pains 8A8Y Other specified headache disorders 8A8Z Headache disorders, unspecified 8B00 Intracerebral haemorrhage – 8B00.0 Deep hemispheric haemorrhage – 8B00.1 Lobar haemorrhage – 8B00.2 Brainstem haemorrhage – 8B00.3 Cerebellar haemorrhage – 8B00.4 Intraventricular haemorrhage without parenchymal haemorrhage – 8B00.5 Haemorrhage of multiple sites – 8B00.Z Intracerebral haemorrhage, site unspecified 8B01 Subarachnoid haemorrhage – 8B01.0 Aneurysmal subarachnoid haemorrhage – 8B01.1 Non-aneurysmal subarachnoid haemorrhage – 8B01.2 Subarachnoid haemorrhage not known if aneurysmal or non-aneurysmal 8B02 Nontraumatic subdural haemorrhage 8B03 Nontraumatic epidural haemorrhage 8B0Z Intracranial haemorrhage, unspecified 8B10 Transient ischaemic attack – 8B10.0 Amaurosis fugax – 8B10.Y Other specified transient ischaemic attack – 8B10.Z Transient ischaemic attack, unspecified 8B11 Cerebral ischaemic stroke – 8B11.0 Cerebral ischaemic stroke due to extracranial large artery atherosclerosis – 8B11.1 Cerebral ischaemic stroke due to intracranial large artery atherosclerosis – 8B11.2 Cerebral ischaemic stroke due to embolic occlusion – 8B11.3 Cerebral ischaemic stroke due to small artery occlusion – 8B11.4 Cerebral ischaemic stroke due to other known cause – 8B11.5 Cerebral ischaemic stroke of unknown cause –– 8B11.20 Cerebral ischaemic stroke due to cardiac embolism –– 8B11.21 Cerebral ischaemic stroke due to aortic arch embolism –– 8B11.22 Cerebral ischaemic stroke due to paradoxical embolism –– 8B11.2Y Cerebral ischaemic stroke due to other specified embolic occlusion –– 8B11.2Z Cerebral ischaemic stroke due to embolic occlusion, unspecified –– 8B11.40 Cerebral ischaemic stroke due to global hypoperfusion with watershed infarct –– 8B11.41 Cerebral ischaemic stroke due to other non-atherosclerotic arteriopathy –– 8B11.42 Cerebral ischaemic stroke due to hypercoagulable state –– 8B11.43 Cerebral ischaemic stroke in association with subarachnoid haemorrhage –– 8B11.44 Cerebral ischemic stroke from dissection –– 8B11.50 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of extracranial large artery –– 8B11.51 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of intracranial large artery –– 8B11.5Z Cerebral ischaemic stroke, unspecified 8B1Y Other specified cerebral ischaemia 8B1Z Cerebral ischaemia, unspecified 8B20 Stroke not known if ischaemic or haemorrhagic 8B21 Cerebrovascular disease with no acute cerebral symptom 8B21.0 Silent cerebral infarct 8B21.1 Silent cerebral microbleed 8B21.Y Other specified cerebrovascular disease with no acute cerebral symptom 8B21.Z Cerebrovascular disease with no acute cerebral symptom, unspecified 8B22 Certain specified cerebrovascular diseases 8B22.0 Dissection of cerebral arteries 8B22.1 Cerebral venous thrombosis 8B22.2 Cerebral vasoconstriction syndromes 8B22.3 Isolated cerebral amyloid angiopathy 8B22.4 Intracranial vascular malformation 8B22.5 Cerebral aneurysm, nonruptured 8B22.6 Familial cerebral saccular aneurysm 8B22.7 Cerebral arteritis, not elsewhere classified 8B22.8 Hypertensive encephalopathy 8B22.9 Migraine-induced stroke 8B22.A Subclavian steal syndrome 8B22.B Moyamoya syndrome 8B22.C Hereditary cerebrovascular diseases 8B22.Y Other specified cerebrovascular disease – 8B22.40 Arteriovenous malformation of cerebral vessels – 8B22.41 Cerebral cavernous malformation – 8B22.42 Dural arteriovenous fistula – 8B22.43 Carotid cavernous fistula – 8B22.4Y Other specified intracranial vascular malformation – 8B22.4Z Intracranial vascular malformation, unspecified – 8B22.70 Primary cerebral arteritis – 8B22.7Y Other specified cerebral arteritis, not elsewhere classified – 8B22.7Z Cerebral arteritis, not elsewhere classified, unspecified – 8B22.C0 CADASIL - [cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome – 8B22.C1 CARASIL - [cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome – 8B22.CY Other specified hereditary cerebrovascular diseases – 8B22.CZ Hereditary cerebrovascular diseases, unspecified 8B23 Cerebrovascular abnormalities 8B24 Hypoxic-ischaemic encephalopathy 8B24.0 Anoxic-ischaemic encephalopathy 8B24.Y Other specified hypoxic-ischaemic encephalopathy 8B24.Z Hypoxic-ischaemic encephalopathy, unspecified 8B25 Late effects of cerebrovascular disease 8B25.0 Late effects of cerebral ischemic stroke 8B25.1 Late effects of intracerebral haemorrhage 8B25.2 Late effects of subarachnoid haemorrhage 8B25.3 Late effects of other nontraumatic intracranial haemorrhage 8B25.4 Late effects of stroke not known if ischaemic or haemorrhagic 8B25.Y Late effects of other specified cerebrovascular disease 8B25.Z Late effects of cerebrovascular disease, unspecified 8B26 Vascular syndromes of brain in cerebrovascular diseases 8B26.0 Brainstem stroke syndrome 8B26.1 Cerebellar stroke syndrome 8B26.2 Middle cerebral artery syndrome 8B26.3 Anterior cerebral artery syndrome 8B26.4 Posterior cerebral artery syndrome 8B26.5 Lacunar syndromes 8B26.Y Other specified vascular syndromes of brain in cerebrovascular diseases 8B26.Z Vascular syndromes of brain in cerebrovascular diseases, unspecified – 8B26.50 Pure motor lacunar syndrome – 8B26.51 Pure sensory lacunar syndrome – 8B26.5Y Other specified lacunar syndromes – 8B26.5Z Lacunar syndromes, unspecified 8B2Z Cerebrovascular diseases, unspecified 8B40 Cauda equina syndrome 8B41 Myelitis 8B42 Myelopathy 8B43 Non-compressive vascular myelopathies 8B43.0 Acute arterial infarction of the spinal cord 8B43.1 Acute venous infarction of the spinal cord 8B43.2 Chronic venous infarction of the spinal cord 8B43.Y Other specified non-compressive vascular myelopathies 8B43.Z Non-compressive vascular myelopathies, unspecified 8B44 Degenerative myelopathic disorders 8B44.0 Hereditary spastic paraplegia 8B44.Y Other specified degenerative myelopathic disorders 8B44.Z Degenerative myelopathic disorders, unspecified – 8B44.00 Autosomal dominant hereditary spastic paraplegia – 8B44.01 Autosomal recessive hereditary spastic paraplegia – 8B44.02 X-linked hereditary spastic paraplegia – 8B44.0Y Other specified hereditary spastic paraplegia – 8B44.0Z Hereditary spastic paraplegia, unspecified 8B4Y Other specified spinal cord disorders excluding trauma 8B4Z Spinal cord disorders excluding trauma, unspecified 8B60 Motor neuron disease 8B60.0 Amyotrophic lateral sclerosis 8B60.1 Progressive bulbar palsy 8B60.2 Progressive pseudobulbar palsy 8B60.3 Progressive muscular atrophy 8B60.4 Primary lateral sclerosis 8B60.5 Amyotrophic lateral sclerosis-Plus 8B60.6 Monomelic amyotrophy 8B60.7 Madras type motor neuron disease 8B60.Y Other specified motor neuron disease 8B60.Z Motor neuron disease, unspecified 8B61 Spinal muscular atrophy 8B61.0 Infantile spinal muscular atrophy, Type I 8B61.1 Late infantile spinal muscular atrophy, Type II 8B61.2 Juvenile form spinal muscular dystrophy, Type III 8B61.3 Adult onset spinal muscular atrophy, Type IV 8B61.4 Localised spinal muscular atrophy 8B61.Y Other specified spinal muscular atrophy 8B61.Z Spinal muscular atrophy, unspecified 8B62 Post polio progressive muscular atrophy 8B6Y Other specified motor neuron diseases or related disorders 8B6Z Motor neuron diseases or related disorders, unspecified 8B80 Disorders of olfactory nerve 8B81 Disorders of vestibulocochlear nerve – 8B81.0 Brainstem lesion – 8B81.Y Other specified disorders of vestibulocochlear nerve – 8B81.Z Disorders of vestibulocochlear nerve, unspecified 8B82 Disorders of trigeminal nerve – 8B82.0 Trigeminal neuralgia – 8B82.Z Disorders of trigeminal nerve, unspecified 8B83 Disorders of spinal accessory nerve 8B84 Disorders of hypoglossal nerve 8B85 Disorders of multiple cranial nerves 8B86 Disorders of vagus nerve 8B87 Disorders of glossopharyngeal nerve 8B88 Disorders of facial nerve – 8B88.0 Bell palsy – 8B88.1 Facial myokymia – 8B88.2 Hemifacial spasm – 8B88.3 Facial neuritis – 8B88.Y Other specified disorders of facial nerve – 8B88.Z Disorders of facial nerve, unspecified 8B8Y Other specified disorders of cranial nerves 8B8Z Disorders of cranial nerves, unspecified 8B90 Nerve root and plexus compressions 8B91 Brachial plexus disorders – 8B91.0 Neuralgic shoulder amyotrophy – 8B91.1 Thoracic outlet syndrome due to cervical rib – 8B91.Y Other specified brachial plexus disorders – 8B91.Z Brachial plexus disorders, unspecified 8B92 Lumbosacral plexus disorders – 8B92.0 Post radiation lumbosacral plexopathy – 8B92.1 Vasculitic lumbosacral plexopathy – 8B92.2 Diabetic lumbosacral plexopathy – 8B92.3 Lumbosacral radiculoplexopathy – 8B92.Y Other specified lumbosacral plexus disorders – 8B92.Z Lumbosacral plexus disorders, unspecified 8B93 Radiculopathy – 8B93.0 Radiculopathy due to compression – 8B93.1 Radiculopathy due to metabolic disorders – 8B93.2 Radiculopathy due to electric shock or lightning – 8B93.3 Radiculopathy due to radiation injury – 8B93.4 Radiculopathy due to nutritional deficiencies – 8B93.5 Radiculopathy due to toxicity – 8B93.6 Radiculopathy due to intervertebral disc disorders – 8B93.7 Radiculopathy due to neoplastic disease – 8B93.8 Radiculopathy due to spondylosis – 8B93.Y Other specified radiculopathy – 8B93.Z Radiculopathy, unspecified 8B94 Diabetic radiculoplexoneuropathy 8B95 Secondary brachial plexus lesion due to certain specified disorders 8B9Y Other specified nerve root or plexus disorders 8B9Z Nerve root or plexus disorders, unspecified 8C00 Idiopathic progressive neuropathy 8C01 Inflammatory polyneuropathy – 8C01.0 Acute inflammatory demyelinating polyneuropathy – 8C01.1 Post vaccinal neuropathy – 8C01.2 Subacute inflammatory demyelinating polyneuropathy – 8C01.3 Chronic inflammatory demyelinating polyneuropathy – 8C01.Y Other specified inflammatory polyneuropathy – 8C01.Z Inflammatory polyneuropathy, unspecified 8C03 Other secondary polyneuropathy – 8C03.0 Diabetic polyneuropathy – 8C03.1 Polyneuropathy due to infectious diseases – 8C03.2 Polyneuropathy in neoplastic disease – 8C03.3 Polyneuropathy in nutritional deficiency – 8C03.4 Polyneuropathy in systemic connective tissue disorders – 8C03.Y Other specified secondary polyneuropathy – 8C03.Z Other secondary polyneuropathy, unspecified 8C0Y Other specified polyneuropathy 8C0Z Polyneuropathy, unspecified 8C10 Mononeuropathies of upper limb – 8C10.0 Carpal tunnel syndrome – 8C10.1 Lesion of ulnar nerve – 8C10.2 Lesion of radial nerve – 8C10.Y Other specified mononeuropathies of upper limb – 8C10.Z Mononeuropathies of upper limb, unspecified 8C11 Mononeuropathies of lower limb – 8C11.0 Lesion of sciatic nerve – 8C11.1 Meralgia paraesthetica – 8C11.2 Lesion of femoral nerve – 8C11.3 Lesion of common peroneal nerve – 8C11.4 Lesion of tibial nerve – 8C11.5 Tarsal tunnel syndrome – 8C11.6 Lesion of plantar nerve – 8C11.Y Other specified mononeuropathies of lower limb – 8C11.Z Mononeuropathies of lower limb, unspecified –– 8C11.00 Sciatic nerve piriformis syndrome –– 8C11.0Y Other specified lesion of sciatic nerve –– 8C11.0Z Lesion of sciatic nerve, unspecified 8C12 Certain specified mononeuropathies – 8C12.0 Intercostal neuropathy – 8C12.1 Mononeuritis multiplex – 8C12.2 Lesion of suprascapular nerve – 8C12.3 Lesion of axillary nerve – 8C12.4 Lesion of long thoracic nerve – 8C12.5 Traumatic neuroma, not otherwise specified – 8C12.Y Mononeuropathy of other specified nerve 8C1Y Mononeuropathy of other specified site 8C1Z Mononeuropathy of unspecified site 8C20 Hereditary motor and sensory neuropathy – 8C20.0 Charcot-Marie-Tooth disease 1 demyelinating – 8C20.1 Charcot-Marie-Tooth disease 2 axonal – 8C20.2 Intermediate Charcot-Marie-Tooth disease – 8C20.Y Other specified hereditary motor and sensory neuropathy – 8C20.Z Hereditary motor and sensory neuropathy, unspecified 8C21 Hereditary sensory or autonomic neuropathy – 8C21.0 Hereditary sensory and autonomic neuropathy type I – 8C21.1 Hereditary sensory and autonomic neuropathy type III – 8C21.2 Hereditary sensory and autonomic neuropathy type IV – 8C21.3 Hereditary sensory and autonomic neuropathy type V – 8C21.Y Other specified hereditary sensory or autonomic neuropathy – 8C21.Z Hereditary sensory or autonomic neuropathy, unspecified 8C2Y Other specified hereditary neuropathy 8C2Z Hereditary neuropathy, unspecified 8C4Y Other specified disorders of nerve root, plexus or peripheral nerves 8C4Z Disorders of nerve root, plexus or peripheral nerves, unspecified 8C60 Myasthenia gravis – 8C60.0 Drug-induced myasthenia gravis – 8C60.Y Other specified myasthenia gravis – 8C60.Z Myasthenia gravis, unspecified 8C61 Congenital myasthenic syndromes 8C62 Lambert-Eaton syndrome 8C6Y Other specified myasthenia gravis and neuromuscular junction disorders 8C6Z Unspecified myasthenia gravis or neuromuscular junction disorders 8C70 Muscular dystrophy – 8C70.0 Becker muscular dystrophy – 8C70.1 Duchenne muscular dystrophy – 8C70.2 Emery-Dreifuss muscular dystrophy – 8C70.3 Facioscapulohumeral muscular dystrophy – 8C70.4 Limb-girdle muscular dystrophy – 8C70.5 Scapuloperoneal muscular dystrophy – 8C70.6 Congenital muscular dystrophy – 8C70.Y Other specified muscular dystrophy – 8C70.Z Muscular dystrophy, unspecified –– 8C70.40 Dominant limb-girdle muscular dystrophy –– 8C70.41 Recessive limb-girdle muscular dystrophy –– 8C70.4Y Other specified limb-girdle muscular dystrophy –– 8C70.4Z Limb-girdle muscular dystrophy, unspecified 8C71 Myotonic disorders – 8C71.0 Myotonic dystrophy – 8C71.1 Chondrodystrophic myotonia – 8C71.2 Myotonia congenita – 8C71.3 Drug-induced myotonia – 8C71.4 Neuromyotonia – 8C71.5 Pseudomyotonia – 8C71.Y Other specified myotonic disorders – 8C71.Z Myotonic disorders, unspecified 8C72 Congenital myopathies – 8C72.0 Congenital myopathy with structural abnormalities – 8C72.1 Congenital myopathy with no structural abnormalities – 8C72.Y Other specified congenital myopathies – 8C72.Z Congenital myopathies, unspecified –– 8C72.00 Nemaline myopathy –– 8C72.01 Centronuclear myopathy –– 8C72.02 Central core disease –– 8C72.0Y Other specified congenital myopathy with structural abnormalities –– 8C72.0Z Congenital myopathy with structural abnormalities, unspecified 8C73 Mitochondrial myopathies – 8C73.0 Autosomal recessive cardiomyopathy or ophthalmoplegia – 8C73.1 Neuropathy, ataxia, and retinitis pigmentosa – 8C73.Y Other specified mitochondrial myopathies – 8C73.Z Mitochondrial myopathies, unspecified 8C74 Periodic paralyses or disorders of muscle membrane excitability – 8C74.0 Paramyotonia congenita – 8C74.1 Periodic paralysis – 8C74.Y Other specified periodic paralyses or disorders of muscle membrane excitability – 8C74.Z Periodic paralyses or disorders of muscle membrane excitability, unspecified –– 8C74.10 Hypokalaemic periodic paralysis –– 8C74.11 Hyperkalaemic periodic paralysis –– 8C74.1Y Other specified periodic paralysis –– 8C74.1Z Periodic paralysis, unspecified 8C75 Distal myopathies 8C76 Myofibrillar myopathy 8C77 Ocular myopathy 8C78 Malignant hyperthermia or hyperpyrexia 8C7Y Other specified primary disorders of muscles 8C7Z Primary disorders of muscles, unspecified 8C80 Drug-induced myopathy 8C81 Autoimmune myopathy 8C82 Myopathy in certain specified infectious or parasitic disease 8C83 Myopathy in certain specified endocrine disease 8C84 Secondary rhabdomyolysis 8C8Y Other specified secondary myopathies 8C8Z Secondary myopathies, unspecified 8D0Y Other specified diseases of neuromuscular junction or muscle 8D0Z Diseases of neuromuscular junction or muscle, unspecified 8D20 Spastic cerebral palsy 8D20.0 Spastic unilateral cerebral palsy 8D20.1 Spastic bilateral cerebral palsy 8D20.Y Other specified spastic cerebral palsy 8D20.Z Spastic cerebral palsy, unspecified – 8D20.10 Spastic quadriplegic cerebral palsy – 8D20.11 Spastic diplegic cerebral palsy – 8D20.1Z Spastic bilateral cerebral palsy, unspecified 8D21 Dyskinetic cerebral palsy 8D22 Ataxic cerebral palsy 8D23 Worster-Drought syndrome 8D2Y Other specified cerebral palsy 8D2Z Cerebral palsy, unspecified 8D40 Neurological disorders due to nutrient deficiency 8D40.0 Encephalopathy due to nutritional deficiency 8D40.1 Neuropathy due to nutritional deficiency 8D40.2 Myopathy due to nutritional deficiency 8D40.3 Intellectual developmental disorder due to nutritional deficiency 8D40.Y Other specified neurological disorders due to nutrient deficiency 8D40.Z Neurological disorders due to nutrient deficiency, unspecified 8D41 Neurological disorders due to an excess of micro or macro nutrients 8D41.0 Peripheral neuropathy due to vitamin B6 hyperalimentation 8D41.1 Myopathy due to hypercalcaemia 8D41.2 Pseudotumour Cerebri related to Hypervitaminosis A 8D41.Y Other specified neurological disorders due to an excess of micro or macro nutrients 8D41.Z Neurological disorders due to an excess of micro or macro nutrients, unspecified 8D42 Neurological disorders due to overweight or obesity in adults or children 8D43 Neurological disorders due to toxicity 8D43.0 Encephalopathy due to toxicity 8D43.1 Cognitive impairment due to toxicity 8D43.2 Neuropathy due to toxicity 8D43.3 Myopathy due to toxicity 8D43.4 Movement disorders due to toxicity 8D43.5 Cassava poisoning 8D43.Y Other specified neurological disorders due to toxicity 8D43.Z Neurological disorders due to toxicity, unspecified – 8D43.00 Encephalopathy due to ammonia – 8D43.0Y Other specified encephalopathy due to toxicity – 8D43.0Z Encephalopathy due to toxicity, unspecified – 8D43.20 Drug-induced polyneuropathy – 8D43.21 Post radiation polyneuropathy – 8D43.2Y Other specified neuropathy due to toxicity – 8D43.2Z Neuropathy due to toxicity, unspecified 8D44 Alcohol-related neurological disorders 8D44.0 Alcoholic polyneuropathy 8D44.1 Alcoholic myopathy 8D44.Y Other specified alcohol-related neurological disorders 8D44.Z Alcohol-related neurological disorders, unspecified 8D4Y Other specified nutritional or toxic disorders of the nervous system 8D4Z Nutritional or toxic disorders of the nervous system, unspecified 8D60 Increased intracranial pressure 8D60.0 Brain herniation syndromes 8D60.1 Cerebral oedema 8D60.Y Other specified increased intracranial pressure 8D60.Z Increased intracranial pressure, unspecified 8D61 Intracranial hypotension 8D61.0 Spontaneous intracranial hypotension 8D61.1 Secondary intracranial hypotension 8D61.Y Other specified intracranial hypotension 8D61.Z Intracranial hypotension, unspecified 8D62 Cerebrospinal fluid rhinorrhoea 8D63 Cerebrospinal fluid otorrhoea 8D64 Hydrocephalus 8D64.0 Communicating hydrocephalus 8D64.1 Non-communicating hydrocephalus 8D64.2 Ex-vacuo hydrocephalus 8D64.Z Hydrocephalus, unspecified – 8D64.00 Increased cerebrospinal fluid production – 8D64.01 Congenital agenesis of arachnoid villi – 8D64.02 Post haemorrhagic hydrocephalus – 8D64.03 Post traumatic hydrocephalus – 8D64.04 Normal-pressure hydrocephalus – 8D64.0Y Other specified communicating hydrocephalus – 8D64.0Z Communicating hydrocephalus, unspecified – 8D64.10 Hydrocephalus due to structural malformations – 8D64.1Y Other specified non-communicating hydrocephalus – 8D64.1Z Non-communicating hydrocephalus, unspecified 8D65 Cerebrospinal fluid fistula 8D66 Syringomyelia or syringobulbia 8D66.0 Idiopathic syringomyelia 8D66.1 Syringomyelia due to certain specified cause 8D66.2 Syringobulbia 8D66.Y Other specified syringomyelia or syringobulbia 8D66.Z Syringomyelia or syringobulbia, unspecified 8D67 Intracranial arachnoid cyst 8D68 Porencephalic cyst 8D6Y Other specified disorders of cerebrospinal fluid pressure or flow 8D6Z Disorders of cerebrospinal fluid pressure or flow, unspecified 8D80 Congenital malformations of the autonomic nervous system 8D81 Inherited autonomic nervous system disorders 8D82 Autoimmune disorders involving the autonomic nervous system 8D83 Autonomic nervous system disorder due to infection 8D84 Pure autonomic nervous system failure 8D85 Autonomic nervous system disorder due to substances 8D86 Autonomic nervous system hyperactivity 8D87 Autonomic nervous system disorder due to certain specified neurodegenerative disorder 8D87.0 Multiple system atrophy 8D87.Y Other specified autonomic nervous system disorder due to specified neurodegenerative disorder – 8D87.00 Multiple system atrophy, Cerebellar type – 8D87.01 Multiple system atrophy, Parkinsonism – 8D87.0Y Other specified multiple system atrophy – 8D87.0Z Multiple system atrophy, unspecified 8D88 Autonomic neuropathies 8D88.0 Autonomic neuropathy due to sodium channelopathies 8D88.1 Autonomic neuropathy due to diabetes mellitus 8D88.2 Immune mediated autonomic neuropathy 8D88.3 Autonomic disorder due to toxins 8D88.4 Autonomic neuropathy in endocrine and metabolic diseases 8D88.Y Other specified autonomic neuropathies 8D88.Z Autonomic neuropathies, unspecified 8D89 Disorders of orthostatic tolerance 8D89.0 Reflex syncope 8D89.1 Syncope due to autonomic failure 8D89.2 Postural orthostatic tachycardia syndrome 8D89.3 Baroreflex failure 8D89.Y Other specified disorders of orthostatic tolerance 8D89.Z Disorders of orthostatic tolerance, unspecified 8D8A Focal or segmental autonomic disorders 8D8A.1 Horner syndrome 8D8A.2 Episodic anisocoria 8D8A.Y Other specified focal or segmental autonomic disorders 8D8A.Z Focal or segmental autonomic disorders, unspecified 8D8B Disorders affecting autonomic synaptic neurotransmission 8D8C Autonomic dysreflexia 8D8D Hypoglycaemia unawareness 8D8Y Other specified disorders of autonomic nervous system 8D8Z Disorders of autonomic nervous system, unspecified 8E00 Sporadic Creutzfeldt-Jakob Disease 8E01 Acquired prion disease 8E01.0 Iatrogenically acquired Creutzfeldt-Jakob Disease 8E01.1 Kuru 8E01.2 Variant Creutzfeldt-Jakob Disease 8E01.3 Other acquired Creutzfeldt-Jakob Disease 8E01.Z Acquired prion disease, unspecified 8E02 Genetic prion diseases 8E02.0 Genetic Creutzfeldt-Jakob disease 8E02.1 Gerstmann-Straussler-Scheinker syndrome 8E02.2 Fatal familial insomnia 8E02.3 Other genetic prion diseases 8E02.Y Other specified Creutzfeldt-Jakob disease 8E02.Z Creutzfeldt-Jakob disease, unspecified 8E03 Variably protease sensitive prionopathy 8E0Y Other specified human prion diseases 8E0Z Human prion diseases, unspecified 8E20 Persistent vegetative state 8E21 Permanent vegetative state 8E22 Minimally conscious state 8E22.0 Minimally conscious state plus 8E22.1 Minimally conscious state minus 8E22.Y Other specified minimally conscious state 8E22.Z Minimally conscious state, unspecified 8E2Y Other specified disorders of consciousness 8E2Z Disorders of consciousness, unspecified 8E40 Disorders of the meninges excluding infection 8E40.0 Neoplastic meningitis 8E40.1 Chemical meningitis 8E40.2 Inflammatory meningitis 8E40.3 Arachnoiditis 8E40.Y Other specified disorders of the meninges excluding infection 8E40.Z Disorders of the meninges excluding infection, unspecified 8E41 Pachymeningitis 8E41.0 Pachymeningitis due to infection 8E41.1 Idiopathic hypertrophic pachymeningitis 8E41.Y Other specified pachymeningitis 8E41.Z Pachymeningitis, unspecified 8E42 Superficial siderosis of the nervous system 8E43 Pain disorders 8E43.0 Neuropathic pain 8E43.Y Other specified pain disorders 8E43.Z Pain disorders, unspecified – 8E43.00 Phantom limb syndrome – 8E43.0Y Other specified neuropathic pain – 8E43.0Z Neuropathic pain, unspecified 8E44 Post anoxic brain damage 8E45 Locked-in syndrome 8E46 Reye syndrome 8E47 Encephalopathy, not elsewhere classified 8E48 Encephalitis, not elsewhere classified 8E49 Postviral fatigue syndrome 8E4A Paraneoplastic or autoimmune disorders of the nervous system 8E4A.0 Paraneoplastic or autoimmune disorders of the central nervous system, brain or spinal cord 8E4A.1 Paraneoplastic or autoimmune disorders of the peripheral or autonomic nervous system 8E4A.2 Paraneoplastic or autoimmune neuromuscular transmission disorders 8E4A.3 Paraneoplastic or autoimmune disorders of the muscle 8E4A.Y Other specified paraneoplastic or autoimmune disorders of the nervous system 8E4A.Z Paraneoplastic or autoimmune disorders of the nervous system, unspecified 8E4Y Other specified disorders of the nervous system 8E60 Post ventricular shunting leak 8E61 Post radiation injury of the nervous system 8E61.0 Radiation-induced brain injury 8E61.1 Spinal cord irradiation 8E61.Z Post radiation injury of the nervous system, unspecified 8E62 Postprocedural meningitis 8E63 Post pump encephalopathy 8E64 Multifocal cerebral infarctions 8E66 Intracranial hypotension due to lumbar puncture 8E7Y Other specified diseases of the nervous system 8E7Z Diseases of the nervous system, unspecified 9A00 Congenital malposition of eyelids – 9A00.0 Dystopia canthorum – 9A00.1 Telecanthus – 9A00.Y Other specified congenital malposition of eyelids – 9A00.Z Congenital malposition of eyelids, unspecified 9A01 Infectious disorders of eyelid – 9A01.0 Preseptal cellulitis – 9A01.1 Abscess of eyelid – 9A01.2 Hordeolum – 9A01.3 Infectious blepharitis – 9A01.4 Infestation of eyelid – 9A01.Y Other specified infectious disorders of eyelid – 9A01.Z Unspecified infectious disorders of eyelid –– 9A01.20 Hordeolum externum –– 9A01.21 Hordeolum internum –– 9A01.2Z Hordeolum, unspecified 9A02 Inflammatory disorders of eyelid – 9A02.0 Chalazion – 9A02.1 Posterior blepharitis – 9A02.2 Ligneous conjunctivitis – 9A02.4 Meibomian gland dysfunction – 9A02.Y Other specified inflammatory disorders of eyelid – 9A02.Z Inflammatory disorders of eyelid, unspecified –– 9A02.00 Chalazion externum –– 9A02.01 Chalazion internum –– 9A02.0Y Other specified chalazion –– 9A02.0Z Chalazion, unspecified 9A03 Acquired malposition of eyelid – 9A03.0 Blepharoptosis – 9A03.1 Entropion of eyelid – 9A03.2 Ectropion of eyelid – 9A03.3 Eyelid retraction – 9A03.4 Lagophthalmos – 9A03.5 Dermatochalasis of eyelid – 9A03.Y Other specified acquired malposition of eyelid – 9A03.Z Acquired malposition of eyelid, unspecified –– 9A03.00 Marcus-Gunn syndrome –– 9A03.01 Mechanical ptosis of eyelid –– 9A03.02 Myogenic ptosis of eyelid –– 9A03.03 Paralytic ptosis of eyelid –– 9A03.0Y Other specified blepharoptosis –– 9A03.0Z Blepharoptosis, unspecified –– 9A03.10 Cicatricial entropion of eyelid –– 9A03.11 Mechanical entropion of eyelid –– 9A03.12 Senile entropion of eyelid –– 9A03.13 Spastic entropion of eyelid –– 9A03.1Y Other specified entropion of eyelid –– 9A03.1Z Entropion of eyelid, unspecified –– 9A03.20 Cicatricial ectropion of eyelid –– 9A03.21 Mechanical ectropion of eyelid –– 9A03.22 Senile ectropion of eyelid –– 9A03.23 Spastic ectropion of eyelid –– 9A03.24 Floppy eyelid syndrome –– 9A03.2Y Other specified ectropion of eyelid –– 9A03.2Z Ectropion of eyelid, unspecified –– 9A03.40 Cicatricial lagophthalmos –– 9A03.41 Mechanical lagophthalmos –– 9A03.42 Paralytic lagophthalmos –– 9A03.4Y Other specified lagophthalmos –– 9A03.4Z Lagophthalmos, unspecified 9A04 Acquired disorders of eyelashes – 9A04.0 Trichiasis without entropion – 9A04.1 Madarosis of eyelid or periocular area – 9A04.Y Other specified acquired disorders of eyelashes – 9A04.Z Acquired disorders of eyelashes, unspecified 9A05 Movement disorders of eyelid – 9A05.0 Myokymia of eyelid – 9A05.1 Eyelid apraxia – 9A05.Y Other specified movement disorders of eyelid – 9A05.Z Movement disorders of eyelid, unspecified 9A06 Certain specified disorders of eyelid – 9A06.0 Involvement of eyelid by dermatosis classified elsewhere – 9A06.1 Vitiligo of eyelid or periocular area – 9A06.2 Symblepharon, acquired – 9A06.3 Traumatic scar of eyelid – 9A06.4 Xanthelasma of eyelid – 9A06.5 Tear Trough Deformity – 9A06.6 Sunken Sulcus Deformity – 9A06.7 Dermatitis or eczema of eyelids – 9A06.8 Blepharochalasis – 9A06.Y Other specified disorders of eyelid –– 9A06.70 Atopic eczema of eyelids –– 9A06.71 Seborrhoeic dermatitis of eyelids –– 9A06.72 Allergic contact blepharoconjunctivitis –– 9A06.7Y Other specified dermatitis or eczema of eyelids –– 9A06.7Z Dermatitis or eczema of eyelids, type unspecified 9A0Y Other specified disorders of eyelid or peri-ocular area 9A0Z Disorders of eyelid or peri-ocular area, unspecified 9A10 Disorders of lacrimal gland – 9A10.0 Infections of the lacrimal gland – 9A10.1 Orbital inflammatory syndrome – 9A10.2 Benign lymphoepithelial lesion of lacrimal gland – 9A10.3 Hyperlacrimation – 9A10.4 Underproduction of tears – 9A10.Y Other specified disorders of lacrimal gland – 9A10.Z Disorders of lacrimal gland, unspecified 9A11 Disorders of lacrimal drainage system – 9A11.0 Eversion of lacrimal punctum – 9A11.1 Canaliculitis – 9A11.2 Dacryocystitis – 9A11.3 Conjunctivochalasis – 9A11.4 Punctal stenosis – 9A11.5 Nasolacrimal canalicular stenosis – 9A11.6 Dacryolith – 9A11.7 Nasolacrimal sac stenosis – 9A11.8 Nasolacrimal duct obstruction – 9A11.Y Other specified disorders of lacrimal drainage system – 9A11.Z Disorders of lacrimal drainage system, unspecified 9A1Y Other specified disorders of lacrimal apparatus 9A1Z Disorders of lacrimal apparatus, unspecified 9A20 Displacement of eyeball – 9A20.0 Axial displacement of eyeball – 9A20.1 Non-axial displacement of eyeball – 9A20.Y Other specified displacement of eyeball – 9A20.Z Displacement of eyeball, unspecified –– 9A20.00 Outward displacement of eyeball –– 9A20.01 Inward displacement of eyeball –– 9A20.0Y Other specified axial displacement of eyeball –– 9A20.0Z Axial displacement of eyeball, unspecified 9A21 Orbital infection – 9A21.0 Orbital cellulitis – 9A21.1 Orbital subperiosteal abscess – 9A21.2 Orbital abscess – 9A21.3 Periostitis of orbit – 9A21.Y Other specified orbital infection – 9A21.Z Orbital infection, unspecified 9A22 Orbital inflammation – 9A22.0 Dysthyroid orbitopathy – 9A22.1 Diffuse orbital inflammation – 9A22.2 Granulomatous orbital inflammation – 9A22.Y Other specified orbital inflammation – 9A22.Z Orbital inflammation, unspecified 9A23 Orbital cyst – 9A23.0 Congenital orbital cyst – 9A23.1 Acquired orbital cyst – 9A23.Z Orbital cyst, unspecified 9A24 Bony deformity of orbit – 9A24.0 Contraction of orbit – 9A24.1 Expansion of orbit – 9A24.2 Distortion of orbit – 9A24.3 Enlargement of bony orbit – 9A24.4 Exostosis of orbit – 9A24.Y Other specified bony deformity of orbit – 9A24.Z Bony deformity of orbit, unspecified 9A25 Soft tissue deformity of orbit – 9A25.0 Anophthalmic socket – 9A25.1 Microphthalmic socket – 9A25.2 Contracted socket – 9A25.3 Oedema of orbit – 9A25.4 Haemorrhage of orbit – 9A25.5 Atrophy of soft tissue of orbit – 9A25.Y Other specified soft tissue deformity of orbit – 9A25.Z Soft tissue deformity of orbit, unspecified 9A26 Combined bony and soft tissue deformity of orbit 9A2Y Other specified disorders of orbit 9A2Z Disorders of orbit, unspecified 9A4Y Other specified disorders of the ocular adnexa or orbit 9A4Z Disorders of the ocular adnexa or orbit, unspecified 9A60 Conjunctivitis – 9A60.0 Papillary conjunctivitis – 9A60.1 Follicular conjunctivitis – 9A60.2 Cicatrizing conjunctivitis – 9A60.3 Mucopurulent conjunctivitis – 9A60.4 Blepharoconjunctivitis – 9A60.5 Vernal keratoconjunctivitis – 9A60.6 Serous conjunctivitis, except viral – 9A60.Y Other specified conjunctivitis – 9A60.Z Conjunctivitis, unspecified –– 9A60.00 Giant papillary conjunctivitis –– 9A60.01 Acute atopic conjunctivitis –– 9A60.02 Allergic conjunctivitis –– 9A60.0Y Other specified papillary conjunctivitis –– 9A60.0Z Papillary conjunctivitis, unspecified –– 9A60.30 Ulceration of conjunctiva –– 9A60.31 Abscess of conjunctiva –– 9A60.32 Conjunctivitis due to Koch-Weeks bacillus –– 9A60.33 Acute epidemic conjunctivitis –– 9A60.3Y Other specified mucopurulent conjunctivitis –– 9A60.3Z Mucopurulent conjunctivitis, unspecified 9A61 Certain specified disorders of conjunctiva – 9A61.0 Pingueculae – 9A61.1 Pterygium – 9A61.2 Pseudopterygium of conjunctiva – 9A61.3 Conjunctival scars – 9A61.4 Conjunctival vascular disorders – 9A61.5 Conjunctival or subconjunctival haemorrhage – 9A61.6 Conjunctival or subconjunctival degenerations or deposits – 9A61.Z Certain specified disorders of conjunctiva, unspecified –– 9A61.40 Vascular abnormalities of conjunctiva –– 9A61.4Y Other specified conjunctival vascular disorders –– 9A61.4Z Conjunctival vascular disorders, unspecified 9A62 Mucous membrane pemphigoid with ocular involvement 9A6Y Other specified disorders of conjunctiva 9A6Z Disorders of conjunctiva, unspecified 9A70 Hereditary corneal dystrophies – 9A70.0 Endothelial corneal dystrophy – 9A70.Y Other specified hereditary corneal dystrophies – 9A70.Z Hereditary corneal dystrophies, unspecified 9A71 Infectious keratitis 9A72 Traumatic keratitis 9A73 Exposure keratitis 9A74 Neurotrophic keratitis 9A75 Autoimmune keratitis 9A76 Corneal ulcer 9A77 Corneal scars or opacities – 9A77.0 Contact lens-associated corneal infiltrates – 9A77.1 Adherent leukoma – 9A77.Y Other specified corneal scars or opacities – 9A77.Z Corneal scars or opacities, unspecified 9A78 Certain specified disorders of cornea – 9A78.0 Corneal neovascularization – 9A78.1 Corneal pigmentations or deposits – 9A78.2 Corneal oedema – 9A78.3 Changes in corneal membranes – 9A78.4 Corneal degeneration – 9A78.5 Corneal deformities – 9A78.6 Anaesthesia of cornea – 9A78.7 Hypoesthesia of cornea – 9A78.8 Recurrent erosion of cornea – 9A78.9 Corneal abscess – 9A78.A Sclerosing keratitis – 9A78.Z Certain specified disorders of cornea, unspecified –– 9A78.20 Bullous keratopathy –– 9A78.21 Secondary corneal oedema –– 9A78.2Y Other specified corneal oedema –– 9A78.2Z Corneal oedema, unspecified –– 9A78.50 Keratoconus –– 9A78.51 Corneal staphyloma –– 9A78.5Y Other specified corneal deformities –– 9A78.5Z Corneal deformities, unspecified 9A79 Keratoconjunctivitis sicca 9A7Y Other specified disorders of the cornea 9A7Z Disorders of the cornea, unspecified 9A80 Hyphaema 9A81 Parasites in the anterior chamber of the eye 9A82 Cyst in the anterior chamber of the eye 9A83 Flat anterior chamber hypotony of eye 9A8Y Other specified disorders of the anterior chamber 9A8Z Disorders of the anterior chamber, unspecified 9A90 Degeneration of iris or ciliary body – 9A90.0 Disorders of chamber angle – 9A90.1 Degeneration of iris – 9A90.2 Iris atrophy – 9A90.Y Other specified degeneration of iris or ciliary body – 9A90.Z Degeneration of iris or ciliary body, unspecified 9A91 Cyst of iris or ciliary body 9A92 Persistent pupillary membranes 9A93 Adhesions or disruptions of iris or ciliary body 9A94 Certain specified disorders of iris or ciliary body – 9A94.0 Rubeosis of iris – 9A94.1 Floppy iris syndrome – 9A94.2 Plateau iris syndrome – 9A94.Y Other disorders of iris and ciliary body 9A96 Anterior uveitis – 9A96.0 Anterior uveitis not associated with systemic conditions – 9A96.1 Anterior uveitis associated with systemic conditions – 9A96.2 Infection-associated anterior uveitis – 9A96.3 Primary anterior uveitis – 9A96.Y Other specified anterior uveitis – 9A96.Z Anterior uveitis, unspecified 9A9Y Other specified disorders of the anterior uvea 9A9Z Disorders of the anterior uvea, unspecified 9B00 Disorders of the afferent pupillary system – 9B00.0 Relative afferent pupillary defects – 9B00.1 Amaurotic pupillary reaction – 9B00.2 Paradoxical pupillary reaction to light or darkness – 9B00.3 Wernicke pupils – 9B00.Y Other specified disorders of the afferent pupillary system – 9B00.Z Disorders of the afferent pupillary system, unspecified 9B01 Disorders of the efferent pupillary system – 9B01.0 Physiologic anisocoria – 9B01.1 Parasympathoparetic pupils – 9B01.2 Pharmacologic inhibition of the parasympathetic pathway – 9B01.3 Iris sphincter disorders – 9B01.4 Pharmacologic parasympathicotonic pupils – 9B01.5 Pharmacologic sympathoparetic pupils – 9B01.6 Sympathotonic pupils – 9B01.7 Episodic unilateral mydriasis – 9B01.Y Other specified disorders of the efferent pupillary system – 9B01.Z Disorders of the efferent pupillary system, unspecified 9B02 Light-near dissociations – 9B02.0 Argyll Robertson pupil – 9B02.1 Pregeniculate light-near dissociations – 9B02.2 Mesencephalic light-near dissociations – 9B02.Y Other specified light-near dissociations – 9B02.Z Light-near dissociations, unspecified 9B0Y Other specified functional disorders of the pupil 9B0Z Functional disorders of the pupil, unspecified 9B10 Cataract – 9B10.0 Age-related cataract – 9B10.1 Infantile or juvenile cataract – 9B10.2 Certain specified cataracts – 9B10.Z Cataract, unspecified –– 9B10.00 Coronary age-related cataract –– 9B10.01 Punctate age-related cataract –– 9B10.02 Mature age-related cataract –– 9B10.0Y Other specified age-related cataract –– 9B10.0Z Age-related cataract, unspecified –– 9B10.10 Combined forms of infantile and juvenile cataract –– 9B10.1Y Other specified infantile or juvenile cataract –– 9B10.1Z Infantile or juvenile cataract, unspecified –– 9B10.20 Traumatic cataract –– 9B10.21 Diabetic cataract –– 9B10.22 After-cataract –– 9B10.23 Subcapsular glaucomatous flecks –– 9B10.2Y Other specified cataracts 9B11 Certain specified disorders of lens – 9B11.0 Aphakia – 9B11.1 Dislocation of lens – 9B11.Y Other disorders of lens 9B1Z Disorders of lens, unspecified 9B3Y Other specified disorders of the eyeball - anterior segment 9B3Z Disorders of the eyeball - anterior segment, unspecified 9B50 Episcleritis 9B51 Scleritis 9B52 Scleral staphyloma 9B5Y Other specified disorders of sclera 9B5Z Disorders of sclera, unspecified 9B60 Choroidal degeneration 9B61 Choroidal dystrophy 9B62 Chorioretinal scars 9B63 Choroidal haemorrhage or rupture 9B64 Choroidal detachment 9B65 Choroiditis – 9B65.0 Noninfectious posterior choroiditis – 9B65.1 Infectious posterior choroiditis – 9B65.2 Chorioretinal inflammation – 9B65.Z Choroiditis, unspecified 9B66 Intermediate choroiditis – 9B66.0 Noninfectious intermediate choroiditis – 9B66.1 Infectious intermediate choroiditis – 9B66.Z Intermediate choroiditis, unspecified 9B6Y Other specified disorders of the choroid 9B6Z Disorders of the choroid, unspecified 9B70 Inherited retinal dystrophies 9B71 Retinopathy – 9B71.0 Diabetic retinopathy – 9B71.1 Hypertensive retinopathy – 9B71.2 Radiation retinopathy – 9B71.3 Retinopathy of prematurity – 9B71.4 Paraneoplastic retinopathy – 9B71.5 Autoimmune retinopathy – 9B71.Y Other specified retinopathy – 9B71.Z Retinopathy, unspecified –– 9B71.00 Nonproliferative diabetic retinopathy –– 9B71.01 Proliferative diabetic retinopathy –– 9B71.02 Diabetic macular oedema –– 9B71.0Z Diabetic retinopathy, unspecified –– 9B71.40 Melanoma associated retinopathy –– 9B71.4Y Other specified paraneoplastic retinopathy –– 9B71.4Z Paraneoplastic retinopathy, unspecified 9B72 Inflammatory diseases of the retina – 9B72.0 Viral retinitis – 9B72.Y Other specified inflammatory diseases of the retina – 9B72.Z Inflammatory diseases of the retina, unspecified –– 9B72.00 Cytomegaloviral retinitis –– 9B72.01 HIV retinitis –– 9B72.0Y Other specified viral retinitis –– 9B72.0Z Viral retinitis, unspecified 9B73 Retinal detachments or breaks – 9B73.0 Retinal detachment with retinal break – 9B73.1 Retinoschisis – 9B73.2 Retinal cysts – 9B73.3 Serous retinal detachment – 9B73.4 Retinal breaks without detachment – 9B73.Y Other specified retinal detachments or breaks – 9B73.Z Retinal detachments or breaks, unspecified –– 9B73.10 Adult retinoschisis –– 9B73.11 Juvenile retinoschisis –– 9B73.1Y Other specified retinoschisis –– 9B73.1Z Retinoschisis, unspecified 9B74 Retinal vascular occlusions – 9B74.0 Retinal artery occlusions – 9B74.1 Retinal venous occlusions – 9B74.2 Combined retinal arterial and vein occlusion – 9B74.Y Other specified retinal vascular occlusions – 9B74.Z Retinal vascular occlusions, unspecified 9B75 Macular disorders – 9B75.0 Age-related macular degeneration – 9B75.1 Non-traumatic macular hole – 9B75.2 Central serous chorioretinopathy – 9B75.3 Macular telangiectasia – 9B75.Y Other specified macular disorders – 9B75.Z Macular disorders, unspecified –– 9B75.00 Early age-related macular degeneration –– 9B75.01 Intermediate age-related macular degeneration –– 9B75.03 Atrophic late-stage age-related macular degeneration –– 9B75.04 Neovascular late-stage age-related macular degeneration –– 9B75.0Y Other specified age-related macular degeneration –– 9B75.0Z Age-related macular degeneration, unspecified 9B76 Degenerative high myopia 9B77 Eales disease 9B78 Certain specified retinal disorders – 9B78.0 Retinal vasculopathy and cerebral leukodystrophy – 9B78.1 Background retinopathy and retinal vascular changes – 9B78.2 Other proliferative retinopathy – 9B78.3 Degeneration of macula or posterior pole – 9B78.4 Peripheral retinal degeneration – 9B78.5 Retinal haemorrhage – 9B78.6 Separation of retinal layers – 9B78.7 Retinal oedema – 9B78.8 Retinal ischaemia – 9B78.9 Retinal atrophy –– 9B78.10 Changes in retinal vascular appearance –– 9B78.11 Exudative retinopathy –– 9B78.12 Retinal vasculitis –– 9B78.13 Retinal telangiectasis –– 9B78.1Y Other specified background retinopathy and retinal vascular changes –– 9B78.1Z Background retinopathy and retinal vascular changes, unspecified –– 9B78.30 Reticular pseudodrusen –– 9B78.3Y Other specified degeneration of macula or posterior pole –– 9B78.3Z Degeneration of macula or posterior pole, unspecified –– 9B78.60 Serous detachment of retinal pigment epithelium –– 9B78.61 Haemorrhagic detachment of retinal pigment epithelium –– 9B78.6Y Other specified separation of retinal layers –– 9B78.6Z Separation of retinal layers, unspecified 9B7Y Other specified disorders of the retina 9B7Z Disorders of the retina, unspecified 9B80 Inherited vitreoretinal disorders 9B81 Posterior vitreous detachment 9B82 Vitreous prolapse 9B83 Vitreous haemorrhage 9B84 Vitreous opacities, membranes or strands 9B8Y Other specified disorders of the vitreous body 9B8Z Disorders of the vitreous body, unspecified 9C0Y Other specified disorders of the eyeball - posterior segment 9C0Z Disorders of the eyeball - posterior segment, unspecified 9C20 Panuveitis 9C20.0 Noninfectious panuveitis 9C20.1 Infectious panuveitis 9C20.2 Purulent endophthalmitis 9C20.Y Other specified panuveitis 9C20.Z Panuveitis, unspecified 9C21 Endophthalmitis 9C21.0 Sympathetic uveitis 9C21.Y Other specified endophthalmitis 9C21.Z Endophthalmitis, unspecified 9C22 Eyeball deformity 9C22.0 Atrophia bulbi 9C22.1 Phthisis bulbi 9C22.Y Other specified eyeball deformity 9C22.Z Eyeball deformity, unspecified 9C2Y Other specified disorders of the eyeball affecting both anterior and posterior segments 9C2Z Disorders of the eyeball affecting both anterior and posterior segments, unspecified 9C40 Disorder of the optic nerve 9C40.0 Infectious optic neuropathy 9C40.1 Optic neuritis 9C40.2 Neuroretinitis 9C40.3 Perineuritis of optic nerve 9C40.4 Ischaemic optic neuropathy 9C40.5 Compressive optic neuropathy 9C40.6 Infiltrative optic neuropathy 9C40.7 Traumatic optic neuropathy 9C40.8 Hereditary optic neuropathy 9C40.9 Glaucomatous optic neuropathy 9C40.A Optic disc swelling 9C40.B Optic atrophy 9C40.Y Other specified disorder of the optic nerve 9C40.Z Disorder of the optic nerve, unspecified – 9C40.10 Retrobulbar neuritis – 9C40.1Y Other specified optic neuritis – 9C40.1Z Optic neuritis, unspecified – 9C40.40 Anterior ischemic optic neuropathy – 9C40.41 Posterior ischemic optic neuropathy – 9C40.4Y Other specified ischaemic optic neuropathy – 9C40.4Z Ischaemic optic neuropathy, unspecified – 9C40.A0 Papilloedema – 9C40.A1 Optic disc swelling associated with uveitis – 9C40.AY Other specified optic disc swelling – 9C40.AZ Optic disc swelling, unspecified – 9C40.B0 Congenital optic atrophy – 9C40.B1 Acquired optic atrophy – 9C40.BZ Optic atrophy, unspecified 9C41 Disorder of optic chiasm 9C42 Disorder of post chiasmal visual pathways 9C43 Disorder of visual cortex 9C44 Disorder of higher visual centres 9C4Y Other specified disorders of the visual pathways or centres 9C4Z Disorders of the visual pathways or centres, unspecified 9C60 Glaucoma suspect 9C61 Glaucoma 9C61.0 Primary open-angle glaucoma 9C61.1 Primary angle closure and angle closure glaucoma 9C61.2 Secondary open-angle glaucoma 9C61.3 Secondary angle closure glaucoma 9C61.4 Developmental glaucoma 9C61.Z Glaucoma, unspecified – 9C61.00 Normal tension glaucoma – 9C61.01 Ocular hypertension – 9C61.0Y Other specified primary open-angle glaucoma – 9C61.0Z Primary open-angle glaucoma, unspecified – 9C61.10 Primary angle closure suspect or anatomical narrow angle – 9C61.11 Primary angle-closure – 9C61.12 Primary angle closure glaucoma – 9C61.13 Primary angle closure without pupillary block – 9C61.14 Acute angle closure with pupillary block – 9C61.15 Intermittent angle-closure – 9C61.16 Chronic angle-closure – 9C61.17 Condition after acute angle-closure glaucoma attack – 9C61.1Y Other specified primary angle closure and angle closure glaucoma – 9C61.1Z Primary angle closure and angle closure glaucoma, unspecified – 9C61.20 Pseudoexfoliative open-angle glaucoma – 9C61.21 Pigmentary open-angle glaucoma – 9C61.22 Lens-induced secondary open-angle glaucoma – 9C61.23 Glaucoma associated with intraocular haemorrhage – 9C61.24 Glaucoma due to eye inflammation – 9C61.25 Glaucomato-cyclitic crisis – 9C61.26 Secondary open-angle glaucoma due to parasitic eye disease – 9C61.27 Glaucoma due to intraocular tumours – 9C61.28 Glaucoma associated with retinal detachment – 9C61.29 Glaucoma due to eye trauma – 9C61.2A Glaucoma due to drugs – 9C61.2B Glaucoma caused by increased episcleral venous pressure – 9C61.2C Secondary glaucoma due to extra-ocular mass – 9C61.2Y Other specified secondary open-angle glaucoma – 9C61.2Z Secondary open-angle glaucoma, unspecified – 9C61.30 Secondary angle closure glaucoma with pupillary block – 9C61.31 Secondary angle closure glaucoma without pupillary block – 9C61.32 Neovascular secondary angle closure glaucoma – 9C61.33 Secondary angle closure glaucoma due to endothelial overgrowth – 9C61.34 Secondary angle closure glaucoma due to epithelial ingrowth – 9C61.35 Ciliary block glaucoma – 9C61.36 Secondary angle closure glaucoma due to other anterior displacement of the lens-iris diaphragm – 9C61.3Y Other specified secondary angle closure glaucoma – 9C61.3Z Secondary angle closure glaucoma, unspecified – 9C61.40 Primary congenital glaucoma – 9C61.41 Primary infantile glaucoma – 9C61.42 Secondary childhood glaucoma – 9C61.4Y Other specified developmental glaucoma – 9C61.4Z Developmental glaucoma, unspecified 9C6Y Other specified glaucoma or glaucoma suspect 9C6Z Glaucoma or glaucoma suspect, unspecified 9C80 Non paralytic strabismus 9C80.0 Esotropia 9C80.1 Exotropia 9C80.2 Vertical or torsional strabismus 9C80.3 Intermittent strabismus 9C80.4 Heterophoria 9C80.5 Mechanical strabismus 9C80.Y Other specified non paralytic strabismus 9C80.Z Non paralytic strabismus, unspecified – 9C80.30 Intermittent divergent exotropia – 9C80.31 Intermittent convergent esotropia – 9C80.3Y Other specified intermittent strabismus – 9C80.3Z Intermittent strabismus, unspecified 9C81 Ocular motor nerve palsies 9C81.0 Third nerve palsy 9C81.1 Fourth nerve palsy 9C81.2 Sixth nerve palsy 9C81.3 Total external ophthalmoplegia 9C81.4 Cavernous sinus syndromes 9C81.Y Palsy of other specified ocular motor nerve 9C81.Z Palsy of unspecified ocular motor nerve – 9C81.00 External bilateral paralysis of oculomotor nerve – 9C81.0Y Other specified third nerve palsy – 9C81.0Z Third nerve palsy, unspecified 9C82 Disorders of extraocular muscles 9C82.0 Progressive external ophthalmoplegia 9C82.1 Muscular dystrophy affecting extraocular muscle 9C82.2 Congenital cranial dysinnervation syndrome 9C82.3 Restrictive ophthalmopathy 9C82.4 Oculomotor apraxia 9C82.Y Other specified disorders of extraocular muscles 9C82.Z Disorders of extraocular muscles, unspecified 9C83 Disorders of binocular movement 9C83.0 Palsy of conjugate gaze 9C83.1 Spasm of conjugate gaze 9C83.2 Convergence insufficiency 9C83.3 Convergence excess 9C83.4 Spasm of the near reflex 9C83.5 Internuclear ophthalmoplegia 9C83.6 Anomalies of divergence or deviation of eye movement 9C83.Y Other specified disorders of binocular movement 9C83.Z Disorders of binocular movement, unspecified – 9C83.00 Horizontal gaze palsy – 9C83.01 Vertical gaze palsy – 9C83.02 Monocular elevator palsy – 9C83.0Y Other specified palsy of conjugate gaze – 9C83.0Z Palsy of conjugate gaze, unspecified – 9C83.10 Horizontal conjugate gaze deviation – 9C83.11 Upward gaze deviation – 9C83.12 Downward gaze deviation – 9C83.13 Oculogyric crisis – 9C83.1Y Other specified spasm of conjugate gaze – 9C83.1Z Spasm of conjugate gaze, unspecified – 9C83.60 Divergence insufficiency – 9C83.61 Divergence paralysis – 9C83.62 Divergence excess – 9C83.63 Synergistic divergence – 9C83.64 Skew deviation – 9C83.65 Ocular tilt reaction – 9C83.66 Alternating skew deviation – 9C83.67 Dissociative vertical divergence – 9C83.6Y Other specified anomalies of divergence or deviation of eye movement – 9C83.6Z Anomalies of divergence or deviation of eye movement, unspecified 9C84 Nystagmus 9C84.0 Physiological nystagmus 9C84.1 Congenital forms of nystagmus 9C84.2 Vestibular nystagmus 9C84.3 Seesaw nystagmus 9C84.4 Gaze-evoked nystagmus 9C84.5 Nystagmus occurring in visual system disorders 9C84.6 Eyelid nystagmus 9C84.Y Other specified nystagmus 9C84.Z Nystagmus, unspecified – 9C84.20 Downbeat nystagmus – 9C84.21 Upbeat nystagmus – 9C84.22 Torsional nystagmus – 9C84.23 Perverted nystagmus – 9C84.2Y Other specified vestibular nystagmus – 9C84.2Z Vestibular nystagmus, unspecified – 9C84.50 Visual deprivation nystagmus – 9C84.51 Divergence nystagmus – 9C84.52 Convergence-retraction nystagmus – 9C84.5Y Other specified nystagmus occurring in visual system disorders – 9C84.5Z Nystagmus occurring in visual system disorders, unspecified 9C85 Certain specified irregular eye movements 9C85.0 Anomalies of saccadic eye movements 9C85.1 Anomalies of smooth pursuit movements 9C85.2 Nonorganic eye movement disorders 9C85.Y Other specified irregular eye movements 9C85.Z Irregular eye movements, unspecified – 9C85.00 Disorders of the saccadic pulse – 9C85.01 Disorders of the saccadic step – 9C85.02 Inappropriate saccades – 9C85.0Y Other specified anomalies of saccadic eye movements – 9C85.0Z Anomalies of saccadic eye movements, unspecified 9C8Y Other specified strabismus or ocular motility disorders 9C8Z Strabismus or ocular motility disorders, unspecified 9D00 Disorders of refraction 9D00.0 Myopia 9D00.1 Hypermetropia 9D00.2 Astigmatism 9D00.3 Presbyopia 9D00.4 Anisometropia 9D00.5 Aniseikonia 9D00.6 Transient refractive change 9D00.Y Other specified disorders of refraction 9D00.Z Disorders of refraction, unspecified 9D01 Disorders of accommodation 9D01.0 Internal ophthalmoplegia 9D01.1 Paresis of accommodation 9D01.2 Spasm of accommodation 9D01.Y Other specified disorders of accommodation 9D01.Z Disorders of accommodation, unspecified 9D0Y Other specified disorders of refraction or accommodation 9D0Z Disorders of refraction or accommodation, unspecified 9D20 Bullous aphakic keratopathy following cataract surgery 9D21 Cataract lens fragments in eye following cataract surgery 9D22 Chorioretinal scars after surgery for detachment 9D23 Conjunctival blebitis after glaucoma surgery 9D24 Complications with glaucoma drainage devices 9D25 Glaucoma due to ocular surgery or laser 9D41 Impairment of visual field 9D42 Patterns of visual field impairment 9D42.0 Visual field loss, pattern not specified 9D42.2 Peripheral field deficit 9D42.3 Hemianopic or quadrantic loss 9D42.4 Central scotoma 9D42.5 Para-central scotoma 9D42.6 Homonymous hemianopia or quadrant anopia 9D42.7 Heteronymous hemianopia or quadrant anopia 9D42.8 Visual field loss, other specified forms 9D42.Y Other specified patterns of visual field impairment 9D42.Z Patterns of visual field impairment, unspecified – 9D42.20 Enlarged blind spot – 9D42.21 Arcuate scotoma – 9D42.22 Nasal step – 9D42.23 Ring scotoma – 9D42.24 Isolated peripheral scotoma – 9D42.2Y Other specified peripheral field deficit – 9D42.2Z Peripheral field deficit, unspecified – 9D42.60 Right hemi-field homonymous hemianopia or quadrant anopia – 9D42.61 Left hemi-field homonymous hemianopia or quadrant anopia – 9D42.6Y Other specified homonymous hemianopia or quadrant anopia – 9D42.6Z Homonymous hemianopia or quadrant anopia, unspecified – 9D42.70 Bi-nasal defects heteronymous hemianopia or quadrant anopia – 9D42.71 Bi-temporal defects heteronymous hemianopia or quadrant anopia – 9D42.7Y Other specified heteronymous hemianopia or quadrant anopia – 9D42.7Z Heteronymous hemianopia or quadrant anopia, unspecified 9D43 Impairment of contrast vision 9D44 Impairment of colour vision 9D45 Impairment of light sensitivity 9D46 Impairment of binocular functions 9D50 Visual discomfort 9D51 Transient visual loss 9D52 Hemifield losses 9D53 Entoptic phenomena 9D54 Visual illusions 9D55 Nonorganic visual loss 9D56 Visual release hallucinations 9D5Y Other specified subjective visual experiences 9D5Z Subjective visual experiences, unspecified 9D7Y Other specified impairment of visual functions 9D7Z Impairment of visual functions, unspecified 9D90 Vision impairment including blindness 9D90.1 Mild vision impairment 9D90.2 Moderate vision impairment 9D90.3 Severe vision impairment 9D90.6 Blindness 9D90.7 Near vision impairment 9D92 Specific vision dysfunctions 9D93 Complex vision-related dysfunctions 9D94 Impairment of presenting visual acuity 9D95 Impairment of best corrected visual acuity 9D96 Impairment of uncorrected visual acuity 9D9Y Other specified vision impairment 9D9Z Vision impairment, unspecified 9E1Y Other specified diseases of the visual system 9E1Z Diseases of the visual system, unspecified AA00 Abscess of external ear AA01 Cellulitis of external ear AA02 Malignant otitis externa AA03 Otomycosis AA04 Perichondritis of external ear AA0Y Other specified infectious diseases of external ear AA0Z Infectious diseases of external ear, unspecified – AA10 Seborrhoeic otitis externa – AA11 Acute noninfectious otitis externa – AA12 Chondrodermatitis nodularis – AA13 Chronic otitis externa – AA1Y Other specified noninfectious inflammation of external ear – AA1Z Noninfectious inflammation of external ear, unspecified AA3Y Other specified otitis externa AA3Z Otitis externa, unspecified AA40 Acquired deformity of external auditory canal – AA40.0 Exostosis of external auditory canal – AA40.1 Acquired stenosis of external auditory canal – AA40.2 Cholesteatoma of external auditory canal – AA40.Y Other specified acquired deformity of external auditory canal AA41 Acquired deformity of pinna – AA41.0 Cauliflower ear – AA41.Y Other specified acquired deformity of pinna AA42 Impacted cerumen AA4Y Other specified noninflammatory disorders of the external ear AA4Z Noninflammatory disorders of the external ear, unspecified AA6Z Diseases of external ear, unspecified – AA80 Acute serous or mucoid otitis media – AA81 Acute nonserous nonsuppurative otitis media – AA82 Chronic serous or mucoid otitis media – AA83 Noninfected otitis media with effusion – AA8Z Nonsuppurative otitis media, unspecified – AA90 Acute suppurative otitis media – AA91 Chronic suppurative otitis media –– AA91.0 Chronic tubotympanic suppurative otitis media –– AA91.1 Chronic atticoantral suppurative otitis media –– AA91.2 Other chronic suppurative otitis media –– AA91.Z Chronic suppurative otitis media, unspecified – AA9Z Suppurative otitis media, unspecified whether acute or chronic AB00 Acute otitis media AB01 Chronic otitis media AB0Y Other specified otitis media AB0Z Otitis media, unspecified AB10 Disorders of Eustachian tube AB10.0 Diverticulum of Eustachian tube AB10.1 Patulous Eustachian tube AB10.2 Eustachian salpingitis AB10.3 Obstruction of Eustachian tube AB10.Y Other specified disorders of Eustachian tube AB10.Z Disorders of Eustachian tube, unspecified AB11 Mastoiditis or related conditions AB11.0 Acute mastoiditis AB11.1 Chronic mastoiditis AB11.2 Petrositis AB11.3 Mastoiditis, not elsewhere classified AB11.Y Other specified mastoiditis or related conditions AB12 Cholesteatoma of middle ear AB13 Perforation of tympanic membrane AB13.0 Central perforation of tympanic membrane AB13.1 Attic perforation of tympanic membrane AB13.2 Other marginal perforations of tympanic membrane AB13.Y Other specified perforation of tympanic membrane AB13.Z Perforation of tympanic membrane, unspecified AB14 Acute myringitis AB15 Chronic myringitis AB16 Tympanosclerosis AB17 Adhesive middle ear disease AB18 Discontinuity or dislocation of ear ossicles AB19 Acquired abnormalities of ear ossicles not related to discontinuity or dislocation AB1A Polyp of middle ear AB1A.0 Aural polyp AB1A.Y Other specified polyp of middle ear AB1A.Z Polyp of middle ear, unspecified AB1B Middle ear cicatrix AB1Y Other specified diseases of middle ear or mastoid AB1Z Diseases of middle ear or mastoid, unspecified AB30 Acute vestibular syndrome AB30.0 Vestibular neuritis AB30.1 Labyrinthitis AB30.Y Other specified acute vestibular syndrome AB30.Z Acute vestibular syndrome, unspecified AB31 Episodic vestibular syndrome AB31.0 Meniere disease AB31.1 Vestibular migraine AB31.2 Benign positional paroxysmal vertigo AB31.3 Superior canal dehiscence syndrome AB31.4 Disembarkment syndrome AB31.5 Autoimmune inner ear disease AB31.6 Vestibular paroxysmia AB31.7 Vertiginous syndromes AB31.Y Other specified episodic vestibular syndrome AB31.Z Episodic vestibular syndrome, unspecified AB32 Chronic vestibular syndrome AB32.0 Persistent Postural-Perceptual Dizziness AB32.1 Chronic unilateral idiopathic vestibulopathy AB32.2 Persistent unilateral vestibulopathy after vestibular neuronitis AB32.3 Unilateral vestibulopathy due to schwannoma AB32.4 Unilateral vestibulopathy after medical intervention AB32.5 Chronic bilateral vestibulopathy AB32.Y Other specified chronic vestibular syndrome AB32.Z Chronic vestibular syndrome, unspecified AB33 Otosclerosis AB34 Disorders of vestibular function AB34.0 Idiopathic bilateral vestibulopathy AB34.1 Other peripheral vertigo AB34.Y Other specified disorders of vestibular function AB34.Z Disorders of vestibular function, unspecified AB35 Labyrinthine fistula AB36 Labyrinthine dysfunction AB37 Noise effects on inner ear AB3Y Other specified diseases of inner ear AB3Z Diseases of inner ear, unspecified AB50 Congenital hearing impairment AB50.0 Congenital conductive hearing loss AB50.1 Congenital sensorineural hearing loss AB50.2 Congenital mixed conductive and sensorineural hearing loss AB50.Y Other specified congenital hearing impairment AB50.Z Congenital hearing impairment, unspecified AB51 Acquired hearing impairment AB51.0 Acquired conductive hearing loss AB51.1 Acquired sensorineural hearing loss AB51.2 Acquired mixed conductive and sensorineural hearing loss AB51.Y Other specified acquired hearing impairment AB51.Z Acquired hearing impairment, unspecified AB52 Deafness not otherwise specified AB53 Ototoxic hearing loss AB54 Presbycusis AB55 Sudden idiopathic hearing loss AB56 Hereditary hearing loss AB57 Auditory synaptopathy or neuropathy AB5Y Other specified disorders with hearing impairment AB5Z Disorders with hearing impairment, unspecified AB70 Otalgia or effusion of ear AB70.0 Otorrhoea AB70.1 Otorrhagia AB70.2 Otalgia AB71 Degenerative or vascular disorders of ear AB72 Disorders of acoustic nerve AB72.0 Acoustic neuritis AB72.Y Other specified disorders of acoustic nerve AB72.Z Disorders of acoustic nerve, unspecified AB73 Atrophy ear AB7Y Other specified disorders of ear, not elsewhere classified AB90 Recurrent cholesteatoma of postmastoidectomy cavity AB91 Mucosal cyst of postmastoidectomy cavity AB92 Granulation of postmastoidectomy cavity AB93 Chronic inflammation of postmastoidectomy cavity AC0Y Other specified diseases of the ear or mastoid process AC0Z Diseases of the ear or mastoid process, unspecified BA00 Essential hypertension BA00.0 Combined diastolic and systolic hypertension BA00.1 Isolated diastolic hypertension BA00.2 Isolated systolic hypertension BA00.Y Other specified essential hypertension BA00.Z Essential hypertension, unspecified BA01 Hypertensive heart disease BA02 Hypertensive renal disease BA03 Hypertensive crisis BA04 Secondary hypertension BA04.0 Combined diastolic and systolic secondary hypertension BA04.1 Isolated diastolic secondary hypertension BA04.2 Isolated systolic secondary hypertension BA04.Y Other specified secondary hypertension BA04.Z Secondary hypertension, unspecified BA20 Idiopathic hypotension BA21 Orthostatic hypotension BA2Y Other specified hypotension BA2Z Hypotension, unspecified BA40 Angina pectoris – BA40.0 Unstable angina – BA40.1 Stable angina – BA40.Y Other specified angina pectoris – BA40.Z Angina pectoris, unspecified BA41 Acute myocardial infarction – BA41.0 Acute ST elevation myocardial infarction – BA41.1 Acute non-ST elevation myocardial infarction – BA41.Z Acute myocardial infarction, unspecified BA42 Subsequent myocardial infarction – BA42.0 Subsequent myocardial infarction, ST elevation myocardial infarction – BA42.1 Subsequent myocardial infarction, non-ST elevation myocardial infarction – BA42.Z Subsequent myocardial infarction, unspecified BA43 Coronary thrombosis not resulting in myocardial infarction BA4Z Acute ischaemic heart disease, unspecified BA50 Old myocardial infarction BA51 Ischaemic cardiomyopathy – BA51.0 Dilated cardiomyopathy due to congenital anomaly of coronary artery – BA51.Y Other specified ischaemic cardiomyopathy – BA51.Z Ischaemic cardiomyopathy, unspecified BA52 Coronary atherosclerosis – BA52.0 Coronary atherosclerosis of native coronary artery – BA52.1 Coronary atherosclerosis of autologous bypass graft – BA52.2 Coronary atherosclerosis of non-autologous bypass graft – BA52.Z Coronary atherosclerosis, unspecified site –– BA52.10 Coronary atherosclerosis of arterial autologous bypass graft –– BA52.11 Coronary atherosclerosis of venous autologous bypass graft –– BA52.1Z Coronary atherosclerosis of unspecified autologous bypass graft BA5Y Other specified chronic ischaemic heart disease BA5Z Chronic ischaemic heart disease, unspecified BA60 Certain current complications following acute myocardial infarction BA60.0 Dressler syndrome BA60.1 Other pericarditis as current complication following acute myocardial infarction BA60.2 Ventricular aneurysm as current complication following acute myocardial infarction BA60.3 Ventricular septal defect as current complication following acute myocardial infarction BA60.4 Cardiac rupture as current complication following acute myocardial infarction BA60.5 Pulmonary embolism as current complication following acute myocardial infarction BA60.6 Rupture of papillary muscle or chordae tendineae as current complication following acute myocardial infarction BA60.7 Mural thrombus as current complication following acute myocardial infarction BA60.8 Arrhythmia as current complication following acute myocardial infarction BA60.9 Cardiogenic shock, unrelated to mechanical complications, as current complication following acute myocardial infarction BA60.Y Other specified current complications following acute myocardial infarction BA60.Z Certain current complications following acute myocardial infarction, unspecified BA6Z Ischaemic heart diseases, unspecified BA81 Coronary artery aneurysm BA81.0 Coronary artery aneurysm with perforation BA81.1 Coronary artery aneurysm with rupture BA81.2 Coronary artery aneurysm without mention of perforation or rupture BA82 Coronary artery dissection BA83 Coronary artery fistula, acquired BA84 Chronic total occlusion of coronary artery BA85 Coronary vasospastic disease BA85.0 Silent coronary vasospastic disease BA85.Y Other specified coronary vasospastic disease BA85.Z Coronary vasospastic disease, unspecified BA86 Coronary microvascular disease BA8Y Other specified diseases of coronary artery BA8Z Diseases of coronary artery, unspecified BB00 Pulmonary thromboembolism BB00.0 Acute pulmonary thromboembolism BB00.1 Chronic pulmonary thromboembolism BB00.Z Pulmonary thromboembolism, unspecified BB01 Pulmonary hypertension BB01.0 Pulmonary arterial hypertension BB01.1 Pulmonary hypertension due to left heart disease BB01.2 Pulmonary hypertension due to lung disease or hypoxia BB01.3 Chronic thromboembolic pulmonary hypertension BB01.4 Pulmonary hypertension with multifactorial mechanism BB01.5 Cor pulmonale BB01.Z Pulmonary hypertension, unspecified BB02 Certain specified diseases of pulmonary vessels BB02.0 Arteriovenous fistula of pulmonary vessels BB02.1 Aneurysm of pulmonary artery BB02.2 Rupture of pulmonary vessels BB02.3 Acquired pulmonary arterial tree abnormality – BB02.10 Aneurysm of pulmonary artery with perforation – BB02.11 Aneurysm of pulmonary artery with rupture – BB02.12 Aneurysm of pulmonary artery without mention of perforation or rupture – BB02.1Y Other specified aneurysm of pulmonary artery – BB02.1Z Aneurysm of pulmonary artery, unspecified BB03 Acquired pulmonary venous abnormality BB03.0 Acquired pulmonary venous obstruction BB03.Y Other specified acquired pulmonary venous abnormality BB03.Z Acquired pulmonary venous abnormality, unspecified BB0Y Other specified pulmonary heart disease or diseases of pulmonary circulation BB0Z Pulmonary heart disease or diseases of pulmonary circulation, unspecified BB20 Acute pericarditis BB20.0 Infectious pericarditis BB20.1 Neoplastic pericarditis BB20.2 Myopericarditis BB20.Y Other specified acute pericarditis BB20.Z Acute pericarditis, unspecified BB21 Chronic rheumatic pericarditis BB22 Constrictive pericarditis BB23 Cardiac tamponade BB24 Haemopericardium BB25 Pericardial effusion BB2Y Other specified pericarditis BB2Z Pericarditis, unspecified BB40 Acute or subacute infectious endocarditis BB41 Myoendocarditis BB42 Periendocarditis BB4Y Other specified acute or subacute endocarditis BB4Z Acute or subacute endocarditis, unspecified BB60 Mitral valve stenosis – BB60.0 Rheumatic mitral valve stenosis – BB60.1 Nonrheumatic mitral valve stenosis – BB60.Z Mitral valve stenosis, unspecified BB61 Mitral valve insufficiency – BB61.0 Rheumatic mitral valve insufficiency – BB61.Y Other specified mitral valve insufficiency – BB61.Z Mitral valve insufficiency, unspecified BB62 Mitral valve prolapse – BB62.0 Rheumatic mitral valve prolapse – BB62.1 Degenerative mitral valve prolapse – BB62.Y Other specified nonrheumatic mitral valve prolapse – BB62.Z Mitral valve prolapse, unspecified BB63 Mitral valve stenosis with insufficiency – BB63.0 Rheumatic mitral stenosis with insufficiency – BB63.1 Nonrheumatic mitral stenosis with insufficiency – BB63.Z Mitral valve stenosis with insufficiency, unspecified BB64 Mitral valvar abscess BB65 Mitral valve rupture BB6Y Other specified mitral valve disease BB6Z Mitral valve disease, unspecified BB70 Aortic valve stenosis – BB70.0 Rheumatic aortic valve stenosis – BB70.1 Nonrheumatic aortic valve stenosis – BB70.Y Other specified aortic valve stenosis – BB70.Z Aortic valve stenosis, unspecified BB71 Aortic valve insufficiency – BB71.0 Rheumatic aortic valve insufficiency – BB71.Y Other specified nonrheumatic aortic valve insufficiency – BB71.Z Aortic valve insufficiency, unspecified BB72 Aortic valve stenosis with insufficiency – BB72.0 Rheumatic aortic stenosis with insufficiency – BB72.1 Nonrheumatic aortic valve stenosis with insufficiency – BB72.Z Aortic valve stenosis with insufficiency, unspecified BB73 Aortic valvar abscess BB74 Aortic valvar prolapse BB7Y Other specified aortic valve disease BB7Z Aortic valve disease, unspecified BB80 Tricuspid valve stenosis – BB80.0 Rheumatic tricuspid valve stenosis – BB80.Y Other specified nonrheumatic tricuspid valve stenosis – BB80.Z Tricuspid valve stenosis, unspecified BB81 Tricuspid valve insufficiency – BB81.0 Rheumatic tricuspid valve insufficiency – BB81.Y Other specified nonrheumatic tricuspid valve insufficiency – BB81.Z Tricuspid valve insufficiency, unspecified BB82 Tricuspid valve stenosis with insufficiency – BB82.0 Rheumatic tricuspid valve stenosis with insufficiency – BB82.Y Other specified nonrheumatic tricuspid valve stenosis with insufficiency – BB82.Z Tricuspid valve stenosis with insufficiency, unspecified BB83 Tricuspid valvular abscess BB84 Tricuspid valve rupture BB8Y Other specified tricuspid valve disease BB8Z Tricuspid valve disease, unspecified BB90 Pulmonary valve stenosis – BB90.0 Rheumatic pulmonary valve stenosis – BB90.Y Other specified nonrheumatic pulmonary valve stenosis – BB90.Z Pulmonary valve stenosis, unspecified BB91 Pulmonary valve insufficiency – BB91.0 Rheumatic pulmonary valve insufficiency – BB91.Y Other specified nonrheumatic pulmonary valve insufficiency – BB91.Z Pulmonary valve insufficiency, unspecified BB92 Pulmonary valve stenosis with insufficiency – BB92.0 Rheumatic pulmonary valve stenosis with insufficiency – BB92.1 Nonrheumatic pulmonary valve stenosis with insufficiency – BB92.Z Pulmonary valve stenosis with insufficiency, unspecified BB93 Pulmonary valvar abscess BB9Y Other specified pulmonary valve disease BB9Z Pulmonary valve disease, unspecified BC00 Multiple valve disease BC01 Prosthetic valve disease BC02 Acquired abnormality of congenitally malformed valve BC02.0 Acquired common atrioventricular valvar abnormality in biventricular connections BC02.1 Acquired truncal valvar abnormality BC02.2 Acquired common atrioventricular valvar abnormality in double inlet ventricle BC02.3 Acquired abnormality of neoaortic valve of pulmonary origin BC02.4 Acquired abnormality of the neoaortic valve of truncal origin BC02.Y Other specified acquired abnormality of congenitally malformed valve BC02.Z Acquired abnormality of congenitally malformed valve, unspecified – BC02.30 Stenosis of the neoaortic valve of pulmonary origin – BC02.31 Insufficiency of the neoaortic valve of pulmonary origin – BC02.3Y Other specified acquired abnormality of neoaortic valve of pulmonary origin – BC02.3Z Acquired abnormality of neoaortic valve of pulmonary origin, unspecified – BC02.40 Acquired stenosis of the neoaortic valve of truncal origin – BC02.41 Acquired regurgitation of the neoaortic valve of truncal origin – BC02.4Y Other specified acquired abnormality of the neoaortic valve of truncal origin – BC02.4Z Acquired abnormality of the neoaortic valve of truncal origin, unspecified BC0Z Heart valve diseases, unspecified BC20 Chronic rheumatic heart diseases, not elsewhere classified BC20.0 Rheumatic diseases of endocardium, valve unspecified BC20.1 Rheumatic heart disease, unspecified BC20.Y Other specified chronic rheumatic heart disease BC20.Z Chronic rheumatic heart disease, unspecified BC40 Acquired atrial abnormality BC40.0 Acquired interatrial communication BC40.Y Other specified acquired atrial abnormality BC40.Z Acquired atrial abnormality, unspecified BC41 Acquired ventricular abnormality BC41.0 Acquired interventricular communication BC41.Y Other specified acquired ventricular abnormality BC41.Z Acquired ventricular abnormality, unspecified BC42 Myocarditis BC42.0 Giant cell myocarditis BC42.1 Infectious myocarditis BC42.2 Hypersensitivity myocarditis BC42.3 Rheumatic myocarditis BC42.Y Other specific myocarditis BC42.Z Myocarditis, unspecified BC43 Cardiomyopathy BC43.0 Dilated cardiomyopathy BC43.1 Hypertrophic cardiomyopathy BC43.2 Restrictive cardiomyopathy BC43.3 Endocardial fibroelastosis BC43.4 Cardiomyopathy due to drugs or other external agents BC43.5 Stress-induced cardiomyopathy BC43.6 Arrhythmogenic ventricular cardiomyopathy BC43.7 Diabetic cardiomyopathy BC43.Y Other specified cardiomyopathy BC43.Z Cardiomyopathy, unspecified – BC43.00 Familial-genetic dilated cardiomyopathy – BC43.01 Nonfamilial dilated cardiomyopathy – BC43.0Z Dilated cardiomyopathy, unspecified – BC43.10 Familial-genetic hypertrophic cardiomyopathy – BC43.11 Non-obstructive hypertrophic cardiomyopathy – BC43.12 Obstructive hypertrophic cardiomyopathy – BC43.1Y Other specified hypertrophic cardiomyopathy – BC43.1Z Hypertrophic cardiomyopathy, unspecified – BC43.20 Nonfamilial restrictive cardiomyopathy – BC43.2Y Other specified restrictive cardiomyopathy – BC43.2Z Restrictive cardiomyopathy, unspecified BC44 Noncompaction cardiomyopathy BC45 Cardiomegaly BC46 Intracardiac thrombosis BC4Y Other specified diseases of the myocardium or cardiac chambers BC4Z Diseases of the myocardium or cardiac chambers, unspecified BC60 Atrial premature depolarization BC61 Junctional premature depolarization BC62 Accessory pathway BC63 Conduction disorders BC63.0 Atrioventricular block, first degree BC63.1 Atrioventricular block, second degree BC63.2 Complete atrioventricular block BC63.3 Right bundle branch block BC63.4 Left bundle branch block BC63.5 Nonspecific intraventricular conduction delay BC63.Y Other specified conduction disorders BC63.Z Conduction disorders, unspecified – BC63.10 High-grade second degree atrioventricular block – BC63.1Y Other specified atrioventricular block, second degree – BC63.1Z Atrioventricular block, second degree, unspecified – BC63.20 Congenital complete atrioventricular block – BC63.21 Acquired complete atrioventricular block – BC63.2Z Complete atrioventricular block, unspecified – BC63.40 Left anterior fascicular block – BC63.41 Left posterior fascicular block – BC63.4Z Left bundle branch block, fascicle unspecified BC64 Sudden arrhythmic death syndrome BC65 Cardiac arrhythmia associated with genetic disorder BC65.0 Long QT syndrome BC65.1 Brugada syndrome BC65.2 Short QT syndrome BC65.3 Early repolarisation syndrome BC65.4 Idiopathic ventricular fibrillation BC65.5 Catecholaminergic polymorphic ventricular tachycardia BC65.Y Other specified cardiac arrhythmia associated with genetic disorder BC65.Z Cardiac arrhythmia associated with genetic disorder, unspecified BC70 Ventricular premature depolarization BC71 Ventricular tachyarrhythmia – BC71.0 Ventricular tachycardia – BC71.1 Ventricular fibrillation – BC71.2 Re-entry ventricular arrhythmia – BC71.Y Other specified ventricular tachyarrhythmia – BC71.Z Ventricular tachyarrhythmia, unspecified –– BC71.00 Right outflow tract ventricular tachycardia –– BC71.01 Polymorphic ventricular tachycardia –– BC71.02 Sustained ventricular tachycardia –– BC71.03 Non-sustained ventricular tachycardia –– BC71.0Y Other specified ventricular tachycardia –– BC71.0Z Ventricular tachycardia, unspecified BC7Y Other specified ventricular rhythm disturbance BC7Z Ventricular rhythm disturbance, unspecified BC80 Supraventricular bradyarrhythmia – BC80.0 Sinus pause – BC80.1 Sinus bradycardia – BC80.2 Sinus node dysfunction – BC80.Y Other specified supraventricular bradyarrhythmia – BC80.Z Supraventricular bradyarrhythmia, unspecified –– BC80.20 Sick sinus syndrome –– BC80.21 Sinoatrial block –– BC80.2Y Other specified sinus node dysfunction –– BC80.2Z Sinus node dysfunction, unspecified BC81 Supraventricular tachyarrhythmia – BC81.0 Ectopic atrial tachycardia – BC81.1 Junctional ectopic tachycardia – BC81.2 Macro reentrant atrial tachycardia – BC81.3 Atrial fibrillation – BC81.4 Wolff-Parkinson-White syndrome – BC81.5 Sinus node reentrant tachycardia – BC81.6 Inappropriate sinus tachycardia – BC81.7 Atrioventricular reciprocating tachycardia – BC81.8 Atrioventricular nodal reentry tachycardia – BC81.Y Other specified supraventricular tachyarrhythmia – BC81.Z Supraventricular tachyarrhythmia, unspecified –– BC81.20 Cavotricuspid isthmus dependent macroreentry tachycardia –– BC81.21 Non-scar, non-isthmus dependent macro reentrant atrial tachycardia –– BC81.22 Scar mediated macro reentrant atrial tachycardia –– BC81.2Y Other specified macro reentrant atrial tachycardia –– BC81.2Z Macro reentrant atrial tachycardia, unspecified –– BC81.30 Paroxysmal atrial fibrillation –– BC81.31 Persistent atrial fibrillation –– BC81.32 Permanent atrial fibrillation –– BC81.33 Preexcited atrial fibrillation –– BC81.3Y Other specified atrial fibrillation –– BC81.3Z Atrial fibrillation, unspecified –– BC81.70 Atrioventricular reciprocating tachycardia, orthodromic –– BC81.71 Atrioventricular reciprocating tachycardia, antidromic –– BC81.7Y Other specified atrioventricular reciprocating tachycardia –– BC81.7Z Atrioventricular reciprocating tachycardia, unspecified BC8Y Other specified supraventricular rhythm disturbance BC8Z Supraventricular rhythm disturbance, unspecified BC90 Rhythm disturbance at level of atrioventricular junction BC91 Pacemaker or implantable cardioverter defibrillator battery at end of battery life BC9Y Other specified cardiac arrhythmia BC9Z Cardiac arrhythmia, unspecified BD10 Congestive heart failure BD11 Left ventricular failure BD11.0 Left ventricular failure with preserved ejection fraction BD11.1 Left ventricular failure with mid range ejection fraction BD11.2 Left ventricular failure with reduced ejection fraction BD11.Z Left ventricular failure, unspecified BD12 High output syndromes BD13 Right ventricular failure BD14 Biventricular failure BD1Y Other specified heart failure BD1Z Heart failure, unspecified BD30 Acute arterial occlusion BD30.0 Acute upper limb arterial occlusion BD30.1 Acute aortoiliac occlusion BD30.2 Acute lower limb arterial occlusion BD30.Y Other specified acute arterial occlusion BD30.Z Acute arterial occlusion, unspecified – BD30.00 Acute thromboembolic upper limb arterial occlusion – BD30.01 Acute thrombotic upper limb arterial occlusion – BD30.0Y Other specified acute upper limb arterial occlusion – BD30.0Z Acute upper limb arterial occlusion, unspecified – BD30.10 Acute thromboembolic aortoiliac occlusion – BD30.11 Acute thrombotic aortoiliac occlusion – BD30.1Y Other specified acute aortoiliac occlusion – BD30.1Z Acute aortoiliac occlusion, unspecified – BD30.20 Acute thromboembolic lower limb arterial occlusion – BD30.21 Acute thrombotic lower limb arterial occlusion – BD30.2Y Other specified acute lower limb arterial occlusion – BD30.2Z Acute lower limb arterial occlusion, unspecified BD40 Atherosclerotic chronic arterial occlusive disease – BD40.0 Lower limb atherosclerosis – BD40.1 Atherosclerosis of aorta – BD40.2 Atherosclerosis of renal artery – BD40.3 Aortic bifurcation syndrome – BD40.Y Other specified atherosclerotic chronic arterial occlusive disease – BD40.Z Atherosclerotic chronic arterial occlusive disease, unspecified BD41 Non-atherosclerotic chronic arterial occlusive disease – BD41.0 Arterial fibromuscular dysplasia – BD41.Y Other specified non-atherosclerotic chronic arterial occlusive disease – BD41.Z Non-atherosclerotic chronic arterial occlusive disease, unspecified BD42 Raynaud phenomenon – BD42.0 Primary Raynaud disease – BD42.1 Secondary Raynaud phenomenon – BD42.Z Raynaud phenomenon, unspecified BD4Y Other specified chronic arterial occlusive disease BD4Z Chronic arterial occlusive disease, unspecified BD50 Aortic aneurysm or dissection BD50.0 Thoracic aortic dissection, ascending aorta dissection and propagation beyond arch BD50.1 Ascending aorta dissection not beyond arch BD50.2 Descending aorta dissection and distal propagation BD50.3 Thoracic aortic aneurysm BD50.4 Abdominal aortic aneurysm BD50.5 Thoracoabdominal aortic aneurysm BD50.Z Aortic aneurysm or dissection, unspecified – BD50.00 Thoracic aortic dissection, ascending aorta dissection and propagation beyond arch with perforation – BD50.01 Thoracic aortic dissection, ascending aorta dissection and propagation beyond arch with rupture – BD50.02 Thoracic aortic dissection, ascending aorta dissection and propagation beyond arch without mention of perforation or rupture – BD50.0Y Other specified thoracic aortic dissection, ascending aorta dissection and propagation beyond arch – BD50.0Z Thoracic aortic dissection, ascending aorta dissection and propagation beyond arch, unspecified – BD50.10 Ascending aorta dissection not beyond arch with perforation – BD50.11 Ascending aorta dissection not beyond arch with rupture – BD50.12 Ascending aorta dissection not beyond arch without mention of perforation or rupture – BD50.1Y Other specified ascending aorta dissection not beyond arch – BD50.1Z Ascending aorta dissection not beyond arch, unspecified – BD50.20 Descending aorta dissection and distal propagation with perforation – BD50.21 Descending aorta dissection and distal propagation with rupture – BD50.22 Descending aorta dissection and distal propagation without mention of perforation or rupture – BD50.2Y Other specified descending aorta dissection and distal propagation – BD50.2Z Descending aorta dissection and distal propagation, unspecified – BD50.30 Thoracic aortic aneurysm with perforation – BD50.31 Thoracic aortic aneurysm with rupture – BD50.32 Thoracic aortic aneurysm without mention of perforation or rupture – BD50.3Y Other specified thoracic aortic aneurysm – BD50.3Z Thoracic aortic aneurysm, unspecified – BD50.40 Abdominal aortic aneurysm with perforation – BD50.41 Abdominal aortic aneurysm with rupture – BD50.4Y Other specified abdominal aortic aneurysm – BD50.4Z Abdominal aortic aneurysm, unspecified – BD50.50 Thoracoabdominal aortic aneurysm with perforation – BD50.51 Thoracoabdominal aortic aneurysm with rupture – BD50.52 Thoracoabdominal aortic aneurysm without mention of perforation or rupture – BD50.5Y Other specified thoracoabdominal aortic aneurysm – BD50.5Z Thoracoabdominal aortic aneurysm, unspecified BD51 Arterial aneurysm or dissection, excluding aorta BD51.0 Aneurysm or dissection of carotid artery BD51.1 Aneurysm or dissection of vertebral artery BD51.2 Aneurysm or dissection of other precerebral arteries BD51.3 Aneurysm or dissection of artery of upper extremity BD51.4 Aneurysm or dissection of renal artery BD51.5 Aneurysm or dissection of iliac artery BD51.6 Aneurysm or dissection of artery of lower extremity BD51.Y Aneurysm and dissection of other artery, excluding aorta BD51.Z Aneurysm and dissection of unspecified artery BD52 Certain specified disorders of arteries or arterioles BD52.0 Segmental arterial mediolysis BD52.1 Arteriovenous fistula, acquired BD52.2 Stricture of artery BD52.3 Rupture of artery BD52.4 Necrosis of artery BD52.5 Coeliac artery compression syndrome BD52.6 Congenital great vessel related acquired abnormality BD52.7 Certain acquired abnormalities of aorta – BD52.70 Acquired abnormality of aortic arch branch – BD52.71 Acquired ascending aorta or root dilation – BD52.7Y Other specified certain acquired abnormalities of aorta – BD52.7Z Certain acquired abnormalities of aorta, unspecified BD53 Secondary disorders of arteries and arterioles BD53.0 Arterial cystic medial diseases BD53.1 Hypothenar hammer syndrome BD53.2 Iliac artery arteriopathy BD53.3 Popliteal entrapment syndrome BD53.4 Cholesterol atheroembolism BD53.Y Other specified secondary disorders of arteries and arterioles BD53.Z Secondary disorders of arteries and arterioles, unspecified – BD53.40 Cholesterol atheroembolism to kidneys – BD53.4Y Cholesterol atheroembolism to other specified sites – BD53.4Z Cholesterol atheroembolism to unspecified site BD54 Diabetic foot ulcer BD55 Asymptomatic stenosis of intracranial or extracranial artery BD56 Asymptomatic occlusion of intracranial or extracranial artery BD5Y Other specified diseases of arteries or arterioles BD5Z Diseases of arteries or arterioles, unspecified BD70 Superficial thrombophlebitis BD70.0 Superficial thrombophlebitis of lower limbs BD70.1 Superficial thrombophlebitis of upper limbs BD70.2 Thrombophlebitis migrans BD70.3 Mondor disease BD70.Y Other specified superficial thrombophlebitis BD70.Z Superficial thrombophlebitis, unspecified BD71 Deep vein thrombosis BD71.0 Upper limb deep vein thrombosis BD71.1 Vena caval thrombosis BD71.2 Renal vein thrombosis BD71.3 Iliac vein thrombosis BD71.4 Lower limb deep vein thrombosis BD71.Y Other specified deep vein thrombosis BD72 Venous thromboembolism BD73 Acquired systemic vein abnormality BD73.0 Acquired inferior caval vein abnormality BD73.1 Acquired superior caval vein abnormality BD73.2 Systemic vein obstruction BD73.3 Acquired coronary sinus abnormality BD73.Y Other specified acquired systemic vein abnormality BD73.Z Acquired systemic vein abnormality, unspecified – BD73.20 Obstruction of peripheral vein – BD73.21 Obstruction of visceral vein – BD73.2Y Other specified systemic vein obstruction – BD73.2Z Systemic vein obstruction, unspecified BD74 Chronic peripheral venous insufficiency of lower extremities BD74.0 Uncomplicated lower limb venous hypertension BD74.1 Lower limb varicose veins BD74.2 Lipodermatosclerosis BD74.3 Venous leg ulcer BD74.Z Chronic peripheral venous insufficiency of lower extremities, unspecified – BD74.10 Varicose veins with great saphenous reflux – BD74.11 Varicose veins with small saphenous reflux – BD74.12 Varicose veins with non-truncal reflux – BD74.1Z Lower limb varicose veins, not further specified – BD74.30 Primary venous leg ulcer – BD74.31 Recurrent venous leg ulcer – BD74.32 Healed venous leg ulcer – BD74.3Z Venous leg ulcer, unspecified BD75 Venous varicosities of sites other than lower extremity BD75.0 Sublingual varices BD75.1 Scrotal varices BD75.2 Vulval varices BD75.3 Pelvic varices BD75.Y Venous varicosities of other specified sites BD75.Z Venous varicosities of unspecified site BD7Y Other specified diseases of veins BD7Z Diseases of veins, unspecified BD90 Lymphadenitis BD90.0 Acute lymphadenitis BD90.1 Nonspecific mesenteric lymphadenitis BD90.2 Chronic lymphadenitis BD90.Y Other specified lymphadenitis BD90.Z Lymphadenitis, unspecified – BD90.20 Chronic cervical lymphadenitis – BD90.21 Chronic axillary lymphadenitis – BD90.22 Chronic inguinal lymphadenitis – BD90.2Y Other specified chronic lymphadenitis – BD90.2Z Chronic lymphadenitis, unspecified BD91 Lymphangitis BD92 Lymphangiectasia BD92.0 Intestinal lymphangiectasia BD92.1 Cutaneous lymphangiectasia BD92.Z Lymphangiectasia, unspecified BD93 Lymphoedema BD93.0 Primary lymphoedema BD93.1 Secondary lymphoedema BD93.Y Other specified forms of lymphoedema BD93.Z Lymphoedema, unspecified – BD93.10 Lymphoedema due to venous insufficiency – BD93.11 Lymphoedema due to dependency and immobility – BD93.12 Lymphoedema due to obesity – BD93.13 Lymphoedema due to lymphatic filariasis – BD93.14 Lymphoedema due to podoconiosis – BD93.15 Lymphoedema due to malignant infiltration – BD93.1Y Lymphoedema secondary to other specified cause – BD93.1Z Secondary lymphoedema, unspecified BD9Y Other specified disorders of lymphatic vessels or lymph nodes BD9Z Disorders of lymphatic vessels or lymph nodes, unspecified BE10 Postcardiotomy syndrome BE11 Other functional disturbances following cardiac surgery BE12 Postprocedural valve disorders BE12.0 Postprocedural mitral valve stenosis BE12.1 Postprocedural mitral valve insufficiency BE12.2 Postprocedural aortic valve stenosis BE12.3 Postprocedural aortic valve insufficiency BE12.4 Postprocedural tricuspid valve stenosis BE12.5 Postprocedural tricuspid valve insufficiency BE12.6 Postprocedural pulmonary valve stenosis BE12.7 Postprocedural pulmonary valve insufficiency BE13 Postprocedural true or false aortic aneurysm BE14 Postprocedural disorder of circulatory system following repair of congenital heart or great vessel anomaly BE14.4 Acquired abnormality of the neopulmonary valve BE14.5 Postprocedural right-sided atrioventricular valvar abnormality in double-inlet ventricle BE14.6 Postprocedural left-sided atrioventricular valvar abnormality in double-inlet ventricle BE14.7 Postprocedural common atrioventricular valvar abnormality in double-inlet ventricle BE14.8 Postprocedural ventricular septal defect disorder BE14.9 Postprocedural aortic disorder related to congenital heart anomaly BE14.A Postprocedural arterial duct disorder BE14.B Postprocedural disorder following cardiovascular conduit or shunt procedure – BE14.40 Neopulmonary valve stenosis – BE14.41 Neopulmonary valve regurgitation BE15 Postprocedural pulmonary arterial tree disorder BE15.0 Postprocedural pulmonary trunk stenosis BE15.1 Postprocedural right pulmonary artery stenosis BE16 Postprocedural pulmonary venous disorder BE17 Postprocedural residual or recurrent interatrial communication BE19 Postprocedural ventricular abnormality BE1A Cardiac transplant associated coronary allograft vasculopathy BE1B Lymphoedema due to surgery or radiotherapy BE1B.0 Postmastectomy lymphoedema syndrome BE1B.1 Lymphoedema due to other medical or surgical procedures BE1C Inferior caval vein obstruction due to foreign body BE1D Superior caval vein obstruction due to foreign body BE1E Postprocedural right atrial complication BE1E.0 Postprocedural right atrial perforation BE1E.1 Right atrial erosion due to implanted device BE1F Postprocedural left atrial complication BE1F.0 Postprocedural left atrial perforation BE1F.1 Left atrial erosion due to implanted device BE2Y Other specified diseases of the circulatory system BE2Z Diseases of the circulatory system, unspecified CA00 Acute nasopharyngitis CA01 Acute sinusitis CA02 Acute pharyngitis CA02.0 Acute pharyngitis due to other bacteria CA02.1 Acute viral pharyngitis CA02.Y Other specified acute pharyngitis CA02.Z Acute pharyngitis, unspecified – CA02.10 Pharyngitis due to Adenovirus – CA02.1Y Other specified acute viral pharyngitis – CA02.1Z Acute viral pharyngitis, unspecified CA03 Acute tonsillitis CA03.0 Streptococcal tonsillitis CA03.Y Other specified acute tonsillitis CA03.Z Acute tonsillitis, unspecified CA04 Acute laryngopharyngitis CA05 Acute laryngitis or tracheitis CA05.0 Acute laryngitis CA05.1 Acute tracheitis CA05.2 Acute laryngotracheitis CA06 Acute obstructive laryngitis or epiglottitis CA06.0 Acute obstructive laryngitis CA06.1 Acute epiglottitis CA06.Z Acute obstructive laryngitis or epiglottitis, unspecified CA07 Acute upper respiratory infections of multiple and unspecified sites CA07.0 Acute upper respiratory infection, site unspecified CA07.1 Acute upper respiratory infections of multiple sites CA08 Vasomotor or allergic rhinitis CA08.0 Allergic rhinitis CA08.1 Non-allergic rhinitis CA08.2 Mixed rhinitis CA08.3 Vasomotor rhinitis CA08.Y Mixed allergic and non-allergic rhinitis CA08.Z Rhinitis, unspecified whether allergic or nonallergic – CA08.00 Allergic rhinitis due to pollen – CA08.01 Allergic rhinitis due to other seasonal allergens – CA08.02 Allergic rhinitis due to house dust mite – CA08.03 Other allergic rhinitis – CA08.0Z Allergic rhinitis, unspecified – CA08.10 Non-allergic rhinitis with eosinophils – CA08.1Y Other specified non-allergic rhinitis – CA08.1Z Non-allergic rhinitis, unspecified CA09 Chronic rhinitis, nasopharyngitis or pharyngitis CA09.0 Chronic rhinitis CA09.1 Chronic nasopharyngitis CA09.2 Chronic pharyngitis CA0A Chronic rhinosinusitis CA0A.0 Samter syndrome CA0A.Y Other specified chronic rhinosinusitis CA0A.Z Chronic rhinosinusitis, unspecified CA0B Silent sinus syndrome CA0C Cyst or mucocele of nose or nasal sinus CA0D Deviated nasal septum CA0E Hypertrophy of nasal turbinates CA0F Chronic diseases of tonsils or adenoids CA0F.0 Hypertrophy of tonsils CA0F.1 Hypertrophy of adenoids CA0F.3 Hypertrophy of tonsils with hypertrophy of adenoids CA0F.Y Other specified chronic diseases of tonsils or adenoids CA0F.Z Chronic diseases of tonsils or adenoids, unspecified CA0G Chronic laryngitis or laryngotracheitis CA0H Diseases of vocal cords or larynx, not elsewhere classified CA0H.0 Paralysis of vocal cords or larynx CA0H.1 Polyp of vocal cord or larynx CA0H.2 Nodules of vocal cords CA0H.3 Oedema of larynx CA0H.4 Laryngeal spasm CA0H.5 Stenosis of larynx CA0H.Y Other specified diseases of vocal cords or larynx, not elsewhere classified CA0H.Z Diseases of vocal cords or larynx, not elsewhere classified, unspecified CA0J Nasal polyp CA0J.0 Polypoid sinus degeneration CA0J.Y Other specified nasal polyp CA0J.Z Nasal polyp, unspecified CA0K Abscess of upper respiratory tract CA0K.0 Retropharyngeal or parapharyngeal abscess CA0K.1 Peritonsillar abscess CA0K.Y Other specified abscess of upper respiratory tract CA0K.Z Abscess of upper respiratory tract, unspecified CA0Y Other specified upper respiratory tract disorders CA0Z Upper respiratory tract disorders, unspecified CA20 Bronchitis CA20.0 Acute noninfectious bronchitis CA20.1 Chronic bronchitis CA20.Y Other specified bronchitis CA20.Z Bronchitis, unspecified – CA20.10 Simple chronic bronchitis – CA20.11 Mucopurulent chronic bronchitis – CA20.12 Mixed simple and mucopurulent chronic bronchitis – CA20.13 Protracted bacterial bronchitis – CA20.1Y Other specified chronic bronchitis – CA20.1Z Chronic bronchitis, unspecified CA21 Emphysema CA21.0 MacLeod syndrome CA21.1 Panlobular emphysema CA21.2 Centrilobular emphysema CA21.Y Other specified emphysema CA21.Z Emphysema, unspecified CA22 Chronic obstructive pulmonary disease CA22.0 Chronic obstructive pulmonary disease with acute exacerbation, unspecified CA22.1 Certain specified chronic obstructive pulmonary disease CA22.Z Chronic obstructive pulmonary disease, unspecified CA23 Asthma CA23.0 Allergic asthma CA23.1 Non-allergic asthma CA23.2 Other specified forms of asthma or bronchospasm CA23.3 Unspecified asthma – CA23.00 Allergic asthma with exacerbation – CA23.01 Allergic asthma with status asthmaticus – CA23.02 Allergic asthma, uncomplicated – CA23.10 Non-allergic asthma with exacerbation – CA23.11 Non-allergic asthma with status asthmaticus – CA23.12 Non-allergic asthma, uncomplicated – CA23.20 Aspirin-induced asthma – CA23.21 Exercise-induced bronchospasm – CA23.22 Cough variant asthma – CA23.30 Unspecified asthma with exacerbation – CA23.31 Unspecified asthma with status asthmaticus – CA23.32 Unspecified asthma, uncomplicated CA24 Bronchiectasis CA25 Cystic fibrosis CA25.0 Classical cystic fibrosis CA25.1 Atypical cystic fibrosis CA25.2 Subclinical cystic fibrosis CA25.Z Cystic fibrosis, unspecified CA26 Chronic bronchiolitis CA26.0 Chronic obliterative bronchiolitis CA26.1 Diffuse panbronchiolitis CA26.Y Other specified chronic bronchiolitis CA26.Z Chronic bronchiolitis, unspecified CA27 Tracheobronchitis CA27.0 Tracheobronchopathia osteochondroplastica CA27.1 Tracheobronchomegaly CA27.Y Other specified tracheobronchitis CA27.Z Tracheobronchitis, unspecified CA2Y Other specified lower respiratory tract disease CA2Z Lower respiratory tract disease, unspecified CA40 Pneumonia CA40.0 Bacterial pneumonia CA40.1 Viral pneumonia CA40.2 Fungal pneumonia CA40.Y Other specified pneumonia CA40.Z Pneumonia, organism unspecified – CA40.00 Pneumonia due to Chlamydophila pneumoniae – CA40.01 Pneumonia due to Escherichia coli – CA40.02 Pneumonia due to Haemophilus influenzae – CA40.03 Pneumonia due to Klebsiella pneumoniae – CA40.04 Pneumonia due to Mycoplasma pneumoniae – CA40.05 Pneumonia due to Pseudomonas aeruginosa – CA40.06 Pneumonia due to Staphylococcus – CA40.07 Pneumonia due to Streptococcus pneumoniae – CA40.08 Pneumonia due to beta-haemolytic streptococcus – CA40.0Y Pneumonia due to other specified bacteria – CA40.0Z Bacterial pneumonia, unspecified – CA40.10 Pneumonia due to Adenovirus – CA40.11 Pneumonia due to Respiratory syncytial virus – CA40.12 Pneumonia due to parainfluenza virus – CA40.13 Pneumonia due to Human metapneumovirus – CA40.1Y Pneumonia due to other specified virus – CA40.1Z Viral pneumonia, unspecified – CA40.20 Pneumonia due to pneumocystis – CA40.2Y Other specified fungal pneumonia – CA40.2Z Fungal pneumonia, unspecified CA41 Acute bronchiolitis CA41.0 Acute bronchiolitis due to respiratory syncytial virus CA41.Y Other specified acute bronchiolitis CA41.Z Acute bronchiolitis, unspecified CA42 Acute bronchitis CA42.0 Acute bronchitis due to Streptococcus CA42.1 Acute bronchitis due to Rhinovirus CA42.2 Acute bronchitis due to Respiratory syncytial virus CA42.3 Acute bronchitis due to Parainfluenza virus CA42.4 Acute bronchitis due to Haemophilus influenzae CA42.5 Acute bronchitis due to Coxsackievirus CA42.Y Other specified acute bronchitis CA42.Z Acute bronchitis, unspecified CA43 Abscess of lung or mediastinum CA43.0 Gangrene or necrosis of lung CA43.1 Abscess of lung with pneumonia CA43.2 Abscess of lung without pneumonia CA43.3 Abscess of mediastinum CA43.Y Other specified abscess of lung or mediastinum CA43.Z Abscess of lung or mediastinum, unspecified CA44 Pyothorax CA45 Respiratory infections, not elsewhere classified CA4Y Other specified lung infections CA4Z Lung infections, unspecified CA60 Pneumoconiosis CA60.0 Pneumoconiosis due to dust containing silica CA60.1 Coal worker pneumoconiosis CA60.2 Pneumoconiosis due to mineral fibres including asbestos CA60.3 Pneumoconiosis associated with tuberculosis CA60.4 Aluminosis of lung CA60.5 Bauxite fibrosis of lung CA60.6 Berylliosis CA60.7 Graphite fibrosis of lung CA60.8 Siderosis CA60.9 Stannosis CA60.Y Other specified pneumoconiosis CA60.Z Pneumoconiosis, unspecified – CA60.00 Pneumoconiosis due to talc dust – CA60.0Y Other specified pneumoconiosis due to dust containing silica – CA60.0Z Pneumoconiosis due to dust containing silica, unspecified CA70 Hypersensitivity pneumonitis due to organic dust – CA70.0 Farmer lung – CA70.1 Bagassosis – CA70.2 Bird fancier lung – CA70.3 Suberosis – CA70.4 Malt worker lung – CA70.5 Mushroom worker lung – CA70.6 Maple bark stripper lung – CA70.7 Air conditioner or humidifier lung – CA70.Y Other specified hypersensitivity pneumonitis due to organic dust – CA70.Z Hypersensitivity pneumonitis due to organic dust, unspecified CA71 Pneumonitis due to solids and liquids – CA71.0 Pneumonitis due to inhalation of food or vomit – CA71.1 Pneumonitis due to oils or essences – CA71.2 Pneumonitis due to aspiration of blood – CA71.3 Lipoid pneumonitis – CA71.Y Other specified pneumonitis due to solids and liquids – CA71.Z Pneumonitis due to solids and liquids, unspecified CA72 Mendelson syndrome CA7Y Other specified pneumonitis CA7Z Pneumonitis, unspecified CA80 Airway disease due to specific organic dust CA80.0 Byssinosis due to exposure to cotton CA80.1 Byssinosis due to exposure to flax CA80.2 Byssinosis due to exposure to cannabis CA80.Y Other specified airway disease due to specific organic dust CA80.Z Airway disease due to specific organic dust, unspecified CA81 Respiratory conditions due to inhalation of chemicals, gases, fumes or vapours CA81.0 Bronchitis or pneumonitis due to chemicals, gases, fumes or vapours CA81.1 Pulmonary oedema due to chemicals, gases, fumes or vapours CA81.2 Upper respiratory inflammation due to chemicals, gases, fumes or vapours, not elsewhere classified CA81.Y Other specified respiratory conditions due to inhalation of chemicals, gases, fumes or vapours CA81.Z Respiratory conditions due to inhalation of chemicals, gases, fumes or vapours, unspecified CA82 Respiratory conditions due to other external agents CA82.0 Acute pulmonary manifestations due to radiation CA82.1 Chronic or other pulmonary manifestations due to radiation CA82.2 Acute drug-induced interstitial lung disorders CA82.3 Chronic drug-induced interstitial lung disorders CA82.4 Aspergillus-induced allergic or hypersensitivity conditions CA82.Y Other specified respiratory conditions due to other external agents CA82.Z Respiratory conditions due to other external agents, unspecified CA8Y Other specified lung diseases due to external agents CA8Z Lung diseases due to external agents, unspecified CB00 Acute respiratory distress syndrome CB01 Pulmonary oedema CB02 Pulmonary eosinophilia CB02.0 Asthmatic pulmonary eosinophilia CB02.1 Idiopathic eosinophilic pneumonitis CB02.2 Tropical pulmonary eosinophilia CB02.Y Other specified pulmonary eosinophilia CB02.Z Pulmonary eosinophilia, unspecified – CB02.10 Idiopathic acute eosinophilic pneumonitis – CB02.11 Idiopathic chronic eosinophilic pneumonitis – CB02.1Y Other specified idiopathic eosinophilic pneumonitis – CB02.1Z Idiopathic eosinophilic pneumonitis, unspecified CB03 Idiopathic interstitial pneumonitis CB03.0 Acute interstitial pneumonitis CB03.1 Combined pulmonary fibrosis and emphysema syndrome CB03.2 Cryptogenic organizing pneumonitis CB03.3 Desquamative interstitial pneumonitis CB03.4 Idiopathic pulmonary fibrosis CB03.5 Lymphoid interstitial pneumonia CB03.6 Respiratory bronchiolitis - interstitial lung disease CB03.Y Other specified idiopathic interstitial pneumonitis CB03.Z Idiopathic interstitial pneumonitis, unspecified CB04 Primary interstitial lung diseases specific to infancy or childhood CB04.0 Diffuse pulmonary developmental disorders CB04.1 Pulmonary lymphatic dysplasia syndromes CB04.2 Disorders of surfactant metabolism CB04.3 Alveolar or peri-alveolar conditions CB04.4 Pulmonary capillaritis CB04.5 Brain-lung-thyroid syndrome CB04.6 Chronic pneumonitis of infancy CB04.7 Neuroendocrine cell hyperplasia of infancy CB04.Y Other specified primary interstitial lung diseases specific to infancy or childhood CB04.Z Primary interstitial lung diseases specific to infancy or childhood, unspecified – CB04.30 Idiopathic pulmonary haemosiderosis – CB04.31 Pulmonary alveolar proteinosis – CB04.3Y Other specified alveolar or peri-alveolar conditions – CB04.3Z Alveolar or peri-alveolar conditions, unspecified CB05 Interstitial lung diseases associated with systemic diseases CB05.0 Diffuse alveolar damage CB05.1 Interstitial lung diseases associated with connective tissue diseases CB05.2 Interstitial lung diseases associated with granulomatous diseases CB05.3 Interstitial lung diseases associated with metabolic diseases CB05.4 Interstitial lung diseases associated with systemic vasculitides CB05.5 Secondary pulmonary haemosiderosis CB05.Y Other specified interstitial lung diseases associated with systemic diseases CB05.Z Interstitial lung diseases associated with systemic diseases, unspecified – CB05.40 Respiratory disorders in Churg-Strauss syndrome – CB05.41 Respiratory disorders in microscopic polyangiitis – CB05.4Y Other specified interstitial lung diseases associated with systemic vasculitides – CB05.4Z Interstitial lung diseases associated with systemic vasculitides, unspecified CB06 Pulmonary alveolar microlithiasis CB07 Lymphangioleiomyomatosis CB07.0 Lymphangioleiomyomatosis associated with tuberous sclerosis complex CB07.1 Sporadic lymphangioleiomyomatosis CB07.Y Other specified lymphangioleiomyomatosis CB07.Z Lymphangioleiomyomatosis, unspecified CB0Y Other specified respiratory diseases principally affecting the lung interstitium CB0Z Respiratory diseases principally affecting the lung interstitium, unspecified CB20 Pleural plaque CB21 Pneumothorax CB21.0 Spontaneous tension pneumothorax CB21.1 Other spontaneous pneumothorax CB21.Y Other specified pneumothorax CB21.Z Pneumothorax, unspecified CB22 Diseases of mediastinum, not elsewhere classified CB22.0 Fibrosing mediastinitis CB22.Y Other specified diseases of mediastinum, not elsewhere classified CB22.Z Diseases of mediastinum, not elsewhere classified, unspecified CB23 Disorders of diaphragm CB24 Chylous effusion CB25 Fibrothorax CB26 Haemothorax CB27 Pleural effusion CB2Y Other specified pleural, diaphragm or mediastinal disorders CB2Z Pleural, diaphragm or mediastinal disorders, unspecified CB40 Certain diseases of the respiratory system CB40.0 Ciliary dyskinesia CB40.1 Young syndrome CB40.2 Pulmonary collapse CB40.3 Interstitial emphysema CB40.4 Compensatory emphysema CB40.Y Other specified diseases of the respiratory system CB41 Respiratory failure CB41.0 Acute respiratory failure CB41.1 Chronic respiratory failure CB41.2 Respiratory failure, unspecified as acute or chronic CB41.00 Acute respiratory failure, Type I CB41.01 Acute respiratory failure, Type II CB41.0Z Acute respiratory failure, unspecified CB41.10 Chronic respiratory failure, Type I CB41.11 Chronic respiratory failure, Type II CB41.1Z Chronic respiratory failure, unspecified CB41.20 Respiratory failure, unspecified, Type I CB41.21 Respiratory failure, unspecified, Type II CB41.2Z Respiratory failure, unspecified CB60 Tracheostomy malfunction CB61 Chronic pulmonary insufficiency following surgery CB62 Postprocedural subglottic stenosis CB63 Postprocedural stenosis of the trachea CB64 Transfusion related acute lung injury CB7Z Diseases of the respiratory system, unspecified DA00 Disorders of lips DA00.0 Cheilitis DA00.1 Self-induced lip trauma DA00.2 Pigmentary abnormalities of lips DA00.3 Lip fissure DA00.Y Other specified disorders of lips DA00.Z Disorder of lips, unspecified DA01 Disorders of oral mucosa DA01.0 Disturbances of oral epithelium DA01.1 Noninfectious erosive or ulcerative disorders of oral mucosa DA01.2 Granuloma or granuloma-like lesions of oral mucosa DA01.3 Infections of lips or oral mucosa DA01.4 Irritative hyperplasia of oral mucosa DA01.Y Other specified disorders of oral mucosa DA01.Z Disorder of oral mucosa, unspecified – DA01.00 Oral leukoplakia – DA01.01 Hairy leukoplakia – DA01.02 Wandering rash of the mouth – DA01.0Y Other specified disturbances of oral epithelium – DA01.10 Oral aphthae or aphtha-like ulceration – DA01.11 Oral mucositis – DA01.12 Chronic ulcerative stomatitis – DA01.13 Erythema multiforme with oral ulceration – DA01.14 Drug-induced oral ulcer – DA01.15 Mouth ulcers – DA01.1Y Other specified noninfectious erosive or ulcerative disorders of oral mucosa – DA01.20 Giant cell granuloma, central – DA01.21 Orofacial granulomatosis – DA01.2Y Other specified granuloma or granuloma-like lesions of oral mucosa – DA01.30 Cellulitis or abscess of soft tissues of the mouth – DA01.3Y Other specified infections of lips or oral mucosa – DA01.40 Papillary hyperplasia of oral mucosa – DA01.41 Denture hyperplasia – DA01.42 Oral fibroepithelial polyp – DA01.4Z Irritative hyperplasia of oral mucosa, unspecified DA02 Miscellaneous specified disorders of lips or oral mucosa DA02.0 Genetic or developmental disorders involving lips or oral mucosa DA02.1 Xerostomia DA02.2 Oral submucous fibrosis DA02.3 Contact gingivostomatitis – DA02.30 Allergic contact gingivostomatitis – DA02.31 Irritant contact gingivostomatitis DA03 Diseases of tongue DA03.0 Glossitis DA03.1 Geographic tongue DA03.2 Atrophy of tongue papillae DA03.3 Median rhomboid glossitis DA03.4 Hypertrophy of tongue papillae DA03.5 Macroglossia DA03.Y Other specified diseases of tongue DA03.Z Diseases of tongue, unspecified DA04 Diseases of salivary glands DA04.0 Atrophy of salivary gland DA04.1 Hypertrophy of salivary gland DA04.2 Sialoadenitis DA04.3 Abscess of salivary gland DA04.4 Sialolithiasis DA04.5 Mucocele of salivary gland DA04.6 Disturbances of salivary secretion DA04.7 Sialophagia DA04.8 Sialoschesis DA04.Y Other specified diseases of salivary glands DA04.Z Diseases of salivary glands, unspecified DA05 Cysts of oral or facial-neck region DA05.0 Developmental odontogenic cysts DA05.1 Developmental nonodontogenic cysts of oral region DA05.Y Other specified cysts of oral or facial-neck region DA05.Z Cysts of oral or facial-neck region, unspecified DA06 Certain specified diseases of jaws DA06.0 Inflammatory conditions of jaws DA06.1 Alveolitis of jaw DA06.2 Exostosis of jaw DA06.3 Stafne mandibular bone cavity DA07 Disorders of tooth development or eruption DA07.0 Fluoride related opacities or lesions DA07.1 Nonfluoride enamel opacities DA07.3 Disturbances in tooth formation DA07.4 Root anomaly DA07.5 Cementum dysplasia DA07.6 Disturbances in tooth eruption DA07.7 Embedded teeth DA07.8 Impacted teeth DA07.Y Other specified disorders of tooth development or eruption DA07.Z Disorders of tooth development or eruption, unspecified – DA07.60 Teething syndrome – DA07.61 Ankylosis of teeth – DA07.6Y Other specified disturbances in tooth eruption – DA07.6Z Disturbances in tooth eruption, unspecified DA08 Diseases of hard tissues of teeth DA08.0 Dental caries DA08.1 Certain specified diseases of hard tissues of teeth DA08.2 Chronic dental injuries DA08.3 Nontraumatic fracture of tooth DA08.4 Deposits on teeth DA08.Y Other specified diseases of hard tissues of teeth DA08.Z Diseases of hard tissues of teeth, unspecified – DA08.10 Excessive attrition of teeth – DA08.11 Abrasion of teeth – DA08.12 Erosion of teeth – DA08.13 Abfraction – DA08.14 Pathological resorption of teeth – DA08.15 Posteruptive colour changes of dental hard tissues DA09 Diseases of pulp or periapical tissues DA09.0 Pulpitis DA09.1 Necrosis of pulp DA09.2 Pulp abscess DA09.3 Phoenix abscess DA09.4 Pulp degeneration DA09.5 Abnormal hard tissue formation in pulp DA09.6 Periapical abscess DA09.7 Periapical periodontitis DA09.8 Radicular cyst DA09.Y Other specified diseases of pulp or periapical tissues DA09.Z Diseases of pulp or periapical tissues, unspecified – DA09.60 Periapical abscess with facial involvement – DA09.61 Periapical abscess with sinus – DA09.62 Periapical abscess without sinus – DA09.6Y Other specified periapical abscess – DA09.6Z Periapical abscess, unspecified – DA09.70 Acute apical periodontitis of pulpal origin – DA09.71 Chronic apical periodontitis – DA09.7Y Other specified periapical periodontitis – DA09.7Z Periapical periodontitis, unspecified DA0A Certain specified disorders of teeth or supporting structures DA0A.0 Exfoliation of teeth due to systemic causes DA0A.1 Loss of teeth due to accident, extraction or local periodontal disease DA0A.2 Atrophy of edentulous alveolar ridge DA0A.3 Retained dental root DA0A.Y Other specified disorders of teeth and supporting structures DA0A.Z Unspecified disorders of teeth and supporting structures DA0B Gingival diseases DA0B.0 Allergic gingivitis DA0B.1 Catarrhal gingivitis DA0B.2 Eruptive gingivitis DA0B.3 Atrophic senile gingivitis DA0B.4 Acute multiple gingival abscesses DA0B.5 Developmental or acquired deformities or conditions of gingiva DA0B.6 Pericoronitis DA0B.Y Other specified gingival diseases DA0B.Z Gingival diseases, unspecified DA0C Periodontal disease DA0C.0 Acute periodontitis DA0C.1 Aggressive periodontitis DA0C.2 Periodontosis DA0C.3 Necrotising periodontal diseases DA0C.4 Abscess of periodontium DA0C.5 Linear gingival erythema DA0C.Y Other specified periodontal disease DA0C.Z Periodontal disease, unspecified – DA0C.30 Necrotising ulcerative periodontitis – DA0C.31 Noma – DA0C.3Y Other specified necrotising periodontal diseases – DA0C.3Z Necrotising periodontal diseases, unspecified DA0D Certain specified disorders of gingiva or edentulous alveolar ridge DA0D.0 Gingival recession DA0D.1 Gingival enlargement DA0D.2 Gingival or edentulous alveolar ridge lesions associated with trauma DA0D.3 Hypoplasminogenaemia DA0D.4 Cotton-roll gingivitis DA0D.5 Gingival ulceration DA0D.Y Other specified disorders of gingival or edentulous alveolar ridge DA0E Dentofacial anomalies DA0E.0 Major anomalies of jaw size DA0E.1 Anomalies of jaw-cranial base relationship DA0E.2 Anomalies of dental arch relationship DA0E.3 Anomalies of tooth position DA0E.4 Food impaction DA0E.5 Malocclusion DA0E.6 Dentofacial functional abnormalities DA0E.7 Dentofacial parafunctional disorders DA0E.8 Temporomandibular joint disorders DA0E.Y Other specified dentofacial anomalies DA0E.Z Dentofacial anomalies, unspecified – DA0E.00 Micrognathia – DA0E.0Y Other specified major anomalies of jaw size – DA0E.0Z Major anomalies of jaw size, unspecified – DA0E.50 Class II division 2 malocclusion – DA0E.51 Angle class I malocclusion – DA0E.5Y Other specified malocclusion – DA0E.5Z Malocclusion, unspecified DA0F Sensory disturbances affecting orofacial complex DA0F.0 Burning mouth syndrome DA0F.Y Other specified sensory disturbances affecting orofacial complex DA0F.Z Sensory disturbances affecting orofacial complex, unspecified DA0Y Other specified diseases or disorders of orofacial complex DA0Z Diseases or disorders of orofacial complex, unspecified DA20 Acquired anatomical alterations of the oesophagus DA20.0 Oesophageal obstruction DA20.1 Diverticulum of oesophagus, acquired DA20.2 Oesophageal web DA20.3 Perforation of oesophagus DA20.Y Other specified acquired anatomical alterations of the oesophagus DA20.Z Acquired anatomical alterations of the oesophagus, unspecified – DA20.30 Spontaneous rupture of oesophagus – DA20.3Y Other specified perforation of oesophagus – DA20.3Z Perforation of oesophagus, unspecified DA21 Motility disorders of oesophagus DA21.0 Achalasia DA21.1 Motility disorder of cervical or upper oesophagus DA21.2 Disorder of oesophageal peristalsis DA21.3 Disorder of lower oesophageal sphincter function DA21.Y Other specified motility disorders of oesophagus DA21.Z Motility disorders of oesophagus, unspecified – DA21.20 Hypertensive peristalsis – DA21.21 Hypotensive peristalsis – DA21.22 Spastic peristalsis – DA21.2Y Other specified disorder of oesophageal peristalsis – DA21.2Z Disorder of oesophageal peristalsis, unspecified DA22 Gastro-oesophageal reflux disease DA22.0 Non-erosive gastro-oesophageal reflux disease DA22.1 Erosive gastro-oesophageal reflux disease DA22.Z Gastro-oesophageal reflux disease, unspecified DA23 Columnar metaplastic epithelium of the oesophagus DA23.0 Barrett epithelium DA23.1 Dysplasia of Barrett epithelium DA23.2 Barrett ulcer DA23.Y Other specified columnar metaplastic epithelium of the oesophagus DA23.Z Columnar metaplastic epithelium of the oesophagus, unspecified DA24 Oesophagitis DA24.0 Infectious oesophagitis DA24.1 Eosinophilic oesophagitis DA24.2 Oesophagitis due to external causes DA24.Y Other specified oesophagitis DA24.Z Oesophagitis, unspecified – DA24.00 Oesophageal phlegmon – DA24.0Y Other specified infectious oesophagitis – DA24.0Z Infectious oesophagitis, unspecified – DA24.20 Chemical oesophagitis – DA24.21 Drug-induced oesophagitis – DA24.22 Radiation oesophagitis – DA24.2Z Oesophagitis due to external causes, unspecified DA25 Oesophageal ulcer DA25.0 Oesophageal erosion DA25.1 Infectious oesophageal ulcer DA25.2 Oesophageal ulcer due to allergic or immunologic disorder DA25.3 Oesophageal ulcer due to external causes DA25.Y Other specified oesophageal ulcer DA25.Z Oesophageal ulcer, unspecified – DA25.10 Bacterial oesophageal ulcer – DA25.11 Fungal oesophageal ulcer – DA25.12 Parasitic oesophageal ulcer – DA25.13 Viral oesophageal ulcer – DA25.1Y Other specified infectious oesophageal ulcer – DA25.1Z Infectious oesophageal ulcer, unspecified – DA25.30 Chemical oesophageal ulcer – DA25.31 Drug-induced oesophageal ulcer – DA25.32 Radiation oesophageal ulcer – DA25.3Y Oesophageal ulcer due to other specified external causes – DA25.3Z Oesophageal ulcer due to external causes, unspecified DA26 Vascular disorders of the oesophagus DA26.0 Oesophageal varices DA26.1 Angiodysplasia or arteriovenous malformation of oesophagus DA26.2 Intramural haemorrhage of oesophagus DA26.3 Gastro-oesophageal laceration-haemorrhage syndrome DA26.Y Other specified vascular disorders of the oesophagus DA26.Z Vascular disorders of the oesophagus, unspecified – DA26.00 Oesophageal varices with bleeding – DA26.01 Oesophageal varices without bleeding – DA26.0Z Oesophageal varices, unspecified DA2Y Other specified diseases of oesophagus DA2Z Diseases of oesophagus, unspecified DA40 Acquired anatomical alterations of the stomach – DA40.0 Gastric outlet obstruction – DA40.1 Gastric fistula, acquired – DA40.2 Gastric volvulus – DA40.3 Gastric diverticulum – DA40.4 Hourglass stricture and stenosis of stomach – DA40.5 Gastroptosis – DA40.Y Other specified acquired anatomical alterations of the stomach – DA40.Z Acquired anatomical alterations of the stomach, unspecified DA41 Gastroduodenal motor or secretory disorders – DA41.0 Abnormal gastric motility – DA41.1 Acute dilatation of stomach – DA41.2 Acid hypersecretion – DA41.3 Achlorhydria – DA41.Y Other specified gastroduodenal motor or secretory disorders – DA41.Z Gastroduodenal motor or secretory disorders, unspecified –– DA41.00 Gastroparesis –– DA41.0Y Other specified abnormal gastric motility –– DA41.0Z Abnormal gastric motility, unspecified DA42 Gastritis – DA42.0 Autoimmune gastritis – DA42.1 Helicobacter pylori induced gastritis – DA42.2 Eosinophilic gastritis – DA42.3 Lymphocytic gastritis – DA42.4 Allergic gastritis – DA42.5 Gastritis due to duodenogastric reflux – DA42.6 Menetrier disease – DA42.7 Gastritis of unknown aetiology with specific endoscopic or pathological features – DA42.8 Gastritis due to external causes – DA42.9 Gastric phlegmon – DA42.Y Other specified gastritis – DA42.Z Gastritis, unspecified –– DA42.40 Allergic gastritis due to IgE-mediated hypersensitivity –– DA42.41 Allergic gastritis due to non-IgE-mediated hypersensitivity –– DA42.4Y Other specified allergic gastritis –– DA42.4Z Allergic gastritis, unspecified –– DA42.70 Acute superficial gastritis of unknown aetiology –– DA42.71 Chronic superficial gastritis of unknown aetiology –– DA42.72 Acute haemorrhagic gastritis of unknown aetiology –– DA42.73 Chronic atrophic gastritis of unknown aetiology –– DA42.74 Metaplastic gastritis of unknown aetiology –– DA42.75 Granulomatous gastritis of unknown aetiology –– DA42.76 Hypertrophic gastritis of unknown aetiology –– DA42.7Y Other specified gastritis of unknown aetiology with specific endoscopic or pathological features –– DA42.80 Alcoholic gastritis –– DA42.81 Radiation gastritis –– DA42.82 Chemical gastritis –– DA42.83 Drug-induced gastritis –– DA42.8Z Gastritis due to external causes, unspecified DA43 Vascular disorders of the stomach – DA43.0 Gastric varices – DA43.1 Angiodysplasia of stomach – DA43.2 Arteriovenous malformation of stomach – DA43.3 Portal hypertensive gastropathy – DA43.4 Diffuse vascular ectasia of stomach – DA43.Y Other specified vascular disorders of the stomach – DA43.Z Vascular disorders of the stomach, unspecified DA44 Gastric polyp – DA44.0 Hyperplastic polyp of stomach – DA44.1 Fundic gland polyp of stomach – DA44.2 Hamartomatous polyp of stomach – DA44.Y Other specified gastric polyp – DA44.Z Gastric polyp, unspecified DA4Y Other specified diseases of stomach DA4Z Diseases of stomach, unspecified DA50 Acquired anatomical alterations of the duodenum – DA50.0 Obstruction of duodenum – DA50.1 Diverticulum of duodenum – DA50.2 Fistula of duodenum – DA50.3 Deformity of duodenum, acquired – DA50.Y Other specified acquired anatomical alterations of the duodenum – DA50.Z Acquired anatomical alterations of the duodenum, unspecified DA51 Duodenitis – DA51.0 Helicobacter-pylori associated duodenitis – DA51.1 Eosinophilic duodenitis – DA51.2 Lymphocytic duodenitis – DA51.3 Allergic duodenitis – DA51.4 Duodenitis of unknown aetiology with specific endoscopic or pathologic features – DA51.5 Duodenitis due to external causes – DA51.6 Infectious duodenitis – DA51.Y Other specified duodenitis – DA51.Z Duodenitis, unspecified –– DA51.40 Acute haemorrhagic duodenitis of unknown aetiology –– DA51.41 Granulomatous duodenitis of unknown aetiology –– DA51.4Z Duodenitis of unknown aetiology with specific endoscopic or pathologic features, unspecified –– DA51.50 Alcoholic duodenitis –– DA51.51 Drug-induced duodenitis –– DA51.52 Chemical duodenitis –– DA51.53 Radiation duodenitis –– DA51.5Y Duodenitis due to other specified external causes –– DA51.5Z Duodenitis due to external causes, unspecified –– DA51.60 Duodenal phlegmon –– DA51.6Y Other specified infectious duodenitis –– DA51.6Z Infectious duodenitis, unspecified DA52 Vascular disorders of the duodenum – DA52.0 Duodenal varices – DA52.1 Angiodysplasia of duodenum – DA52.2 Arteriovenous malformation of duodenum – DA52.Y Other specified vascular disorders of the duodenum – DA52.Z Vascular disorders of the duodenum, unspecified DA53 Duodenal polyp – DA53.0 Hyperplastic duodenal polyp – DA53.Y Other specified duodenal polyp – DA53.Z Duodenal polyp, unspecified DA5Y Other specified diseases of duodenum DA5Z Diseases of duodenum, unspecified DA60 Gastric ulcer – DA60.0 Gastric erosion – DA60.1 Helicobacter pylori associated gastric ulcer – DA60.2 Helicobacter pylori associated and drug-induced gastric ulcer – DA60.3 Stress ulcer of stomach – DA60.4 Eosinophilic gastric ulcer – DA60.5 Lymphocytic gastric ulcer – DA60.6 Gastric ulcer due to external causes – DA60.7 Infectious secondary gastric ulcer – DA60.Y Other specified gastric ulcer – DA60.Z Gastric ulcer, unspecified –– DA60.60 Alcohol-induced gastric ulcer –– DA60.61 Chemical gastric ulcer –– DA60.62 Drug-induced gastric ulcer –– DA60.63 Radiation gastric ulcer –– DA60.6Y Other specified gastric ulcer due to external causes –– DA60.6Z Gastric ulcer due to external causes, unspecified DA61 Peptic ulcer, site unspecified DA62 Anastomotic ulcer – DA62.0 Anastomotic erosion – DA62.1 Helicobacter pylori associated anastomotic ulcer – DA62.2 Drug-induced anastomotic ulcer – DA62.3 Peptic anastomotic ulcer – DA62.Y Other specified anastomotic ulcer – DA62.Z Anastomotic ulcer, unspecified DA63 Duodenal ulcer – DA63.0 Duodenal erosion – DA63.1 Helicobacter-pylori associated duodenal ulcer – DA63.2 Helicobacter-pylori associated and drug-induced duodenal ulcer – DA63.3 Stress ulcer of duodenum – DA63.4 Eosinophilic duodenal ulcer – DA63.5 Duodenal ulcer due to external causes – DA63.6 Infectious duodenal ulcer – DA63.Y Other specified duodenal ulcer – DA63.Z Duodenal ulcer, unspecified –– DA63.50 Drug-induced duodenal ulcer –– DA63.51 Radiation duodenal ulcer –– DA63.52 Chemical duodenal ulcer –– DA63.5Y Duodenal ulcer due to other specified external causes –– DA63.5Z Duodenal ulcer due to external causes, unspecified –– DA63.60 Bacterial duodenal ulcer –– DA63.61 Viral duodenal ulcer –– DA63.62 Fungal duodenal ulcer –– DA63.6Z Infectious duodenal ulcer, unspecified DA7Z Diseases of the stomach or the duodenum, unspecified DA90 Nonstructural developmental anomalies of small intestine DA90.0 Syndromic diarrhoea DA90.1 Congenital intestinal transport defect DA90.2 Congenital intestinal motility disorders DA90.Y Other specified nonstructural developmental anomalies of small intestine DA90.Z Nonstructural developmental anomalies of small intestine, unspecified DA91 Obstruction of small intestine DA91.0 Intussusception of small intestine DA91.1 Volvulus of small intestine DA91.2 Intestinal adhesions or bands of small intestine with obstruction DA91.3 Obstructive ileus of small intestine due to impaction DA91.Y Other specified obstruction of small intestine DA91.Z Obstruction of small intestine, unspecified – DA91.30 Gallstone ileus of small intestine – DA91.31 Enterolith of small intestine – DA91.3Y Other specified obstructive ileus of small intestine due to impaction – DA91.3Z Obstructive ileus of small intestine due to impaction, unspecified DA92 Other acquired anatomical alterations of small intestine DA92.0 Fistula of small intestine DA92.1 Pneumatosis intestinalis of small intestine DA92.Y Other specified other acquired anatomical alterations of small intestine DA92.Z Other acquired anatomical alterations of small intestine, unspecified DA93 Motility disorders of small intestine DA93.0 Paralytic ileus DA93.Y Other specified motility disorders of small intestine DA93.Z Motility disorders of small intestine, unspecified DA94 Noninfectious enteritis or ulcer of small intestine DA94.0 Primary ulcer of small intestine DA94.1 Drug-induced or toxic enteritis of small intestine DA94.2 Allergic or dietetic enteritis of small intestine DA94.3 Enteritis or ulcer of small intestine due to other external causes DA94.Y Other specified noninfectious enteritis or ulcer of small intestine DA94.Z Noninfectious enteritis or ulcer of small intestine, unspecified – DA94.00 Primary nonspecific ulceration of small intestine – DA94.01 Chronic non-specific multiple ulcers of small intestine – DA94.02 Cryptogenic multifocal ulcerous stenosing enteritis – DA94.0Y Other specified primary ulcer of small intestine – DA94.0Z Primary ulcer of small intestine, unspecified – DA94.20 IgE mediated allergic enteritis of small intestine – DA94.21 Eosinophilic enteritis – DA94.22 Food protein-induced enterocolitis syndrome – DA94.2Y Other specified allergic or dietetic enteritis of small intestine – DA94.2Z Allergic or dietetic enteritis of small intestine, unspecified – DA94.30 Enteritis or ulcer of small intestine due to foreign body – DA94.31 Enteritis or ulcer of small intestine due to radiation – DA94.32 Enteritis or ulcer of small intestine due to trauma – DA94.3Z Enteritis or ulcer of small intestine due to other external causes, unspecified DA95 Coeliac disease DA96 Intestinal malabsorption or protein-losing enteropathy DA96.0 Intestinal malabsorption DA96.1 Protein-losing enteropathy DA96.Y Other specified intestinal malabsorption or protein-losing enteropathy DA96.Z Intestinal malabsorption or protein-losing enteropathy, unspecified – DA96.00 Bacterial overgrowth syndrome – DA96.01 Tropical sprue – DA96.02 Malabsorption or intolerance of specific nutrients – DA96.04 Short bowel syndrome – DA96.05 Intestinal failure – DA96.0Y Other specified intestinal malabsorption – DA96.0Z Intestinal malabsorption, unspecified DA97 Certain vascular disorders of small intestine DA97.0 Angiodysplasia of small intestine DA97.1 Arteriovenous malformation of small intestine DA97.2 Vasculitis of mesenteric arteries DA97.3 Varices of small intestine DA97.Z Certain vascular disorders of small intestine, unspecified DA98 Polyps of small intestine DA98.0 Hamartoma of small intestine DA98.1 Hyperplastic polyp of small intestine DA98.2 Inflammatory fibroid polyp of small intestine DA98.3 Lymphoid hyperplasia of small intestine DA98.Y Other specified polyps of small intestine DA98.Z Polyps of small intestine, unspecified DA9Y Other specified diseases of small intestine DA9Z Diseases of small intestine, unspecified DB10 Appendicitis DB10.0 Acute appendicitis DB10.1 Chronic appendicitis DB10.Y Other specified appendicitis DB10.Z Appendicitis, unspecified – DB10.00 Acute appendicitis with generalised peritonitis – DB10.01 Acute appendicitis with localised peritonitis – DB10.02 Acute appendicitis without localised or generalised peritonitis DB11 Certain specified diseases of appendix DB11.0 Megaloappendix DB11.1 Hyperplasia of appendix DB11.2 Appendicular concretions DB11.3 Diverticulum of appendix, acquired DB11.4 Fistula of appendix DB11.5 Intussusception of appendix DB11.6 Mucocele of appendix DB1Y Other specified diseases of appendix DB1Z Diseases of appendix, unspecified DB30 Obstruction of large intestine DB30.0 Intussusception of the large intestine DB30.1 Volvulus of large intestine DB30.2 Adhesions of large intestine with obstruction DB30.3 Impaction of large intestine DB30.4 Stenosis of the rectum DB30.Y Other specified obstruction of large intestine DB30.Z Obstruction of large intestine, unspecified DB31 Other acquired anatomical alterations of large intestine DB31.0 Fistula of large intestine DB31.1 Pneumatosis intestinalis of large intestine DB31.2 Rectal prolapse DB31.Y Other specified other acquired anatomical alterations of large intestine DB31.Z Other acquired anatomical alterations of large intestine, unspecified DB32 Motility disorders of large intestine DB32.0 Pseudo-obstruction of colon DB32.1 Slow transit constipation DB32.2 Megacolon DB32.3 Acquired hypoganglionosis of large intestine DB32.Y Other specified motility disorders of large intestine DB32.Z Motility disorders of large intestine, unspecified – DB32.20 Toxic megacolon – DB32.2Y Other specified megacolon – DB32.2Z Megacolon, unspecified DB33 Certain noninfectious colitis or proctitis DB33.0 Primary ulcer of colon DB33.1 Microscopic colitis DB33.2 Allergic or dietetic colitis DB33.3 Diversion colitis DB33.4 Colitis or proctitis due to external causes DB33.Y Other specified noninfectious colitis or proctitis DB33.Z Certain noninfectious colitis or proctitis, unspecified – DB33.10 Collagenous colitis – DB33.11 Lymphocytic colitis – DB33.1Y Other specified microscopic colitis – DB33.1Z Microscopic colitis, unspecified – DB33.20 Food protein-induced proctitis or colitis of infants – DB33.2Y Other specified allergic or dietetic colitis – DB33.2Z Allergic or dietetic colitis, unspecified – DB33.40 Chemical colitis or proctitis – DB33.41 Radiation-induced colitis – DB33.42 Radiation proctitis – DB33.43 Drug-induced colitis – DB33.4Y Other specified colitis or proctitis due to external causes – DB33.4Z Colitis or proctitis due to external causes, unspecified DB34 Certain vascular disorders of large intestine DB34.0 Angiodysplasia of colon DB34.1 Arteriovenous malformation of large intestine DB34.2 Vasculitis of large intestine DB34.3 Varices of large intestine DB34.4 Acute haemorrhagic rectal ulcer DB34.Y Other specified vascular disorders of large intestine DB34.Z Vascular disorders of large intestine, unspecified DB35 Polyp of large intestine DB35.0 Hyperplastic polyp of large intestine DB35.1 Inflammatory polyp of large intestine DB35.2 Benign lymphoid polyp of large intestine DB35.3 Hamartomatous polyp DB35.4 Inflammatory fibroid polyp of large intestine DB35.Y Other specified polyp of large intestine DB35.Z Polyp of large intestine, unspecified DB36 Certain infections of the large intestine DB36.0 Colonic abscess DB36.1 Rectal abscess DB36.Y Other specified infections of the large intestine DB36.Z Certain infections of the large intestine, unspecified – DB36.10 Perirectal abscess – DB36.11 Ischiorectal abscess – DB36.12 Rectal cellulitis DB3Y Other specified diseases of large intestine DB3Z Diseases of large intestine, unspecified DB50 Fissure or fistula of anal regions – DB50.0 Anal fissure – DB50.1 Anal fistula – DB50.2 Anorectal fistula – DB50.Y Other specified fissure or fistula of anal regions – DB50.Z Fissure or fistula of anal regions, unspecified DB51 Stenosis of anal canal DB52 Ulcer of anus DB53 Anal prolapse DB5Y Other specified acquired anatomical alterations of the anal canal DB5Z Acquired anatomical alterations of the anal canal, unspecified DB60 Haemorrhoids – DB60.0 First degree haemorrhoids – DB60.1 Second degree haemorrhoids – DB60.2 Third degree haemorrhoids – DB60.3 Fourth degree haemorrhoids – DB60.Z Haemorrhoids, unspecified DB61 Perianal venous thrombosis DB62 Residual haemorrhoidal skin tags DB6Y Other specified haemorrhoids or perianal venous conditions DB6Z Haemorrhoids or perianal venous conditions, unspecified DB70 Infections of the anal region DB70.0 Abscess of anal regions DB70.Y Other specified infections of the anal region DB70.Z Infections of the anal region, unspecified – DB70.00 Anal abscess – DB70.01 Anorectal abscess – DB70.02 Intrasphincteric abscess – DB70.0Y Other specified abscess of anal regions – DB70.0Z Abscess of anal regions, unspecified DB71 Anal polyp DB71.0 Inflammatory anal polyp DB71.1 Lymphoid polyp DB71.2 Hypertrophied anal papillae DB71.Y Other specified anal polyp DB71.Z Anal polyp, unspecified DB72 Certain specified diseases of anal canal DB72.0 Anal spasm DB72.Z Certain specified diseases of anal canal, unspecified DB7Y Other specified diseases of anal canal DB7Z Diseases of anal canal, unspecified DB90 Infectious liver disease DB90.0 Abscess of liver DB90.Y Other specified infectious liver disease DB90.Z Infectious liver disease, unspecified DB91 Acute or subacute hepatic failure DB91.0 Acute or subacute hepatic failure due to hepatitis virus DB91.1 Other acute or subacute hepatic failure DB91.Z Acute or subacute hepatic failure, unspecified DB92 Non-alcoholic fatty liver disease DB92.0 Non-alcoholic fatty liver disease without non-alcoholic steatohepatitis DB92.1 Non-alcoholic steatohepatitis DB92.Y Other specified non-alcoholic fatty liver disease DB92.Z Non-alcoholic fatty liver disease, unspecified DB93 Hepatic fibrosis or cirrhosis DB93.0 Hepatic fibrosis DB93.1 Hepatic cirrhosis DB93.2 Certain specified fibrosis or cirrhosis of liver DB93.Y Other specified hepatic fibrosis or cirrhosis – DB93.20 Hereditary North American Indian childhood cirrhosis – DB93.21 Idiopathic copper-associated cirrhosis DB94 Alcoholic liver disease DB94.0 Alcoholic fatty liver DB94.1 Alcoholic hepatitis DB94.2 Alcoholic liver fibrosis DB94.3 Alcoholic cirrhosis of liver without hepatitis DB94.Y Other specified alcoholic liver disease DB94.Z Alcoholic liver disease, unspecified – DB94.10 Alcoholic hepatitis with cirrhosis – DB94.1Y Other specified alcoholic hepatitis – DB94.1Z Alcoholic hepatitis, unspecified DB95 Drug-induced or toxic liver disease DB95.0 Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis DB95.1 Drug-induced or toxic liver disease with chronic hepatitis DB95.2 Drug-induced or toxic liver disease with cholestasis DB95.3 Drug-induced or toxic liver disease with fatty liver DB95.4 Drug-induced or toxic liver disease with granulomatous hepatitis DB95.5 Drug-induced or toxic liver disease with fibrosis or cirrhosis of liver DB95.6 Drug-induced or toxic liver disease with vascular disorders of the liver DB95.7 Drug-induced or toxic liver disease with liver tumours DB95.Y Other specified drug-induced or toxic liver disease DB95.Z Drug-induced or toxic liver disease, unspecified – DB95.10 Drug-induced or toxic liver disease with chronic hepatitis with cirrhosis – DB95.11 Drug-induced or toxic liver disease with chronic hepatitis without cirrhosis – DB95.1Y Other specified drug-induced or toxic liver disease with chronic hepatitis – DB95.1Z Drug-induced or toxic liver disease with chronic hepatitis, unspecified – DB95.20 Chronic drug-induced or toxic liver disease with cholestasis – DB95.2Y Other specified drug-induced or toxic liver disease with cholestasis – DB95.2Z Drug-induced or toxic liver disease with cholestasis, unspecified – DB95.30 Drug-induced or toxic liver disease with chronic fatty liver disease – DB95.3Y Other specified drug-induced or toxic liver disease with fatty liver – DB95.3Z Drug-induced or toxic liver disease with fatty liver, unspecified DB96 Autoimmune liver disease DB96.0 Autoimmune hepatitis DB96.1 Primary biliary cholangitis DB96.2 Primary sclerosing cholangitis DB96.Y Other specified autoimmune liver disease DB96.Z Autoimmune liver disease, unspecified – DB96.10 Primary biliary cholangitis with overlap syndrome – DB96.1Y Other specified primary biliary cholangitis – DB96.1Z Primary biliary cholangitis, unspecified – DB96.20 Primary sclerosing cholangitis with cirrhosis – DB96.2Y Other specified primary sclerosing cholangitis – DB96.2Z Primary sclerosing cholangitis, unspecified DB97 Certain specified inflammatory liver diseases DB97.0 Idiopathic granulomatous hepatitis DB97.1 Hepatic berylliosis DB97.2 Chronic hepatitis, not elsewhere classified DB97.Y Other specified inflammatory liver disease DB97.Z Inflammatory liver disease, unspecified DB98 Vascular disorders of the liver DB98.0 Infarction of liver DB98.1 Peliosis hepatis DB98.2 Nodular regenerative hyperplasia of liver DB98.3 Portal vein thrombosis DB98.4 Splenic vein thrombosis DB98.5 Budd-Chiari syndrome DB98.6 Hepatic veno-occlusive disease DB98.7 Portal hypertension DB98.8 Passive congestion of liver DB98.9 Hepatic artery aneurysm DB98.A Hepatic haemorrhage DB98.B Ischaemia reperfusion injury of liver DB98.Y Other specified vascular disorders of the liver DB98.Z Vascular disorders of the liver, unspecified – DB98.70 Idiopathic portal hypertension – DB98.71 Non-cirrhotic portal fibrosis – DB98.72 Partial nodular transformation of liver – DB98.73 Splanchnic arteriovenous fistula – DB98.74 Secondary portal hypertension – DB98.7Y Other specified portal hypertension – DB98.7Z Portal hypertension, unspecified DB99 Certain specified diseases of liver DB99.0 Chronic liver disease DB99.1 Hepatic cyst DB99.2 Hepatorenal syndrome DB99.3 Portopulmonary hypertension DB99.4 Hepatopulmonary syndrome DB99.5 Hepatic encephalopathy DB99.6 Intrahepatic cholestasis, not elsewhere classified DB99.7 Hepatic failure without mention whether acute or chronic DB99.8 Chronic hepatic failure DB99.Y Other diseases of liver – DB99.10 Polycystic liver disease – DB99.1Y Other specified hepatic cyst – DB99.1Z Hepatic cyst, unspecified – DB99.60 Cholestasis of parenteral nutrition – DB99.6Y Other specified intrahepatic cholestasis, not elsewhere classified – DB99.6Z Intrahepatic cholestasis, not elsewhere classified, unspecified DB9Z Diseases of liver, unspecified DC10 Acquired anatomical alterations of gallbladder or bile ducts DC10.0 Obstruction of gallbladder or bile ducts DC10.1 Hydrops of gallbladder DC10.2 Fistula of gallbladder or bile duct DC10.3 Polyp of gallbladder DC10.4 Cholesterolosis of gallbladder DC10.Y Other specified acquired anatomical alterations of gallbladder or bile ducts DC10.Z Acquired anatomical alterations of gallbladder or bile ducts, unspecified – DC10.00 Obstruction of cystic duct – DC10.01 Obstruction of gall bladder – DC10.02 Obstruction of bile duct – DC10.0Y Other specified obstruction of gallbladder or bile ducts – DC10.0Z Obstruction of gallbladder or bile ducts, unspecified DC11 Cholelithiasis DC11.0 Calculus of gallbladder or cystic duct with acute cholecystitis DC11.1 Calculus of gallbladder or cystic duct with other cholecystitis DC11.2 Calculus of gallbladder or cystic duct with cholangitis DC11.3 Calculus of gallbladder or cystic duct without cholecystitis or cholangitis DC11.4 Calculus of bile duct with cholangitis DC11.5 Calculus of bile duct with cholecystitis DC11.6 Calculus of bile duct without cholangitis or cholecystitis DC11.7 Intrahepatic cholelithiasis DC11.Y Other specified cholelithiasis DC11.Z Cholelithiasis, unspecified DC12 Cholecystitis DC12.0 Acute cholecystitis DC12.1 Chronic cholecystitis DC12.Y Other specified cholecystitis DC12.Z Cholecystitis, unspecified – DC12.00 Acute on chronic cholecystitis – DC12.0Y Other specified acute cholecystitis – DC12.0Z Acute cholecystitis, unspecified DC13 Cholangitis DC14 Certain specified biliary diseases DC14.0 Haemorrhage of bile duct DC14.1 Postcholecystectomy syndrome DC14.2 Dyskinesia of sphincter of Oddi DC14.3 Adenomyomatosis of gallbladder DC14.Y Other biliary diseases DC14.Z Biliary disease, unspecified DC1Y Other specified diseases of gallbladder or biliary tract DC1Z Diseases of gallbladder or biliary tract, unspecified DC30 Cystic diseases of the pancreas DC30.0 Cyst of pancreas DC30.1 Pseudocyst of pancreas DC30.Y Other specified cystic diseases of the pancreas DC30.Z Cystic diseases of the pancreas, unspecified DC31 Acute pancreatitis DC31.0 Acute idiopathic pancreatitis DC31.1 Acute alcohol-induced pancreatitis DC31.2 Acute biliary pancreatitis DC31.3 Acute drug-induced pancreatitis DC31.4 Hereditary acute pancreatitis DC31.5 Acute exacerbation of chronic pancreatitis DC31.Y Other specified acute pancreatitis DC31.Z Acute pancreatitis, unspecified DC32 Chronic pancreatitis DC32.0 Calcific pancreatitis DC32.1 Groove pancreatitis DC32.2 Hereditary chronic pancreatitis DC32.3 Chronic alcohol-induced pancreatitis DC32.4 Chronic idiopathic pancreatitis DC32.5 Tropical pancreatitis DC32.Y Other specified chronic pancreatitis DC32.Z Chronic pancreatitis, unspecified DC33 Autoimmune pancreatitis DC34 Obstructive pancreatitis DC35 Certain specified diseases of pancreas DC35.0 Atrophy of pancreas DC35.1 Secondary pancreatic insufficiency DC35.2 Pancreatic steatorrhoea DC35.Z Certain specified diseases of pancreas, unspecified DC3Y Other specified diseases of pancreas DC3Z Diseases of pancreas, unspecified DC50 Peritonitis DC50.0 Primary peritonitis DC50.1 Secondary peritonitis DC50.2 Peritoneal abscess DC50.Z Peritonitis, unspecified – DC50.00 Spontaneous bacterial peritonitis – DC50.01 Other specified primary peritonitis – DC50.10 Eosinophilic peritonitis – DC50.11 Mesenteric peritonitis – DC50.12 Chronic proliferative peritonitis – DC50.13 Peritonitis due to Streptococcus pneumoniae – DC50.1Y Other specified secondary peritonitis – DC50.1Z Secondary peritonitis, unspecified DC51 Certain specified disorders of peritoneum or retroperitoneum DC51.0 Chylous ascites DC51.1 Peritoneal adhesions DC51.2 Haemoperitoneum DC51.Y Other specified disorders of peritoneum or retroperitoneum DC5Z Diseases of peritoneum, unspecified DC70 Diverticulitis of small intestine – DC70.0 Diverticulitis of small intestine with complication – DC70.1 Diverticulitis of small intestine without complication – DC70.Z Diverticulitis of small intestine without specification of presence of complications –– DC70.00 Diverticulitis of small intestine with perforation or abscess –– DC70.0Y Diverticulitis of small intestine with other specified complication –– DC70.0Z Diverticulitis of small intestine with unspecified complication DC71 Diverticulosis of small intestine – DC71.0 Diverticulosis of small intestine with haemorrhage – DC71.1 Diverticulosis of small intestine without haemorrhage – DC71.Z Diverticulosis of small intestine, unspecified DC72 Diverticulum of small intestine – DC72.0 Diverticulum of small intestine with haemorrhage – DC72.1 Diverticulum of small intestine without haemorrhage – DC72.Z Diverticulum of small intestine, no specification about presence or absence of haemorrhage DC80 Diverticulitis of large intestine – DC80.0 Diverticulitis of large intestine with complication – DC80.1 Diverticulitis of large intestine without complication – DC80.Z Diverticulitis of large intestine without specification of presence of complications –– DC80.00 Diverticulitis of large intestine with perforation or abscess –– DC80.0Z Diverticulitis of large intestine with complication, unspecified DC81 Diverticulosis of large intestine – DC81.0 Diverticulosis of large intestine with haemorrhage – DC81.1 Diverticulosis of large intestine without haemorrhage – DC81.Z Diverticulosis of large intestine, unspecified DC82 Diverticulum of large intestine – DC82.0 Diverticulum of large intestine with haemorrhage – DC82.1 Diverticulum of large intestine without haemorrhage – DC82.Z Diverticulum of large intestine, unspecified DC90 Diverticular disease of small and large intestine DD00 Diverticulitis of unspecified part of intestine – DD00.0 Diverticulitis of unspecified part of intestine with complication – DD00.1 Diverticulitis of unspecified part of intestine without complication – DD00.Z Diverticulitis of unspecified part of intestine without specification of presence or absence of complications –– DD00.00 Diverticulitis of unspecified part of intestine with perforation or abscess –– DD00.0Y Other specified diverticulitis of unspecified part of intestine with complication –– DD00.0Z Diverticulitis of unspecified part of intestine with complication, unspecified DD01 Diverticulosis of unspecified part of intestine – DD01.0 Diverticulosis of unspecified part of intestine with haemorrhage – DD01.1 Diverticulosis of unspecified part of intestine without haemorrhage – DD01.Z Diverticulosis of unspecified part of intestine, unspecified DD02 Diverticulum of unspecified part of intestine – DD02.0 Diverticular disease of unspecified part of intestine with haemorrhage – DD02.1 Diverticulum of unspecified part of intestine without complication – DD02.Z Diverticulum of unspecified part of intestine, unspecified DD1Z Diverticular disease of intestine, unspecified DD30 Acute vascular disorders of intestine DD30.0 Acute mesenteric arterial infarction DD30.1 Acute mesenteric arterial ischaemia DD30.2 Acute mesenteric venous occlusion DD30.Y Other specified acute vascular disorders of intestine DD30.Z Acute vascular disorders of intestine, unspecified DD31 Chronic vascular disorders of intestine DD31.0 Non-occlusive mesenteric ischaemia DD31.Y Other specified chronic vascular disorders of intestine DD31.Z Chronic vascular disorders of intestine, unspecified – DD31.00 Ischaemic colitis – DD31.0Y Other specified non-occlusive mesenteric ischaemia – DD31.0Z Non-occlusive mesenteric ischaemia, unspecified DD3Y Other specified ischaemic vascular disorders of intestine DD3Z Ischaemic vascular disorders of intestine, unspecified DD50 Non-abdominal wall hernia DD50.0 Diaphragmatic hernia DD50.1 Pelvic hernia DD50.2 Intra-abdominal hernia DD50.Y Other specified non-abdominal wall hernia DD50.Z Non-abdominal wall hernia, unspecified – DD50.20 Primary intra-abdominal hernia – DD50.21 Secondary intra-abdominal hernia – DD50.2Y Other specified intra-abdominal hernia – DD50.2Z Intra-abdominal hernia, unspecified DD51 Inguinal hernia DD52 Femoral hernia DD53 Umbilical hernia DD54 Paraumbilical hernia DD55 Epigastric hernia DD56 Incisional hernia DD57 Parastomal hernia DD5Y Other specified hernias DD5Z Hernias, unspecified DD70 Crohn disease DD70.0 Crohn disease of upper gastrointestinal tract DD70.1 Crohn disease of small intestine DD70.2 Crohn disease of appendix DD70.3 Crohn disease of large intestine DD70.4 Crohn disease of anal region DD70.5 Crohn disease of both small and large intestine DD70.6 Crohn disease of anastomotic sites DD70.Y Crohn disease of other specified site DD70.Z Crohn disease, unspecified site DD71 Ulcerative colitis DD71.0 Ulcerative pancolitis DD71.1 Left sided ulcerative colitis DD71.2 Ulcerative rectosigmoiditis DD71.3 Ulcerative proctitis DD71.Y Other specified ulcerative colitis DD71.Z Ulcerative colitis, unspecified DD72 Indeterminate colitis DD7Y Other specified inflammatory bowel diseases DD7Z Inflammatory bowel diseases, unspecified DD90 Functional oesophageal or gastroduodenal disorders DD90.0 Globus DD90.1 Functional swallowing disorder DD90.2 Functional heartburn DD90.3 Functional dyspepsia DD90.4 Functional nausea or vomiting DD90.5 Functional belching disorders DD90.6 Adult rumination syndrome DD90.Y Other specified functional oesophageal or gastroduodenal disorders DD90.Z Functional oesophageal or gastroduodenal disorders, unspecified DD91 Irritable bowel syndrome or certain specified functional bowel disorders DD91.0 Irritable bowel syndrome DD91.1 Functional constipation DD91.2 Functional diarrhoea DD91.3 Functional bloating DD91.4 Functional abdominal pain syndrome DD91.Y Other specified irritable bowel syndrome or functional bowel disorders DD91.Z Irritable bowel syndrome or functional bowel disorders, unspecified – DD91.00 Irritable bowel syndrome, constipation predominant – DD91.01 Irritable bowel syndrome, diarrhoea predominant – DD91.02 Irritable bowel syndrome, mixed type – DD91.03 Irritable bowel syndrome, unsubtyped – DD91.0Z Irritable bowel syndrome, type unspecified DD92 Functional anorectal disorders DD92.0 Functional faecal incontinence DD92.1 Functional anorectal pain DD92.2 Functional defaecation disorders DD92.Y Other specified functional anorectal disorders DD92.Z Functional anorectal disorders, unspecified DD93 Functional digestive disorders of infants, toddlers or children DD93.0 Infant regurgitation DD93.1 Infantile colic DD93.2 Infant dyschezia DD93.Y Other functional digestive disorders of infants, neonates or toddlers DD93.Z Functional digestive disorders of infants, toddlers or children, unspecified DD94 Functional gallbladder disorder DD95 Functional sphincter of Oddi disorder DD9Y Other specified functional gastrointestinal disorders DD9Z Functional gastrointestinal disorders, unspecified DE10 Vomiting following gastrointestinal surgery DE11 Dumping syndrome DE12 Malfunction or complication of external stoma of digestive organs DE12.0 Colostomy or enterostomy malfunction or complication DE12.1 Gastrostomy malfunction DE13 Postsurgical malabsorption, not elsewhere classified DE2Y Other specified diseases of the digestive system DE2Z Diseases of the digestive system, unspecified – EA00 Viral exanthem due to unknown or unspecified agent – EA0Y Viral exanthem due to other specified virus – EA10 Pityriasis rosea – EA11 Papular purpuric gloves and socks syndrome – EA12 Infantile papular acrodermatitis – EA20 Necrolytic acral erythema EA3Z Unspecified skin disorder attributable to viral infection – EA40 Tropical phagedaenic ulcer EA50 Toxin-mediated cutaneous reactions to distant or systemic bacterial infection – EA50.0 Erythema marginatum rheumaticum – EA50.1 Streptococcal toxin-mediated perineal erythema – EA50.2 Staphylococcal scalded skin syndrome – EA50.3 Staphylococcal scarlatina – EA50.Y Other specified toxin-mediated cutaneous reactions to distant or systemic bacterial infection – EA50.Z Toxin-mediated cutaneous reactions to distant or systemic bacterial infection, unspecified EA51 Skin complications of BCG immunisation EA5Y Cutaneous involvement by other specified bacterial infection EA5Z Cutaneous involvement by unspecified bacterial infection EA60 Certain skin disorders attributable to fungal infection EA60.0 Subcutaneous mycoses EA60.1 Systemic mycoses affecting skin EA60.Y Skin involvement in other specified fungal infection EA60.Z Fungal infection of the skin, unspecified EA6Y Cutaneous involvement by other specified infection or infestation EA80 Atopic eczema – EA80.0 Infantile atopic eczema – EA80.1 Childhood atopic eczema – EA80.2 Adult atopic eczema – EA80.Y Other specified forms of atopic eczema – EA80.Z Atopic eczema, unspecified EA81 Seborrhoeic dermatitis and related conditions – EA81.0 Seborrhoeic dermatitis of face – EA81.1 Seborrhoeic dermatitis of the scalp – EA81.Y Seborrhoeic dermatosis of other specified type or distribution – EA81.Z Seborrhoeic dermatitis, unspecified EA82 Nummular dermatitis EA83 Lichen simplex or lichenification – EA83.0 Lichen simplex – EA83.1 Secondary lichenification –– EA83.00 Lichen simplex of vulva –– EA83.01 Lichen simplex of male genitalia –– EA83.02 Perianal lichen simplex –– EA83.0Y Lichen simplex of other specified site –– EA83.0Z Lichen simplex of unspecified site EA84 Asteatotic eczema EA85 Dermatitis or eczema of hands and feet – EA85.0 Vesicular dermatitis of hands and feet – EA85.1 Hyperkeratotic dermatitis of hands and feet – EA85.2 Dermatitis of hands – EA85.3 Dermatitis of feet –– EA85.20 Atopic eczema of hands –– EA85.2Y Other specified dermatitis of hands –– EA85.2Z Dermatitis of hands, unspecified EA86 Dermatitis and eczema of lower legs – EA86.0 Stasis dermatitis of the lower legs EA87 Dermatitis or eczema of anogenital region – EA87.0 Dermatitis or eczema of male genitalia – EA87.1 Dermatitis or eczema of female genitalia – EA87.2 Dermatitis or eczema of perianal area – EA87.Z Dermatitis or eczema of anogenital region, unspecified EA88 Miscellaneous specified eczematous dermatoses – EA88.0 Infectious dermatitis – EA88.1 Post traumatic eczema – EA88.2 Disseminated secondary eczema – EA88.3 Secondary eczema – EA88.4 Pityriasis alba –– EA88.00 Human T-cell lymphotropic virus type 1 associated infective dermatitis of childhood –– EA88.0Y Other specified infectious dermatitis –– EA88.0Z Infectious dermatitis, unspecified EA89 Generalised eczematous dermatitis of unspecified type EA8Y Other specified eczematous dermatosis EA8Z Dermatitis or eczema, unspecified EA90 Psoriasis – EA90.0 Plaque psoriasis – EA90.1 Guttate psoriasis – EA90.2 Unstable psoriasis – EA90.3 Erythrodermic psoriasis – EA90.4 Pustular psoriasis – EA90.5 Psoriasis of specified site or distribution – EA90.Y Other specified forms of psoriasis – EA90.Z Psoriasis of unspecified type –– EA90.40 Generalised pustular psoriasis –– EA90.41 Acropustulosis of Hallopeau –– EA90.42 Palmoplantar pustulosis –– EA90.4Y Other specified pustular psoriasis –– EA90.4Z Pustular psoriasis, unspecified –– EA90.50 Scalp psoriasis –– EA90.51 Nail psoriasis –– EA90.52 Flexural and intertriginous psoriasis –– EA90.53 Anogenital psoriasis –– EA90.5Y Psoriasis of other specified site or distribution EA91 Lichen planus – EA91.0 Acute eruptive lichen planus – EA91.1 Hypertrophic lichen planus – EA91.2 Follicular lichen planus – EA91.3 Lichen planus of genital skin and mucous membranes – EA91.4 Lichen planus and lichenoid reactions of oral mucosa – EA91.5 Lichen planus of the nails – EA91.6 Subacute lichen planus – EA91.Y Other specified lichen planus – EA91.Z Lichen planus of unspecified type –– EA91.40 Non-erosive lichen planus of oral mucosa –– EA91.41 Erosive oral lichen planus –– EA91.42 Oral lichen planus, unspecified –– EA91.43 Lichenoid mucositis –– EA91.4Y Other specified lichenoid reactions of oral mucosa EA92 Lichenoid dermatoses EA93 Pityriasis lichenoides EA94 Pityriasis rubra pilaris EA95 Small plaque parapsoriasis EB00 Spontaneous urticaria – EB00.0 Acute urticaria – EB00.1 Chronic urticaria – EB00.Z Spontaneous urticaria, unspecified EB01 Inducible urticaria and angioedema – EB01.0 Dermographism – EB01.1 Cold urticaria – EB01.2 Delayed pressure urticaria – EB01.3 Contact urticaria – EB01.Y Other specified forms of inducible urticaria and angioedema – EB01.Z Inducible urticaria and angioedema, unspecified EB02 Cholinergic urticaria and related conditions – EB02.0 Cholinergic urticaria – EB02.Y Other conditions mediated by cholinergic activation EB03 Syndromes with urticarial reactions or angioedema EB04 Idiopathic angioedema EB05 Urticaria of unspecified type EB0Y Other specified urticarial disorders EB10 Diffuse inflammatory erythemas EB11 Annular erythema EB12 Erythema multiforme – EB12.0 Cutaneous erythema multiforme – EB12.1 Mucocutaneous erythema multiforme – EB12.Y Other specified erythema multiforme – EB12.Z Erythema multiforme, unspecified EB13 Stevens-Johnson syndrome or toxic epidermal necrolysis – EB13.0 Stevens-Johnson syndrome – EB13.1 Toxic epidermal necrolysis – EB13.2 Stevens-Johnson and toxic epidermal necrolysis overlap syndrome – EB20 Acute febrile neutrophilic dermatosis – EB21 Pyoderma gangrenosum – EB2Y Other specified neutrophilic dermatoses EB30 Eosinophilic cellulitis EB31 Erythema nodosum EB40 Pemphigus – EB40.0 Pemphigus vulgaris – EB40.1 Pemphigus foliaceus – EB40.2 Paraneoplastic pemphigus – EB40.Y Other specified pemphigus – EB40.Z Pemphigus, unspecified –– EB40.00 Oral pemphigus –– EB40.0Y Other specified pemphigus vulgaris –– EB40.0Z Pemphigus vulgaris, unspecified EB41 Pemphigoid – EB41.0 Bullous pemphigoid – EB41.1 Mucous membrane pemphigoid – EB41.Y Other specified pemphigoid – EB41.Z Pemphigoid, unspecified EB42 Linear IgA bullous dermatosis EB43 Epidermolysis bullosa acquisita EB44 Dermatitis herpetiformis EB4Y Other specified immunobullous disorder EB50 Subacute cutaneous lupus erythematosus EB51 Chronic cutaneous lupus erythematosus – EB51.0 Discoid lupus erythematosus – EB51.Y Other specified chronic cutaneous lupus erythematosus – EB51.Z Chronic cutaneous lupus erythematosus, unspecified EB5Z Cutaneous lupus erythematosus of unspecified type EB60 Lichen sclerosus – EB60.0 Lichen sclerosus of vulva – EB60.1 Lichen sclerosus of penis – EB60.Y Lichen sclerosus of other specified sites – EB60.Z Lichen sclerosus, unspecified EB61 Morphoea – EB61.0 Plaque morphoea – EB61.1 Linear morphoea – EB61.Y Other specified forms of morphoea – EB61.Z Morphoea, unspecified EB7Y Other specified inflammatory dermatoses EB90 Dermatoses resulting from disturbed metabolic processes EB90.0 Diabetic skin lesions EB90.1 Cutaneous mucinosis EB90.2 Cutaneous and subcutaneous xanthomata EB90.3 Porphyria or pseudoporphyria affecting the skin EB90.4 Calcification of skin or subcutaneous tissue – EB90.10 Pretibial myxoedema – EB90.11 Lichen myxoedematosus – EB90.12 Reticular erythematous mucinosis – EB90.1Y Other specified forms of cutaneous mucinosis – EB90.20 Plane xanthoma – EB90.21 Tuberous xanthoma – EB90.22 Eruptive xanthoma – EB90.23 Tendinous xanthoma – EB90.24 Xanthoma due to specified disorder of lipid metabolism – EB90.2Z Cutaneous and subcutaneous xanthomata of unspecified type – EB90.30 Pseudoporphyria – EB90.3Y Other specified porphyria or pseudoporphyria affecting the skin – EB90.40 Dystrophic calcification of the skin of uncertain or unspecified aetiology – EB90.41 Calcific panniculitis – EB90.42 Calcific arteriolopathy – EB90.4Y Other specified calcification of skin or subcutaneous tissue EB9Y Other specified metabolic and nutritional disorders affecting the skin EC10 Genetic syndromes with poikiloderma EC1Y Other specified genetic syndromes affecting the skin EC20 Genetic disorders of keratinisation EC20.0 Non-syndromic ichthyosis EC20.1 Hereditary skin peeling EC20.2 Hereditary acantholytic dermatoses EC20.3 Hereditary palmoplantar keratodermas EC20.Y Other specified genetic disorders of keratinisation – EC20.00 Ichthyosis vulgaris – EC20.01 X-linked ichthyosis – EC20.02 Autosomal recessive congenital ichthyosis – EC20.03 Keratinopathic ichthyoses – EC20.0Y Other specified or unclassifiable non-syndromic ichthyosis – EC20.30 Diffuse palmoplantar keratodermas – EC20.31 Focal palmoplantar keratodermas – EC20.32 Papular palmoplantar keratodermas – EC20.3Z Hereditary palmoplantar keratoderma of unspecified type EC21 Genetic defects of hair or hair growth EC21.0 Genetic defects of the hair shaft EC21.1 Genetic syndromes with abnormalities of the hair shaft EC21.2 Hereditary alopecia or hypotrichosis EC21.3 Genetic syndromes with alopecia or hypotrichosis EC21.4 Genetically-determined hypertrichosis EC21.Y Other specified genetic defects of hair or hair growth EC21.Z Genetic defects of hair or hair growth, unspecified EC22 Genetic defects of nails or nail growth EC22.0 Inherited deformities of nails EC23 Genetic disorders of skin pigmentation EC23.0 Non-syndromic genetically-determined hypermelanosis or lentiginosis EC23.1 Syndromic genetically-determined hypermelanosis or lentiginosis EC23.2 Albinism or other specified genetically-determined hypomelanotic disorders EC23.Y Other specified genetic disorders of skin pigmentation EC23.Z Genetic disorders of skin pigmentation, unspecified – EC23.20 Oculocutaneous albinism – EC23.2Y Other specified genetically-determined hypomelanotic disorders EC30 Epidermolysis bullosa simplex EC31 Junctional epidermolysis bullosa EC32 Dystrophic epidermolysis bullosa EC33 Syndromic epidermolysis bullosa EC3Z Epidermolysis bullosa EC40 Pseudoxanthoma elasticum EC4Y Other specified genetic disorders affecting dermal matrix proteins EC50 Developmental anomalies of the umbilicus EC5Y Other specified developmental anomalies affecting the skin EC7Y Other specified genetic and developmental disorders affecting the skin EC90 Pruritus – EC90.0 Pruritus due to skin disorder – EC90.1 Pruritus due to systemic disorder – EC90.2 Drug-induced pruritus – EC90.3 Pruritus due to neurological disorder – EC90.4 Psychogenic pruritus – EC90.5 Anogenital pruritus – EC90.6 Pruritus of unknown cause – EC90.Y Pruritus of other specified type or aetiology – EC90.Z Pruritus, unspecified –– EC90.10 Uraemic pruritus –– EC90.11 Cholestatic pruritus –– EC90.12 Haemodialysis-associated pruritus –– EC90.1Y Pruritus due to other specified systemic disorder EC91 Prurigo – EC91.0 Nodular prurigo – EC91.1 Atopic prurigo – EC91.Z Prurigo, unspecified EC92 Mucocutaneous or cutaneous pain syndromes – EC92.0 Penoscrotodynia – EC92.1 Scalp dysaesthesia EC9Y Other specified disturbances of cutaneous sensation – ED00 Artefactual skin disorder – ED01 Simulated skin disease – ED02 Painful bruising syndrome – ED0Y Other specified self-inflicted skin disorders ED2Y Other specified mental conditions affecting the skin ED30 Neuropathic skin damage – ED30.0 Neuropathic skin ulceration – ED30.Y Other specified neuropathic skin damage ED31 Burning feet syndrome ED3Y Cutaneous involvement in other specified neurological condition – ED50 Ichthyoses –– ED50.0 Acquired ichthyosis –– ED50.Z Ichthyosis of unspecified type – ED51 Diffuse epidermal hyperkeratosis and acanthosis –– ED51.0 Acanthosis nigricans –– ED51.Y Other specified hyperkeratotic and acanthotic dermatoses ––– ED51.00 Benign acanthosis nigricans ––– ED51.0Y Other specified acanthosis nigricans ––– ED51.0Z Acanthosis nigricans, unspecified – ED52 Porokeratoses – ED53 Skin peeling – ED54 Xerosis cutis or asteatosis – ED55 Palmoplantar keratodermas –– ED55.0 Acquired palmoplantar keratodermas –– ED55.Z Palmoplantar keratoderma, unspecified – ED56 Keratosis pilaris – ED5Y Other specified disorders of epidermal keratinisation – ED60 Acquired hypermelanosis –– ED60.0 Physiological hypermelanosis –– ED60.1 Melasma –– ED60.2 Postinflammatory hypermelanosis –– ED60.Y Hypermelanosis of other specified aetiology –– ED60.Z Hypermelanosis of unspecified aetiology ––– ED60.00 Suntan ––– ED60.01 Tanning due to exposure to artificial sources of ultraviolet radiation – ED61 Acquired melanotic macules or lentigines –– ED61.0 Freckles –– ED61.1 Mucosal melanosis –– ED61.Y Other specified acquired melanotic macules or lentigines ––– ED61.10 Penile melanotic macule ––– ED61.11 Vulval melanotic macule ––– ED61.1Y Other specified mucosal melanosis – ED62 Endogenous non-melanin pigmentation –– ED62.0 Haemosiderin pigmentation of skin –– ED62.Y Other specified endogenous non-melanin pigmentation – ED63 Acquired hypomelanotic disorders –– ED63.0 Vitiligo –– ED63.1 Hypomelanosis due to exposure to chemicals –– ED63.2 Postinflammatory hypomelanosis –– ED63.3 Vogt-Koyanagi-Harada syndrome –– ED63.Y Acquired hypomelanosis due to other specified disorder –– ED63.Z Acquired hypomelanosis of unknown or unspecified aetiology – ED64 Abnormal skin pigmentation – ED6Y Other specified disorders of skin pigmentation – ED70 Alopecia or hair loss –– ED70.0 Male pattern hair loss –– ED70.1 Female pattern hair loss –– ED70.2 Alopecia areata –– ED70.3 Telogen effluvium –– ED70.4 Anagen effluvium –– ED70.5 Scarring alopecia –– ED70.Y Other specified alopecia or hair loss –– ED70.Z Alopecia, unspecified ––– ED70.20 Patchy alopecia areata of scalp ––– ED70.21 Alopecia totalis ––– ED70.2Y Other specified forms of alopecia areata ––– ED70.2Z Alopecia areata, unspecified ––– ED70.30 Acute telogen effluvium ––– ED70.31 Postpartum telogen effluvium ––– ED70.3Y Telogen hair shedding due to other specified cause ––– ED70.3Z Telogen effluvium unspecified ––– ED70.50 Folliculitis decalvans ––– ED70.51 Dissecting cellulitis ––– ED70.5Y Scarring alopecia due to other specified cause ––– ED70.5Z Scarring alopecia of unknown or unspecified aetiology – ED71 Hypertrichosis – ED72 Hirsutism and syndromes with hirsutism –– ED72.0 Constitutional hirsutism –– ED72.1 Hirsutism associated with hyperandrogenaemia –– ED72.Z Hirsutism, unspecified – ED73 Acquired disorders of the hair shaft –– ED73.0 Weathered hair –– ED73.1 Acquired changes in hair colour –– ED73.Y Other specified acquired disorders of the hair shaft ––– ED73.10 Premature canities ––– ED73.11 Acquired poliosis – ED7Y Other specified disorders of hair –– ED80 Acne ––– ED80.0 Comedonal acne ––– ED80.1 Superficial mixed comedonal and papulopustular acne ––– ED80.2 Papulopustular acne ––– ED80.3 Nodular acne ––– ED80.4 Severe inflammatory acne ––– ED80.5 Acne scarring ––– ED80.6 Infantile acne ––– ED80.Y Other specified acne ––– ED80.Z Acne, unspecified –––– ED80.40 Acne fulminans –––– ED80.41 Acne conglobata –––– ED80.4Y Other specified severe inflammatory acne –––– ED80.4Z Severe inflammatory acne, unspecified –– ED81 Acneform inflammatory disorders ––– ED81.0 Folliculitis cruris pustulosa atrophicans ––– ED81.1 Acneform reactions to halogenated aromatic hydrocarbons ––– ED81.Y Other specified acneform inflammatory disorders – ED90 Rosacea and related disorders –– ED90.0 Rosacea –– ED90.1 Periorificial dermatitis –– ED90.Y Other specified rosacea-like disorders –– ED90.Z Rosacea-like disorders unspecified ––– ED90.00 Erythematotelangiectatic rosacea ––– ED90.01 Papulopustular rosacea ––– ED90.02 Phymatous rosacea ––– ED90.0Y Other specified rosacea ––– ED90.0Z Rosacea, unspecified – ED91 Disorders of the sebaceous gland –– ED91.0 Heterotopic sebaceous glands –– ED91.1 Sebaceous gland hyperplasia –– ED91.2 Seborrhoea –– ED91.Y Other specified disorders of the sebaceous gland –– ED91.Z Disorders of the sebaceous gland, unspecified – ED92 Disorders involving the apocrine follicular unit –– ED92.0 Hidradenitis suppurativa –– ED92.1 Apocrine sweat disorders –– ED92.Y Other specified disorders involving the apocrine follicular unit –– ED92.Z Disorders involving the apocrine follicular unit, unspecified – ED9Y Other specified disorders involving the hair follicle – EE00 Hyperhidrosis –– EE00.0 Localised hyperhidrosis –– EE00.1 Primary generalised hyperhidrosis –– EE00.Z Hyperhidrosis, unspecified ––– EE00.00 Palmoplantar hyperhidrosis ––– EE00.01 Axillary hyperhidrosis ––– EE00.02 Craniofacial hyperhidrosis ––– EE00.0Y Other specified localised hyperhidrosis ––– EE00.0Z Localised hyperhidrosis, unspecified – EE01 Hypohidrosis –– EE01.0 Hypohidrosis attributable to defective sudomotor innervation or function –– EE01.1 Hypohidrosis due to genetic abnormalities of eccrine gland structure or function –– EE01.2 Hypohidrosis of undetermined aetiology –– EE01.Y Other specified forms of hypohidrosis –– EE01.Z Hypohidrosis, unspecified – EE02 Miliaria –– EE02.0 Neonatal miliaria –– EE02.Y Other specified forms of miliaria –– EE02.Z Miliaria, unspecified – EE0Y Other specified disorders of eccrine sweat glands or sweating – EE10 Acquired deformities of the nail plate –– EE10.0 Abnormality of nail shape –– EE10.1 Abnormality of nail surface –– EE10.2 Onycholysis –– EE10.3 Nail hypertrophy –– EE10.4 Nail atrophy –– EE10.5 Nail dystrophy, not otherwise specified –– EE10.Y Other specified acquired deformities of the nail plate –– EE10.Z Acquired deformities of the nail plate, unspecified ––– EE10.10 Nail pitting ––– EE10.1Y Other specified abnormality of nail surface ––– EE10.1Z Abnormality of nail surface, unspecified – EE11 Acquired abnormalities of nail colour –– EE11.0 Melanonychia –– EE11.1 Yellow nail syndrome –– EE11.Y Other abnormalities of nail colour –– EE11.Z Acquired abnormalities of nail colour, unspecified – EE12 Infections of the nail or perionychium –– EE12.0 Acute bacterial paronychia –– EE12.1 Onychomycosis –– EE12.Y Other specified infections of the nail or perionychium –– EE12.Z Infections of the nail or perionychium, unspecified – EE13 Certain disorders affecting the nails or perionychium –– EE13.0 Nail fragility –– EE13.1 Ingrowing nail –– EE13.2 Chronic paronychia –– EE13.3 Nail disorder associated with specified dermatosis –– EE13.4 Nail disorder associated with specified systemic disease –– EE13.5 Eczematous nail dystrophy –– EE13.Y Other specified nail disorder ––– EE13.10 Ingrowing toenail ––– EE13.11 Infected ingrowing toenail ––– EE13.1Y Other specified ingrowing nail ––– EE13.1Z Ingrowing nail, unspecified – EE1Y Other specified disorders of the nail or perionychium – EE1Z Disorders of the nail or perionychium, unspecified – EE20 Acute cutaneous distension syndrome – EE21 Epidermal fragility – EE40 Atrophy or degeneration of dermal or subcutaneous connective tissue –– EE40.0 Corticosteroid-induced skin atrophy –– EE40.1 Stretch marks –– EE40.2 Atrophic scarring of the skin –– EE40.3 Skin fragility –– EE40.Y Other specified atrophy or degeneration of dermal or subcutaneous connective tissue –– EE40.Z Atrophy or degeneration of dermal or subcutaneous connective tissue, unspecified type ––– EE40.10 Stretch marks of pregnancy ––– EE40.1Y Stretch marks of other specified aetiology ––– EE40.1Z Stretch marks, unspecified ––– EE40.30 Genetically-determined skin fragility ––– EE40.31 Age-related skin fragility ––– EE40.32 Purpura or bruising due to vascular fragility – EE41 Abnormalities of dermal elastin –– EE41.0 Cutis laxa –– EE41.1 Anetoderma –– EE41.Y Other specified dermatoses characterised by abnormal dermal elastin –– EE41.Z Abnormalities of dermal elastin, unspecified –– EE50 Acquired poikiloderma –– EE60 Keloid or hypertrophic scars ––– EE60.0 Keloid ––– EE60.1 Hypertrophic scar ––– EE60.Y Other specified keloidal disorders –––– EE60.00 Ear-lobe keloid –––– EE60.0Y Other specified keloid –––– EE60.0Z Keloid, unspecified –– EE61 Superficial fibromatoses –– EE6Y Other specified fibromatous disorders of skin and soft tissue – EE70 Perforating dermatoses –– EE70.0 Acquired perforating dermatosis –– EE70.Y Other specified perforating dermatoses –– EE70.Z Perforating dermatoses, unspecified – EE7Y Other specified disorders of cutaneous connective tissue – EE80 Necrobiotic granulomatous skin disorders –– EE80.0 Granuloma annulare –– EE80.1 Necrobiosis lipoidica –– EE80.Z Necrobiotic granulomatous skin disorders, unspecified – EE81 Dermal dendrocyte, Class IIa histiocytoses – EE8Y Other specified histiocytic and granulomatous disorders of the skin – EE90 Benign lymphocytic infiltration of the skin – EE91 Lymphocytoma cutis – EF00 Panniculitis –– EF00.0 Pancreatic enzyme panniculitis –– EF00.Y Panniculitis of other specified aetiology –– EF00.Z Panniculitis of undetermined or unspecified etiology – EF01 Lipoatrophy or lipodystrophy –– EF01.0 Acquired partial lipodystrophy –– EF01.1 Localised lipoatrophy and lipodystrophy –– EF01.Y Other specified forms of lipodystrophy and lipoatrophy –– EF01.Z Lipodystrophy of unspecified type – EF02 Certain noninflammatory disorders of subcutaneous fat –– EF02.0 Fat hypertrophy –– EF02.1 Subcutaneous lipomatosis –– EF02.2 Lipoedema –– EF02.3 Cellulite –– EF02.Y Other specified noninflammatory disorders of subcutaneous fat –– EF02.Z Noninflammatory disorders of subcutaneous fat, unspecified – EF0Y Other specified disorders of subcutaneous fat – EF20 Acquired malformations of cutaneous blood vessels –– EF20.0 Venous lake –– EF20.1 Angiokeratoma –– EF20.2 Lower limb venous telangiectases –– EF20.3 Spider telangiectasis –– EF20.4 Generalised essential telangiectasia –– EF20.Y Other specified acquired malformations of cutaneous blood vessels –– EF20.Z Acquired malformations of cutaneous blood vessels, unspecified – EF2Z Cutaneous vascular malformation, unspecified – EF30 Purpura or bruising due to disorders of coagulation – EF31 Traumatic purpura – EF3Y Other specified purpura – EF3Z Purpura of unspecified aetiology EF40 Vasculitis or capillaritis involving the skin – EF40.0 Capillaritis – EF40.1 Vasculitis affecting small cutaneous blood vessels – EF40.2 Localised cutaneous vasculitis – EF40.Z Cutaneous vasculitis unspecified –– EF40.10 Urticarial vasculitis –– EF40.1Y Other specified vasculitis affecting small cutaneous blood vessels –– EF40.20 Granuloma faciale –– EF40.2Y Other specified localised cutaneous vasculitis – EF50 Livedoid vasculopathy – EF5Y Other specified dermatoses attributable to hyperviscosity or microvascular occlusion – EF60 Ischaemic ulceration of skin –– EF70 Lower limb venous eczema –– EF7Y Other specified dermatoses due to venous disease –– EF7Z Dermatoses due to venous disease, unspecified – EF9Y Other specified dermatoses resulting from vascular insufficiency – EG00 Vasodilatation of extremities – EG01 Vasoconstriction of extremities – EG02 Flushing disorders EG30 Skin disorders localised to the scalp – EG30.0 Scalp folliculitis – EG30.1 Erosive pustular dermatosis of scalp – EG30.2 Pityriasis amiantacea – EG30.Y Other specified scalp disorders not elsewhere classifiable – EG30.Z Skin disorders localised to the scalp, unspecified –– EG40 Contact dermatitis of external ear ––– EG40.0 Allergic contact dermatitis of external ear –– EG4Y Other specified inflammatory disorder of external ear –– EG4Z Inflammatory disorder of external ear, unspecified – EG60 Anal pruritus – EG61 Infections of the anus or perianal skin – EG62 Inflammatory dermatoses of the perianal area – EG63 Sacrococcygeal pilonidal disease –– EG63.0 Sacrococcygeal pilonidal sinus –– EG63.1 Sacrococcygeal pilonidal cyst –– EG63.2 Sacrococcygeal pilonidal abscess –– EG63.Z Sacrococcygeal pilonidal disease, unspecified EG7Y Other specified skin disorders involving the genital and perianal regions EG9Y Skin disorders involving other specific body regions EG9Z Skin disorders involving certain specific body regions, unspecified – EH10 Neonatal viral infections involving the skin – EH11 Neonatal pyogenic skin infections – EH12 Neonatal fungal infections involving the skin – EH1Z Neonatal skin infection, unspecified EH3Y Other specified skin disorders specific to the perinatal or neonatal period EH40 Dermatoses of infancy EH40.0 Infantile seborrhoeic dermatitis EH40.1 Infantile napkin dermatoses EH40.2 Erythrodermas of infancy EH40.3 Acute haemorrhagic oedema of infancy EH40.Y Other specified dermatoses of infancy EH40.Z Dermatoses of infancy, unspecified – EH40.00 Cradle cap – EH40.01 Disseminated infantile seborrhoeic dermatitis – EH40.02 Psoriasiform napkin dermatitis – EH40.0Z Infantile seborrhoeic dermatitis, unspecified – EH40.10 Primary irritant napkin dermatitis – EH40.1Y Other specified infantile napkin dermatoses – EH40.1Z Infantile napkin dermatoses, unspecified EH60 Exanthematic drug eruption EH61 Drug-induced urticaria, angioedema and anaphylaxis – EH61.0 Drug-induced urticaria – EH61.1 Drug-induced angioedema EH62 Lichenoid drug eruption EH63 Stevens-Johnson syndrome and toxic epidermal necrolysis due to drug – EH63.0 Drug-induced Stevens-Johnson syndrome – EH63.1 Drug-induced toxic epidermal necrolysis – EH63.2 Drug-induced Stevens-Johnson and toxic epidermal necrolysis overlap syndrome EH64 Drug-induced erythroderma EH65 DRESS syndrome EH66 Fixed drug eruption EH67 Acne or acneform reactions attributable to drugs – EH67.0 Drug-induced acute generalised exanthematous pustulosis – EH67.Y Other specified acne or acneform reactions attributable to drugs – EH67.Z Acne or acneform reactions attributable to drugs, unspecified EH6Y Drug eruption of other specified type EH6Z Drug eruption of unspecified type EH70 Pigmentary abnormalities of skin due to drug EH71 Dermatoses precipitated by drug therapy EH72 Drug-induced hair abnormalities EH72.0 Drug-induced alopecia EH72.Y Other specified drug-induced hair abnormalities EH72.Z Drug-induced hair abnormalities, unspecified – EH72.00 Drug-induced telogen hair loss – EH72.01 Drug-induced anagen effluvium EH73 Drug-induced nail abnormalities EH74 Drug-induced oral conditions EH75 Photosensitivity due to drug EH76 Dermatoses associated with specific classes of medication EH76.0 Dermatoses resulting from cytotoxic or cancer chemotherapy EH76.1 Dermatoses resulting from immunosuppressive therapy EH76.2 Dermatoses attributable to corticosteroid therapy EH76.3 Dermatoses resulting from anticoagulant therapy EH76.Y Other dermatoses associated with specific classes of medication EH77 Localised adverse cutaneous reactions to administration of drug EH78 Adverse cutaneous reactions to herbal, homoeopathic or other alternative therapies EH7Y Other specified adverse cutaneous reactions to medication EH7Z Unspecified adverse cutaneous reactions to medication EH90 Pressure ulceration EH90.0 Pressure ulceration grade 1 EH90.1 Pressure ulceration grade 2 EH90.2 Pressure ulceration grade 3 EH90.3 Pressure ulceration grade 4 EH90.4 Suspected deep pressure-induced tissue damage, depth unknown EH90.5 Pressure ulceration, ungradable EH90.Z Pressure ulcer of unspecified grade EH92 Dermatoses provoked by friction or mechanical stress EH92.0 Corns or callosities EH92.1 Friction blister EH92.Y Other specified skin damage due to repetitive friction and mechanical trauma – EH92.00 Hard corn – EH92.01 Soft corn – EH92.0Z Callosity, unspecified EH93 Dermatoses due to foreign bodies EH93.0 Tattoos or tattoo reactions EH93.1 Foreign body reaction to inorganic matter in the skin EH93.2 Foreign body reaction to organic matter in the skin EH93.3 Foreign body granuloma of skin EH93.Y Other specified reaction to foreign body in the skin EH93.Z Dermatoses due to foreign bodies, unspecified EH94 Scar of skin, not elsewhere classified EJ0Y Other specified dermatoses provoked or exacerbated by exposure to cold EJ10 Erythema ab igne EJ1Y Other specified dermatoses provoked by heat or electricity – EJ20 Photoaging of the skin –– EJ20.0 Actinic elastosis –– EJ20.1 Actinic lentigo –– EJ20.2 Actinic lentiginosis –– EJ20.3 Actinic telangiectasia –– EJ20.Z Photoaging of the skin, unspecified – EJ2Y Other specified chronic effects of ultraviolet radiation on the skin EJ30 Autoimmune or other photodermatoses – EJ30.0 Polymorphic light eruption – EJ30.1 Chronic actinic dermatitis – EJ30.Y Other specified photodermatoses – EJ30.Z Photodermatoses, unspecified – EJ40 Sunburn –– EJ40.0 Sunburn erythema –– EJ40.1 Sunburn with blisters or exudation –– EJ40.Z Sunburn, unspecified – EJ41 Burn from exposure to artificial source of ultraviolet radiation –– EJ41.0 Burn from exposure to therapeutic ultraviolet radiation –– EJ41.Y Other specified burn from exposure to artificial source of ultraviolet radiation –– EJ41.Z Burn from exposure to artificial source of ultraviolet radiation, unspecified – EJ4Z Acute effects of ultraviolet radiation on normal skin, unspecified EJ6Y Other specified dermatoses provoked by light or UV radiation EJ71 Chronic effects of ionizing radiation on the skin EJ7Z Dermatoses due to ionizing radiation, unspecified EK00 Allergic contact dermatitis EK00.0 Allergic contact dermatitis due to clothing or footwear EK00.1 Allergic contact dermatitis due to cosmetics or fragrances EK00.2 Allergic contact dermatitis due to dental materials EK00.3 Allergic contact dermatitis due to food flavours or additives EK00.4 Allergic contact dermatitis due to hairdressing products EK00.5 Allergic contact dermatitis due to industrial biocides, cutting oils or disinfectants EK00.6 Allergic contact dermatitis due to metals or metal salts EK00.7 Allergic contact dermatitis due to allergenic haptens derived from plants or organic matter EK00.8 Allergic contact dermatitis due to plastics, glues or resin systems EK00.9 Allergic contact dermatitis due to preservatives or biocides EK00.A Allergic contact dermatitis due to rubber chemicals EK00.B Allergic contact dermatitis due to systemic medicaments EK00.C Allergic contact dermatitis due to topical medicaments EK00.Y Other specified allergic contact dermatitis EK00.Z Allergic contact dermatitis, unspecified EK01 Photo-allergic contact dermatitis EK02 Irritant contact dermatitis EK02.0 Irritant contact dermatitis from specified external agents EK02.1 Irritant contact dermatitis of specified site EK02.2 Irritant contact dermatitis due to friction, sweating or contact with body fluids EK02.Y Irritant contact dermatitis due to other specified cause EK02.Z Irritant contact dermatitis, unspecified – EK02.00 Irritant contact dermatitis due to wet work – EK02.01 Irritant contact dermatitis due to solvents – EK02.02 Irritant contact dermatitis due to exposure to acids, alkalis or other specified chemical irritants – EK02.03 Irritant contact dermatitis due to cosmetics or emollients – EK02.04 Irritant contact dermatitis due to topical medicaments or antimicrobials – EK02.05 Irritant contact dermatitis due to plants or other vegetable matter – EK02.06 Irritant contact dermatitis due to foods – EK02.10 Irritant contact dermatitis of external ear – EK02.11 Irritant contact blepharoconjunctivitis – EK02.12 Irritant contact dermatitis of hands – EK02.13 Irritant contact dermatitis of vulva – EK02.1Y Irritant contact dermatitis of other specified site – EK02.20 Intertriginous dermatitis due to friction, sweating or contact with body fluids – EK02.21 Irritant contact dermatitis due to saliva – EK02.22 Irritant contact dermatitis due to incontinence – EK02.23 Irritant contact dermatitis related to stoma or fistula – EK02.24 Irritant contact dermatitis related to skin contact with prostheses or surgical appliances EK10 Allergic contact urticaria EK10.0 Oral allergy syndrome EK10.1 Contact urticaria due to food allergen EK10.Y Other specified allergic contact urticaria EK10.Z Allergic contact urticaria, unspecified EK11 Protein contact dermatitis EK12 Allergic contact sensitisation EK20 Phototoxic reaction to fragrance or cosmetics EK2Y Phototoxic reaction to skin contact with other specified photoactive agent EK2Z Phototoxic dermatitis, unspecified EK50 Cutaneous reactions to venomous or noxious animals EK50.0 Cutaneous insect bite reactions – EK50.00 Papular urticaria – EK50.01 Bullous insect bite reaction – EK50.02 Persistent insect bite reaction – EK50.0Y Other specified cutaneous insect bite reactions – EK50.0Z Cutaneous insect bite reactions, unspecified EK5Y Other specified skin disorders provoked by external factors EK70 Cutaneous cysts EK70.0 Epidermoid cyst EK70.1 Trichilemmal cyst EK70.2 Digital myxoid pseudocyst EK70.3 Hidrocystoma EK70.Y Other specified cutaneous cysts EK70.Z Cutaneous cysts, unspecified – EK70.00 Infected epidermoid cyst – EK70.0Z Epidermoid cyst, unspecified EK71 Skin tags or polyps EK71.0 Fibroepithelial polyp of skin EK71.1 Multiple skin tags EK71.Z Polyp of skin not elsewhere classified EK90 Actinic keratosis and other discrete epidermal dysplasias EK90.0 Actinic keratosis EK90.1 Diffuse actinic keratinocyte dysplasia EK90.Y Other discrete epidermal dysplasias EK91 Dermatoses which may presage cutaneous lymphoma EK91.0 Large plaque parapsoriasis EK91.1 Poikiloderma vasculare atrophicans EK91.2 Primary cutaneous plasmacytosis EK92 Histiocytoses of uncertain malignant potential EL10 Paraneoplastic syndromes involving skin EL1Y Other specified cutaneous markers of internal malignancy EL3Y Other specified cutaneous markers of internal disorders EL50 Unsatisfactory surgical scar of skin EL50.0 Keloidal surgical scar EL50.1 Hypertrophic surgical scar EL50.2 Atrophic surgical scar EL50.3 Expanded surgical scar EL50.Z Unsatisfactory surgical scar of skin, unspecified EL51 Cutaneous flap necrosis EL52 Myocutaneous flap necrosis EL53 Skin graft failure EL54 Composite graft failure EL60 Acute radiodermatitis following radiotherapy EL61 Chronic radiodermatitis following radiotherapy EL63 Radionecrosis of skin due to therapeutic ionizing irradiation EL73 Unsatisfactory outcome from cutaneous cosmetic surgical procedure – EL73.0 Adverse reaction to dermal or deep fillers – EL73.1 Adverse reaction to chemical peel – EL73.2 Adverse reaction to injection of neurotoxin – EL73.3 Unsatisfactory outcome from cosmetic laser surgery – EL73.4 Hypomelanosis resulting from cosmetic procedure – EL73.5 Dyspigmentation resulting from cosmetic procedure – EL73.6 Fibrosis or scarring following cosmetic procedure EL80 Adverse cutaneous effects of diagnostic procedures EM0Y Other specified diseases of the skin EM0Z Skin disease of unspecified nature FA00 Osteoarthritis of hip – FA00.0 Primary osteoarthritis of hip – FA00.1 Post traumatic osteoarthritis of hip – FA00.2 Other secondary osteoarthritis of hip – FA00.Z Osteoarthritis of hip, unspecified FA01 Osteoarthritis of knee – FA01.0 Primary osteoarthritis of knee – FA01.1 Post traumatic osteoarthritis of knee – FA01.2 Other secondary osteoarthritis of knee – FA01.Z Osteoarthritis of knee, unspecified FA02 Osteoarthritis of wrist or hand – FA02.0 Primary osteoarthritis of wrist or hand – FA02.1 Post traumatic osteoarthritis of wrist or hand – FA02.2 Other secondary osteoarthritis of wrist or hand – FA02.Z Osteoarthritis of wrist or hand, unspecified FA03 Osteoarthritis of other specified joint – FA03.0 Primary osteoarthritis of other specified joint – FA03.1 Post traumatic osteoarthritis of other specified joint – FA03.2 Other secondary osteoarthritis of other specified joint – FA03.Z Osteoarthritis of other specified joint, unspecified FA04 Oligoosteoarthritis FA05 Polyosteoarthritis FA0Z Osteoarthritis, unspecified FA10 Direct infections of joint – FA10.0 Bacterial infection of joint – FA10.1 Viral infection of joint – FA10.2 Fungal infection of joint – FA10.Z Direct infections of joint, unspecified FA11 Reactive arthropathies – FA11.0 Arthropathy following intestinal bypass – FA11.1 Arthropathy following vaccination – FA11.2 Arthropathy following genitourinary infection – FA11.Y Other specified reactive arthropathies – FA11.Z Reactive arthropathies, unspecified FA12 Postinfectious arthropathies – FA12.0 Bacterial postinfectious arthropathy – FA12.1 Viral postinfectious arthropathies – FA12.2 Fungal postinfectious arthropathies – FA12.3 Parasitic postinfectious arthropathies – FA12.Y Other specified postinfectious arthropathies – FA12.Z Postinfectious arthropathies, unspecified FA13 Infectious spondyloarthritis FA1Y Other specified infection related arthropathies FA1Z Infection related arthropathies, unspecified FA20 Rheumatoid arthritis – FA20.0 Seropositive rheumatoid arthritis – FA20.1 Seronegative rheumatoid arthritis – FA20.Z Rheumatoid arthritis, serology unspecified FA21 Psoriatic arthritis – FA21.0 Psoriatic spondyloarthritis – FA21.Y Other specified psoriatic arthritis – FA21.Z Psoriatic arthritis, unspecified FA22 Polymyalgia rheumatica FA23 Adult-onset Still disease FA24 Juvenile idiopathic arthritis – FA24.0 Juvenile idiopathic oligoarthritis – FA24.1 Juvenile idiopathic polyarthritis – FA24.2 Juvenile psoriatic arthritis – FA24.3 Juvenile enthesitis related arthritis – FA24.4 Juvenile systemic arthritis – FA24.Y Other specified juvenile idiopathic arthritis – FA24.Z Juvenile idiopathic arthritis, unspecified –– FA24.00 Juvenile idiopathic oligoarthritis, onset persistent –– FA24.01 Juvenile idiopathic oligoarthritis, onset extended –– FA24.0Z Juvenile idiopathic oligoarthritis, onset unspecified FA25 Gout – FA25.0 Primary gout – FA25.1 Secondary gout – FA25.2 Gout without specification whether primary or secondary –– FA25.10 Lead-induced gout –– FA25.11 Drug-induced gout –– FA25.12 Gouty arthropathy due to enzyme defects or other inherited disorders –– FA25.1Y Other specified secondary gout –– FA25.1Z Secondary gout, unspecified –– FA25.20 Tophaceous gout –– FA25.2Y Other specified gout without specification whether primary or secondary –– FA25.2Z Gout, unspecified FA26 Certain specified crystal arthropathies – FA26.0 Calcium pyrophosphate dehydrate deposition disease – FA26.1 Hydroxyapatite deposition disease – FA26.2 Chondrocalcinosis – FA26.Y Other specified crystal arthropathies – FA26.Z Crystal arthropathies, unspecified FA27 Certain specified inflammatory arthropathies – FA27.0 Kashin-Beck disease – FA27.1 Pigmented villonodular synovitis – FA27.2 Palindromic rheumatism – FA27.3 Transient synovitis – FA27.4 Intermittent hydrarthrosis – FA27.Y Other specified inflammatory arthropathies FA2Z Inflammatory arthropathies, unspecified FA30 Acquired deformities of fingers or toes – FA30.0 Acquired hallux valgus – FA30.1 Hallux rigidus – FA30.2 Acquired hammer toe – FA30.Y Other specified acquired deformities of fingers or toes – FA30.Z Acquired deformities of fingers or toes, unspecified FA31 Other acquired deformities of limbs – FA31.0 Valgus deformity, not elsewhere classified – FA31.1 Varus deformity, not elsewhere classified – FA31.2 Flexion deformity – FA31.3 Acquired wrist drop – FA31.4 Acquired foot drop – FA31.5 Acquired pes planus – FA31.6 Acquired clawhand or clubhand – FA31.7 Acquired clawfoot or clubfoot – FA31.8 Acquired unequal limb length – FA31.Y Other specified acquired deformities of limbs – FA31.Z Acquired deformities of limbs, unspecified FA32 Disorders of patella – FA32.0 Recurrent instability of patella – FA32.1 Patellofemoral disorders – FA32.Y Other specified disorders of patella – FA32.Z Disorders of patella, unspecified FA33 Internal derangement of knee – FA33.0 Cystic meniscus – FA33.1 Discoid meniscus – FA33.2 Derangement of meniscus due to old tear or injury – FA33.3 Loose body in knee – FA33.4 Chronic instability of knee – FA33.Y Other specified internal derangement of knee – FA33.Z Internal derangement of knee, unspecified –– FA33.40 Chronic instability of knee, medial collateral ligament or other or unspecified part of medial meniscus –– FA33.4Y Other specified chronic instability of knee –– FA33.4Z Chronic instability of knee, unspecified FA34 Certain specified joint derangements – FA34.0 Loose body in joint – FA34.1 Disorder of ligament – FA34.2 Recurrent instability of joint – FA34.3 Contracture of joint – FA34.4 Ankylosis of joint – FA34.5 Impingement syndrome of hip – FA34.Y Other joint derangements FA35 Wear of articular bearing surface of joint prosthesis – FA35.0 Wear of articular bearing surface of joint prosthesis of hip – FA35.1 Wear of articular bearing surface of joint prosthesis of knee – FA35.2 Wear of articular bearing surface of joint prosthesis of other joint – FA35.Z Wear of articular bearing surface of joint prosthesis of unspecified joint FA36 Effusion of joint – FA36.0 Effusion of joint containing blood – FA36.Y Other specified effusion of joint – FA36.Z Effusion of joint, unspecified FA37 Certain joint disorders, not elsewhere classified – FA37.0 Osteophyte – FA37.Y Other specified certain joint disorders, not elsewhere classified – FA37.Z Certain joint disorders, not elsewhere classified, unspecified FA38 Arthropathy in diseases classified elsewhere – FA38.0 Diabetic arthropathy – FA38.1 Neuropathic arthropathy – FA38.2 Arthropathy in hypersensitivity reactions classified elsewhere – FA38.3 Haemophilic arthropathy – FA38.Y Other specified arthropathy in diseases classified elsewhere – FA38.Z Unspecified arthropathy in diseases classified elsewhere –– FA38.10 Diabetic Charcot arthropathy –– FA38.1Y Other specified neuropathic arthropathy –– FA38.1Z Neuropathic arthropathy, unspecified FA3Z Unspecified joint disorders and deformities of limbs FA5Y Other specified arthropathies FA5Z Arthropathies, unspecified FA70 Spinal deformities – FA70.0 Kyphosis – FA70.1 Scoliosis – FA70.2 Lordosis – FA70.Z Spinal deformities, unspecified FA71 Torticollis FA72 Disorders of vertebra – FA72.0 Ankylosing hyperostosis – FA72.1 Kissing spine – FA72.2 Traumatic spondylopathy – FA72.3 Fatigue fracture of vertebra – FA72.4 Collapsed vertebra, not elsewhere classified – FA72.Y Other specified disorders of vertebra – FA72.Z Disorders of vertebra, unspecified FA7Y Other specified structural disorders of spine FA7Z Structural disorders of spine, unspecified FA80 Intervertebral disc degeneration – FA80.0 Intervertebral disc degeneration of cervical spine without prolapsed disc – FA80.1 Intervertebral disc degeneration of cervical spine with prolapsed disc – FA80.2 Intervertebral disc degeneration of cervical spine with bony spur at the vertebra – FA80.3 Intervertebral disc degeneration of cervical spine with nervous system involvement – FA80.4 Intervertebral disc degeneration of thoracic spine without prolapsed disc – FA80.5 Intervertebral disc degeneration of thoracic spine with prolapsed disc – FA80.6 Intervertebral disc degeneration of thoracic spine with bony spur at the vertebra – FA80.7 Intervertebral disc degeneration of thoracic spine with nervous system involvement – FA80.8 Intervertebral disc degeneration of lumbar spine without prolapsed disc – FA80.9 Intervertebral disc degeneration of lumbar spine with prolapsed disc – FA80.A Intervertebral disc degeneration of lumbar spine with bony spur at the vertebra – FA80.B Intervertebral disc degeneration of lumbar spine with nervous system involvement – FA80.Y Other specified intervertebral disc degeneration – FA80.Z Intervertebral disc degeneration, unspecified FA81 Spondylolysis – FA81.0 Spondylolysis with slippage – FA81.1 Spondylolysis without slippage – FA81.Z Spondylolysis, unspecified FA82 Spinal stenosis FA83 Ossification of spinal ligaments FA84 Spondylolisthesis – FA84.0 Spondylolisthesis with pars defect – FA84.1 Spondylolisthesis without pars defect – FA84.Z Spondylolisthesis, unspecified FA85 Spinal endplate defects – FA85.0 Spinal epiphysiopathy with no determinant – FA85.1 Spinal epiphysiopathy with determinants – FA85.Y Other specified spinal endplate defects – FA85.Z Spinal endplate defects, unspecified –– FA85.10 Localised central endplate defect –– FA85.11 Multiple anterior endplate defect –– FA85.12 Separation of ring apophysis –– FA85.1Y Other specified spinal epiphysiopathy with determinants –– FA85.1Z Spinal epiphysiopathy with determinants, unspecified FA8Y Other specified degenerative condition of spine FA8Z Degenerative condition of spine, unspecified FA90 Infection of vertebra – FA90.0 Infection of vertebra with no determinant – FA90.1 Infection of vertebra with determinants – FA90.Y Other specified infection of vertebra – FA90.Z Infection of vertebra, unspecified FA91 Infection of intervertebral disc FA92 Inflammatory spondyloarthritis – FA92.0 Axial spondyloarthritis – FA92.1 Peripheral spondyloarthritis – FA92.Y Other specified inflammatory spondyloarthritis – FA92.Z Inflammatory spondyloarthritis, unspecified –– FA92.00 Spinal enthesitis –– FA92.01 Sacroiliitis, not elsewhere classified –– FA92.0Y Other specified axial spondyloarthritis –– FA92.0Z Axial spondyloarthritis, unspecified FA9Y Other specified inflammation of spine FA9Z Inflammation of spine, unspecified FB00 Ankylosis of spinal joint FB0Y Other specified spondylopathies FB0Z Spondylopathies, unspecified FB10 Spinal instabilities FB1Y Other specified conditions associated with the spine FB1Z Conditions associated with the spine, unspecified FB30 Infectious myositis FB31 Calcification or ossification of muscle – FB31.0 Progressive osseous heteroplasia – FB31.1 Fibrodysplasia ossificans progressiva – FB31.Y Other specified calcification or ossification of muscle – FB31.Z Calcification or ossification of muscle, unspecified FB32 Certain specified disorders of muscle – FB32.0 Diastasis of muscle – FB32.1 Spontaneous rupture of muscle – FB32.2 Ischaemic infarction of muscle – FB32.3 Immobility syndrome – FB32.4 Contracture of muscle – FB32.5 Muscle strain or sprain – FB32.Y Other specified disorders of muscles –– FB32.20 Idiopathic rhabdomyolysis –– FB32.2Y Other specified ischaemic infarction of muscle –– FB32.2Z Ischaemic infarction of muscle, unspecified FB33 Secondary disorders of muscle FB3Z Disorders of muscles, unspecified FB40 Tenosynovitis – FB40.0 Infectious tenosynovitis – FB40.1 Plantar fasciitis – FB40.2 Posterior tibial tendonitis – FB40.3 Calcific tendinitis – FB40.4 Trigger finger – FB40.5 Radial styloid tenosynovitis – FB40.Y Other specified tenosynovitis – FB40.Z Tenosynovitis, unspecified FB41 Spontaneous rupture of synovium or tendon – FB41.0 Spontaneous rupture of popliteal cyst – FB41.1 Spontaneous rupture of synovium – FB41.2 Spontaneous rupture of tendon – FB41.Y Other specified spontaneous rupture of synovium or tendon – FB41.Z Spontaneous rupture of synovium or tendon, unspecified FB42 Certain specified disorders of synovium or tendon – FB42.0 Acquired short Achilles tendon – FB42.1 Contracture of tendon sheath – FB42.2 Ganglion – FB42.3 Synovial hypertrophy, not elsewhere classified FB43 Secondary disorders of synovium or tendon FB4Y Other specified disorders of synovium or tendon FB4Z Disorders of synovium or tendon, unspecified FB50 Bursitis – FB50.0 Infectious bursitis – FB50.1 Bursitis related to use, overuse or pressure – FB50.2 Synovial cyst of popliteal space – FB50.3 Calcium deposit in bursa – FB50.Y Other specified bursitis – FB50.Z Bursitis, unspecified FB51 Fibroblastic disorders – FB51.0 Palmar fascial fibromatosis – FB51.1 Knuckle pads – FB51.2 Fasciitis and fibromatosis – FB51.3 Fibroblastic rheumatism – FB51.4 Retroperitoneal fibrosis – FB51.Y Other specified fibroblastic disorders – FB51.Z Fibroblastic disorders, unspecified –– FB51.40 Primary retroperitoneal fibrosis –– FB51.4Y Other specified retroperitoneal fibrosis –– FB51.4Z Retroperitoneal fibrosis, unspecified FB52 Soft tissue disorders in diseases classified elsewhere FB53 Shoulder lesions – FB53.0 Adhesive capsulitis of shoulder – FB53.1 Rotator cuff syndrome – FB53.2 Impingement syndrome of shoulder – FB53.Y Other specified shoulder lesions – FB53.Z Shoulder lesions, unspecified FB54 Enthesopathies of lower limb – FB54.0 Iliac crest spur – FB54.1 Iliotibial band syndrome – FB54.2 Tibial collateral bursitis – FB54.3 Calcaneal spur – FB54.4 Metatarsalgia – FB54.Y Other specified enthesopathies of lower limb – FB54.Z Enthesopathies of lower limb, unspecified FB55 Certain specified enthesopathies – FB55.0 Medial epicondylitis of elbow – FB55.1 Lateral epicondylitis of elbow – FB55.2 Periarthritis of wrist – FB55.Z Enthesopathies, unspecified FB56 Specified soft tissue disorders, not elsewhere classified – FB56.0 Foreign body granuloma of soft tissue, not elsewhere classified – FB56.1 Residual foreign body in soft tissue – FB56.2 Myalgia – FB56.3 Hypertrophy of infrapatellar fat pad – FB56.4 Pain in limb – FB56.6 Other specified soft tissue disorders FB6Z Soft tissue disorders, unspecified FB80 Certain specified disorders of bone density or structure FB80.0 Fibrous dysplasia of bone FB80.1 Skeletal fluorosis FB80.2 Osteitis condensans FB80.3 Hyperostosis of skull FB80.4 Osteosclerosis FB80.5 Solitary bone cyst FB80.6 Aneurysmal bone cyst FB80.7 Malunion of fracture FB80.8 Nonunion of fracture FB80.9 Delayed union of fracture FB80.A Stress fracture, not elsewhere classified FB80.B Pathological fracture FB80.Y Other specified disorders of bone density and structure FB80.Z Disorder of bone density and structure, unspecified FB81 Osteonecrosis FB81.0 Idiopathic aseptic osteonecrosis FB81.1 Osteonecrosis due to dialysis FB81.2 Drug-induced osteonecrosis FB81.3 Osteonecrosis due to trauma FB81.4 Osteonecrosis due to haemoglobinopathy FB81.5 Osteonecrosis due to ionizing radiation FB81.6 Alcohol induced osteonecrosis FB81.Y Other specified osteonecrosis FB81.Z Osteonecrosis, unspecified FB82 Chondropathies FB82.0 Chondromalacia FB82.1 Osteochondrosis or osteochondritis dissecans FB82.2 Slipped upper femoral epiphysis FB82.3 Relapsing polychondritis FB82.Y Other specified chondropathies FB82.Z Chondropathies, unspecified – FB82.00 Chondromalacia patellae – FB82.0Y Other specified chondromalacia – FB82.0Z Chondromalacia, unspecified FB83 Low bone mass disorders FB83.0 Osteopenia FB83.1 Osteoporosis FB83.2 Adult osteomalacia – FB83.00 Premenopausal idiopathic osteopenia – FB83.01 Postmenopausal osteopenia – FB83.02 Senile osteopenia – FB83.03 Osteopenia of disuse – FB83.04 Drug-induced osteopenia – FB83.0Y Other specified osteopenia – FB83.0Z Osteopenia, unspecified – FB83.10 Premenopausal idiopathic osteoporosis – FB83.11 Postmenopausal osteoporosis – FB83.12 Osteoporosis of disuse – FB83.13 Drug-induced osteoporosis – FB83.14 Osteoporosis due to malabsorption – FB83.1Y Other specified osteoporosis – FB83.1Z Osteoporosis, unspecified – FB83.20 Aluminium bone disease – FB83.21 Adult osteomalacia due to malnutrition – FB83.22 Drug-induced adult osteomalacia – FB83.2Y Other specified adult osteomalacia – FB83.2Z Adult osteomalacia, unspecified FB84 Osteomyelitis or osteitis FB84.0 Acute haematogenous osteomyelitis FB84.1 Other acute osteomyelitis FB84.2 Subacute osteomyelitis FB84.3 Chronic multifocal osteomyelitis FB84.4 Chronic osteomyelitis with draining sinus FB84.5 Other chronic haematogenous osteomyelitis FB84.Y Other specified osteomyelitis or osteitis FB84.Z Osteomyelitis or osteitis, unspecified FB85 Paget disease of bone FB85.0 Juvenile Paget disease FB85.1 Paget disease of bone in neoplastic disease FB85.Y Other specified Paget disease of bone FB85.Z Paget disease of bone, unspecified FB86 Disorders associated with bone growth FB86.0 Epiphyseal arrest FB86.1 Bone hyperplasias FB86.2 Osteolysis FB86.Y Other specified disorders associated with bone growth FB86.Z Disorders associated with bone growth, unspecified – FB86.10 Hypertrophic osteoarthropathy – FB86.11 Hypertrophy of bone – FB86.1Y Other specified bone hyperplasias – FB86.1Z Bone hyperplasias, unspecified FB8Y Other specified osteopathies or chondropathies FB8Z Osteopathies or chondropathies, unspecified FC00 Certain specified acquired deformities of musculoskeletal system or connective tissue, not elsewhere classified FC00.0 Acquired deformity of nose FC00.1 Acquired deformity of neck FC00.2 Acquired deformity of chest or rib FC00.3 Acquired deformity of pelvis FC00.4 Acquired deformity of trunk FC00.Y Acquired deformities of musculoskeletal system and connective tissue, not classified elsewhere, other specified sites FC01 Postprocedural disorders of the musculoskeletal system FC01.0 Pseudarthrosis after fusion or arthrodesis FC01.1 Postlaminectomy syndrome, not elsewhere classified FC01.2 Post radiation kyphosis FC01.3 Postlaminectomy kyphosis FC01.4 Postsurgical lordosis FC01.5 Post radiation scoliosis FC01.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate FC01.7 Nonunion after arthrodesis FC01.8 Postsurgical osteolysis FC01.9 Postoophorectomy osteoporosis FC01.A Postsurgical malabsorption osteoporosis FC01.70 Nonunion after spinal arthrodesis FC01.7Y Nonunion after arthrodesis of other sites FC0Y Other specified diseases of the musculoskeletal system or connective tissue FC0Z Diseases of the musculoskeletal system or connective tissue, unspecified GA00 Vulvitis – GA00.0 Acute vulvitis – GA00.1 Subacute, chronic or recurrent vulvitis – GA00.2 Abscess of vulva – GA00.3 Genital ulcer of vulva – GA00.4 Vulvovaginal ulceration and inflammation –– GA00.40 Vulvovaginal ulceration –– GA00.4Y Other specified vulvovaginal ulceration and inflammation –– GA00.4Z Vulvovaginal ulceration and inflammation, unspecified GA01 Inflammatory disorders of the uterus, except cervix – GA01.0 Acute inflammatory disease of uterus – GA01.1 Chronic inflammatory disease of uterus – GA01.Y Other specified inflammatory disorders of the uterus, except cervix – GA01.Z Inflammatory disorders of the uterus, except cervix, unspecified –– GA01.00 Acute endometritis –– GA01.01 Acute inflammatory disease of uterus with pyometra –– GA01.0Z Acute inflammatory disease of uterus, unspecified –– GA01.10 Chronic endometritis –– GA01.11 Chronic inflammatory disease of uterus with pyometra –– GA01.1Z Chronic inflammatory disease of uterus, unspecified GA02 Vaginitis – GA02.0 Acute vaginitis – GA02.1 Inflammatory vaginitis – GA02.2 Subacute or chronic vaginitis – GA02.3 Genital ulcer disease of vagina – GA02.Z Vaginitis, unspecified GA03 Diseases of Bartholin gland – GA03.0 Abscess of Bartholin gland – GA03.1 Cyst of Bartholin gland – GA03.Y Other specified diseases of Bartholin gland – GA03.Z Diseases of Bartholin gland, unspecified GA04 Cervicitis GA05 Female pelvic inflammatory diseases – GA05.0 Acute female pelvic inflammatory disease – GA05.1 Chronic pelvic inflammatory disease – GA05.2 Female pelvic peritonitis, unspecified – GA05.3 Tuboovarian abscess – GA05.Y Other specified female pelvic inflammatory diseases – GA05.Z Female pelvic inflammatory diseases, unspecified GA06 Pelvic peritoneal adhesions of unknown or combined origin GA07 Salpingitis and oophoritis – GA07.0 Acute salpingitis and oophoritis – GA07.1 Chronic salpingitis and oophoritis – GA07.Z Salpingitis and oophoritis, unspecified GA0Z Inflammatory disorders of the female genital tract, unspecified GA10 Endometriosis GA10.B Endometriosis of the reproductive system GA10.C Endometriosis of the digestive system GA10.D Endometriosis of urinary system GA10.E Endometriosis of the circulatory system GA10.F Endometriosis of the nervous system GA10.G Thoracic endometriosis GA10.H Endometriosis in cutaneous scar GA10.J Endometriosis-related adhesions GA10.Y Endometriosis of other specified sites GA10.Z Endometriosis of unspecified site – GA10.B0 Endometriosis of the uterosacral ligaments – GA10.B1 Endometriosis of the pelvic side wall – GA10.B2 Endometriosis of rectovaginal septum or vagina – GA10.B3 Endometriosis of fallopian tube – GA10.B4 Superficial ovarian endometriosis – GA10.B5 Deep ovarian endometriosis – GA10.BY Endometriosis of other sites of the reproductive system – GA10.BZ Endometriosis of unspecified site of reproductive system – GA10.C0 Endometriosis of the gallbladder – GA10.C1 Endometriosis of intestine – GA10.C2 Endometriosis of pelvic peritoneum – GA10.C3 Peritoneal pockets due to endometriosis – GA10.CY Endometriosis of other sites within the digestive system – GA10.CZ Endometriosis of unspecified site within the digestive system – GA10.D0 Endometriosis of the bladder – GA10.DY Endometriosis of other sites in the urinary system – GA10.DZ Endometriosis of unspecified site in the urinary system GA11 Adenomyosis GA12 Dyspareunia GA13 Acquired abnormalities of vulva or perineum – GA13.0 Polyp of vulva – GA13.1 Low grade squamous intraepithelial lesion of vulva – GA13.2 Hypertrophy of vulva – GA13.3 Vulvar cyst – GA13.4 Labial agglutination – GA13.5 Skene duct cyst – GA13.6 Vulvar laceration – GA13.7 Vulvar haematoma – GA13.Y Other specified acquired abnormalities of vulva or perineum – GA13.Z Acquired abnormalities of vulva or perineum, unspecified GA14 Acquired abnormalities of vagina – GA14.0 Polyp of vagina – GA14.1 Haematocolpos – GA14.2 Vaginal foreign body – GA14.3 Vaginal haematoma – GA14.5 Leukoplakia of vagina – GA14.6 Low grade squamous intraepithelial lesion of vagina – GA14.Y Other specified acquired abnormalities of vagina – GA14.Z Acquired abnormalities of vagina, unspecified GA15 Acquired abnormalities of cervix uteri – GA15.0 Polyp of cervix uteri – GA15.1 Erosion or ectropion of cervix uteri – GA15.2 Nabothian cyst – GA15.3 Old laceration of cervix uteri – GA15.4 Stricture or stenosis of cervix uteri – GA15.5 Hypertrophic elongation of cervix uteri – GA15.6 Incompetence of cervix uteri – GA15.7 Low grade squamous intraepithelial lesion of cervix uteri – GA15.Y Other specified acquired abnormalities of cervix uteri – GA15.Z Acquired abnormalities of cervix uteri, unspecified GA16 Acquired abnormalities of uterus, except cervix – GA16.0 Endometrial glandular hyperplasia – GA16.1 Malposition of uterus – GA16.2 Intrauterine synechiae – GA16.3 Haematometra – GA16.Y Other specified acquired abnormalities of uterus, except cervix – GA16.Z Acquired abnormalities of uterus, except cervix, unspecified GA17 Acquired abnormalities of fallopian tube – GA17.0 Acquired parafimbrial cyst of the fallopian tube – GA17.1 Fimbrial agglutination – GA17.2 Hydrosalpinx – GA17.3 Haematosalpinx – GA17.4 Salpingitis isthmica nodosa – GA17.Y Other specified acquired abnormalities of fallopian tube – GA17.Z Acquired abnormalities of fallopian tube, unspecified GA18 Acquired abnormalities of ovary – GA18.0 Follicular cyst of ovary – GA18.1 Corpus luteum cyst – GA18.2 Theca lutein cyst – GA18.4 Para ovarian cyst – GA18.5 Torsion of ovary, ovarian pedicle or fallopian tube – GA18.6 Other or unspecified ovarian cysts – GA18.7 Acquired atrophy of ovary or fallopian tube – GA18.Y Other specified acquired abnormalities of ovary – GA18.Z Acquired abnormalities of ovary, unspecified GA19 Acquired abnormalities of broad ligament – GA19.0 Haematoma of broad ligament – GA19.Y Other specified acquired abnormalities of broad ligament – GA19.Z Acquired abnormalities of broad ligament, unspecified GA1Y Other specified noninflammatory disorders of female genital tract GA1Z Noninflammatory disorders of female genital tract, unspecified GA20 Menstrual cycle bleeding disorders – GA20.0 Amenorrhoea – GA20.1 Abnormal frequency of uterine bleeding – GA20.2 Ovulation bleeding – GA20.3 Abnormal regularity of uterine bleeding – GA20.4 Abnormal duration of uterine bleeding – GA20.5 Abnormal volume of uterine bleeding – GA20.Y Other specified menstrual cycle bleeding disorders – GA20.Z Menstrual cycle bleeding disorders, unspecified –– GA20.00 Primary amenorrhoea –– GA20.01 Secondary amenorrhoea –– GA20.02 Lactational amenorrhoea –– GA20.0Y Other specified amenorrhoea –– GA20.0Z Amenorrhoea, unspecified –– GA20.10 Frequent menstrual bleeding –– GA20.11 Infrequent menstrual bleeding –– GA20.1Z Abnormal frequency of uterine bleeding, unspecified –– GA20.20 Intermenstrual bleeding –– GA20.2Y Other specified ovulation bleeding –– GA20.2Z Ovulation bleeding, unspecified –– GA20.50 Heavy menstrual bleeding –– GA20.51 Light menstrual bleeding –– GA20.5Z Abnormal volume of uterine bleeding, unspecified GA21 Nonmenstrual bleeding disorders – GA21.0 Postcoital or contact bleeding – GA21.Y Other specified nonmenstrual bleeding disorders – GA21.Z Nonmenstrual bleeding disorders, unspecified GA22 Excessive menstruation with irregular cycle GA23 Anovulatory bleeding GA2Y Other specified abnormal uterine or vaginal bleeding GA2Z Abnormal uterine or vaginal bleeding, unspecified GA30 Menopausal or certain specified perimenopausal disorders GA30.0 Menopause GA30.1 Postmenopausal uterine bleeding GA30.2 Postmenopausal atrophic vaginitis GA30.3 States associated with artificial menopause GA30.4 Menopausal hot flush GA30.5 Menopausal osteoporosis GA30.6 Premature ovarian failure GA30.Y Other specified menopausal and perimenopausal disorders GA30.Z Menopausal and perimenopausal disorders, unspecified – GA30.00 Menopausal or female climacteric states – GA30.01 Menopausal transition – GA30.02 Excessive bleeding in the premenopausal period – GA30.0Y Other specified menopause – GA30.0Z Menopause, unspecified GA31 Female infertility GA31.0 Primary female infertility GA31.1 Secondary female infertility GA31.Z Female infertility without specification whether primary or secondary – GA31.00 Primary female infertility of uterine origin – GA31.01 Primary female infertility of tubal origin – GA31.0Y Primary female infertility of other specified origin – GA31.0Z Primary female infertility of unspecified origin – GA31.10 Secondary female infertility of uterine origin – GA31.11 Secondary female infertility of tubal origin – GA31.1Y Secondary female infertility of other specified origin – GA31.1Z Secondary female infertility of unspecified origin GA32 Complications associated with medically assisted reproduction GA32.0 Ovarian hyperstimulation syndrome GA32.1 Bleeding after egg retrieval GA32.2 Infection associated with medically assisted reproduction GA32.3 Complications of attempted embryo transfer or medically assisted insemination GA32.Y Other specified complications associated with medically assisted reproduction GA32.Z Complications associated with medically assisted reproduction, unspecified GA33 Recurrent pregnancy loss GA34 Female pelvic pain associated with genital organs or menstrual cycle GA34.0 Pain related to vulva, vagina or pelvic floor GA34.1 Vaginal laxity GA34.2 Female pelvic pain GA34.3 Dysmenorrhoea GA34.4 Premenstrual disturbances GA34.5 Ovarian remnant syndrome GA34.6 Female genital pain GA34.Y Other specified female pelvic pain associated with genital organs or menstrual cycle GA34.Z Female pelvic pain associated with genital organs or menstrual cycle, unspecified – GA34.00 Vulval pain – GA34.01 Perineal pain – GA34.02 Vulvodynia – GA34.0Y Other specified pain related to vulva, vagina or pelvic floor – GA34.0Z Pain related to vulva, vagina or pelvic floor, unspecified – GA34.20 Cyclic pelvic pain – GA34.21 Noncyclic pelvic pain – GA34.2Z Female pelvic pain, unspecified – GA34.40 Premenstrual tension syndrome – GA34.41 Premenstrual dysphoric disorder – GA34.4Y Other specified premenstrual disturbances – GA34.4Z Premenstrual disturbances, unspecified GA40 Inflammatory dermatoses of the vulva GA41 Ulcerative or erosive disorders of the vulva – GA41.0 Vulval aphthosis – GA41.Y Other specified ulcerative or erosive disorders of the vulva GA42 Sensory disturbance of the vulva – GA42.0 Vulval pruritus GA4Y Other specified dermatoses of female genitalia GA6Y Other specified diseases of the female genital system GA6Z Diseases of the female genital system, unspecified GA80 Ulcerative disorders of the penis or scrotum – GA80.0 Aphthosis of penis or scrotum – GA80.1 Ulcer of penis of uncertain nature – GA80.Y Other specified ulcerative disorders of penis and scrotum GA81 Miscellaneous dermatoses of male genitalia – GA81.0 Penoscrotal pruritus – GA81.Y Other specified dermatoses of male genitalia GA90 Hyperplasia of prostate GA91 Inflammatory and other diseases of prostate – GA91.0 Chronic prostatitis – GA91.1 Abscess of prostate – GA91.2 Prostatocystitis – GA91.3 Calculus of prostate – GA91.4 Haemorrhage of the prostate – GA91.5 Atrophy of prostate – GA91.6 Low grade intraepithelial lesion of prostate – GA91.Y Other specified inflammatory and other diseases of prostate – GA91.Z Inflammatory and other diseases of prostate, unspecified GB00 Hydrocele or spermatocele GB00.0 Encysted hydrocele GB00.1 Infected hydrocele GB00.2 Spermatocele GB00.Y Other specified hydrocele or spermatocele GB00.Z Hydrocele or spermatocele, unspecified GB01 Torsion of testis, epididymis or appendices GB01.0 Torsion of testis GB01.1 Torsion of epididymis GB01.2 Torsion of hydatids GB01.Z Torsion of testis, epididymis or appendices, unspecified GB02 Orchitis or epididymitis GB02.0 Orchitis, epididymitis or epididymo-orchitis with abscess GB02.1 Orchitis, epididymitis or epididymo-orchitis without abscess GB02.Y Other specified orchitis or epididymitis GB02.Z Orchitis or epididymitis, unspecified GB03 Atrophy of testis GB04 Male infertility GB04.0 Azoospermia GB04.Y Other specified male infertility GB04.Z Male infertility, unspecified GB05 Redundant prepuce, phimosis or paraphimosis GB05.0 Redundant prepuce GB05.1 Frenulum breve GB05.2 Phimosis GB05.3 Paraphimosis GB05.4 Adherent prepuce GB05.Z Redundant prepuce, phimosis or paraphimosis, unspecified GB06 Certain specified disorders of penis GB06.0 Balanoposthitis GB06.1 Priapism GB06.2 Penile fibromatosis GB06.3 Mondor disease of the penis GB06.4 Chronic penile oedema GB06.5 Sclerosing lymphangitis of penis GB06.Y Other specified disorders of penis GB06.Z Disorders of penis, unspecified – GB06.01 Irritant balanoposthitis – GB06.02 Balanoposthitis due to infection – GB06.0Y Other specified forms of balanitis and balanoposthitis – GB06.0Z Balanoposthitis, unspecified GB07 Inflammatory disorders of male genital organs, not elsewhere classified GB07.0 Inflammatory disorders of seminal vesicle GB07.1 Inflammatory disorders of spermatic cord, tunica vaginalis or vas deferens GB07.2 Inflammatory disorders of scrotum GB07.Y Other specified inflammatory disorders of male genital organs, not elsewhere classified GB08 Vascular disorders of male genital organs GB0Y Other specified diseases of the male genital system GB0Z Diseases of the male genital system, unspecified GB20 Benign breast disease GB20.0 Fibrocystic change of breast GB20.1 Fibroadenosis of breast GB20.Y Other specified benign breast disease GB20.Z Benign breast disease, unspecified GB21 Inflammatory disorders of breast GB21.0 Breast abscess GB21.Y Other specified inflammatory disorders of breast GB21.Z Inflammatory disorders of breast, unspecified GB22 Hypertrophy of breast GB23 Certain specified disorders of breast GB23.0 Mammary duct ectasia GB23.1 Fissure or fistula of nipple GB23.2 Fat necrosis of breast GB23.3 Atrophy of breast GB23.4 Galactorrhoea not associated with childbirth GB23.5 Mastodynia GB2Z Disorders of breast, unspecified GB40 Nephritic syndrome GB41 Nephrotic syndrome GB42 Persistent proteinuria or albuminuria – GB42.0 Albuminuria, Grade A2 – GB42.1 Albuminuria, Grade A3 – GB42.Y Other specified persistent proteinuria or albuminuria – GB42.Z Persistent proteinuria or albuminuria, unspecified GB4Y Other specified glomerular diseases GB4Z Glomerular diseases, unspecified GB50 Acute tubulo-interstitial nephritis GB51 Acute pyelonephritis GB52 Acute tubular necrosis GB53 Acute renal papillary necrosis GB54 Tubulo-interstitial nephritis, not specified as acute or chronic GB55 Chronic tubulo-interstitial nephritis – GB55.0 Balkan nephropathy – GB55.1 Nephropathy induced by heavy metals – GB55.2 Chronic urate nephropathy – GB55.Y Other specified chronic tubulo-interstitial nephritis – GB55.Z Chronic tubulo-interstitial nephritis, unspecified GB56 Obstructive or reflux nephropathy – GB56.0 Hydronephrosis with ureteropelvic junction obstruction – GB56.1 Hydronephrosis with ureteral obstruction – GB56.2 Hydronephrosis with ureteral orifice obstruction – GB56.3 Hydronephrosis due to bladder obstruction – GB56.4 Other or unspecified hydronephrosis – GB56.5 Hydronephrosis and reflux nephropathy with vesicoureteral or vesico-uretero-renal reflux – GB56.Y Other specified obstructive or reflux nephropathy – GB56.Z Obstructive or reflux nephropathy, unspecified GB57 Nephrocalcinosis GB58 Pyonephrosis GB59 Renal or perinephric abscess GB5Y Other specified renal tubulo-interstitial diseases GB5Z Renal tubulo-interstitial diseases, unspecified GB60 Acute kidney failure – GB60.0 Acute kidney failure, stage 1 – GB60.1 Acute kidney failure, stage 2 – GB60.2 Acute kidney failure, stage 3 – GB60.Y Other specified acute kidney failure – GB60.Z Acute kidney failure, stage unspecified GB61 Chronic kidney disease – GB61.0 Chronic kidney disease, stage 1 – GB61.1 Chronic kidney disease, stage 2 – GB61.2 Chronic kidney disease, stage 3a – GB61.3 Chronic kidney disease, stage 3b – GB61.4 Chronic kidney disease, stage 4 – GB61.5 Chronic kidney disease, stage 5 – GB61.Z Chronic kidney disease, stage unspecified GB6Z Kidney failure, unspecified GB70 Calculus of upper urinary tract – GB70.0 Calculus of kidney – GB70.1 Calculus of ureter – GB70.Z Calculus of upper urinary tract, unspecified –– GB70.00 Staghorn calculus –– GB70.0Y Other specified calculus of kidney –– GB70.0Z Calculus of kidney, unspecified GB71 Calculus of lower urinary tract – GB71.0 Calculus in bladder – GB71.1 Calculus in urethra – GB71.2 Calculus of bowel segments for urinary diversion – GB71.Z Calculus of lower urinary tract, unspecified GB7Z Urolithiasis, unspecified GB80 Nonfamilial nongenetic cystic kidney disease – GB80.0 Simple renal cyst – GB80.1 Complex renal cyst – GB80.2 Subscapular or perirenal urinoma – GB80.Y Other specified nonfamilial nongenetic cystic kidney disease – GB80.Z Nonfamilial nongenetic cystic kidney disease, unspecified GB81 Autosomal dominant polycystic kidney disease GB82 Autosomal dominant tubulointerstitial disease GB83 Nephronophthisis GB8Y Other specified cystic or dysplastic kidney disease GB8Z Cystic or dysplastic kidney disease, unspecified GB90 Certain specified disorders of kidney or ureter GB90.0 Nephroptosis GB90.1 Hydroureter GB90.2 Ureteral kinking or deviation without obstruction GB90.3 Ischaemia or infarction of kidney GB90.4 Renal tubular function disorders GB90.Y Other specified disorders of kidney or ureter – GB90.40 Hypotonia-cystinuria type 1 – GB90.41 Pseudohypoaldosteronism type 1 – GB90.42 Fanconi syndrome – GB90.43 Bartter syndrome – GB90.44 Renal tubular acidosis – GB90.45 Renal glycosuria – GB90.46 Tubular disorders of sodium or potassium transport – GB90.47 Aminoaciduria – GB90.48 Disorders of calcium or phosphate excretion – GB90.49 Renal hypocalciuria – GB90.4A Nephrogenic diabetes insipidus – GB90.4Y Other specified renal tubular function disorders – GB90.4Z Renal tubular function disorders, unspecified GC00 Cystitis – GC00.0 Trigonitis – GC00.1 Infectious cystitis – GC00.2 Contracted urinary bladder – GC00.3 Interstitial cystitis – GC00.Y Other specified cystitis – GC00.Z Cystitis, unspecified GC01 Other disorders of bladder – GC01.0 Bladder neck obstruction – GC01.1 Vesical fistula, not elsewhere classified – GC01.2 Diverticulum of bladder – GC01.3 Rupture of bladder, nontraumatic – GC01.4 Neuromuscular dysfunction of bladder, not elsewhere classified – GC01.Y Other specified disorders of bladder – GC01.Z Disorder of bladder, unspecified GC02 Urethritis and urethral syndrome – GC02.0 Urethral abscess – GC02.1 Nonspecific urethritis – GC02.Y Other specified urethritis and urethral syndrome – GC02.Z Urethritis and urethral syndrome, unspecified GC03 Urethral stricture GC04 Fistula of the genitourinary tract – GC04.0 Urethral fistula – GC04.1 Fistulae involving female genital tract – GC04.2 Ureteral fistula – GC04.Y Other specified fistula of the genitourinary tract – GC04.Z Fistula of the genitourinary tract, unspecified –– GC04.10 Vesicovaginal fistula –– GC04.11 Fistula of small intestine to vagina –– GC04.12 Fistula of large intestine to vagina –– GC04.13 Female genital tract-skin fistulae –– GC04.14 Urethrovaginal fistula –– GC04.15 Combined urethrovesicovaginal fistula –– GC04.16 Rectovaginal fistula –– GC04.17 Vesicouterine fistula with severe scar or extensive tissue loss –– GC04.18 Other combined urinary fistula with severe scar or extensive tissue loss –– GC04.19 Combined urinary and rectal fistula including cloaca with severe scar or extensive tissue loss –– GC04.1A Vaginal stenosis or gynatresia related to obstetric fistula –– GC04.1Y Other specified fistulae involving female genital tract –– GC04.1Z Fistulae involving female genital tract, unspecified GC05 Prolapsed urethral mucosa GC06 Urethral diverticulum GC07 Urethral caruncle GC08 Urinary tract infection, site not specified – GC08.0 Urinary tract infection, site not specified, due to Escherichia coli – GC08.1 Urinary tract infection, site not specified, due to Klebsiella pneumoniae – GC08.2 Urinary tract infection, site not specified, due to Proteus – GC08.Y Urinary tract infection, site not specified due to other agent – GC08.Z Urinary tract infection, site and agent not specified GC0Y Other diseases of urinary system GC2Z Diseases of the urinary system, unspecified GC40 Pelvic organ prolapse – GC40.0 Prolapse of anterior vaginal wall – GC40.1 Prolapse of posterior vaginal wall – GC40.2 Prolapse of the vaginal apex – GC40.3 Uterovaginal prolapse – GC40.4 Pelvic floor muscle disruption – GC40.5 Urinary incontinence associated with pelvic organ prolapse – GC40.6 Functional bladder disorders associated with pelvic organ prolapse – GC40.Z Pelvic organ prolapse, unspecified –– GC40.00 Incomplete anterior vaginal wall prolapse –– GC40.01 Complete anterior vaginal wall prolapse –– GC40.0Z Prolapse of anterior vaginal wall, unspecified –– GC40.10 Incomplete posterior vaginal wall prolapse –– GC40.11 Complete posterior vaginal wall prolapse –– GC40.1Z Prolapse of posterior vaginal wall, unspecified –– GC40.20 Incomplete apical vaginal wall prolapse –– GC40.21 Complete apical vaginal wall prolapse –– GC40.2Z Prolapse of the vaginal apex, unspecified –– GC40.30 Incomplete uterovaginal prolapse –– GC40.31 Incomplete uterine prolapse with anterior vaginal wall prolapse –– GC40.32 Incomplete uterine prolapse with posterior vaginal wall prolapse –– GC40.33 Incomplete uterine prolapse with anterior and posterior vaginal wall prolapse –– GC40.34 Complete uterovaginal prolapse –– GC40.35 Complete uterine prolapse with anterior vaginal wall prolapse –– GC40.36 Complete uterine prolapse with posterior vaginal wall prolapse –– GC40.37 Complete uterine prolapse with anterior and posterior vaginal wall prolapse –– GC40.3Z Uterovaginal prolapse, unspecified –– GC40.40 Levator avulsion from symphysis pubis –– GC40.4Y Other specified pelvic floor muscle disruption –– GC40.4Z Pelvic floor muscle disruption, unspecified –– GC40.50 Stress incontinence associated with pelvic organ prolapse –– GC40.51 Urge incontinence associated with pelvic organ prolapse –– GC40.52 Mixed urinary incontinence associated with pelvic organ prolapse –– GC40.53 Overflow incontinence associated with pelvic organ prolapse –– GC40.54 Urinary incontinence, not otherwise specified with pelvic organ prolapse –– GC40.60 Overactive bladder associated with pelvic organ prolapse –– GC40.6Y Other specified functional bladder disorders associated with pelvic organ prolapse –– GC40.6Z Functional bladder disorders associated with pelvic organ prolapse, unspecified GC41 Anorectal dysfunction associated with pelvic organ prolapse GC42 Sexual dysfunction associated with pelvic organ prolapse – GC42.0 Diminished sensation due to vaginal or introital laxity – GC42.1 Obstructed intercourse GC4Z Female pelvic floor dysfunction, unspecified GC50 Functional bladder disorders, not otherwise specified GC50.0 Overactive bladder GC50.1 Absent or diminished bladder sensation GC50.Y Other specified functional bladder disorders, not otherwise specified GC50.Z Functional bladder disorders, not otherwise specified, unspecified – GC50.10 Absent or diminished bladder sensation associated with pelvic organ prolapse – GC50.1Y Other specified absent or diminished bladder sensation – GC50.1Z Absent or diminished bladder sensation, unspecified GC51 Female Genital Mutilation GC51.0 Female Genital Mutilation Type 1 GC51.1 Female Genital Mutilation Type 2 GC51.2 Female Genital Mutilation Type 3 GC51.3 Female Genital Mutilation Type 4 GC51.Z Female Genital Mutilation, unspecified – GC51.00 Female Genital Mutilation Type 1a – GC51.01 Female Genital Mutilation Type 1b – GC51.0Z Female Genital Mutilation Type 1, unspecified – GC51.10 Female Genital Mutilation Type 2a – GC51.11 Female Genital Mutilation Type 2b – GC51.12 Female Genital Mutilation Type 2c – GC51.1Z Female Genital Mutilation Type 2, unspecified – GC51.20 Female Genital Mutilation Type 3a – GC51.21 Female Genital Mutilation Type 3b – GC51.2Z Female Genital Mutilation Type 3, unspecified GC70 Postoperative adhesions of vagina GC71 Prolapse of vaginal vault after hysterectomy GC72 Postprocedural urethral stricture GC73 Postprocedural pelvic peritoneal adhesions GC74 Malfunction or complication of external stoma of urinary tract GC75 Malfunction of the afferent segment of a continent urinary pouch GC76 Malfunction of the efferent segment of a continent urinary pouch GC77 Postprocedural nonmenstrual uterine bleeding GC78 Postprocedural acute female pelvic inflammatory disease GC79 Disorders of breast reduction GC7A Disorders of breast augmentation GC7B Postinterventional ischemia or infarction of kidney GC8Y Other specified diseases of the genitourinary system GC8Z Diseases of the genitourinary system, unspecified JA00 Abortion JA00.0 Spontaneous abortion JA00.1 Induced abortion JA00.2 Unspecified abortion JA00.3 Failed attempted abortion – JA00.00 Spontaneous abortion, incomplete, complicated by genital tract or pelvic infection – JA00.01 Spontaneous abortion, incomplete, complicated by delayed or excessive haemorrhage – JA00.02 Spontaneous abortion, incomplete, complicated by embolism – JA00.03 Spontaneous abortion, incomplete, with other or unspecified complications – JA00.04 Spontaneous abortion, incomplete, without complication – JA00.05 Spontaneous abortion, complete or unspecified, complicated by genital tract or pelvic infection – JA00.06 Spontaneous abortion, complete or unspecified, complicated by delayed or excessive haemorrhage – JA00.07 Spontaneous abortion, complete or unspecified, complicated by embolism – JA00.08 Spontaneous abortion, complete or unspecified, with other or unspecified complications – JA00.09 Spontaneous abortion, complete or unspecified, without complication – JA00.10 Induced abortion, incomplete, complicated by genital tract or pelvic infection – JA00.11 Induced abortion, incomplete, complicated by delayed or excessive haemorrhage – JA00.12 Induced abortion, incomplete, complicated by embolism – JA00.13 Induced abortion, incomplete, with other or unspecified complications – JA00.14 Induced abortion, incomplete, without complication – JA00.15 Induced abortion, complete or unspecified, complicated by genital tract or pelvic infection – JA00.16 Induced abortion, complete or unspecified, complicated by delayed or excessive haemorrhage – JA00.17 Induced abortion, complete or unspecified, complicated by embolism – JA00.18 Induced abortion, complete or unspecified, with other complication – JA00.19 Induced abortion, complete or unspecified, without complication – JA00.20 Unspecified abortion, incomplete, complicated by genital tract or pelvic infection – JA00.21 Unspecified abortion, incomplete, complicated by delayed or excessive haemorrhage – JA00.22 Unspecified abortion, incomplete, complicated by embolism – JA00.23 Unspecified abortion, incomplete, with other or unspecified complications – JA00.24 Unspecified abortion, incomplete, without complication – JA00.25 Unspecified abortion, complete or unspecified, complicated by genital tract or pelvic infection – JA00.26 Unspecified abortion, complete or unspecified, complicated by delayed or excessive haemorrhage – JA00.27 Unspecified abortion, complete or unspecified, complicated by embolism – JA00.28 Unspecified abortion, complete or unspecified, with other or unspecified complications – JA00.29 Unspecified abortion, complete or unspecified, without complication – JA00.30 Failed medical abortion, complicated by genital tract or pelvic infection – JA00.31 Failed medical abortion, complicated by delayed or excessive haemorrhage – JA00.32 Failed medical abortion, complicated by embolism – JA00.33 Failed medical abortion, with other or unspecified complications – JA00.34 Failed medical abortion, without complication – JA00.35 Other or unspecified failed attempted abortion, complicated by genital tract or pelvic infection – JA00.36 Other or unspecified failed attempted abortion, complicated by delayed or excessive haemorrhage – JA00.37 Other or unspecified failed attempted abortion, complicated by embolism – JA00.38 Other or unspecified failed attempted abortion, with other or unspecified complications – JA00.39 Other or unspecified failed attempted abortion, without complication JA01 Ectopic pregnancy JA01.0 Abdominal pregnancy JA01.1 Tubal pregnancy JA01.2 Ovarian pregnancy JA01.Y Other specified ectopic pregnancy JA01.Z Ectopic pregnancy, unspecified JA02 Molar pregnancy JA02.0 Complete hydatidiform mole JA02.1 Incomplete or partial hydatidiform mole JA02.Y Other specified molar pregnancy JA02.Z Molar pregnancy, unspecified JA03 Missed abortion JA04 Blighted ovum or nonhydatidiform mole JA05 Complications following abortion, ectopic or molar pregnancy JA05.0 Genital tract or pelvic infection following abortion, ectopic or molar pregnancy JA05.1 Delayed or excessive haemorrhage following abortion, ectopic or molar pregnancy JA05.2 Embolism following abortion, ectopic or molar pregnancy JA05.3 Shock following abortion, ectopic or molar pregnancy JA05.4 Renal failure following abortion, ectopic or molar pregnancy JA05.5 Metabolic disorders following abortion, ectopic or molar pregnancy JA05.6 Damage to pelvic organs and tissues following abortion, ectopic or molar pregnancy JA05.7 Other venous complications following abortion, ectopic or molar pregnancy JA05.Y Other specified complications following abortion, ectopic or molar pregnancy JA05.Z Complications following abortion, ectopic or molar pregnancy, unspecified JA0Z Abortive outcome of pregnancy, unspecified JA20 Pre-existing hypertension complicating pregnancy, childbirth or the puerperium JA20.0 Pre-existing essential hypertension complicating pregnancy, childbirth or the puerperium JA20.1 Pre-existing hypertensive heart disease complicating pregnancy, childbirth or the puerperium JA20.2 Pre-existing hypertensive renal disease complicating pregnancy, childbirth or the puerperium JA20.3 Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth or the puerperium JA20.4 Pre-existing secondary hypertension complicating pregnancy, childbirth or the puerperium JA20.Y Other specified pre-existing hypertension complicating pregnancy, childbirth or the puerperium JA20.Z Pre-existing hypertension complicating pregnancy, childbirth or the puerperium, unspecified JA21 Pre-eclampsia superimposed on chronic hypertension JA22 Gestational oedema or proteinuria without hypertension JA22.0 Gestational proteinuria without hypertension JA22.1 Gestational oedema without hypertension JA22.2 Gestational oedema with proteinuria without hypertension JA23 Gestational hypertension JA24 Pre-eclampsia JA24.0 Mild to moderate pre-eclampsia JA24.1 Severe pre-eclampsia JA24.2 HELLP syndrome JA24.Z Pre-eclampsia, unspecified JA25 Eclampsia JA25.0 Eclampsia in pregnancy JA25.1 Eclampsia in labour JA25.2 Eclampsia in the puerperium JA25.3 Eclampsia, time period unspecified JA2Z Oedema, proteinuria, or hypertensive disorders in pregnancy, childbirth, or the puerperium, unspecified JA40 Haemorrhage in early pregnancy JA40.0 Threatened abortion JA40.Y Other specified haemorrhage in early pregnancy JA40.Z Haemorrhage in early pregnancy, unspecified JA41 Antepartum haemorrhage JA41.0 Antepartum haemorrhage with coagulation defect JA41.Y Other specified antepartum haemorrhage JA41.Z Antepartum haemorrhage, unspecified JA42 Intrapartum haemorrhage JA42.0 Intrapartum haemorrhage with coagulation defect JA42.1 Intrapartum haemorrhage resulting from obstructed labour with uterine rupture JA42.2 Intrapartum haemorrhage resulting from obstructed labour without mention of uterine rupture JA42.Y Other specified intrapartum haemorrhage JA42.Z Intrapartum haemorrhage, unspecified JA43 Postpartum haemorrhage JA43.0 Third-stage haemorrhage JA43.1 Other immediate postpartum haemorrhage JA43.2 Delayed or secondary postpartum haemorrhage JA43.3 Postpartum coagulation defects JA43.4 Postpartum haemorrhage following obstructed labour with uterine rupture JA43.5 Postpartum haemorrhage following obstructed labour without mention of uterine rupture JA43.Y Other specified postpartum haemorrhage JA43.Z Postpartum haemorrhage, unspecified JA4Z Obstetric haemorrhage, unspecified JA60 Excessive vomiting in pregnancy JA60.0 Mild hyperemesis gravidarum JA60.1 Hyperemesis gravidarum with metabolic disturbance JA60.2 Late vomiting of pregnancy JA60.Y Other specified excessive vomiting in pregnancy JA60.Z Excessive vomiting in pregnancy, unspecified JA61 Venous complications in pregnancy JA61.0 Varicose veins of lower extremity in pregnancy JA61.1 Genital varices in pregnancy JA61.2 Superficial thrombophlebitis in pregnancy JA61.3 Deep phlebothrombosis in pregnancy JA61.4 Haemorrhoids in pregnancy JA61.5 Cerebral venous thrombosis in pregnancy JA61.Y Other specified venous complications in pregnancy JA61.Z Venous complications in pregnancy, unspecified JA62 Infections of genitourinary tract in pregnancy JA62.0 Infections of kidney in pregnancy JA62.1 Infections of bladder in pregnancy JA62.2 Infections of urethra in pregnancy JA62.3 Infections of other parts of urinary tract in pregnancy JA62.4 Infections of the genital tract in pregnancy JA62.Y Infections of genitourinary tract in pregnancy, other specified site JA62.Z Infection of genitourinary tract in pregnancy, site unspecified JA63 Diabetes mellitus in pregnancy JA63.0 Pre-existing type 1 diabetes mellitus in pregnancy JA63.1 Pre-existing type 2 diabetes mellitus in pregnancy JA63.2 Diabetes mellitus arising in pregnancy JA63.Y Other specified diabetes mellitus in pregnancy JA63.Z Diabetes mellitus in pregnancy, unspecified JA64 Malnutrition in pregnancy JA65 Maternal care for other conditions predominantly related to pregnancy JA65.0 Liver disorders in pregnancy, childbirth or the puerperium JA65.1 Pregnancy dermatoses JA65.2 Excessive weight gain in pregnancy JA65.3 Low weight gain in pregnancy JA65.4 Pregnancy care of habitual aborter JA65.5 Retained intrauterine contraceptive device in pregnancy JA65.6 Maternal hypotension syndrome JA65.7 Subluxation of symphysis pubis in pregnancy, childbirth or the puerperium JA65.Y Maternal care for other specified conditions predominantly related to pregnancy JA65.Z Maternal care for unspecified conditions predominantly related to pregnancy – JA65.10 Gestational pemphigoid – JA65.11 Pruritus of pregnancy – JA65.12 Polymorphic eruption of pregnancy – JA65.1Y Other specified pregnancy dermatoses JA66 Clinical findings on antenatal screening of mother JA66.0 Abnormal haematological finding on antenatal screening of mother JA66.1 Abnormal biochemical finding on antenatal screening of mother JA66.2 Abnormal cytological finding on antenatal screening of mother JA66.3 Abnormal ultrasonic finding on antenatal screening of mother JA66.4 Abnormal radiological finding on antenatal screening of mother JA66.5 Abnormal chromosomal or genetic finding on antenatal screening of mother JA66.Y Other specified clinical findings on antenatal screening of mother JA66.Z Clinical findings on antenatal screening of mother, unspecified JA67 Complications of anaesthesia during pregnancy JA67.0 Pulmonary complications of anaesthesia during pregnancy JA67.1 Cardiac complications of anaesthesia during pregnancy JA67.2 Central nervous system complications of anaesthesia during pregnancy JA67.3 Toxic reaction to local anaesthesia during pregnancy JA67.4 Spinal or epidural anaesthesia-induced headache during pregnancy JA67.5 Failed or difficult intubation during pregnancy JA67.6 Awareness under general anaesthesia during pregnancy JA67.Y Other specified complications of anaesthesia during pregnancy JA67.Z Complications of anaesthesia during pregnancy, unspecified JA6Z Maternal disorders predominantly related to pregnancy, unspecified JA80 Maternal care related to multiple gestation JA80.0 Twin pregnancy JA80.1 Triplet pregnancy JA80.2 Quadruplet pregnancy JA80.Y Maternal care related to other specified multiple gestation JA80.Z Maternal care related to unspecified multiple gestation JA81 Maternal care related to complications specific to multiple gestation JA81.0 Papyraceous fetus JA81.1 Continuing pregnancy after abortion of one fetus or more JA81.2 Continuing pregnancy after intrauterine death of one fetus or more JA81.3 Loss of pregnancy after abortion or intrauterine death of one fetus or more JA81.Y Other specified maternal care related to complications specific to multiple gestation JA81.Z Maternal care related to complications specific to multiple gestation, unspecified JA82 Maternal care for known or suspected malpresentation of fetus JA82.0 Maternal care for unstable lie JA82.1 Maternal care for breech presentation JA82.2 Maternal care for transverse or oblique lie JA82.3 Maternal care for face, brow or chin presentation JA82.4 Maternal care for high head at term JA82.5 Maternal care for multiple gestation with malpresentation of one fetus or more JA82.6 Maternal care for compound presentation JA82.Y Maternal care for known or suspected other specified malpresentation of fetus JA82.Z Maternal care for known or suspected malpresentation of fetus, unspecified JA83 Maternal care for known or suspected disproportion JA83.0 Maternal care for disproportion due to deformity of maternal pelvic bones JA83.1 Maternal care for disproportion due to generally contracted pelvis JA83.2 Maternal care for disproportion due to inlet contraction of pelvis JA83.3 Maternal care for disproportion due to outlet contraction of pelvis JA83.4 Maternal care for disproportion of mixed maternal and fetal origin JA83.5 Maternal care for disproportion due to unusually large fetus JA83.6 Maternal care for disproportion due to hydrocephalic fetus JA83.Y Maternal care for known or suspected other specified disproportion JA83.Z Maternal care for known or suspected disproportion, unspecified JA84 Maternal care for known or suspected abnormality of pelvic organs JA84.0 Maternal care for congenital malformation of uterus JA84.1 Maternal care for tumour of corpus uteri JA84.2 Maternal care due to uterine scar from previous surgery JA84.3 Maternal care for cervical incompetence JA84.4 Maternal care for abnormality of vagina JA84.5 Maternal care for abnormality of vulva or perineum JA84.Y Maternal care for known or suspected other specified abnormality of pelvic organs JA84.Z Maternal care for known or suspected abnormality of pelvic organs, unspecified JA85 Maternal care for known or suspected fetal abnormality or damage JA85.0 Maternal care for known or suspected central nervous system malformation in fetus JA85.1 Maternal care for known or suspected chromosomal abnormality in fetus JA85.2 Maternal care for known or suspected hereditary disease in fetus JA85.3 Maternal care for known or suspected damage to fetus from viral disease in mother JA85.Y Maternal care for known or suspected other specified fetal abnormality or damage JA85.Z Maternal care for known or suspected fetal abnormality or damage, unspecified JA86 Maternal care for other known or suspected fetal problems JA86.0 Maternal care for red cell antibodies JA86.1 Maternal care for hydrops fetalis JA86.2 Maternal care for signs of fetal hypoxia JA86.3 Maternal care for intrauterine death JA86.4 Maternal care for fetal growth restriction JA86.5 Maternal care for suspected macrosomia JA86.6 Maternal care for viable fetus in abdominal pregnancy JA86.Y Maternal care for other specified fetal problems JA86.Z Maternal care for other known or suspected fetal problems, unspecified JA87 Maternal care related to polyhydramnios JA88 Maternal care related to certain specified disorders of amniotic fluid or membranes JA88.0 Oligohydramnios JA88.1 Infection of amniotic sac or membranes JA88.Y Other specified disorders of amniotic fluid and membranes JA88.Z Disorders of amniotic fluid and membranes, unspecified JA89 Maternal care related to premature rupture of membranes JA89.0 Premature rupture of membranes, onset of labour within 24 hours JA89.1 Premature rupture of membranes, onset of labour after 24 hours JA89.2 Premature rupture of membranes, labour delayed by therapy JA89.3 Preterm premature rupture of membranes JA89.Y Other specified maternal care related to premature rupture of membranes JA89.Z Maternal care related to premature rupture of membranes, unspecified JA8A Maternal care related to placental disorders JA8A.0 Placental transfusion syndromes JA8A.1 Malformation of placenta JA8A.2 Morbidly adherent placenta JA8A.Y Other specified maternal care related to placental disorders JA8A.Z Maternal care related to placental disorders, unspecified JA8B Maternal care related to placenta praevia or low lying placenta JA8B.0 Placenta praevia specified as without haemorrhage JA8B.1 Placenta praevia with haemorrhage JA8B.Z Maternal care related to placenta praevia or low lying placenta, unspecified JA8C Maternal care related to premature separation of placenta JA8C.0 Premature separation of placenta with coagulation defect JA8C.Y Other specified maternal care related to premature separation of placenta JA8C.Z Maternal care related to premature separation of placenta, unspecified JA8D Maternal care related to false labour JA8D.0 False labour before 37 completed weeks of gestation JA8D.1 False labour at or after 37 completed weeks of gestation JA8D.Z Maternal care related to false labour, unspecified JA8E Maternal care related to prolonged pregnancy JA8Y Maternal care related to other specified fetus, amniotic cavity or possible delivery problems JA8Z Maternal care related to unspecified fetus, amniotic cavity or possible delivery problems JB00 Preterm labour or delivery JB00.0 Preterm labour without delivery JB00.1 Preterm spontaneous labour with preterm delivery JB00.2 Preterm labour with term delivery JB00.3 Preterm delivery following iatrogenic induction of labour or caesarean section JB00.Y Other specified preterm labour or delivery JB00.Z Preterm labour or delivery, unspecified JB01 Failed induction of labour JB01.0 Failed medical induction of labour JB01.1 Failed instrumental induction of labour JB01.Z Failed induction of labour, unspecified JB02 Abnormalities of forces of labour JB02.0 Primary uterine inertia JB02.1 Secondary uterine inertia JB02.2 Other uterine inertia JB02.3 Precipitate labour JB02.4 Hypertonic, incoordinate, or prolonged uterine contractions JB02.Y Other specified abnormalities of forces of labour JB02.Z Abnormalities of forces of labour, unspecified JB03 Long labour JB03.0 Prolonged first stage of labour JB03.1 Prolonged second stage of labour JB03.2 Delayed delivery of successive neonates JB03.Z Long labour, unspecified JB04 Obstructed labour due to malposition or malpresentation of fetus JB04.0 Obstructed labour due to incomplete rotation of fetal head JB04.1 Obstructed labour due to breech presentation JB04.2 Obstructed labour due to face presentation JB04.3 Obstructed labour due to brow presentation JB04.4 Obstructed labour due to shoulder presentation JB04.5 Obstructed labour due to compound presentation JB04.Y Obstructed labour due to other malposition and malpresentation of fetus JB04.Z Obstructed labour due to malposition or malpresentation of fetus, unspecified JB05 Obstructed labour due to maternal pelvic abnormality JB05.0 Obstructed labour due to deformed pelvis JB05.1 Obstructed labour due to generally contracted pelvis JB05.2 Obstructed labour due to pelvic inlet contraction JB05.3 Obstructed labour due to pelvic outlet or mid-cavity contraction JB05.4 Obstructed labour due to foetopelvic disproportion, unspecified JB05.5 Obstructed labour due to abnormality of maternal pelvic organs JB05.Y Obstructed labour due to other maternal pelvic abnormalities JB05.Z Obstructed labour due to maternal pelvic abnormality, unspecified JB06 Obstructed labour due to other causes JB06.0 Obstructed labour due to shoulder dystocia JB06.1 Obstructed labour due to locked twins JB06.2 Obstructed labour due to unusually large fetus JB06.3 Obstructed labour due to other abnormalities of fetus JB06.Y Obstructed labour due to other specified causes JB06.Z Obstructed labour due to unspecified causes JB07 Labour or delivery complicated by fetal distress JB07.0 Labour or delivery complicated by fetal heart rate anomaly JB07.1 Labour or delivery complicated by meconium in amniotic fluid JB07.2 Labour or delivery complicated by biochemical evidence of fetal stress JB07.Y Other specified labour or delivery complicated by fetal distress JB07.Z Labour or delivery complicated by fetal distress, unspecified JB08 Labour or delivery complicated by umbilical cord complications JB08.0 Labour or delivery complicated by prolapse of cord JB08.1 Labour or delivery complicated by cord around neck, with compression JB08.2 Labour or delivery complicated by short cord JB08.3 Labour or delivery complicated by vasa praevia JB08.4 Labour or delivery complicated by vascular lesion of cord JB08.5 Labour or delivery complicated by other cord entanglement, with compression JB08.Y Labour and delivery complicated by other specified umbilical cord complications JB08.Z Labour or delivery complicated by umbilical cord complications, unspecified JB09 Perineal laceration during delivery JB09.0 First degree perineal laceration during delivery JB09.1 Second degree perineal laceration during delivery JB09.2 Third degree perineal laceration during delivery JB09.3 Fourth degree perineal laceration during delivery JB09.Z Perineal laceration during delivery, unspecified JB0A Certain specified obstetric trauma JB0A.0 Rupture of uterus before onset of labour JB0A.1 Rupture of uterus during labour JB0A.2 Postpartum inversion of uterus JB0A.3 Obstetric laceration of cervix JB0A.4 Obstetric high vaginal laceration JB0A.5 Obstetric uterine laceration or tear JB0A.6 Other obstetric injury to pelvic organs JB0A.7 Obstetric damage to pelvic joints or ligaments JB0A.8 Obstetric haematoma of pelvis JB0A.Y Other specified obstetric trauma JB0A.Z Obstetric trauma, unspecified JB0B Retained placenta or membranes, without haemorrhage JB0B.0 Retained placenta without haemorrhage JB0B.1 Retained portions of placenta or membranes, without haemorrhage JB0C Complications of anaesthesia during labour or delivery JB0C.0 Aspiration pneumonitis due to anaesthesia during labour or delivery JB0C.1 Other pulmonary complications of anaesthesia during labour or delivery JB0C.2 Cardiac complications of anaesthesia during labour or delivery JB0C.3 Central nervous system complications of anaesthesia during labour or delivery JB0C.4 Toxic reaction to local anaesthesia during labour or delivery JB0C.5 Spinal or epidural anaesthesia-induced headache during labour or delivery JB0C.6 Other complications of spinal or epidural anaesthesia during labour or delivery JB0C.7 Failed or difficult intubation during labour or delivery JB0C.8 Awareness under general anaesthesia during labour or delivery JB0C.Y Other specified complications of anaesthesia during labour or delivery JB0C.Z Complications of anaesthesia during labour or delivery, unspecified JB0D Certain specified complications of labour or delivery, not elsewhere classified JB0D.0 Maternal distress during labour or delivery JB0D.1 Shock during or following labour or delivery JB0D.2 Pyrexia during labour, not elsewhere classified JB0D.3 Other complications of obstetric surgery or procedures JB0D.4 Delayed delivery after artificial rupture of membranes JB0D.5 Delayed delivery after spontaneous or unspecified rupture of membranes JB0D.6 Vaginal delivery following previous caesarean section JB0D.7 Failed application of vacuum extractor or forceps, unspecified JB0D.8 Failed trial of labour, unspecified JB0D.Y Other specified complications of labour or delivery, not elsewhere classified JB0Y Other specified complications of labour or delivery JB0Z Complications of labour or delivery, unspecified JB20 Single spontaneous delivery JB20.0 Spontaneous vertex delivery JB20.1 Spontaneous breech delivery JB20.Y Single spontaneous delivery with other specified presentation JB20.Z Single spontaneous delivery, unspecified JB21 Single delivery by forceps or vacuum extractor JB22 Single delivery by caesarean section JB22.0 Delivery by elective caesarean section JB22.1 Delivery by emergency caesarean section JB22.2 Single delivery by caesarean hysterectomy JB22.Z Single delivery by caesarean section, unspecified JB23 Other assisted single delivery JB23.0 Breech extraction JB23.1 Other assisted breech delivery JB23.2 Other manipulation-assisted delivery JB23.3 Delivery of viable fetus in abdominal pregnancy JB23.4 Destructive operation for delivery JB23.Z Other assisted single delivery, unspecified JB24 Multiple delivery JB24.0 Multiple delivery, all spontaneous JB24.1 Multiple delivery, all by forceps or vacuum extractor JB24.2 Multiple delivery, all by caesarean section JB24.3 Multiple delivery by combination of methods with caesarean JB24.Y Other specified multiple delivery JB24.Z Multiple delivery, unspecified JB2Z Delivery, unspecified JB40 Infections in the puerperium JB40.0 Puerperal sepsis JB40.1 Infection of obstetric surgical wound JB40.2 Other infection of genital tract following delivery JB40.3 Urinary tract infection following delivery JB40.4 Pyrexia of unknown origin following delivery JB40.Y Other specified infections in the puerperium JB40.Z Infections in the puerperium, unspecified JB41 Venous complications in the puerperium JB41.0 Superficial thrombophlebitis in the puerperium JB41.1 Deep phlebothrombosis in the puerperium JB41.2 Haemorrhoids in the puerperium JB41.3 Cerebral venous thrombosis in the puerperium JB41.Y Other specified venous complications in the puerperium JB41.Z Venous complications in the puerperium, unspecified JB42 Obstetric embolism JB42.0 Obstetric air embolism JB42.1 Amniotic fluid embolism JB42.2 Obstetric blood-clot embolism JB42.3 Obstetric pyaemic or septic embolism JB42.Y Other specified obstetric embolism JB42.Z Obstetric embolism, unspecified JB43 Complications of anaesthesia during the puerperium JB43.0 Pulmonary complications of anaesthesia during the puerperium JB43.1 Cardiac complications of anaesthesia during the puerperium JB43.2 Central nervous system complications of anaesthesia during the puerperium JB43.3 Spinal or epidural anaesthesia-induced headache during the puerperium JB43.4 Other complications of spinal or epidural anaesthesia during the puerperium JB43.5 Failed or difficult intubation during the puerperium JB43.6 Awareness under general anaesthesia during the puerperium JB43.Y Other specified complications of anaesthesia during the puerperium JB43.Z Complications of anaesthesia during the puerperium, unspecified JB44 Certain specified complications of the puerperium JB44.0 Disruption of caesarean section wound JB44.1 Disruption of perineal obstetric wound JB44.2 Haematoma of obstetric wound JB44.3 Cardiomyopathy in the puerperium JB44.4 Postpartum acute renal failure JB44.5 Postpartum thyroiditis JB44.6 Puerperal osteomalacia JB44.Y Other specified complications of the puerperium JB44.Z Complications of the puerperium, unspecified JB45 Infections of breast associated with childbirth JB45.0 Abscess of breast associated with childbirth JB45.1 Nonpurulent mastitis associated with childbirth JB45.Y Other specified infections of breast associated with childbirth JB45.Z Infections of breast associated with childbirth, unspecified JB46 Certain specified disorders of breast or lactation associated with childbirth JB46.0 Retracted nipple associated with childbirth JB46.1 Cracked nipple associated with childbirth JB46.2 Other or unspecified disorders of breast associated with childbirth JB46.3 Agalactia JB46.4 Hypogalactia JB46.5 Suppressed lactation JB46.6 Galactorrhoea JB46.7 Other or unspecified disorders of lactation JB4Z Complications predominantly related to the puerperium, unspecified JB60 Obstetric death of unspecified cause JB61 Death from any obstetric cause occurring more than 42 days but less than one year after delivery JB61.0 Death from direct obstetric cause occurring more than 42 days but less than one year after delivery JB61.1 Death from indirect obstetric cause occurring more than 42 days but less than one year after delivery JB61.Z Death from obstetric cause occurring more than 42 days but less than one year after delivery, unspecified whether direct or indirect JB62 Death from sequelae of obstetric causes JB62.0 Death from sequelae of direct obstetric cause JB62.1 Death from sequelae of indirect obstetric cause JB62.Z Death from sequelae of obstetric causes, unspecified JB63 Maternal infectious diseases classifiable elsewhere but complicating pregnancy, childbirth or the puerperium JB63.0 Tuberculosis complicating pregnancy, childbirth or the puerperium JB63.1 Syphilis complicating pregnancy, childbirth or the puerperium JB63.2 Gonorrhoea complicating pregnancy, childbirth or the puerperium JB63.3 Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth or the puerperium JB63.4 Viral hepatitis complicating pregnancy, childbirth or the puerperium JB63.5 Other viral diseases complicating pregnancy, childbirth or the puerperium JB63.6 Protozoal diseases complicating pregnancy, childbirth or the puerperium JB63.7 Human immunodeficiency disease complicating pregnancy, childbirth or the puerperium JB63.Y Other specified maternal infectious diseases classifiable elsewhere but complicating pregnancy, childbirth or the puerperium JB63.Z Maternal infectious diseases classifiable elsewhere but complicating pregnancy, childbirth or the puerperium, unspecified – JB63.00 Tuberculous placenta – JB63.0Y Other specified tuberculosis complicating pregnancy, childbirth or the puerperium – JB63.0Z Tuberculosis complicating pregnancy, childbirth or the puerperium, unspecified – JB63.60 Malaria complicating pregnancy, childbirth, or the puerperium – JB63.6Y Other specified protozoal diseases complicating pregnancy, childbirth or the puerperium – JB63.6Z Protozoal diseases complicating pregnancy, childbirth or the puerperium, unspecified JB64 Certain maternal diseases classifiable elsewhere but complicating pregnancy, childbirth or the puerperium JB64.0 Anaemia complicating pregnancy, childbirth or the puerperium JB64.1 Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium JB64.2 Endocrine, nutritional or metabolic diseases complicating pregnancy, childbirth or the puerperium JB64.3 Diseases of the nervous system complicating pregnancy, childbirth or the puerperium JB64.4 Diseases of the circulatory system complicating pregnancy, childbirth or the puerperium JB64.5 Diseases of the respiratory system complicating pregnancy, childbirth or the puerperium JB64.6 Diseases of the digestive system complicating pregnancy, childbirth or the puerperium JB64.7 Diseases of the skin complicating pregnancy, childbirth or the puerperium JB64.8 Congenital anomaly complicating pregnancy JB64.Y Other specified maternal diseases classifiable elsewhere but complicating pregnancy, childbirth or the puerperium JB65 Sequelae of complication of pregnancy, childbirth or the puerperium JB6Y Other specified obstetric conditions, not elsewhere classified JB6Z Unspecified obstetric condition KA00 Fetus or newborn affected by maternal conditions that may be unrelated to present pregnancy KA00.0 Fetus or newborn affected by maternal hypertensive disorders KA00.1 Fetus or newborn affected by gestational oedema or proteinuria without hypertension KA00.2 Fetus or newborn affected by maternal renal or urinary tract diseases KA00.3 Fetus or newborn affected by maternal infectious diseases KA00.4 Fetus or newborn affected by periodontal disease in mother KA00.5 Fetus or newborn affected by maternal respiratory diseases KA00.6 Fetus or newborn affected by maternal nutritional disorders KA00.7 Fetus or newborn affected by abnormal maternal chemistry KA00.8 Fetus or newborn affected by maternal injury KA00.9 Fetus or newborn affected by maternal chemotherapy KA00.A Fetus or newborn affected by surgical procedure on mother KA00.B Fetus or newborn affected by maternal anaemia KA00.Y Fetus or newborn affected by other specified maternal condition that may be unrelated to present pregnancy KA00.Z Fetus or newborn affected by unspecified maternal condition that may be unrelated to present pregnancy – KA00.60 Fetus or newborn affected by maternal malnutrition – KA00.61 Fetus or newborn affected by maternal overweight or obesity – KA00.6Y Other specified fetus or newborn affected by maternal nutritional disorders – KA00.6Z Fetus or newborn affected by maternal nutritional disorders, unspecified KA01 Fetus or newborn affected by maternal complications of pregnancy KA01.0 Fetus or newborn affected by incompetence of cervix uteri KA01.1 Fetus or newborn affected by premature rupture of membranes KA01.2 Fetus or newborn affected by oligohydramnios KA01.3 Fetus or newborn affected by polyhydramnios KA01.4 Fetus or newborn affected by ectopic pregnancy KA01.5 Fetus or newborn affected by multiple pregnancy KA01.6 Fetus or newborn affected by maternal death KA01.7 Fetus or newborn affected by malpresentation before labour KA01.8 Fetus or newborn affected by maternal blood loss KA01.Y Fetus or newborn affected by other specified maternal complication of pregnancy KA01.Z Fetus or newborn affected by unspecified maternal complication of pregnancy KA02 Fetus or newborn affected by complications of placenta KA02.0 Fetus or newborn affected by placenta praevia KA02.1 Fetus or newborn affected by placental oedema or large placenta KA02.2 Fetus or newborn affected by placental infarction KA02.3 Fetus or newborn affected by placental insufficiency or small placenta KA02.4 Fetus or newborn affected by placental transfusion syndromes KA02.Y Fetus or newborn affected by other specified complication of placenta KA02.Z Fetus or newborn affected by unspecified complication of placenta KA03 Fetus or newborn affected by complications of umbilical cord KA03.0 Fetus or newborn affected by prolapsed cord KA03.1 Fetus or newborn affected by other compression of umbilical cord KA03.2 Fetus or newborn affected by abnormalities of umbilical cord length KA03.3 Fetus or newborn affected by vasa praevia KA03.4 Fetus or newborn affected by traumatic injury of the umbilical cord KA03.Y Fetus or newborn affected by other specified complication of umbilical cord KA03.Z Fetus or newborn affected by unspecified complication of umbilical cord – KA03.20 Fetus or newborn affected by short umbilical cord – KA03.21 Fetus or newborn affected by long umbilical cord – KA03.2Y Other specified fetus or newborn affected by abnormalities of umbilical cord length – KA03.2Z Fetus or newborn affected by abnormalities of umbilical cord length, unspecified KA04 Fetus or newborn affected by other abnormalities of membranes KA04.0 Fetus or newborn affected by chorioamnionitis KA04.1 Fetus or newborn affected by amniotic band syndrome KA04.Y Fetus or newborn affected by other specified abnormality of membranes KA04.Z Fetus or newborn affected by unspecified abnormality of membranes KA05 Fetus or newborn affected by certain complications of labour or delivery KA05.0 Fetus or newborn affected by breech delivery or extraction KA05.1 Fetus or newborn affected by other malpresentation, malposition or disproportion during labour or delivery KA05.2 Fetus or newborn affected by forceps delivery KA05.3 Fetus or newborn affected by delivery by vacuum extractor KA05.4 Fetus or newborn affected by caesarean delivery KA05.5 Fetus or newborn affected by precipitate delivery KA05.6 Fetus or newborn affected by abnormal uterine contractions KA05.7 Fetus or newborn affected by abnormality in fetal intrauterine heart rate or rhythm KA05.8 Meconium passage during delivery KA05.Y Fetus or newborn affected or suspected to be affected by other specified complications of labour or delivery KA05.Z Fetus or newborn affected or suspected to be affected by unspecified complications of labour or delivery – KA05.70 Fetus and newborn affected by abnormality in fetal intrauterine heart rate or rhythm before onset of labour – KA05.71 Fetus and newborn affected by abnormality in fetal intrauterine heart rate or rhythm during labour – KA05.7Z Fetus or newborn affected by abnormality in fetal intrauterine heart rate or rhythm, unspecified KA06 Fetus or newborn affected by noxious influences transmitted via placenta or breast milk KA06.0 Fetus or newborn affected by maternal anaesthesia or analgesia in pregnancy, labour or delivery KA06.1 Fetus or newborn affected by maternal use of tobacco KA06.2 Fetus or newborn affected by maternal use of alcohol KA06.3 Fetus or newborn affected by maternal use of drugs of addiction KA06.4 Fetus or newborn affected by maternal use of nutritional chemical substances KA06.5 Fetus or newborn affected by maternal exposure to environmental chemical substances KA06.Y Fetus or newborn affected by other specified noxious influence transmitted via placenta or breast milk KA06.Z Fetus or newborn affected by unspecified noxious influence transmitted via placenta or breast milk KA07 Neonatal dermatoses due to maternal antibodies KA07.0 Neonatal lupus erythematosus KA07.1 Neonatal pemphigus KA07.Y Other specified neonatal dermatoses due to maternal antibodies KA0Z Fetus or newborn affected by unspecified maternal factors or by complications of pregnancy, labour or delivery KA20 Disorders of newborn related to slow fetal growth or fetal malnutrition KA20.0 Small for gestational age KA20.1 Intrauterine growth restriction KA20.2 Fetal intrauterine malnutrition without mention of small for gestational age KA20.Y Other specified disorders of newborn related to slow fetal growth or fetal malnutrition KA20.Z Disorders of newborn related to slow fetal growth or fetal malnutrition, unspecified – KA20.00 Small for gestational age, symmetrical – KA20.01 Small for gestational age, asymmetrical – KA20.0Z Small for gestational age, unspecified – KA20.10 Asymmetrical intrauterine growth restriction – KA20.11 Symmetrical intrauterine growth restriction – KA20.12 Intrauterine growth restriction associated with small for gestational age – KA20.1Y Other specified intrauterine growth restriction – KA20.1Z Intrauterine growth restriction, unspecified KA21 Disorders of newborn related to short gestation or low birth weight, not elsewhere classified KA21.0 Extremely low birth weight of newborn KA21.1 Very low birth weight of newborn KA21.2 Low birth weight of newborn KA21.3 Extreme prematurity of newborn KA21.4 Preterm newborn – KA21.00 Extremely low birth weight of newborn, 499g or less – KA21.01 Extremely low birth weight of newborn, 500-749g – KA21.02 Extremely low birth weight of newborn, 750-999g – KA21.0Z Extremely low birth weight of newborn, unspecified – KA21.10 Very low birth weight of newborn, 1000-1249g – KA21.11 Very low birth weight of newborn, 1250-1499g – KA21.1Z Very low birth weight of newborn, unspecified – KA21.20 Low birth weight of newborn, 1500-1999g – KA21.21 Low birth weight of newborn, 2000-2499g – KA21.2Z Low birth weight of newborn, unspecified – KA21.30 Extreme prematurity of newborn, gestational age less than 22 completed weeks – KA21.31 Extreme prematurity of newborn, gestational age 22 completed weeks – KA21.32 Extreme prematurity of newborn, gestational age 23 completed weeks – KA21.33 Extreme prematurity of newborn, gestational age 24 completed weeks – KA21.34 Extreme prematurity of newborn, gestational age 25 completed weeks – KA21.35 Extreme prematurity of newborn, gestational age 26 completed weeks – KA21.36 Extreme prematurity of newborn, gestational age 27 completed weeks – KA21.3Z Extreme prematurity of newborn, unspecified – KA21.40 Preterm newborn, gestational age 28 completed weeks – KA21.41 Preterm newborn, gestational age 29 completed weeks – KA21.42 Preterm newborn, gestational age 30 completed weeks – KA21.43 Preterm newborn, gestational age 31 completed weeks – KA21.44 Preterm newborn, gestational age 32 completed weeks – KA21.45 Preterm newborn, gestational age 33 completed weeks – KA21.46 Preterm newborn, gestational age 34 completed weeks – KA21.47 Preterm newborn, gestational age 35 completed weeks – KA21.48 Preterm newborn, gestational age 36 completed weeks – KA21.4Z Preterm newborn, unspecified KA22 Disorders of newborn related to long gestation or high birth weight KA22.0 Exceptionally large newborn KA22.1 Large newborn for gestational age KA22.2 Post-term newborn KA22.3 Postmaturity syndrome KA2Y Other specified disorders of newborn related to length of gestation or fetal growth KA2Z Disorders of newborn related to length of gestation or fetal growth, unspecified KA40 Birth injury to central nervous system KA40.0 Intracranial laceration or haemorrhage due to birth injury KA40.1 Cerebral oedema due to birth injury KA40.2 Birth injury to spine or spinal cord KA40.3 Birth injury to brainstem KA40.Y Other specified birth injury to central nervous system KA40.Z Birth injury to central nervous system, unspecified – KA40.00 Subdural haemorrhage due to birth injury – KA40.01 Cerebral haemorrhage due to birth injury – KA40.02 Cerebellar haemorrhage due to birth injury – KA40.03 Intraventricular haemorrhage due to birth injury – KA40.04 Subarachnoid haemorrhage due to birth injury – KA40.05 Tentorial tear due to birth injury – KA40.06 Cerebellar contusion due to birth injury – KA40.07 Cerebral contusion due to birth injury – KA40.08 Extradural or epidural haemorrhage due to birth injury – KA40.0Y Other specified intracranial laceration or haemorrhage due to birth injury – KA40.0Z Intracranial laceration or haemorrhage due to birth injury, unspecified KA41 Birth injury to eye KA42 Birth injury to scalp KA42.0 Bruising of scalp due to birth injury KA42.1 Cephalohaematoma due to birth injury KA42.2 Chignon due to birth injury KA42.3 Monitoring injury of scalp of newborn KA42.4 Subgaleal epicranial subaponeurotic haemorrhage due to birth injury KA42.Y Other specified birth injury to scalp KA42.Z Birth injury to scalp, unspecified KA43 Birth injury to skin or soft tissues KA43.0 Birth injury to sternocleidomastoid KA43.1 Birth injury to external genitalia KA43.2 Subcutaneous fat necrosis due to birth injury KA43.3 Birth injury to face KA43.Y Other specified birth injury to skin or soft tissues KA43.Z Birth injury to skin or soft tissues, unspecified KA44 Birth injury to peripheral nervous system KA44.0 Birth injury to cranial nerves KA44.1 Brachial plexus palsy in newborn KA44.2 Phrenic nerve paralysis due to birth injury KA44.Y Birth injury to other specified peripheral nerve KA44.Z Birth injury to unspecified peripheral nerve – KA44.00 Birth injury to facial nerve – KA44.0Y Birth injury to other specified cranial nerve – KA44.0Z Birth injury to unspecified cranial nerve – KA44.10 Erb paralysis – KA44.11 Klumpke paralysis – KA44.1Z Brachial plexus palsy in newborn, unspecified KA45 Birth injury to skeleton KA45.0 Fracture of skull due to birth injury KA45.1 Occipital osteodiastasis due to birth injury KA45.2 Birth injury to facial bones KA45.3 Birth injury of thorax KA45.4 Fracture, dislocation or subluxation of spine due to birth injury KA45.5 Fracture of clavicle due to birth injury KA45.6 Birth injury to long bones KA45.Y Other specified birth injury to skeleton KA45.Z Birth injury to skeleton, unspecified – KA45.00 Linear skull fracture due to birth injury – KA45.01 Depressed skull fracture due to birth injury – KA45.0Y Other specified fracture of skull due to birth injury – KA45.0Z Fracture of skull due to birth injury, unspecified – KA45.20 Mandibular bone fracture due to birth injury – KA45.21 Nasal bone fracture due to birth injury – KA45.2Y Birth injury to other specified facial bones – KA45.2Z Birth injury to facial bones, unspecified KA46 Birth injury to other organs KA46.0 Birth injury to liver KA46.1 Birth injury to spleen KA46.2 Adrenal haemorrhage due to birth injury KA46.Y Birth injury to other specified organ KA4Z Birth injury, unspecified KA60 Sepsis of fetus or newborn KA61 Other bacterial infections of the fetus or newborn KA61.0 Congenital tuberculosis KA61.1 Neonatal listeriosis KA61.Z Bacterial infection of the fetus or newborn, unspecified KA62 Viral infection in the fetus or newborn KA62.0 Congenital Zika virus infection KA62.1 Congenital Epstein-Barr virus infection KA62.2 Congenital Varicella Zoster virus infection KA62.3 Congenital cytomegalovirus infection KA62.4 Congenital echovirus infection KA62.5 Congenital enterovirus infection KA62.6 Congenital human immunodeficiency virus infection KA62.7 Congenital parvovirus syndrome KA62.8 Congenital rubella syndrome KA62.9 Congenital viral hepatitis KA62.A Perinatal Herpes simplex infection KA62.Y Other specified viral infection in the fetus or newborn KA62.Z Viral infection in the fetus or newborn, unspecified KA63 Fungal infection of fetus or newborn KA63.0 Malassezia infection in newborn KA63.1 Neonatal aspergillosis KA63.2 Neonatal candidosis KA63.Y Other specified fungal infection of fetus or newborn KA63.Z Fungal infection of fetus or newborn, unspecified KA64 Parasitic diseases in the fetus or newborn KA64.0 Congenital toxoplasmosis KA64.1 Congenital falciparum malaria KA64.Y Other specified parasitic diseases in the fetus or newborn KA64.Z Parasitic diseases in the fetus or newborn, unspecified KA65 Neonatal infections of certain specified sites KA65.0 Neonatal conjunctivitis or dacryocystitis KA65.1 Omphalitis of newborn KA65.2 Neonatal urinary tract infection KA65.3 Neonatal infectious mastitis KA65.4 Neonatal meningitis KA65.Y Neonatal infections of other specified sites KA6Y Other specified infections of the fetus or newborn KA6Z Infections of the fetus or newborn, unspecified KA80 Fetal blood loss KA80.0 Fetal blood loss from vasa praevia KA80.1 Fetal blood loss from ruptured cord KA80.2 Fetal blood loss from placenta KA80.3 Haemorrhage into co-twin KA80.4 Haemorrhage into maternal circulation KA80.5 Fetal blood loss from cut end of co-twin cord KA80.Y Other specified fetal blood loss KA80.Z Fetal blood loss, unspecified KA81 Umbilical haemorrhage of newborn KA82 Intracranial nontraumatic haemorrhage of fetus or newborn KA82.0 Intraventricular nontraumatic haemorrhage, grade 1, of fetus or newborn KA82.1 Intraventricular nontraumatic haemorrhage, grade 2, of fetus or newborn KA82.2 Intraventricular nontraumatic haemorrhage, grade 3, of fetus or newborn KA82.3 Intraventricular nontraumatic haemorrhage, grade 4, of fetus or newborn KA82.4 Intracerebral nontraumatic haemorrhage of fetus or newborn KA82.5 Subarachnoid nontraumatic haemorrhage of fetus or newborn KA82.6 Cerebellar nontraumatic, hemispheres or vermis or posterior fossa haemorrhage of fetus or newborn KA82.7 Subdural nontraumatic haemorrhage of fetus or newborn KA82.Z Intracranial nontraumatic haemorrhage of fetus or newborn, unspecified KA83 Certain specified neonatal haemorrhages KA83.0 Neonatal bleeding originating in the mouth, nose or pharynx KA83.1 Neonatal bleeding originating in the oesophagus, stomach, small or large intestine KA83.2 Neonatal rectal haemorrhage KA83.3 Neonatal hepatic haemorrhage KA83.4 Neonatal haemorrhage originating in adrenal gland KA83.5 Neonatal haemorrhage originating in spleen KA83.6 Neonatal haemorrhage originating in kidney or bladder KA83.7 Neonatal haemorrhage originating in trachea or pulmonary parenchyma KA83.8 Neonatal cutaneous haemorrhage KA83.9 Neonatal vaginal or uterine haemorrhage KA83.A Neonatal epistaxis KA84 Haemolytic disease of fetus or newborn KA84.0 Rh isoimmunization of fetus or newborn KA84.1 Isoimmunization due to other red cell factors KA84.2 ABO isoimmunization of fetus or newborn KA84.3 Haemolytic anaemia due to other unclassified antibodies of fetus or newborn KA84.4 Haemolytic disease due to disease of other neonatal organs KA84.5 Neonatal haemolysis due to systemic bacterial infection with or without concomitant diffuse intravascular coagulation KA84.Z Haemolytic disease of fetus or newborn, unspecified KA85 Hydrops fetalis due to haemolytic disease KA85.0 Hydrops fetalis due to isoimmunization KA85.Y Other specified hydrops fetalis due to haemolytic disease KA85.Z Hydrops fetalis due to haemolytic disease, unspecified KA86 Neonatal kernicterus KA87 Neonatal hyperbilirubinaemia KA87.0 Neonatal hyperbilirubinaemia due to swallowed maternal blood KA87.1 Neonatal hyperbilirubinaemia due to enzymatic defect in bilirubin degradation KA87.2 Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation KA87.3 Neonatal hyperbilirubinaemia due to total parenteral nutrition KA87.4 Neonatal hyperbilirubinaemia due to drugs or toxins transmitted from mother KA87.5 Neonatal hyperbilirubinaemia due to drugs or toxins given to newborn KA87.6 Neonatal hyperbilirubinaemia from other or unspecified hepatocellular damage KA87.Y Other specified neonatal hyperbilirubinaemia KA87.Z Neonatal hyperbilirubinaemia, unspecified KA88 Disseminated intravascular coagulation of fetus or newborn KA89 Transient neonatal thrombocytopaenia KA89.0 Thrombocytopaenia following systemic infection, including diffuse intravascular coagulation KA89.Y Other specified transient neonatal thrombocytopaenia KA89.Z Transient neonatal thrombocytopaenia, unspecified KA8A Polycythaemia neonatorum KA8A.0 Polycythaemia neonatorum due to placental insufficiency or fetal intrauterine growth restriction KA8A.1 Polycythaemia neonatorum due to twin to twin transfusion KA8A.2 Polycythaemia neonatorum due to inherited disorder of erythropoietin production KA8A.3 Polycythaemia neonatorum following umbilical cord transfusion or stripping at delivery KA8A.4 Polycythaemia neonatorum following blood transfusion KA8A.Y Other specified polycythaemia neonatorum KA8A.Z Polycythaemia neonatorum, unspecified KA8B Anaemia of prematurity KA8C Congenital hypoplastic anaemia KA8D Transient neonatal neutropaenia KA8E Alloimmune neonatal neutropaenia KA8F Neonatal vitamin K deficiency KA8F.0 Diffuse bleeding diathesis due to vitamin K deficient haemorrhagic disease of fetus or newborn KA8F.Y Other specified neonatal vitamin K deficiency KA8F.Z Neonatal vitamin K deficiency, unspecified KA8Y Other specified haemorrhagic or haematological disorders of fetus or newborn KA8Z Haemorrhagic or haematological disorders of fetus or newborn, unspecified KB00 Neonatal cerebral ischaemia KB00.0 Perinatal arterial stroke KB00.1 Neonatal cerebral sinovenous thrombosis KB00.Y Other specified neonatal cerebral ischaemia KB00.Z Neonatal cerebral ischaemia, unspecified KB01 Periventricular cysts of newborn KB02 Neonatal cerebral leukomalacia KB03 Neonatal encephalopathy KB04 Hypoxic ischaemic encephalopathy of newborn KB05 Neonatal hydrocephalus KB05.0 Neonatal obstructive hydrocephalus KB05.Y Other specified neonatal hydrocephalus KB05.Z Neonatal hydrocephalus, unspecified KB06 Neonatal seizures KB07 Compression of brain in neonate KB08 Disorders of muscle tone of newborn KB08.0 Transient neonatal myasthenia gravis KB08.1 Congenital hypertonia KB08.2 Congenital hypotonia KB08.Y Other specified disorders of muscle tone of newborn KB08.Z Disorders of muscle tone of newborn, unspecified KB0Y Other specified neurological disorders specific to the perinatal or neonatal period KB0Z Neurological disorders specific to the perinatal or neonatal period, unspecified KB20 Intrauterine hypoxia KB20.0 Intrauterine hypoxia first noted before onset of labour KB20.1 Intrauterine hypoxia first noted during labour or delivery KB20.Z Intrauterine hypoxia, unspecified KB21 Birth asphyxia KB21.0 Severe birth asphyxia KB21.1 Mild and moderate birth asphyxia KB21.Z Birth asphyxia, unspecified KB22 Metabolic acidaemia in newborn KB23 Respiratory distress of newborn KB23.0 Respiratory distress syndrome of newborn KB23.1 Transient tachypnoea of newborn KB23.2 Respiratory instability of prematurity KB23.Y Other specified respiratory distress of newborn KB23.Z Respiratory distress of newborn, unspecified – KB23.00 Respiratory distress syndrome of the newborn, altered by maternal corticosteroid therapy – KB23.01 Respiratory distress syndrome of the newborn, altered by pulmonary surfactant replacement therapy – KB23.02 Respiratory distress syndrome of the newborn, altered by maternal corticosteroid therapy or pulmonary surfactant replacement therapy – KB23.0Y Other specified respiratory distress syndrome of newborn – KB23.0Z Respiratory distress syndrome of newborn, unspecified KB24 Congenital pneumonia KB25 Neonatal tracheitis KB26 Neonatal aspiration syndromes KB26.0 Neonatal aspiration of meconium KB26.1 Neonatal aspiration of amniotic fluid or mucus KB26.2 Neonatal aspiration of blood KB26.3 Neonatal aspiration of milk or regurgitated food KB26.Y Other specified neonatal aspiration syndromes KB26.Z Neonatal aspiration syndromes, unspecified KB27 Pulmonary air leak or related conditions originating in the perinatal period KB27.0 Interstitial emphysema originating in the perinatal period KB27.1 Pneumothorax originating in the perinatal period KB27.2 Pneumomediastinum originating in the perinatal period KB27.3 Pneumopericardium originating in the perinatal period KB27.4 Pneumoperitoneum, originating in the perinatal period, due to primary pulmonary air leak syndromes KB27.Y Other specified pulmonary air leak or related conditions originating in the perinatal period KB27.Z Pulmonary air leak or related conditions originating in the perinatal period, unspecified KB28 Pulmonary haemorrhage originating in the perinatal period KB28.0 Tracheobronchial haemorrhage originating in the perinatal period KB28.1 Traumatic pulmonary haemorrhage originating in the perinatal period KB28.Y Other specified pulmonary haemorrhage originating in the perinatal period KB28.Z Pulmonary haemorrhage originating in the perinatal period, unspecified KB29 Chronic respiratory disease originating in the perinatal period KB29.0 Bronchopulmonary dysplasia originating in the perinatal period KB29.Y Other specified chronic respiratory disease originating in the perinatal period KB29.Z Chronic respiratory disease originating in the perinatal period, unspecified KB2A Apnoea of newborn KB2A.0 Central neonatal apnoea KB2A.1 Obstructive neonatal apnoea KB2A.2 Mixed neonatal apnoea KB2A.3 Apnoea of newborn, due to neurologic injury KB2A.Y Other specified apnoea of newborn KB2A.Z Apnoea of newborn, unspecified KB2B Primary atelectasis of newborn KB2C Cyanotic attacks of newborn KB2D Respiratory failure of newborn KB2E Respiratory arrest of newborn KB2F Congenital lung or lobar atelectasis KB2G Tracheal haemorrhage of newborn due to airway trauma KB2H Acquired vocal cord paralysis in newborn KB2J Airway obstruction in the neonate due to airway abnormality KB2J.0 Hypotonia of hypopharynx in neonate KB2J.1 Hypopharyngeal mass in neonate KB2J.2 Tracheo-bronchial malacia in neonate KB2J.Y Other specified airway obstruction in the neonate due to airway abnormality KB2J.Z Airway obstruction in the neonate due to airway abnormality, unspecified KB2K Pulmonary cysts in newborn KB2K.0 Acquired pulmonary cysts in newborn KB2K.Z Pulmonary cysts in newborn, unspecified KB2Y Other specified respiratory disorders specific to the perinatal or neonatal period KB2Z Respiratory disorders specific to the perinatal or neonatal period, unspecified KB40 Neonatal cardiac failure KB40.0 Neonatal cardiac failure due to pulmonary overperfusion KB40.1 Neonatal cardiac failure due to decreased left ventricular output KB40.Y Other specified neonatal cardiac failure KB40.Z Neonatal cardiac failure, unspecified KB41 Cardiac arrhythmias in the neonate KB42 Persistent pulmonary hypertension of the newborn KB44 Transient myocardial ischaemia of newborn KB45 Neonatal hypertension KB46 Neonatal hypotension KB47 Benign or innocent cardiac murmurs in newborn KB48 Patent arterial duct of prematurity KB4Y Other specified cardiovascular disorders present in the perinatal or neonatal period KB4Z Cardiovascular disorders present in the perinatal or neonatal period, unspecified KB60 Transitory disorders of carbohydrate metabolism specific to fetus or newborn KB60.0 Syndrome of infant of mother with gestational diabetes KB60.1 Syndrome of infant of a diabetic mother, type 1 or 2, nongestational, insulin dependent KB60.2 Neonatal diabetes mellitus KB60.3 Neonatal hyperglycaemia KB60.4 Neonatal hypoglycaemia KB60.Y Other specified transitory disorders of carbohydrate metabolism specific to fetus or newborn KB60.Z Transitory disorders of carbohydrate metabolism specific to fetus or newborn, unspecified – KB60.20 Transient neonatal diabetes mellitus – KB60.2Y Other specified neonatal diabetes mellitus – KB60.2Z Neonatal diabetes mellitus, unspecified – KB60.30 Neonatal hyperglycaemia due to insulin deficiency – KB60.31 Neonatal hyperglycaemia due to iatrogenic intravenous therapy – KB60.3Y Other specified neonatal hyperglycaemia – KB60.3Z Neonatal hyperglycaemia, unspecified – KB60.40 Transient hyperinsulinaemic neonatal hypoglycaemia – KB60.41 Transitory iatrogenic neonatal hypoglycaemia – KB60.42 Other transitory neonatal hypoglycaemia – KB60.4Y Other specified neonatal hypoglycaemia – KB60.4Z Neonatal hypoglycaemia, unspecified KB61 Transitory neonatal disorders of calcium or magnesium metabolism KB61.0 Neonatal hypomagnesaemia KB61.1 Neonatal tetany without calcium or magnesium deficiency KB61.2 Neonatal hypocalcaemia KB61.3 Neonatal osteopenia KB61.Y Other specified transitory neonatal disorders of calcium or magnesium metabolism KB61.Z Transitory neonatal disorders of calcium or magnesium metabolism, unspecified KB62 Transitory neonatal disorders of thyroid function KB62.0 Transitory neonatal hyperthyroidism KB62.1 Other transitory neonatal disorders of thyroid function, not elsewhere classified KB62.2 Transient hyperthyrotropinaemia KB62.3 Transient hypothyroxinaemia KB62.Y Other specified transitory neonatal disorders of thyroid function KB62.Z Transitory neonatal disorders of thyroid function, unspecified KB63 Certain specified transitory neonatal electrolyte or metabolic disturbances KB63.0 Late metabolic acidosis of newborn KB63.1 Dehydration of newborn KB63.2 Disturbances of sodium balance of newborn KB63.3 Disturbances of potassium balance of newborn KB63.4 Transitory tyrosinaemia of newborn KB63.5 Metabolic bone disease of prematurity – KB63.20 Hyponatremia of newborn – KB63.21 Hypernatremia of newborn – KB63.2Y Other specified disturbances of sodium balance of newborn – KB63.2Z Disturbances of sodium balance of newborn, unspecified – KB63.30 Hypokalaemia of newborn – KB63.31 Hyperkalaemia of newborn – KB63.3Y Other specified disturbances of potassium balance of newborn – KB63.3Z Disturbances of potassium balance of newborn, unspecified KB64 Transitory neonatal hypoparathyroidism KB6Z Transitory endocrine or metabolic disorders specific to fetus or newborn, unspecified KB80 Gastro-oesophageal reflux disease in newborn KB81 Oesophagitis in newborn KB81.0 Neonatal eosinophilic oesophagitis KB81.Y Other specified oesophagitis in newborn KB81.Z Oesophagitis in newborn, unspecified KB82 Prenatal gastric perforation KB83 Postnatal gastric perforation KB84 Postnatal isolated ileal perforation KB85 Prenatal intrauterine intestinal perforation KB85.0 Prenatal intrauterine intestinal perforation due to in utero volvulus KB85.1 Prenatal intrauterine intestinal perforation due to intestinal atresia or stenosis KB85.2 Prenatal intrauterine intestinal perforation due to intraluminal obstruction KB85.Y Other specified prenatal intrauterine intestinal perforation KB85.Z Prenatal intrauterine intestinal perforation, unspecified KB86 Postnatal intestinal perforation KB86.0 Postnatal intestinal perforation due to drugs KB86.1 Postnatal intestinal perforation due to in utero volvulus KB86.2 Postnatal intestinal perforation due to intestinal atresia or stenosis KB86.3 Postnatal intestinal perforation due to intraluminal obstruction KB86.Y Other specified postnatal intestinal perforation KB86.Z Postnatal intestinal perforation, unspecified KB87 Intestinal obstruction of newborn KB87.0 Intestinal obstruction due to inspissated milk KB87.1 Meconium plug without ileus KB87.2 Meconium ileus without perforation KB87.3 Transitory ileus of newborn KB87.4 Meconium ileus with perforation KB87.Y Other specified intestinal obstruction of newborn KB87.Z Intestinal obstruction of newborn, unspecified KB88 Necrotising enterocolitis of newborn KB88.0 Necrotising enterocolitis of newborn, Stage 1A & B KB88.1 Necrotising enterocolitis of newborn, Stage 2A & B KB88.2 Necrotising enterocolitis of newborn, Stage 3A KB88.3 Necrotising enterocolitis of newborn, Stage 3B KB88.Y Other specified necrotising enterocolitis of newborn KB88.Z Necrotising enterocolitis of newborn, unspecified KB89 Neonatal malabsorption syndromes KB89.0 Neonatal malabsorption due to endocrine secreting tumour KB89.1 Short bowel syndrome in neonate KB89.Y Other specified neonatal malabsorption syndromes KB89.Z Neonatal malabsorption syndromes, unspecified KB8A Neonatal haematemesis or melaena due to swallowed maternal blood KB8B Neonatal peritonitis KB8C Noninfectious neonatal diarrhoea KB8Y Other specified digestive system disorders of fetus or newborn KB8Z Digestive system disorders of fetus or newborn, unspecified KC00 Congenital hydrocele KC01 Congenital renal failure KC0Y Other specified genitourinary system disorders specific to the perinatal or neonatal period KC0Z Genitourinary system disorders specific to the perinatal or neonatal period, unspecified KC20 Conditions involving the umbilical cord KC20.0 Delayed separation of umbilical cord KC20.1 Umbilical cutis or polyp of newborn KC20.2 Umbilical granuloma of newborn KC20.Y Other specified conditions involving the umbilical cord KC20.Z Conditions involving the umbilical cord, unspecified KC21 Inflammatory dermatoses of the newborn KC21.0 Neonatal acne KC21.1 Neonatal toxic erythema KC21.2 Perianal dermatitis of the newborn KC21.Y Other specified inflammatory dermatoses of the newborn KC22 Neonatal disorders of subcutaneous fat KC22.0 Subcutaneous fat necrosis of the newborn KC22.1 Cold panniculitis of the newborn KC22.2 Sclerema neonatorum KC22.Y Other specified neonatal disorders of subcutaneous fat KC22.Z Neonatal disorders of subcutaneous fat, unspecified KC23 Neonatal disorders of the oral mucosa KC24 Neonatal nutritional disorders affecting the skin KC30 Skin fragility of prematurity KC31 Congenital erosive or vesicular dermatosis healing with reticulated supple scarring KC3Y Other specified skin disorders associated with prematurity KC40 Miscellaneous skin disorders in the neonate KC40.0 Congenital sucking blisters KC40.1 Neonatal milia KC40.Y Other specified skin disorders in the neonate KC41 Miscellaneous specified conditions of integument specific to fetus or newborn KC41.0 Breast engorgement of newborn KC41.1 Hydrops fetalis not due to haemolytic disease KC41.Y Other specified conditions of integument specific to fetus and newborn – KC50 Neonatal phototherapy burn – KC5Y Other specified postnatal iatrogenic skin injury – KC5Z Postnatal iatrogenic skin injury, unspecified KC7Y Other specified iatrogenic injuries involving the skin of the neonate KC9Z Disorders involving the integument of fetus or newborn, unspecified KD10 Environmental hyperthermia of newborn KD11 Fever of newborn KD12 Hypothermia of newborn KD12.0 Neonatal cold injury syndrome KD12.Y Other specified hypothermia of newborn KD12.Z Hypothermia of newborn, unspecified KD1Y Other specified disturbances of temperature regulation of newborn KD1Z Disturbances of temperature regulation of newborn, unspecified KD30 Birth depression KD30.0 Birth depression with 5 minute Apgar score 0-3 KD30.1 Birth depression with 5 minute Apgar score 4-6 KD30.2 Birth depression with associated metabolic acidaemia of cord blood KD30.Z Birth depression, unspecified KD31 Wide cranial sutures of newborn KD32 Feeding problems of newborn KD32.0 Slow feeding of newborn KD32.1 Underfeeding of newborn KD32.2 Overfeeding of newborn KD32.3 Neonatal difficulty in feeding at breast KD32.4 Failure to thrive in newborn KD32.Y Other specified feeding problems of newborn KD32.Z Feeding problems of newborn, unspecified KD33 Jittery baby, not elsewhere classified KD34 Reactions or intoxications due to drugs administered to fetus or newborn KD35 Neonatal withdrawal syndrome from maternal use of drugs of addiction KD36 Withdrawal symptoms from therapeutic use of drugs in newborn KD37 Exposure to tobacco smoke in the perinatal period KD38 Meconium staining KD39 Complications of intrauterine procedures, not elsewhere classified KD39.0 Fetus or newborn affected by amniocentesis KD39.1 Fetus or newborn affected by chorionic villous sampling KD39.2 Fetus or newborn affected by fetal blood sampling KD39.3 Fetus or newborn affected by complications of fetal surgery KD39.4 Fetus or newborn affected by complications of intrauterine fetal surgery KD39.Y Other specified complications of intrauterine procedures, not elsewhere classified KD39.Z Complications of intrauterine procedures, not elsewhere classified, unspecified KD3A Termination of pregnancy, affecting surviving fetus or newborn KD3B Fetal death, cause not specified KD3B.0 Antepartum fetal death KD3B.1 Intrapartum fetal death KD3B.Z Unspecified time of fetal death, cause not specified KD3C Vomiting in newborn KD3C.0 Bilious vomiting of newborn KD3C.Y Other specified vomiting in newborn KD3C.Z Vomiting in newborn, unspecified KD3Y Other specified disorders originating in the perinatal period KD5Z Conditions originating in the perinatal or neonatal period, unspecified MA00 Symptom or complaint of the blood MA01 Enlarged lymph nodes MA01.0 Localised lymph node enlargement MA01.1 Generalised lymph node enlargement MA01.Z Enlarged lymph nodes, unspecified MA0Y Other specified symptoms of blood, blood-forming organs, or the immune system MA10 Abnormal serum enzyme levels – MA10.0 Elevation of levels of transaminase or lactic acid dehydrogenase – MA10.1 Abnormal levels of other specified serum enzymes – MA10.2 Abnormal level of unspecified serum enzyme MA11 Clinical findings of hormones in blood, blood-forming organs, or the immune system MA12 Clinical findings of drugs, medicaments and biological substances in blood, blood-forming organs, or the immune system – MA12.0 Finding of opiate drug in blood – MA12.1 Finding of cocaine in blood – MA12.2 Finding of hallucinogen in blood – MA12.3 Finding of psychotropic drug in blood – MA12.4 Finding of steroid agent in blood – MA12.Y Other specified clinical findings of drugs, medicaments and biological substances in blood, blood-forming organs, or the immune system MA13 Clinical findings of substances chiefly nonmedicinal as to source in blood, blood-forming organs, or the immune system – MA13.0 Finding of abnormal level of heavy metals in blood – MA13.1 Finding of alcohol in blood – MA13.Y Abnormal level of other specified substances chiefly nonmedicinal as to source in blood, blood-forming organs and the immune system –– MA13.00 Abnormal level of lead in blood –– MA13.0Y Finding of abnormal level of other specified heavy metals in blood MA14 Immunological findings in blood, blood-forming organs, or the immune system – MA14.0 Laboratory evidence of human immunodeficiency virus – MA14.1 Certain specified immunological findings – MA14.Y Other specified immunological findings in blood, blood-forming organs, or the immune system –– MA14.10 Abnormal reaction to tuberculin test –– MA14.11 Anticitrullinated protein antibody negative –– MA14.12 Anticitrullinated protein antibody positive –– MA14.13 Anti-nuclear antibody negative –– MA14.14 Anti-nuclear antibody positive –– MA14.15 Elevated C-reactive protein –– MA14.16 False-positive serological test for syphilis –– MA14.17 Human leukocyte antigen negative –– MA14.18 Human leukocyte antigen positive –– MA14.19 Neural autoantibody negative –– MA14.1A Neural autoantibody positive –– MA14.1B Prostate specific antigen positive –– MA14.1C Raised antibody titre –– MA14.1D Rheumatoid factor negative –– MA14.1E Rheumatoid factor positive MA15 Microbiological findings in blood, blood-forming organs, or the immune system – MA15.0 Bacteraemia – MA15.1 Fungaemia – MA15.Y Other specified microbiological findings in blood, blood-forming organs, or the immune system MA16 Cytological findings in blood, blood-forming organs, or the immune system – MA16.0 Abnormality of red blood cells – MA16.1 Abnormality of white blood cells – MA16.Y Other specified cytological findings in blood, blood-forming organs, or the immune system – MA16.Z Cytological findings in blood, blood-forming organs, or the immune system, unspecified –– MA16.00 Haemolysis, not elsewhere classified –– MA16.0Y Other specified abnormality of red blood cells –– MA16.0Z Abnormality of red blood cells, unspecified –– MA16.10 Decreased white blood cell count –– MA16.11 Elevated white blood cell count –– MA16.1Z Abnormality of white blood cells, unspecified MA17 Histological findings in blood, blood-forming organs, or the immune system MA18 Certain clinical findings of blood chemistry – MA18.0 Elevated blood glucose level – MA18.1 Abnormal level of blood mineral – MA18.2 Abnormal arterial blood-gas level – MA18.3 Abnormal coagulation profile – MA18.4 Low haemoglobin – MA18.Y Other specified abnormal findings of blood chemistry – MA18.Z Abnormal findings of blood chemistry, unspecified –– MA18.00 Abnormal glucose tolerance test –– MA18.0Y Other specified elevated blood glucose level –– MA18.0Z Elevated blood glucose level, unspecified MA19 Certain abnormalities of plasma proteins – MA19.0 Abnormality of albumin – MA19.1 Abnormality of alphafetoprotein – MA19.2 Abnormality of globulin – MA19.Y Abnormalities of other specified plasma proteins – MA19.Z Abnormalities of unspecified plasma proteins MA1A Elevated erythrocyte sedimentation rate or abnormality of plasma viscosity – MA1A.0 Elevated erythrocyte sedimentation rate – MA1A.1 Abnormal plasma viscosity MA1Y Other specified clinical findings in blood, blood-forming organs, or the immune system MA3Y Other specified symptoms, signs or clinical findings of blood, blood-forming organs, or the immune system MA50 Abnormal results of thyroid function studies MA51 Abnormal results of other endocrine function studies MA6Y Other specified symptoms, signs or clinical findings of endocrine, nutritional or metabolic diseases MA80 Speech disturbances – MA80.0 Aphasia – MA80.1 Dysphasia – MA80.2 Dysarthria – MA80.Y Other specified speech disturbances – MA80.Z Speech disturbances, unspecified –– MA80.20 Anarthria –– MA80.2Y Other specified dysarthria –– MA80.2Z Dysarthria, unspecified MA81 Speech dysfluency MA82 Voice disturbances – MA82.0 Aphonia – MA82.1 Dysphonia – MA82.2 Nasality – MA82.Y Other specified voice disturbances – MA82.Z Voice disturbances, unspecified –– MA82.10 Hoarseness –– MA82.1Y Other specified dysphonia –– MA82.1Z Dysphonia, unspecified MA8Y Other specified symptoms or signs involving speech or voice MB0Y Other specified symptoms, signs or clinical findings of speech or voice MB20 Symptoms, signs or clinical findings involving consciousness MB20.0 Stupor MB20.1 Coma MB20.2 Clouding of consciousness MB20.Y Other specified symptoms, signs or clinical findings involving consciousness MB21 Symptoms, signs or clinical findings involving cognition MB21.0 Age-associated cognitive decline MB21.1 Amnesia MB21.2 Anosognosia MB21.3 Confabulation MB21.4 Disorientation MB21.5 Distractibility MB21.6 Impaired abstract thinking MB21.7 Impaired executive functioning MB21.8 Impaired judgment MB21.9 Perseveration MB21.A Poor concentration MB21.B Racing thoughts MB21.Y Other specified symptoms and signs involving cognition MB21.Z Symptoms and signs involving cognition, unspecified – MB21.10 Anterograde amnesia – MB21.11 Retrograde amnesia – MB21.12 Transient global amnesia – MB21.1Y Other specified amnesia – MB21.1Z Amnesia, unspecified MB22 Symptoms or signs involving motivation or energy MB22.0 Avolition MB22.1 Decreased libido MB22.2 Demoralization MB22.3 Hopelessness MB22.4 Increased energy MB22.5 Increased goal-directed activity MB22.6 Increased libido MB22.7 Tiredness MB22.Y Other specified symptoms and signs involving motivation or energy MB22.Z Symptoms or signs involving motivation or energy, unspecified MB23 Symptoms or signs involving appearance or behaviour MB23.0 Aggressive behaviour MB23.1 Antisocial behaviour MB23.2 Avoidance behaviour MB23.3 Bradyphrenia MB23.4 Compulsions MB23.5 Coprolalia MB23.6 Disorganised behaviour MB23.7 Disheveled appearance MB23.8 Disruptive behaviour MB23.9 Echolalia MB23.A Excessive crying of child, adolescent, or adult MB23.C Increased sociability MB23.D Mutism MB23.E Non-suicidal self-injury MB23.F Odd or peculiar appearance MB23.G Odd or peculiar behaviour MB23.H Panic attack MB23.J Poor personal hygiene MB23.K Poverty of speech MB23.L Pressured speech MB23.M Psychomotor agitation MB23.N Psychomotor retardation MB23.Q Social withdrawal MB23.R Suicide attempt MB23.S Suicidal behaviour MB23.Y Other specified symptoms and signs involving appearance and behaviour MB23.Z Symptoms and signs involving appearance and behaviour, unspecified MB24 Symptoms or signs involving mood or affect MB24.0 Ambivalence MB24.1 Anger MB24.2 Anhedonia MB24.3 Anxiety MB24.4 Apathy MB24.5 Depressed mood MB24.6 Disturbance of affect MB24.7 Dysphoria MB24.8 Elevated mood MB24.9 Euphoria MB24.A Fear MB24.B Feelings of guilt MB24.C Irritability MB24.D Leaden paralysis MB24.E Mental rumination MB24.F Restlessness MB24.G Tantrum MB24.H Worry MB24.Y Other specified symptoms and signs involving mood or affect MB24.Z Symptoms and signs involving mood or affect, unspecified – MB24.60 Constricted affect – MB24.61 Blunted affect – MB24.62 Flat affect – MB24.63 Labile affect – MB24.64 Inappropriate affect – MB24.6Y Other specified disturbance of affect – MB24.6Z Disturbance of affect, unspecified MB25 Symptoms or signs involving form of thought MB25.0 Symptoms and signs of thought disorder MB25.1 Flight of ideas MB25.2 Neologisms MB25.3 Thought blocking MB25.Y Other specified symptoms and signs of form of thought MB25.Z Symptoms and signs of form of thought, unspecified – MB25.00 Circumstantiality – MB25.01 Tangentiality – MB25.02 Disorganised thinking – MB25.03 Incoherence – MB25.0Y Other specified symptoms and signs of thought disorder – MB25.0Z Symptoms and signs of thought disorder, unspecified MB26 Symptoms or signs involving content of thought MB26.0 Delusion MB26.1 Experiences of influence, passivity, and control MB26.2 Grandiosity MB26.3 Homicidal ideation MB26.4 Identity disturbance MB26.5 Obsessions MB26.6 Overvalued ideas MB26.7 Paranoid ideation MB26.8 Referential thinking MB26.9 Suspiciousness MB26.A Suicidal ideation MB26.Y Other specified symptoms or signs involving content of thought MB26.Z Symptoms or signs involving content of thought, unspecified – MB26.00 Bizarre delusion – MB26.01 Delusion of being controlled – MB26.02 Delusion of guilt – MB26.03 Delusion of reference – MB26.04 Erotomanic delusion – MB26.05 Grandiose delusion – MB26.06 Jealous delusion – MB26.07 Persecutory delusion – MB26.08 Religious delusion – MB26.09 Somatic delusion – MB26.0A Nihilistic delusion – MB26.0B Misidentification delusion – MB26.0C Delusion of impoverishment – MB26.0Y Other specified delusion – MB26.0Z Delusion, unspecified – MB26.10 Thought broadcasting – MB26.11 Thought insertion – MB26.12 Thought withdrawal – MB26.1Y Other specified experiences of influence, passivity, and control – MB26.1Z Experiences of influence, passivity, and control, unspecified MB27 Symptoms or signs involving perceptual disturbance MB27.0 Depersonalisation MB27.1 Derealisation MB27.2 Hallucinations MB27.3 Disturbance of body image MB27.4 Illusions MB27.Y Other specified symptoms and signs of perceptual disturbance MB27.Z Symptoms and signs of perceptual disturbance, unspecified – MB27.20 Auditory hallucinations – MB27.21 Gustatory hallucinations – MB27.22 Hypnopompic hallucinations – MB27.23 Hypnagogic hallucinations – MB27.24 Olfactory hallucinations – MB27.25 Somatic hallucinations – MB27.26 Tactile hallucinations – MB27.27 Visual hallucinations – MB27.2Y Other specified hallucinations – MB27.2Z Hallucinations, unspecified MB28 Symptoms or signs related to personality features MB28.0 Attention seeking MB28.1 Callousness MB28.2 Eccentricity MB28.3 Entitlement MB28.4 Hostility MB28.5 Impulsivity MB28.6 Indecisiveness MB28.7 Irresponsibility MB28.8 Low frustration tolerance MB28.9 Low self-esteem MB28.A Negative affectivity MB28.B Negativism MB28.C Perfectionism MB28.D Pessimism MB28.E Recklessness MB28.F Sensation seeking MB28.G Stubbornness MB28.H Submissiveness MB28.Y Other specified symptoms and signs related to personality features MB28.Z Symptoms and signs related to personality features, unspecified MB29 Symptoms or signs involving eating and related behaviour MB29.0 Avoidant or restrictive eating MB29.1 Binge eating MB29.2 Eating of non-nutritive substances MB29.3 Purging behaviour MB29.4 Rumination-regurgitation MB29.Y Other specified symptoms and signs involving eating and related behaviour MB29.Z Symptoms and signs involving eating and related behaviour, unspecified MB2A Symptoms or signs involving elimination MB2A.0 Soiling MB2A.1 Wetting MB2A.Y Other specified symptoms and signs involving elimination MB2A.Z Symptoms and signs involving elimination, unspecified MB2Y Other specified mental or behavioural symptoms, signs or clinical findings MB40 Sensation disturbance – MB40.0 Asomatognosia – MB40.1 Allodynia – MB40.2 Anacusis – MB40.3 Anaesthesia of skin – MB40.4 Tingling fingers or feet or toes – MB40.5 Hyperaesthesia – MB40.6 Dysesthesia – MB40.7 Acroparaesthesia – MB40.8 Analgesia – MB40.9 Neurological neglect syndrome – MB40.Y Other specified sensation disturbance – MB40.Z Sensation disturbance, unspecified MB41 Disturbances of smell and taste – MB41.0 Anosmia – MB41.1 Parosmia – MB41.2 Dysgeusia – MB41.3 Hyposmia – MB41.Y Other specified disturbances of smell and taste – MB41.Z Disturbances of smell and taste, unspecified MB42 Phonophobia MB43 Dyssomnia MB44 Abnormalities of gait and mobility – MB44.0 Ataxic gait – MB44.1 Paralytic gait – MB44.2 Difficulty in walking – MB44.3 Immobility – MB44.Y Other specified abnormalities of gait and mobility – MB44.Z Abnormalities of gait and mobility, unspecified MB45 Lack of coordination – MB45.0 Ataxia, unspecified – MB45.1 Automatism – MB45.2 Atonia – MB45.3 Head drop – MB45.4 Intention tremor – MB45.Y Other specified lack of coordination – MB45.Z Lack of coordination, unspecified MB46 Abnormal involuntary movements – MB46.0 Asterixis – MB46.1 Abnormal head movements – MB46.2 Athetosis – MB46.3 Drop attack – MB46.4 Titubation – MB46.5 Shuddering – MB46.Y Other specified abnormal involuntary movements – MB46.Z Abnormal involuntary movements, unspecified MB47 Abnormality of tonus and reflex – MB47.0 Abnormal reflex – MB47.1 Abnormal posture – MB47.2 Clonus – MB47.3 Cramp or spasm – MB47.4 Dystonia – MB47.5 Fasciculation – MB47.6 Meningismus – MB47.7 Muscle fibrillation – MB47.8 Muscular hypertonia – MB47.9 Myotonia – MB47.A Ophthalmoparesis – MB47.B Opisthotonos – MB47.C Tendency to fall – MB47.D Tetany – MB47.Y Other specified abnormality of tonus and reflex – MB47.Z Abnormality of tonus and reflex, unspecified MB48 Dizziness and giddiness – MB48.0 Vertigo – MB48.1 Disorder of equilibrium – MB48.2 Exertional dizziness – MB48.3 Light-headedness – MB48.4 Presyncope – MB48.Y Other specified dizziness and giddiness – MB48.Z Dizziness and giddiness, unspecified –– MB48.00 Vertigo of central origin –– MB48.0Y Other specified vertigo –– MB48.0Z Vertigo, unspecified MB49 Aura MB4A Apraxia MB4B Symbolic dysfunctions – MB4B.0 Dyslexia and alexia – MB4B.1 Agnosia – MB4B.2 Acalculia – MB4B.3 Agraphia – MB4B.4 Anomia – MB4B.5 Dyscalculia – MB4B.Y Other specified symbolic dysfunctions – MB4B.Z Symbolic dysfunctions, unspecified MB4C Gerstmann syndrome MB4D Headache, not elsewhere classified – MB50 Tetraplegia –– MB50.0 Flaccid tetraplegia –– MB50.1 Spastic tetraplegia –– MB50.Z Tetraplegia, unspecified – MB51 Diplegia of upper extremities –– MB51.0 Flaccid diplegia of upper extremities –– MB51.1 Spastic diplegia of upper extremities –– MB51.Z Diplegia of upper extremities, unspecified – MB52 Diplegia of lower extremities – MB53 Hemiplegia –– MB53.0 Alternating hemiplegia –– MB53.1 Flaccid hemiplegia –– MB53.2 Spastic hemiplegia –– MB53.Z Hemiplegia, unspecified – MB54 Monoplegia of upper extremity –– MB54.0 Flaccid monoplegia of upper extremity –– MB54.1 Spastic monoplegia of upper extremity –– MB54.Z Monoplegia of upper extremity, unspecified – MB55 Monoplegia of lower extremity –– MB55.0 Flaccid monoplegia of lower extremity –– MB55.1 Spastic monoplegia of lower extremity –– MB55.Z Monoplegia of lower extremity, unspecified – MB56 Paraplegia – MB57 Functional level of injury of spinal cord –– MB57.0 Functional level of injury of cervical spinal cord –– MB57.1 Functional level of injury of thoracic spinal cord –– MB57.2 Functional level of injury of lumbar spinal cord –– MB57.3 Functional level of injury of spinal cord, sacrum –– MB57.Y Other specified functional level of injury of spinal cord –– MB57.Z Functional level of injury of spinal cord, unspecified – MB5Y Other specified paralytic symptoms – MB5Z Paralytic symptoms, unspecified MB60 Sleeptalking MB6Y Other specified symptoms or signs involving the nervous system MB70 Clinical findings in cerebrospinal fluid – MB70.0 Abnormal level of enzymes in cerebrospinal fluid – MB70.1 Abnormal level of hormones in cerebrospinal fluid – MB70.2 Abnormal level of drugs, medicaments and biological substances in cerebrospinal fluid – MB70.3 Abnormal level of substances chiefly nonmedicinal as to source in cerebrospinal fluid – MB70.4 Abnormal immunological findings in cerebrospinal fluid – MB70.5 Abnormal microbiological findings in cerebrospinal fluid – MB70.6 Abnormal cytological findings in cerebrospinal fluid – MB70.7 Abnormal histological findings in cerebrospinal fluid – MB70.8 Other abnormal findings in cerebrospinal fluid – MB70.Y Other specified clinical findings in cerebrospinal fluid – MB70.Z Clinical findings in cerebrospinal fluid, unspecified MB71 Clinical findings on diagnostic imaging of central nervous system – MB71.0 Intracranial space-occupying lesion – MB71.Y Other specified clinical findings on diagnostic imaging of central nervous system – MB71.Z Clinical findings on diagnostic imaging of central nervous system, unspecified MB72 Results of function studies of the nervous system MB7Y Other specified clinical findings in the nervous system MB9Y Other specified symptoms, signs or clinical findings of the nervous system MC10 Eye appearance abnormal MC11 Eye sensation abnormal MC12 Chronic enlargement of lacrimal gland MC13 Epiphora MC14 Eye discharge MC15 Red eye MC16 Pallor conjunctiva MC17 Icteric sclera MC18 Ocular pain MC19 Quadrantanopia MC1A Visual floaters MC1B Symptom or complaint of the eyelid MC1C Symptom or complaint of glasses MC1D Symptom or complaint of contact lens MC1Y Other specified symptoms or signs involving the visual system MC20 Clinical findings of the visual system MC20.0 Staphyloma MC20.1 Small drusen of the macula MC20.2 Hypopyon MC20.Y Other specified clinical findings of the visual system MC21 Impairment of electrophysiological functions MC21.0 Profound impairment of electrooculogram MC21.1 Normal electroretinogram MC21.Y Other specified impairment of electrophysiological functions MC21.Z Impairment of electrophysiological functions, unspecified MC2Y Other specified symptoms, signs or clinical findings of the visual system MC40 Plugged feeling ear MC41 Tinnitus MC4Y Other specified symptoms or signs involving the ear or mastoid process MC6Y Other specified symptoms, signs or clinical findings of ear or mastoid process MC80 Abnormal blood-pressure reading, without diagnosis – MC80.0 Elevated blood-pressure reading, without diagnosis of hypertension – MC80.1 Nonspecific low blood-pressure reading – MC80.Y Other specified abnormal blood-pressure reading, without diagnosis – MC80.Z Abnormal blood-pressure reading, without diagnosis, unspecified –– MC80.00 White coat hypertension –– MC80.01 Combined diastolic and systolic elevated blood pressure reading without diagnosis of hypertension –– MC80.02 Diastolic elevated blood pressure reading without diagnosis of hypertension –– MC80.03 Systolic elevated blood pressure reading without diagnosis of hypertension –– MC80.0Y Other specified elevated blood-pressure reading, without diagnosis of hypertension –– MC80.0Z Elevated blood-pressure reading, without diagnosis of hypertension, unspecified MC81 Abnormalities of heart beat – MC81.0 Tachycardia, unspecified – MC81.1 Bradycardia, unspecified – MC81.2 Palpitations – MC81.3 Paroxysmal tachycardia – MC81.4 Pulseless electrical activity, not elsewhere classified – MC81.Y Other specified abnormalities of heart beat – MC81.Z Abnormalities of heart beat, unspecified MC82 Cardiac arrest – MC82.0 Ventricular tachycardia and fibrillation cardiac arrest – MC82.1 Bradycardic cardiac arrest – MC82.2 Asystolic cardiac arrest – MC82.3 Cardiac arrest with pulseless electrical activity – MC82.4 Cardiopulmonary arrest – MC82.Z Cardiac arrest, unspecified MC83 Cardiac murmurs and other cardiac sounds – MC83.0 Benign and innocent cardiac murmurs – MC83.1 Other cardiac sounds – MC83.Z Cardiac murmurs and sounds, unspecified MC84 Cardiovascular pain MC85 Gangrene MC86 Precordial pain MC87 Pressure or tightness of heart MC88 Prominent veins MC8Y Other specified symptoms or signs involving the circulatory system MC90 Clinical findings on diagnostic imaging of heart or coronary circulation MC91 Results of function studies of the circulatory system MC9Y Other specified symptoms, signs or clinical findings of the circulatory system MD10 Abnormal sputum MD11 Abnormalities of breathing – MD11.0 Apnoea – MD11.1 Asphyxia – MD11.2 Ataxic breathing – MD11.3 Breath holding – MD11.4 Sleep related Cheyne-Stokes respiration – MD11.5 Dyspnoea – MD11.6 Hiccough – MD11.7 Hyperventilation – MD11.8 Mouth breathing – MD11.9 Nasal congestion – MD11.A Sneezing – MD11.B Stridor – MD11.C Wheezing – MD11.D Yawning – MD11.Y Other specified abnormalities of breathing – MD11.Z Abnormalities of breathing, unspecified –– MD11.80 Stertor –– MD11.8Y Other specified mouth breathing –– MD11.8Z Mouth breathing, unspecified MD12 Cough – MD20 Epistaxis – MD21 Haemorrhage from throat – MD22 Haemoptysis – MD23 Haemorrhage from other sites in respiratory passages – MD24 Acute idiopathic pulmonary haemorrhage in infants over 28 days of age – MD2Z Haemorrhage from respiratory passages, unspecified MD30 Pain in throat or chest – MD30.0 Chest pain on breathing – MD30.1 Other chest pain – MD30.Z Chest pain, unspecified MD31 Pleurisy MD32 Rales MD33 Respiratory arrest MD34 Symptom or complaint of the nose MD35 Symptom or complaint of the sinus MD36 Symptom or complaint of the throat – MD36.0 Pain in throat – MD36.Y Other specified symptom or complaint of the throat – MD36.Z Symptom or complaint of the throat, unspecified MD3Y Other specified symptoms or signs involving the respiratory system MD40 Clinical findings in specimens from respiratory organs and thorax – MD40.0 Abnormal level of enzymes in specimens from respiratory organs and thorax – MD40.1 Abnormal level of hormones in specimens from respiratory organs and thorax – MD40.2 Abnormal level of drugs, medicaments and biological substances in specimens from respiratory organs and thorax – MD40.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax – MD40.4 Abnormal immunological findings in specimens from respiratory organs and thorax – MD40.5 Abnormal microbiological findings in specimens from respiratory organs and thorax – MD40.6 Abnormal cytological findings in specimens from respiratory organs and thorax – MD40.7 Abnormal histological findings in specimens from respiratory organs and thorax – MD40.Y Other specified clinical findings in specimens from respiratory organs and thorax –– MD40.50 Positive culture from nose –– MD40.51 Positive sputum culture –– MD40.52 Positive throat culture –– MD40.5Y Other specified abnormal microbiological findings in specimens from respiratory organs and thorax –– MD40.5Z Abnormal microbiological findings in specimens from respiratory organs and thorax, unspecified MD41 Clinical findings on diagnostic imaging of lung MD42 Results of function studies of the respiratory system MD4Y Other specified clinical findings in the respiratory system MD6Y Other specified symptoms, signs or clinical findings of the respiratory system MD80 Symptoms or signs of the orofacial complex – MD80.0 Symptom or complaint of the teeth or gum – MD80.1 Symptom or complaint of the mouth, tongue or lip – MD80.Y Other specified symptoms or signs of the orofacial complex MD81 Abdominal or pelvic pain – MD81.0 Abdominal tenderness – MD81.1 Localised abdominal pain – MD81.2 Generalised abdominal pain – MD81.3 Acute abdomen – MD81.4 Other and unspecified abdominal pain –– MD81.10 Pain localised to upper abdomen –– MD81.11 Pelvic or perineal pain –– MD81.12 Pain localised to other parts of lower abdomen –– MD81.1Z Localised abdominal pain, unspecified MD82 Intra-abdominal or pelvic swelling, mass or lump – MD90 Nausea or vomiting –– MD90.0 Nausea –– MD90.1 Vomiting – MD91 Belching – MD92 Dyspepsia – MD93 Dysphagia – MD94 Halitosis – MD95 Heartburn – MD9Y Other specified symptoms related to the upper gastrointestinal tract – ME00 Abdominal compartment syndrome – ME01 Abdominal distension – ME02 Abdominal rigidity – ME03 Abnormal bowel sounds –– ME03.0 Hyperactive bowel sounds –– ME03.1 Absent bowel sounds –– ME03.Z Abnormal bowel sounds, unspecified – ME04 Ascites –– ME04.0 Fluid in peritoneal cavity –– ME04.Y Other specified ascites –– ME04.Z Ascites, unspecified – ME05 Change in bowel habit –– ME05.0 Constipation –– ME05.1 Diarrhoea –– ME05.Z Other and unspecified change in bowel habit – ME06 Chronic enteritis of uncertain aetiology – ME07 Faecal incontinence –– ME07.0 Faecal smearing –– ME07.1 Incomplete defaecation –– ME07.2 Faecal urgency –– ME07.Y Other specified faecal incontinence –– ME07.Z Faecal incontinence, unspecified – ME08 Flatulence and related conditions – ME09 Rectal tenesmus – ME0A Visible peristalsis – ME0B Problems with defaecation, not otherwise specified – ME0Y Other specified symptoms related to the lower gastrointestinal tract or abdomen ME10 Abnormalities related to hepatobiliary system – ME10.0 Hepatomegaly or splenomegaly – ME10.1 Unspecified jaundice –– ME10.00 Hepatomegaly, not elsewhere classified –– ME10.01 Splenomegaly, not elsewhere classified –– ME10.02 Hepatomegaly with splenomegaly ME1Y Other specified symptoms or signs involving the digestive system or abdomen ME20 Clinical findings in specimens from digestive organs or abdominal cavity – ME20.0 Abnormal level of enzymes in specimens from digestive organs or abdominal cavity – ME20.1 Abnormal level of hormones in specimens from digestive organs or abdominal cavity – ME20.2 Abnormal level of drugs, medicaments or biological substances in specimens from digestive organs of abdominal cavity – ME20.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity – ME20.4 Abnormal immunological findings in specimens from digestive organs and abdominal cavity – ME20.5 Abnormal microbiological findings in specimens from digestive organs and abdominal cavity – ME20.6 Abnormal cytological findings in specimens from digestive organs and abdominal cavity – ME20.7 Abnormal histological findings in specimens from digestive organs and abdominal cavity – ME20.Y Other specified clinical findings in specimens from digestive organs or abdominal cavity – ME20.Z Clinical findings in specimens from digestive organs or abdominal cavity, unspecified ME21 Clinical findings on diagnostic imaging of liver or biliary tract ME22 Clinical findings on diagnostic imaging of digestive tract ME23 Results of function studies of the digestive system ME24 Clinical manifestations of the digestive system – ME24.0 Digestive system abscess – ME24.1 Digestive system fistula – ME24.2 Digestive system obstruction – ME24.3 Digestive system perforation – ME24.4 Digestive system stenosis – ME24.5 Digestive system ulcer – ME24.6 Digestive system dilatation – ME24.7 Digestive system incarceration – ME24.8 Digestive system strangulation or gangrene – ME24.9 Gastrointestinal bleeding – ME24.A Other digestive system haemorrhage, not elsewhere classified – ME24.Y Other specified clinical manifestations of the digestive system –– ME24.30 Perforation of small intestine –– ME24.31 Perforation of large intestine –– ME24.35 Perforation of gallbladder or bile ducts –– ME24.3Y Digestive system perforation of other specified site –– ME24.3Z Digestive system perforation of unspecified site –– ME24.90 Acute gastrointestinal bleeding, not elsewhere classified –– ME24.91 Chronic gastrointestinal bleeding, not elsewhere classified –– ME24.9Z Gastrointestinal bleeding, unspecified –– ME24.A0 Obscure gastrointestinal bleeding –– ME24.A1 Haemorrhage of anus and rectum –– ME24.A2 Oesophageal haemorrhage –– ME24.A3 Haematochezia –– ME24.A4 Melaena –– ME24.A5 Haematemesis –– ME24.A6 Positive occult blood in stool ME2Y Other specified clinical findings in the digestive system ME4Y Other specified symptoms, signs or clinical findings of the digestive system or abdomen ME60 Skin lesion of uncertain or unspecified nature – ME60.0 Skin lesion of uncertain nature – ME60.1 Pigmented skin lesion of uncertain nature – ME60.2 Ulcer of skin of uncertain nature – ME60.3 Keratosis of skin of uncertain or unspecified nature – ME60.Z Skin lesion of unspecified nature ME61 Subcutaneous swelling, mass or lump of uncertain or unspecified nature ME62 Acute skin eruption of uncertain or unspecified nature – ME62.0 Acute erythematous skin eruption – ME62.1 Acute purpuric skin eruption – ME62.2 Acute urticarial skin eruption – ME62.3 Acute maculopapular skin eruption – ME62.4 Acute papular skin eruption – ME62.5 Acute exudative skin eruption – ME62.6 Acute blistering skin eruption – ME62.7 Acute desquamating skin eruption – ME62.8 Acute discoid or annular skin eruption – ME62.9 Acute excoriation of skin – ME62.Y Other specified acute skin eruption of uncertain or unspecified nature ME63 Chronic skin disorder of uncertain or unspecified nature – ME63.0 Chronic erythematous skin disorder – ME63.1 Chronic urticarial skin disorder – ME63.2 Chronic papular skin disorder – ME63.3 Chronic blistering skin disorder – ME63.4 Chronic scaling or hyperkeratotic skin disorder – ME63.5 Chronic lichenified skin disorder – ME63.6 Chronic discoid or annular skin disorder – ME63.7 Chronic excoriation of skin ME64 Non-specific cutaneous vascular signs – ME64.0 Erythema – ME64.1 Cyanosis – ME64.2 Pallor – ME64.3 Petechiae – ME64.4 Flushing ME65 Disturbances of skin sensation of unspecified aetiology – ME65.0 Burning of skin – ME65.1 Itching of skin – ME65.2 Pain or tenderness of skin – ME65.3 Stinging of skin – ME65.4 Tingling of skin – ME65.Y Other specified disturbance of skin sensation ME66 Miscellaneous non-specific skin-related symptoms and signs – ME66.0 Abnormal sensitivity to light or UV radiation of uncertain or unspecified nature – ME66.1 Changes in skin texture – ME66.2 Excess and redundant skin – ME66.3 Symptom or complaint relating to hair or scalp – ME66.4 Symptom or complaint relating to nails – ME66.5 Complaint of abnormal sweating – ME66.6 Rash – ME66.Y Other specified skin changes –– ME66.60 Rash localised –– ME66.61 Rash generalised –– ME66.6Y Other specified rash –– ME66.6Z Rash, unspecified ME67 Skin disorder of uncertain or unspecified nature ME6Y Other specified symptoms or signs involving the skin ME80 Clicking hip ME81 Musculoskeletal chest pain – ME81.0 Intercostal pain – ME81.Y Other specified musculoskeletal chest pain – ME81.Z Musculoskeletal chest pain, unspecified ME82 Pain in joint ME83 Rheumatism, unspecified ME84 Spinal pain – ME84.0 Cervical spine pain – ME84.1 Thoracic spine pain – ME84.2 Low back pain – ME84.3 Sciatica – ME84.Z Spinal pain, unspecified –– ME84.20 Lumbago with sciatica –– ME84.2Y Other specified low back pain –– ME84.2Z Low back pain, unspecified ME85 Stiffness of joint ME86 Symptom or complaint of a body part – ME86.0 Symptom or complaint of the ankle – ME86.1 Symptom or complaint of the arm – ME86.2 Symptom or complaint of the back – ME86.3 Symptom or complaint of the chest – ME86.4 Symptom or complaint of the elbow – ME86.5 Symptom or complaint of the flank or axilla – ME86.6 Symptom or complaint of the foot or toe – ME86.7 Symptom or complaint of the hand or finger – ME86.8 Symptom or complaint of the hip – ME86.9 Symptom or complaint of the jaw – ME86.A Symptom or complaint of the knee – ME86.B Symptom or complaint of the leg or thigh – ME86.C Symptom or complaint of the neck – ME86.D Symptom or complaint of the shoulder – ME86.E Symptom or complaint of the wrist – ME86.F Symptom or complaint of joint, not otherwise specified – ME86.G Symptom or complaint of muscle, not otherwise specified – ME86.Y Problem of other specified body part – ME86.Z Problem of unspecified body part –– ME86.20 Back syndrome without radiating pain –– ME86.21 Back syndrome with radiating pain –– ME86.22 Symptom or complaint of the low back –– ME86.2Y Other specified symptom or complaint of the back –– ME86.2Z Symptom or complaint of the back, unspecified –– ME86.D0 Shoulder syndrome –– ME86.DY Other specified symptom or complaint of the shoulder –– ME86.DZ Symptom or complaint of the shoulder, unspecified ME8Y Other specified symptoms or signs of the musculoskeletal system ME90 Clinical findings on diagnostic imaging of skull and head ME91 Clinical findings on diagnostic imaging of limbs ME92 Clinical findings on diagnostic imaging of other parts of musculoskeletal system – ME92.0 Wedging of vertebra – ME92.1 Bony erosion – ME92.Y Other specified clinical findings on diagnostic imaging of other parts of musculoskeletal system – ME92.Z Clinical findings on diagnostic imaging of other parts of musculoskeletal system, unspecified ME93 Biomechanical lesions, not elsewhere classified – ME93.0 Segmental and somatic dysfunction – ME93.1 Subluxation stenosis of neural canal – ME93.2 Osseous stenosis of neural canal – ME93.3 Connective tissue stenosis of neural canal – ME93.4 Intervertebral disc stenosis of neural canal – ME93.5 Osseous and subluxation stenosis of intervertebral foramina – ME93.6 Connective tissue and disc stenosis of intervertebral foramina – ME93.Y Other specified biomechanical lesions, not elsewhere classified – ME93.Z Biomechanical lesions, unspecified –– ME93.40 Intervertebral disc stenosis of neural canal, head region –– ME93.41 Intervertebral disc stenosis of neural canal, cervical region –– ME93.42 Intervertebral disc stenosis of neural canal, thoracic region –– ME93.43 Intervertebral disc stenosis of neural canal, lumbar region –– ME93.44 Intervertebral disc stenosis of neural canal, sacral region –– ME93.45 Intervertebral disc stenosis of neural canal, pelvic region –– ME93.46 Intervertebral disc stenosis of neural canal, lower extremity –– ME93.47 Intervertebral disc stenosis of neural canal, upper extremity –– ME93.48 Intervertebral disc stenosis of neural canal, rib cage –– ME93.4Y Other specified intervertebral disc stenosis of neural canal –– ME93.4Z Intervertebral disc stenosis of neural canal, unspecified ME9Y Other specified clinical findings in the musculoskeletal system MF1Y Other specified symptoms, signs or clinical findings of the musculoskeletal system MF30 Breast lump or mass female MF31 Breast or lactation symptom or complaint MF32 Menopausal symptom or complaint MF33 Premenstrual symptom or complaint MF34 Pregnancy symptom or complaint MF35 Postpartum symptom or complaint MF36 Other symptom or complaint of vagina MF37 Symptom or complaint of female nipple MF38 Symptom or complaint of female pelvis MF39 Symptom or complaint of the vulva MF3A Vaginal discharge MF3Y Other specified symptoms, signs or clinical findings involving the female genital system MF40 Problems of male genital organs – MF40.0 Symptom or complaint of the penis – MF40.1 Problems of the prostate – MF40.2 Symptom or complaint of the scrotum or testis – MF40.3 Retrograde ejaculation – MF40.Y Other specified problems of male genital organs – MF40.Z Problems of male genital organs, unspecified –– MF40.00 Pain in penis –– MF40.0Y Other specified symptom or complaint of the penis –– MF40.0Z Symptom or complaint of the penis, unspecified –– MF40.20 Acute scrotal pain –– MF40.21 Testicular pain –– MF40.2Y Other specified symptom or complaint of the scrotum or testis –– MF40.2Z Symptom or complaint of the scrotum or testis, unspecified MF41 Symptom or complaint of male sexual function MF42 Retractile testis migrans MF4Y Other specified symptoms, signs or clinical findings involving the male genital system MF50 Abnormal micturition – MF50.0 Frequent micturition – MF50.1 Pollakiuria – MF50.2 Urinary incontinence – MF50.3 Retention of urine – MF50.4 Haematuria – MF50.5 Extravasation of urine – MF50.6 Other difficulties with micturition – MF50.7 Dysuria – MF50.8 Vesical tenesmus – MF50.Y Other specified abnormal micturition – MF50.Z Abnormal micturition, unspecified –– MF50.20 Stress incontinence –– MF50.21 Urge Incontinence –– MF50.22 Mixed incontinence –– MF50.23 Functional urinary incontinence –– MF50.24 Reflex incontinence –– MF50.2Y Other specified urinary incontinence –– MF50.2Z Urinary incontinence, unspecified –– MF50.40 Macroscopic haematuria –– MF50.41 Microscopic haematuria –– MF50.4Z Haematuria, unspecified –– MF50.60 Hesitancy of micturition –– MF50.61 Poor urinary stream –– MF50.62 Splitting of urinary stream –– MF50.63 Urgency of urination –– MF50.64 Feeling of incomplete bladder emptying –– MF50.65 Straining to void –– MF50.6Y Other specified difficulties with micturition –– MF50.6Z Difficulties with micturition, unspecified MF51 Anuria or oliguria MF52 Bladder pain MF53 Extrarenal uraemia MF54 Macroscopic changes of size of the kidney – MF54.0 Smooth contracted kidney – MF54.1 Irregularly contracted kidney – MF54.2 Small kidney – MF54.Y Other specified macroscopic changes of size of the kidney – MF54.Z Macroscopic changes of size of the kidney, unspecified MF55 Polyuria MF56 Renal colic MF57 Symptom or complaint of bladder MF58 Urethral discharge MF59 Urinary symptom or complaint MF5Y Other specified symptoms, signs or clinical findings involving the urinary system MF60 Abnormal level of enzymes in specimens from female genital organs MF61 Abnormal level of hormones in specimens from female genital organs MF62 Abnormal level of drugs, medicaments and biological substances in specimens from female genital organs MF63 Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs MF64 Abnormal immunological findings in specimens from female genital organs MF65 Abnormal microbiological findings in specimens from female genital organs MF66 Abnormal cytological findings in specimens from female genital organs – MF66.0 Abnormal cervix smear – MF66.Y Other specified abnormal cytological findings in specimens from female genital organs – MF66.Z Abnormal cytological findings in specimens from female genital organs, unspecified MF67 Abnormal histological findings in specimens from female genital organs MF68 Abnormal chromosomal findings in specimens from female genital organs MF6Y Other specified clinical findings in specimens from female genital organs MF6Z Clinical findings in specimens from female genital organs, unspecified MF70 Abnormal level of enzymes in specimens from male genital organs MF71 Abnormal level of hormones in specimens from male genital organs MF72 Abnormal level of drugs, medicaments and biological substances in specimens from male genital organs MF73 Abnormal level of substances chiefly nonmedicinal as to source in specimens from male genital organs MF74 Abnormal immunological findings in specimens from male genital organs MF75 Abnormal microbiological findings in specimens from male genital organs MF76 Abnormal cytological findings in specimens from male genital organs MF77 Abnormal histological findings in specimens from male genital organs MF78 Abnormal chromosomal findings in specimens from male genital organs MF7Y Other specified clinical findings in specimens from male genital organs MF7Z Clinical findings in specimens from male genital organs, unspecified MF80 Diffuse mesangial sclerosis MF81 Fibronectin glomerulopathy MF82 Lipoprotein glomerulopathy MF83 Diabetic glomerular changes MF84 Pauci-immune proliferative glomerulonephritis MF85 Anti-glomerular basement membrane antibody mediated disease MF8Y Other specified clinical findings in specimens from the urinary system MF8Z Clinical findings in specimens from the urinary system, unspecified MF90 Acetonuria MF91 Bilirubinuria MF92 Chyluria MF93 Glycosuria MF94 Haemoglobinuria MF95 Myoglobinuria MF96 Proteinuria – MF96.0 Orthostatic proteinuria – MF96.1 Bence Jones proteinuria – MF96.Y Other specified proteinuria – MF96.Z Proteinuria, unspecified MF97 Pyuria MF98 Abnormal levels of serum electrolytes in the urine – MF98.0 Hypercalciuria – MF98.1 Hyperkaluria – MF98.2 Hypermagnesuria – MF98.3 Hypocalciuria – MF98.4 Hypokaluria – MF98.5 Hypomagnesuria – MF98.6 Hypophosphaturia – MF98.Y Other specified abnormal levels of serum electrolytes in the urine – MF98.Z Abnormal levels of serum electrolytes in the urine, unspecified MF99 Elevated urine levels of drugs, medicaments and biological substances MF9A Abnormal urine levels of substances chiefly nonmedicinal as to source MF9B Abnormal findings on microbiological examination of urine MF9C Abnormal findings on cytological and histological examination of urine MF9Y Other specified clinical findings on examination of urine, without diagnosis MG00 Clinical findings on diagnostic imaging of breast MG01 Clinical findings on diagnostic imaging of urinary organs MG02 Results of kidney function studies MG0Y Other specified symptoms, signs or clinical findings of the genitourinary system MG20 Cachexia – MG20.0 Malignant cachexia – MG20.Z Cachexia, unspecified MG21 Chills MG22 Fatigue MG23 Fear of death or dying MG24 Fear of disease – MG24.0 Fear of cancer – MG24.1 Fear of human immunodeficiency virus – MG24.2 Fear of haematological disease – MG24.3 Fear of digestive disease – MG24.4 Fear of eye disease – MG24.5 Fear of heart disease – MG24.6 Fear of hypertension – MG24.7 Fear of cardiovascular disease – MG24.8 Fear of musculoskeletal disease – MG24.9 Fear of neurological disease – MG24.A Fear of respiratory disease – MG24.B Fear of endocrine, metabolic or nutritional disease – MG24.C Fear of urinary disease – MG24.D Fear of complications of pregnancy – MG24.E Fear of sexually transmitted disease female – MG24.F Fear of female genital or breast disease – MG24.G Fear of sexually transmitted disease male – MG24.H Fear of genital disease male – MG24.J Fear of mental disorder – MG24.Y Fear of other specified disease – MG24.Z Fear of disease, unspecified –– MG24.00 Fear of cancer of digestive system –– MG24.01 Fear of breast cancer female –– MG24.02 Fear of genital cancer male –– MG24.0Y Other specified fear of cancer –– MG24.0Z Fear of cancer, unspecified MG25 Feeling ill MG26 Fever of other or unknown origin MG27 Haemorrhage, not elsewhere classified MG28 Hypothermia, not associated with low environmental temperature MG29 Oedema – MG29.0 Localised oedema – MG29.1 Generalised oedema – MG29.2 Infectious oedema – MG29.3 Pitting oedema – MG29.Z Oedema, unspecified –– MG29.00 Ankle oedema –– MG29.01 Oedema of legs –– MG29.02 Pitting of lip –– MG29.0Y Other specified localised oedema –– MG29.10 Oedema due to increased capillary pressure –– MG29.1Y Other specified generalised oedema MG2A Ageing associated decline in intrinsic capacity – MG30 Chronic pain –– MG30.0 Chronic primary pain –– MG30.1 Chronic cancer related pain –– MG30.2 Chronic postsurgical or post traumatic pain –– MG30.3 Chronic secondary musculoskeletal pain –– MG30.4 Chronic secondary visceral pain –– MG30.5 Chronic neuropathic pain –– MG30.6 Chronic secondary headache or orofacial pain –– MG30.Y Other specified chronic pain –– MG30.Z Chronic pain, unspecified ––– MG30.00 Chronic primary visceral pain ––– MG30.01 Chronic widespread pain ––– MG30.02 Chronic primary musculoskeletal pain ––– MG30.03 Chronic primary headache or orofacial pain ––– MG30.04 Complex regional pain syndrome ––– MG30.0Y Other specified chronic primary pain ––– MG30.0Z Chronic primary pain, unspecified ––– MG30.10 Chronic cancer pain ––– MG30.11 Chronic post cancer treatment pain ––– MG30.1Y Other specified chronic cancer related pain ––– MG30.1Z Chronic cancer related pain, unspecified ––– MG30.20 Chronic post traumatic pain ––– MG30.21 Chronic postsurgical pain ––– MG30.2Y Other specified chronic postsurgical or post traumatic pain ––– MG30.2Z Chronic postsurgical or post traumatic pain, unspecified ––– MG30.30 Chronic secondary musculoskeletal pain from persistent inflammation ––– MG30.31 Chronic secondary musculoskeletal pain associated with structural changes ––– MG30.32 Chronic secondary musculoskeletal pain due to disease of the nervous system ––– MG30.3Y Other specified chronic secondary musculoskeletal pain ––– MG30.3Z Chronic secondary musculoskeletal pain, unspecified ––– MG30.40 Chronic visceral pain from mechanical factors ––– MG30.41 Chronic visceral pain from vascular mechanisms ––– MG30.42 Chronic visceral pain from persistent inflammation ––– MG30.4Y Other specified chronic secondary visceral pain ––– MG30.4Z Chronic secondary visceral pain, unspecified ––– MG30.50 Chronic central neuropathic pain ––– MG30.51 Chronic peripheral neuropathic pain ––– MG30.5Y Other specified chronic neuropathic pain ––– MG30.5Z Chronic neuropathic pain, unspecified ––– MG30.61 Chronic dental pain ––– MG30.62 Chronic neuropathic orofacial pain ––– MG30.63 Headache or orofacial pain associated with chronic secondary temporomandibular disorders ––– MG30.64 Chronic headache or orofacial pain associated with disorders of homoeostasis or their nonpharmacological treatment ––– MG30.65 Chronic headache or orofacial pain associated with cranial or cervical vascular disorder ––– MG30.66 Chronic headache or orofacial pain associated with non-vascular intracranial disorder ––– MG30.67 Chronic headache associated with a substance or its withdrawal ––– MG30.6Y Other specified chronic secondary headache or orofacial pain ––– MG30.6Z Chronic secondary headache or orofacial pain, unspecified – MG31 Acute pain –– MG31.0 Acute pain in the face, not elsewhere classified –– MG31.1 Acute headache, not elsewhere classified –– MG31.2 Acute postoperative pain, not elsewhere classified –– MG31.Y Other specified acute pain –– MG31.Z Acute pain, unspecified – MG3Z Pain, unspecified MG40 Shock – MG40.0 Cardiogenic shock – MG40.1 Hypovolaemic shock – MG40.Y Other specified shock – MG40.Z Shock, unspecified MG41 Sleep disturbance, not elsewhere classified MG42 Somnolence, not elsewhere classified MG43 Symptoms and signs concerning food and fluid intake – MG43.0 Polydipsia – MG43.1 Overeating – MG43.2 Abulia – MG43.3 Feeding difficulties – MG43.4 Insufficient intake of food and water due to self neglect – MG43.5 Excessive weight loss – MG43.6 Excessive weight gain – MG43.7 Anorexia – MG43.8 Decreased appetite – MG43.9 Increased appetite – MG43.Y Other specified symptoms and signs concerning food and fluid intake –– MG43.30 Feeding problem of infant –– MG43.31 Feeding problem of child –– MG43.32 Feeding problem of adult –– MG43.3Z Feeding difficulties, unspecified –– MG43.40 Refusal of food, not elsewhere classified –– MG43.41 Refusal of fluid, not elsewhere classified –– MG43.4Y Other specified insufficient intake of food and water due to self neglect –– MG43.4Z Insufficient intake of food and water due to self neglect, unspecified MG44 Symptoms peculiar to infancy – MG44.0 Excessive crying of infant – MG44.1 Lack of expected normal physiological development – MG44.Y Other specified symptoms peculiar to infancy – MG44.Z Symptoms peculiar to infancy, unspecified –– MG44.10 Delayed milestone –– MG44.11 Failure to thrive in infant or child –– MG44.12 Short stature of child –– MG44.13 Constitutional delay of growth and puberty –– MG44.14 Familial short stature –– MG44.1Y Other specified lack of expected normal physiological development –– MG44.1Z Lack of expected normal physiological development, unspecified MG45 Syncope and collapse – MG45.0 Cardiac syncope – MG45.Y Other specified syncope and collapse – MG45.Z Syncope and collapse, unspecified MG46 Systemic inflammatory response syndrome of noninfectious origin MG47 Toxicosis not further specified MG48 Unknown and unspecified causes of morbidity MG49 Hangover MG4A Multi organ failure MG4Y Other specified general symptoms MG50 Finding of gram negative bacteria resistant to antimicrobial drugs – MG50.0 Antibiotic resistant Acinetobacter baumannii – MG50.1 Antibiotic resistant Campylobacter – MG50.2 Antibiotic resistant Escherichia coli – MG50.3 Antibiotic resistant Haemophilus influenzae – MG50.4 Antibiotic resistant Helicobacter pylori – MG50.5 Antibiotic resistant Klebsiella pneumoniae – MG50.6 Antibiotic resistant Neisseria gonorrhoeae – MG50.7 Antibiotic resistant Neisseria meningitidis – MG50.8 Antibiotic resistant Pseudomonas aeruginosa – MG50.9 Antibiotic resistant Salmonella – MG50.A Antibiotic resistant Shigella – MG50.B Antibiotic resistant Vibrio – MG50.C Other antibiotic resistant Enterobacterales – MG50.Y Other specified finding of gram negative bacteria resistant to antimicrobial drugs – MG50.Z Finding of gram negative bacteria resistant to antimicrobial drugs, unspecified –– MG50.00 Tetracycline resistant Acinetobacter baumannii –– MG50.01 Aminoglycoside resistant Acinetobacter baumannii –– MG50.02 Carbapenem resistant Acinetobacter baumannii –– MG50.03 Polymyxin resistant Acinetobacter baumannii –– MG50.0Y Acinetobacter resistant to other antibiotic –– MG50.0Z Acinetobacter resistant to unspecified antibiotic –– MG50.10 Fluoroquinolone resistant Campylobacter –– MG50.1Y Other specified antibiotic resistant Campylobacter –– MG50.1Z Campylobacter resistant to unspecified antibiotic –– MG50.20 Sulfonamide or trimethoprim resistant Escherichia coli –– MG50.21 Fluoroquinolone resistant Escherichia coli –– MG50.22 Third generation cephalosporin resistant Escherichia coli –– MG50.23 Fourth-generation cephalosporins resistant Escherichia coli –– MG50.24 Carbapenem resistant Escherichia coli –– MG50.25 Polymyxin resistant Escherichia coli –– MG50.26 Penicillin resistant Escherichia coli –– MG50.27 Extended spectrum beta-lactamase producing Escherichia coli –– MG50.2Y Escherichia coli resistant to other antibiotic –– MG50.2Z Escherichia coli resistant to unspecified antibiotic –– MG50.30 Ampicillin resistant Haemophilus influenzae –– MG50.3Y Other specified antibiotic resistant Haemophilus influenzae –– MG50.3Z Antibiotic resistant Haemophilus influenzae, unspecified –– MG50.40 Clarithromycin resistant Helicobacter pylori –– MG50.4Y Other specified antibiotic resistant Helicobacter pylori –– MG50.4Z Antibiotic resistant Helicobacter pylori, unspecified –– MG50.50 Sulfonamide or trimethoprim resistant Klebsiella pneumoniae –– MG50.51 Fluoroquinolone resistant Klebsiella pneumoniae –– MG50.52 Third-generation cephalosporin resistant Klebsiella pneumoniae –– MG50.53 Fourth-generation cephalosporin resistant Klebsiella pneumoniae –– MG50.54 Carbapenem resistant Klebsiella pneumoniae –– MG50.55 Polymyxin resistant Klebsiella pneumoniae –– MG50.56 Extended-spectrum beta-lactamase producing Klebsiella pneumoniae –– MG50.5Y Klebsiella pneumoniae resistant to other antibiotic –– MG50.5Z Klebsiella pneumoniae resistant to unspecified antibiotic –– MG50.60 Third generation cephalosporin resistant Neisseria gonorrhoeae –– MG50.61 Macrolide resistant Neisseria gonorrhoeae –– MG50.62 Aminocyclitol resistant Neisseria gonorrhoeae –– MG50.63 Fluoroquinolone resistant Neisseria gonorrhoeae –– MG50.64 Aminoglycoside resistant Neisseria gonorrhoeae –– MG50.6Y Neisseria gonorrhoeae resistant to other antibiotic –– MG50.6Z Neisseria gonorrhoeae resistant to unspecified antibiotic –– MG50.70 Penicillin resistant Neisseria meningitidis –– MG50.7Y Other specified antibiotic resistant Neisseria meningitidis –– MG50.7Z Antibiotic resistant Neisseria meningitidis, unspecified –– MG50.80 Carbapenem-resistant Pseudomonas aeruginosa –– MG50.81 Polymyxin-resistant Pseudomonas aeruginosa –– MG50.8Y Pseudomonas aeruginosa resistant to other antibiotic –– MG50.8Z Pseudomonas aeruginosa resistant to unspecified antibiotic –– MG50.90 Fluoroquinolone resistant Salmonella –– MG50.91 Third generation cephalosporin resistant Salmonella –– MG50.92 Carbapenem resistant Salmonella –– MG50.9Y Salmonella resistant to other antibiotic –– MG50.9Z Salmonella resistant to unspecified antibiotic –– MG50.A0 Carbapenem resistant Shigella –– MG50.A1 Fluoroquinolone resistant Shigella –– MG50.A2 Third-generation cephalosporins resistant Shigella –– MG50.A3 Macrolides resistant Shigella –– MG50.AY Shigella resistant to other antibiotic –– MG50.AZ Shigella resistant to unspecified antibiotic –– MG50.B0 Fluoroquinolone resistant Vibrio –– MG50.BY Vibrio resistant to other antibiotic –– MG50.BZ Vibrio resistant to unspecified antibiotic –– MG50.C0 Other carbapenem resistant Enterobacterales –– MG50.C1 Other third-generation cephalosporin resistant Enterobacterales –– MG50.CY Other specified other antibiotic resistant Enterobacterales –– MG50.CZ Other antibiotic resistant Enterobacterales, unspecified MG51 Finding of gram positive bacteria resistant to antimicrobial drugs – MG51.0 Antibiotic resistant Staphylococcus aureus – MG51.1 Antibiotic resistant Streptococcus pneumoniae – MG51.2 Antibiotic resistant Enterococcus – MG51.Y Other specified finding of gram positive bacteria resistant to antimicrobial drugs – MG51.Z Finding of gram positive bacteria resistant to antimicrobial drugs, unspecified –– MG51.00 Methicillin resistant Staphylococcus aureus –– MG51.01 Vancomycin resistant Staphylococcus aureus –– MG51.02 Penicillinase-stable beta lactams resistant Staphylococcus aureus –– MG51.0Y Other specified antibiotic resistant Staphylococcus aureus –– MG51.0Z Antibiotic resistant Staphylococcus aureus, unspecified –– MG51.10 Penicillin resistant Streptococcus pneumoniae –– MG51.11 Sulfonamide and trimethoprim resistant Streptococcus pneumoniae –– MG51.12 Third-generation cephalosporins resistant Streptococcus pneumoniae –– MG51.1Y Streptococcus pneumoniae resistant to other antibiotic –– MG51.1Z Streptococcus pneumoniae resistant to unspecified antibiotic –– MG51.20 Vancomycin resistant Enterococcus –– MG51.2Y Enterococcus resistant to other antibiotic –– MG51.2Z Enteroccus resistant to unspecified antibiotic MG52 Finding of bacteria, neither gram negative nor positive, resistant to antimicrobial drugs – MG52.0 Antibiotic resistant Mycobacterium – MG52.Y Other specified finding of bacteria, neither gram negative nor positive, resistant to antimicrobial drugs – MG52.Z Finding of bacteria, neither gram negative nor positive, resistant to antimicrobial drugs, unspecified –– MG52.00 Multi-drug resistant Mycobacterium tuberculosis –– MG52.01 Antibiotic resistant non-tuberculous Mycobacterium –– MG52.02 Extensively drug-resistant mycobacterium tuberculosis –– MG52.0Y Other specified antibiotic resistant Mycobacterium –– MG52.0Z Antibiotic resistant Mycobacterium, unspecified MG53 Finding of virus resistant to antimicrobial drugs – MG53.0 Antiretroviral therapy resistant Human immunodeficiency virus – MG53.Y Other specified finding of virus resistant to antimicrobial drugs – MG53.Z Finding of virus resistant to antimicrobial drugs, unspecified MG54 Finding of fungus resistant to antimicrobial drugs MG55 Finding of parasite resistant to antimicrobial drugs – MG55.0 Artemisinin resistant Plasmodium falciparum – MG55.Y Other specified finding of parasite resistant to antimicrobial drugs – MG55.Z Finding of parasite resistant to antimicrobial drugs, unspecified MG56 Finding of microorganism resistant to other multiple antimicrobial drugs MG5Y Finding of other microorganism resistant to antimicrobial drugs MG5Z Finding of microorganism resistant to antimicrobial drugs, unspecified MG60 Abnormal level of enzymes in specimens from other organs, systems and tissues MG61 Abnormal level of hormones in specimens from other organs, systems and tissues MG62 Abnormal level of drugs, medicaments and biological substances in specimens from other organs, systems and tissues MG63 Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues MG64 Abnormal immunological findings in specimens from other organs, systems and tissues MG65 Abnormal microbiological findings in specimens from other organs, systems and tissues MG66 Abnormal cytological findings in specimens from other organs, systems and tissues MG67 Abnormal histological findings in specimens from other organs, systems and tissues MG6Y Other specified clinical findings in specimens from other specified organs, systems and tissues MG70 Abnormal diagnostic imaging results not elsewhere classified MG71 Abnormal laboratory results, not elsewhere classified – MG71.0 Abnormal findings on neonatal screening – MG71.Y Other specified abnormal laboratory results, not elsewhere classified – MG71.Z Abnormal laboratory results, not elsewhere classified, unspecified MG72 Abnormal results of function studies of other organs and systems MG7Y Other specified abnormal results, not elsewhere classified MG7Z Abnormal results, not elsewhere classified, unspecified MG9Y Other specified general symptoms, signs or clinical findings MH10 Brain death MH11 Sudden infant death syndrome MH11.0 Sudden infant death syndrome with mention of autopsy MH11.1 Sudden infant death syndrome without autopsy MH11.Z Sudden infant death syndrome, unspecified MH12 Other sudden death, cause unknown MH12.0 Instantaneous death MH12.1 Death occurring less than 24 hours from onset of symptoms, not otherwise explained MH12.Y Other specified sudden death, cause unknown MH13 Unattended death MH14 Other ill-defined and unspecified causes of mortality MH15 Sudden unexpected death in epilepsy MH2Y Other specified symptoms, signs or clinical findings, not elsewhere classified NA00 Superficial injury of head NA00.0 Superficial injury of scalp NA00.1 Superficial injury of eyelid or periocular area NA00.2 Superficial injury of ear NA00.3 Superficial injury of nose NA00.4 Superficial injury of lip or oral cavity NA00.5 Multiple superficial injuries of head NA00.6 Abrasion of other or unspecified sites of head NA00.7 Contusion of other or unspecified sites of head NA00.Y Superficial injury of other specified part of head NA00.Z Superficial injury of unspecified part of head – NA00.00 Abrasion of scalp – NA00.01 Contusion of scalp – NA00.02 Superficial foreign body in scalp – NA00.0Y Other specified superficial injury of scalp – NA00.0Z Superficial injury of scalp, type unspecified – NA00.10 Abrasion of eyelid or periocular area – NA00.11 Contusion of eyelid or periocular area – NA00.1Y Other specified superficial injury of eyelid or periocular area – NA00.1Z Superficial injury of eyelid or periocular area, unspecified NA01 Open wound of head NA01.2 Laceration without foreign body of head NA01.3 Laceration with foreign body of head NA01.4 Puncture wound without foreign body of head NA01.5 Puncture wound with foreign body of head NA01.6 Open bite of head NA01.7 Multiple open wounds of head NA01.Y Other specified open wound of head NA01.Z Open wound of head, unspecified NA02 Fracture of skull or facial bones NA02.0 Fracture of vault of skull NA02.1 Fracture of base of skull NA02.2 Orbital fracture NA02.3 Fracture of nasal bones NA02.4 Fracture of maxilla NA02.5 Fracture of zygoma NA02.7 Fracture of mandible NA02.8 Multiple fractures involving skull or facial bones NA02.Y Fracture of other specified skull or facial bones NA02.Z Fracture of skull and facial bones, part unspecified – NA02.00 Fracture of squama of frontal bone of skull – NA02.01 Fracture of parietal bone of skull – NA02.02 Fracture of squama of temporal bone of skull – NA02.03 Fracture of squama of occipital bone of skull – NA02.0Z Fracture of vault of skull, unspecified – NA02.10 Fracture of anterior fossa of base of skull – NA02.11 Fracture of middle fossa of base of skull – NA02.12 Fracture of posterior fossa of base of skull – NA02.13 Fracture of sinus of ethmoid bone of skull – NA02.14 Fracture of frontal sinus of skull – NA02.15 Fracture of sphenoid bone of skull – NA02.16 Fracture of occipital condyle of skull, type I – NA02.17 Fracture of occipital condyle of skull, type II – NA02.18 Fracture of occipital condyle of skull, type III – NA02.19 Fracture of other part of occipital bone of skull – NA02.1A Other fractures of base of skull – NA02.1Z Fracture of base of skull, unspecified – NA02.20 Fracture of orbital roof – NA02.21 Fracture of orbital floor – NA02.2Y Other specified orbital fracture – NA02.2Z Orbital fracture, unspecified – NA02.40 Le Fort fracture type I – NA02.41 Le Fort fracture type II – NA02.42 Le Fort fracture type III – NA02.4Y Other specified fracture of maxilla – NA02.4Z Fracture of maxilla, unspecified – NA02.70 Fracture of condylar process of mandible – NA02.71 Fracture of subcondylar process of mandible – NA02.72 Fracture of coronoid process of mandible – NA02.73 Fracture of ramus of mandible – NA02.74 Fracture of angle of mandible – NA02.75 Fracture of alveolar margin of mandible – NA02.76 Fracture of symphysis of mandible – NA02.7Y Other specified fracture of mandible – NA02.7Z Fracture of mandible, unspecified NA03 Dislocation or strain or sprain of joints or ligaments of head NA03.0 Dislocation of jaw NA03.1 Dislocation of septal cartilage of nose NA03.3 Strain or sprain of jaw NA03.Y Dislocation or sprain of other specified joints or ligaments of head NA03.Z Dislocation or strain or sprain of joints or ligaments of head, unspecified NA04 Injury of cranial nerves NA04.0 Injury of olfactory nerve NA04.1 Injury of optic nerve or pathways NA04.2 Injury of oculomotor nerve NA04.3 Injury of trochlear nerve NA04.4 Injury of trigeminal nerve NA04.5 Injury of abducent nerve NA04.6 Injury of facial nerve NA04.7 Injury of acoustic nerve NA04.8 Injury of glossopharyngeal nerve NA04.9 Injury of vagus nerve NA04.A Injury of accessory nerve NA04.B Injury of hypoglossal nerve NA04.Z Injury of cranial nerves, unspecified – NA04.10 Injury of optic nerve, unilateral – NA04.11 Injury of optic nerve, bilateral – NA04.12 Injury of optic chiasm – NA04.13 Injury of optic tract or pathways, unilateral – NA04.14 Injury of optic tract or pathways, bilateral – NA04.15 Injury of visual cortex, unilateral – NA04.16 Injury of visual cortex, bilateral – NA04.1Y Other specified injury of optic nerve or pathways – NA04.1Z Injury of optic nerve or pathways, unspecified NA05 Injury of blood vessels of head NA05.0 Injury of intracranial vessels of head NA05.1 Injury of extracranial vessels of head NA05.Z Injury of blood vessels of head, unspecified NA06 Injury of eye or orbit NA06.0 Eyelid trauma NA06.1 Penetrating wound of orbit with or without foreign body NA06.2 Retained foreign body following penetrating wound of orbit NA06.3 Traumatic orbital haemorrhage NA06.4 Injury of conjunctiva or corneal abrasion without mention of foreign body NA06.5 Trauma to the iris sphincter NA06.6 Traumatic injuries of the retina NA06.7 Traumatic retinal haemorrhage NA06.8 Traumatic injury to eyeball NA06.9 Contusion of eyeball or orbital tissues NA06.A Injury of lens NA06.Y Other specified injury of eye or orbit NA06.Z Injury of eye or orbit, unspecified – NA06.00 Eyelid avulsion – NA06.01 Haematoma of eyelid – NA06.02 Oedema of eyelid – NA06.03 Retained foreign body in eyelid – NA06.04 Open wound of eyelid or periocular area – NA06.0Y Other specified eyelid trauma – NA06.0Z Eyelid trauma, unspecified – NA06.60 Traumatic macular hole – NA06.61 Choroidal rupture – NA06.62 Commotio retinae – NA06.63 Optic nerve avulsion – NA06.6Y Other specified traumatic injuries of the retina – NA06.6Z Traumatic injuries of the retina, unspecified – NA06.80 Retained intraocular magnetic foreign body, unilateral – NA06.81 Retained intraocular nonmagnetic foreign body, unilateral – NA06.82 Closed eyeball trauma, unilateral – NA06.83 Closed eyeball trauma, bilateral – NA06.84 Penetrating wound of eyeball without foreign body, unilateral – NA06.85 Avulsion of eye, unilateral – NA06.86 Avulsion of eye, bilateral – NA06.87 Ocular laceration or rupture with prolapse or loss of intraocular tissue, unilateral – NA06.88 Ocular laceration or rupture with prolapse or loss of intraocular tissue, bilateral – NA06.89 Penetrating injury of eyeball, bilateral – NA06.8A Perforating injury of eyeball, bilateral – NA06.8B Retained intraocular magnetic foreign body, bilateral – NA06.8C Retained intraocular nonmagnetic foreign body, bilateral – NA06.8D Ocular laceration without prolapse or loss of intraocular tissue, unilateral – NA06.8E Ocular laceration without prolapse or loss of intraocular tissue, bilateral – NA06.8Y Other specified traumatic injury to eyeball – NA06.8Z Traumatic injury to eyeball, unspecified NA07 Intracranial injury NA07.0 Concussion NA07.1 Traumatic intracerebral haemorrhage NA07.2 Traumatic cerebral oedema NA07.3 Diffuse brain injury NA07.4 Focal brain injury NA07.5 Traumatic epidural haemorrhage NA07.6 Traumatic subdural haemorrhage NA07.7 Traumatic subarachnoid haemorrhage NA07.8 Traumatic haemorrhage in brain tissue NA07.Y Other specified intracranial injury NA07.Z Intracranial injury, unspecified – NA07.00 Concussion with incomplete loss of consciousness with amnesia – NA07.01 Concussion with incomplete loss of consciousness without amnesia – NA07.02 Concussion with loss of consciousness, short duration of less than 30 minutes – NA07.03 Concussion with loss of consciousness, short duration of 30 minutes to less than one hour – NA07.04 Concussion with loss of consciousness, short duration of one hour to less than 6 hours – NA07.05 Concussion with loss of consciousness, intermediate duration of 6 hours to less than 24 hours – NA07.06 Concussion with loss of consciousness, persisting longer than 24 hours or until discharge or latest assessment – NA07.07 Concussion with loss of consciousness, persisting until death – NA07.08 Concussion with loss of consciousness, duration unspecified or unknown due to effects of therapy – NA07.09 Concussion with loss of consciousness, duration unspecified or unknown due to lack of information – NA07.0Y Other specified concussion – NA07.0Z Concussion, unspecified – NA07.20 Diffuse traumatic cerebral oedema – NA07.21 Focal traumatic cerebral oedema – NA07.2Y Other specified traumatic cerebral oedema – NA07.2Z Traumatic cerebral oedema, unspecified – NA07.30 Diffuse injury of cerebrum – NA07.31 Diffuse injury of cerebellum – NA07.32 Diffuse injury of brainstem – NA07.33 Diffuse injury of multiple parts of brain – NA07.3Y Other specified diffuse brain injury – NA07.3Z Unspecified diffuse traumatic brain injury – NA07.40 Focal non-haemorrhagic contusion of cerebrum – NA07.41 Focal haemorrhagic contusion of cerebrum – NA07.42 Focal laceration of cerebrum – NA07.43 Multiple focal injuries of cerebrum – NA07.44 Focal non-haemorrhagic contusion of cerebellum – NA07.45 Focal haematoma or haemorrhage of cerebellum – NA07.46 Focal laceration of cerebellum – NA07.47 Multiple focal injuries of cerebellum – NA07.48 Focal non-haemorrhagic contusion of brainstem – NA07.49 Focal haematoma or haemorrhage of brainstem – NA07.4A Contusion of temporal lobe – NA07.4B Focal laceration of brainstem – NA07.4C Focal brain contusion – NA07.4D Focal brain laceration – NA07.4E Contusion of parietal lobe – NA07.4F Contusion of occipital lobe – NA07.4Z Unspecified focal traumatic brain injury – NA07.60 Acute traumatic subdural haemorrhage – NA07.61 Chronic traumatic subdural haemorrhage – NA07.6Z Traumatic subdural haemorrhage, unspecified whether acute or chronic – NA07.80 Traumatic haemorrhage in cerebrum white matter – NA07.81 Traumatic haemorrhage in thalamus or basal ganglia – NA07.82 Traumatic haemorrhage in cerebellum – NA07.83 Traumatic haemorrhage in brainstem without specification whether primary or secondary – NA07.84 Traumatic haemorrhage in brainstem, primary – NA07.85 Traumatic haemorrhage in brainstem, secondary – NA07.86 Multiple traumatic haemorrhages – NA07.8Y Other specified traumatic haemorrhage in brain tissue – NA07.8Z Traumatic haemorrhage in brain tissue, unspecified NA08 Crushing injury of head NA08.0 Crushing injury of brain NA08.1 Crushing injury of face NA08.2 Crushing injury of skull NA08.3 Crushed scalp NA08.Y Other specified crushing injury of head NA08.Z Crushing injury of head, unspecified NA09 Traumatic amputation of part of head NA09.0 Avulsion of scalp NA09.1 Traumatic amputation of ear NA09.2 Traumatic amputation of nose NA09.3 Traumatic amputation of lip NA09.Y Other specified traumatic amputation of part of head NA09.Z Traumatic amputation of part of head, unspecified – NA09.10 Traumatic amputation of ear, complete – NA09.11 Traumatic amputation of ear, partial – NA09.1Z Traumatic amputation of ear, unspecified – NA09.20 Traumatic amputation of nose, complete – NA09.21 Traumatic amputation of nose, partial – NA09.2Z Traumatic amputation of nose, unspecified NA0A Certain specified injuries of head NA0A.0 Complex wounds to the head NA0A.1 Injury of muscle, fascia or tendon of head NA0A.2 Traumatic rupture of ear drum NA0A.3 Multiple injuries of head NA0A.Y Other specified injuries of head – NA0A.00 Complex wounds to the head with retained external material – NA0A.01 Complex wounds to the head with intracranial haemorrhage – NA0A.02 Complex wounds to the head with through and through perforation – NA0A.03 Complex wounds to the head with avulsive loss of part of skull and cranial contents – NA0A.0Y Other specified complex wounds to the head – NA0A.0Z Complex wounds to the head, unspecified – NA0A.10 Strain or sprain of muscle, fascia or tendon of head – NA0A.11 Laceration of muscle, fascia or tendon of head – NA0A.1Y Other specified injury of muscle, fascia or tendon of head – NA0A.1Z Injury of muscle, fascia or tendon of head, unspecified NA0B Injury of the auricle NA0C Injury of middle or inner ear NA0D Injury of teeth or supporting structures NA0D.0 Injury of hard dental tissues and pulp NA0D.1 Injury of periodontal tissues NA0D.Y Other specified injury of teeth or supporting structures NA0D.Z Injury of teeth or supporting structures, unspecified – NA0D.00 Enamel infraction – NA0D.01 Enamel fracture – NA0D.02 Enamel-dentin fracture – NA0D.03 Complicated crown fracture – NA0D.04 Uncomplicated crown-root fracture – NA0D.05 Complicated crown-root fracture – NA0D.06 Root fracture – NA0D.0Y Other specified injury of hard dental tissues and pulp – NA0D.0Z Injury of hard dental tissues and pulp, unspecified – NA0D.10 Concussion of periodontal tissue – NA0D.11 Subluxation of tooth – NA0D.12 Extrusive luxation of tooth – NA0D.13 Lateral luxation of tooth – NA0D.14 Intrusive luxation of tooth – NA0D.15 Avulsion of tooth – NA0D.1Y Other specified injury of periodontal tissues – NA0D.1Z Injury of periodontal tissues, unspecified NA0Z Injuries to the head, unspecified NA20 Superficial injury of neck NA20.0 Abrasion of throat NA20.1 Contusion of throat NA20.2 Other or unspecified superficial injuries of throat NA20.3 Multiple superficial injuries of neck NA20.Y Other specified superficial injury of neck NA20.Z Superficial injury of neck, unspecified NA21 Open wound of neck NA21.0 Laceration without foreign body of neck NA21.1 Laceration with foreign body of neck NA21.2 Puncture wound without foreign body of neck NA21.3 Puncture wound with foreign body of neck NA21.4 Open bite of neck NA21.5 Multiple open wounds of neck NA21.Y Other specified open wound of neck NA21.Z Open wound of neck, unspecified NA22 Fracture of neck NA22.0 Fracture of first cervical vertebra NA22.1 Fracture of second cervical vertebra NA22.2 Fracture of other specified cervical vertebra NA22.3 Multiple fractures of cervical spine NA22.Z Fracture of neck, unspecified – NA22.00 Fracture of first cervical vertebra, burst fracture – NA22.01 Fracture of posterior arch of first cervical vertebra – NA22.02 Fracture of lateral mass of first cervical vertebra – NA22.03 Other fracture of first cervical vertebra – NA22.0Z Fracture of first cervical vertebra, unspecified – NA22.10 Traumatic spondylolisthesis of second cervical vertebra, type III – NA22.11 Other traumatic spondylolisthesis of second cervical vertebra – NA22.12 Fracture of odontoid process – NA22.13 Other fracture of second cervical vertebra – NA22.1Z Fracture of second cervical vertebra, unspecified NA23 Dislocation or strain or sprain of joints or ligaments at neck level NA23.0 Traumatic rupture of cervical intervertebral disc NA23.1 Dislocation of cervical vertebra NA23.2 Dislocation of other or unspecified parts of neck NA23.3 Multiple dislocations of neck NA23.4 Strain or sprain of cervical spine NA23.5 Strain or sprain of thyroid region NA23.Y Other specified dislocation or strain or sprain of joints or ligaments at neck level NA23.Z Dislocation or strain or sprain of joints or ligaments at neck level, unspecified – NA23.10 Cranio-cervical dissociation – NA23.11 Atlanto-axial dislocation – NA23.12 Dislocation of other specified cervical vertebra – NA23.1Z Dislocation of cervical vertebra, unspecified – NA23.40 Acute whiplash associated disorder with complaint of neck pain, stiffness or tenderness only – NA23.41 Acute whiplash associated disorder with complaint of neck pain with musculoskeletal signs – NA23.42 Acute whiplash associated disorder with complaint of neck pain with neurological signs – NA23.4Y Other specified strain or sprain of cervical spine – NA23.4Z Strain or sprain of cervical spine, unspecified – NA30 Concussion or oedema of cervical spinal cord – NA31 Certain specified injuries of cervical spinal cord –– NA31.0 Complete lesion of cervical spinal cord –– NA31.1 Central cord syndrome of cervical spinal cord –– NA31.2 Anterior cord syndrome of cervical spinal cord –– NA31.3 Posterior cord syndrome of cervical spinal cord –– NA31.4 Brown-Sequard syndrome of cervical spinal cord –– NA31.5 Other incomplete cord syndrome of cervical spinal cord – NA3Z Injury of cervical spinal cord, unspecified – NA40 Injury of nerve root of cervical spine – NA41 Injury of brachial plexus –– NA41.0 Injury of brachial plexus cord –– NA41.1 Injury of brachial plexus division –– NA41.2 Injury of brachial plexus trunk –– NA41.Y Other specified injury of brachial plexus –– NA41.Z Injury of brachial plexus, unspecified – NA42 Injury of peripheral nerves of neck –– NA42.0 Injury of supraclavicular nerve –– NA42.1 Injury to anterior cutaneous nerve of neck –– NA42.Y Injury of other specified peripheral nerves of neck –– NA42.Z Injury of peripheral nerves of neck, unspecified – NA43 Injury of cervical sympathetic nerves – NA44 Injury of phrenic nerve – NA4Y Injury of other specified nerves at neck level – NA4Z Injury of nerves at neck level, unspecified NA60 Injury of blood vessels at neck level NA60.0 Injury of carotid artery NA60.1 Injury of vertebral artery NA60.2 Injury of external jugular vein NA60.3 Injury of internal jugular vein NA60.4 Injury of multiple blood vessels at neck level NA60.Y Injury of other specified blood vessels at neck level NA60.Z Injury of blood vessels at neck level, unspecified – NA60.00 Laceration of carotid artery, minor – NA60.01 Laceration of carotid artery, major – NA60.0Y Other specified injury of carotid artery – NA60.0Z Injury of carotid artery, unspecified – NA60.10 Laceration of vertebral artery, minor – NA60.11 Laceration of vertebral artery, major – NA60.1Y Other specified injury of vertebral artery – NA60.1Z Injury of vertebral artery, unspecified – NA60.20 Laceration of external jugular vein, minor – NA60.21 Laceration of external jugular vein, major – NA60.2Y Other specified injury of external jugular vein – NA60.2Z Injury of external jugular vein, unspecified – NA60.30 Laceration of internal jugular vein, minor – NA60.31 Laceration of internal jugular vein, major – NA60.3Y Other specified injury of internal jugular vein – NA60.3Z Injury of internal jugular vein, unspecified NA61 Injury of muscle, fascia or tendon at neck level NA61.0 Strain or sprain of muscle, fascia or tendon at neck level NA61.1 Laceration of muscle, fascia or tendon at neck level NA61.Y Other specified injury of muscle, fascia or tendon at neck level NA61.Z Injury of muscle, fascia or tendon at neck level, unspecified NA62 Crushing injury of neck NA62.0 Crushing injury of larynx or trachea NA62.Y Crushing injury of other specified site of neck NA62.Z Crushing injury of neck, unspecified NA63 Traumatic amputation at neck level NA64 Multiple injuries of neck NA6Y Other specified injuries to the neck NA6Z Injuries to the neck, unspecified NA80 Superficial injury of thorax NA80.0 Abrasion of breast NA80.1 Contusion of breast NA80.2 Other or unspecified superficial injuries of breast NA80.3 Other superficial injuries of front wall of thorax NA80.4 Other superficial injuries of back wall of thorax NA80.5 Abrasion of thorax NA80.6 Contusion of thorax NA80.7 Multiple superficial injuries of thorax NA80.Y Other specified superficial injury of thorax NA80.Z Superficial injury of thorax, unspecified NA81 Open wound of thorax NA81.0 Laceration without foreign body of thorax NA81.1 Laceration with foreign body of thorax NA81.2 Puncture wound without foreign body of thorax NA81.3 Puncture wound with foreign body of thorax NA81.4 Open bite of thorax NA81.5 Multiple open wounds of thoracic wall NA81.Y Other specified open wound of thorax NA81.Z Open wound of thorax, unspecified NA82 Fracture of rib, sternum or thoracic spine NA82.0 Fracture of thoracic vertebra NA82.1 Multiple fractures of thoracic spine NA82.2 Fracture of sternum NA82.3 Fracture of rib NA82.4 Multiple fractures of ribs NA82.5 Flail chest NA82.Y Other specified fracture of rib, sternum or thoracic spine NA82.Z Fracture of rib, sternum or thoracic spine, unspecified – NA82.30 Fracture of rib, posterior or posterior and lateral – NA82.3Y Other specified fracture of rib – NA82.3Z Fracture of rib, unspecified NA83 Dislocation or strain or sprain of joints or ligaments of thorax NA83.0 Traumatic rupture of thoracic intervertebral disc NA83.1 Dislocation of thoracic vertebra NA83.2 Dislocation of other or unspecified parts of thorax NA83.3 Strain or sprain of ligaments of thoracic spine NA83.4 Strain or sprain of ribs or sternum NA83.Y Other specified dislocation or strain or sprain of joints or ligaments of thorax NA83.Z Dislocation or strain or sprain of joints or ligaments of thorax, unspecified – NA83.40 Strain or sprain of sternum – NA83.41 Strain or sprain of sterno-clavicular joint or ligament – NA83.42 Strain or sprain of chondro-sternal joint – NA83.4Y Strain or sprain of other specified site of ribs or sternum – NA83.4Z Strain or sprain of ribs or sternum, unspecified – NA90 Concussion or oedema of thoracic spinal cord – NA91 Certain specified injuries of thoracic spinal cord –– NA91.0 Complete lesion of thoracic spinal cord –– NA91.1 Central cord syndrome of thoracic spinal cord –– NA91.2 Anterior cord syndrome of thoracic spinal cord –– NA91.3 Posterior cord syndrome of thoracic spinal cord –– NA91.4 Brown-Sequard syndrome of thoracic spinal cord –– NA91.5 Other incomplete cord syndrome of thoracic spinal cord – NA9Z Injury of thoracic spinal cord, unspecified – NB00 Injury of nerve root of thoracic spine – NB01 Injury of peripheral nerves of thorax – NB02 Injury of thoracic sympathetic nerves – NB0Y Injury of other specified nerves at thorax level NB2Y Other specified injury of nerves or spinal cord at thorax level NB2Z Injury of nerves or spinal cord at thorax level, unspecified NB30 Injury of blood vessels of thorax NB30.0 Injury of thoracic aorta NB30.1 Injury of innominate or subclavian artery NB30.2 Injury of superior vena cava NB30.3 Injury of innominate or subclavian vein NB30.4 Injury of pulmonary blood vessels NB30.5 Injury of intercostal blood vessels NB30.6 Injury of multiple blood vessels of thorax NB30.Y Injury of other specified blood vessels of thorax NB30.Z Injury of unspecified blood vessels of thorax – NB30.00 Minor laceration of thoracic aorta – NB30.01 Major laceration of thoracic aorta – NB30.0Y Other specified injury of thoracic aorta – NB30.0Z Injury of thoracic aorta, unspecified – NB30.10 Minor laceration of innominate or subclavian artery – NB30.11 Major laceration of innominate or subclavian artery – NB30.1Y Other specified injury of innominate or subclavian artery – NB30.1Z Injury of innominate or subclavian artery, unspecified – NB30.20 Minor laceration of superior vena cava – NB30.21 Major laceration of superior vena cava – NB30.2Y Other specified injury of superior vena cava – NB30.2Z Injury of superior vena cava, unspecified – NB30.30 Minor laceration of innominate or subclavian vein – NB30.31 Major laceration of innominate or subclavian vein – NB30.3Y Other specified injury of innominate or subclavian vein – NB30.3Z Injury of innominate or subclavian vein, unspecified – NB30.40 Minor laceration of pulmonary blood vessels – NB30.41 Major laceration of pulmonary blood vessels – NB30.4Y Other specified injury of pulmonary blood vessels – NB30.4Z Injury of pulmonary blood vessels, unspecified – NB30.50 Laceration of intercostal blood vessels – NB30.5Y Other specified injury of intercostal blood vessels – NB30.5Z Injury of intercostal blood vessels, unspecified NB31 Injury of heart NB31.0 Injury of heart with haemopericardium NB31.1 Injury of heart without haemopericardium NB31.2 Injury of heart, unspecified without open wound into thoracic cavity NB31.3 Injury of heart, unspecified with open wound into thoracic cavity NB31.4 Injury of heart valve NB31.Y Other specified injury of heart NB31.Z Injury of heart, unspecified – NB31.00 Contusion of heart with haemopericardium – NB31.01 Minor laceration of heart with haemopericardium – NB31.02 Moderate laceration of heart with haemopericardium – NB31.03 Major laceration of heart with haemopericardium – NB31.0Y Other specified injury of heart with haemopericardium – NB31.0Z Injury of heart with haemopericardium, unspecified – NB31.10 Contusion of heart without haemopericardium – NB31.11 Laceration of heart without haemopericardium – NB31.1Y Other specified injury of heart without haemopericardium – NB31.1Z Injury of heart without haemopericardium, unspecified – NB31.40 Injury to mitral valve – NB31.4Y Injury of other specified heart valve – NB31.4Z Injury of heart valve, unspecified NB32 Injury of other or unspecified intrathoracic organs NB32.0 Traumatic pneumothorax NB32.1 Traumatic haemothorax NB32.2 Traumatic haemopneumothorax NB32.3 Certain injuries of lung NB32.4 Injury of bronchus NB32.5 Injury of thoracic trachea NB32.6 Injury of pleura NB32.7 Multiple injuries of intrathoracic organs NB32.Y Other specified injury of other or unspecified intrathoracic organs NB32.Z Unspecified injury of unspecified intrathoracic organs – NB32.30 Contusion of lung – NB32.31 Laceration of lung – NB32.32 Inhalation injury of lung – NB32.33 Primary blast injury of lung – NB32.3Y Other injury of lung – NB32.3Z Injury of lung, unspecified – NB32.40 Contusion of bronchus – NB32.41 Minor laceration of bronchus – NB32.42 Moderate laceration of bronchus – NB32.43 Major laceration of bronchus – NB32.4Y Other specified injury of bronchus – NB32.4Z Injury of bronchus, unspecified – NB32.50 Contusion of thoracic trachea – NB32.51 Minor laceration of thoracic trachea – NB32.52 Moderate laceration of thoracic trachea – NB32.53 Major laceration of thoracic trachea – NB32.5Y Other specified injury of thoracic trachea – NB32.5Z Injury of thoracic trachea, unspecified – NB32.60 Laceration of pleura – NB32.6Y Other specified injury of pleura – NB32.6Z Injury of pleura, unspecified NB33 Crushing injury of thorax or traumatic amputation of part of thorax NB33.0 Crushed chest NB33.1 Traumatic amputation of breast NB33.2 Traumatic amputation of other or unspecified part of thorax – NB33.10 Traumatic amputation of part of breast – NB33.11 Traumatic amputation of entire breast – NB33.1Z Traumatic amputation of breast, unspecified NB34 Injury of muscle, fascia or tendon at thorax level NB34.0 Strain or sprain of muscle, fascia or tendon at thorax level NB34.1 Laceration of muscle, fascia or tendon at thorax level NB34.Y Other specified injury of muscle, fascia or tendon at thorax level NB34.Z Injury of muscle, fascia or tendon at thorax level, unspecified NB35 Multiple injuries of thorax NB3Y Other specified injuries to the thorax NB3Z Injuries to the thorax, unspecified NB50 Superficial injury of abdomen, lower back or pelvis NB50.0 Abrasion of lower back or pelvis NB50.1 Contusion of lower back or pelvis NB50.2 Abrasion of abdominal wall NB50.3 Contusion of abdominal wall NB50.4 Abrasion of external genital organs NB50.5 Contusion of external genital organs NB50.6 Multiple superficial injuries of abdomen, lower back or pelvis NB50.Y Other specified superficial injury of abdomen, lower back or pelvis NB50.Z Superficial injury of abdomen, lower back or pelvis, unspecified NB51 Open wound of abdomen, lower back or pelvis NB51.0 Laceration without foreign body of abdomen, lower back or pelvis NB51.1 Laceration with foreign body of abdomen, lower back or pelvis NB51.2 Puncture wound without foreign body of abdomen, lower back or pelvis NB51.3 Puncture wound with foreign body of abdomen, lower back or pelvis NB51.4 Open bite of abdomen, lower back or pelvis NB51.5 Multiple open wounds of abdomen, lower back or pelvis NB51.Y Other specified open wound of abdomen, lower back or pelvis NB51.Z Open wound of abdomen, lower back or pelvis, unspecified NB52 Fracture of lumbar spine or pelvis NB52.0 Fracture of lumbar vertebra NB52.1 Fracture of pelvic bone without disruption of posterior arch of pelvic ring NB52.2 Fracture of the pelvic ring with incomplete disruption of posterior arch NB52.3 Fracture of pelvic ring with complete disruption of posterior arch NB52.4 Multiple fractures of lumbar spine or pelvis NB52.Y Other specified fracture of lumbar spine or pelvis NB52.Z Fracture of lumbar spine or pelvis, unspecified – NB52.10 Fracture of sacrum without disruption of pelvic ring – NB52.11 Fracture of coccyx – NB52.12 Fracture of ilium without disruption of pelvic ring – NB52.13 Fracture of acetabulum without disruption of pelvic ring – NB52.14 Fracture of pubis without disruption of pelvic ring – NB52.15 Fracture of ischium without disruption of pelvic ring – NB52.1Y Fracture of other specified pelvic bone without disruption of posterior arch of pelvic ring – NB52.1Z Fracture of unspecified pelvic bone without disruption of posterior arch of pelvic ring NB53 Dislocation or strain or sprain of joints or ligaments of lumbar spine or pelvis NB53.0 Traumatic rupture of lumbar intervertebral disc NB53.1 Dislocation of lumbar vertebra NB53.2 Dislocation of sacroiliac or sacrococcygeal joint without disruption of pelvic ring NB53.3 Dislocation of other or unspecified parts of lumbar spine or pelvis without disruption of pelvic ring NB53.4 Traumatic rupture of symphysis pubis without disruption of pelvic ring NB53.5 Strain or sprain of lumbar spine NB53.6 Strain or sprain of sacroiliac joint NB53.Y Other specified dislocation or strain or sprain of joints or ligaments of lumbar spine or pelvis NB53.Z Dislocation or strain or sprain of joints or ligaments of lumbar spine or pelvis, unspecified – NB60 Concussion or oedema of lumbar spinal cord – NB61 Concussion or oedema of sacral spinal cord – NB62 Certain specified injuries of lumbar spinal cord –– NB62.0 Complete lesion of lumbar spinal cord –– NB62.1 Central cord syndrome of lumbar spinal cord –– NB62.2 Anterior cord syndrome of lumbar spinal cord –– NB62.3 Posterior cord syndrome of lumbar spinal cord –– NB62.4 Brown-Sequard syndrome of lumbar spinal cord –– NB62.5 Other incomplete cord syndrome of lumbar spinal cord –– NB62.6 Puncture wound or laceration of dura mater of lumbar spinal cord – NB63 Certain specified injuries of sacral spinal cord –– NB63.0 Complete injury of sacral spinal cord –– NB63.1 Incomplete injury of sacral spinal cord –– NB63.Z Injury of sacral spinal cord, unspecified – NB6Z Injury of spinal cord at abdomen, lower back or pelvis level, unspecified – NB70 Injury of nerve root of lumbar spine – NB71 Injury of nerve root of sacral spine – NB72 Injury of cauda equina – NB73 Injury of lumbosacral plexus – NB74 Injury of lumbar, sacral or pelvic sympathetic nerves – NB75 Injury of peripheral nerve of abdomen, lower back or pelvis – NB7Y Other specified injury of nerves at abdomen, lower back or pelvis level – NB7Z Injury of nerves at abdomen, lower back or pelvis level, unspecified NB90 Injury of blood vessels at abdomen, lower back or pelvis level NB90.0 Injury of abdominal aorta NB90.1 Injury of inferior vena cava NB90.2 Injury of coeliac artery NB90.3 Injury of mesenteric artery NB90.4 Injury of portal or splenic vein NB90.5 Injury of renal blood vessels NB90.6 Injury of iliac blood vessels NB90.7 Injury of multiple blood vessels at abdomen, lower back or pelvis level NB90.Y Injury of other specified blood vessels at abdomen, lower back or pelvis level NB90.Z Injury of unspecified blood vessel at abdomen, lower back or pelvis level – NB90.00 Minor laceration of abdominal aorta – NB90.01 Major laceration of abdominal aorta – NB90.0Y Other specified injury of abdominal aorta – NB90.0Z Injury of abdominal aorta, unspecified – NB90.10 Minor laceration of inferior vena cava – NB90.11 Major laceration of inferior vena cava – NB90.1Y Other specified injury of inferior vena cava – NB90.1Z Injury of inferior vena cava, unspecified – NB90.20 Minor laceration of coeliac artery – NB90.21 Major laceration of coeliac artery – NB90.2Y Other specified injury of coeliac artery – NB90.2Z Injury of coeliac artery, unspecified – NB90.30 Minor laceration mesenteric artery – NB90.31 Major laceration of mesenteric artery – NB90.3Y Other specified injury of mesenteric artery – NB90.3Z Injury of mesenteric artery, unspecified – NB90.40 Minor laceration of portal or splenic vein – NB90.41 Major laceration of portal or splenic vein – NB90.4Y Other specified injury of portal or splenic vein – NB90.4Z Injury of portal or splenic vein, unspecified – NB90.50 Minor laceration of renal blood vessels – NB90.51 Major laceration of renal blood vessels – NB90.5Y Other specified injury of renal blood vessels – NB90.5Z Injury of renal blood vessels, unspecified – NB90.60 Minor laceration of iliac blood vessels – NB90.61 Major laceration of iliac blood vessels – NB90.6Y Other specified injury of iliac blood vessels – NB90.6Z Injury of iliac blood vessels, unspecified NB91 Injury of intra-abdominal organs NB91.0 Injury of spleen NB91.1 Injury of liver NB91.2 Injury of gallbladder NB91.3 Injury of bile duct NB91.4 Injury of pancreas NB91.5 Injury of stomach NB91.6 Injury of duodenum NB91.7 Injury of small intestine NB91.8 Injury of colon NB91.9 Injury of rectum NB91.A Injury of mesentery NB91.B Injury of multiple intra-abdominal organs NB91.Y Injury of other specified intra-abdominal organs NB91.Z Injury of intra-abdominal organs, unspecified – NB91.00 Contusion of spleen, minor – NB91.01 Contusion of spleen, major – NB91.02 Laceration of spleen, minor – NB91.03 Laceration of spleen, moderate – NB91.04 Laceration of spleen, major – NB91.05 Avulsion of spleen – NB91.0Y Other specified injury of spleen – NB91.0Z Injury of spleen, unspecified – NB91.10 Contusion of liver – NB91.11 Laceration of liver, minor – NB91.12 Laceration of liver, moderate – NB91.13 Laceration of liver, major – NB91.14 Injury of hepatic duct – NB91.1Y Other specified injury of liver – NB91.1Z Injury of liver, unspecified – NB91.40 Contusion of pancreas – NB91.41 Laceration of pancreas, minor – NB91.42 Laceration of pancreas, moderate – NB91.43 Laceration of pancreas, major – NB91.4Y Other specified injury of pancreas – NB91.4Z Injury of pancreas, unspecified – NB91.50 Contusion of stomach – NB91.51 Laceration of stomach without perforation – NB91.52 Laceration of stomach with perforation, avulsion or massive damage – NB91.53 Ingestion injury of stomach without perforation – NB91.54 Ingestion injury of stomach with perforation – NB91.5Y Other specified injury of stomach – NB91.5Z Injury of stomach, unspecified – NB91.60 Contusion of duodenum – NB91.61 Laceration of duodenum – NB91.62 Primary blast injury of duodenum – NB91.63 Perforation of duodenum – NB91.6Y Other specified injury of duodenum – NB91.6Z Injury of duodenum, unspecified – NB91.70 Contusion of small intestine – NB91.71 Laceration of small intestine – NB91.72 Primary blast injury of small intestine – NB91.7Y Other specified injury of small intestine – NB91.7Z Injury of small intestine, unspecified – NB91.80 Contusion of colon – NB91.81 Laceration of colon – NB91.82 Primary blast injury of colon – NB91.8Y Other specified injury of colon – NB91.8Z Injury of colon, unspecified – NB91.90 Contusion of rectum – NB91.91 Laceration of rectum – NB91.92 Primary blast injury of rectum – NB91.9Y Other specified injury of rectum – NB91.9Z Injury of rectum, unspecified NB92 Injury of urinary or pelvic organs NB92.0 Injury of kidney NB92.1 Injury of ureter NB92.2 Injury of bladder NB92.3 Injury of urethra NB92.4 Injury of ovary NB92.5 Injury of fallopian tube NB92.6 Injury of uterus NB92.7 Injury of urinary tract NB92.8 Injury of multiple pelvic organs NB92.Y Injury of other specified pelvic organs NB92.Z Injury of urinary or pelvic organs, unspecified – NB92.00 Contusion of kidney, minor – NB92.01 Contusion of kidney, major – NB92.02 Laceration of kidney, minor – NB92.03 Laceration of kidney, moderate – NB92.04 Laceration of kidney, major – NB92.0Y Other specified injury of kidney – NB92.0Z Injury of kidney, unspecified – NB92.10 Contusion of ureter – NB92.11 Laceration of ureter – NB92.1Y Other specified injury of ureter – NB92.1Z Injury of ureter, unspecified – NB92.20 Contusion of bladder – NB92.21 Laceration of bladder – NB92.2Y Other specified injury of bladder – NB92.2Z Injury of bladder, unspecified – NB92.30 Contusion of urethra – NB92.31 Laceration of urethra – NB92.3Y Other specified injury of urethra – NB92.3Z Injury of urethra, unspecified – NB92.40 Contusion of ovary – NB92.41 Laceration of ovary – NB92.4Y Other specified injury of ovary – NB92.4Z Injury of ovary, unspecified NB93 Crushing injury or traumatic amputation of part of abdomen, lower back or pelvis NB93.0 Crushing injury of external genital organs NB93.1 Crushing injury of other or unspecified parts of abdomen, lower back or pelvis NB93.2 Traumatic amputation of external genital organs NB93.3 Traumatic amputation of other or unspecified parts of abdomen, lower back or pelvis – NB93.00 Crushing injury of penis – NB93.01 Crushing injury of testes or scrotum – NB93.02 Crushing injury of vulva – NB93.0Z Crushing injury of external genital organs, unspecified – NB93.20 Traumatic amputation of entire penis – NB93.21 Traumatic amputation of part of penis – NB93.22 Traumatic amputation of entire testes or scrotum – NB93.23 Traumatic amputation of part of testes or scrotum – NB93.24 Traumatic amputation of entire vulva – NB93.25 Traumatic amputation of part of vulva – NB93.2Z Traumatic amputation of external genital organs, unspecified NB94 Injury of muscle, fascia or tendon of abdomen, lower back or pelvis NB94.0 Strain or sprain of muscle, fascia or tendon of abdomen NB94.1 Strain or sprain of muscle, fascia or tendon of lower back NB94.2 Strain or sprain of muscle, fascia or tendon of pelvis NB94.3 Laceration of muscle, fascia or tendon of abdomen NB94.4 Laceration of muscle, fascia or tendon of lower back NB94.5 Laceration of muscle, fascia or tendon of pelvis NB94.Y Other specified injury of muscle, fascia or tendon of abdomen, lower back or pelvis NB94.Z Injury of muscle, fascia or tendon of abdomen, lower back or pelvis, unspecified NB95 Injury of intra-abdominal organ with pelvic organ NB96 Other multiple injuries of abdomen, lower back or pelvis NB97 Certain specified injuries of abdomen, lower back or pelvis NB97.0 Retroperitoneal haemorrhage or haematoma NB97.1 Fractured penis NB98 Injury to female genital organ without further specification NB99 Injury to male genital organ without further specification NB9Y Other specified injuries to the abdomen, lower back, lumbar spine or pelvis NB9Z Injuries to the abdomen, lower back, lumbar spine or pelvis, unspecified NC10 Superficial injury of shoulder or upper arm NC10.0 Abrasion of shoulder or upper arm NC10.1 Contusion of shoulder or upper arm NC10.2 Multiple superficial injuries of shoulder or upper arm NC10.Y Other specified superficial injury of shoulder or upper arm NC10.Z Superficial injury of shoulder or upper arm, unspecified NC11 Open wound of shoulder or upper arm NC11.0 Laceration without foreign body of shoulder or upper arm NC11.1 Laceration with foreign body of shoulder or upper arm NC11.2 Puncture wound without foreign body of shoulder or upper arm NC11.3 Puncture wound with foreign body of shoulder or upper arm NC11.4 Open bite of shoulder or upper arm NC11.5 Multiple open wounds of shoulder or upper arm NC11.Y Other specified open wound of shoulder or upper arm NC11.Z Open wound of shoulder or upper arm, unspecified NC12 Fracture of shoulder or upper arm NC12.0 Fracture of clavicle NC12.1 Fracture of scapula NC12.2 Fracture of upper end of humerus NC12.3 Fracture of shaft of humerus NC12.4 Fracture of lower end of humerus NC12.5 Multiple fractures of clavicle, scapula or humerus NC12.7 Fracture of shoulder girdle, part unspecified NC12.Z Fracture of shoulder or upper arm, unspecified – NC12.00 Fracture of sternal end of clavicle – NC12.01 Fracture of shaft of clavicle – NC12.02 Fracture of acromial end of clavicle – NC12.03 Multiple fractures of clavicle, alone – NC12.0Y Other specified fracture of clavicle – NC12.0Z Fracture of clavicle, unspecified – NC12.10 Multiple fractures of scapula – NC12.1Y Other specified fracture of scapula – NC12.1Z Fracture of scapula, unspecified – NC12.20 Fracture of upper end of humerus, head – NC12.21 Fracture of surgical neck of humerus – NC12.22 Fracture of anatomical neck of humerus – NC12.23 Fracture of greater tuberosity of humerus – NC12.24 Fracture of lesser tuberosity of humerus – NC12.2Z Fracture of upper end of humerus, unspecified site – NC12.40 Supracondylar fracture of humerus – NC12.41 Fracture of lateral epicondyle of humerus – NC12.42 Fracture of medial epicondyle of humerus – NC12.43 Fracture of lateral condyle of humerus – NC12.44 Fracture of medial condyle of humerus – NC12.4Y Other specified fracture of lower end of humerus – NC12.4Z Fracture of lower end of humerus, unspecified NC13 Dislocation or strain or sprain of joints or ligaments of shoulder girdle NC13.0 Dislocation of shoulder joint NC13.1 Dislocation of acromioclavicular joint NC13.2 Dislocation of sternoclavicular joint NC13.3 Dislocation of scapula NC13.4 Dislocation of other or unspecified parts of shoulder girdle NC13.5 Strain or sprain of shoulder joint NC13.6 Strain or sprain of acromioclavicular joint NC13.7 Strain or sprain of sternoclavicular joint NC13.8 Strain or sprain of other or unspecified parts of shoulder girdle NC13.Y Dislocation or sprain of other specified joints and ligaments of shoulder girdle NC13.Z Dislocation or strain or sprain of joints or ligaments of shoulder girdle, unspecified NC14 Injury of nerves at shoulder or upper arm level NC14.0 Injury of ulnar nerve at upper arm level NC14.1 Injury of median nerve at upper arm level NC14.2 Injury of radial nerve at upper arm level NC14.3 Injury of axillary nerve NC14.4 Injury of musculocutaneous nerve NC14.5 Injury of cutaneous sensory nerve at shoulder or upper arm level NC14.6 Injury of multiple nerves at shoulder or upper arm level NC14.Y Injury of other specified nerves at shoulder or upper arm level NC14.Z Injury of unspecified nerve at shoulder or upper arm level NC15 Injury of blood vessels at shoulder or upper arm level NC15.0 Injury of axillary artery NC15.1 Injury of brachial artery NC15.2 Injury of axillary or brachial vein NC15.3 Injury of superficial vein at shoulder or upper arm level NC15.4 Injury of multiple blood vessels at shoulder or upper arm level NC15.Y Injury of other specified blood vessels at shoulder or upper arm level NC15.Z Injury of unspecified blood vessel at shoulder or upper arm level – NC15.00 Laceration of axillary artery – NC15.0Y Other specified injury of axillary artery – NC15.0Z Injury of axillary artery, unspecified – NC15.10 Laceration of brachial artery – NC15.1Y Other specified injury of brachial artery – NC15.1Z Injury of brachial artery, unspecified – NC15.20 Laceration of axillary or brachial vein – NC15.2Y Other specified injury of axillary or brachial vein – NC15.2Z Injury of axillary or brachial vein, unspecified – NC15.30 Laceration of superficial vein at shoulder or upper arm level – NC15.3Y Other specified injury of superficial vein at shoulder or upper arm level – NC15.3Z Injury of superficial vein at shoulder or upper arm level, unspecified NC16 Injury of muscle, fascia, tendon or bursa at shoulder or upper arm level NC16.0 Injury of muscle or tendon of the rotator cuff of shoulder NC16.1 Injury of muscle, fascia or tendon of long head of biceps NC16.2 Injury of muscle, fascia or tendon of other parts of biceps NC16.3 Injury of muscle, fascia or tendon of triceps NC16.4 Injury of multiple muscles or tendons at shoulder or upper arm level NC16.5 Injury of bursa of shoulder NC16.Y Injury of other specified muscle, fascia, tendon or bursa at shoulder or upper arm level NC16.Z Injury of unspecified muscle, fascia or tendon at shoulder or upper arm level – NC16.00 Strain or sprain of muscle or tendon of the rotator cuff of shoulder – NC16.01 Laceration of muscle or tendon of the rotator cuff of shoulder – NC16.0Y Other specified injury of muscle or tendon of the rotator cuff of shoulder – NC16.0Z Injury of muscle or tendon of the rotator cuff of shoulder, unspecified – NC16.10 Strain or sprain of muscle, fascia or tendon of long head of biceps – NC16.11 Laceration of muscle, fascia or tendon of long head of biceps – NC16.1Y Other specified injury of muscle, fascia or tendon of long head of biceps – NC16.1Z Injury of muscle, fascia or tendon of long head of biceps, unspecified – NC16.20 Strain or sprain of muscle, fascia or tendon of other parts of biceps – NC16.21 Laceration of muscle, fascia or tendon of other parts of biceps – NC16.2Y Other specified injury of muscle, fascia or tendon of other parts of biceps – NC16.2Z Injury of muscle, fascia or tendon of other parts of biceps, unspecified – NC16.30 Strain or sprain of muscle, fascia or tendon of triceps – NC16.31 Laceration of muscle, fascia or tendon of triceps – NC16.3Y Other specified injury of muscle, fascia or tendon of triceps – NC16.3Z Injury of muscle, fascia or tendon of triceps, unspecified – NC16.40 Strain or sprain of multiple muscles or tendons at shoulder or upper arm level – NC16.41 Laceration of multiple muscles or tendons at shoulder or upper arm level – NC16.4Y Other specified injury of multiple muscles or tendons at shoulder or upper arm level – NC16.4Z Injury of multiple muscles or tendons at shoulder or upper arm level, unspecified NC17 Crushing injury of shoulder or upper arm NC18 Traumatic amputation of shoulder or upper arm NC18.0 Traumatic amputation at right shoulder joint NC18.1 Traumatic amputation at left shoulder joint NC18.2 Traumatic amputation at shoulder joint, bilateral NC18.3 Traumatic amputation at level between right shoulder and elbow NC18.4 Traumatic amputation at level between left shoulder and elbow NC18.5 Traumatic amputation at level between shoulder and elbow, bilateral NC18.Z Traumatic amputation of shoulder or upper arm, unspecified NC19 Multiple injuries of shoulder or upper arm NC1Y Other specified injuries to the shoulder or upper arm NC1Z Injuries to the shoulder or upper arm, unspecified NC30 Superficial injury of forearm NC30.0 Abrasion of elbow NC30.1 Contusion of elbow NC30.2 Abrasion of other or unspecified parts of forearm NC30.3 Contusion of other or unspecified parts of forearm NC30.4 Multiple superficial injuries of forearm NC30.Y Other specified superficial injury of forearm NC30.Z Superficial injury of forearm, unspecified NC31 Open wound of forearm NC31.0 Laceration without foreign body of forearm NC31.1 Laceration with foreign body of forearm NC31.2 Puncture wound without foreign body of forearm NC31.3 Puncture wound with foreign body of forearm NC31.4 Open bite of forearm NC31.5 Multiple open wounds of forearm NC31.Y Other specified open wound of forearm NC31.Z Open wound of forearm, unspecified NC32 Fracture of forearm NC32.0 Fracture of upper end of ulna NC32.1 Fracture of upper end of radius NC32.2 Fracture of shaft of ulna NC32.3 Fracture of shaft of radius NC32.4 Fracture of shafts of both ulna and radius NC32.5 Fracture of lower end of radius NC32.6 Fracture of lower end of both ulna and radius NC32.7 Multiple fractures of forearm NC32.Y Fracture of other specified parts of forearm NC32.Z Fracture of forearm, unspecified – NC32.50 Fracture of lower end of radius, dorsal tilt – NC32.51 Fracture of lower end of radius, volar tilt – NC32.5Y Other specified fracture of lower end of radius – NC32.5Z Fracture of lower end of radius, unspecified NC33 Dislocation or strain or sprain of joints or ligaments of elbow NC33.0 Dislocation of radial head NC33.1 Dislocation of elbow NC33.2 Traumatic rupture of radial collateral ligament NC33.3 Traumatic rupture of ulnar collateral ligament NC33.4 Strain or sprain of elbow NC33.Y Dislocation or sprain of other specified joints or ligaments of elbow NC33.Z Dislocation or strain or sprain of joints or ligaments of elbow, unspecified NC34 Injury of nerves at forearm level NC34.0 Injury of ulnar nerve at forearm level NC34.1 Injury of median nerve at forearm level NC34.2 Injury of radial nerve at forearm level NC34.3 Injury of cutaneous sensory nerve at forearm level NC34.4 Injury of multiple nerves at forearm level NC34.Y Injury of other specified nerves at forearm level NC34.Z Injury of unspecified nerve at forearm level NC35 Injury of blood vessels at forearm level NC35.0 Injury of ulnar artery at forearm level NC35.1 Injury of radial artery at forearm level NC35.2 Injury of vein at forearm level NC35.3 Injury of multiple blood vessels at forearm level NC35.Y Injury of other specified blood vessels at forearm level NC35.Z Injury of unspecified blood vessel at forearm level – NC35.00 Laceration of ulnar artery at forearm level – NC35.0Y Other specified injury of ulnar artery at forearm level – NC35.0Z Injury of ulnar artery at forearm level, unspecified – NC35.10 Laceration of radial artery at forearm level – NC35.1Y Other specified injury of radial artery at forearm level – NC35.1Z Injury of radial artery at forearm level, unspecified – NC35.20 Laceration of vein at forearm level – NC35.2Y Other specified injury of vein at forearm level – NC35.2Z Injury of vein at forearm level, unspecified NC36 Injury of muscle, fascia, tendon or bursa at forearm level NC36.0 Injury of flexor muscle, fascia or tendon of thumb at forearm level NC36.1 Injury of long flexor muscle, fascia or tendon of other finger at forearm level NC36.2 Injury of other flexor muscle, fascia or tendon at forearm level NC36.3 Injury of extensor or abductor muscles or tendons of thumb at forearm level NC36.4 Injury of extensor muscle, fascia or tendon of other finger at forearm level NC36.5 Injury of other extensor muscle, fascia or tendon at forearm level NC36.6 Injury of multiple muscles or tendons at forearm level NC36.7 Injury of bursa of elbow NC36.Y Injury of other specified muscle, fascia, tendon or bursa at forearm level NC36.Z Injury of unspecified muscle, fascia, tendon or bursa at forearm level – NC36.00 Strain or sprain of flexor muscle, fascia or tendon of thumb at forearm level – NC36.01 Laceration of flexor muscle, fascia or tendon of thumb at forearm level – NC36.0Y Other specified injury of flexor muscle, fascia or tendon of thumb at forearm level – NC36.0Z Injury of flexor muscle, fascia or tendon of thumb at forearm level, unspecified – NC36.10 Strain or sprain of long flexor muscle, fascia or tendon of other finger at forearm level – NC36.11 Laceration of long flexor muscle, fascia or tendon of other finger at forearm level – NC36.1Y Other specified injury of long flexor muscle, fascia or tendon of other finger at forearm level – NC36.1Z Injury of long flexor muscle, fascia or tendon of other finger at forearm level, unspecified – NC36.20 Strain or sprain of other flexor muscle, fascia or tendon at forearm level – NC36.21 Laceration of other flexor muscle, fascia or tendon at forearm level – NC36.2Y Other specified injury of other flexor muscle, fascia or tendon at forearm level – NC36.2Z Injury of other flexor muscle, fascia or tendon at forearm level, unspecified – NC36.30 Strain or sprain of extensor or abductor muscles or tendons of thumb at forearm level – NC36.31 Laceration of extensor or abductor muscles or tendons of thumb at forearm level – NC36.3Y Other specified injury of extensor or abductor muscles or tendons of thumb at forearm level – NC36.3Z Injury of extensor or abductor muscles or tendons of thumb at forearm level, unspecified – NC36.40 Strain or sprain of extensor muscle, fascia or tendon of other finger at forearm level – NC36.41 Laceration of extensor muscle, fascia or tendon of other finger at forearm level – NC36.4Y Other specified injury of extensor muscle, fascia or tendon of other finger at forearm level – NC36.4Z Injury of extensor muscle, fascia or tendon of other finger at forearm level, unspecified – NC36.50 Strain or sprain of other extensor muscle, fascia or tendon at forearm level – NC36.51 Laceration of other extensor muscle, fascia or tendon at forearm level – NC36.5Y Other specified injury of other extensor muscle, fascia or tendon at forearm level – NC36.5Z Injury of other extensor muscle, fascia or tendon at forearm level, unspecified NC37 Crushing injury of forearm NC37.0 Crushing injury of elbow NC37.Y Crushing injury of other specified part of forearm NC37.Z Crushing injury of forearm, unspecified NC38 Traumatic amputation of forearm NC38.0 Traumatic amputation at right elbow level NC38.1 Traumatic amputation at left elbow level NC38.2 Traumatic amputation at elbow level, bilateral NC38.3 Traumatic amputation at level between right elbow and wrist NC38.4 Traumatic amputation at level between left elbow and wrist NC38.5 Traumatic amputation between elbow and wrist, bilateral NC38.Z Traumatic amputation of forearm, unspecified NC39 Multiple injuries of forearm NC3Y Other specified injuries to the elbow or forearm NC3Z Injuries to the elbow or forearm, unspecified NC50 Injury to fingernail NC51 Superficial injury of wrist or hand NC51.0 Superficial injury of finger or thumb NC51.1 Superficial injury of other parts of wrist or hand NC51.2 Multiple superficial injuries of wrist or hand – NC51.00 Abrasion of finger or thumb – NC51.01 Contusion of finger or thumb – NC51.0Y Other specified superficial injury of finger or thumb – NC51.0Z Superficial injury of finger or thumb, unspecified – NC51.10 Contusion of other parts of wrist or hand – NC51.11 Nonvenomous insect bite of other parts of wrist or hand – NC51.1Y Other specified superficial injury of other parts of wrist or hand – NC51.1Z Superficial injury of other parts of wrist or hand, unspecified NC52 Open wound of wrist or hand NC52.0 Open wound of finger or thumb NC52.1 Open wound of other parts of wrist or hand NC52.2 Multiple open wounds of wrist or hand – NC52.00 Laceration without foreign body of finger or thumb – NC52.01 Laceration with foreign body of finger or thumb – NC52.02 Puncture wound without foreign body of finger or thumb – NC52.03 Puncture wound with foreign body of finger or thumb – NC52.04 Open bite of finger or thumb – NC52.0Y Other specified open wound of finger or thumb – NC52.0Z Open wound of finger or thumb, unspecified – NC52.10 Laceration without foreign body of other parts of wrist or hand – NC52.11 Laceration with foreign body of other parts of wrist or hand – NC52.12 Puncture wound with foreign body of other parts of wrist or hand – NC52.13 Puncture wound without foreign body of other parts of wrist or hand – NC52.14 Open bite of other parts of wrist or hand – NC52.1Y Other specified open wound of other parts of wrist or hand – NC52.1Z Open wound of other parts of wrist or hand, unspecified NC53 Fracture at wrist or hand level NC53.0 Fracture of scaphoid bone of hand NC53.1 Fracture of other carpal bone NC53.2 Fracture of first metacarpal bone NC53.3 Fracture of other metacarpal bone NC53.4 Multiple fractures of metacarpal bones NC53.5 Fracture of thumb bone NC53.6 Fracture of other finger bone NC53.7 Multiple fractures of fingers NC53.Y Fracture at other specified part of wrist or hand level NC53.Z Fracture at wrist or hand level, unspecified – NC53.30 Fracture of shaft of other metacarpal bone – NC53.31 Fracture of neck of other metacarpal bone – NC53.3Y Fracture of other specified part of other metacarpal bone – NC53.3Z Fracture of other metacarpal bone, unspecified – NC53.60 Fracture of index finger – NC53.61 Fracture of middle finger – NC53.62 Fracture of ring finger – NC53.63 Fracture of little finger – NC53.6Y Other specified fracture of other finger bone – NC53.6Z Fracture of other finger bone, unspecified NC54 Dislocation or strain or sprain of joints or ligaments at wrist or hand level NC54.0 Dislocation of wrist NC54.1 Dislocation of thumb NC54.2 Dislocation of finger NC54.3 Multiple dislocations of fingers NC54.4 Traumatic rupture of ligament of wrist or carpus NC54.5 Traumatic rupture of ligament of finger at metacarpophalangeal or interphalangeal joint NC54.6 Strain or sprain of wrist NC54.7 Strain or sprain of thumb NC54.8 Strain or sprain of finger NC54.Y Dislocation or sprain of other specified joints or ligaments at wrist or hand level NC54.Z Dislocation or strain or sprain of joints or ligaments at wrist or hand level, unspecified – NC54.00 Dislocation of distal radioulnar joint – NC54.01 Dislocation of radiocarpal joint – NC54.02 Dislocation of midcarpal joint – NC54.03 Dislocation of carpometacarpal joint of thumb – NC54.04 Dislocation of other carpometacarpal joint – NC54.05 Dislocation of metacarpal bone, proximal end – NC54.0Y Dislocation of other specified part of wrist – NC54.0Z Dislocation of wrist, unspecified – NC54.10 Dislocation of metacarpophalangeal joint of thumb – NC54.11 Dislocation of interphalangeal joint of thumb – NC54.1Y Dislocation of other specified part of thumb – NC54.1Z Dislocation of thumb, unspecified – NC54.20 Dislocation of metacarpophalangeal joint of finger – NC54.21 Dislocation of interphalangeal joint of finger – NC54.2Y Dislocation of other specified part of finger – NC54.2Z Dislocation of finger, unspecified – NC54.40 Traumatic rupture of scapholunate ligament – NC54.41 Traumatic rupture of radiocarpal ligament – NC54.42 Traumatic rupture of ulnocarpal ligament – NC54.43 Traumatic rupture of lunotriquetral ligament – NC54.4Y Traumatic rupture of other specified ligament of wrist or carpus – NC54.4Z Traumatic rupture of ligament of wrist or carpus, unspecified – NC54.50 Traumatic rupture of collateral ligament of finger at metacarpophalangeal or interphalangeal joint – NC54.51 Traumatic rupture of palmar ligament of finger at metacarpophalangeal or interphalangeal joint – NC54.52 Traumatic rupture of volar plate of finger at metacarpophalangeal or interphalangeal joint – NC54.53 Traumatic rupture of other ligament of finger at metacarpophalangeal or interphalangeal joint – NC54.5Z Traumatic rupture of ligament of finger at metacarpophalangeal or interphalangeal joint, unspecified – NC54.60 Strain or sprain of carpal joint – NC54.61 Strain or sprain of radiocarpal joint – NC54.62 Strain or sprain of carpometacarpal joint – NC54.6Y Sprain of other specified part of wrist – NC54.6Z Strain or sprain of wrist, unspecified – NC54.70 Strain or sprain of metacarpophalangeal joint of thumb – NC54.71 Strain or sprain of interphalangeal joint of thumb – NC54.7Y Sprain or strain of other specified part of thumb – NC54.7Z Strain or sprain of thumb, unspecified – NC54.80 Strain or sprain of metacarpophalangeal joint of finger – NC54.81 Strain or sprain of interphalangeal joint of finger – NC54.8Y Sprain of other specified part of finger – NC54.8Z Strain or sprain of finger, unspecified NC55 Injury of nerves at wrist or hand level NC55.0 Injury of ulnar nerve at wrist or hand level NC55.1 Injury of median nerve at wrist or hand level NC55.2 Injury of radial nerve at wrist or hand level NC55.3 Injury of multiple nerves at wrist or hand level NC55.Y Injury of other specified nerves at wrist or hand level NC55.Z Injury of unspecified nerve at wrist or hand level NC56 Injury of blood vessels at wrist or hand level NC56.0 Injury of ulnar artery at wrist or hand level NC56.1 Injury of radial artery at wrist or hand level NC56.2 Injury of superficial palmar arch NC56.3 Injury of deep palmar arch NC56.4 Injury of blood vessel of thumb NC56.5 Injury of blood vessel of other finger NC56.6 Injury of multiple blood vessels at wrist or hand level NC56.Y Injury of other specified blood vessels at wrist and hand level NC56.Z Injury of unspecified blood vessel at wrist or hand level – NC56.00 Laceration of ulnar artery at wrist or hand level – NC56.01 Contusion of ulnar artery at wrist or hand level – NC56.0Y Other specified injury of ulnar artery at wrist or hand level – NC56.0Z Injury of ulnar artery at wrist or hand level, unspecified – NC56.10 Laceration of radial artery at wrist or hand level – NC56.11 Contusion of radial artery at wrist or hand level – NC56.1Y Other specified injury of radial artery at wrist or hand level – NC56.1Z Injury of radial artery at wrist or hand level, unspecified – NC56.20 Laceration of superficial palmar arch – NC56.21 Contusion of superficial palmar arch – NC56.2Y Other specified injury of superficial palmar arch – NC56.2Z Injury of superficial palmar arch, unspecified – NC56.30 Laceration of deep palmar arch – NC56.31 Contusion of deep palmar arch – NC56.3Y Other specified injury of deep palmar arch – NC56.3Z Injury of deep palmar arch, unspecified – NC56.40 Laceration of blood vessel of thumb – NC56.41 Contusion of blood vessel of thumb – NC56.4Y Other specified injury of blood vessel of thumb – NC56.4Z Injury of blood vessel of thumb, unspecified – NC56.50 Laceration of blood vessel of other finger – NC56.51 Contusion of blood vessel of other finger – NC56.5Y Other specified injury of blood vessel of other finger – NC56.5Z Injury of blood vessel of other finger, unspecified – NC56.60 Laceration of multiple blood vessels at wrist or hand level – NC56.61 Contusion of multiple blood vessels at wrist or hand level – NC56.6Y Other specified injury of multiple blood vessels at wrist or hand level – NC56.6Z Injury of multiple blood vessels at wrist or hand level, unspecified NC57 Injury of muscle, fascia or tendon at wrist or hand level NC57.0 Injury of long flexor muscle, fascia or tendon of thumb at wrist or hand level NC57.1 Injury of flexor muscle, fascia or tendon of other finger at wrist or hand level NC57.2 Injury of extensor muscle, fascia or tendon of thumb at wrist or hand level NC57.3 Injury of extensor muscle, fascia or tendon of other finger at wrist or hand level NC57.4 Injury of intrinsic muscle, fascia or tendon of thumb at wrist or hand level NC57.5 Injury of intrinsic muscle, fascia or tendon of other finger at wrist or hand level NC57.6 Injury of multiple flexor muscles or tendons at wrist or hand level NC57.7 Injury of multiple extensor muscles or tendons at wrist or hand level NC57.Y Injury of other specified muscle, fascia or tendon at wrist or hand level NC57.Z Injury of unspecified muscle, fascia or tendon at wrist or hand level – NC57.00 Strain or sprain of long flexor muscle, fascia or tendon of thumb at wrist or hand level – NC57.01 Laceration of long flexor muscle, fascia or tendon of thumb at wrist or hand level – NC57.0Y Other specified injury of long flexor muscle, fascia or tendon of thumb at wrist or hand level – NC57.0Z Injury of long flexor muscle, fascia or tendon of thumb at wrist or hand level, unspecified – NC57.10 Strain or sprain of flexor muscle, fascia or tendon of other finger at wrist or hand level – NC57.11 Laceration of flexor muscle, fascia or tendon of other finger at wrist or hand level – NC57.1Y Other specified injury of flexor muscle, fascia or tendon of other finger at wrist or hand level – NC57.1Z Injury of flexor muscle, fascia or tendon of other finger at wrist or hand level, unspecified – NC57.20 Strain or sprain of extensor muscle, fascia or tendon of thumb at wrist or hand level – NC57.21 Laceration of extensor muscle, fascia or tendon of thumb at wrist or hand level – NC57.2Y Other specified injury of extensor muscle, fascia or tendon of thumb at wrist or hand level – NC57.2Z Injury of extensor muscle, fascia or tendon of thumb at wrist or hand level, unspecified – NC57.30 Strain or sprain of extensor muscle, fascia or tendon of other finger at wrist or hand level – NC57.31 Laceration of extensor muscle, fascia or tendon of other finger at wrist or hand level – NC57.3Y Other specified injury of extensor muscle, fascia or tendon of other finger at wrist or hand level – NC57.3Z Injury of extensor muscle, fascia or tendon of other finger at wrist or hand level, unspecified – NC57.40 Strain or sprain of intrinsic muscle, fascia or tendon of thumb at wrist or hand level – NC57.41 Laceration of intrinsic muscle, fascia or tendon of thumb at wrist or hand level – NC57.4Y Other specified injury of intrinsic muscle, fascia or tendon of thumb at wrist or hand level – NC57.4Z Injury of intrinsic muscle, fascia or tendon of thumb at wrist or hand level, unspecified – NC57.50 Strain or sprain of intrinsic muscle, fascia or tendon of other finger at wrist or hand level – NC57.51 Laceration of intrinsic muscle, fascia or tendon of other finger at wrist or hand level – NC57.5Y Other specified injury of intrinsic muscle, fascia or tendon of other finger at wrist or hand level – NC57.5Z Injury of intrinsic muscle, fascia or tendon of other finger at wrist or hand level, unspecified NC58 Crushing injury of wrist or hand NC58.0 Crushing injury of thumb NC58.1 Crushing injury of other finger NC58.2 Crushing injury of hand NC58.3 Crushing injury of wrist NC58.Y Crushing injury of other specified part of wrist or hand NC58.Z Crushing injury of wrist or hand, unspecified NC59 Traumatic amputation of wrist or hand NC59.0 Traumatic amputation of thumb NC59.1 Traumatic amputation of other single finger NC59.2 Traumatic amputation of two or more fingers alone NC59.3 Combined traumatic amputation of finger with other parts of wrist or hand NC59.4 Traumatic amputation of hand at metacarpal level NC59.Z Traumatic amputation of wrist or hand, unspecified – NC59.00 Traumatic amputation at or near base of right thumb – NC59.01 Traumatic amputation at or near base of left thumb – NC59.02 Traumatic amputation at or near base of thumb, bilateral – NC59.0Y Other specified traumatic amputation of thumb – NC59.0Z Traumatic amputation of thumb, unspecified – NC59.20 Traumatic amputation of two or more fingers at or near base, right hand – NC59.21 Traumatic amputation of two or more fingers at or near base, left hand – NC59.22 Traumatic amputation of two or more fingers alone at or near base, bilateral – NC59.2Y Other specified traumatic amputation of two or more fingers alone – NC59.2Z Traumatic amputation of two or more fingers alone, unspecified NC5A Multiple injuries of wrist or hand NC5A.0 Injury of multiple sites of hand NC5A.1 Injury of multiple sites of wrist NC5A.Y Other specified multiple injuries of wrist or hand NC5A.Z Multiple injuries of wrist or hand, unspecified NC5Y Other specified injuries to the wrist or hand NC5Z Injuries to the wrist or hand, unspecified NC70 Superficial injury of hip or thigh NC70.0 Abrasion of hip NC70.1 Contusion of hip NC70.2 Abrasion of thigh NC70.3 Contusion of thigh NC70.4 Multiple superficial injuries of hip or thigh NC70.Y Other specified superficial injury of hip or thigh NC70.Z Superficial injury of hip or thigh, unspecified NC71 Open wound of hip or thigh NC71.0 Laceration without foreign body of hip or thigh NC71.1 Laceration with foreign body of hip or thigh NC71.2 Puncture wound without foreign body of hip or thigh NC71.3 Puncture wound with foreign body of hip or thigh NC71.4 Open bite of hip or thigh NC71.5 Multiple open wounds of hip or thigh NC71.Y Other specified open wound of hip or thigh NC71.Z Open wound of hip or thigh, unspecified NC72 Fracture of femur NC72.0 Fracture of head of femur NC72.1 Fracture of upper epiphysis of femur NC72.2 Fracture of neck of femur NC72.3 Fracture of trochanteric section of femur NC72.4 Subtrochanteric fracture of femur NC72.5 Fracture of shaft of femur NC72.6 Fracture of lower end of femur NC72.7 Multiple fractures of femur NC72.8 Fractures of other parts of femur NC72.Y Other specified fracture of femur NC72.Z Fracture of femur, unspecified – NC72.20 Fracture of neck of femur, subcapital – NC72.21 Fracture of neck of femur, mid-cervical – NC72.22 Fracture of base of neck of femur – NC72.23 Intracapsular fracture of femur – NC72.2Y Other specified fracture of neck of femur – NC72.2Z Fracture of neck of femur, unspecified – NC72.30 Intertrochanteric fracture of femur – NC72.31 Pertrochanteric fracture of femur – NC72.3Y Fracture of other specified trochanteric section of femur – NC72.3Z Fracture of unspecified trochanteric section of femur – NC72.60 Fracture of lower end of femur not extending into joint, simple – NC72.61 Fracture of lower end of femur not extending into joint, wedge – NC72.62 Fracture of lower end of femur not extending into joint, complex – NC72.63 Fracture of lower end of femur extending into joint, lateral condyle – NC72.64 Fracture of lower end of femur extending into joint, medial condyle – NC72.65 Fracture of lower end of femur extending into joint, frontal – NC72.66 Fracture of lower end of femur extending into joint, complete articular – NC72.6Y Other specified fracture of lower end of femur – NC72.6Z Fracture of lower end of femur, unspecified NC73 Dislocation or strain or sprain of joint or ligaments of hip NC73.0 Dislocation of hip NC73.1 Strain or sprain of hip – NC73.00 Posterior dislocation of hip – NC73.01 Obturator dislocation of hip – NC73.02 Other anterior dislocation of hip – NC73.03 Central dislocation of hip – NC73.0Y Other specified dislocation of hip – NC73.0Z Dislocation of hip, unspecified – NC73.10 Iliofemoral ligament strain or sprain of hip – NC73.11 Ischiocapsular ligament strain or sprain of hip – NC73.1Y Other specified strain or sprain of hip – NC73.1Z Strain or sprain of hip, unspecified NC74 Injury of nerves at hip or thigh level NC74.0 Injury of sciatic nerve at hip or thigh level NC74.1 Injury of femoral nerve at hip or thigh level NC74.2 Injury of cutaneous sensory nerve at hip or thigh level NC74.3 Injury of multiple nerves at hip or thigh level NC74.Y Injury of other specified nerves at hip or thigh level NC74.Z Injury of unspecified nerve at hip or thigh level NC75 Injury of blood vessels at hip or thigh level NC75.0 Injury of femoral artery NC75.1 Injury of femoral vein at hip or thigh level NC75.2 Injury of greater saphenous vein at hip or thigh level NC75.3 Injury of multiple blood vessels at hip or thigh level NC75.Y Injury of other specified blood vessels at hip and thigh level NC75.Z Injury of unspecified blood vessel at hip or thigh level – NC75.00 Laceration of femoral artery, minor – NC75.01 Laceration of femoral artery, major – NC75.0Y Other specified injury of femoral artery – NC75.0Z Injury of femoral artery, unspecified – NC75.10 Laceration of femoral vein at hip or thigh level, minor – NC75.11 Laceration of femoral vein at hip or thigh level, major – NC75.1Y Other specified injury of femoral vein at hip or thigh level – NC75.1Z Injury of femoral vein at hip or thigh level, unspecified – NC75.20 Laceration of greater saphenous vein at hip or thigh level, minor – NC75.21 Laceration of greater saphenous vein at hip or thigh level, major – NC75.2Y Other specified injury of greater saphenous vein at hip or thigh level – NC75.2Z Injury of greater saphenous vein at hip or thigh level, unspecified NC76 Injury of muscle, fascia, tendon or bursa at hip or thigh level NC76.0 Injury of muscle, fascia or tendon of hip NC76.1 Injury of quadriceps muscle or tendon NC76.2 Injury of adductor muscle, fascia or tendon of thigh NC76.3 Injury of muscle, fascia or tendon of the posterior muscle group at thigh level NC76.4 Injury of multiple muscles or tendons at hip or thigh level NC76.Y Injury of other specified muscle, fascia, tendon or bursa at hip or thigh level NC76.Z Injury of unspecified muscle, fascia, tendon or bursa at hip or thigh level – NC76.00 Strain or sprain of muscle, fascia or tendon of hip – NC76.01 Laceration of muscle, fascia or tendon of hip – NC76.0Y Other specified injury of muscle, fascia or tendon of hip – NC76.0Z Injury of muscle, fascia or tendon of hip, unspecified – NC76.10 Strain or sprain of quadriceps muscle or tendon – NC76.11 Laceration of quadriceps muscle or tendon – NC76.1Y Other specified injury of quadriceps muscle or tendon – NC76.1Z Injury of quadriceps muscle or tendon, unspecified – NC76.20 Strain or sprain of adductor muscle, fascia or tendon of thigh – NC76.21 Laceration of adductor muscle, fascia or tendon of thigh – NC76.2Y Other specified injury of adductor muscle, fascia or tendon of thigh – NC76.2Z Injury of adductor muscle, fascia or tendon of thigh, unspecified – NC76.30 Strain or sprain of muscle, fascia or tendon of the posterior muscle group at thigh level – NC76.31 Laceration of muscle, fascia or tendon of the posterior muscle group at thigh level – NC76.3Y Other specified injury of muscle, fascia or tendon of the posterior muscle group at thigh level – NC76.3Z Injury of muscle, fascia or tendon of the posterior muscle group at thigh level, unspecified – NC76.40 Injury of bursa of hip – NC76.4Y Other specified injury of multiple muscles or tendons at hip or thigh level – NC76.4Z Injury of multiple muscles or tendons at hip or thigh level, unspecified NC77 Crushing injury of hip or thigh NC77.0 Crushing injury of hip NC77.1 Crushing injury of thigh NC77.2 Crushing injury of hip with thigh NC77.Z Crushing injury of hip or thigh, unspecified NC78 Traumatic amputation of hip or thigh NC78.0 Traumatic amputation at right hip joint NC78.1 Traumatic amputation at left hip joint NC78.2 Traumatic amputation at hip joint, bilateral NC78.3 Traumatic amputation at level between right hip and knee NC78.4 Traumatic amputation at level between left hip and knee NC78.5 Traumatic amputation at level between hip and knee, bilateral NC78.Z Traumatic amputation of hip or thigh, unspecified NC79 Multiple injuries of hip or thigh NC7Y Other specified injuries to the hip or thigh NC7Z Injuries to the hip or thigh, unspecified NC90 Superficial injury of knee or lower leg NC90.0 Abrasion of knee NC90.1 Contusion of knee NC90.2 Abrasion of other or unspecified parts of lower leg NC90.3 Contusion of other or unspecified parts of lower leg NC90.4 Multiple superficial injuries of lower leg NC90.Y Other specified superficial injury of knee or lower leg NC90.Z Superficial injury of knee or lower leg, unspecified NC91 Open wound of knee or lower leg NC91.0 Laceration without foreign body of lower leg NC91.1 Laceration with foreign body of lower leg NC91.2 Puncture wound without foreign body of lower leg NC91.3 Puncture wound with foreign body of lower leg NC91.4 Open bite of lower leg NC91.5 Multiple open wounds of lower leg NC91.Y Other specified open wound of knee or lower leg NC91.Z Open wound of knee or lower leg, unspecified NC92 Fracture of lower leg, including ankle NC92.0 Fracture of patella NC92.1 Fracture of upper end of tibia NC92.2 Fracture of shaft of tibia NC92.3 Fracture of lower end of tibia NC92.4 Fracture of fibula NC92.5 Fracture of medial malleolus NC92.6 Fracture of lateral malleolus NC92.7 Complex fractures of ankle NC92.8 Multiple fractures of lower leg NC92.Y Fracture of other specified part of lower leg, including ankle NC92.Z Fracture of lower leg, including ankle, unspecified – NC92.10 Avulsion of cruciate ligament insertion – NC92.11 Avulsion of tibial tuberosity – NC92.12 Metaphyseal fracture of upper end of tibia – NC92.13 Fracture of upper end of tibia, lateral condyle – NC92.14 Fracture of upper end of tibia, medial condyle – NC92.1Y Other specified fracture of upper end of tibia – NC92.1Z Fracture of upper end of tibia, unspecified – NC92.40 Avulsion of fibular head – NC92.4Y Other specified fracture of fibula – NC92.4Z Fracture of fibula, unspecified – NC92.70 Fracture, avulsion or collateral ligament rupture of lateral malleolus below syndesmosis with fracture, avulsion or collateral ligament rupture of medial malleolus – NC92.71 Fracture, avulsion or collateral ligament rupture of lateral malleolus below syndesmosis with fracture, avulsion or collateral ligament rupture of medial malleolus and fracture of posterior margin of distal tibia – NC92.72 Fracture of lateral malleolus at syndesmosis with fracture, avulsion or collateral ligament rupture of medial malleolus – NC92.73 Fracture of lateral malleolus at syndesmosis with fracture, avulsion or collateral ligament rupture of medial malleolus and fracture of posterior margin of distal tibia – NC92.74 Fracture, avulsion or collateral ligament rupture of medial malleolus with fracture of fibula above syndesmosis – NC92.75 Fracture, avulsion or collateral ligament rupture of medial malleolus with fracture of fibula above syndesmosis and fracture of posterior margin of distal tibia – NC92.76 Bimalleolar fracture of ankle, not otherwise specified – NC92.77 Trimalleolar fracture of ankle, not otherwise specified – NC92.7Y Other specified complex fractures of ankle – NC92.7Z Complex fractures of ankle, unspecified NC93 Dislocation or strain or sprain of joints or ligaments of knee NC93.0 Acute internal damage of knee NC93.1 Dislocation of patella NC93.2 Dislocation of knee NC93.3 Tear of meniscus, current NC93.4 Tear of articular cartilage of knee NC93.5 Strain or sprain involving fibular or tibial collateral ligament of knee NC93.6 Strain or sprain involving anterior or posterior cruciate ligament of knee NC93.7 Strain or sprain of other or unspecified parts of knee NC93.8 Injury to multiple structures of knee NC93.Y Other specified dislocation or strain or sprain of joints or ligaments of knee NC93.Z Dislocation or strain or sprain of joints or ligaments of knee, unspecified – NC93.10 Lateral dislocation of patella – NC93.1Y Other specified dislocation of patella – NC93.1Z Dislocation of patella, unspecified – NC93.20 Anterior dislocation of proximal end of tibia – NC93.21 Posterior dislocation of proximal end of tibia – NC93.22 Medial dislocation of proximal end of tibia – NC93.23 Lateral dislocation of proximal end of tibia – NC93.2Y Other specified dislocation of knee – NC93.2Z Dislocation of knee, unspecified – NC93.30 Tear of medial meniscus – NC93.31 Tear of lateral meniscus – NC93.3Y Other specified tear of meniscus, current – NC93.3Z Tear of meniscus, current, unspecified – NC93.50 Strain or sprain of medial collateral ligament of knee, excluding rupture – NC93.51 Strain or sprain of lateral collateral ligament of knee, excluding rupture – NC93.52 Rupture of medial collateral ligament of knee – NC93.53 Rupture of lateral collateral ligament of knee – NC93.5Y Other specified strain or sprain involving fibular or tibial collateral ligament of knee – NC93.5Z Strain or sprain involving fibular or tibial collateral ligament of knee, unspecified – NC93.60 Strain or sprain of anterior cruciate ligament of knee, excluding rupture – NC93.61 Strain or sprain of posterior cruciate ligament of knee, excluding rupture – NC93.62 Rupture of anterior cruciate ligament – NC93.63 Rupture of posterior cruciate ligament – NC93.6Y Other specified strain or sprain involving anterior or posterior cruciate ligament of knee – NC93.6Z Strain or sprain involving anterior or posterior cruciate ligament of knee, unspecified NC94 Injury of nerves at lower leg level NC94.0 Injury of tibial nerve at lower leg level NC94.1 Injury of peroneal nerve at lower leg level NC94.2 Injury of cutaneous sensory nerve at lower leg level NC94.3 Injury of multiple nerves at lower leg level NC94.Y Injury of other specified nerves at lower leg level NC94.Z Injury of unspecified nerve at lower leg level NC95 Injury of blood vessels at lower leg level NC95.0 Injury of popliteal artery NC95.1 Injury of anterior tibial artery NC95.2 Injury of posterior tibial artery NC95.3 Injury of peroneal artery NC95.4 Injury of greater saphenous vein at lower leg level NC95.5 Injury of lesser saphenous vein at lower leg level NC95.6 Injury of popliteal vein NC95.7 Injury of multiple blood vessels at lower leg level NC95.Y Injury of other specified blood vessels at lower leg level NC95.Z Injury of unspecified blood vessel at lower leg level – NC95.00 Laceration of popliteal artery – NC95.0Y Other specified injury of popliteal artery – NC95.0Z Injury of popliteal artery, unspecified – NC95.10 Laceration of anterior tibial artery – NC95.1Y Other specified injury of anterior tibial artery – NC95.1Z Injury of anterior tibial artery, unspecified – NC95.20 Laceration of posterior tibial artery – NC95.2Y Other specified injury of posterior tibial artery – NC95.2Z Injury of posterior tibial artery, unspecified – NC95.30 Laceration of peroneal artery – NC95.3Y Other specified injury of peroneal artery – NC95.3Z Injury of peroneal artery, unspecified – NC95.40 Laceration of greater saphenous vein at lower leg level – NC95.4Y Other specified injury of greater saphenous vein at lower leg level – NC95.4Z Injury of greater saphenous vein at lower leg level, unspecified – NC95.50 Laceration of lesser saphenous vein at lower leg level – NC95.5Y Other specified injury of lesser saphenous vein at lower leg level – NC95.5Z Injury of lesser saphenous vein at lower leg level, unspecified – NC95.60 Laceration of popliteal vein – NC95.6Y Other specified injury of popliteal vein – NC95.6Z Injury of popliteal vein, unspecified NC96 Injury of muscle, fascia, tendon or bursa at lower leg level NC96.0 Injury of Achilles tendon NC96.1 Injury of other muscle, fascia or tendon of posterior muscle group at lower leg level NC96.2 Injury of muscle, fascia or tendon of anterior muscle group at lower leg level NC96.3 Injury of muscle, fascia or tendon of peroneal muscle group at lower leg level NC96.4 Injury of multiple muscles, fasciae or tendons at lower leg level NC96.5 Injury of bursa of knee NC96.Y Injury of other specified muscle, fascia, tendon or bursa at lower leg level NC96.Z Injury of unspecified muscle, fascia, tendon or bursa at lower leg level – NC96.00 Strain or sprain of Achilles tendon – NC96.01 Laceration of Achilles tendon – NC96.02 Rupture of Achilles tendon – NC96.0Y Other specified injury of Achilles tendon – NC96.0Z Injury of Achilles tendon, unspecified – NC96.10 Strain or sprain of other muscle, fascia or tendon of posterior muscle group at lower leg level – NC96.11 Laceration of other muscle, fascia or tendon of posterior muscle group at lower leg level – NC96.1Y Other specified injury of other muscle, fascia or tendon of posterior muscle group at lower leg level – NC96.1Z Injury of other muscle, fascia or tendon of posterior muscle group at lower leg level, unspecified – NC96.20 Strain or sprain of muscle, fascia or tendon of anterior muscle group at lower leg level – NC96.21 Laceration of muscle, fascia or tendon of anterior muscle group at lower leg level – NC96.2Y Other specified injury of muscle, fascia or tendon of anterior muscle group at lower leg level – NC96.2Z Injury of muscle, fascia or tendon of anterior muscle group at lower leg level, unspecified – NC96.30 Strain or sprain of muscle, fascia or tendon of peroneal muscle group at lower leg level – NC96.31 Laceration of muscle, fascia or tendon of peroneal muscle group at lower leg level – NC96.3Y Other specified injury of muscle, fascia or tendon of peroneal muscle group at lower leg level – NC96.3Z Injury of muscle, fascia or tendon of peroneal muscle group at lower leg level, unspecified NC97 Crushing injury of lower leg NC97.0 Crushing injury of knee NC97.Y Crushing injury of other specified part of lower leg NC97.Z Crushing injury of lower leg, unspecified NC98 Traumatic amputation of lower leg NC98.0 Traumatic amputation of right lower leg at knee level NC98.1 Traumatic amputation of left lower leg at knee level NC98.2 Traumatic amputation at knee level, bilateral NC98.3 Traumatic amputation at level between right knee and ankle NC98.4 Traumatic amputation at level between left knee and ankle NC98.5 Traumatic amputation at level between knee and ankle, bilateral NC98.Y Other specified traumatic amputation of lower leg NC98.Z Traumatic amputation of lower leg, unspecified NC99 Multiple injuries of lower leg NC9Y Other specified injuries to the knee or lower leg NC9Z Injuries to the knee or lower leg, unspecified ND10 Injury to toenail ND11 Superficial injury of ankle or foot ND11.0 Abrasion of ankle ND11.1 Contusion of ankle ND11.2 Nonthermal blister of ankle ND11.3 Nonvenomous insect bite of ankle ND11.4 Superficial foreign body in ankle ND11.5 Abrasion of toe ND11.6 Contusion of toe ND11.7 Abrasion of other or unspecified parts of foot ND11.8 Contusion of other or unspecified parts of foot ND11.9 Nonthermal blister of other or unspecified parts of foot ND11.A Nonvenomous insect bite of other or unspecified parts of foot ND11.B Superficial foreign body in other or unspecified parts of foot ND11.C Multiple superficial injuries of ankle or foot ND11.Y Other specified superficial injury of ankle or foot ND11.Z Superficial injury of ankle or foot, unspecified – ND11.40 Splinter in ankle – ND11.4Y Other specified superficial foreign body in ankle – ND11.4Z Superficial foreign body in ankle, unspecified – ND11.B0 Splinter in other or unspecified parts of foot – ND11.BY Other specified superficial foreign body in other or unspecified parts of foot – ND11.BZ Superficial foreign body in other or unspecified parts of foot, unspecified ND12 Open wound of ankle or foot ND12.0 Laceration without foreign body of ankle or foot ND12.1 Laceration with foreign body of ankle or foot ND12.2 Puncture wound with foreign body of ankle or foot ND12.3 Puncture wound without foreign body of ankle or foot ND12.4 Open bite of ankle or foot ND12.5 Multiple open wounds of ankle or foot ND12.6 Open wound of toe ND12.Y Other specified open wound of ankle or foot ND12.Z Open wound of ankle or foot, unspecified – ND12.60 Laceration without foreign body of toe – ND12.61 Laceration with foreign body of toe – ND12.62 Puncture wound without foreign body of toe – ND12.63 Puncture wound with foreign body of toe – ND12.64 Open bite of toe – ND12.6Y Other specified open wound of toe – ND12.6Z Open wound of toe, unspecified ND13 Fracture of foot, except ankle ND13.0 Fracture of calcaneus ND13.1 Fracture of talus ND13.2 Fracture of unspecified tarsal bone ND13.3 Fracture of metatarsal bone ND13.4 Fracture of great toe ND13.5 Fracture of other toe ND13.6 Multiple fractures of foot ND13.7 Fracture of cuboid bone ND13.8 Fracture of lateral cuneiform ND13.9 Fracture of intermediate cuneiform ND13.A Fracture of medial cuneiform ND13.B Fracture of navicular of foot ND13.Y Fracture of other specified part of foot, except ankle ND13.Z Fracture of foot, except ankle, unspecified ND14 Dislocation or strain or sprain of joints or ligaments at ankle or foot level ND14.0 Dislocation of ankle joint ND14.1 Dislocation of great toe ND14.2 Dislocation of other toe ND14.3 Dislocation of tarsal joint ND14.4 Dislocation of tarsometatarsal joint ND14.5 Rupture of ligaments at ankle or foot level ND14.6 Dislocation of other or unspecified parts of foot ND14.7 Strain or sprain of ankle ND14.8 Strain or sprain of other toe ND14.9 Strain or sprain of great toe ND14.A Strain or sprain of other or unspecified parts of foot ND14.Y Other specified dislocation or strain or sprain of joints or ligaments at ankle or foot level ND14.Z Dislocation or strain or sprain of joints or ligaments at ankle or foot level, unspecified – ND14.10 Dislocation of metatarsophalangeal joint of great toe – ND14.11 Dislocation of interphalangeal joint of great toe – ND14.1Z Dislocation of great toe, unspecified – ND14.20 Dislocation of metatarsophalangeal joint of lesser toe – ND14.21 Dislocation of interphalangeal joints of lesser toe – ND14.2Y Dislocation of other specified toe – ND14.2Z Dislocation of other toe, unspecified – ND14.70 Strain or sprain of calcaneofibular ligament – ND14.71 Strain or sprain of deltoid ligament – ND14.72 Strain or sprain of tibiofibular ligament – ND14.73 Strain or sprain of other ligament of ankle – ND14.7Z Strain or sprain of ankle, unspecified – ND14.80 Strain or sprain of metatarsophalangeal joint of lesser toe – ND14.81 Strain or sprain of interphalangeal joints of lesser toe – ND14.8Y Strain or sprain of other specified toe – ND14.8Z Strain or sprain of other toe, unspecified – ND14.90 Strain or sprain of metatarsophalangeal joint of great toe – ND14.91 Strain or sprain of interphalangeal joint of great toe – ND14.9Z Strain or sprain of great toe, unspecified ND15 Injury of nerves at ankle or foot level ND15.0 Injury of lateral plantar nerve ND15.1 Injury of medial plantar nerve ND15.2 Injury of deep peroneal nerve at ankle or foot level ND15.3 Injury of cutaneous sensory nerve at ankle or foot level ND15.4 Injury of multiple nerves at ankle or foot level ND15.Y Injury of other specified nerves at ankle and foot level ND15.Z Injury of unspecified nerve at ankle or foot level ND16 Injury of blood vessels at ankle or foot level ND16.0 Injury of dorsal artery of foot ND16.1 Injury of plantar artery of foot ND16.2 Injury of dorsal vein of foot ND16.3 Injury of multiple blood vessels at ankle or foot level ND16.Y Injury of other specified blood vessels at ankle and foot level ND16.Z Injury of unspecified blood vessel at ankle or foot level – ND16.00 Laceration of dorsal artery of foot – ND16.0Y Other specified injury of dorsal artery of foot – ND16.0Z Injury of dorsal artery of foot, unspecified – ND16.10 Laceration of plantar artery of foot – ND16.1Y Other specified injury of plantar artery of foot – ND16.1Z Injury of plantar artery of foot, unspecified – ND16.20 Laceration of dorsal vein of foot – ND16.2Y Other specified injury of dorsal vein of foot – ND16.2Z Injury of dorsal vein of foot, unspecified ND17 Injury of muscle, fascia or tendon at ankle or foot level ND17.0 Injury of muscle, fascia or tendon of long flexor muscle of toe at ankle or foot level ND17.1 Injury of muscle, fascia or tendon of long extensor muscle of toe at ankle or foot level ND17.2 Injury of intrinsic muscle, fascia or tendon at ankle or foot level ND17.3 Injury of multiple muscles or tendons at ankle or foot level ND17.Y Injury of other specified muscle, fascia or tendon at ankle or foot level ND17.Z Injury of unspecified muscle, fascia or tendon at ankle or foot level – ND17.00 Strain or sprain of muscle, fascia or tendon of long flexor muscle of toe at ankle or foot level – ND17.01 Laceration of muscle, fascia or tendon of long flexor muscle of toe at ankle or foot level – ND17.0Y Other specified injury of muscle, fascia or tendon of long flexor muscle of toe at ankle or foot level – ND17.0Z Injury of muscle, fascia or tendon of long flexor muscle of toe at ankle or foot level, unspecified – ND17.10 Strain or sprain of muscle, fascia or tendon of long extensor muscle of toe at ankle or foot level – ND17.11 Laceration of muscle, fascia or tendon of long extensor muscle of toe at ankle or foot level – ND17.1Y Other specified injury of muscle, fascia or tendon of long extensor muscle of toe at ankle or foot level – ND17.1Z Injury of muscle, fascia or tendon of long extensor muscle of toe at ankle or foot level, unspecified – ND17.20 Strain or sprain of intrinsic muscle, fascia or tendon at ankle or foot level – ND17.21 Laceration of intrinsic muscle, fascia or tendon at ankle or foot level – ND17.2Y Other specified injury of intrinsic muscle, fascia or tendon at ankle or foot level – ND17.2Z Injury of intrinsic muscle, fascia or tendon at ankle or foot level, unspecified ND18 Crushing injury of ankle or foot ND18.0 Crushing injury of ankle ND18.1 Crushing injury of toe ND18.2 Crushing injury of other parts of ankle or foot ND18.Z Crushing injury of ankle or foot, unspecified ND19 Traumatic amputation of ankle or foot ND19.0 Traumatic amputation of right foot at ankle level ND19.1 Traumatic amputation of left foot at ankle level ND19.2 Traumatic amputation of foot at ankle level, bilateral ND19.3 Traumatic amputation of right foot at metatarsal level ND19.4 Traumatic amputation of left foot at metatarsal level ND19.5 Traumatic amputation of foot at metatarsal level, bilateral ND19.6 Traumatic amputation of one toe ND19.7 Traumatic amputation of two or more toes ND19.8 Traumatic amputation of other parts of foot ND19.Z Traumatic amputation of ankle or foot, unspecified ND1A Multiple injuries of ankle or foot ND1Y Other specified injuries to the ankle or foot ND1Z Injuries to the ankle or foot, unspecified ND30 Superficial injuries involving multiple body regions ND31 Open wounds involving multiple body regions ND32 Fractures involving multiple body regions ND33 Dislocations, strains or sprains involving multiple body regions ND34 Crushing injuries involving multiple body regions ND35 Traumatic amputations involving multiple body regions ND36 Other injuries involving multiple body regions, not elsewhere classified ND37 Unspecified multiple injuries ND50 Fracture of spine, level unspecified ND51 Other injuries of spine or trunk, level unspecified ND51.0 Dislocation or strain or sprain of unspecified joint or ligament of trunk ND51.1 Injury of unspecified nerve, spinal nerve root or plexus of trunk ND51.2 Injury of spinal cord, level unspecified ND51.3 Injury of unspecified muscle, fascia or tendon of trunk ND51.4 Crushing injury of spine or trunk, level unspecified ND51.Y Other specified injuries of spine or trunk, level unspecified ND51.Z Unspecified injuries of spine or trunk, level unspecified ND52 Fracture of arm, level unspecified ND53 Other injuries of arm, level unspecified ND53.0 Crushing injury of arm, level unspecified ND53.Y Other specified injuries of arm, level unspecified ND54 Fracture of leg, level unspecified ND55 Other injuries of leg, level unspecified ND56 Injury of unspecified body region ND56.0 Superficial injury of unspecified body region ND56.1 Open wound of unspecified body region ND56.2 Fracture of unspecified body region ND56.3 Dislocation or strain or sprain of unspecified body region ND56.4 Injury of nerve of unspecified body region ND56.5 Injury of blood vessel of unspecified body region ND56.6 Injury of muscles or tendons of unspecified body region ND56.7 Crushing injury of unspecified body region ND56.8 Traumatic amputation of unspecified body region ND56.9 Injury complicating pregnancy ND56.Y Other specified injury of unspecified body region ND56.Z Unspecified injury to unspecified part of trunk, limb or body region ND57 Secondary effect of trauma ND5Y Other specified injuries to unspecified part of trunk, limb or body region ND5Z Injuries to unspecified part of trunk, limb or body region, unspecified ND70 Foreign body on external eye ND70.0 Foreign body in cornea ND70.1 Foreign body in conjunctival sac ND70.2 Foreign body in multiple parts of external eye ND70.Y Foreign body in other specified part of external eye ND70.Z Foreign body on external eye, unspecified ND71 Foreign body in ear ND72 Foreign body in respiratory tract ND72.0 Foreign body in nasal sinus ND72.1 Foreign body in nostril ND72.2 Foreign body in pharynx ND72.3 Foreign body in larynx ND72.4 Foreign body in trachea ND72.5 Foreign body in bronchus ND72.6 Foreign body in multiple parts of respiratory tract ND72.Y Foreign body in other parts of respiratory tract ND72.Z Foreign body in unspecified part of respiratory tract – ND72.20 Asphyxia on mucous in nasopharynx – ND72.2Y Other specified foreign body in pharynx – ND72.2Z Foreign body in pharynx, unspecified ND73 Foreign body in alimentary tract ND73.0 Foreign body in mouth ND73.1 Foreign body in oesophagus ND73.2 Foreign body in stomach ND73.3 Foreign body in small intestine ND73.4 Foreign body in colon ND73.5 Foreign body in anus or rectum ND73.Y Foreign body in other specified part of alimentary tract ND73.Z Foreign body in alimentary tract, unspecified – ND73.20 Trichobezoar – ND73.2Y Other specified foreign body in stomach – ND73.2Z Foreign body in stomach, unspecified ND74 Foreign body in genitourinary tract ND74.0 Foreign body in urethra ND74.1 Foreign body in bladder ND74.2 Foreign body in vulva or vagina ND74.3 Foreign body in uterus, any part ND74.Y Foreign body in other specified part of genitourinary tract ND74.Z Foreign body in genitourinary tract, unspecified ND7Z Effects of foreign body entering through natural orifice, unspecified ND90 Burn of head or neck except face – ND90.0 Burn of head or neck except face, epidermal burn – ND90.1 Burn of head or neck except face, superficial partial thickness burn – ND90.2 Burn of head or neck except face, deep partial thickness burn – ND90.3 Burn of head and neck except face, full thickness burn – ND90.4 Burn of head or neck except face, deep full thickness or complex burn – ND90.Z Burn of head and neck except face, depth of burn unspecified ND91 Burn of face except eye or ocular adnexa – ND91.0 Burn of face except eye or ocular adnexa, epidermal burn – ND91.1 Burn of face except eye or ocular adnexa, superficial partial thickness burn – ND91.2 Burn of face except eye or ocular adnexa, deep partial thickness burn – ND91.3 Burn of face except eye or ocular adnexa, full thickness burn – ND91.4 Burn of face except eye or ocular adnexa, deep full thickness or complex burn – ND91.Z Burn of face except eye, depth of burn unspecified ND92 Burn of trunk except perineum or genitalia – ND92.0 Burn of trunk except perineum or genitalia, epidermal burn – ND92.1 Burn of trunk except perineum or genitalia, superficial partial thickness burn – ND92.2 Burn of trunk except perineum or genitalia, deep partial thickness burn – ND92.3 Burn of trunk except perineum or genitalia, full thickness burn – ND92.4 Burn of trunk except perineum or genitalia, deep full thickness or complex burn – ND92.Z Burn of trunk except perineum and genitalia, depth of burn unspecified –– ND92.00 Burn of breast, epidermal burn –– ND92.01 Burn of chest wall, epidermal burn –– ND92.02 Burn of abdominal wall, epidermal burn –– ND92.03 Burn of back, any part, epidermal burn –– ND92.0Y Other specified burn of trunk except perineum or genitalia, epidermal burn –– ND92.0Z Burn of trunk except perineum or genitalia, epidermal burn, unspecified ND93 Burn of perineum or genitalia – ND93.0 Burn of perineum or genitalia, epidermal burn – ND93.1 Burn of perineum or genitalia, superficial partial thickness burn – ND93.2 Burn of perineum or genitalia, deep partial thickness burn – ND93.3 Burn of perineum or genitalia, full thickness burn – ND93.4 Burn of perineum or genitalia, deep full thickness or complex burn – ND93.Z Burn of perineum and genitalia, depth of burn unspecified ND94 Burn of shoulder or arm, except wrist or hand – ND94.0 Burn of shoulder or arm, except wrist or hand, epidermal burn – ND94.1 Burn of shoulder or arm, except wrist or hand, superficial partial thickness burn – ND94.2 Burn of shoulder or arm, except wrist or hand, deep partial thickness burn – ND94.3 Burn of shoulder or arm, except wrist or hand, full thickness burn – ND94.4 Burn of shoulder or arm, except wrist or hand, deep full thickness or complex burn – ND94.Z Burn of shoulder and arm except wrist and hand, depth of burn unspecified –– ND94.10 Burn of forearm and elbow, superficial partial thickness burn –– ND94.1Y Other specified burn of shoulder or arm, except wrist or hand, superficial partial thickness burn –– ND94.1Z Burn of shoulder or arm, except wrist or hand, superficial partial thickness burn, unspecified –– ND94.20 Burn of forearm or elbow, deep partial thickness burn –– ND94.2Y Other specified burn of shoulder or arm, except wrist or hand, deep partial thickness burn –– ND94.2Z Burn of shoulder or arm, except wrist or hand, deep partial thickness burn, unspecified ND95 Burn of wrist or hand – ND95.0 Burn of wrist or hand, epidermal burn – ND95.1 Burn of wrist or hand, superficial partial thickness burn – ND95.2 Burn of wrist or hand, deep partial thickness burn – ND95.3 Burn of wrist or hand, full thickness burn – ND95.4 Burn of wrist or hand, deep full thickness or complex burn – ND95.Z Burn of wrist and hand, depth of burn unspecified ND96 Burn of hip or leg, except ankle or foot – ND96.0 Burn of hip or leg, except ankle or foot, epidermal burn – ND96.1 Burn of hip or leg, except ankle or foot, superficial partial thickness burn – ND96.2 Burn of hip or leg, except ankle or foot, deep partial thickness burn – ND96.3 Burn of hip or leg, except ankle or foot, full thickness burn – ND96.4 Burn of hip or leg, except ankle or foot, deep full thickness or complex burn – ND96.Z Burn of hip and leg except ankle and foot, depth of burn unspecified ND97 Burn of ankle or foot – ND97.0 Burn of ankle or foot, epidermal burn – ND97.1 Burn of ankle or foot, superficial partial thickness burn – ND97.2 Burn of ankle or foot, deep partial thickness burn – ND97.3 Burn of ankle or foot, full thickness burn – ND97.4 Burn of ankle or foot, deep full thickness or complex burn – ND97.Z Burn of ankle and foot, depth of burn unspecified ND99 Acute skin injury due to skin contact with corrosive substance – ND99.1 Chemical burn due to skin contact with corrosive substance ND9Y Burns of external body surface, other specified site ND9Z Burns of external body surface, unspecified site NE00 Burn of eye or ocular adnexa NE01 Burn of respiratory tract NE02 Burn of other internal organs NE0Z Burns of unspecified internal organ NE10 Burns of multiple body regions NE11 Burn of unspecified body region NE2Z Burns, unspecified NE40 Superficial frostbite NE41 Frostbite with tissue necrosis NE42 Frostbite involving multiple body regions NE4Z Frostbite, unspecified NE60 Harmful effects of drugs, medicaments or biological substances, not elsewhere classified NE61 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified NE6Z Harmful effects of unspecified substance NE80 Injury or harm arising following infusion, transfusion or therapeutic injection, not elsewhere classified NE80.0 Air embolism following infusion, transfusion or therapeutic injection NE80.1 ABO incompatibility reaction NE80.2 Rh incompatibility reaction NE80.3 Other serum reactions NE80.Y Other specified injury or harm arising following infusion, transfusion or therapeutic injection, not elsewhere classified NE80.Z Injury or harm arising following infusion, transfusion or therapeutic injection, not elsewhere classified, unspecified NE81 Injury or harm arising from a procedure, not elsewhere classified NE81.0 Haemorrhage or haematoma complicating a procedure, not elsewhere classified NE81.1 Disruption of operation wound, not elsewhere classified NE81.2 Surgical site infection NE81.3 Postsurgical leak NE81.Y Other specified injury or harm arising from a procedure, not elsewhere classified NE81.Z Injury or harm arising from a procedure, not elsewhere classified, unspecified – NE81.00 Haematoma of surgical wound of skin – NE81.01 Haemorrhage and haematoma of eye or ocular adnexa complicating a procedure – NE81.0Z Haemorrhage or haematoma of other or unspecified site complicating a procedure, not elsewhere classified – NE81.20 Superficial incisional site infection – NE81.21 Deep incisional site infection – NE81.22 Organ or organ space surgical site infection – NE81.2Y Other specified surgical site infection – NE81.2Z Surgical site infection, unspecified NE82 Dysfunction or complication of pacemaker, pacemaker lead or implantable cardioverter defibrillator, not elsewhere classified NE82.0 Pacemaker or implantable cardioverter defibrillator complication NE82.1 Pacemaker or implantable cardioverter defibrillator dysfunction NE82.2 Pacemaker or implantable cardioverter defibrillator lead complication NE82.3 Pacemaker or implantable cardioverter defibrillator lead dysfunction NE82.Y Other specified dysfunction or complication of pacemaker, pacemaker lead or implantable cardioverter defibrillator, not elsewhere classified NE82.Z Dysfunction or complication of pacemaker, pacemaker lead or implantable cardioverter defibrillator, not elsewhere classified, unspecified – NE82.00 Pacemaker or implantable cardioverter defibrillator pocket erosion – NE82.01 Pacemaker or implantable cardioverter defibrillator pocket muscle stimulation – NE82.02 Pacemaker or implantable cardioverter defibrillator phrenic nerve stimulation – NE82.03 Pacing-induced cardiomyopathy – NE82.0Y Other specified pacemaker or implantable cardioverter defibrillator complication – NE82.0Z Pacemaker or implantable cardioverter defibrillator complication, unspecified – NE82.10 Inappropriate implantable cardioverter defibrillator shock – NE82.11 Pacemaker syndrome – NE82.12 Pacemaker generator dysfunction – NE82.1Y Other specified pacemaker or implantable cardioverter defibrillator dysfunction – NE82.1Z Pacemaker or implantable cardioverter defibrillator dysfunction, unspecified – NE82.20 Pacemaker or implantable cardioverter defibrillator lead fracture – NE82.21 Pacemaker or implantable cardioverter defibrillator lead dislodgement – NE82.22 Pacemaker or implantable cardioverter defibrillator lead insulation break – NE82.2Y Other specified pacemaker or implantable cardioverter defibrillator lead complication – NE82.2Z Pacemaker or implantable cardioverter defibrillator lead complication, unspecified NE83 Injury or harm arising from other device, implant or graft, not elsewhere classified NE83.0 Destruction or cartilage wear of joint with hemiarthroplasty NE83.1 Infection arising from device, implant or graft, not elsewhere classified NE83.Y Other specified injury or harm arising from other device, implant or graft, not elsewhere classified NE84 Failure or rejection of transplanted organs or tissues NE85 Complications peculiar to reattachment or amputation NE85.0 Complications of reattached upper extremity NE85.1 Complications of reattached lower extremity NE85.2 Complications of other reattached body part NE85.3 Neuroma of amputation stump NE85.4 Infection of amputation stump NE85.5 Necrosis of amputation stump NE85.6 Other or unspecified complications of amputation stump NE86 Malignant hyperthermia due to anaesthesia NE87 Failed or difficult intubation NE88 Drug toxicity associated with harm in surgical or medical care, not elsewhere classified NE89 Awareness under general anaesthesia NE8Y Other specified injury or harm arising from surgical or medical care, not elsewhere classified NE8Z Injury or harm arising from surgical or medical care, not elsewhere classified, unspecified NF00 Effects of radiation, not elsewhere classified NF01 Effects of heat NF01.0 Heat stroke NF01.1 Heat syncope NF01.2 Heat exhaustion due to fluid depletion NF01.3 Heat fatigue, transient NF01.Y Other specified effects of heat NF01.Z Effects of heat, unspecified NF02 Hypothermia NF03 Other effects of reduced temperature NF03.0 Chilblains NF03.1 Immersion hand or foot NF03.Y Other specified effects of reduced temperature NF03.Z Unspecified effects of reduced temperature NF04 Effects of air pressure or water pressure NF04.0 Otitic barotrauma NF04.1 Sinus barotrauma NF04.2 Caisson disease NF04.3 Effects of high-pressure fluids NF04.Y Other specified effects of air pressure or water pressure NF04.Z Effects of air pressure or water pressure, unspecified NF05 Asphyxiation NF06 Effects of strenuous physical exercise NF06.0 Exertional heat stroke NF06.1 Post exercise postural hypotension NF06.2 Post exertional dehydration NF06.3 Exercise muscle cramp NF06.Y Other specified effects of strenuous physical exercise NF06.Z Effects of strenuous physical exercise, unspecified NF07 Effects of other deprivation NF07.0 Effects of hunger NF07.1 Effects of thirst NF07.2 Exhaustion due to exposure NF07.Y Other specified effects of deprivation NF07.Z Effects of other deprivation, unspecified NF08 Effects of certain specified external causes NF08.0 Effects of lightning NF08.1 Drowning or nonfatal submersion NF08.2 Effects of vibration NF08.3 Motion sickness NF08.4 Effects of electric current – NF08.20 Hand and arm vibration syndrome – NF08.2Y Other specified effects of vibration – NF08.2Z Effects of vibration, unspecified NF09 Adverse effects, not elsewhere classified NF0A Certain early complications of trauma, not elsewhere classified NF0A.0 Air embolism, traumatic, not elsewhere classified NF0A.1 Fat embolism, traumatic, not elsewhere classified NF0A.2 Traumatic secondary or recurrent haemorrhage, not elsewhere classified NF0A.3 Post traumatic wound infection, not elsewhere classified NF0A.4 Traumatic shock, not elsewhere classified NF0A.5 Traumatic anuria, not elsewhere classified NF0A.6 Traumatic ischaemia of muscle, not elsewhere classified NF0A.7 Traumatic subcutaneous emphysema, not elsewhere classified NF0A.Y Other early complication of trauma, not elsewhere classified NF0A.Z Early complications of trauma, not elsewhere classified NF0Y Other specified effects of external causes NF0Z Unspecified effects of external causes NF2Y Other specified injury, poisoning or certain other consequences of external causes NF2Z Unspecified injury, poisoning or certain other consequences of external causes PL13 Mode of injury or harm associated with exposure to a drug, medicament or biological substance PL13.0 Overdose of substance, as mode of injury or harm PL13.1 Underdosing, as mode of injury or harm PL13.2 Drug-related injury or harm in the context of correct administration or dosage, as mode of injury or harm PL13.3 Incorrect substance, as mode of injury or harm PL13.5 Incorrect administration of drug or medicament, as mode of injury PL13.6 Medication or substance that is known to be an allergen, as mode of injury or harm PL13.7 Medication or substance that is known to be contraindicated for the patient, as mode of injury or harm PL13.8 Expired or deteriorated medication or substance, as mode of injury or harm PL13.9 Drug or substance interactions, as mode of injury or harm PL13.A Inappropriate stoppage or discontinuation of drug, as mode of injury or harm PL13.Y Other specified mode of injury or harm associated with exposure to a drug, medicament or biological substance PL13.Z Mode of injury or harm associated with exposure to a drug, medicament or biological substance, unspecified – PL13.50 Incorrect route of drug or medicament, as mode of injury – PL13.51 Incorrect rate of drug or medicament, as mode of injury – PL13.52 Incorrect timing of drug or medicament, as mode of injury – PL13.53 Incorrect duration of drug or medicament, as mode of injury – PL13.5Y Other specified incorrect administration of drug or medicament, as mode of injury – PL13.5Z Incorrect administration of drug or medicament, as mode of injury, unspecified
synonyms Drugs, medicaments or biological substances associated with injury or harm in therapeutic use Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Systemic antibiotics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Systemic antibiotics, Penicillins Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Systemic antibiotics, Cephalosporins or other beta-lactam antibiotics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Systemic antibiotics, Chloramphenicol group Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Systemic antibiotics, Macrolides Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Systemic antibiotics, Tetracyclines Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Systemic antibiotics, Aminoglycosides Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Systemic antibiotics, Rifamycins Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Systemic antibiotics, Antifungal antibiotics, systemically used Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Sulfonamides Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Antimycobacterial drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Antimalarials or drugs acting on other blood protozoa Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Other antiprotozoal drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Anthelminthics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Antiviral drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other systemic anti-infectives or antiparasitics, Other specified systemic anti-infectives or antiparasitics Injury or harm in therapeutic use by hydroxyquinoline derivatives Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Hormones or their synthetic substitutes or antagonists, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Hormones or their synthetic substitutes or antagonists, not elsewhere classified, Glucocorticoids or synthetic analogues Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Hormones or their synthetic substitutes or antagonists, not elsewhere classified, Thyroid hormones or substitutes Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Hormones or their synthetic substitutes or antagonists, not elsewhere classified, Antithyroid drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Hormones or their synthetic substitutes or antagonists, not elsewhere classified, Insulin or oral hypoglycaemic drugs Injury or harm in therapeutic use by insulin and oral hypoglycaemic [antidiabetic] drugs, Antidiabetic drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Hormones or their synthetic substitutes or antagonists, not elsewhere classified, Oral contraceptives Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Hormones or their synthetic substitutes or antagonists, not elsewhere classified, Other estrogens or progestogens Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Hormones or their synthetic substitutes or antagonists, not elsewhere classified, Antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified Injury or harm in therapeutic use by tamoxifen Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Hormones or their synthetic substitutes or antagonists, not elsewhere classified, Androgens or anabolic congeners Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Primarily systemic agents Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Primarily systemic agents, Antiallergic or antiemetic drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Primarily systemic agents, Antineoplastic antimetabolites Injury or harm in therapeutic use by cytarabine Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Primarily systemic agents, Antineoplastic natural products Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Primarily systemic agents, Other antineoplastic drugs Injury or harm in therapeutic use by antineoplastic antibiotics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Primarily systemic agents, Immunosuppressive agents Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Primarily systemic agents, Acidifying or alkalizing agents Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Primarily systemic agents, Enzymes, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting blood constituents Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting blood constituents, Iron preparations or other anti-hypochromic-anaemia preparations Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting blood constituents, Vitamin B, folic acid or other anti-megaloblastic-anaemia preparations Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting blood constituents, Anticoagulants Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting blood constituents, Anticoagulant antagonists, vitamin K or other coagulants Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting blood constituents, Antithrombotic drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting blood constituents, Thrombolytic drugs Injury or harm caused by tissue‐type plasminogen activator in therapeutic use Injury or harm caused by tPA [tissue‐type plasminogen activator] in therapeutic use Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting blood constituents, Natural blood or blood products Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting blood constituents, Plasma substitutes Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Analgesics, antipyretics or anti-inflammatory drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Analgesics, antipyretics or anti-inflammatory drugs, Opioids or related analgesics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Analgesics, antipyretics or anti-inflammatory drugs, Salicylates Injury or harm in therapeutic use of acetylsalicylic acid Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Analgesics, antipyretics or anti-inflammatory drugs, Propionic acid derivatives Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Analgesics, antipyretics or anti-inflammatory drugs, Other nonsteroidal anti-inflammatory drugs Other NSAID Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Analgesics, antipyretics or anti-inflammatory drugs, Antirheumatics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Analgesics, antipyretics or anti-inflammatory drugs, 4-Aminophenol derivatives Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs, Succinimides Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs, Oxazolidinediones Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs, Hydantoin derivatives Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs, Deoxybarbiturates Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs, Iminostilbenes Injury or harm in therapeutic use by carbamazepine Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs, Valproic acid Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs, Other or unspecified antiepileptics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs, Antiparkinsonism drugs Injury or harm in therapeutic use by amantadine Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Antiepileptics or antiparkinsonism drugs, Antispasticity drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Sedatives, hypnotics or antianxiety drugs Injury or harm in therapeutic use by sleeping draught NOS Injury or harm in therapeutic use by sleeping drug NOS Injury or harm in therapeutic use by sleeping tablet NOS Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Sedatives, hypnotics or antianxiety drugs, Barbiturates, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Sedatives, hypnotics or antianxiety drugs, Benzodiazepines Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Sedatives, hypnotics or antianxiety drugs, Cloral derivatives Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Sedatives, hypnotics or antianxiety drugs, Paraldehyde Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Sedatives, hypnotics or antianxiety drugs, Bromine compounds Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Sedatives, hypnotics or antianxiety drugs, Mixed sedatives or hypnotics, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Anaesthetics or therapeutic gases Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Anaesthetics or therapeutic gases, Inhaled anaesthetics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Anaesthetics or therapeutic gases, Parenteral anaesthetics Injury or harm in therapeutic use of thiobarbiturates Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Anaesthetics or therapeutic gases, Other or unspecified general anaesthetics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Anaesthetics or therapeutic gases, Local anaesthetics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Anaesthetics or therapeutic gases, Therapeutic gases Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Tricyclic or tetracyclic antidepressants Drugs medicaments or biological, substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Monoamine-oxidase-inhibitor antidepressants Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Other or unspecified antidepressants Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Phenothiazine antipsychotics or neuroleptics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Butyrophenone or thioxanthene neuroleptics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Other antipsychotics or neuroleptics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Psychodysleptics Injury or harm in therapeutic use of hallucinogens Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Psychotropic drugs, not elsewhere classified, Psychostimulants with abuse potential Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Central nervous system stimulants, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Central nervous system stimulants, not elsewhere classified, Analeptics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Central nervous system stimulants, not elsewhere classified, Opioid receptor antagonists Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Central nervous system stimulants, not elsewhere classified, Methylxanthines, not elsewhere classified Injury or harm in therapeutic use of caffeine Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Drugs primarily affecting the autonomic nervous system Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Drugs primarily affecting the autonomic nervous system, Anticholinesterase agents Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Drugs primarily affecting the autonomic nervous system, Other parasympathomimetics Injury or harm in therapeutic use of cholinergics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Drugs primarily affecting the autonomic nervous system, Ganglionic blocking drugs, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Drugs primarily affecting the autonomic nervous system, Other parasympatholytics or spasmolytics, not elsewhere classified Injury or harm in therapeutic use of anticholinergics or antimuscarinics Injury or harm in therapeutic use of papaverine Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Drugs primarily affecting the autonomic nervous system, Predominantly alpha-adrenoreceptor agonists, not elsewhere classified Injury or harm in therapeutic use of metaraminol Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Drugs primarily affecting the autonomic nervous system, Predominantly beta-adrenoreceptor agonists, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Drugs primarily affecting the autonomic nervous system, Alpha-adrenoreceptor antagonists, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Drugs primarily affecting the autonomic nervous system, Beta-adrenoreceptor antagonists, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Drugs primarily affecting the autonomic nervous system, Centrally acting or adrenergic-neuron-blocking agents, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Cardiac-stimulant glycosides or drugs of similar action Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Calcium-channel blockers Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Other antidysrhythmic drugs, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Coronary vasodilators, not elsewhere classified Injury or harm in therapeutic use of dipyridamole Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Angiotensin-converting-enzyme inhibitors Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Other antihypertensive drugs, not elsewhere classified Injury or harm in therapeutic use of clonidine Injury or harm in therapeutic use of guanethidine Injury or harm in therapeutic use of rauwolfia Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Antihyperlipidaemic or antiarteriosclerotic drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Peripheral vasodilators Injury or harm in therapeutic use by nicotinic acid derivatives Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the cardiovascular system, Antivaricose drugs, including sclerosing agents Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Histamine H-receptor antagonists histamine h 2 -receptor antagonists associated with injury or harm in therapeutic use Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Other antacids or anti-gastric-secretion drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Stimulant laxatives Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Saline or osmotic laxatives Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Other laxatives injury or harm in therapeutic use of intestinal atonia drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Digestants Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Antidiarrhoeal drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting the gastrointestinal system, Emetics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Mineralocorticoids Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Mineralocorticoid antagonists injury or harm in therapeutic use of aldosterone antagonists Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Carbonic-anhydrase inhibitors Injury or harm in therapeutic use of acetazolamide Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Benzothiadiazine derivatives Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Loop diuretics injury or harm in therapeutic use of high-ceiling diuretics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Other diuretics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Electrolytic, caloric or water-balance agents Injury or harm in therapeutic use of oral rehydration salts Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Agents affecting calcification Injury or harm in therapeutic use of parathyroid hormones or derivatives Injury or harm in therapeutic use of vitamin D group Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Agents affecting uric acid metabolism Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily affecting water-balance or mineral or uric acid metabolism, Mineral salts, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily acting on smooth or skeletal muscles or the respiratory system Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily acting on smooth or skeletal muscles or the respiratory system, Oxytocic drugs Injury or harm in therapeutic use of ergot alkaloids Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily acting on smooth or skeletal muscles or the respiratory system, Skeletal muscle relaxants injury or harm in therapeutic use of neuromuscular blocking agents Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily acting on smooth or skeletal muscles or the respiratory system, Other or unspecified agents primarily acting on muscles Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily acting on smooth or skeletal muscles or the respiratory system, Antitussives Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily acting on smooth or skeletal muscles or the respiratory system, Expectorants Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily acting on smooth or skeletal muscles or the respiratory system, Anti-common-cold drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily acting on smooth or skeletal muscles or the respiratory system, Antiasthmatics, not elsewhere classified Injury or harm in therapeutic use of aminophylline Injury or harm in therapeutic use of salbutamol Injury or harm in therapeutic use of theobromine Injury or harm in therapeutic use of theophylline Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Agents primarily acting on smooth or skeletal muscles or the respiratory system, Other or unspecified agents primarily acting on the respiratory system Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs, Local antifungal, anti-infective or anti-inflammatory drugs, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs, Antipruritics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs, Local astringents or local detergents Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs, Emollients, demulcents or protectants Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs, Keratolytics, keratoplastics or other hair treatment drugs or preparations Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs, Ophthalmological drugs or preparations Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological drugs or preparations or dental drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs, Dental drugs, topically applied Injury or harm in therapeutic use of glucocorticoids, topically used Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified drugs or medicaments Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified drugs or medicaments, Appetite depressants injury or harm in therapeutic use of anorectics Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified drugs or medicaments, Lipotropic drugs Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified drugs or medicaments, Antidotes or chelating agents, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified drugs or medicaments, Alcohol deterrents Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified drugs or medicaments, Pharmaceutical excipients Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified drugs or medicaments, X-ray contrast media Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified drugs or medicaments, Other diagnostic agents Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified drugs or medicaments, Vitamins, not elsewhere classified Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Bacterial vaccines Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Bacterial vaccines, BCG vaccine Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Bacterial vaccines, Typhoid or paratyphoid vaccine Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Bacterial vaccines, Cholera vaccine Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Bacterial vaccines, Plague vaccine Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Bacterial vaccines, Tetanus vaccine Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Bacterial vaccines, Diphtheria vaccine Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Bacterial vaccines, Pertussis vaccine, including combinations with a pertussis component Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Bacterial vaccines, Mixed bacterial vaccines, except combinations with a pertussis component Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified vaccines or biological substances Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified vaccines or biological substances, Viral vaccines Drugs, medicaments or biological substances associated with injury or harm in therapeutic use, COVID-19 vaccine Correct administration of COVID-19 vaccine in prophylactic therapeutic use as the cause of any adverse effect Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified vaccines or biological substances, Rickettsial vaccines Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified vaccines or biological substances, Protozoal vaccines Drugs medicaments or biological substances associated with injury or harm in therapeutic use, Other or unspecified vaccines or biological substances, Immunoglobulin
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com